,entities,start_tokens,end_tokens,start_chars,end_chars,text,pmid,olabel,orig_index,label,prob_0
0,adenomatous polyposis coli tumour,8,12,43,76,"Identification of APC2, a homologue of the adenomatous polyposis coli tumour suppressor.",10021369_0,-1,0,-1,0.1858847
1,adenomatous polyposis coli,1,4,5,31,"
The adenomatous polyposis coli (APC) tumour-suppressor protein controls the Wnt signalling pathway by forming a complex with glycogen synthase kinase 3beta (GSK-3beta), axin/conductin and betacatenin.",10021369_1,-1,1,-1,0.2022805
2,colon carcinoma,1,3,3,18,"In colon carcinoma cells, loss of APC leads to the accumulation of betacatenin in the nucleus, where it binds to and activates the Tcf-4 transcription factor (reviewed in [1] [2]).",10021369_3,-1,2,-1,0.16022518
3,colon carcinoma,22,24,153,168,"Like APC, APC2 regulates the formation of active betacatenin-Tcf complexes, as demonstrated using transient transcriptional activation assays in APC -/- colon carcinoma cells.",10021369_6,-1,3,-1,0.15394552
5,colorectal cancer,22,24,132,149,"A common MSH2 mutation in English and North American HNPCC families: origin, phenotypic expression, and sex specific differences in colorectal cancer.",10051005_0,-1,5,-1,0.13829349
6,cancer syndrome,22,24,153,168,"
The frequency, origin, and phenotypic expression of a germline MSH2 gene mutation previously identified in seven kindreds with hereditary non-polyposis cancer syndrome (HNPCC) was investigated.",10051005_1,-1,6,-1,0.15463762
7,colorectal cancer,10,12,60,77,"Although this mutation was initially detected in four of 33 colorectal cancer families analysed from eastern England, more extensive analysis has reduced the frequency to four of 52 (8%) English HNPCC kindreds analysed.",10051005_3,-1,7,-1,0.14371046
8,contrast,1,2,3,11,"In contrast, the MSH2 mutation was identified in 10 of 20 (50%) separately identified colorectal families from Newfoundland.",10051005_4,-1,8,-1,0.27254283
9,colorectal cancer,8,10,46,63,"To investigate the origin of this mutation in colorectal cancer families from England (n = 4), Newfoundland (n = 10), and the United States (n = 3), haplotype analysis using microsatellite markers linked to MSH2 was performed.",10051005_5,-1,9,-1,0.14615436
10,n,14,15,87,88,"To investigate the origin of this mutation in colorectal cancer families from England (n = 4), Newfoundland (n = 10), and the United States (n = 3), haplotype analysis using microsatellite markers linked to MSH2 was performed.",10051005_5,-1,10,-1,0.26345456
11,n,21,22,109,110,"To investigate the origin of this mutation in colorectal cancer families from England (n = 4), Newfoundland (n = 10), and the United States (n = 3), haplotype analysis using microsatellite markers linked to MSH2 was performed.",10051005_5,-1,11,-1,0.26164746
12,n,31,32,141,142,"To investigate the origin of this mutation in colorectal cancer families from England (n = 4), Newfoundland (n = 10), and the United States (n = 3), haplotype analysis using microsatellite markers linked to MSH2 was performed.",10051005_5,-1,12,-1,0.25897893
13,contrast,1,2,3,11,"In contrast, a common haplotype was identified at the two flanking markers (CA5 and D2S288) in eight of the Newfoundland families.",10051005_7,-1,13,-1,0.27622378
15,n,26,27,130,131,"We calculated age related risks of all, colorectal, endometrial, and ovarian cancers in nt943 + 3 A-- > T MSH2 mutation carriers (n = 76) for all patients and for men and women separately.",10051005_9,-1,15,-1,0.28718728
17,colorectal cancer,17,19,82,99,"For both sexes combined, the penetrances at age 60 years for all cancers  and for colorectal cancer were 0.",10051005_10,-1,17,-1,0.16007864
18,colorectal cancer,3,5,12,29,The risk of colorectal cancer was significantly higher (p < 0. 01) in males than females (0. 63 v 0. 30 and 0.,10051005_12,-1,18,-1,0.17180683
19,p,9,10,56,57,The risk of colorectal cancer was significantly higher (p < 0. 01) in males than females (0. 63 v 0. 30 and 0.,10051005_12,-1,19,-1,0.30125484
22,colorectal cancer,4,6,30,47,These intersex differences in colorectal cancer risks have implications for screening programmes and for attempts to identify colorectal cancer susceptibility modifiers.,10051005_16,-1,22,-1,0.14727044
23,colorectal cancer,17,19,126,143,These intersex differences in colorectal cancer risks have implications for screening programmes and for attempts to identify colorectal cancer susceptibility modifiers.,10051005_16,-1,23,-1,0.15608504
24,Huntington disease,4,6,16,34,Age of onset in Huntington disease : sex specific influence of apolipoprotein E genotype and normal CAG repeat length.,10051007_0,-1,24,-1,0.18981843
25,E,12,13,78,79,Age of onset in Huntington disease : sex specific influence of apolipoprotein E genotype and normal CAG repeat length.,10051007_0,-1,25,-1,0.24320276
26,Huntington disease,7,9,22,40,"
Age of onset (AO) of Huntington disease (HD) is known to be correlated with the length of an expanded CAG repeat in the HD gene.",10051007_1,-1,26,-1,0.2020913
27,E,1,2,15,16,"Apolipoprotein E (APOE) genotype, in turn, is known to influence AO in Alzheimer disease, rendering the APOE gene a likely candidate to affect AO in other neurological diseases too.",10051007_2,-1,27,-1,0.22659351
28,Alzheimer disease,16,18,71,88,"Apolipoprotein E (APOE) genotype, in turn, is known to influence AO in Alzheimer disease, rendering the APOE gene a likely candidate to affect AO in other neurological diseases too.",10051007_2,-1,28,-1,0.18791947
29,diseases,32,33,168,176,"Apolipoprotein E (APOE) genotype, in turn, is known to influence AO in Alzheimer disease, rendering the APOE gene a likely candidate to affect AO in other neurological diseases too.",10051007_2,-1,29,-1,0.16857849
30,blind,5,6,34,39,Genotyping for APOE was performed blind to clinical information.,10051007_4,-1,30,-1,0.30544803
31,neurodegeneration,11,12,66,83,Our findings suggest that subtle differences in the course of the neurodegeneration  in HD  may allow interacting genes to exert gender specific effects upon AO.,10051007_7,-1,31,-1,0.21486399
36,hemolytic,31,32,184,193,"
The serum of a 29-year old woman with a recent episode of disseminated gonococcal infection and a history of meningococcal meningitis and arthritis as a child was found to lack serum hemolytic complement activity.",100562_1,-1,36,-1,0.24199264
37,hemolytic,23,24,138,147,"The seventh component of complement (C7) was not detected by functional or immunochemical assays, whereas other components were normal by hemolytic and immunochemical assessment.",100562_2,-1,37,-1,0.24177037
38,hemolytic,27,28,192,201,"Her fresh serum lacked complement-mediated bactericidal activity against Neisseria gonorrhoeae, but the addition of fresh normal serum or purified C7 restored bactericidal activity as well as hemolytic activity.",100562_3,-1,38,-1,0.21051668
39,syndrome,14,15,74,82,Complete absence of C7 was also found in one sibling who had the clinical syndrome of meningococcal meningitis and arthritis  as a child and in this siblings clinically well eight-year-old son.,100562_6,-1,39,-1,0.23548779
44,cartilage-hair hypoplasia,7,9,47,72,Increased incidence of cancer in patients with cartilage-hair hypoplasia.,10064668_0,-1,44,-1,0.19726877
46,cartilage-hair hypoplasia,14,16,92,117,"
OBJECTIVE  Previous reports have suggested an increased risk of cancer among patients with cartilage-hair hypoplasia (CHH).",10064668_1,-1,46,-1,0.20114301
50,lymphoma,41,42,215,223,"RESULTS  A statistically significant excess risk of cancer was seen among the patients with CHH (standardized incidence ratio 6. 9, 95% confidence interval 2. 3 to 16), which was mainly attributable to non-Hodgkins lymphoma  (standardized incidence ratio 90, 95% confidence interval 18 to 264).",10064668_6,-1,50,-1,0.16954353
51,basal cell carcinoma,8,11,42,62,"In addition, a significant excess risk of basal cell carcinoma was seen (standardized incidence ratio 35, 95% confidence interval 7. 2 to 102).",10064668_7,-1,51,-1,0.17549641
55,lymphoma,13,14,86,94,"CONCLUSIONS  This study confirms an increased risk of cancer, especially non-Hodgkins lymphoma, probably attributable to defective immunity, among patients with CHH.",10064668_9,-1,55,-1,0.15196127
56,dihydropyrimidine dehydrogenase deficiency,6,9,40,82,Genotype and phenotype in patients with dihydropyrimidine dehydrogenase deficiency.,10071185_0,-1,56,-1,0.2096721
57,Dihydropyrimidine,0,1,1,18,"
Dihydropyrimidine dehydrogenase (DPD) deficiency is an autosomal recessive disease characterised by thymine-uraciluria in homozygous deficient patients and has been associated with a variable clinical phenotype.",10071185_1,-1,57,-1,0.2575516
58,disease,10,11,76,83,"
Dihydropyrimidine dehydrogenase (DPD) deficiency is an autosomal recessive disease characterised by thymine-uraciluria in homozygous deficient patients and has been associated with a variable clinical phenotype.",10071185_1,-1,58,-1,0.19246013
59,C,44,45,194,195,"In this group of patients, 7 different mutations have been identified, including 2 deletions [295-298delTCAT, 1897delC], 1 splice-site mutation [IVS14 + 1G > A)] and 4 missense mutations (85T > C, 703C > T, 2658G > A, 2983G > T).",10071185_3,-1,59,-1,0.3592287
60,703C,46,47,197,201,"In this group of patients, 7 different mutations have been identified, including 2 deletions [295-298delTCAT, 1897delC], 1 splice-site mutation [IVS14 + 1G > A)] and 4 missense mutations (85T > C, 703C > T, 2658G > A, 2983G > T).",10071185_3,-1,60,-1,0.33939764
62,mental retardation,15,17,99,117,"A large phenotypic variability has been observed, with convulsive disorders, motor retardation and mental retardation being the most abundant manifestations.",10071185_5,-1,62,-1,0.21569504
63,Borjeson-Forssman-Lehmann syndrome,17,19,99,133,"Fibroblast growth factor homologous factor 2 (FHF2): gene structure, expression and mapping to the Borjeson-Forssman-Lehmann syndrome region in Xq26 delineated by a duplication breakpoint in a BFLS-like patient.",10071193_0,-1,63,-1,0.22067119
64,Borjeson-Forssman-Lehmann syndrome,0,2,1,35,"
Borjeson-Forssman-Lehmann syndrome (BFLS) is a syndromal X-linked mental retardation, which maps by linkage to the q26 region of the human X chromosome.",10071193_1,-1,64,-1,0.21613725
65,mental retardation,9,11,67,85,"
Borjeson-Forssman-Lehmann syndrome (BFLS) is a syndromal X-linked mental retardation, which maps by linkage to the q26 region of the human X chromosome.",10071193_1,-1,65,-1,0.18114421
66,BFLS,20,21,126,130,The FHF2 gene localisation and tissue-specific expression pattern suggest it to be a candidate gene for familial cases of the BFLS syndrome and other syndromal and non-specific forms of X-linked mental retardation mapping to the region.,10071193_11,-1,66,-1,0.26899034
67,syndrome,21,22,131,139,The FHF2 gene localisation and tissue-specific expression pattern suggest it to be a candidate gene for familial cases of the BFLS syndrome and other syndromal and non-specific forms of X-linked mental retardation mapping to the region.,10071193_11,-1,67,-1,0.21203572
68,mental retardation,30,32,195,213,The FHF2 gene localisation and tissue-specific expression pattern suggest it to be a candidate gene for familial cases of the BFLS syndrome and other syndromal and non-specific forms of X-linked mental retardation mapping to the region.,10071193_11,-1,68,-1,0.19336513
69,gastric cancer,10,12,65,79,Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer.,10072428_0,-1,69,-1,0.13123377
70,colorectal cancer,13,15,84,101,Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer.,10072428_0,-1,70,-1,0.1445138
71,gastric cancer,18,20,113,127,"
Inherited mutations in the E-cadherin gene (CDH1) were described recently in three Maori kindreds with familial gastric cancer.",10072428_1,-1,71,-1,0.1295138
72,gastric cancer,1,3,9,23,Familial gastric cancer is genetically heterogeneous and it is not clear what proportion of gastric cancer susceptibility in non-Maori populations is due to germline CDH1 mutations.,10072428_2,-1,72,-1,0.13510102
73,gastric cancer,14,16,92,106,Familial gastric cancer is genetically heterogeneous and it is not clear what proportion of gastric cancer susceptibility in non-Maori populations is due to germline CDH1 mutations.,10072428_2,-1,73,-1,0.1428733
74,gastric cancer,6,8,38,52,"Therefore, we screened eight familial gastric cancer kindreds of British and Irish origin for germline CDH1 mutations, by SSCP analysis of all 16 exons and flanking sequences.",10072428_3,-1,74,-1,0.12855291
75,gastric cancer,10,12,40,54,Each family contained  (i) two cases of gastric cancer in first degree relatives with one affected before age 50 years; or (ii) three or more cases of gastric cancer.,10072428_4,-1,75,-1,0.14897712
76,gastric cancer,33,35,151,165,Each family contained  (i) two cases of gastric cancer in first degree relatives with one affected before age 50 years; or (ii) three or more cases of gastric cancer.,10072428_4,-1,76,-1,0.15342753
77,colorectal cancer,14,16,90,107,"In one family there was evidence of non-penetrance and susceptibility to both gastric and colorectal cancer; thus, in addition to six cases of gastric cancer, a CDH1 mutation carrier developed colorectal cancer at age 30 years.",10072428_7,-1,77,-1,0.14119844
78,gastric cancer,25,27,143,157,"In one family there was evidence of non-penetrance and susceptibility to both gastric and colorectal cancer; thus, in addition to six cases of gastric cancer, a CDH1 mutation carrier developed colorectal cancer at age 30 years.",10072428_7,-1,78,-1,0.14343074
79,colorectal cancer,33,35,193,210,"In one family there was evidence of non-penetrance and susceptibility to both gastric and colorectal cancer; thus, in addition to six cases of gastric cancer, a CDH1 mutation carrier developed colorectal cancer at age 30 years.",10072428_7,-1,79,-1,0.14357257
80,gastric cancer,12,14,74,88,We have confirmed that germline mutations in the CDH1 gene cause familial gastric cancer in non-Maori populations.,10072428_8,-1,80,-1,0.13076472
83,colorectal cancer,30,32,199,216,"Loss of E-cadherin function has been implicated in the pathogenesis of sporadic colorectal and other cancers, and our findings provide evidence that germline CDH1 mutations predispose to early onset colorectal cancer.",10072428_10,-1,83,-1,0.13246556
85,zinc,1,2,2,6,A zinc finger truncation of murine WT1 results in the characteristic urogenital abnormalities of Denys-Drash syndrome .,10077614_0,-1,85,-1,0.25796017
86,urogenital abnormalities,11,13,69,93,A zinc finger truncation of murine WT1 results in the characteristic urogenital abnormalities of Denys-Drash syndrome .,10077614_0,-1,86,-1,0.21214144
87,Denys-Drash syndrome,14,16,97,117,A zinc finger truncation of murine WT1 results in the characteristic urogenital abnormalities of Denys-Drash syndrome .,10077614_0,-1,87,-1,0.22584282
88,Wilms,1,2,5,10,"
The Wilms tumor -suppressor gene, WT1, plays a key role in urogenital development, and WT1 dysfunction is implicated in both neoplastic (Wilms tumor, mesothelioma, leukemias, and breast cancer) and nonneoplastic (glomerulosclerosis) disease.",10077614_1,-1,88,-1,0.18442243
89,Wilms tumor,25,27,138,149,"
The Wilms tumor -suppressor gene, WT1, plays a key role in urogenital development, and WT1 dysfunction is implicated in both neoplastic (Wilms tumor, mesothelioma, leukemias, and breast cancer) and nonneoplastic (glomerulosclerosis) disease.",10077614_1,-1,89,-1,0.1743881
90,mesothelioma,28,29,151,163,"
The Wilms tumor -suppressor gene, WT1, plays a key role in urogenital development, and WT1 dysfunction is implicated in both neoplastic (Wilms tumor, mesothelioma, leukemias, and breast cancer) and nonneoplastic (glomerulosclerosis) disease.",10077614_1,-1,90,-1,0.17877604
93,disease,41,42,234,241,"
The Wilms tumor -suppressor gene, WT1, plays a key role in urogenital development, and WT1 dysfunction is implicated in both neoplastic (Wilms tumor, mesothelioma, leukemias, and breast cancer) and nonneoplastic (glomerulosclerosis) disease.",10077614_1,-1,93,-1,0.18414107
94,diseases,3,4,16,24,"The analysis of diseases linked specifically with WT1 mutations, such as Denys-Drash syndrome (DDS), can provide valuable insight concerning the role of WT1 in development and disease.",10077614_2,-1,94,-1,0.16781288
95,Denys-Drash syndrome,12,14,73,93,"The analysis of diseases linked specifically with WT1 mutations, such as Denys-Drash syndrome (DDS), can provide valuable insight concerning the role of WT1 in development and disease.",10077614_2,-1,95,-1,0.21990365
96,disease,30,31,176,183,"The analysis of diseases linked specifically with WT1 mutations, such as Denys-Drash syndrome (DDS), can provide valuable insight concerning the role of WT1 in development and disease.",10077614_2,-1,96,-1,0.16957861
97,disease,5,6,24,31,"DDS is a rare childhood disease characterized by a nephropathy involving mesangial sclerosis, XY pseudohermaphroditism, and/or Wilms tumor (WT).",10077614_3,-1,97,-1,0.19952099
99,sclerosis,12,13,83,92,"DDS is a rare childhood disease characterized by a nephropathy involving mesangial sclerosis, XY pseudohermaphroditism, and/or Wilms tumor (WT).",10077614_3,-1,99,-1,0.23393172
100,Wilms tumor,18,20,127,138,"DDS is a rare childhood disease characterized by a nephropathy involving mesangial sclerosis, XY pseudohermaphroditism, and/or Wilms tumor (WT).",10077614_3,-1,100,-1,0.21501943
101,zinc,23,24,162,166,"DDS patients are constitutionally heterozygous for exonic point mutations in WT1, which include mutations predicted to truncate the protein within the C-terminal zinc finger (ZF) region.",10077614_4,-1,101,-1,0.24146686
102,sclerosis,25,26,130,139,"We report that heterozygosity for a targeted murine Wt1 allele, Wt1 (tmT396), which truncates ZF3 at codon 396, induces mesangial sclerosis characteristic of DDS in adult heterozygous and chimeric mice.",10077614_5,-1,102,-1,0.21646756
103,Wilms tumor,13,15,70,81,"Male genital defects also were evident and there was a single case of Wilms tumor in which the transcript of the nontargeted allele showed an exon 9 skipping event, implying a causal link between Wt1 dysfunction and Wilms tumorigenesis in mice.",10077614_6,-1,103,-1,0.17479333
104,iron,3,4,23,27,Mechanism of increased iron absorption in murine model of hereditary hemochromatosis : increased duodenal expression of the iron transporter DMT1.,10077651_0,-1,104,-1,0.2153847
105,hemochromatosis,10,11,69,84,Mechanism of increased iron absorption in murine model of hereditary hemochromatosis : increased duodenal expression of the iron transporter DMT1.,10077651_0,-1,105,-1,0.17267068
106,iron,17,18,124,128,Mechanism of increased iron absorption in murine model of hereditary hemochromatosis : increased duodenal expression of the iron transporter DMT1.,10077651_0,-1,106,-1,0.21247895
107,hemochromatosis,1,2,12,27,"
Hereditary hemochromatosis (HH) is a common autosomal recessive disorder characterized by tissue iron deposition secondary to excessive dietary iron absorption.",10077651_1,-1,107,-1,0.17244092
108,iron,14,15,98,102,"
Hereditary hemochromatosis (HH) is a common autosomal recessive disorder characterized by tissue iron deposition secondary to excessive dietary iron absorption.",10077651_1,-1,108,-1,0.19577038
109,iron,20,21,145,149,"
Hereditary hemochromatosis (HH) is a common autosomal recessive disorder characterized by tissue iron deposition secondary to excessive dietary iron absorption.",10077651_1,-1,109,-1,0.20154962
110,iron,37,38,223,227,"We recently reported that HFE, the protein defective in HH, was physically associated with the transferrin receptor (TfR) in duodenal crypt cells and proposed that mutations in HFE attenuate the uptake of transferrin-bound iron from plasma by duodenal crypt cells, leading to up-regulation of transporters for dietary iron.",10077651_2,-1,110,-1,0.20111696
111,iron,52,53,318,322,"We recently reported that HFE, the protein defective in HH, was physically associated with the transferrin receptor (TfR) in duodenal crypt cells and proposed that mutations in HFE attenuate the uptake of transferrin-bound iron from plasma by duodenal crypt cells, leading to up-regulation of transporters for dietary iron.",10077651_2,-1,111,-1,0.20411752
112,iron,10,11,48,52,"By 4 weeks of age, the HFE-/- mice demonstrated iron loading when compared with HFE +/+ littermates, with elevated transferrin saturations (68. 4% vs. 49. 8%) and elevated liver iron concentrations (985 micrograms vs. 381 micrograms).",10077651_4,-1,112,-1,0.22931723
113,iron,38,39,178,182,"By 4 weeks of age, the HFE-/- mice demonstrated iron loading when compared with HFE +/+ littermates, with elevated transferrin saturations (68. 4% vs. 49. 8%) and elevated liver iron concentrations (985 micrograms vs. 381 micrograms).",10077651_4,-1,113,-1,0.23670405
114,iron,20,21,123,127,"By using Northern blot analyses, we quantitated duodenal expression of both classes of DMT1 transcripts  one containing an iron responsive element (IRE), called DMT1 (IRE), and one containing no IRE, called DMT1 (non-IRE).",10077651_5,-1,114,-1,0.23398277
115,iron,12,13,74,78,The positive control for DMT1 up-regulation was a murine model of dietary iron deficiency that demonstrated greatly increased levels of duodenal DMT1 (IRE) mRNA.,10077651_6,-1,115,-1,0.19896574
116,iron,27,28,149,153,"HFE-/- mice also demonstrated an increase in duodenal DMT1 (IRE) mRNA (average 7. 7-fold), despite their elevated transferrin saturation and hepatic iron content.",10077651_7,-1,116,-1,0.23910628
117,lead,11,12,59,63,"These data support the model for HH in which HFE mutations lead to inappropriately low crypt cell iron, with resultant stabilization of DMT1 (IRE) mRNA, up-regulation of DMT1, and increased absorption of dietary iron.",10077651_9,-1,117,-1,0.25085914
118,iron,17,18,98,102,"These data support the model for HH in which HFE mutations lead to inappropriately low crypt cell iron, with resultant stabilization of DMT1 (IRE) mRNA, up-regulation of DMT1, and increased absorption of dietary iron.",10077651_9,-1,118,-1,0.2387442
119,iron,38,39,212,216,"These data support the model for HH in which HFE mutations lead to inappropriately low crypt cell iron, with resultant stabilization of DMT1 (IRE) mRNA, up-regulation of DMT1, and increased absorption of dietary iron.",10077651_9,-1,119,-1,0.21267086
120,adrenoleukodystrophy,8,9,73,93,Neurophysiologic follow-up of long-term dietary treatment in adult-onset adrenoleukodystrophy.,10078732_0,-1,120,-1,0.20358425
121,adrenoleukodystrophy,11,12,71,91,"
OBJECTIVE  To monitor the effects of dietary treatment in adult-onset adrenoleukodystrophy (ALD) by means of somatosensory evoked potentials (SEPs) and motor evoked potentials (MEPs).",10078732_1,-1,121,-1,0.2022949
122,disease,26,27,170,177,"After treatment, the three patients with pure spinal abnormalities showed clinical and neurophysiologic worsening, whereas the two patients with a more advanced stage of disease (exhibited by SEPs) showed substantially unchanged clinical and neurophysiologic features.",10078732_6,-1,122,-1,0.1947421
123,disease,22,23,137,144,"Moreover, in patients without clear signs of inflammatory damage, this treatment does not modify significantly the natural course of the disease.",10078732_9,-1,123,-1,0.23111364
124,oromandibular dystonia,7,9,44,66,GCH1 mutation in a patient with adult-onset oromandibular dystonia.,10078749_0,-1,124,-1,0.19260553
125,oromandibular dystonia,15,17,79,101,"
The authors report a mutation in exon 5 of GCH1 in a patient with adult-onset oromandibular dystonia and no obvious family history of dystonia.",10078749_1,-1,125,-1,0.19859901
127,dystonic,13,14,88,96,These findings demonstrate that GCH1 mutations must be considered even in patients with dystonic symptoms not typical of dopa-responsive dystonia.,10078749_3,-1,127,-1,0.17545356
129,adenomatous polyposis coli,27,30,169,195,"
We extensively analyzed genomic DNA and messenger RNA (mRNA) from 62 unrelated Korean patients with familial adenomatous polyposis (FAP) for identification of germline adenomatous polyposis coli (APC) gene mutations.",10083733_1,-1,129,-1,0.20260836
130,C9 deficiency,3,5,26,39,Molecular epidemiology of C9 deficiency heterozygotes with an Arg95Stop mutation of the C9 gene in Japan.,10083734_0,-1,130,-1,0.28910765
131,C9 deficiency,4,6,29,42,Genetic analyses of Japanese C9 deficiency have shown that a C-to-T transition leading to TGA stop codon for Arg95 in exon 4 of the C9 gene (Arg95Stop) is common in Japanese C9 deficiency.,10083734_2,-1,131,-1,0.26092497
132,C9 deficiency,33,35,174,187,Genetic analyses of Japanese C9 deficiency have shown that a C-to-T transition leading to TGA stop codon for Arg95 in exon 4 of the C9 gene (Arg95Stop) is common in Japanese C9 deficiency.,10083734_2,-1,132,-1,0.2723717
133,C9 deficiency,11,13,44,57,An estimated frequency (0. 12%) of complete C9 deficiency due to homozygous Arg95Stop mutation was consistent with frequencies determined by serological studies,10083734_9,-1,133,-1,0.27594846
134,hemochromatosis,2,3,15,30,"The hereditary hemochromatosis protein, HFE, specifically regulates transferrin-mediated iron uptake in HeLa cells.",10085150_0,-1,134,-1,0.17252496
135,iron,10,11,89,93,"The hereditary hemochromatosis protein, HFE, specifically regulates transferrin-mediated iron uptake in HeLa cells.",10085150_0,-1,135,-1,0.19626364
136,disease,13,14,75,82,"
HFE is the protein product of the gene mutated in the autosomal recessive disease hereditary hemochromatosis (Feder, J. N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D. A., Basava, A., Dormishian, F., Domingo, R. J., Ellis, M. C., Fullan, A., Hinton, L. M., Jones, N. L., Kimmel, B. E., Kronmal, G. S., Lauer, P., Lee, V. K., Loeb, D. B., Mapa, F. A., McClelland, E., Meyer, N. C., Mintier, G. A., Moeller, N., Moore, T., Morikang, E., Prasss, C. E ., Quintana, L., Starnes, S. M ., Schatzman, R. C ., Brunke, K. J ., Drayna, D. T., Risch, N. J ., Bacon, B. R ., and Wolff, R. R . (1996) Nat.",10085150_1,-1,136,-1,0.21928704
137,hemochromatosis,15,16,94,109,"
HFE is the protein product of the gene mutated in the autosomal recessive disease hereditary hemochromatosis (Feder, J. N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D. A., Basava, A., Dormishian, F., Domingo, R. J., Ellis, M. C., Fullan, A., Hinton, L. M., Jones, N. L., Kimmel, B. E., Kronmal, G. S., Lauer, P., Lee, V. K., Loeb, D. B., Mapa, F. A., McClelland, E., Meyer, N. C., Mintier, G. A., Moeller, N., Moore, T., Morikang, E., Prasss, C. E ., Quintana, L., Starnes, S. M ., Schatzman, R. C ., Brunke, K. J ., Drayna, D. T., Risch, N. J ., Bacon, B. R ., and Wolff, R. R . (1996) Nat.",10085150_1,-1,137,-1,0.20043756
138,E,129,130,454,455,"
HFE is the protein product of the gene mutated in the autosomal recessive disease hereditary hemochromatosis (Feder, J. N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D. A., Basava, A., Dormishian, F., Domingo, R. J., Ellis, M. C., Fullan, A., Hinton, L. M., Jones, N. L., Kimmel, B. E., Kronmal, G. S., Lauer, P., Lee, V. K., Loeb, D. B., Mapa, F. A., McClelland, E., Meyer, N. C., Mintier, G. A., Moeller, N., Moore, T., Morikang, E., Prasss, C. E ., Quintana, L., Starnes, S. M ., Schatzman, R. C ., Brunke, K. J ., Drayna, D. T., Risch, N. J ., Bacon, B. R ., and Wolff, R. R . (1996) Nat.",10085150_1,-1,138,-1,0.35848013
139,tetracycline,14,15,71,83,"Using a HeLa cell line in which the expression of HFE is controlled by tetracycline, we show that the expression of HFE reduces 55Fe uptake from Tf by 33% but does not affect the endocytic or exocytic rates of TfR cycling.",10085150_8,-1,139,-1,0.220809
140,iron,9,10,57,61,"Therefore, HFE appears to reduce cellular acquisition of iron from Tf within endocytic compartments.",10085150_9,-1,140,-1,0.24554874
141,iron,3,4,25,29,"HFE specifically reduces iron uptake from Tf, as non-Tf-mediated iron uptake from Fe-nitrilotriacetic acid is not altered.",10085150_10,-1,141,-1,0.23302644
142,iron,10,11,65,69,"HFE specifically reduces iron uptake from Tf, as non-Tf-mediated iron uptake from Fe-nitrilotriacetic acid is not altered.",10085150_10,-1,142,-1,0.23892133
143,iron,25,26,157,161,These results explain the decreased ferritin levels seen in our HeLa cell system and demonstrate the specific control of HFE over the Tf-mediated pathway of iron uptake.,10085150_11,-1,143,-1,0.21747018
144,iron,10,11,71,75,"These results also have implications for the understanding of cellular iron homeostasis in organs such as the liver, pancreas, heart, and spleen that are iron loaded in hereditary hemochromatotic individuals lacking functional HFE.",10085150_12,-1,144,-1,0.20435148
145,iron,27,28,154,158,"These results also have implications for the understanding of cellular iron homeostasis in organs such as the liver, pancreas, heart, and spleen that are iron loaded in hereditary hemochromatotic individuals lacking functional HFE.",10085150_12,-1,145,-1,0.21403603
146,familial Mediterranean fever,5,8,34,62,Mutation and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Ashkenazi Jewish population.,10090880_0,-1,146,-1,0.20775507
147,Familial Mediterranean fever,0,3,1,29,"
Familial Mediterranean fever (FMF) is a recessive disorder characterized by episodes of fever with serositis or synovitis.",10090880_1,-1,147,-1,0.20242523
149,serositis,16,17,100,109,"
Familial Mediterranean fever (FMF) is a recessive disorder characterized by episodes of fever with serositis or synovitis.",10090880_1,-1,149,-1,0.1861635
150,synovitis,18,19,113,122,"
Familial Mediterranean fever (FMF) is a recessive disorder characterized by episodes of fever with serositis or synovitis.",10090880_1,-1,150,-1,0.19758129
151,Autoimmune lymphoproliferative syndrome,0,3,0,39,Autoimmune lymphoproliferative syndrome  with defective Fas: genotype influences penetrance.,10090885_0,-1,151,-1,0.17164838
152,Autoimmune lymphoproliferative syndrome,0,3,1,40,"
Autoimmune lymphoproliferative syndrome (ALPS) is a disorder of lymphocyte homeostasis and immunological tolerance.",10090885_1,-1,152,-1,0.167564
154,hemochromatosis,3,4,23,38,Multicentric origin of hemochromatosis gene (HFE) mutations.,10090890_0,-1,154,-1,0.18913628
155,hemochromatosis,1,2,9,24,"
Genetic hemochromatosis (GH) is believed to be a disease restricted to those of European ancestry.",10090890_1,-1,155,-1,0.1919645
156,disease,10,11,50,57,"
Genetic hemochromatosis (GH) is believed to be a disease restricted to those of European ancestry.",10090890_1,-1,156,-1,0.21814379
157,tyrosine,19,20,98,106,"In northwestern Europe, > 80% of GH patients are homozygous for one mutation, the substitution of tyrosine for cysteine at position 282 (C282Y) in the unprocessed protein.",10090890_2,-1,157,-1,0.25026536
158,cysteine,21,22,111,119,"In northwestern Europe, > 80% of GH patients are homozygous for one mutation, the substitution of tyrosine for cysteine at position 282 (C282Y) in the unprocessed protein.",10090890_2,-1,158,-1,0.27157074
159,disease,25,26,142,149,The clinical significance of this second mutation is such that it appears to predispose 1% -2% of compound heterozygotes to expression of the disease.,10090890_4,-1,159,-1,0.22207731
160,Mb,12,13,60,62,"The C282Y mutation occurs on a haplotype that extends </= 6 Mb, suggesting that this mutation has arisen during the past 2, 000 years.",10090890_6,-1,160,-1,0.23856187
161,diseases,8,9,53,61,"These selection pressures could be due to infectious diseases, environmental conditions,  or other genetic disorders such as anemia.",10090890_11,-1,161,-1,0.17637758
163,hemochromatosis,29,30,180,195,"
We have retrospectively analyzed 837 random anonymized dried blood spot (DBS) samples from neonatal screening programs in Scandinavia for mutations in HFE, the candidate gene for hemochromatosis.",10094552_1,-1,163,-1,0.19461437
164,alkaptonuria,6,7,38,50,Identification of the mutation in the alkaptonuria mouse model.,10094559_0,-1,164,-1,0.27920726
165,Alkaptonuria,0,1,1,13,"
Alkaptonuria (aku), an inborn error of metabolism caused by the loss of homogentisate 1, 2-dioxygenase (HGD), has been described in a mouse model created by ethylnitrosourea mutagenesis but the mutation in these mice has not previously been identified.",10094559_1,-1,165,-1,0.27721936
166,hearing loss,1,3,14,26,Non-syndromic hearing loss associated with enlarged vestibular aqueduct is caused by PDS mutations.,10190331_0,-1,166,-1,0.18197237
168,Pendred syndrome,22,24,125,141,"The locus for non-syndromic sensorineural hearing loss with EVA has been mapped to the same chromosomal region, 7q31, as the Pendred syndrome locus.",10190331_2,-1,168,-1,0.2124449
169,Pendred syndrome,19,21,86,102,"In the present study, seven mutations in the PDS gene (PDS), the gene responsible for Pendred syndrome, have been found in families of non-syndromic sensorineural hearing loss with EVA.",10190331_3,-1,169,-1,0.21666257
171,hearing loss,14,16,98,110,The present results provide evidence that mutations in PDS cause both syndromic and non-syndromic hearing loss..,10190331_5,-1,171,-1,0.17956373
172,adrenoleukodystrophy,12,13,103,123,Mutational analysis and genotype-phenotype correlation of 29 unrelated Japanese patients with X-linked adrenoleukodystrophy.,10190819_0,-1,172,-1,0.19451462
173,adrenoleukodystrophy,3,4,22,42,"
BACKGROUND  X-linked adrenoleukodystrophy (ALD) is an inherited disease characterized by progressive neurologic dysfunction, occasionally associated with adrenal insufficiency.",10190819_1,-1,173,-1,0.1981397
174,disease,10,11,65,72,"
BACKGROUND  X-linked adrenoleukodystrophy (ALD) is an inherited disease characterized by progressive neurologic dysfunction, occasionally associated with adrenal insufficiency.",10190819_1,-1,174,-1,0.19517972
175,adrenal insufficiency,20,22,155,176,"
BACKGROUND  X-linked adrenoleukodystrophy (ALD) is an inherited disease characterized by progressive neurologic dysfunction, occasionally associated with adrenal insufficiency.",10190819_1,-1,175,-1,0.1770257
176,neurologic deterioration,18,20,92,116,"The classic form of ALD usually has onset in childhood (childhood cerebral ALD), with rapid neurologic deterioration leading to a vegetative state.",10190819_2,-1,176,-1,0.20084877
177,Addison disease,6,8,52,67,Milder phenotypes such as adrenomyeloneuropathy and Addison disease only also have been recognized.,10190819_4,-1,177,-1,0.2061269
178,nucleotide,19,20,130,140,"We conducted detailed mutational analyses of 29 unrelated Japanese patients with ALD by genomic Southern blot analysis and direct nucleotide sequence analysis of reverse transcriptase-polymerase chain reaction products derived from total RNA that was extracted from cultured skin fibroblasts, lymphoblastoid cells, or peripheral blood leukocytes.",10190819_8,-1,178,-1,0.2772532
179,nucleotide,19,20,126,136,"The remaining 26 patients were identified as having 21 independent mutations, including 12 novel mutations resulting in small nucleotide alterations in the ALD gene.",10190819_10,-1,179,-1,0.24470878
180,amino acids,4,6,33,44,"Most missense mutations involved amino acids conserved in homologous gene products, including PMP70, mALDRP, and Pxa1p.",10190819_12,-1,180,-1,0.27783173
181,AG,1,2,4,6,"The AG dinucleotide deletion at position 1081-1082, which has been reported previously to be the most common mutation in white patients (12% -17%), was also identified as the most common mutation in Japanese patients (12%).",10190819_13,-1,181,-1,0.35102838
182,amino acid,12,14,88,98,All phenotypes were associated with mutations resulting in protein truncation or subtle amino acid changes.,10190819_14,-1,182,-1,0.29227656
183,amino acids,12,14,99,110,There were no differences in phenotypic expressions between missense mutations involving conserved amino acids and those involving nonconserved amino acids.,10190819_15,-1,183,-1,0.29342598
184,amino acids,18,20,144,155,There were no differences in phenotypic expressions between missense mutations involving conserved amino acids and those involving nonconserved amino acids.,10190819_15,-1,184,-1,0.28204575
185,tumour,4,5,20,26,A common human skin tumour is caused by activating mutations in beta-catenin.,10192393_0,-1,185,-1,0.16945183
186,lead,19,20,122,126,"One of the target genes for beta-catenin/TCF encodes c-MYC, explaining why constitutive activation of the WNT pathway can lead to cancer, particularly in the colon.",10192393_3,-1,186,-1,0.21900249
189,adenomatous polyposis coli,10,13,61,87,"Most colon cancers arise from mutations in the gene encoding adenomatous polyposis coli (APC), a protein required for ubiquitin-mediated degradation of beta-catenin, but a small percentage of colon and some other cancers harbour beta-catenin-stabilizing mutations.",10192393_4,-1,189,-1,0.19709823
191,tumours,16,17,117,124,"Recently, we discovered that transgenic mice expressing an activated beta-catenin are predisposed to developing skin tumours resembling pilomatricomas.",10192393_5,-1,191,-1,0.15168858
192,tumour,14,15,73,79,"Here, we explore the cell origin and aetiology of this common human skin tumour.",10192393_7,-1,192,-1,0.1973487
193,tumour,7,8,39,45,"We found nuclear LEF-1 in the dividing tumour cells, providing biochemical evidence that pilomatricomas are derived from hair matrix cells.",10192393_8,-1,193,-1,0.18341133
194,tumours,6,7,22,29,"At least 75% of these tumours possess mutations affecting the amino-terminal segment, normally involved in phosphorylation-dependent, ubiquitin-mediated degradation of the protein.",10192393_9,-1,194,-1,0.22488372
195,tumours,12,13,71,78,"This percentage of CTNNB1 mutations is greater than in all other human tumours examined thus far, and directly implicates beta-catenin/LEF misregulation as the major cause of hair matrix cell tumorigenesis in humans..",10192393_10,-1,195,-1,0.15485212
196,Pendred syndrome,1,3,4,20,The Pendred syndrome gene encodes a chloride-iodide transport protein.,10192399_0,-1,196,-1,0.22365065
197,Pendred syndrome,0,2,1,17,"
Pendred syndrome is the most common form of syndromic deafness and characterized by congenital sensorineural hearing loss and goitre.",10192399_1,-1,197,-1,0.22360545
198,deafness,9,10,55,63,"
Pendred syndrome is the most common form of syndromic deafness and characterized by congenital sensorineural hearing loss and goitre.",10192399_1,-1,198,-1,0.21782292
200,Pendred syndrome,11,13,62,78,This disorder was mapped to chromosome 7 and the gene causing Pendred syndrome (PDS) was subsequently identified by positional cloning.,10192399_2,-1,200,-1,0.22253864
201,amino acid,24,26,140,150,"Pendrin is closely related to a family of sulfate transport proteins that includes the rat sulfate-anion transporter (encoded by Sat-1; 29% amino acid sequence identity), the human diastrophic dysplasia sulfate transporter (encoded by DTD; 32%) and the human sulfate transporter downregulated in adenoma (encoded by DRA; 45%).",10192399_4,-1,201,-1,0.32738477
202,diastrophic dysplasia,32,34,181,202,"Pendrin is closely related to a family of sulfate transport proteins that includes the rat sulfate-anion transporter (encoded by Sat-1; 29% amino acid sequence identity), the human diastrophic dysplasia sulfate transporter (encoded by DTD; 32%) and the human sulfate transporter downregulated in adenoma (encoded by DRA; 45%).",10192399_4,-1,202,-1,0.26570043
203,adenoma,51,52,296,303,"Pendrin is closely related to a family of sulfate transport proteins that includes the rat sulfate-anion transporter (encoded by Sat-1; 29% amino acid sequence identity), the human diastrophic dysplasia sulfate transporter (encoded by DTD; 32%) and the human sulfate transporter downregulated in adenoma (encoded by DRA; 45%).",10192399_4,-1,203,-1,0.23625004
205,chloride,7,8,38,46,The rates of transport for iodide and chloride were significantly increased following the expression of pendrin in both cell systems.,10192399_7,-1,205,-1,0.24847876
206,chloride,10,11,67,75,"Our results demonstrate that pendrin functions as a transporter of chloride and iodide, but not sulfate, and may provide insight into thyroid physiology and the pathophysiology of Pendred syndrome..",10192399_8,-1,206,-1,0.25081575
207,Pendred syndrome,29,31,180,196,"Our results demonstrate that pendrin functions as a transporter of chloride and iodide, but not sulfate, and may provide insight into thyroid physiology and the pathophysiology of Pendred syndrome..",10192399_8,-1,207,-1,0.21027377
208,hemochromatosis,5,6,30,45,HFE mutations analysis in 711 hemochromatosis probands: evidence for S65C implication in mild form of hemochromatosis.,10194428_0,-1,208,-1,0.19077091
209,hemochromatosis,16,17,102,117,HFE mutations analysis in 711 hemochromatosis probands: evidence for S65C implication in mild form of hemochromatosis.,10194428_0,-1,209,-1,0.19463418
210,hemochromatosis,1,2,12,27,"
Hereditary hemochromatosis (HH) is a common autosomal recessive genetic disorder of iron metabolism.",10194428_1,-1,210,-1,0.17293951
211,iron,13,14,85,89,"
Hereditary hemochromatosis (HH) is a common autosomal recessive genetic disorder of iron metabolism.",10194428_1,-1,211,-1,0.20837967
212,disease,32,33,152,159,"Two missense mutations have been described  C282Y, accounting for 80% to 90% of HH chromosomes, and H63D, which is associated with a milder form of the disease representing 40% to 70% of non-C282Y HH chromosomes.",10194428_3,-1,212,-1,0.2121947
213,hemochromatosis,13,14,82,97,"The results confirm that the C282Y substitution was the main mutation involved in hemochromatosis, accounting for 85% of carrier chromosomes, whereas the H63D substitution represented 39% of the HH chromosomes that did not carry the C282Y mutation.",10194428_5,-1,213,-1,0.19025281
214,hemochromatosis,19,20,117,132,This enrichment of S65C among HH chromosomes suggests that the S65C substitution is associated with the mild form of hemochromatosis.,10194428_9,-1,214,-1,0.18188949
224,P,10,11,59,60,"The rare form of the Q356R polymorphism was significantly (P = 0. 03) associated with a family history of ovarian cancer, suggesting that this polymorphism may influence ovarian cancer risk.",10196379_9,-1,224,-1,0.2610144
228,adrenoleukodystrophy protein deficiency,6,9,69,108,Adrenoleukodystrophy-related protein can compensate functionally for adrenoleukodystrophy protein deficiency (X-ALD): implications for therapy.,10196381_0,-1,228,-1,0.20481318
229,adrenoleukodystrophy,11,12,77,97,"
Inherited defects in the peroxisomal ATP-binding cassette (ABC) transporter adrenoleukodystrophy protein (ALDP) lead to the lethal peroxisomal disorder X-linked adrenoleukodystrophy (X-ALD), for which no efficient treatment has been established so far.",10196381_1,-1,229,-1,0.19751656
230,lead,16,17,113,117,"
Inherited defects in the peroxisomal ATP-binding cassette (ABC) transporter adrenoleukodystrophy protein (ALDP) lead to the lethal peroxisomal disorder X-linked adrenoleukodystrophy (X-ALD), for which no efficient treatment has been established so far.",10196381_1,-1,230,-1,0.2728771
231,adrenoleukodystrophy,23,24,162,182,"
Inherited defects in the peroxisomal ATP-binding cassette (ABC) transporter adrenoleukodystrophy protein (ALDP) lead to the lethal peroxisomal disorder X-linked adrenoleukodystrophy (X-ALD), for which no efficient treatment has been established so far.",10196381_1,-1,231,-1,0.2046069
232,fatty acids,7,9,50,61,The pathognomonic accumulation of very long chain fatty acids could also be prevented by overexpression of ALDRP in immortalized X-ALD cells.,10196381_4,-1,232,-1,0.25093368
235,lead,9,10,67,71,"Mutant fibroblasts contain multiple, functional centrosomes, which lead to unequal chromosome segregation, abnormal nuclear division, and aneuploidy.",10198641_5,-1,235,-1,0.2446023
236,aneuploidy,20,21,138,148,"Mutant fibroblasts contain multiple, functional centrosomes, which lead to unequal chromosome segregation, abnormal nuclear division, and aneuploidy.",10198641_5,-1,236,-1,0.20926453
237,autoimmune lymphoproliferative syndrome,8,11,63,102,"Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia.
Heterozygous mutations in the CD95 (APO-1/Fas) receptor occur in most individuals with autoimmune lymphoproliferative syndrome (ALPS) and dominantly interfere with apoptosis by an unknown mechanism.",10200300_0,-1,237,-1,0.16316473
238,autoimmune lymphoproliferative syndrome,28,31,200,239,"Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia.
Heterozygous mutations in the CD95 (APO-1/Fas) receptor occur in most individuals with autoimmune lymphoproliferative syndrome (ALPS) and dominantly interfere with apoptosis by an unknown mechanism.",10200300_0,-1,238,-1,0.16646941
240,alkaptonuria,2,3,12,24,"Analysis of alkaptonuria (AKU) mutations and polymorphisms reveals that the CCC sequence motif is a mutational hot spot in the homogentisate 1,2 dioxygenase gene (HGO).",10205262_0,-1,240,-1,0.29623878
241,alkaptonuria,4,5,25,37,"
We recently showed that alkaptonuria (AKU) is caused by loss-of-function mutations in the homogentisate 1, 2 dioxygenase gene (HGO).",10205262_1,-1,241,-1,0.2869705
242,nucleotide,15,16,95,105,"Reexamination of all 29 mutations and polymorphisms thus far described in HGO shows that these nucleotide changes are not randomly distributed; the CCC sequence motif and its inverted complement, GGG, are preferentially mutated.",10205262_4,-1,242,-1,0.25716674
243,nucleotide,6,7,42,52,"These analyses also demonstrated that the nucleotide substitutions in HGO do not involve CpG dinucleotides, which illustrates important differences between HGO and other genes for the occurrence of mutation at specific short-sequence motifs.",10205262_5,-1,243,-1,0.25164035
244,Fabry disease,0,2,0,13,Fabry disease: identification of novel alpha-galactosidase A mutations and molecular carrier detection by use of fluorescent chemical cleavage of mismatches.,10208848_0,-1,244,-1,0.20583908
245,Fabry disease,0,2,1,14,"
Fabry disease (FD) (angiokeratoma corporis diffusum) is an X-linked inborn error of glycosphingolipid metabolism caused by defects in the lysosomal alpha-galactosidase A gene (GLA).",10208848_1,-1,245,-1,0.22189961
246,angiokeratoma,6,7,21,34,"
Fabry disease (FD) (angiokeratoma corporis diffusum) is an X-linked inborn error of glycosphingolipid metabolism caused by defects in the lysosomal alpha-galactosidase A gene (GLA).",10208848_1,-1,246,-1,0.25287843
247,angiokeratoma,6,7,43,56,"Clinically, affected hemizygous males have angiokeratoma, severe acroparesthesia, renal failure, and vasculopathy of the heart and brain.",10208848_3,-1,247,-1,0.21847837
248,renal failure,11,13,82,95,"Clinically, affected hemizygous males have angiokeratoma, severe acroparesthesia, renal failure, and vasculopathy of the heart and brain.",10208848_3,-1,248,-1,0.22878318
249,K,19,20,94,95,"The mutational spectrum included five missense mutations (C202W, C223G, N224D, R301Q, and Q327K) and one splice-site mutation [IVS3 G (-1) -- > C].",10208848_6,-1,249,-1,0.32625753
250,C,33,34,144,145,"The mutational spectrum included five missense mutations (C202W, C223G, N224D, R301Q, and Q327K) and one splice-site mutation [IVS3 G (-1) -- > C].",10208848_6,-1,250,-1,0.31591326
251,Pelizaeus-Merzbacher disease,8,10,44,72,Prenatal diagnosis by FISH in a family with Pelizaeus-Merzbacher disease caused by duplication of PLP gene.,10210128_0,-1,251,-1,0.2501251
252,Pelizaeus-Merzbacher disease,3,5,16,44,"
A diagnosis of Pelizaeus-Merzbacher disease (MIM 312080) was made in a young boy.",10210128_1,-1,252,-1,0.25183094
253,disease,16,17,102,109,"The proband was found to carry the duplication, thus confirming the diagnosis of Pelizaeus Merzbacher disease, but neither the aunt nor the fetus carried a duplication..",10210128_5,-1,253,-1,0.22096422
254,adenomatous polyposis coli,3,6,21,47,"
Inactivation of the adenomatous polyposis coli (APC) gene product initiates colorectal tumorigenesis.",10213492_1,-1,254,-1,0.18806322
255,colorectal adenomas,17,19,96,115,Patients with familial APC (FAP) carry germ-line mutations in the APC gene and develop multiple colorectal adenomas and subsequent carcinomas early in life.,10213492_2,-1,255,-1,0.14585787
256,disease,4,5,20,27,The severity of the disease correlates with the position of the inherited APC mutation (genotype-phenotype correlation).,10213492_3,-1,256,-1,0.2017852
257,contrast,1,2,3,11,"In contrast, mutant APC gene products that are associated with attenuated polyposis (codon 386 or 1465) interfered only weakly with wild-type APC activity.",10213492_8,-1,257,-1,0.25156364
260,disease,2,3,12,19,"No clinical disease was associated with this deficiency which was transmitted through the subjects family as a single genetic characteristic, the C6 deficiency being associated with a silent allele at the structural locus.",102474_2,-1,260,-1,0.2509331
261,X-linked Emery-Dreifuss muscular dystrophy,11,15,79,121,Changes at P183 of emerin weaken its protein-protein interactions resulting in X-linked Emery-Dreifuss muscular dystrophy.,10323252_0,-1,261,-1,0.20491222
262,muscular dystrophy,1,3,16,34,"
Emery-Dreifuss muscular dystrophy (EDMD) is an X-linked recessive muscular dystrophy characterized by early contractures of the elbows, Achilles tendons and spine, slowly progressive muscle wasting and weakness, and cardiomyopathy associated with cardiac conduction defects.",10323252_1,-1,262,-1,0.18298362
263,muscular dystrophy,10,12,67,85,"
Emery-Dreifuss muscular dystrophy (EDMD) is an X-linked recessive muscular dystrophy characterized by early contractures of the elbows, Achilles tendons and spine, slowly progressive muscle wasting and weakness, and cardiomyopathy associated with cardiac conduction defects.",10323252_1,-1,263,-1,0.17765032
264,contractures,15,16,109,121,"
Emery-Dreifuss muscular dystrophy (EDMD) is an X-linked recessive muscular dystrophy characterized by early contractures of the elbows, Achilles tendons and spine, slowly progressive muscle wasting and weakness, and cardiomyopathy associated with cardiac conduction defects.",10323252_1,-1,264,-1,0.2318292
267,contractures,24,25,134,146,"In comparison with the usual EDMD phenotype, patients with P183 missense mutations have a later age at onset of first symptoms, elbow contractures, ankle contractures, upper limb weakness and lower limb weakness, but there is no difference for the age at onset of cardiac involvement.",10323252_7,-1,267,-1,0.25386295
268,contractures,27,28,154,166,"In comparison with the usual EDMD phenotype, patients with P183 missense mutations have a later age at onset of first symptoms, elbow contractures, ankle contractures, upper limb weakness and lower limb weakness, but there is no difference for the age at onset of cardiac involvement.",10323252_7,-1,268,-1,0.25289154
271,Van der Woude syndrome,9,13,58,80,Microdeletions at chromosome bands 1q32-q41 as a cause of Van der Woude syndrome.,10323740_0,-1,271,-1,0.22731675
272,Van der Woude syndrome,0,4,1,23,"
Van der Woude syndrome (VWS) is an autosomal dominant disorder comprising cleft lip and/or cleft palate and lip pits.",10323740_1,-1,272,-1,0.22997786
273,cleft lip,13,15,75,84,"
Van der Woude syndrome (VWS) is an autosomal dominant disorder comprising cleft lip and/or cleft palate and lip pits.",10323740_1,-1,273,-1,0.21946667
274,cleft palate,16,18,92,104,"
Van der Woude syndrome (VWS) is an autosomal dominant disorder comprising cleft lip and/or cleft palate and lip pits.",10323740_1,-1,274,-1,0.21997455
275,cleft,2,3,11,16,"Along with cleft lip/palate and lip pits, affected relatives exhibit developmental delays, suggesting that the function of a gene nearby may also be disrupted.",10323740_3,-1,275,-1,0.22114085
276,Mb,16,17,73,75,"Surprisingly, mapping of the new deletion showed that it extended 0. 2-1 Mb beyond the proximal breakpoint for the deletion described previously.",10323740_8,-1,276,-1,0.23459496
277,syndrome,10,11,64,72,"No deletions were detected in seven cases of popliteal pterygia syndrome, 76 cases of mixed syndromic forms of cleft lip and palate, and 178 cases of nonsyndromic cleft lip and palate.",10323740_9,-1,277,-1,0.21028334
278,cleft lip,19,21,111,120,"No deletions were detected in seven cases of popliteal pterygia syndrome, 76 cases of mixed syndromic forms of cleft lip and palate, and 178 cases of nonsyndromic cleft lip and palate.",10323740_9,-1,278,-1,0.21273881
279,cleft lip,29,31,163,172,"No deletions were detected in seven cases of popliteal pterygia syndrome, 76 cases of mixed syndromic forms of cleft lip and palate, and 178 cases of nonsyndromic cleft lip and palate.",10323740_9,-1,279,-1,0.21989098
280,AG,10,11,65,67,Fewer than half of the splicing mutations involved the canonical AG splice-acceptor site or GT splice-donor site.,10330348_2,-1,280,-1,0.32507798
281,nucleotide,18,19,118,128,"A higher percentage of mutations occurred at less stringently conserved sites, including silent mutations of the last nucleotide of exons, mutations in nucleotides other than the conserved AG and GT in the consensus splice sites, and creation of splice-acceptor or splice-donor sites in either introns or exons.",10330348_3,-1,281,-1,0.30960822
282,AG,29,30,189,191,"A higher percentage of mutations occurred at less stringently conserved sites, including silent mutations of the last nucleotide of exons, mutations in nucleotides other than the conserved AG and GT in the consensus splice sites, and creation of splice-acceptor or splice-donor sites in either introns or exons.",10330348_3,-1,282,-1,0.34393045
283,disease,5,6,31,38,Alpha-cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy.,10330430_0,-1,283,-1,0.18746684
284,hypertrophic cardiomyopathy,9,11,56,83,Alpha-cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy.,10330430_0,-1,284,-1,0.16876797
285,disease,12,13,62,69,"
We identified the alpha-cardiac actin gene (ACTC) as a novel disease gene in a pedigree suffering from familial hypertrophic cardiomyopathy (FHC).",10330430_1,-1,285,-1,0.18854833
286,hypertrophic cardiomyopathy,20,22,113,140,"
We identified the alpha-cardiac actin gene (ACTC) as a novel disease gene in a pedigree suffering from familial hypertrophic cardiomyopathy (FHC).",10330430_1,-1,286,-1,0.16347682
287,disease,11,12,75,82,"Linkage analyses excluded all the previously reported FHC loci as possible disease loci in the family studied, with lod scores varying between -2.",10330430_2,-1,287,-1,0.19311544
288,disease,20,21,131,138,"Further linkage analyses of plausible candidate genes highly expressed in the adult human heart identified ACTC as the most likely disease gene, showing a maximal lod score of 3.",10330430_4,-1,288,-1,0.18808462
289,idiopathic dilated cardiomyopathy,24,27,147,180,Mutation analysis of ACTC revealed an Ala295Ser mutation in exon 5 close to 2 missense mutations recently described to cause the inherited form of idiopathic dilated cardiomyopathy (IDC).,10330430_6,-1,289,-1,0.17621651
290,aspartylglucosaminuria,12,13,62,84,"Overgrowth of oral mucosa and facial skin, a novel feature of aspartylglucosaminuria.",10353787_0,-1,290,-1,0.248573
291,Aspartylglucosaminuria,0,1,1,23,"
Aspartylglucosaminuria (AGU) is a lysosomal storage disorder caused by deficiency of aspartylglucosaminidase (AGA).",10353787_1,-1,291,-1,0.24744555
292,aspartylglucosaminidase,13,14,86,109,"
Aspartylglucosaminuria (AGU) is a lysosomal storage disorder caused by deficiency of aspartylglucosaminidase (AGA).",10353787_1,-1,292,-1,0.26684958
293,mental retardation,5,7,32,50,The main symptom is progressive mental retardation.,10353787_2,-1,293,-1,0.21894093
294,disease,10,11,60,67,"A spectrum of different mutations has been reported in this disease, one missense mutation (Cys163Ser) being responsible for the majority of Finnish cases.",10353787_3,-1,294,-1,0.21884066
295,erythema,10,11,60,68,"Skin was seborrhoeic in adolescent and adult patients, with erythema of the facial skin already common in childhood.",10353787_7,-1,295,-1,0.25858733
296,tumours,13,14,53,60,"Of 44 patients, nine (20%) had facial angiofibromas, tumours primarily occurring in association with tuberous sclerosis.",10353787_8,-1,296,-1,0.20375821
297,sclerosis,20,21,110,119,"Of 44 patients, nine (20%) had facial angiofibromas, tumours primarily occurring in association with tuberous sclerosis.",10353787_8,-1,297,-1,0.18819703
298,p,19,20,113,114,Oedemic buccal mucosa (leucoedema) and gingival overgrowths were more frequent in AGU patients than in controls (p < 0. 001).,10353787_9,-1,298,-1,0.30573002
299,syndrome,9,10,63,71,"Characterization of a germline mosaicism in families with Lowe syndrome, and identification of seven novel mutations in the OCRL1 gene.",10364518_0,-1,299,-1,0.20585218
300,oculocerebrorenal syndrome,1,3,5,31,"
The oculocerebrorenal syndrome of Lowe (OCRL) is an X-linked disorder characterized by major abnormalities of eyes, nervous system, and kidneys.",10364518_1,-1,300,-1,0.20362292
301,disease,10,11,58,65,Mutations in the OCRL1 gene have been associated with the disease.,10364518_2,-1,301,-1,0.22117968
302,amino acids,20,22,108,119,"Finally, one frameshift mutation, 2799delC, modifies the C-terminal part of OCRL1, with an extension of six amino acids.",10364518_7,-1,302,-1,0.2815433
303,syndrome,10,11,72,80,This observation has direct implications for genetic counseling of Lowe syndrome families..,10364518_10,-1,303,-1,0.21843499
304,Familial Mediterranean fever,6,9,45,73,MEFV-Gene analysis in armenian patients with Familial Mediterranean fever: diagnostic value and unfavorable renal prognosis of the M694V homozygous genotype-genetic and therapeutic implications.,10364520_0,-1,304,-1,0.19055456
305,Familial Mediterranean fever,0,3,1,29,"
Familial Mediterranean fever (FMF) is a recessively inherited disorder that is common in patients of Armenian ancestry.",10364520_1,-1,305,-1,0.21065018
307,lead,32,33,181,185,"To date, its diagnosis, which can be made only retrospectively, is one of exclusion, based entirely on nonspecific clinical signs that result from serosal inflammation and that may lead to unnecessary surgery.",10364520_2,-1,307,-1,0.2466319
308,amyloidosis,1,2,6,17,"Renal amyloidosis, prevented by colchicine, is the most severe complication of FMF, a disorder associated with mutations in the MEFV gene.",10364520_3,-1,308,-1,0.20910716
309,disease,17,18,130,137,"In several instances, family studies provided molecular evidence for pseudodominant transmission and incomplete penetrance of the disease phenotype.",10364520_6,-1,309,-1,0.21757239
310,amyloidosis,15,16,91,102,"The M694V homozygous genotype was found to be associated with a higher prevalence of renal amyloidosis and arthritis, compared with other genotypes (P =.",10364520_7,-1,310,-1,0.20008165
312,P,24,25,149,150,"The M694V homozygous genotype was found to be associated with a higher prevalence of renal amyloidosis and arthritis, compared with other genotypes (P =.",10364520_7,-1,312,-1,0.26872572
313,P,2,3,9,10,0002 and P =.,10364520_8,-1,313,-1,0.29085267
314,lead,18,19,122,126,The demonstration of both the diagnostic and prognostic value of MEFV analysis and particular modes of inheritance should lead to new ways for management of FMF-including genetic counseling and therapeutic decisions in affected families.,10364520_10,-1,314,-1,0.26842013
315,fragile X syndrome,3,6,21,39,"Noninvasive test for fragile X syndrome, using hair root analysis.",10364521_0,-1,315,-1,0.2106671
316,fragile X syndrome,10,13,80,98,"
Identification of the FMR1 gene and the repeat-amplification mechanism causing fragile X syndrome led to development of reliable DNA-based diagnostic methods, including Southern blot hybridization and PCR.",10364521_1,-1,316,-1,0.20221886
317,fragile X syndrome,19,22,126,144,"Using an immunocytochemical technique on blood smears, we recently developed a novel test for identification of patients with fragile X syndrome.",10364521_3,-1,317,-1,0.18868771
318,fragile X syndrome,12,15,70,88,"Here we describe a new diagnostic test to identify male patients with fragile X syndrome, on the basis of lack of FMRP in their hair roots.",10364521_5,-1,318,-1,0.1981071
324,P,4,5,14,15,64 at D1S202 (P =.,10364525_6,-1,324,-1,0.27623484
325,P,4,5,14,15,95 at D1S422 (P =. 03).,10364525_10,-1,325,-1,0.32742995
327,mucopolysaccharidosis,11,12,76,97,Molecular basis of feline beta-glucuronidase deficiency: an animal model of mucopolysaccharidosis VII.,10366443_0,-1,327,-1,0.2247824
328,mucopolysaccharidosis VII,15,17,107,132,"
A family of domestic cats was found that exhibited clinical and biochemical abnormalities consistent with mucopolysaccharidosis VII, an autosomal recessive lysosomal storage disorder caused by beta-glucuronidase deficiency.",10366443_1,-1,328,-1,0.2365651
329,K,14,15,77,78,"There was a G-to-A transition in the affected cat cDNA that predicted an E351K substitution, destroyed a BssSI site, and eliminated GUSB enzymatic activity in expression studies.",10366443_5,-1,329,-1,0.30532235
331,syndrome,6,7,44,52,"Three congenital anomaly disorders, cat-eye syndrome, der () syndrome and velo-cardio-facial syndrome/DiGeorge syndrome (VCFS/DGS) are associated with tetrasomy, trisomy or monosomy, respectively, for part of chromosome 22q11.",10369860_2,-1,331,-1,0.21189937
332,syndrome,11,12,61,69,"Three congenital anomaly disorders, cat-eye syndrome, der () syndrome and velo-cardio-facial syndrome/DiGeorge syndrome (VCFS/DGS) are associated with tetrasomy, trisomy or monosomy, respectively, for part of chromosome 22q11.",10369860_2,-1,332,-1,0.23974186
333,syndrome,15,16,111,119,"Three congenital anomaly disorders, cat-eye syndrome, der () syndrome and velo-cardio-facial syndrome/DiGeorge syndrome (VCFS/DGS) are associated with tetrasomy, trisomy or monosomy, respectively, for part of chromosome 22q11.",10369860_2,-1,333,-1,0.19120003
334,tetrasomy,22,23,151,160,"Three congenital anomaly disorders, cat-eye syndrome, der () syndrome and velo-cardio-facial syndrome/DiGeorge syndrome (VCFS/DGS) are associated with tetrasomy, trisomy or monosomy, respectively, for part of chromosome 22q11.",10369860_2,-1,334,-1,0.24497697
335,trisomy,24,25,162,169,"Three congenital anomaly disorders, cat-eye syndrome, der () syndrome and velo-cardio-facial syndrome/DiGeorge syndrome (VCFS/DGS) are associated with tetrasomy, trisomy or monosomy, respectively, for part of chromosome 22q11.",10369860_2,-1,335,-1,0.2623089
336,monosomy,26,27,173,181,"Three congenital anomaly disorders, cat-eye syndrome, der () syndrome and velo-cardio-facial syndrome/DiGeorge syndrome (VCFS/DGS) are associated with tetrasomy, trisomy or monosomy, respectively, for part of chromosome 22q11.",10369860_2,-1,336,-1,0.2564734
337,syndrome,5,6,28,36,VCFS/DGS is the most common syndrome associated with 22q11 rearrangements.,10369860_3,-1,337,-1,0.18259642
338,Mb,7,8,40,42,"Most VCFS/DGS patients have a similar 3 Mb deletion, some have a nested distal deletion breakpoint resulting in a 1. 5 Mb deletion and a few rare patients have unique deletions or translocations.",10369860_5,-1,338,-1,0.22261247
339,Mb,23,24,119,121,"Most VCFS/DGS patients have a similar 3 Mb deletion, some have a nested distal deletion breakpoint resulting in a 1. 5 Mb deletion and a few rare patients have unique deletions or translocations.",10369860_5,-1,339,-1,0.23767032
340,Mb,19,20,108,110,"To support this idea further, we identified a family that carries an interstitial duplication of the same 3 Mb region that is deleted in VCFS/DGS patients.",10369860_8,-1,340,-1,0.24283937
341,disease,17,18,108,115,We identified five additional copies of the LCR22 on 22q11 that may mediate other rearrangements leading to disease.,10369860_10,-1,341,-1,0.1950083
342,neuropathies,14,15,93,105,"Mutations in the human EGR2 gene have recently been associated with the inherited peripheral neuropathies Charcot-Marie-Tooth type 1, Dejerine-Sottas syndrome and congenital hypomyelinating neuropathy.",10369870_3,-1,342,-1,0.20151506
343,syndrome,20,21,150,158,"Mutations in the human EGR2 gene have recently been associated with the inherited peripheral neuropathies Charcot-Marie-Tooth type 1, Dejerine-Sottas syndrome and congenital hypomyelinating neuropathy.",10369870_3,-1,343,-1,0.20163026
345,zinc,12,13,67,71,Three of the four EGR2 mutations are dominant and occur within the zinc finger DNA-binding domain.,10369870_4,-1,345,-1,0.24631107
346,zinc,1,2,4,8,The zinc finger mutations affect DNA binding and the amount of residual binding directly correlates with disease severity.,10369870_7,-1,346,-1,0.25131175
347,disease,16,17,105,112,The zinc finger mutations affect DNA binding and the amount of residual binding directly correlates with disease severity.,10369870_7,-1,347,-1,0.19750832
348,disease,7,8,45,52,These data provide insight into the possible disease mechanisms underlying EGR2 mutations and the reason for varying severity and differences in inheritance patterns..,10369870_9,-1,348,-1,0.18587326
349,diabetes insipidus,4,6,46,64,Autosomal recessive familial neurohypophyseal diabetes insipidus with continued secretion of mutant weakly active vasopressin.,10369876_0,-1,349,-1,0.21128452
350,vasopressin,13,14,114,125,Autosomal recessive familial neurohypophyseal diabetes insipidus with continued secretion of mutant weakly active vasopressin.,10369876_0,-1,350,-1,0.22793321
351,diabetes insipidus,2,4,27,45,"
Familial neurohypophyseal diabetes insipidus is an autosomal dominant disorder characterized by post-natal development of arginine vasopressin (AVP) deficiency due to mutations in the AVP gene.",10369876_1,-1,351,-1,0.21411715
352,arginine vasopressin,14,16,123,143,"
Familial neurohypophyseal diabetes insipidus is an autosomal dominant disorder characterized by post-natal development of arginine vasopressin (AVP) deficiency due to mutations in the AVP gene.",10369876_1,-1,352,-1,0.2095693
353,AVP,17,18,145,148,"
Familial neurohypophyseal diabetes insipidus is an autosomal dominant disorder characterized by post-natal development of arginine vasopressin (AVP) deficiency due to mutations in the AVP gene.",10369876_1,-1,353,-1,0.25677314
354,AVP,25,26,185,188,"
Familial neurohypophyseal diabetes insipidus is an autosomal dominant disorder characterized by post-natal development of arginine vasopressin (AVP) deficiency due to mutations in the AVP gene.",10369876_1,-1,354,-1,0.25043684
356,diabetes insipidus,18,20,139,157,"We studied an unusual Palestinian family consisting of asymptomatic first cousin parents and three children affected with neurohypophyseal diabetes insipidus, suggesting autosomal recessive inheritance.",10369876_3,-1,356,-1,0.21742535
357,AVP,28,29,149,152,"All three affected children were homozygous and the parents heterozygous for a single novel mutation (C301- > T) in exon 1, replacing Pro7 of mature AVP with Leu (Leu-AVP).",10369876_4,-1,357,-1,0.29632318
358,Leu-AVP,32,33,163,170,"All three affected children were homozygous and the parents heterozygous for a single novel mutation (C301- > T) in exon 1, replacing Pro7 of mature AVP with Leu (Leu-AVP).",10369876_4,-1,358,-1,0.28659493
359,Leu-AVP,0,1,0,7,Leu-AVP was a weak agonist with approximately 30-fold reduced binding to the human V2 receptor.,10369876_5,-1,359,-1,0.30100706
360,AVP,36,37,221,224,"The youngest child (2 years old) was only mildly affected but had Leu-AVP levels similar to her severely affected 8-year-old brother, suggesting that unknown mechanisms may partially compensate for a deficiency of active AVP in very young children..",10369876_7,-1,360,-1,0.26545006
361,hemoglobinuria,30,31,193,207,"
A somatic mutation in the X linked PIGA gene is responsible for the deficiency of glycosyl phosphatidylinositol (GPI) -anchored proteins on blood cells from patients with paroxysmal nocturnal hemoglobinuria.",10377440_1,-1,361,-1,0.19480976
362,hemochromatosis,5,6,38,53,The C282Y mutation causing hereditary hemochromatosis does not produce a null allele.,10381492_0,-1,362,-1,0.18825172
363,hemochromatosis,11,12,70,85,"
Targeted mutagenesis was used to produce two mutations in the murine hemochromatosis gene (Hfe) locus.",10381492_1,-1,363,-1,0.18752345
364,hemochromatosis,12,13,87,102,This mutation is identical to the disease-causing mutation in patients with hereditary hemochromatosis.,10381492_4,-1,364,-1,0.17818977
365,iron,7,8,54,58,Homozygosity for either mutation results in postnatal iron loading.,10381492_6,-1,365,-1,0.23756316
366,iron,7,8,54,58,Mice heterozygous for either mutation accumulate more iron than normal controls.,10381492_8,-1,366,-1,0.24480101
367,iron,4,5,30,34,"Interestingly, although liver iron stores are greatly increased, splenic iron is decreased.",10381492_9,-1,367,-1,0.23093356
368,iron,11,12,73,77,"Interestingly, although liver iron stores are greatly increased, splenic iron is decreased.",10381492_9,-1,368,-1,0.23985933
369,X-linked Emery-Dreifuss muscular dystrophy,3,7,31,73,Genotype-phenotype analysis in X-linked Emery-Dreifuss muscular dystrophy and identification of a missense mutation associated with a milder phenotype.,10382909_0,-1,369,-1,0.19839141
370,muscular dystrophy,11,13,73,91,"
Direct sequencing of the emerin gene in 22 families with Emery-Dreifuss muscular dystrophy (EMD) revealed mutations in 21 (95%), confirming that emerin mutations can be identified in the majority of families with X-linked EMD.",10382909_1,-1,370,-1,0.17169608
371,X-linked EMD,38,40,214,226,"
Direct sequencing of the emerin gene in 22 families with Emery-Dreifuss muscular dystrophy (EMD) revealed mutations in 21 (95%), confirming that emerin mutations can be identified in the majority of families with X-linked EMD.",10382909_1,-1,371,-1,0.20976783
372,contractures,13,14,71,83,Age at onset was later for first symptoms and for development of ankle contractures and muscle weakness.,10382909_7,-1,372,-1,0.2570212
373,muscle weakness,15,17,88,103,Age at onset was later for first symptoms and for development of ankle contractures and muscle weakness.,10382909_7,-1,373,-1,0.22345854
374,X-linked Emery-Dreifuss muscular dystrophy,4,8,30,72,Severe clinical expression in X-linked Emery-Dreifuss muscular dystrophy.,10382910_0,-1,374,-1,0.20329277
375,X-linked Emery-Dreifuss muscular dystrophy,0,4,1,43,"
X-linked Emery-Dreifuss muscular dystrophy (EDMD) is a relatively rare benign neuromuscular disorder which can vary remarkably in onset, course and severity.",10382910_1,-1,375,-1,0.19934547
376,disease,22,23,118,125,"In the present study, a TCTAC deletion spanning the nucleotides 631-635 of the emerin gene caused an unusually severe disease phenotype including loss of ambulation and severe muscle wasting in two affected brothers.",10382910_2,-1,376,-1,0.17126197
377,muscular dystrophy,29,31,202,220,The interfamilial heterogeneity in distribution and in severity of the features in the two families point to environmental or genetic modification as the cause of clinical variability in Emery-Dreifuss muscular dystrophy..,10382910_4,-1,377,-1,0.1831371
386,hepatoblastoma,9,10,61,75,Beta-catenin accumulation and mutation of the CTNNB1 gene in hepatoblastoma.,10398436_0,-1,386,-1,0.16240706
387,Hepatoblastoma,0,1,1,15,"
Hepatoblastoma is a rare malignant tumor of the liver that occurs in children at an average age of 2 to 3 years.",10398436_1,-1,387,-1,0.18672448
388,malignant tumor,4,6,26,41,"
Hepatoblastoma is a rare malignant tumor of the liver that occurs in children at an average age of 2 to 3 years.",10398436_1,-1,388,-1,0.16472842
390,adenomatous polyposis coli,15,18,99,125,Epidemiologic studies have shown an increased frequency of this tumor type in families affected by adenomatous polyposis coli.,10398436_2,-1,390,-1,0.18226472
392,hepatoblastoma,22,23,138,152,"In addition to the epidemiologic data, molecular genetic studies suggest that inactivation of the APC tumor suppressor may be involved in hepatoblastoma tumorigenesis.",10398436_3,-1,392,-1,0.1547662
394,adenomatous polyposis coli,18,21,125,151,"In an ongoing immunohistochemical study of beta-catenin expression in sporadic cases of tumor types that are associated with adenomatous polyposis coli, we observed increased beta-catenin levels in the cytoplasm and in the nuclei of three investigated hepatoblastomas.",10398436_5,-1,394,-1,0.18877172
396,hepatoblastoma,18,19,106,120,Our data indicate for the first time that beta-catenin accumulation may play a role in the development of hepatoblastoma and that activating mutations of the beta-catenin gene may substitute biallelic APC inactivation in this tumor type.,10398436_7,-1,396,-1,0.14501154
402,pendred syndrome,6,8,37,53,Sulfate transport is not impaired in pendred syndrome thyrocytes.,10404839_0,-1,402,-1,0.23877648
403,Pendred syndrome,0,2,1,17,"
Pendred syndrome is the most common form of syndromic deafness, characterized by dyshormonogenic goiter associated with sensory-neural deafness.",10404839_1,-1,403,-1,0.21719703
404,deafness,9,10,55,63,"
Pendred syndrome is the most common form of syndromic deafness, characterized by dyshormonogenic goiter associated with sensory-neural deafness.",10404839_1,-1,404,-1,0.20727913
405,goiter,14,15,98,104,"
Pendred syndrome is the most common form of syndromic deafness, characterized by dyshormonogenic goiter associated with sensory-neural deafness.",10404839_1,-1,405,-1,0.2652024
406,deafness,18,19,136,144,"
Pendred syndrome is the most common form of syndromic deafness, characterized by dyshormonogenic goiter associated with sensory-neural deafness.",10404839_1,-1,406,-1,0.20828137
407,disease,5,6,29,36,"The gene responsible for the disease (PDS) has been cloned, but its function is as yet unknown and the connection between thyroid goiter and sensory-neural deafness remains an enigma.",10404839_2,-1,407,-1,0.20918573
408,goiter,25,26,130,136,"The gene responsible for the disease (PDS) has been cloned, but its function is as yet unknown and the connection between thyroid goiter and sensory-neural deafness remains an enigma.",10404839_2,-1,408,-1,0.21688764
409,deafness,28,29,156,164,"The gene responsible for the disease (PDS) has been cloned, but its function is as yet unknown and the connection between thyroid goiter and sensory-neural deafness remains an enigma.",10404839_2,-1,409,-1,0.22136596
410,Pendred syndrome,8,10,56,72,We tested sulfate transport in thyrocytes obtained from Pendred syndrome patients and found that it was not defective.,10404839_5,-1,410,-1,0.22526284
411,kniest dysplasia,10,12,61,77,Small deletions in the type II collagen triple helix produce kniest dysplasia.,10406661_0,-1,411,-1,0.23390459
412,myopia,23,24,148,154,"
Kniest dysplasia is a moderately severe type II collagenopathy, characterized by short trunk and limbs, kyphoscoliosis, midface hypoplasia, severe myopia, and hearing loss.",10406661_1,-1,412,-1,0.21507822
413,hearing loss,26,28,160,172,"
Kniest dysplasia is a moderately severe type II collagenopathy, characterized by short trunk and limbs, kyphoscoliosis, midface hypoplasia, severe myopia, and hearing loss.",10406661_1,-1,413,-1,0.19565405
414,Kniest dysplasia,28,30,153,169,"Mutations in the gene that encodes type II collagen (COL2A1), the predominant protein of cartilage, have been identified in a number of individuals with Kniest dysplasia.",10406661_2,-1,414,-1,0.21918319
415,Kniest dysplasia,12,14,86,102,We used heteroduplex analysis to identify sequence anomalies in five individuals with Kniest dysplasia.,10406661_5,-1,415,-1,0.23108135
416,Kniest dysplasia,17,19,109,125,"Sequencing of the index patients genomic DNA identified four new dominant mutations in COL2A1 that result in Kniest dysplasia  a 21-bp deletion in exon 16, an 18-bp deletion in exon 19, and 4-bp deletions in the splice donor sites of introns 14 and 20.",10406661_6,-1,416,-1,0.35512283
417,Kniest dysplasia,4,6,24,40,"These data suggest that Kniest dysplasia results from shorter type II collagen monomers, and support the hypothesis that alteration of a specific COL2A1 domain, which may span from exons 12 to 24, leads to the Kniest dysplasia phenotype..",10406661_9,-1,417,-1,0.20596604
418,Kniest dysplasia,38,40,210,226,"These data suggest that Kniest dysplasia results from shorter type II collagen monomers, and support the hypothesis that alteration of a specific COL2A1 domain, which may span from exons 12 to 24, leads to the Kniest dysplasia phenotype..",10406661_9,-1,418,-1,0.20039001
419,Los,4,5,13,16,"Duarte 1 (or Los Angeles) and Duarte 2 (or Duarte) variants carry the same amino acid substitution, N314D, even though D1 is associated with increased erythrocyte GALT activity and D2 with reduced activity.",10408771_11,-1,419,-1,0.2578558
420,amino acid,18,20,75,85,"Duarte 1 (or Los Angeles) and Duarte 2 (or Duarte) variants carry the same amino acid substitution, N314D, even though D1 is associated with increased erythrocyte GALT activity and D2 with reduced activity.",10408771_11,-1,420,-1,0.3036142
421,renal cell carcinoma,7,10,38,58,Mutations of the VHL gene in sporadic renal cell carcinoma: definition of a risk factor for VHL patients to develop an RCC.,10408776_0,-1,421,-1,0.14456789
423,renal cell carcinoma,8,11,50,70,"VHL mutations were found only in the nonpapillary renal cell carcinoma (RCC) subtype, as previously reported.",10408776_5,-1,423,-1,0.16412033
424,P,35,36,221,222,The study of mutational events revealed a significant difference between somatic and germline mutations with mutations leading to truncated proteins observed in 78% of somatic mutations vs only 37% in germline mutations (P < 0. 001).,10408776_7,-1,424,-1,0.30169198
425,P,32,33,165,166,We observed RCC in at least one member of the VHL families in 77% of cases with mutations leading to truncated proteins versus 55% in cases with missense mutations (P < 0. 05).,10408776_11,-1,425,-1,0.29669198
426,lead,8,9,52,56,"Thus, mutations resulting in truncated proteins may lead to a higher risk of RCC in VHL patients",10408776_12,-1,426,-1,0.22503033
427,Chediak-Higashi syndrome,5,7,36,60,Defective CTLA-4 cycling pathway in Chediak-Higashi syndrome: a possible mechanism for deregulation of T lymphocyte activation.,10411929_0,-1,427,-1,0.22467312
428,Chediak-Higashi syndrome,0,2,0,24,"Chediak-Higashi syndrome (CHS) is an inherited disorder caused by mutations in the lysosomal trafficking regulator gene, LYST.",10411929_3,-1,428,-1,0.22629361
429,syndrome,27,28,172,180,"It results in defective membrane targeting of the proteins present in secretory lysosomes, and it is associated with a variety of features, including a lymphoproliferative syndrome with hemophagocytosis.",10411929_4,-1,429,-1,0.1675515
430,syndrome,18,19,117,125,"The murine equivalent of CHS, beige mice, present similar characteristics but do not develop the lymphoproliferative syndrome.",10411929_5,-1,430,-1,0.20391074
431,disease,22,23,141,148,It is therefore proposed that the defective surface expression of CTLA-4 by CHS T cells is involved in the generation of lymphoproliferative disease.,10411929_7,-1,431,-1,0.16296571
432,Pelizaeus-Merzbacher Disease,8,10,61,89,"Proteolipoprotein gene analysis in 82 patients with sporadic Pelizaeus-Merzbacher Disease: duplications, the major cause of the disease, originate more frequently in male germ cells, but point mutations do not.",10417279_0,-1,432,-1,0.2492411
433,disease,18,19,128,135,"Proteolipoprotein gene analysis in 82 patients with sporadic Pelizaeus-Merzbacher Disease: duplications, the major cause of the disease, originate more frequently in male germ cells, but point mutations do not.",10417279_0,-1,433,-1,0.21049635
434,Disease,7,8,54,61,The Clinical European Network on Brain Dysmyelinating Disease.,10417279_1,-1,434,-1,0.21328026
435,Pelizaeus-Merzbacher Disease,0,2,1,29,"
Pelizaeus-Merzbacher Disease (PMD) is an X-linked developmental defect of myelination affecting the central nervous system and segregating with the proteolipoprotein (PLP) locus.",10417279_2,-1,435,-1,0.24372894
436,contrast,2,3,9,17,"In sharp contrast, among the 34 duplicated cases, 91% of mothers were carriers, a value significantly (chi2 = 9. 20, P <. 01) in favor of a male bias, with an estimation of the male/female mutation frequency (k) of 9.",10417279_6,-1,436,-1,0.30042517
437,P,27,28,117,118,"In sharp contrast, among the 34 duplicated cases, 91% of mothers were carriers, a value significantly (chi2 = 9. 20, P <. 01) in favor of a male bias, with an estimation of the male/female mutation frequency (k) of 9.",10417279_6,-1,437,-1,0.3405152
438,k,48,49,209,210,"In sharp contrast, among the 34 duplicated cases, 91% of mothers were carriers, a value significantly (chi2 = 9. 20, P <. 01) in favor of a male bias, with an estimation of the male/female mutation frequency (k) of 9.",10417279_6,-1,438,-1,0.30935556
439,k,27,28,179,180,"Moreover, we observed the occurrence of de novo mutations between parental and grandparental generations in 17 three-generation families, which allowed a direct estimation of the k value (k = 11).",10417279_8,-1,439,-1,0.28001437
440,k,30,31,188,189,"Moreover, we observed the occurrence of de novo mutations between parental and grandparental generations in 17 three-generation families, which allowed a direct estimation of the k value (k = 11).",10417279_8,-1,440,-1,0.2734475
441,Chromosome breakage,0,2,0,19,"Chromosome breakage in the Prader-Willi and Angelman syndromes involves recombination between large, transcribed repeats at proximal and distal breakpoints.",10417280_0,-1,441,-1,0.22735262
442,Prader-Willi syndrome,0,2,1,22,"
Prader-Willi syndrome (PWS) and Angelman syndrome (AS) are distinct neurobehavioral disorders that most often arise from a 4-Mb deletion of chromosome 15q11-q13 during paternal or maternal gametogenesis, respectively.",10417280_1,-1,442,-1,0.21505651
443,Angelman syndrome,6,8,33,50,"
Prader-Willi syndrome (PWS) and Angelman syndrome (AS) are distinct neurobehavioral disorders that most often arise from a 4-Mb deletion of chromosome 15q11-q13 during paternal or maternal gametogenesis, respectively.",10417280_1,-1,443,-1,0.20829733
444,van der Woude syndrome,8,12,50,72,Linkage analysis in a large Brazilian family with van der Woude syndrome suggests the existence of a susceptibility locus for cleft palate at 17p11.2-11.1.,10417286_0,-1,444,-1,0.21869016
445,cleft palate,20,22,126,138,Linkage analysis in a large Brazilian family with van der Woude syndrome suggests the existence of a susceptibility locus for cleft palate at 17p11.2-11.1.,10417286_0,-1,445,-1,0.22194682
446,van der Woude syndrome,0,4,1,23,"
van der Woude syndrome (VWS), which has been mapped to 1q32-41, is characterized by pits and/or sinuses of the lower lip, cleft lip/palate (CL/P), cleft palate (CP), bifid uvula, and hypodontia (H).",10417286_1,-1,446,-1,0.24193965
447,cleft palate,34,36,148,160,"
van der Woude syndrome (VWS), which has been mapped to 1q32-41, is characterized by pits and/or sinuses of the lower lip, cleft lip/palate (CL/P), cleft palate (CP), bifid uvula, and hypodontia (H).",10417286_1,-1,447,-1,0.2427455
448,CP,37,38,162,164,"
van der Woude syndrome (VWS), which has been mapped to 1q32-41, is characterized by pits and/or sinuses of the lower lip, cleft lip/palate (CL/P), cleft palate (CP), bifid uvula, and hypodontia (H).",10417286_1,-1,448,-1,0.2578196
449,CP,6,7,32,34,Both the occurrence of CL/P and CP within the same genealogy and a recurrence risk < 40% for CP among descendants with VWS have suggested that the development of clefts in this syndrome is influenced by modifying genes at other loci.,10417286_3,-1,449,-1,0.2519075
450,recurrence,13,14,67,77,Both the occurrence of CL/P and CP within the same genealogy and a recurrence risk < 40% for CP among descendants with VWS have suggested that the development of clefts in this syndrome is influenced by modifying genes at other loci.,10417286_3,-1,450,-1,0.26811513
451,CP,19,20,93,95,Both the occurrence of CL/P and CP within the same genealogy and a recurrence risk < 40% for CP among descendants with VWS have suggested that the development of clefts in this syndrome is influenced by modifying genes at other loci.,10417286_3,-1,451,-1,0.23796976
452,syndrome,33,34,177,185,Both the occurrence of CL/P and CP within the same genealogy and a recurrence risk < 40% for CP among descendants with VWS have suggested that the development of clefts in this syndrome is influenced by modifying genes at other loci.,10417286_3,-1,452,-1,0.18549043
453,CP,24,25,144,146,"To test this hypothesis, we have conducted linkage analysis in a large Brazilian kindred with VWS, considering as affected the individuals with CP, regardless of whether it is associated with other clinical signs of VWS.",10417286_4,-1,453,-1,0.23868516
454,CP,32,33,123,125,"Our results suggest that a gene at 17p11. 2-11 2-11. 1, together with the VWS gene at 1p32-41, enhances the probability of CP in an individual carrying the two at-risk genes.",10417286_5,-1,454,-1,0.27690595
455,syndrome,7,8,42,50,A novel frameshift mutation in the McLeod syndrome gene in a Japanese family.,10426139_0,-1,455,-1,0.23350134
456,syndrome,18,19,82,90,"
We report a novel mutation in the XK gene (XK) in a Japanese patient with McLeod syndrome.",10426139_1,-1,456,-1,0.19760647
457,muscular atrophy,5,7,37,53,"A 50-year-old man showed progressive muscular atrophy, choreic movement, elevated level of serum creatinine kinase, and acanthocytosis.",10426139_2,-1,457,-1,0.18052767
458,creatinine,15,16,97,107,"A 50-year-old man showed progressive muscular atrophy, choreic movement, elevated level of serum creatinine kinase, and acanthocytosis.",10426139_2,-1,458,-1,0.3332649
459,nucleotide,24,25,141,151,The expression level of all the Kell antigens in erythrocyte was decreased and molecular analysis revealed a single-base (T) deletion at the nucleotide position 1095 in XK.,10426139_3,-1,459,-1,0.31201956
460,amino acid,16,18,91,101,"This deletion caused a frameshift in translation, leading to a premature stop codon at the amino acid position 408.",10426139_4,-1,460,-1,0.35102397
464,phenylalanine,13,14,94,107,"Relationship among genotype, biochemical phenotype, and cognitive performance in females with phenylalanine hydroxylase deficiency: report from the Maternal Phenylketonuria Collaborative Study.",10429004_0,-1,464,-1,0.23927706
465,phenylalanine,7,8,43,56,"
OBJECTIVE  To examine the relationship of phenylalanine hydroxylase (PAH) genotypes to biochemical phenotype and cognitive development in maternal phenylketonuria (PKU).",10429004_1,-1,465,-1,0.26117554
466,PAH,10,11,70,73,"
OBJECTIVE  To examine the relationship of phenylalanine hydroxylase (PAH) genotypes to biochemical phenotype and cognitive development in maternal phenylketonuria (PKU).",10429004_1,-1,466,-1,0.23939742
467,PAH,2,3,13,16,METHODOLOGY  PAH gene mutations were examined in 222 hyperphenylalaninemic females enrolled in the Maternal PKU Collaborative Study (MPKUCS).,10429004_2,-1,467,-1,0.23131533
468,phenylalanine,19,20,141,154,RESULTS  The biochemical phenotype predicted from the genotype in functionally hemizygous patients was related significantly to the assigned phenylalanine level.,10429004_8,-1,468,-1,0.28699863
469,xanthomatosis,1,2,7,20,Spinal xanthomatosis: a variant of cerebrotendinous xanthomatosis.,10430841_0,-1,469,-1,0.19905752
470,xanthomatosis,7,8,52,65,Spinal xanthomatosis: a variant of cerebrotendinous xanthomatosis.,10430841_0,-1,470,-1,0.18495789
471,syndrome,16,17,98,106,"
We describe seven Dutch patients from six families with a slowly progressive, mainly spinal cord syndrome that remained for many years the sole expression of cerebrotendinous xanthomatosis (CTX).",10430841_1,-1,471,-1,0.19219087
472,xanthomatosis,27,28,176,189,"
We describe seven Dutch patients from six families with a slowly progressive, mainly spinal cord syndrome that remained for many years the sole expression of cerebrotendinous xanthomatosis (CTX).",10430841_1,-1,472,-1,0.1871811
473,CTX,29,30,191,194,"
We describe seven Dutch patients from six families with a slowly progressive, mainly spinal cord syndrome that remained for many years the sole expression of cerebrotendinous xanthomatosis (CTX).",10430841_1,-1,473,-1,0.23014623
474,xanthomatosis,4,5,24,37,We conclude that spinal xanthomatosis is a clinical and radiological separate entity of CTX that should be included in the differential diagnosis of chronic myelopathy..,10430841_5,-1,474,-1,0.20243938
475,CTX,13,14,88,91,We conclude that spinal xanthomatosis is a clinical and radiological separate entity of CTX that should be included in the differential diagnosis of chronic myelopathy..,10430841_5,-1,475,-1,0.2634044
476,myelopathy,24,25,157,167,We conclude that spinal xanthomatosis is a clinical and radiological separate entity of CTX that should be included in the differential diagnosis of chronic myelopathy..,10430841_5,-1,476,-1,0.17268516
477,chromosome deletion,6,8,43,62,A transgene insertion creating a heritable chromosome deletion mouse model of Prader-Willi and angelman syndromes.,10430930_0,-1,477,-1,0.23989426
478,Prader-Willi syndrome,0,2,1,22,"
Prader-Willi syndrome (PWS) and Angelman syndrome (AS) result from the loss of function of imprinted genes in human chromosome 15q11-q13.",10430930_1,-1,478,-1,0.23609366
479,Angelman syndrome,6,8,33,50,"
Prader-Willi syndrome (PWS) and Angelman syndrome (AS) result from the loss of function of imprinted genes in human chromosome 15q11-q13.",10430930_1,-1,479,-1,0.22503944
480,van der Woude syndrome,5,9,28,50,Linkage analysis of 5 novel van der Woude syndrome kindreds to 1q32-q41 markers further supports locus homogeneity of the disease trait.,10434119_0,-1,480,-1,0.24322668
481,disease,19,20,122,129,Linkage analysis of 5 novel van der Woude syndrome kindreds to 1q32-q41 markers further supports locus homogeneity of the disease trait.,10434119_0,-1,481,-1,0.2126157
482,van der Woude syndrome,0,4,1,23,"
van der Woude syndrome (vWS, MIM 119300) is a rare autosomal dominant clefting condition with cardinal features of mucous cysts (lower-lip pits) and clefts to the lip and/or palate.",10434119_1,-1,482,-1,0.23253162
483,cysts,22,23,123,128,"
van der Woude syndrome (vWS, MIM 119300) is a rare autosomal dominant clefting condition with cardinal features of mucous cysts (lower-lip pits) and clefts to the lip and/or palate.",10434119_1,-1,483,-1,0.19519891
484,cleft lip,11,13,72,81,"We have investigated 5 novel vWS families through probands attended for cleft lip and/or palate repair at the Department of Maxillofacial Surgery of Hopital Trousseau, Paris, in order to tentatively refine the genetic map of the vWS region in 1q32-q41 and possibly identify unlinked pedigrees.",10434119_3,-1,484,-1,0.20019764
485,map,35,36,218,221,"We have investigated 5 novel vWS families through probands attended for cleft lip and/or palate repair at the Department of Maxillofacial Surgery of Hopital Trousseau, Paris, in order to tentatively refine the genetic map of the vWS region in 1q32-q41 and possibly identify unlinked pedigrees.",10434119_3,-1,485,-1,0.22871217
486,disease,21,22,122,129,Our results support linkage of vWS within a region of tightly linked markers and do not favour locus heterogeneity of the disease trait.,10434119_8,-1,486,-1,0.21071433
487,Wilson disease,7,9,35,49,Null mutation of the murine ATP7B (Wilson disease) gene results in intracellular copper accumulation and late-onset hepatic nodular transformation.,10441329_0,-1,487,-1,0.22656082
488,copper,14,15,81,87,Null mutation of the murine ATP7B (Wilson disease) gene results in intracellular copper accumulation and late-onset hepatic nodular transformation.,10441329_0,-1,488,-1,0.23690277
489,lead,5,6,28,32,"Mutations in the ATP7B gene lead to Wilson disease, a copper toxicity disorder characterized by dramatic build-up of intracellular hepatic copper with subsequent hepatic and neuro-logical abnormalities.",10441329_2,-1,489,-1,0.27087876
490,Wilson disease,7,9,36,50,"Mutations in the ATP7B gene lead to Wilson disease, a copper toxicity disorder characterized by dramatic build-up of intracellular hepatic copper with subsequent hepatic and neuro-logical abnormalities.",10441329_2,-1,490,-1,0.21408026
491,copper toxicity,11,13,54,69,"Mutations in the ATP7B gene lead to Wilson disease, a copper toxicity disorder characterized by dramatic build-up of intracellular hepatic copper with subsequent hepatic and neuro-logical abnormalities.",10441329_2,-1,491,-1,0.20620476
492,copper,21,22,139,145,"Mutations in the ATP7B gene lead to Wilson disease, a copper toxicity disorder characterized by dramatic build-up of intracellular hepatic copper with subsequent hepatic and neuro-logical abnormalities.",10441329_2,-1,492,-1,0.23524249
493,Wilson disease,27,29,153,167,"Using homologous recombination to disrupt the normal translation of ATP7B, we have generated a strain of mice that are homozygous mutants (null) for the Wilson disease gene.",10441329_3,-1,493,-1,0.21482708
494,copper,10,11,62,68,The ATP7B null mice display a gradual accumulation of hepatic copper that increases to a level 60-fold greater than normal by 5 months of age.,10441329_4,-1,494,-1,0.26759434
495,copper,3,4,15,21,"An increase in copper concentration was also observed in the kidney, brain, placenta and lactating mammary glands of homo-zygous mutants, although milk from the mutant glands was copper deficient.",10441329_5,-1,495,-1,0.25102514
496,copper,30,31,179,185,"An increase in copper concentration was also observed in the kidney, brain, placenta and lactating mammary glands of homo-zygous mutants, although milk from the mutant glands was copper deficient.",10441329_5,-1,496,-1,0.24504405
498,neurological abnormalities,7,9,54,80,Progeny of the homozygous mutant females demonstrated neurological abnormalities and growth retardation characteristic of copper deficiency.,10441329_7,-1,498,-1,0.21655701
499,growth retardation,10,12,85,103,Progeny of the homozygous mutant females demonstrated neurological abnormalities and growth retardation characteristic of copper deficiency.,10441329_7,-1,499,-1,0.19727343
500,copper,14,15,122,128,Progeny of the homozygous mutant females demonstrated neurological abnormalities and growth retardation characteristic of copper deficiency.,10441329_7,-1,500,-1,0.24334793
501,Copper,0,1,0,6,Copper concentration in the livers of the newborn homozygous null mutants was decreased dramatically.,10441329_8,-1,501,-1,0.25279504
502,cirrhotic liver disease,13,16,69,92,"In summary, inactivation of the murine ATP7B gene produces a form of cirrhotic liver disease that resembles Wilson disease in humans and the toxic milk phenotype in the mouse..",10441329_9,-1,502,-1,0.17186226
503,Wilson disease,18,20,108,122,"In summary, inactivation of the murine ATP7B gene produces a form of cirrhotic liver disease that resembles Wilson disease in humans and the toxic milk phenotype in the mouse..",10441329_9,-1,503,-1,0.20960934
504,Machado-Joseph disease,1,3,7,29,French Machado-Joseph disease patients do not exhibit gametic segregation distortion: a sperm typing analysis.,10441343_0,-1,504,-1,0.22829524
505,Machado-Joseph disease,15,17,84,106,"On the basis of a sperm typing study performed in patients of Japanese descent with Machado-Joseph disease (MJD), it was reported that disease alleles are preferentially transmitted during meiosis.",10441343_2,-1,505,-1,0.24195695
506,disease,25,26,135,142,"On the basis of a sperm typing study performed in patients of Japanese descent with Machado-Joseph disease (MJD), it was reported that disease alleles are preferentially transmitted during meiosis.",10441343_2,-1,506,-1,0.2124846
507,disease,10,11,51,58,"Among 910 sperm analyzed, the allele linked to the disease chromosome was detected in 50.",10441343_5,-1,507,-1,0.2502823
508,P,12,13,69,70,The difference in frequency of these two alleles is not significant (P = 0. 8423).,10441343_8,-1,508,-1,0.33815107
509,disease,10,11,65,72,The previous report on the Japanese patients also suggested that disease allele stability may be influenced by a trans effect of an intragenic polymorphism (987 G/C) in the wild-type allele.,10441343_10,-1,509,-1,0.22091125
510,aniridia,23,24,138,146,"
The PAX6 gene is involved in ocular morphogenesis, and PAX6 mutations have been detected in various types of ocular anomalies, including aniridia, Peters anomaly, corneal dystrophy, congenital cataract, and foveal hypoplasia.",10441571_1,-1,510,-1,0.23652743
511,Peters anomaly,25,27,148,162,"
The PAX6 gene is involved in ocular morphogenesis, and PAX6 mutations have been detected in various types of ocular anomalies, including aniridia, Peters anomaly, corneal dystrophy, congenital cataract, and foveal hypoplasia.",10441571_1,-1,511,-1,0.26331955
513,amino acids,10,12,46,57,"The insertion, into the NTS, of 14 additional amino acids encoded by exon 5a abolishes the DNA-binding activity of the NTS and unmasks the DNA-binding ability of the CTS.",10441571_5,-1,513,-1,0.27451885
514,Peters anomaly,10,12,64,78,"We ascertained a novel missense mutation in four pedigrees with Peters anomaly, congenital cataract, Axenfeldt anomaly, and/or foveal hypoplasia, which, to our knowledge, is the first mutation identified in the splice-variant region.",10441571_7,-1,514,-1,0.24462591
516,nucleotide,8,9,33,43,A T-- > A transition at the 20th nucleotide position of exon 5a results in a Val-- > Asp (GTC-- > GAC) substitution at the 7th codon of the alternative splice region.,10441571_8,-1,516,-1,0.2842393
521,n,20,21,114,115,Index cases for the present study were found two different ways  through a series of consecutive ovarian cancers (n = 16) and through our family cancer clinic (n = 14).,10441573_3,-1,521,-1,0.26419377
523,n,31,32,160,161,Index cases for the present study were found two different ways  through a series of consecutive ovarian cancers (n = 16) and through our family cancer clinic (n = 14).,10441573_3,-1,523,-1,0.26046497
525,disease,5,6,31,38,The overall findings were that disease started to occur at age 30 years and that by age 50 years 48% of the mutation-carrying women had experienced breast and/or ovarian cancer.,10441573_7,-1,525,-1,0.19788323
531,dermatofibrosarcoma,1,2,4,23,The dermatofibrosarcoma protuberans-associated collagen type Ialpha1/platelet-derived growth factor (PDGF) B-chain fusion gene generates a transforming protein that is processed to functional PDGF-BB.,10446987_0,-1,531,-1,0.18800038
532,Dermatofibrosarcoma,0,1,1,20,"
Dermatofibrosarcoma protuberans (DFSP) displays chromosomal rearrangements involving chromosome 17 and 22, which fuse the collagen type Ialpha1 (COLIA1) gene to the platelet-derived growth factor (PDGF) B-chain (PDGFB) gene.",10446987_1,-1,532,-1,0.18726085
534,c,8,9,65,66,"Finally, COLIA1/PDGFB-expressing cells generated tumors after s. c c. injection into nude mice, and tumor growth was reduced by treatment with CGP57148B.",10446987_7,-1,534,-1,0.3374399
537,Zellweger syndrome,7,9,44,62,Identification of a common PEX1 mutation in Zellweger syndrome.,10447258_0,-1,537,-1,0.22365661
538,disease,4,5,27,34,"
The Zellweger spectrum of disease, encompassing Zellweger syndrome and the progressively milder phenotypes of neonatal adrenoleukodystrophy and infantile Refsum disease, is due to a failure to form functional peroxisomes.",10447258_1,-1,538,-1,0.19698836
539,Zellweger syndrome,7,9,49,67,"
The Zellweger spectrum of disease, encompassing Zellweger syndrome and the progressively milder phenotypes of neonatal adrenoleukodystrophy and infantile Refsum disease, is due to a failure to form functional peroxisomes.",10447258_1,-1,539,-1,0.23581804
540,adrenoleukodystrophy,16,17,120,140,"
The Zellweger spectrum of disease, encompassing Zellweger syndrome and the progressively milder phenotypes of neonatal adrenoleukodystrophy and infantile Refsum disease, is due to a failure to form functional peroxisomes.",10447258_1,-1,540,-1,0.19117987
541,Refsum disease,19,21,155,169,"
The Zellweger spectrum of disease, encompassing Zellweger syndrome and the progressively milder phenotypes of neonatal adrenoleukodystrophy and infantile Refsum disease, is due to a failure to form functional peroxisomes.",10447258_1,-1,541,-1,0.24537921
542,diseases,7,8,60,68,"Cell fusion complementation studies demonstrated that these diseases are genetically heterogeneous, with two-thirds of all patients lying within a single complementation group, CG1.",10447258_2,-1,542,-1,0.18253122
543,Zellweger syndrome,23,25,130,148,"However, previous studies have focused on mildly affected patients and there is still no report of two mutant PEX1 alleles in any Zellweger syndrome patient.",10447258_4,-1,543,-1,0.21878514
544,Zellweger syndrome,13,15,74,92,"Furthermore, mutations in the PMP70 gene have also been identified in two Zellweger syndrome patients from CG1, raising the possibility that CG1 patients may represent a mixture of PEX1-deficient and PMP70-deficient individuals.",10447258_5,-1,544,-1,0.22483464
545,disease,6,7,34,41,"To address the molecular basis of disease in Zellweger syndrome patients from CG1, we examined all 24 PEX1 exons in four patients, including both patients that have mutations in PMP70.",10447258_6,-1,545,-1,0.21018715
546,Zellweger syndrome,8,10,45,63,"To address the molecular basis of disease in Zellweger syndrome patients from CG1, we examined all 24 PEX1 exons in four patients, including both patients that have mutations in PMP70.",10447258_6,-1,546,-1,0.23220341
547,c.,14,15,79,81,"PEX1 mutations were detected in all four patients, including a 1-bp insertion (c. 2097insT) in exon 13 that was present in three of the four patients.",10447258_7,-1,547,-1,0.3379531
548,Zellweger syndrome,18,20,118,136,Subsequent studies demonstrated that this mutation is present in one-half of all CG1 patients and correlates with the Zellweger syndrome phenotype.,10447258_8,-1,548,-1,0.20610552
549,Zellweger syndrome,19,21,101,119,"As this mutation leads to a loss of protein function its frequency makes it the most common cause of Zellweger syndrome, helping to explain the high percentage of patients that belong to CG1.",10447258_9,-1,549,-1,0.215949
550,Wiskott-Aldrich syndrome,4,6,23,47,"Novel mutations in the Wiskott-Aldrich syndrome protein gene and their effects on transcriptional, translational, and clinical phenotypes.",10447259_0,-1,550,-1,0.18724245
551,Wiskott-Aldrich syndrome,0,2,1,25,"
Wiskott-Aldrich syndrome (WAS) is an X-linked recessive immunodeficiency characterized by thrombocytopenia, eczema, and recurrent infections, and caused by mutations in the WAS protein (WASP) gene.",10447259_1,-1,551,-1,0.19973636
552,immunodeficiency,9,10,57,73,"
Wiskott-Aldrich syndrome (WAS) is an X-linked recessive immunodeficiency characterized by thrombocytopenia, eczema, and recurrent infections, and caused by mutations in the WAS protein (WASP) gene.",10447259_1,-1,552,-1,0.16152424
554,eczema,14,15,109,115,"
Wiskott-Aldrich syndrome (WAS) is an X-linked recessive immunodeficiency characterized by thrombocytopenia, eczema, and recurrent infections, and caused by mutations in the WAS protein (WASP) gene.",10447259_1,-1,554,-1,0.18626359
556,Aminoglycoside,0,1,0,14,Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice.,10449429_0,-1,556,-1,0.2622896
557,muscular dystrophy,1,3,10,28,"
Duchenne muscular dystrophy (DMD) is caused by mutations in the dystrophin gene, leading to the absence of the dystrophin protein in striated muscle.",10449429_1,-1,557,-1,0.18103606
558,aminoglycoside,7,8,37,51,"On the basis of the observation that aminoglycoside treatment can suppress stop codons in cultured cells, we tested the effect of gentamicin on cultured muscle cells from the mdx mouse - an animal model for DMD that possesses a premature stop codon in the dystrophin gene.",10449429_3,-1,558,-1,0.25326696
559,gentamicin,22,23,130,140,"On the basis of the observation that aminoglycoside treatment can suppress stop codons in cultured cells, we tested the effect of gentamicin on cultured muscle cells from the mdx mouse - an animal model for DMD that possesses a premature stop codon in the dystrophin gene.",10449429_3,-1,559,-1,0.24207473
560,gentamicin,5,6,28,38,Exposure of mdx myotubes to gentamicin led to the expression and localization of dystrophin to the cell membrane.,10449429_4,-1,560,-1,0.26400355
561,gentamicin,9,10,54,64,We then evaluated the effects of differing dosages of gentamicin on expression and functional protection of the muscles of mdx mice.,10449429_5,-1,561,-1,0.24956642
562,aminoglycosides,12,13,64,79,"To our knowledge, our results are the first to demonstrate that aminoglycosides can suppress stop codons not only in vitro but also in vivo.",10449429_7,-1,562,-1,0.26243037
563,muscular dystrophy,13,15,82,100,"Furthermore, these results raise the possibility of a novel treatment regimen for muscular dystrophy and other diseases caused by premature stop codon mutations.",10449429_8,-1,563,-1,0.17957559
564,diseases,17,18,111,119,"Furthermore, these results raise the possibility of a novel treatment regimen for muscular dystrophy and other diseases caused by premature stop codon mutations.",10449429_8,-1,564,-1,0.17005016
566,neurodegeneration,21,22,140,157,"
Ataxia-telangiectasia (A-T) is characterized by a markedly increased sensitivity to ionizing radiation, increased incidence of cancer, and neurodegeneration, especially of the cerebellar Purkinje cells.",10449794_1,-1,566,-1,0.19738579
567,tissue damage,6,8,54,67,Ionizing radiation oxidizes macromolecules and causes tissue damage through the generation of reactive oxygen species (ROS).,10449794_2,-1,567,-1,0.19893247
568,reactive oxygen species,12,15,94,117,Ionizing radiation oxidizes macromolecules and causes tissue damage through the generation of reactive oxygen species (ROS).,10449794_2,-1,568,-1,0.22815536
569,diastrophic dysplasia,9,11,53,74,"
We have observed over 25 different mutations in the diastrophic dysplasia sulphate transporter gene (DTDST) in association with the recessive disorders achondrogenesis 1B, atelosteogenesis 2, and diastrophic dysplasia.",10465113_1,-1,569,-1,0.22019878
570,achondrogenesis,23,24,153,168,"
We have observed over 25 different mutations in the diastrophic dysplasia sulphate transporter gene (DTDST) in association with the recessive disorders achondrogenesis 1B, atelosteogenesis 2, and diastrophic dysplasia.",10465113_1,-1,570,-1,0.2574349
571,diastrophic dysplasia,30,32,197,218,"
We have observed over 25 different mutations in the diastrophic dysplasia sulphate transporter gene (DTDST) in association with the recessive disorders achondrogenesis 1B, atelosteogenesis 2, and diastrophic dysplasia.",10465113_1,-1,571,-1,0.21693942
572,cm,29,30,133,135,We had not seen a case of homozygosity for c862t (R279W) until we analysed DNA from a 36 year old male with tall-normal stature (180 cm) who asked for genetic counselling for suspected multiple epiphyseal dysplasia.,10465113_3,-1,572,-1,0.2539397
573,Cleft palate,0,2,0,12,"Cleft palate, swelling of the ear pinna, and hitch hiker thumb were absent.",10465113_6,-1,573,-1,0.27910733
574,swelling,3,4,14,22,"Cleft palate, swelling of the ear pinna, and hitch hiker thumb were absent.",10465113_6,-1,574,-1,0.27968705
575,diastrophic dysplasia,17,19,97,118,Homozygosity for a novel DTDST mutation in a child with a 'broad bone-platyspondylic' variant of diastrophic dysplasia.,10466420_0,-1,575,-1,0.21201377
576,diastrophic dysplasia,9,11,54,75,"We report on a girl with clinical features suggesting diastrophic dysplasia but with unusual radiographic features including severe platyspondyly, wide metaphyses, and fibular overgrowth, which are partially reminiscent of metatropic dysplasia.",10466420_2,-1,576,-1,0.22598562
580,disease,10,11,70,77,"Clues from attenuated polyposis, missense germline variants with mild disease and the somatic mutation cluster region (codons 1, 250-1, 450) indicate, however, that APC mutations might not result in simple loss of protein function.",10470088_4,-1,580,-1,0.20950013
581,colorectal adenomas,32,34,147,166,"We have found that FAP patients with germline APC mutations within a small region (codons 1, 194-1, 392 at most) mainly show allelic loss in their colorectal adenomas, in contrast to other FAP patients, whose second hits tend to occur by truncating mutations in the mutation cluster region.",10470088_5,-1,581,-1,0.15964125
582,contrast,36,37,171,179,"We have found that FAP patients with germline APC mutations within a small region (codons 1, 194-1, 392 at most) mainly show allelic loss in their colorectal adenomas, in contrast to other FAP patients, whose second hits tend to occur by truncating mutations in the mutation cluster region.",10470088_5,-1,582,-1,0.27841622
584,disease,8,9,47,54,"Our findings also indicate a new mechanism for disease severity  if a broader spectrum of mutations is selected in tumors, the somatic mutation rate is effectively higher and more tumors grow..",10470088_10,-1,584,-1,0.17502674
594,Val,12,13,54,57,"We discovered a missense mutation, GCA to GTA (Ala 54 Val), in exon 2 in a neurofibrosarcoma patient (case 1), two missense mutations, AAA to CAA (Lys 118 Gln) and GAA to GGA (Glu 154 Gly) in exon 5 of another neurofibrosarcoma patient (case 2), and 3 amino acid substitutions, GTG to GCG (Val 179 Ala), GTT to GCT (Val 181 Ala) and TTC to CTC (Phe 186 Leu), in a third neurofibrosarcoma patient (case 3).",10470286_6,-1,594,-1,0.26945996
595,neurofibrosarcoma,20,21,75,92,"We discovered a missense mutation, GCA to GTA (Ala 54 Val), in exon 2 in a neurofibrosarcoma patient (case 1), two missense mutations, AAA to CAA (Lys 118 Gln) and GAA to GGA (Glu 154 Gly) in exon 5 of another neurofibrosarcoma patient (case 2), and 3 amino acid substitutions, GTG to GCG (Val 179 Ala), GTT to GCT (Val 181 Ala) and TTC to CTC (Phe 186 Leu), in a third neurofibrosarcoma patient (case 3).",10470286_6,-1,595,-1,0.17582804
596,CAA,33,34,142,145,"We discovered a missense mutation, GCA to GTA (Ala 54 Val), in exon 2 in a neurofibrosarcoma patient (case 1), two missense mutations, AAA to CAA (Lys 118 Gln) and GAA to GGA (Glu 154 Gly) in exon 5 of another neurofibrosarcoma patient (case 2), and 3 amino acid substitutions, GTG to GCG (Val 179 Ala), GTT to GCT (Val 181 Ala) and TTC to CTC (Phe 186 Leu), in a third neurofibrosarcoma patient (case 3).",10470286_6,-1,596,-1,0.3528557
597,Glu,44,45,176,179,"We discovered a missense mutation, GCA to GTA (Ala 54 Val), in exon 2 in a neurofibrosarcoma patient (case 1), two missense mutations, AAA to CAA (Lys 118 Gln) and GAA to GGA (Glu 154 Gly) in exon 5 of another neurofibrosarcoma patient (case 2), and 3 amino acid substitutions, GTG to GCG (Val 179 Ala), GTT to GCT (Val 181 Ala) and TTC to CTC (Phe 186 Leu), in a third neurofibrosarcoma patient (case 3).",10470286_6,-1,597,-1,0.33631754
598,neurofibrosarcoma,53,54,210,227,"We discovered a missense mutation, GCA to GTA (Ala 54 Val), in exon 2 in a neurofibrosarcoma patient (case 1), two missense mutations, AAA to CAA (Lys 118 Gln) and GAA to GGA (Glu 154 Gly) in exon 5 of another neurofibrosarcoma patient (case 2), and 3 amino acid substitutions, GTG to GCG (Val 179 Ala), GTT to GCT (Val 181 Ala) and TTC to CTC (Phe 186 Leu), in a third neurofibrosarcoma patient (case 3).",10470286_6,-1,598,-1,0.17962365
599,amino acid,62,64,252,262,"We discovered a missense mutation, GCA to GTA (Ala 54 Val), in exon 2 in a neurofibrosarcoma patient (case 1), two missense mutations, AAA to CAA (Lys 118 Gln) and GAA to GGA (Glu 154 Gly) in exon 5 of another neurofibrosarcoma patient (case 2), and 3 amino acid substitutions, GTG to GCG (Val 179 Ala), GTT to GCT (Val 181 Ala) and TTC to CTC (Phe 186 Leu), in a third neurofibrosarcoma patient (case 3).",10470286_6,-1,599,-1,0.340439
600,Val,70,71,290,293,"We discovered a missense mutation, GCA to GTA (Ala 54 Val), in exon 2 in a neurofibrosarcoma patient (case 1), two missense mutations, AAA to CAA (Lys 118 Gln) and GAA to GGA (Glu 154 Gly) in exon 5 of another neurofibrosarcoma patient (case 2), and 3 amino acid substitutions, GTG to GCG (Val 179 Ala), GTT to GCT (Val 181 Ala) and TTC to CTC (Phe 186 Leu), in a third neurofibrosarcoma patient (case 3).",10470286_6,-1,600,-1,0.33684412
601,Val,79,80,316,319,"We discovered a missense mutation, GCA to GTA (Ala 54 Val), in exon 2 in a neurofibrosarcoma patient (case 1), two missense mutations, AAA to CAA (Lys 118 Gln) and GAA to GGA (Glu 154 Gly) in exon 5 of another neurofibrosarcoma patient (case 2), and 3 amino acid substitutions, GTG to GCG (Val 179 Ala), GTT to GCT (Val 181 Ala) and TTC to CTC (Phe 186 Leu), in a third neurofibrosarcoma patient (case 3).",10470286_6,-1,601,-1,0.32304612
602,TTC,84,85,333,336,"We discovered a missense mutation, GCA to GTA (Ala 54 Val), in exon 2 in a neurofibrosarcoma patient (case 1), two missense mutations, AAA to CAA (Lys 118 Gln) and GAA to GGA (Glu 154 Gly) in exon 5 of another neurofibrosarcoma patient (case 2), and 3 amino acid substitutions, GTG to GCG (Val 179 Ala), GTT to GCT (Val 181 Ala) and TTC to CTC (Phe 186 Leu), in a third neurofibrosarcoma patient (case 3).",10470286_6,-1,602,-1,0.36343187
603,Phe,88,89,345,348,"We discovered a missense mutation, GCA to GTA (Ala 54 Val), in exon 2 in a neurofibrosarcoma patient (case 1), two missense mutations, AAA to CAA (Lys 118 Gln) and GAA to GGA (Glu 154 Gly) in exon 5 of another neurofibrosarcoma patient (case 2), and 3 amino acid substitutions, GTG to GCG (Val 179 Ala), GTT to GCT (Val 181 Ala) and TTC to CTC (Phe 186 Leu), in a third neurofibrosarcoma patient (case 3).",10470286_6,-1,603,-1,0.37933734
604,neurofibrosarcoma,96,97,370,387,"We discovered a missense mutation, GCA to GTA (Ala 54 Val), in exon 2 in a neurofibrosarcoma patient (case 1), two missense mutations, AAA to CAA (Lys 118 Gln) and GAA to GGA (Glu 154 Gly) in exon 5 of another neurofibrosarcoma patient (case 2), and 3 amino acid substitutions, GTG to GCG (Val 179 Ala), GTT to GCT (Val 181 Ala) and TTC to CTC (Phe 186 Leu), in a third neurofibrosarcoma patient (case 3).",10470286_6,-1,604,-1,0.18387769
605,TTC,13,14,72,75,"In case 3, loss of heterozygosity was also demonstrated by informative (TTC) 3/(TTC) 2 polymorphism.",10470286_7,-1,605,-1,0.3049086
606,neurofibrosarcoma,11,12,62,79,Our data demonstrate that mutations occur in the Mxi1 gene in neurofibrosarcoma.,10470286_8,-1,606,-1,0.16454874
607,neurofibrosarcoma,18,19,106,123,Missense mutations in the functional domain of Mxi1 in these cases may be involved in the pathogenesis of neurofibrosarcoma..,10470286_9,-1,607,-1,0.15542315
608,hemochromatosis,9,10,59,74,A population-based study of the clinical expression of the hemochromatosis gene.,10471457_0,-1,608,-1,0.19468273
609,hemochromatosis,5,6,36,51,"
BACKGROUND AND METHODS  Hereditary hemochromatosis is associated with homozygosity for the C282Y mutation in the hemochromatosis (HFE) gene on chromosome 6, elevated serum transferrin saturation, and excess iron deposits throughout the body.",10471457_1,-1,609,-1,0.19072413
610,hemochromatosis,16,17,114,129,"
BACKGROUND AND METHODS  Hereditary hemochromatosis is associated with homozygosity for the C282Y mutation in the hemochromatosis (HFE) gene on chromosome 6, elevated serum transferrin saturation, and excess iron deposits throughout the body.",10471457_1,-1,610,-1,0.19627129
611,iron,32,33,208,212,"
BACKGROUND AND METHODS  Hereditary hemochromatosis is associated with homozygosity for the C282Y mutation in the hemochromatosis (HFE) gene on chromosome 6, elevated serum transferrin saturation, and excess iron deposits throughout the body.",10471457_1,-1,611,-1,0.22918287
612,iron,37,38,224,228,"In 1994, we obtained blood samples for the determination of serum transferrin saturation and ferritin levels and the presence or absence of the C282Y mutation and the H63D mutation (which may contribute to increased hepatic iron levels) in 3011 unrelated white adults.",10471457_3,-1,612,-1,0.22622506
613,ng,12,13,75,77,We recommended liver biopsy for subjects with serum ferritin levels of 300 ng per milliliter or higher.,10471457_5,-1,613,-1,0.3181555
614,hemochromatosis,12,13,73,88,"Four of the homozygous subjects had previously been given a diagnosis of hemochromatosis, and 12 had not.",10471457_9,-1,614,-1,0.2071681
616,alcohol,24,25,123,130,"Eleven of the 16 homozygous subjects underwent liver biopsy; 3 had hepatic fibrosis, and 1, who had a history of excessive alcohol consumption, had cirrhosis and mild microvesicular steatosis.",10471457_12,-1,616,-1,0.19266222
618,steatosis,32,33,182,191,"Eleven of the 16 homozygous subjects underwent liver biopsy; 3 had hepatic fibrosis, and 1, who had a history of excessive alcohol consumption, had cirrhosis and mild microvesicular steatosis.",10471457_12,-1,618,-1,0.2264451
619,hemochromatosis,17,18,111,126,"Eight of the 16 homozygous subjects had clinical findings that were consistent with the presence of hereditary hemochromatosis, such as hepatomegaly, skin pigmentation, and arthritis.",10471457_13,-1,619,-1,0.18474808
622,hemochromatosis,13,14,73,88,"However, only half of those who were homozygous had clinical features of hemochromatosis, and one quarter had serum ferritin levels that remained normal over a four-year period.",10471457_15,-1,622,-1,0.19669113
623,phenylalanine,22,23,122,135,We present a child in whom phenylketonuria was apparently caused by homozygosity for the mutation E390G in exon 11 of the phenylalanine hydroxylase (PAH) gene.,10472529_3,-1,623,-1,0.24849215
624,PAH,25,26,149,152,We present a child in whom phenylketonuria was apparently caused by homozygosity for the mutation E390G in exon 11 of the phenylalanine hydroxylase (PAH) gene.,10472529_3,-1,624,-1,0.22351344
625,disease,7,8,38,45,"However, the clinical severity of the disease was not quite as mild as expected, the mutation was not identified in the father despite confirmed paternity, and the paternal allele showed a highly unusual pattern of polymorphic markers in the PAH gene.",10472529_4,-1,625,-1,0.19947782
626,PAH,42,43,242,245,"However, the clinical severity of the disease was not quite as mild as expected, the mutation was not identified in the father despite confirmed paternity, and the paternal allele showed a highly unusual pattern of polymorphic markers in the PAH gene.",10472529_4,-1,626,-1,0.23199518
627,phenylalanine,14,15,65,78,"Presence of a large deletion involving exons 9, 10 and 11 of the phenylalanine hydroxylase gene was confirmed by long-range PCR.",10472529_5,-1,627,-1,0.2591785
628,X-linked Emery-Dreifuss muscular dystrophy,3,7,15,57,Early onset of X-linked Emery-Dreifuss muscular dystrophy in a boy with emerin gene deletion.,10480214_0,-1,628,-1,0.19355105
629,contractures,3,4,17,29,"
A boy developed contractures of the Achilles tendons at 3 years and of the postcervical muscles at 7 years, although neither contractures of the elbows nor cardiac abnormality were recognized by the age of 9 years.",10480214_1,-1,629,-1,0.25460234
630,contractures,22,23,126,138,"
A boy developed contractures of the Achilles tendons at 3 years and of the postcervical muscles at 7 years, although neither contractures of the elbows nor cardiac abnormality were recognized by the age of 9 years.",10480214_1,-1,630,-1,0.25298694
631,X-linked Emery-Dreifuss muscular dystrophy,6,10,41,83,"These results confirmed the diagnosis of X-linked Emery-Dreifuss muscular dystrophy (EDMD), and reinforce the necessity of molecular genetic diagnosis of the membrane protein emerin in younger patients with possible EDMD before appearance of the typical symptoms, to avoid sudden cardiac death..",10480214_4,-1,631,-1,0.20260568
632,sudden cardiac death,42,45,273,293,"These results confirmed the diagnosis of X-linked Emery-Dreifuss muscular dystrophy (EDMD), and reinforce the necessity of molecular genetic diagnosis of the membrane protein emerin in younger patients with possible EDMD before appearance of the typical symptoms, to avoid sudden cardiac death..",10480214_4,-1,632,-1,0.1878463
633,muscular dystrophy,1,3,16,34,Duchenne/Becker muscular dystrophy: correlation of phenotype by electroretinography with sites of dystrophin mutations.,10480348_0,-1,633,-1,0.17633656
634,muscular dystrophy,12,14,79,97,"
The dark-adapted electroretinogram (ERG) of patients with Duchenne and Becker muscular dystrophy (DMD/BMD) shows a marked reduction in b-wave amplitude.",10480348_1,-1,634,-1,0.18312517
635,disease,21,22,129,136,"Our results suggest that the most important determinant in the ERG b-wave phenotype is the mutation position, rather than muscle disease severity.",10480348_7,-1,635,-1,0.20334631
636,myotonic dystrophy,6,8,29,47,Cis and trans effects of the myotonic dystrophy (DM) mutation in a cell culture model.,10484765_0,-1,636,-1,0.18453221
637,DM,9,10,49,51,Cis and trans effects of the myotonic dystrophy (DM) mutation in a cell culture model.,10484765_0,-1,637,-1,0.22336936
638,myotonic dystrophy,3,5,22,40,"
The mutation causing myotonic dystrophy (DM) has been identified as a CTG expansion in the 3-untranslated region (3-UTR) of the DM protein kinase gene (DMPK), but the mechanism (s) of pathogenesis remain unknown.",10484765_1,-1,638,-1,0.17881598
639,DM,6,7,42,44,"
The mutation causing myotonic dystrophy (DM) has been identified as a CTG expansion in the 3-untranslated region (3-UTR) of the DM protein kinase gene (DMPK), but the mechanism (s) of pathogenesis remain unknown.",10484765_1,-1,639,-1,0.19732484
640,DM,24,25,129,131,"
The mutation causing myotonic dystrophy (DM) has been identified as a CTG expansion in the 3-untranslated region (3-UTR) of the DM protein kinase gene (DMPK), but the mechanism (s) of pathogenesis remain unknown.",10484765_1,-1,640,-1,0.23713712
641,DM,2,3,14,16,Studies using DM patient materials have often produced confusing results.,10484765_2,-1,641,-1,0.3224142
642,DM,8,9,39,41,"Therefore, to study the effects of the DM mutation in a controlled environment, we have established a cell culture model system using C2C12 mouse myoblasts.",10484765_3,-1,642,-1,0.24594346
643,DM,28,29,165,167,"By expressing chimeric reporter constructs containing a reporter gene fused to a human DMPK 3-UTR, we identified both cis and trans effects that are mediated by the DM mutation.",10484765_4,-1,643,-1,0.25838003
644,n,12,13,59,60,We determined by deletion analysis that an expanded (CTG) (n) tract alone was sufficient to mediate these cis effects.,10484765_6,-1,644,-1,0.34984142
645,contrast,3,4,16,24,"Furthermore, in contrast to the normal DMPK 3-UTR mRNA, a mutant DMPK 3-UTR mRNA with (CUG) (200) selectively inhibited myogenic differentiation of C2C12 myoblasts.",10484765_7,-1,645,-1,0.2843476
646,n,15,16,91,92,Characterization of spontaneous deletion events mapped the inhibitory effect to the (CTG) (n) expansion and/or the 3 end of the DMPK 3-UTR.,10484765_9,-1,646,-1,0.3719952
647,DM,6,7,40,42,These results provide evidence that the DM mutation acts in cis to reduce protein production (consistent with DMPK haploinsufficiency) and in trans as a riboregulator to inhibit myogenesis..,10484765_10,-1,647,-1,0.22232234
648,disease,2,3,7,14,Coats' disease of the retina (unilateral retinal telangiectasis) caused by somatic mutation in the NDP gene: a role for norrin in retinal angiogenesis.,10484772_0,-1,648,-1,0.20576464
649,retinal telangiectasis,8,10,41,63,Coats' disease of the retina (unilateral retinal telangiectasis) caused by somatic mutation in the NDP gene: a role for norrin in retinal angiogenesis.,10484772_0,-1,649,-1,0.20423128
650,disease,1,2,7,14,"
Coats disease is characterized by abnormal retinal vascular development (so-called retinal telangiectasis) which results in massive intraretinal and subretinal lipid accumulation (exudative retinal detachment).",10484772_1,-1,650,-1,0.21633609
651,retinal telangiectasis,11,13,84,106,"
Coats disease is characterized by abnormal retinal vascular development (so-called retinal telangiectasis) which results in massive intraretinal and subretinal lipid accumulation (exudative retinal detachment).",10484772_1,-1,651,-1,0.22238107
652,retinal detachment,25,27,191,209,"
Coats disease is characterized by abnormal retinal vascular development (so-called retinal telangiectasis) which results in massive intraretinal and subretinal lipid accumulation (exudative retinal detachment).",10484772_1,-1,652,-1,0.20315866
653,disease,5,6,28,35,"The classical form of Coats disease is almost invariably isolated, unilateral and seen in males.",10484772_2,-1,653,-1,0.23154885
654,disease,8,9,44,51,A female with a unilateral variant of Coats disease gave birth to a son affected by Norrie disease.,10484772_3,-1,654,-1,0.2069173
655,Norrie disease,16,18,84,98,A female with a unilateral variant of Coats disease gave birth to a son affected by Norrie disease.,10484772_3,-1,655,-1,0.21558271
656,disease,13,14,83,90,Subsequently analysis of the retinas of nine enucleated eyes from males with Coats disease demonstrated in one a somatic mutation in the NDP gene which was not present within non-retinal tissue.,10484772_6,-1,656,-1,0.21627355
657,telangiectasis,4,5,22,36,We suggest that Coats telangiectasis is secondary to somatic mutation in the NDP gene which results in a deficiency of norrin (the protein product of the NDP gene) within the developing retina.,10484772_7,-1,657,-1,0.24169926
658,Li-Fraumeni syndrome,12,14,71,91,Hereditary TP53 codon 292 and somatic P16INK4A codon 94 mutations in a Li-Fraumeni syndrome family.,10484981_0,-1,658,-1,0.2645109
659,Li-Fraumeni syndrome,0,2,1,21,"
Li-Fraumeni syndrome is an autosomal dominant disorder that is characterized by various types of cancer in childhood and adult cases.",10484981_1,-1,659,-1,0.2679085
662,Li-Fraumeni syndrome,18,20,110,130,"Although hereditary TP53 mutation is very rare in different human cancers, it has been frequently reported in Li-Fraumeni syndrome.",10484981_2,-1,662,-1,0.2596455
664,Li-Fraumeni syndrome,8,10,42,62,"In a Turkish family with the diagnosis of Li-Fraumeni syndrome, we analyzed the mutation pattern of TP53, P57KIP2, P15INK4B, and P16INK4A in the peripheral blood, and loss of heterozygosity (homo/hemizygous deletion) pattern of TP53 and P15INK4B/P16INK4A in two tumor tissues.",10484981_4,-1,664,-1,0.2866664
666,seminoma,4,5,21,29,"The propositus had a seminoma, his daughter a medulloblastoma, and one of his healthy cousins, a TP53 codon 292 missense point mutation (AAA-- > ATA; Lys-- > Ile) in the peripheral blood cells.",10484981_5,-1,666,-1,0.18758076
667,medulloblastoma,9,10,46,61,"The propositus had a seminoma, his daughter a medulloblastoma, and one of his healthy cousins, a TP53 codon 292 missense point mutation (AAA-- > ATA; Lys-- > Ile) in the peripheral blood cells.",10484981_5,-1,667,-1,0.17235264
669,seminoma,8,9,51,59,Tumor tissue obtained from the propositus with the seminoma revealed loss of heterozygosity in the TP53 gene.,10484981_6,-1,669,-1,0.19428809
671,Glu,27,28,137,140,"In the analyses of tumor tissues from the propositus and his daughter, a P16INK4A codon 94 missense point mutation (GCG-- > GAG; Ala-- > Glu) was observed with the hereditary TP53 mutation.",10484981_7,-1,671,-1,0.26244935
672,Li-Fraumeni syndrome,13,15,73,93,P16INK4A codon 94 mutation observed in our family is a novel mutation in Li-Fraumeni syndrome.,10484981_8,-1,672,-1,0.2719397
674,congenital hypothyroidism,11,13,76,101,"
We previously reported nine children with an autosomally recessive form of congenital hypothyroidism due to an iodide transport defect in a large Hutterite family with extensive consanguinity living in central Canada.",10487695_1,-1,674,-1,0.23300497
675,congenital hypothyroidism,8,10,45,70,"Since the original report, we have diagnosed congenital hypothyroidism by newborn TSH screening in 9 additional children from the family.",10487695_2,-1,675,-1,0.2474717
676,congenital hypothyroidism,17,19,97,122,It is now possible to use gene diagnostics of this unique NIS mutation to identify patients with congenital hypothyroidism due to an iodide transport defect in this family and to determine the carrier state of potential parents for genetic counseling and arranging rapid and early diagnosis of their infants.,10487695_9,-1,676,-1,0.21022533
677,diabetes insipidus,5,7,48,66,Molecular analysis in familial neurohypophyseal diabetes insipidus: early diagnosis of an asymptomatic carrier.,10487710_0,-1,677,-1,0.20953563
678,diabetes insipidus,2,4,27,45,"
Familial neurohypophyseal diabetes insipidus (FNDI) is an inherited deficiency of the hormone arginine vasopressin (AVP) and is transmitted as an autosomal dominant trait.",10487710_1,-1,678,-1,0.21789408
679,arginine vasopressin,14,16,95,115,"
Familial neurohypophyseal diabetes insipidus (FNDI) is an inherited deficiency of the hormone arginine vasopressin (AVP) and is transmitted as an autosomal dominant trait.",10487710_1,-1,679,-1,0.22170566
680,AVP,17,18,117,120,"
Familial neurohypophyseal diabetes insipidus (FNDI) is an inherited deficiency of the hormone arginine vasopressin (AVP) and is transmitted as an autosomal dominant trait.",10487710_1,-1,680,-1,0.26358944
681,AVP-NPII,6,7,32,40,The entire coding region of the AVP-NPII gene of all family members was amplified by PCR and sequenced.,10487710_5,-1,681,-1,0.282331
682,glycine,16,17,83,90,All affected individuals presented a missense mutation (G1757-- > A) that replaces glycine at position 23 with arginine within the NPII domain.,10487710_6,-1,682,-1,0.3060589
683,disease,30,31,156,163,"Additionally, one of the asymptomatic relatives (a girl 8 months old at the time of study) was identified as carrier of the same mutation and developed the disease 3 months later.",10487710_8,-1,683,-1,0.22597617
684,disease,19,20,99,106,"The alteration found in the second exon of the gene in this family seems to be responsible for the disease, as all individuals harboring the mutation had been previously diagnosed or have eventually developed FNDI.",10487710_9,-1,684,-1,0.20625378
685,ATP,5,6,33,36,Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia.,10500204_0,-1,685,-1,0.21043527
686,Friedreich ataxia,10,12,65,82,Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia.,10500204_0,-1,686,-1,0.22413976
687,Friedreich ataxia,0,2,1,18,"
Friedreich ataxia (FRDA), the most common of the inherited ataxias, is an autosomal recessive degenerative disorder, characterized clinically by onset before the age of 25 of progressive gait and limb ataxia, absence of deep tendon reflexes, extensor plantar responses, and loss of position and vibration sense in the lower limbs.",10500204_1,-1,687,-1,0.24074316
689,iron,32,33,210,214,Frataxin function is still unknown but the knockout of the yeast frataxin homologue gene (YFH1) showed a severe defect of mitochondrial respiration and loss of mtDNA associated with elevated intramitochondrial iron.,10500204_4,-1,689,-1,0.24888295
690,phosphorus,1,2,6,16,Using phosphorus magnetic resonance spectroscopy we demonstrated a maximum rate of muscle mitochondrial ATP production (V (max)) below the normal range in all 12 FRDA patients and a strong negative correlation between mitochondrial V (max) and the number of GAA repeats in the smaller allele.,10500204_6,-1,690,-1,0.33436432
691,ATP,13,14,104,107,Using phosphorus magnetic resonance spectroscopy we demonstrated a maximum rate of muscle mitochondrial ATP production (V (max)) below the normal range in all 12 FRDA patients and a strong negative correlation between mitochondrial V (max) and the number of GAA repeats in the smaller allele.,10500204_6,-1,691,-1,0.21982762
692,C,11,12,64,65,All patients were found to be homozygous for a newly identified C - > T transition in codon 21 (exon 2) substituting arginine for a premature stop codon (R21X  CGA to TGA) and generating a NlaIII restriction site.,10502833_3,-1,692,-1,0.3411771
693,sterol,3,4,16,22,Mutation of the sterol 27-hydroxylase gene (CYP27) results in truncation of mRNA expressed in leucocytes in a Japanese family with cerebrotendinous xanthomatosis.,10519880_0,-1,693,-1,0.2548262
694,xanthomatosis,23,24,148,161,Mutation of the sterol 27-hydroxylase gene (CYP27) results in truncation of mRNA expressed in leucocytes in a Japanese family with cerebrotendinous xanthomatosis.,10519880_0,-1,694,-1,0.1716124
695,xanthomatosis,7,8,53,66,"
OBJECTIVES  A Japanese family with cerebrotendinous xanthomatosis (CTX) was investigated for a sequence alteration in the sterol 27-hydroxylase gene (CYP27).",10519880_1,-1,695,-1,0.18911077
696,CTX,9,10,68,71,"
OBJECTIVES  A Japanese family with cerebrotendinous xanthomatosis (CTX) was investigated for a sequence alteration in the sterol 27-hydroxylase gene (CYP27).",10519880_1,-1,696,-1,0.22565752
697,Wolfram syndrome,7,9,46,62,Clinical and molecular genetic analysis of 19 Wolfram syndrome kindreds demonstrating a wide spectrum of mutations in WFS1.,10521293_0,-1,697,-1,0.22209397
698,Wolfram syndrome,0,2,1,17,"
Wolfram syndrome is an autosomal recessive neurodegenerative disorder characterized by juvenile-onset diabetes mellitus and progressive optic atrophy.",10521293_1,-1,698,-1,0.21156745
699,neurodegenerative,6,7,44,61,"
Wolfram syndrome is an autosomal recessive neurodegenerative disorder characterized by juvenile-onset diabetes mellitus and progressive optic atrophy.",10521293_1,-1,699,-1,0.18102005
700,diabetes mellitus,11,13,103,120,"
Wolfram syndrome is an autosomal recessive neurodegenerative disorder characterized by juvenile-onset diabetes mellitus and progressive optic atrophy.",10521293_1,-1,700,-1,0.1776538
701,optic atrophy,15,17,137,150,"
Wolfram syndrome is an autosomal recessive neurodegenerative disorder characterized by juvenile-onset diabetes mellitus and progressive optic atrophy.",10521293_1,-1,701,-1,0.18845367
702,amino acid,25,27,130,140,"mtDNA deletions have been described, and a gene (WFS1) recently has been identified, on chromosome 4p16, encoding a predicted 890 amino acid transmembrane protein.",10521293_2,-1,702,-1,0.269523
703,Wolfram syndrome,23,25,128,144,Direct DNA sequencing was done to screen the entire coding region of the WFS1 gene in 30 patients from 19 British kindreds with Wolfram syndrome.,10521293_3,-1,703,-1,0.20557113
704,disease,29,30,192,199,"Although some interesting cases were noted, consideration of the small sample size and frequency of each mutation indicated no clear-cut correlations between any of the observed mutations and disease severity.",10521293_10,-1,704,-1,0.2015599
705,Wolfram syndrome,5,7,31,47,"Hence, molecular screening for Wolfram syndrome in affected families and for Wolfram syndrome-carrier status in subjects with psychiatric disorders or diabetes mellitus will require complete analysis of exon 8 and upstream exons..",10521293_12,-1,705,-1,0.20404443
706,psychiatric disorders,18,20,126,147,"Hence, molecular screening for Wolfram syndrome in affected families and for Wolfram syndrome-carrier status in subjects with psychiatric disorders or diabetes mellitus will require complete analysis of exon 8 and upstream exons..",10521293_12,-1,706,-1,0.15674461
707,diabetes mellitus,21,23,151,168,"Hence, molecular screening for Wolfram syndrome in affected families and for Wolfram syndrome-carrier status in subjects with psychiatric disorders or diabetes mellitus will require complete analysis of exon 8 and upstream exons..",10521293_12,-1,707,-1,0.18231787
708,familial Mediterranean fever,1,4,11,39,"Late-onset familial Mediterranean fever (FMF): a subset with distinct clinical, demographic, and molecular genetic characteristics.",10528243_0,-1,708,-1,0.20987275
709,familial Mediterranean fever,14,17,93,121,"
To determine the prevalence and characterize demographic, clinical, and genetic features of familial Mediterranean fever (FMF) of late onset, all patients experiencing their first FMF attack at age 40 years or more were identified using the computerized registry of our FMF clinic, and then thoroughly interviewed and examined.",10528243_1,-1,709,-1,0.235007
710,disease,4,5,20,27,"The severity of the disease in patients and controls was determined using a modified score, developed previously.",10528243_3,-1,710,-1,0.24245131
711,P,11,12,61,62,"These patients were mostly men, of non-North African origin, P < 0.",10528243_6,-1,711,-1,0.3577179
712,disease,14,15,81,88,"All had abdominal attacks and in most these were the only manifestation of their disease, P < 0. 001 001.",10528243_8,-1,712,-1,0.2522704
713,P,16,17,90,91,"All had abdominal attacks and in most these were the only manifestation of their disease, P < 0. 001 001.",10528243_8,-1,713,-1,0.3350166
714,amyloidosis,12,13,66,77,"None had chronic or prolonged manifestations of FMF, for example, amyloidosis, chronic arthritis, or protracted myalgia, P < 0. 001.",10528243_9,-1,714,-1,0.21501853
717,P,21,22,121,122,"None had chronic or prolonged manifestations of FMF, for example, amyloidosis, chronic arthritis, or protracted myalgia, P < 0. 001.",10528243_9,-1,717,-1,0.3308337
718,P,12,13,70,71,"The response to treatment was good despite using low colchicine dose, P < 0. 05.",10528243_10,-1,718,-1,0.35504162
719,disease,7,8,44,51,"The overall severity score indicated a mild disease, P < 0. 001.",10528243_11,-1,719,-1,0.23858997
720,P,9,10,53,54,"The overall severity score indicated a mild disease, P < 0. 001.",10528243_11,-1,720,-1,0.30048522
721,P,8,9,60,61,"Mutational analysis revealed absence of M694V homozygosity, P < 0. 01, compared to our regular FMF population.",10528243_12,-1,721,-1,0.33501324
722,disease,16,17,73,80,"We conclude that the onset of FMF in a late age defines a milder form of disease with typical clinical, demographic, and molecular genetic characteristics",10528243_13,-1,722,-1,0.20224082
723,breast and ovarian cancer syndrome,2,7,16,50,"
The hereditary breast and ovarian cancer syndrome is associated with a high frequency of BRCA1 mutations.",10528853_1,-1,723,-1,0.16265267
724,nucleotide,4,5,22,32,All were confirmed by nucleotide sequencing.,10528853_7,-1,724,-1,0.2799106
725,uniparental disomy,1,3,9,27,Maternal uniparental disomy for chromosome 14 in a boy with a normal karyotype.,10528860_0,-1,725,-1,0.21892224
726,uniparental disomy,8,10,36,54,"
We report on a boy with a maternal uniparental disomy for chromosome 14 (UPD (14)).",10528860_1,-1,726,-1,0.21944913
727,Prader-Willi syndrome,17,19,84,105,At 7 years of age he was referred to us by the paediatrician because of symptoms of Prader-Willi syndrome (PWS).,10528860_2,-1,727,-1,0.22500876
728,obesity,5,6,25,32,"He showed short stature, obesity, mild developmental delay, cryptorchidism, and some mild dysmorphic features.",10528860_3,-1,728,-1,0.23132378
729,cryptorchidism,11,12,60,74,"He showed short stature, obesity, mild developmental delay, cryptorchidism, and some mild dysmorphic features.",10528860_3,-1,729,-1,0.2638844
730,intrauterine growth retardation,4,7,30,61,The history further indicated intrauterine growth retardation at the end of the pregnancy.,10528860_4,-1,730,-1,0.20569468
731,hypotonia,4,5,22,31,"After birth he showed hypotonia with poor sucking, for which gavage feeding was needed.",10528860_6,-1,731,-1,0.22723965
734,sleep disturbance,6,8,38,55,There were no behavioural problems or sleep disturbance.,10528860_10,-1,734,-1,0.23732845
735,Prader-Willi syndrome,3,5,17,38,DNA analysis for Prader-Willi syndrome showed no abnormalities.,10528860_12,-1,735,-1,0.23954737
736,Friedreich ataxia,5,7,30,47,Clinical and genetic study of Friedreich ataxia in an Australian population.,10533031_0,-1,736,-1,0.23181278
737,Friedreich ataxia,0,2,1,18,"
Friedreich ataxia is an autosomal recessive disorder caused by mutations in the FRDA gene that encodes a 210-amino acid protein called frataxin.",10533031_1,-1,737,-1,0.23901233
738,scoliosis,24,25,122,131,"We found a correlation between the size of the smaller of the two expanded alleles and age at onset, age into wheelchair, scoliosis, impaired vibration sense, and the presence of foot deformity.",10533031_5,-1,738,-1,0.22214
740,diabetes mellitus,15,17,96,113,"There was no significant correlation between the size of the smaller allele and cardiomyopathy, diabetes mellitus, loss of proprioception, or bladder symptoms.",10533031_6,-1,740,-1,0.24552439
741,disease,3,4,16,23,"The duration of disease is correlated with wheelchair use and the presence of diabetes, scoliosis, bladder symptoms and impaired proprioception, and vibration sense but no other complications studied..",10533031_8,-1,741,-1,0.24482618
743,scoliosis,15,16,88,97,"The duration of disease is correlated with wheelchair use and the presence of diabetes, scoliosis, bladder symptoms and impaired proprioception, and vibration sense but no other complications studied..",10533031_8,-1,743,-1,0.21376485
744,retinoschisis,5,6,33,46,"Novel mutations in XLRS1 causing retinoschisis, including first evidence of putative leader sequence change.",10533068_0,-1,744,-1,0.26124597
745,retinoschisis,1,2,10,23,"
Juvenile retinoschisis is an X-linked recessive disease caused by mutations in the XLRS1 gene.",10533068_1,-1,745,-1,0.25089473
746,disease,6,7,49,56,"
Juvenile retinoschisis is an X-linked recessive disease caused by mutations in the XLRS1 gene.",10533068_1,-1,746,-1,0.18208224
747,Retinoschisis,23,24,140,153,"We screened 31 new unrelated patients and families for XLRS1 mutations in addition to previously reported mutations for 60 of our families (Retinoschisis Consortium, Hum Mol Genet 1998; 7  1185-1192).",10533068_2,-1,747,-1,0.28710032
748,C,7,8,32,33,"Two novel mutations, c. 38T-- > C (L13P) and c. 667T-- > C (C223R), respectively, present the first genetic evidence for the functional significance of the putative leader peptide sequence and for the functional significance at the carboxyl terminal of the XLRS1 protein beyond the discoidin domain.",10533068_5,-1,748,-1,0.36142552
749,C,15,16,57,58,"Two novel mutations, c. 38T-- > C (L13P) and c. 667T-- > C (C223R), respectively, present the first genetic evidence for the functional significance of the putative leader peptide sequence and for the functional significance at the carboxyl terminal of the XLRS1 protein beyond the discoidin domain.",10533068_5,-1,749,-1,0.38880298
750,Growth hormone,0,2,0,14,"Growth hormone treatment increases CO(2) response, ventilation and central inspiratory drive in children with Prader-Willi syndrome.",10541953_0,-1,750,-1,0.2413114
751,Prader-Willi syndrome,16,18,110,131,"Growth hormone treatment increases CO(2) response, ventilation and central inspiratory drive in children with Prader-Willi syndrome.",10541953_0,-1,751,-1,0.2378413
752,growth hormone,7,9,46,60,"
We studied whether the beneficial effects of growth hormone (GH) treatment on growth and body composition in PWS are accompanied by an improvement in respiratory function.",10541953_1,-1,752,-1,0.23602834
753,P,9,10,60,61,"We measured resting ventilation, airway occlusion pressure (P (0. 1)) and ventilatory response to CO (2) in nine children, aged 7-14 years, before and 6-9 months after the start of GH treatment.",10541953_2,-1,753,-1,0.35447595
754,CO,20,21,98,100,"We measured resting ventilation, airway occlusion pressure (P (0. 1)) and ventilatory response to CO (2) in nine children, aged 7-14 years, before and 6-9 months after the start of GH treatment.",10541953_2,-1,754,-1,0.33673286
755,P,11,12,59,60,"During GH treatment, resting ventilation increased by 26%, P (0. 1) by 72% and the response to CO (2) by 65% (P < 0. 002, < 0. 04 and < 0. 02, respectively).",10541953_3,-1,755,-1,0.3481037
756,CO,24,25,95,97,"During GH treatment, resting ventilation increased by 26%, P (0. 1) by 72% and the response to CO (2) by 65% (P < 0. 002, < 0. 04 and < 0. 02, respectively).",10541953_3,-1,756,-1,0.3310938
757,P,32,33,110,111,"During GH treatment, resting ventilation increased by 26%, P (0. 1) by 72% and the response to CO (2) by 65% (P < 0. 002, < 0. 04 and < 0. 02, respectively).",10541953_3,-1,757,-1,0.32622814
758,Prader-Willi syndrome,6,8,39,60,CONCLUSION  Treatment of children with Prader-Willi syndrome (PWS) seems to have a stimulatory effect on central respiratory structures.,10541953_5,-1,758,-1,0.22392972
759,growth hormone,22,24,148,162,The observed increase in ventilation and inspiratory drive may contribute to the improved activity level reported by parents of PWS children during growth hormone therapy,10541953_6,-1,759,-1,0.2312326
760,Friedreich ataxia,0,2,1,18,"
Friedreich ataxia (FRDA) is the most common inherited ataxia.",10543403_1,-1,760,-1,0.24333553
762,fragile X syndrome,1,4,6,24,"
Most fragile X syndrome patients have expansion of a (CGG) (n) sequence with > 200 repeats (full mutation) in the FMR1 gene responsible for this condition.",10545613_1,-1,762,-1,0.21449961
763,n,13,14,61,62,"
Most fragile X syndrome patients have expansion of a (CGG) (n) sequence with > 200 repeats (full mutation) in the FMR1 gene responsible for this condition.",10545613_1,-1,763,-1,0.32739502
764,sodium,16,17,96,102,"We observed a consistent, although modest, reactivation of the FMR1 gene with 4-phenylbutyrate, sodium butyrate and trichostatin A, as shown by RT-PCR.",10545613_5,-1,764,-1,0.33235186
765,disease,5,6,25,32,"
von Hippel-Lindau (VHL) disease is an autosomal dominantly inherited cancer syndrome predisposing to a variety of tumor types that include retinal hemangioblastomas, hemangioblastomas of the central nervous system, renal cell carcinomas, pancreatic cysts and tumors, pheochromocytomas, endolymphatic sac tumors, and epididymal cystadenomas [W. M. Linehan et al., J. Am.",10554035_1,-1,765,-1,0.18568729
766,cancer syndrome,11,13,70,85,"
von Hippel-Lindau (VHL) disease is an autosomal dominantly inherited cancer syndrome predisposing to a variety of tumor types that include retinal hemangioblastomas, hemangioblastomas of the central nervous system, renal cell carcinomas, pancreatic cysts and tumors, pheochromocytomas, endolymphatic sac tumors, and epididymal cystadenomas [W. M. Linehan et al., J. Am.",10554035_1,-1,766,-1,0.17117964
768,cysts,37,38,250,255,"
von Hippel-Lindau (VHL) disease is an autosomal dominantly inherited cancer syndrome predisposing to a variety of tumor types that include retinal hemangioblastomas, hemangioblastomas of the central nervous system, renal cell carcinomas, pancreatic cysts and tumors, pheochromocytomas, endolymphatic sac tumors, and epididymal cystadenomas [W. M. Linehan et al., J. Am.",10554035_1,-1,768,-1,0.2011663
779,neuroectodermal tumors,17,19,118,140,Recurrent hSNF5/INI1 alterations were also observed in choroid plexus carcinomas and in a subset of central primitive neuroectodermal tumors (cPNETs) and medulloblastomas.,10556283_7,-1,779,-1,0.1883921
780,contrast,1,2,3,11,"In contrast, hSNF5/INI1 point mutations were not detected in breast cancers, Wilms tumors, gliomas, ependymomas, sarcomas and other tumor types, even though most analyzed cases harbored loss of heterozygosity at 22q11.",10556283_8,-1,780,-1,0.24816452
783,gliomas,16,17,91,98,"In contrast, hSNF5/INI1 point mutations were not detected in breast cancers, Wilms tumors, gliomas, ependymomas, sarcomas and other tumor types, even though most analyzed cases harbored loss of heterozygosity at 22q11.",10556283_8,-1,783,-1,0.15894929
784,sarcomas,20,21,113,121,"In contrast, hSNF5/INI1 point mutations were not detected in breast cancers, Wilms tumors, gliomas, ependymomas, sarcomas and other tumor types, even though most analyzed cases harbored loss of heterozygosity at 22q11.",10556283_8,-1,784,-1,0.17362702
789,Machado-Joseph disease,4,6,34,56,"
Spinocerebellar ataxia type-3 or Machado-Joseph disease (SCA3/MJD) is a member of the CAG/polyglutamine repeat disease family.",10556285_1,-1,789,-1,0.23967336
790,disease,16,17,112,119,"
Spinocerebellar ataxia type-3 or Machado-Joseph disease (SCA3/MJD) is a member of the CAG/polyglutamine repeat disease family.",10556285_1,-1,790,-1,0.1883143
791,disease,24,25,148,155,"In this family of disorders, a normally polymorphic CAG repeat becomes expanded, resulting in expression of an expanded polyglutamine domain in the disease gene product.",10556285_2,-1,791,-1,0.1967743
792,disease,4,5,37,44,"Experimental models of polyglutamine disease implicate the nucleus in pathogenesis; however, the link between intranuclear expression of expanded polyglutamine and neuronal dysfunction remains unclear.",10556285_3,-1,792,-1,0.172562
793,disease,7,8,39,46,"Here we demonstrate that ataxin-3, the disease protein in SCA3/MJD, adopts a unique conformation when expressed within the nucleus of transfected cells.",10556285_4,-1,793,-1,0.2448464
794,glutamine,26,27,158,167,"The monoclonal antibody 1C2 is known preferentially to bind expanded polyglutamine, but we find that it also binds a fragment of ataxin-3 containing a normal glutamine repeat.",10556285_5,-1,794,-1,0.2652192
795,glutamine,11,12,67,76,"In addition, expression of ataxin-3 within the nucleus exposes the glutamine domain of the full-length non-pathological protein, allowing it to bind the monoclonal antibody 1C2.",10556285_6,-1,795,-1,0.28610685
796,Prader-Willi syndrome,0,2,1,22,"
Prader-Willi syndrome (PWS) is a complex neurogenetic disorder.",10556298_1,-1,796,-1,0.23204704
797,syndrome,9,10,48,56,"The phenotype is likely to be a contiguous gene syndrome involving genes which are paternally expressed only, located in the human 15q11-q13 region.",10556298_2,-1,797,-1,0.23323865
798,rhabdomyosarcoma,1,2,10,26,"
Alveolar rhabdomyosarcoma is an aggressive pediatric cancer of striated muscle characterized in 60% of cases by a t (2; 13) (q35; q14).",10557309_1,-1,798,-1,0.17014189
800,rhabdomyosarcoma,26,27,138,154,"Relevance of this model was suggested by verification that three of these genes (IGFBP5, HSIX1, and Slug) were also expressed in alveolar rhabdomyosarcoma cell lines.",10557309_7,-1,800,-1,0.16693035
801,hemochromatosis,1,2,13,28,Experimental hemochromatosis due to MHC class I HFE deficiency: immune status and iron metabolism.,10557317_0,-1,801,-1,0.18123327
802,iron,13,14,82,86,Experimental hemochromatosis due to MHC class I HFE deficiency: immune status and iron metabolism.,10557317_0,-1,802,-1,0.2035225
803,hemochromatosis,5,6,38,53,"
The puzzling linkage between genetic hemochromatosis and histocompatibility loci became even more so when the gene involved, HFE, was identified.",10557317_1,-1,803,-1,0.20692092
804,iron,9,10,45,49,"As yet, our understanding of HFE function in iron homeostasis is only partial; an even more open question is its possible role in the immune system.",10557317_3,-1,804,-1,0.22532979
805,hemochromatosis,3,4,27,42,"Faithfully mimicking human hemochromatosis, mice homozygous for this deletion develop iron overload, characterized by a higher plasma iron content and a raised transferrin saturation as well as an elevated hepatic iron load.",10557317_6,-1,805,-1,0.2095242
806,iron,11,12,86,90,"Faithfully mimicking human hemochromatosis, mice homozygous for this deletion develop iron overload, characterized by a higher plasma iron content and a raised transferrin saturation as well as an elevated hepatic iron load.",10557317_6,-1,806,-1,0.21127777
807,iron,19,20,134,138,"Faithfully mimicking human hemochromatosis, mice homozygous for this deletion develop iron overload, characterized by a higher plasma iron content and a raised transferrin saturation as well as an elevated hepatic iron load.",10557317_6,-1,807,-1,0.20948058
808,iron,32,33,214,218,"Faithfully mimicking human hemochromatosis, mice homozygous for this deletion develop iron overload, characterized by a higher plasma iron content and a raised transferrin saturation as well as an elevated hepatic iron load.",10557317_6,-1,808,-1,0.22687145
809,iron,13,14,69,73,"The primary defect could, indeed, be traced to an augmented duodenal iron absorption.",10557317_7,-1,809,-1,0.26622808
810,iron,8,9,44,48,"In parallel, measurement of the gut mucosal iron content as well as iron regulatory proteins allows a more informed evaluation of various hypotheses regarding the precise role of HFE in iron homeostasis.",10557317_8,-1,810,-1,0.22262037
811,iron,13,14,68,72,"In parallel, measurement of the gut mucosal iron content as well as iron regulatory proteins allows a more informed evaluation of various hypotheses regarding the precise role of HFE in iron homeostasis.",10557317_8,-1,811,-1,0.21489376
812,iron,31,32,186,190,"In parallel, measurement of the gut mucosal iron content as well as iron regulatory proteins allows a more informed evaluation of various hypotheses regarding the precise role of HFE in iron homeostasis.",10557317_8,-1,812,-1,0.20668222
814,leukemia,18,19,115,123,Chromosomes of lymphocytes from one of the patients were studied before and after the onset of chronic lymphocytic leukemia.,1056013_6,-1,814,-1,0.1730507
815,leukemia,1,2,7,15,"Before leukemia was diagnosed, the patient had a lymphocyte clone with a 14q translocation.",1056013_7,-1,815,-1,0.22546773
816,leukemic,9,10,45,53,This clone appears to have given rise to the leukemic cells.,1056013_8,-1,816,-1,0.24724741
818,lymphoma,16,17,103,111,"Increasing evidence, provided by others, for the nonrandom involvement of 14q in African-type Burkitts lymphoma and other lymphoid neoplasms further strengthens this hypothesis..",1056013_10,-1,818,-1,0.17264119
819,neoplasms,20,21,131,140,"Increasing evidence, provided by others, for the nonrandom involvement of 14q in African-type Burkitts lymphoma and other lymphoid neoplasms further strengthens this hypothesis..",1056013_10,-1,819,-1,0.14942904
820,Frasier syndrome,18,20,100,116,"Exon 9 mutations in the WT1 gene, without influencing KTS splice isoforms, are also responsible for Frasier syndrome.",10571943_0,-1,820,-1,0.22686355
821,Frasier syndrome,28,30,138,154,"
We report new mutations in exon 9 of the WT1 gene that did not alter the ratio of +/- KTS splice isoforms in two unrelated patients with Frasier syndrome (FS).",10571943_1,-1,821,-1,0.21545479
822,syndrome,16,17,105,113,The mutation of intron 9 inducing defective alternative splicing was reported to be responsible for this syndrome.,10571943_2,-1,822,-1,0.21179564
823,Denys-Drash syndrome,18,20,90,110,The mutations found in our cases occurred in the same exon of the WT1 gene as detected in Denys-Drash syndrome (DDS) and could not be explained by the previously proposed mechanism.,10571943_3,-1,823,-1,0.23211397
824,diseases,13,14,69,77,"From a molecular biological point of view, we concluded that the two diseases were not separable, and that FS should be included as an atypical form of DDS..",10571943_5,-1,824,-1,0.22536813
825,deafness,12,13,81,89,Splice-site mutation in the PDS gene may result in intrafamilial variability for deafness in Pendred syndrome.,10571950_0,-1,825,-1,0.2042898
826,Pendred syndrome,14,16,93,109,Splice-site mutation in the PDS gene may result in intrafamilial variability for deafness in Pendred syndrome.,10571950_0,-1,826,-1,0.21487509
827,Pendred syndrome,0,2,1,17,"
Pendred syndrome is a recessive inherited disorder that consists of developmental abnormalities of the cochlea, sensorineural hearing loss, and diffuse thyroid enlargement (goiter).",10571950_1,-1,827,-1,0.21707891
829,goiter,25,26,174,180,"
Pendred syndrome is a recessive inherited disorder that consists of developmental abnormalities of the cochlea, sensorineural hearing loss, and diffuse thyroid enlargement (goiter).",10571950_1,-1,829,-1,0.24695694
830,deafness,13,14,63,71,This disorder may account for up to 10% of cases of hereditary deafness.,10571950_2,-1,830,-1,0.21434392
831,disease,1,2,4,11,"The disease gene (PDS) has been mapped to chromosome 7q22-q31, and encodes a chloride-iodide transport protein.",10571950_3,-1,831,-1,0.2181535
832,deafness,21,22,133,141,We performed mutation analysis of individual exons of the PDS gene in one Spanish family that shows intrafamilial variability of the deafness phenotype (two patients with profound and one with moderate-severe deafness).,10571950_4,-1,832,-1,0.21410504
833,deafness,32,33,209,217,We performed mutation analysis of individual exons of the PDS gene in one Spanish family that shows intrafamilial variability of the deafness phenotype (two patients with profound and one with moderate-severe deafness).,10571950_4,-1,833,-1,0.21171044
834,nucleotide,15,16,80,90,"We identified a new splice-site mutation affecting intron 4 of the PDS gene, at nucleotide position 639 + 7.",10571950_5,-1,834,-1,0.3293102
835,deafness,38,39,210,218,"Since the newly created donor splice site is likely to compete with the normal one, variations of the levels of normal and aberrant transcripts of the PDS gene in the cochlea may explain the variability in the deafness presentation..",10571950_7,-1,835,-1,0.22432253
836,Sjogren-Larsson syndrome,4,6,23,47,The molecular basis of Sjogren-Larsson syndrome: mutation analysis of the fatty aldehyde dehydrogenase gene.,10577908_0,-1,836,-1,0.21945165
837,aldehyde dehydrogenase,12,14,80,102,The molecular basis of Sjogren-Larsson syndrome: mutation analysis of the fatty aldehyde dehydrogenase gene.,10577908_0,-1,837,-1,0.23267196
838,Sjogren-Larsson syndrome,0,2,1,25,"
Sjogren-Larsson syndrome (SLS) is an autosomal recessive disorder characterized by ichthyosis, mental retardation, spasticity, and deficient activity of fatty aldehyde dehydrogenase (FALDH).",10577908_1,-1,838,-1,0.22035293
839,ichthyosis,12,13,84,94,"
Sjogren-Larsson syndrome (SLS) is an autosomal recessive disorder characterized by ichthyosis, mental retardation, spasticity, and deficient activity of fatty aldehyde dehydrogenase (FALDH).",10577908_1,-1,839,-1,0.20830473
840,mental retardation,14,16,96,114,"
Sjogren-Larsson syndrome (SLS) is an autosomal recessive disorder characterized by ichthyosis, mental retardation, spasticity, and deficient activity of fatty aldehyde dehydrogenase (FALDH).",10577908_1,-1,840,-1,0.1991446
841,spasticity,17,18,116,126,"
Sjogren-Larsson syndrome (SLS) is an autosomal recessive disorder characterized by ichthyosis, mental retardation, spasticity, and deficient activity of fatty aldehyde dehydrogenase (FALDH).",10577908_1,-1,841,-1,0.19037455
842,aldehyde dehydrogenase,24,26,160,182,"
Sjogren-Larsson syndrome (SLS) is an autosomal recessive disorder characterized by ichthyosis, mental retardation, spasticity, and deficient activity of fatty aldehyde dehydrogenase (FALDH).",10577908_1,-1,842,-1,0.2329926
843,amino acid,14,16,86,96,"Among these patients, 49 different mutations-including 10 deletions, 2 insertions, 22 amino acid substitutions, 3 nonsense mutations, 9 splice-site defects, and 3 complex mutations-were found.",10577908_3,-1,843,-1,0.30494377
844,C,27,28,163,164,"Nineteen of the missense mutations resulted in a severe reduction of FALDH enzyme catalytic activity when expressed in mammalian cells, but one mutation (798G-- > C [K266N]) seemed to have a greater effect on mRNA stability.",10577908_5,-1,844,-1,0.3350813
845,T,10,11,48,49,"At least four of the common mutations (551C-- > T, 682C-- > T, 733G-- > A, and 798 + 1delG) were associated with multiple SNP haplotypes, suggesting that these mutations originated independently on more than one occasion or were ancient SLS genes that had undergone intragenic recombination.",10577908_9,-1,845,-1,0.33350465
846,SNP,29,30,122,125,"At least four of the common mutations (551C-- > T, 682C-- > T, 733G-- > A, and 798 + 1delG) were associated with multiple SNP haplotypes, suggesting that these mutations originated independently on more than one occasion or were ancient SLS genes that had undergone intragenic recombination.",10577908_9,-1,846,-1,0.23314656
847,C,5,6,44,45,Loss-of-function mutations in the cathepsin C gene result in periodontal disease and palmoplantar keratosis.,10581027_0,-1,847,-1,0.24288447
848,disease,10,11,73,80,Loss-of-function mutations in the cathepsin C gene result in periodontal disease and palmoplantar keratosis.,10581027_0,-1,848,-1,0.19564031
849,syndrome,1,2,18,26,"
Papillon-Lefevre syndrome, or keratosis palmoplantaris with periodontopathia (PLS, MIM 245000), is an autosomal recessive disorder that is mainly ascertained by dentists because of the severe periodontitis that afflicts patients.",10581027_1,-1,849,-1,0.19740126
850,keratosis,4,5,31,40,"
Papillon-Lefevre syndrome, or keratosis palmoplantaris with periodontopathia (PLS, MIM 245000), is an autosomal recessive disorder that is mainly ascertained by dentists because of the severe periodontitis that afflicts patients.",10581027_1,-1,850,-1,0.23810206
851,periodontitis,30,31,193,206,"
Papillon-Lefevre syndrome, or keratosis palmoplantaris with periodontopathia (PLS, MIM 245000), is an autosomal recessive disorder that is mainly ascertained by dentists because of the severe periodontitis that afflicts patients.",10581027_1,-1,851,-1,0.2163307
852,tooth loss,12,14,81,91,"Both the deciduous and permanent dentitions are affected, resulting in premature tooth loss.",10581027_2,-1,852,-1,0.23467842
853,keratosis,1,2,13,22,"Palmoplantar keratosis, varying from mild psoriasiform scaly skin to overt hyperkeratosis, typically develops within the first three years of life.",10581027_3,-1,853,-1,0.2019939
854,Keratosis,0,1,0,9,Keratosis also affects other sites such as elbows and knees.,10581027_4,-1,854,-1,0.25923786
855,periodontitis,5,6,31,44,Most PLS patients display both periodontitis and hyperkeratosis.,10581027_5,-1,855,-1,0.22552395
856,keratosis,5,6,37,46,"Some patients have only palmoplantar keratosis or periodontitis, and in rare individuals the periodontitis is mild and of late onset.",10581027_6,-1,856,-1,0.20461279
857,periodontitis,7,8,50,63,"Some patients have only palmoplantar keratosis or periodontitis, and in rare individuals the periodontitis is mild and of late onset.",10581027_6,-1,857,-1,0.20183939
858,periodontitis,14,15,93,106,"Some patients have only palmoplantar keratosis or periodontitis, and in rare individuals the periodontitis is mild and of late onset.",10581027_6,-1,858,-1,0.20708077
859,C,10,11,58,59,The gene (CTSC) encoding the lysosomal protease cathepsin C (or dipeptidyl aminopeptidase I) lies within this interval.,10581027_10,-1,859,-1,0.253294
860,C,18,19,101,102,In two of these families we used a functional assay to demonstrate an almost total loss of cathepsin C activity in PLS patients and reduced activity in obligate carriers.,10581027_12,-1,860,-1,0.25195843
861,Van der Woude syndrome,4,8,27,49,Confirmation of linkage of Van der Woude syndrome to chromosome 1q32: evidence of association with STR alleles suggests possible unique origin of the disease mutation.,10589394_0,-1,861,-1,0.24729805
862,STR,16,17,99,102,Confirmation of linkage of Van der Woude syndrome to chromosome 1q32: evidence of association with STR alleles suggests possible unique origin of the disease mutation.,10589394_0,-1,862,-1,0.26814726
863,disease,24,25,150,157,Confirmation of linkage of Van der Woude syndrome to chromosome 1q32: evidence of association with STR alleles suggests possible unique origin of the disease mutation.,10589394_0,-1,863,-1,0.23027396
864,Van der Woude syndrome,0,4,1,23,"
Van der Woude syndrome (VWS) is an autosomal dominant craniofacial disorder with high penetrance and variable expression.",10589394_1,-1,864,-1,0.23634118
865,cleft lip,9,11,58,67,"Its clinical features are variably expressed, but include cleft lip and/or cleft palate, lip pits and hypodontia.",10589394_2,-1,865,-1,0.23560096
866,cleft palate,12,14,75,87,"Its clinical features are variably expressed, but include cleft lip and/or cleft palate, lip pits and hypodontia.",10589394_2,-1,866,-1,0.22148931
867,map,6,7,33,36,"All VWS families studied to date map the disease gene to a < 2 cM region of chromosome 1q32, with no evidence of locus heterogeneity.",10589394_3,-1,867,-1,0.2475391
868,disease,8,9,41,48,"All VWS families studied to date map the disease gene to a < 2 cM region of chromosome 1q32, with no evidence of locus heterogeneity.",10589394_3,-1,868,-1,0.23202623
869,cM,14,15,63,65,"All VWS families studied to date map the disease gene to a < 2 cM region of chromosome 1q32, with no evidence of locus heterogeneity.",10589394_3,-1,869,-1,0.2792347
870,STR,8,9,42,45,"Our assay method for short tandem repeat (STR) markers provided highly accurate size estimation of marker allele fragment sizes, and therefore enabled us to determine the specific alleles segregating with the VWS gene in each of our four families.",10589394_11,-1,870,-1,0.20577882
871,STR,6,7,34,37,We observed a striking pattern of STR allele sharing at several closely linked loci among our four Caucasian VWS families recruited at three different locations in the US.,10589394_12,-1,871,-1,0.2664542
873,Nucleotide,18,19,103,113,"Immunochemical studies demonstrated that the Sit (a) epitopes reside on platelet glycoprotein (GP) Ia. Nucleotide sequence analysis of GPIa cDNA derived from Sit (a) -positive platelets showed C (2531) -- > T (2531) point mutation, resulting in Thr (799) Met dimorphism.",10590055_3,-1,873,-1,0.270759
874,C,33,34,193,194,"Immunochemical studies demonstrated that the Sit (a) epitopes reside on platelet glycoprotein (GP) Ia. Nucleotide sequence analysis of GPIa cDNA derived from Sit (a) -positive platelets showed C (2531) -- > T (2531) point mutation, resulting in Thr (799) Met dimorphism.",10590055_3,-1,874,-1,0.373244
875,Glu,23,24,162,165,"Analysis of stable Chinese hamster ovary transfectants expressing allele-specific recombinant forms of GPIa showed that anti-Sit (a) exclusively reacted with the Glu (505) Met (799), but not with the Glu (505) Thr (799) and the Lys (505) Thr (799) isoforms.",10590055_8,-1,875,-1,0.29802406
876,Glu,36,37,200,203,"Analysis of stable Chinese hamster ovary transfectants expressing allele-specific recombinant forms of GPIa showed that anti-Sit (a) exclusively reacted with the Glu (505) Met (799), but not with the Glu (505) Thr (799) and the Lys (505) Thr (799) isoforms.",10590055_8,-1,876,-1,0.31125933
877,contrast,1,2,3,11,"In contrast, anti-Br (a) (HPA-5b) only recognized the Lys (505) Thr (799) form, whereas anti-Br (b) (HPA-5a) reacted with both Glu (505) Thr (799) and Glu (505) Met (799) isoforms.",10590055_9,-1,877,-1,0.28839475
878,Glu,34,35,127,130,"In contrast, anti-Br (a) (HPA-5b) only recognized the Lys (505) Thr (799) form, whereas anti-Br (b) (HPA-5a) reacted with both Glu (505) Thr (799) and Glu (505) Met (799) isoforms.",10590055_9,-1,878,-1,0.30953044
879,Glu,43,44,151,154,"In contrast, anti-Br (a) (HPA-5b) only recognized the Lys (505) Thr (799) form, whereas anti-Br (b) (HPA-5a) reacted with both Glu (505) Thr (799) and Glu (505) Met (799) isoforms.",10590055_9,-1,879,-1,0.3023827
880,amino acid,23,25,126,136,"These results demonstrated that the Met (799) is responsible for formation of the Sit (a) alloantigenic determinants, whereas amino acid 505 (Lys or Glu) specifically controls the expression of Br (a) and Br (b) epitopes, respectively.",10590055_10,-1,880,-1,0.33598197
881,Glu,29,30,149,152,"These results demonstrated that the Met (799) is responsible for formation of the Sit (a) alloantigenic determinants, whereas amino acid 505 (Lys or Glu) specifically controls the expression of Br (a) and Br (b) epitopes, respectively.",10590055_10,-1,881,-1,0.2808871
883,C,4,5,27,28,Mutations of the cathepsin C gene are responsible for Papillon-Lefevre syndrome.,10593994_0,-1,883,-1,0.23994918
884,syndrome,10,11,71,79,Mutations of the cathepsin C gene are responsible for Papillon-Lefevre syndrome.,10593994_0,-1,884,-1,0.19334327
885,syndrome,1,2,18,26,"
Papillon-Lefevre syndrome (PLS) is an autosomal recessive disorder characterised by palmoplantar hyperkeratosis and severe early onset periodontitis that results in the premature loss of the primary and secondary dentitions.",10593994_1,-1,885,-1,0.1852281
886,periodontitis,18,19,136,149,"
Papillon-Lefevre syndrome (PLS) is an autosomal recessive disorder characterised by palmoplantar hyperkeratosis and severe early onset periodontitis that results in the premature loss of the primary and secondary dentitions.",10593994_1,-1,886,-1,0.22152801
887,cM,1,2,2,4,8 cM interval on chromosome 11q14.,10593994_3,-1,887,-1,0.30771965
888,C,25,26,159,160,Correlation of physical and genetic maps of this interval indicate it includes at least 40 ESTs and six known genes including the lysosomal protease cathepsin C gene (CTSC).,10593994_4,-1,888,-1,0.20997225
889,amino acid,16,18,78,88,An exon 1 nonsense mutation (856C-- > T) introduces a premature stop codon at amino acid 286.,10593994_9,-1,889,-1,0.37050068
890,nucleotide,10,11,59,69,"Three exon 2 mutations were identified, including a single nucleotide deletion (2692delA) of codon 349 introducing a frameshift and premature termination codon, a 2 bp deletion (2673-2674delCT) that results in introduction of a stop codon at amino acid 343, and a G-- > A substitution in codon 429 (2931G-- > A) introducing a premature termination codon.",10593994_10,-1,890,-1,0.28860167
891,amino acid,44,46,242,252,"Three exon 2 mutations were identified, including a single nucleotide deletion (2692delA) of codon 349 introducing a frameshift and premature termination codon, a 2 bp deletion (2673-2674delCT) that results in introduction of a stop codon at amino acid 343, and a G-- > A substitution in codon 429 (2931G-- > A) introducing a premature termination codon.",10593994_10,-1,891,-1,0.37838098
892,C,7,8,47,48,All PLS patients were homozygous for cathepsin C mutations inherited from a common ancestor.,10593994_11,-1,892,-1,0.2630717
893,C,6,7,44,45,Parents and sibs heterozygous for cathepsin C mutations do not show either the palmoplantar hyperkeratosis or severe early onset periodontitis characteristic of PLS.,10593994_12,-1,893,-1,0.26575908
894,periodontitis,19,20,129,142,Parents and sibs heterozygous for cathepsin C mutations do not show either the palmoplantar hyperkeratosis or severe early onset periodontitis characteristic of PLS.,10593994_12,-1,894,-1,0.2806625
895,C,10,11,72,73,A more complete understanding of the functional physiology of cathepsin C carries significant implications for understanding normal and abnormal skin development and periodontal disease susceptibility,10593994_13,-1,895,-1,0.22703944
896,disease,23,24,178,185,A more complete understanding of the functional physiology of cathepsin C carries significant implications for understanding normal and abnormal skin development and periodontal disease susceptibility,10593994_13,-1,896,-1,0.17713337
897,alkaptonuria,8,9,47,59,Mutational analysis of the HGO gene in Finnish alkaptonuria patients.,10594001_0,-1,897,-1,0.2636931
898,Alkaptonuria,0,1,1,13,"
Alkaptonuria (AKU), the prototypic inborn error of metabolism, has recently been shown to be caused by loss of function mutations in the homogentisate-1, 2-dioxygenase gene (HGO).",10594001_1,-1,898,-1,0.27627692
899,adenomatous polyps,10,12,69,87,"
Inherited mutations of the APC gene predispose carriers to multiple adenomatous polyps of the colon and rectum and to colorectal cancer.",10598803_1,-1,899,-1,0.16979541
900,colorectal cancer,19,21,119,136,"
Inherited mutations of the APC gene predispose carriers to multiple adenomatous polyps of the colon and rectum and to colorectal cancer.",10598803_1,-1,900,-1,0.15517518
901,disease,20,21,99,106,"Mutations located at the extreme 5 end of the APC gene, however, are associated with a less severe disease known as attenuated adenomatous polyposis coli (AAPC).",10598803_2,-1,901,-1,0.18387516
902,adenomatous polyposis coli,24,27,127,153,"Mutations located at the extreme 5 end of the APC gene, however, are associated with a less severe disease known as attenuated adenomatous polyposis coli (AAPC).",10598803_2,-1,902,-1,0.18845078
903,polyps,8,9,61,67,Many individuals with AAPC develop relatively few colorectal polyps but are still at high risk for colorectal cancer.,10598803_3,-1,903,-1,0.18394542
904,colorectal cancer,16,18,99,116,Many individuals with AAPC develop relatively few colorectal polyps but are still at high risk for colorectal cancer.,10598803_3,-1,904,-1,0.16066568
905,Alstrom syndrome,0,2,0,16,Alstrom syndrome: further evidence for linkage to human chromosome 2p13.,10598815_0,-1,905,-1,0.26591006
906,Alstrom syndrome,0,2,1,17,"
Alstrom syndrome is a rare autosomal recessive disorder characterized by retinal degeneration, sensorineural hearing loss, early-onset obesity, and non-insulin-dependent diabetes mellitus.",10598815_1,-1,906,-1,0.25166085
907,retinal degeneration,10,12,74,94,"
Alstrom syndrome is a rare autosomal recessive disorder characterized by retinal degeneration, sensorineural hearing loss, early-onset obesity, and non-insulin-dependent diabetes mellitus.",10598815_1,-1,907,-1,0.1804773
909,obesity,18,19,136,143,"
Alstrom syndrome is a rare autosomal recessive disorder characterized by retinal degeneration, sensorineural hearing loss, early-onset obesity, and non-insulin-dependent diabetes mellitus.",10598815_1,-1,909,-1,0.22827533
910,diabetes mellitus,22,24,171,188,"
Alstrom syndrome is a rare autosomal recessive disorder characterized by retinal degeneration, sensorineural hearing loss, early-onset obesity, and non-insulin-dependent diabetes mellitus.",10598815_1,-1,910,-1,0.19219059
911,Alstrom syndrome,3,5,13,29,The gene for Alstrom syndrome (ALMS1) has been previously localized to human chromosome 2p13 by homozygosity mapping in two distinct isolated populations - French Acadian and North African.,10598815_2,-1,911,-1,0.23941556
912,Alstrom syndrome,17,19,109,125,"To confirm these findings, a large linkage study was performed in twelve additional families segregating for Alstrom syndrome.",10598815_5,-1,912,-1,0.23796195
913,map,5,6,35,38,A fine resolution radiation hybrid map of 31 genes and markers has been constructed.,10598815_11,-1,913,-1,0.22963835
914,Pendred syndrome,0,2,0,16,Pendred syndrome: phenotypic variability in two families carrying the same PDS missense mutation.,10602116_0,-1,914,-1,0.22615021
915,Pendred syndrome,0,2,1,17,"
Pendred syndrome comprises congenital sensorineural hearing loss, thyroid goiter, and positive perchlorate discharge test.",10602116_1,-1,915,-1,0.23556386
917,goiter,9,10,75,81,"
Pendred syndrome comprises congenital sensorineural hearing loss, thyroid goiter, and positive perchlorate discharge test.",10602116_1,-1,917,-1,0.21596092
918,deafness,26,27,179,187,"Molecular analysis of the PDS gene was performed in two consanguineous large families from Southern Tunisia comprising a total of 23 individuals affected with profound congenital deafness; the same missense mutation, L445W, was identified in all affected individuals.",10602116_3,-1,918,-1,0.20647125
919,contrast,1,2,3,11,"In contrast, goiter was present in only 11 affected individuals, who interestingly had a normal result of the perchlorate discharge test whenever performed.",10602116_5,-1,919,-1,0.23885188
920,goiter,3,4,13,19,"In contrast, goiter was present in only 11 affected individuals, who interestingly had a normal result of the perchlorate discharge test whenever performed.",10602116_5,-1,920,-1,0.2609197
921,Pendred syndrome,14,16,90,106,The present results question the sensitivity of the perchlorate test for the diagnosis of Pendred syndrome and support the use of a molecular analysis of the PDS gene in the assessment of individuals with severe to profound congenital hearing loss associated with inner ear morphological anomaly even in the absence of a thyroid goiter..,10602116_6,-1,921,-1,0.20373477
922,hearing loss,38,40,235,247,The present results question the sensitivity of the perchlorate test for the diagnosis of Pendred syndrome and support the use of a molecular analysis of the PDS gene in the assessment of individuals with severe to profound congenital hearing loss associated with inner ear morphological anomaly even in the absence of a thyroid goiter..,10602116_6,-1,922,-1,0.17868061
923,goiter,53,54,329,335,The present results question the sensitivity of the perchlorate test for the diagnosis of Pendred syndrome and support the use of a molecular analysis of the PDS gene in the assessment of individuals with severe to profound congenital hearing loss associated with inner ear morphological anomaly even in the absence of a thyroid goiter..,10602116_6,-1,923,-1,0.22425447
924,Knobloch syndrome,0,2,0,17,Knobloch syndrome involving midline scalp defect of the frontal region.,10607954_0,-1,924,-1,0.21425623
925,Knobloch syndrome,7,9,36,53,"
We report on a 4-year-old boy with Knobloch syndrome.",10607954_1,-1,925,-1,0.20225763
926,myopia,6,7,40,46,"He has vitreoretinal degeneration, high myopia, cataract, telecanthus, hypertelorism, and a high-arched palate.",10607954_2,-1,926,-1,0.22741473
928,telecanthus,10,11,58,69,"He has vitreoretinal degeneration, high myopia, cataract, telecanthus, hypertelorism, and a high-arched palate.",10607954_2,-1,928,-1,0.28765553
929,hypertelorism,12,13,71,84,"He has vitreoretinal degeneration, high myopia, cataract, telecanthus, hypertelorism, and a high-arched palate.",10607954_2,-1,929,-1,0.22672231
930,syndrome,11,12,56,64,We present a review of the 23 published cases with this syndrome.,10607954_5,-1,930,-1,0.24813445
932,osteolysis,14,15,87,97,"Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis.",10615125_0,-1,932,-1,0.18992873
933,osteolysis,2,3,20,30,"
Familial expansile osteolysis (FEO, MIM 174810) is a rare, autosomal dominant bone disorder characterized by focal areas of increased bone remodelling.",10615125_1,-1,933,-1,0.18909207
934,cM,17,18,95,97,Our previous linkage studies mapped the gene responsible for FEO to an interval of less than 5 cM between D18S64 and D18S51 on chromosome 18q21.,10615125_3,-1,934,-1,0.29044342
935,disease,22,23,138,145,We identified two heterozygous insertion mutations in exon 1 of TNFRSF11A in affected members of four families with FEO or familial Paget disease of bone (PDB).,10615125_8,-1,935,-1,0.24136879
936,Brugada syndrome,6,8,37,53,Cardiac Na(+) channel dysfunction in Brugada syndrome is aggravated by beta(1)-subunit.,10618304_0,-1,936,-1,0.24386276
937,Na,10,11,62,64,"
BACKGROUND  Mutations in the gene encoding the human cardiac Na (+) channel alpha-subunit (hH1) are responsible for chromosome 3-linked congenital long-QT syndrome (LQT3) and idiopathic ventricular fibrillation (IVF).",10618304_1,-1,937,-1,0.29024032
938,syndrome,26,27,156,164,"
BACKGROUND  Mutations in the gene encoding the human cardiac Na (+) channel alpha-subunit (hH1) are responsible for chromosome 3-linked congenital long-QT syndrome (LQT3) and idiopathic ventricular fibrillation (IVF).",10618304_1,-1,938,-1,0.19767557
939,idiopathic ventricular fibrillation,31,34,176,211,"
BACKGROUND  Mutations in the gene encoding the human cardiac Na (+) channel alpha-subunit (hH1) are responsible for chromosome 3-linked congenital long-QT syndrome (LQT3) and idiopathic ventricular fibrillation (IVF).",10618304_1,-1,939,-1,0.19780332
940,Na,35,36,227,229,"An auxiliary beta (1) -subunit, widely expressed in excitable tissues, shifts the voltage dependence of steady-state inactivation toward more negative potentials and restores normal gating kinetics of brain and skeletal muscle Na (+) channels expressed in Xenopus oocytes but has little if any functional effect on the cardiac isoform.",10618304_2,-1,940,-1,0.31560442
941,contrast,19,20,106,114,"METHODS AND RESULTS  When expressed alone in Xenopus oocytes, T1620M exhibited no persistent currents, in contrast to the LQT3 mutant channels, but the midpoint of steady-state inactivation (V (1/2)) was significantly shifted toward more positive potentials than for wild-type hH1.",10618304_4,-1,941,-1,0.2751465
942,RB1,4,5,32,35,Meiotic segregation analysis of RB1 alleles in retinoblastoma pedigrees by use of single-sperm typing.,10631148_0,-1,942,-1,0.21019311
943,retinoblastoma,7,8,47,61,Meiotic segregation analysis of RB1 alleles in retinoblastoma pedigrees by use of single-sperm typing.,10631148_0,-1,943,-1,0.16177537
944,retinoblastoma,2,3,15,29,"
In hereditary retinoblastoma, different epidemiological studies have indicated a preferential paternal transmission of mutant retinoblastoma alleles to offspring, suggesting the occurrence of a meiotic drive.",10631148_1,-1,944,-1,0.162582
945,retinoblastoma,15,16,127,141,"
In hereditary retinoblastoma, different epidemiological studies have indicated a preferential paternal transmission of mutant retinoblastoma alleles to offspring, suggesting the occurrence of a meiotic drive.",10631148_1,-1,945,-1,0.17123052
946,retinoblastoma,19,20,132,146,"To investigate this mechanism, we analyzed sperm samples from six individuals from five unrelated families affected with hereditary retinoblastoma.",10631148_2,-1,946,-1,0.15617256
947,retinoblastoma,23,24,145,159,Single-sperm typing techniques were performed for each sample by study of two informative short tandem repeats located either in or close to the retinoblastoma gene (RB1).,10631148_3,-1,947,-1,0.16789296
948,RB1,26,27,166,169,Single-sperm typing techniques were performed for each sample by study of two informative short tandem repeats located either in or close to the retinoblastoma gene (RB1).,10631148_3,-1,948,-1,0.21983011
949,RB1,5,6,38,41,"The segregation probability of mutant RB1 alleles in sperm samples was assessed by use of the SPERMSEG program, which includes experimental parameters, recombination fractions between the markers, and segregation parameters.",10631148_4,-1,949,-1,0.247928
950,P,13,14,73,74,We detected a significant segregation distortion in the data as a whole (P =. 0099) and a significant heterogeneity in the segregation rate across donors (.,10631148_6,-1,950,-1,0.29576513
951,RB1,6,7,47,50,"The segregation distortion favoring the mutant RB1 allele does not seem to occur during spermatogenesis, and, thus, meiotic drive may result either from various mechanisms, including a fertilization advantage or a better mobility in sperm bearing a mutant RB1 gene, or from the existence of a defectively imprinted gene located on the human X chromosome.",10631148_9,-1,951,-1,0.21342647
952,RB1,42,43,256,259,"The segregation distortion favoring the mutant RB1 allele does not seem to occur during spermatogenesis, and, thus, meiotic drive may result either from various mechanisms, including a fertilization advantage or a better mobility in sperm bearing a mutant RB1 gene, or from the existence of a defectively imprinted gene located on the human X chromosome.",10631148_9,-1,952,-1,0.20101312
953,Friedreich ataxia,0,2,0,17,Friedreich ataxia: an overview.,10633128_0,-1,953,-1,0.2546412
954,Friedreich ataxia,0,2,1,18,"
Friedreich ataxia, an autosomal recessive neurodegenerative disease, is the most common of the inherited ataxias.",10633128_1,-1,954,-1,0.22660701
955,neurodegenerative disease,6,8,43,68,"
Friedreich ataxia, an autosomal recessive neurodegenerative disease, is the most common of the inherited ataxias.",10633128_1,-1,955,-1,0.18447182
956,Friedreich ataxia,27,29,144,161,"The recent discovery of the gene that is mutated in this condition, FRDA, has led to rapid advances in the understanding of the pathogenesis of Friedreich ataxia.",10633128_2,-1,956,-1,0.20994861
957,Friedreich ataxia,7,9,43,60,"There is mounting evidence to suggest that Friedreich ataxia is the result of accumulation of iron in mitochondria leading to excess production of free radicals, which then results in cellular damage and death.",10633128_5,-1,957,-1,0.23228128
958,iron,15,16,94,98,"There is mounting evidence to suggest that Friedreich ataxia is the result of accumulation of iron in mitochondria leading to excess production of free radicals, which then results in cellular damage and death.",10633128_5,-1,958,-1,0.2376199
959,free radicals,23,25,147,160,"There is mounting evidence to suggest that Friedreich ataxia is the result of accumulation of iron in mitochondria leading to excess production of free radicals, which then results in cellular damage and death.",10633128_5,-1,959,-1,0.23990883
961,disease,13,14,76,83,Currently there is no known treatment that alters the natural course of the disease.,10633128_6,-1,961,-1,0.25284836
962,retinoschisis,1,2,9,22,X-linked retinoschisis with point mutations in the XLRS1 gene.,10636421_0,-1,962,-1,0.25126898
963,retinoschisis,3,4,22,35,"
BACKGROUND  X-linked retinoschisis (XLRS) is a relatively rare vitreoretinal dystrophy that causes visual loss in young men.",10636421_1,-1,963,-1,0.24794109
965,disease,7,8,38,45,"Recently, a gene responsible for this disease, designated XLRS1, was identified, and several deleterious gene mutations were reported.",10636421_2,-1,965,-1,0.20592263
966,disease,13,14,78,85,"However, the limited data failed to reveal a correlation between mutation and disease phenotype.",10636421_11,-1,966,-1,0.20410661
967,disease,5,6,53,60,"
Ataxia-telangiectasia is a hereditary multisystemic disease resulting from mutations of ataxia telangiectasia, mutated (ATM) and is characterized by neurodegeneration, cancer, immune defects, and hypersensitivity to ionizing radiation.",10639175_1,-1,967,-1,0.1898376
969,neurodegeneration,21,22,150,167,"
Ataxia-telangiectasia is a hereditary multisystemic disease resulting from mutations of ataxia telangiectasia, mutated (ATM) and is characterized by neurodegeneration, cancer, immune defects, and hypersensitivity to ionizing radiation.",10639175_1,-1,969,-1,0.17133912
974,syndrome,1,2,10,18,"Haim-Munk syndrome and Papillon-Lefevre syndrome are allelic mutations in cathepsin C.
Of the many palmoplantar keratoderma (PPK) conditions, only Papillon-Lefevre syndrome (PLS) and Haim-Munk syndrome (HMS) are associated with premature periodontal destruction.",10662807_0,-1,974,-1,0.2162877
975,syndrome,4,5,40,48,"Haim-Munk syndrome and Papillon-Lefevre syndrome are allelic mutations in cathepsin C.
Of the many palmoplantar keratoderma (PPK) conditions, only Papillon-Lefevre syndrome (PLS) and Haim-Munk syndrome (HMS) are associated with premature periodontal destruction.",10662807_0,-1,975,-1,0.2285793
976,syndrome,23,24,164,172,"Haim-Munk syndrome and Papillon-Lefevre syndrome are allelic mutations in cathepsin C.
Of the many palmoplantar keratoderma (PPK) conditions, only Papillon-Lefevre syndrome (PLS) and Haim-Munk syndrome (HMS) are associated with premature periodontal destruction.",10662807_0,-1,976,-1,0.1991859
977,syndrome,29,30,193,201,"Haim-Munk syndrome and Papillon-Lefevre syndrome are allelic mutations in cathepsin C.
Of the many palmoplantar keratoderma (PPK) conditions, only Papillon-Lefevre syndrome (PLS) and Haim-Munk syndrome (HMS) are associated with premature periodontal destruction.",10662807_0,-1,977,-1,0.20211808
978,periodontitis,13,14,72,85,"Although both PLS and HMS share the cardinal features of PPK and severe periodontitis, a number of additional findings are reported in HMS including arachnodactyly, acro-osteolysis, atrophic changes of the nails, and a radiographic deformity of the fingers.",10662807_1,-1,978,-1,0.19079015
979,arachnodactyly,25,26,149,163,"Although both PLS and HMS share the cardinal features of PPK and severe periodontitis, a number of additional findings are reported in HMS including arachnodactyly, acro-osteolysis, atrophic changes of the nails, and a radiographic deformity of the fingers.",10662807_1,-1,979,-1,0.24722223
980,acro-osteolysis,27,28,165,180,"Although both PLS and HMS share the cardinal features of PPK and severe periodontitis, a number of additional findings are reported in HMS including arachnodactyly, acro-osteolysis, atrophic changes of the nails, and a radiographic deformity of the fingers.",10662807_1,-1,980,-1,0.22464761
981,C,6,7,37,38,"Recently, mutations of the cathepsin C gene have been identified as the underlying genetic defect in PLS.",10662807_5,-1,981,-1,0.24842398
982,C,5,6,28,29,"To determine if a cathepsin C mutation is also responsible for HMS, we sequenced the gene in affected and unaffected subjects from the Cochin isolate in which both the PLS and HMS phenotypes appear.",10662807_6,-1,982,-1,0.23434307
983,C,9,10,57,58,"Here we report identification of a mutation of cathepsin C (exon 6, 2127A-- > G) that changes a highly conserved amino acid in the cathepsin C peptide.",10662807_7,-1,983,-1,0.2526749
984,amino acid,23,25,113,123,"Here we report identification of a mutation of cathepsin C (exon 6, 2127A-- > G) that changes a highly conserved amino acid in the cathepsin C peptide.",10662807_7,-1,984,-1,0.29287848
985,C,28,29,141,142,"Here we report identification of a mutation of cathepsin C (exon 6, 2127A-- > G) that changes a highly conserved amino acid in the cathepsin C peptide.",10662807_7,-1,985,-1,0.25450605
986,C,15,16,97,98,"Additionally, the existence of a shared common haplotype for genetic loci flanking the cathepsin C gene suggests that affected subjects descended from the Cochin isolate are homozygous for a mutation inherited "" identical by descent "" from a common ancestor.",10662807_9,-1,986,-1,0.2597963
987,C,13,14,83,84,These findings provide evidence that PLS and HMS are allelic variants of cathepsin C gene mutations..,10662807_12,-1,987,-1,0.2053951
996,glucose,3,4,19,26,Human mutations in glucose 6-phosphate dehydrogenase reflect evolutionary history.,10698963_0,-1,996,-1,0.26358047
997,Glucose,0,1,1,8,"
Glucose 6-phosphate dehydrogenase (G6PD) is a cytosolic enzyme encoded by a housekeeping X-linked gene whose main function is to produce NADPH, a key electron donor in the defense against oxidizing agents and in reductive biosynthetic reactions.",10698963_1,-1,997,-1,0.24831314
998,NADPH,22,23,138,143,"
Glucose 6-phosphate dehydrogenase (G6PD) is a cytosolic enzyme encoded by a housekeeping X-linked gene whose main function is to produce NADPH, a key electron donor in the defense against oxidizing agents and in reductive biosynthetic reactions.",10698963_1,-1,998,-1,0.22337261
1001,amino acid,5,7,26,36,"From the alignment of the amino acid (aa) sequence of 52 glucose 6-phosphate dehydrogenase (G6PD) species from 42 different organisms, we found a striking correlation between the aa replacements that cause G6PD deficiency in humans and the sequence conservation of G6PD  two-thirds of such replacements are in highly and moderately conserved (50-99%) aa; relatively few are in fully conserved aa (where they might be lethal) or in poorly conserved aa, where presumably they simply would not cause G6PD deficiency.",10698963_4,-1,1001,-1,0.30885324
1002,glucose,13,14,57,64,"From the alignment of the amino acid (aa) sequence of 52 glucose 6-phosphate dehydrogenase (G6PD) species from 42 different organisms, we found a striking correlation between the aa replacements that cause G6PD deficiency in humans and the sequence conservation of G6PD  two-thirds of such replacements are in highly and moderately conserved (50-99%) aa; relatively few are in fully conserved aa (where they might be lethal) or in poorly conserved aa, where presumably they simply would not cause G6PD deficiency.",10698963_4,-1,1002,-1,0.2455549
1003,amino acid,19,21,133,143,Comparing the distribution of mutations in a human housekeeping gene with evolutionary conservation is a useful tool for pinpointing amino acid residues important for the stability or the function of the corresponding protein.,10698963_6,-1,1003,-1,0.28195134
1004,myotonic dystrophy,9,11,63,81,Constitutive and regulated modes of splicing produce six major myotonic dystrophy protein kinase (DMPK) isoforms with distinct properties.,10699184_0,-1,1004,-1,0.19209887
1005,Myotonic dystrophy,0,2,1,19,"
Myotonic dystrophy (DM) is the most prevalent inherited neuromuscular disease in adults.",10699184_1,-1,1005,-1,0.19904305
1006,DM,3,4,21,23,"
Myotonic dystrophy (DM) is the most prevalent inherited neuromuscular disease in adults.",10699184_1,-1,1006,-1,0.22003551
1007,neuromuscular disease,10,12,57,78,"
Myotonic dystrophy (DM) is the most prevalent inherited neuromuscular disease in adults.",10699184_1,-1,1007,-1,0.17841208
1008,myotonic dystrophy,15,17,89,107,"The genetic defect is a CTG triplet repeat expansion in the 3-untranslated region of the myotonic dystrophy protein kinase (DMPK) gene, consisting of 15 exons.",10699184_2,-1,1008,-1,0.186326
1009,contrast,1,2,3,11,"In contrast, the excision of exons 13/14 that causes a frameshift and creates a C-terminally truncated protein is clearly cell type dependent and occurs predominantly in smooth muscle.",10699184_5,-1,1009,-1,0.25377586
1010,n,21,22,127,128,Information on DMPK mRNA and protein isoform expression patterns will be useful for recognizing differential effects of (CTG) (n) expansion in DM manifestation..,10699184_7,-1,1010,-1,0.2798104
1011,DM,25,26,143,145,Information on DMPK mRNA and protein isoform expression patterns will be useful for recognizing differential effects of (CTG) (n) expansion in DM manifestation..,10699184_7,-1,1011,-1,0.22801737
1012,venous thrombosis,9,11,52,69,"Genetic analysis, phenotypic diagnosis, and risk of venous thrombosis in families with inherited deficiencies of protein S.
Protein S deficiency is a recognized risk factor for venous thrombosis.",10706858_0,-1,1012,-1,0.18330859
1013,Protein S deficiency,19,22,124,144,"Genetic analysis, phenotypic diagnosis, and risk of venous thrombosis in families with inherited deficiencies of protein S.
Protein S deficiency is a recognized risk factor for venous thrombosis.",10706858_0,-1,1013,-1,0.25018042
1014,venous thrombosis,28,30,177,194,"Genetic analysis, phenotypic diagnosis, and risk of venous thrombosis in families with inherited deficiencies of protein S.
Protein S deficiency is a recognized risk factor for venous thrombosis.",10706858_0,-1,1014,-1,0.18175913
1015,lead,21,22,134,138,"Of all the inherited thrombophilic conditions, it remains the most difficult to diagnose because of phenotypic variability, which can lead to inconclusive results.",10706858_1,-1,1015,-1,0.2481627
1016,protein S deficiency,4,7,33,53,"Twenty-eight index patients with protein S deficiency and a PROS1 gene defect were studied, together with 109 first-degree relatives.",10706858_3,-1,1016,-1,0.22203532
1021,protein S deficiency,9,12,53,73,We conclude that persons with PROS1 gene defects and protein S deficiency are at increased risk of thrombosis and that free protein S estimation offers the most reliable way of diagnosing the deficiency.,10706858_11,-1,1021,-1,0.24595147
1023,Autoimmune lymphoproliferative syndrome,0,3,0,39,"Autoimmune lymphoproliferative syndrome (ALPS) in a child from consanguineous parents: a dominant or recessive disease?
Autoimmune lymphoproliferative syndrome (ALPS) is characterized by autoimmune features and lymphoproliferations and is generally caused by defective Fas-mediated apoptosis.",10709732_0,-1,1023,-1,0.1777113
1024,disease,17,18,111,118,"Autoimmune lymphoproliferative syndrome (ALPS) in a child from consanguineous parents: a dominant or recessive disease?
Autoimmune lymphoproliferative syndrome (ALPS) is characterized by autoimmune features and lymphoproliferations and is generally caused by defective Fas-mediated apoptosis.",10709732_0,-1,1024,-1,0.19341451
1025,Autoimmune lymphoproliferative syndrome,19,22,120,159,"Autoimmune lymphoproliferative syndrome (ALPS) in a child from consanguineous parents: a dominant or recessive disease?
Autoimmune lymphoproliferative syndrome (ALPS) is characterized by autoimmune features and lymphoproliferations and is generally caused by defective Fas-mediated apoptosis.",10709732_0,-1,1025,-1,0.18707423
1026,autoimmune,28,29,187,197,"Autoimmune lymphoproliferative syndrome (ALPS) in a child from consanguineous parents: a dominant or recessive disease?
Autoimmune lymphoproliferative syndrome (ALPS) is characterized by autoimmune features and lymphoproliferations and is generally caused by defective Fas-mediated apoptosis.",10709732_0,-1,1026,-1,0.18059653
1027,Prader-Willi syndrome,7,9,53,74,Identification of novel imprinted transcripts in the Prader-Willi syndrome and Angelman syndrome deletion region: further evidence for regional imprinting control.,10712201_0,-1,1027,-1,0.2270046
1028,Angelman syndrome,10,12,79,96,Identification of novel imprinted transcripts in the Prader-Willi syndrome and Angelman syndrome deletion region: further evidence for regional imprinting control.,10712201_0,-1,1028,-1,0.20775849
1029,Prader-Willi syndrome,15,17,114,135,"
Deletions and other abnormalities of human chromosome 15q11-q13 are associated with two developmental disorders, Prader-Willi syndrome (PWS) and Angelman syndrome (AS).",10712201_1,-1,1029,-1,0.21760175
1030,Angelman syndrome,21,23,146,163,"
Deletions and other abnormalities of human chromosome 15q11-q13 are associated with two developmental disorders, Prader-Willi syndrome (PWS) and Angelman syndrome (AS).",10712201_1,-1,1030,-1,0.2143128
1031,map,29,30,193,196,"To identify additional imprinted genes that could contribute to the PWS phenotype and to understand the regional control of imprinting in 15q11-q13, we have constructed an imprinted transcript map of the PWS-AS deletion interval.",10712201_4,-1,1031,-1,0.22000046
1032,map,36,37,245,248,The imprinting status of 22 expressed sequence tags derived from the radiation-hybrid human transcript maps or physical maps was determined in a reverse transcriptase-PCR assay and correlated with the position of the transcripts on the physical map.,10712201_5,-1,1032,-1,0.22607723
1039,P,2,3,4,5,40 (P =. 01) at D1S212.,10712209_5,-1,1039,-1,0.28748775
1040,disease,12,13,90,97,Further parametric analysis revealed a significant effect of the presence of male-to-male disease transmission within the families.,10712209_10,-1,1040,-1,0.22714627
1041,P,16,17,61,62,"In the subset of 491 such families, the peak HLOD was 2. 56 (P =.",10712209_12,-1,1041,-1,0.27852273
1042,disease,5,6,38,45,"Within the families with male-to-male disease transmission, alpha increased with the early mean age at diagnosis (< 65 years, alpha =.",10712209_16,-1,1042,-1,0.19807293
1043,P,24,25,108,109,"The highest value of alpha was observed for the 48 families that met all three criteria (peak HLOD = 2. 25, P =.",10712209_21,-1,1043,-1,0.31255162
1046,disease,41,42,242,249,"Although HPC1 accounts for only a small proportion of all families affected by hereditary prostate cancer, it appears to play a more prominent role in the subset of families with several members affected at an early age and with male-to-male disease transmission.",10712209_26,-1,1046,-1,0.17772187
1047,Huntington disease,12,14,70,88,A recurrent expansion of a maternal allele with 36 CAG repeats causes Huntington disease in two sisters.,10712225_0,-1,1047,-1,0.20426926
1048,Huntington disease,31,33,161,179,"We describe a recurrent large expansion of a maternal allele with 36 CAG repeats (to 66 and 57 repeats, respectively, in two daughters) associated with onset of Huntington disease (HD) in the second and third decade in a family without history of HD.",10712225_2,-1,1048,-1,0.21309175
1050,disease,19,20,126,133,"
Motor incoordination, immune deficiencies, and an increased risk of cancer are the characteristic features of the hereditary disease ataxia-telangiectasia (A-T), which is caused by mutations in the ATM gene.",10716718_1,-1,1050,-1,0.21192263
1051,contrast,1,2,3,11,"In contrast to other Atm mutant mice, Atm (y/y) mice show a lower incidence of thymic lymphoma and survive beyond a few months of age.",10716718_3,-1,1051,-1,0.27043375
1052,lymphoma,19,20,86,94,"In contrast to other Atm mutant mice, Atm (y/y) mice show a lower incidence of thymic lymphoma and survive beyond a few months of age.",10716718_3,-1,1052,-1,0.17162833
1053,cerebellar dysfunction,12,14,64,86,Atm (y/y) mice exhibit deficits in motor learning indicative of cerebellar dysfunction.,10716718_4,-1,1053,-1,0.21118726
1054,Wilson disease,10,12,60,74,Novel mutations of the ATP7B gene in Japanese patients with Wilson disease.,10721669_0,-1,1054,-1,0.2016803
1055,Wilson disease,0,2,1,15,"
Wilson disease (WD) is an autosomal recessive disorder characterized by copper accumulation in the liver, brain, kidneys, and corneas, and culminating in copper toxication in these organs.",10721669_1,-1,1055,-1,0.21853474
1056,copper,12,13,73,79,"
Wilson disease (WD) is an autosomal recessive disorder characterized by copper accumulation in the liver, brain, kidneys, and corneas, and culminating in copper toxication in these organs.",10721669_1,-1,1056,-1,0.22919318
1057,copper,28,29,155,161,"
Wilson disease (WD) is an autosomal recessive disorder characterized by copper accumulation in the liver, brain, kidneys, and corneas, and culminating in copper toxication in these organs.",10721669_1,-1,1057,-1,0.24138723
1058,contrast,1,2,3,11,"In contrast to these mutations found in patients with hepatic-type of early onset, the mutations A874V, R778L, and 3892delGTC were either missense mutations or in frame 1-amino acid deletion, and occurred in the patients with hepato-neurologic type of late onset.",10721669_5,-1,1058,-1,0.28787535
1059,Wiskott-Aldrich syndrome,6,8,48,72,Autoinhibition and activation mechanisms of the Wiskott-Aldrich syndrome protein.,10724160_0,-1,1059,-1,0.199351
1060,Wiskott-Aldrich syndrome,14,16,89,113,"
The Rho-family GTPase, Cdc42, can regulate the actin cytoskeleton through activation of Wiskott-Aldrich syndrome protein (WASP) family members.",10724160_1,-1,1060,-1,0.19218086
1061,C,15,16,113,114,"In the autoinhibited complex, intramolecular interactions with the GTPase-binding domain occlude residues of the C terminus that regulate the Arp2/3 actin-nucleating complex.",10724160_4,-1,1061,-1,0.25098833
1062,C,24,25,154,155,"Binding of Cdc42 to the GTPase-binding domain causes a dramatic conformational change, resulting in disruption of the hydrophobic core and release of the C terminus, enabling its interaction with the actin regulatory machinery.",10724160_5,-1,1062,-1,0.2668085
1063,tumour,9,10,33,39,"
Mutations in the BRCA1 (ref. 1) tumour suppressor gene are found in almost all of the families with inherited breast and ovarian cancers and about half of the families with only breast cancer.",10724175_1,-1,1063,-1,0.16894706
1067,Machado-Joseph disease,0,2,1,23,"
Machado-Joseph disease (MJD) belongs to a group of clinically and genetically heterogeneous neurodegenerative disorders characterized by progressive cerebellar ataxia.",10732811_1,-1,1067,-1,0.23114191
1068,neurodegenerative disorders,14,16,93,120,"
Machado-Joseph disease (MJD) belongs to a group of clinically and genetically heterogeneous neurodegenerative disorders characterized by progressive cerebellar ataxia.",10732811_1,-1,1068,-1,0.17167383
1069,cerebellar ataxia,19,21,150,167,"
Machado-Joseph disease (MJD) belongs to a group of clinically and genetically heterogeneous neurodegenerative disorders characterized by progressive cerebellar ataxia.",10732811_1,-1,1069,-1,0.17562376
1070,n,15,16,92,93,The disease-causing mutation has recently been identified as an unstable and expanded (CAG) n trinucleotide repeat in a novel gene of unknown function.,10732811_2,-1,1070,-1,0.34741256
1072,C-terminal,3,4,13,23,"However, the C-terminal end of the putative protein differs strongly from the published human sequence.",10732811_6,-1,1072,-1,0.30775213
1073,n,4,5,10,11,The (CAG) n block in the rat cDNA consists of just three interrupted units suggesting that a long polyglutamine stretch is not essential for the normal function of the ataxin-3 protein in rodents.,10732811_7,-1,1073,-1,0.35348
1074,muscular dystrophy,7,9,50,68,"Emerin, deficiency of which causes Emery-Dreifuss muscular dystrophy, is localized at the inner nuclear membrane.",10732816_0,-1,1074,-1,0.17377906
1075,muscular dystrophy,3,5,35,53,"
X-linked recessive Emery-Dreifuss muscular dystrophy (EDMD) is an inherited muscle disorder characterized by the clinical triad of progressive wasting of humero-peroneal muscles, early contractures of the elbows, Achilles tendons and postcervical muscles, and cardiac conduction block with a high risk of sudden death.",10732816_1,-1,1075,-1,0.18206121
1076,contractures,26,27,186,198,"
X-linked recessive Emery-Dreifuss muscular dystrophy (EDMD) is an inherited muscle disorder characterized by the clinical triad of progressive wasting of humero-peroneal muscles, early contractures of the elbows, Achilles tendons and postcervical muscles, and cardiac conduction block with a high risk of sudden death.",10732816_1,-1,1076,-1,0.22573936
1077,sudden death,46,48,306,318,"
X-linked recessive Emery-Dreifuss muscular dystrophy (EDMD) is an inherited muscle disorder characterized by the clinical triad of progressive wasting of humero-peroneal muscles, early contractures of the elbows, Achilles tendons and postcervical muscles, and cardiac conduction block with a high risk of sudden death.",10732816_1,-1,1077,-1,0.19132888
1078,gold,6,7,43,47,"We found that the immune-labeled colloidal gold particles were localized on the nucleoplasmic surface of the inner nuclear membrane, but not on the nuclear pore.",10732816_4,-1,1078,-1,0.23408149
1079,calcium,32,33,222,229,"We speculate that emerin contributes to maintain the nuclear structure and stability, as well as nuclear functions, particularly in muscle tissues that have severe stress with rigorous contraction-relaxation movements and calcium flux..",10732816_7,-1,1079,-1,0.25846553
1080,Friedreich ataxia,3,5,23,40,Locus heterogeneity in Friedreich ataxia.,10735274_0,-1,1080,-1,0.2318587
1081,Friedreich ataxia,0,2,1,18,"
Friedreich ataxia (FRDA) is the most common form of autosomal recessive ataxia.",10735274_1,-1,1081,-1,0.23879215
1083,disease,1,2,4,11,"The disease locus was assigned to chromosome 9 and the disease gene, STM7/X25, has been isolated.",10735274_2,-1,1083,-1,0.22434765
1084,disease,10,11,55,62,"The disease locus was assigned to chromosome 9 and the disease gene, STM7/X25, has been isolated.",10735274_2,-1,1084,-1,0.20557363
1085,impaired glucose tolerance,5,8,27,53,Glycerol as a correlate of impaired glucose tolerance: dissection of a complex system by use of a simple genetic trait.,10736265_0,-1,1085,-1,0.23089753
1086,glucose,12,13,68,75,"
Glycerol kinase (GK) represents the primary entry of glycerol into glucose and triglyceride metabolism.",10736265_1,-1,1086,-1,0.2554772
1087,triglyceride,14,15,80,92,"
Glycerol kinase (GK) represents the primary entry of glycerol into glucose and triglyceride metabolism.",10736265_1,-1,1087,-1,0.26794228
1088,Impaired glucose tolerance,0,3,0,26,Impaired glucose tolerance (IGT) and hypertriglyceridemia are associated with an increased risk of diabetes mellitus and cardiovascular disease.,10736265_2,-1,1088,-1,0.23193535
1089,hypertriglyceridemia,7,8,37,57,Impaired glucose tolerance (IGT) and hypertriglyceridemia are associated with an increased risk of diabetes mellitus and cardiovascular disease.,10736265_2,-1,1089,-1,0.23765658
1090,diabetes mellitus,15,17,99,116,Impaired glucose tolerance (IGT) and hypertriglyceridemia are associated with an increased risk of diabetes mellitus and cardiovascular disease.,10736265_2,-1,1090,-1,0.18669073
1091,cardiovascular disease,18,20,121,143,Impaired glucose tolerance (IGT) and hypertriglyceridemia are associated with an increased risk of diabetes mellitus and cardiovascular disease.,10736265_2,-1,1091,-1,0.19573
1092,hyperglycerolemia,14,15,88,105,Family screening in the initial cohort identified 18 men from five families with severe hyperglycerolemia (values above 2. 0 mmol/liter) and demonstrated an X-linked pattern of inheritance.,10736265_5,-1,1092,-1,0.22955103
1093,disease,5,6,32,39,-Jean region of Quebec-a common disease haplotype was sought.,10736265_10,-1,1093,-1,0.212142
1094,cM,1,2,2,4,5 cM was observed in all families.,10736265_12,-1,1094,-1,0.32257318
1095,aspartic acid,36,38,208,221,"Resequencing of the GK gene in family members led to the discovery of a N288D missense mutation in exon 10, which resulted in the substitution of a highly conserved asparagine residue by a negatively charged aspartic acid.",10736265_13,-1,1095,-1,0.28145495
1096,dystonias,6,7,43,52,Clinical and molecular genetics of primary dystonias.,10737119_0,-1,1096,-1,0.2113074
1097,dystonias,1,2,9,18,"
Primary dystonias are movement disorders with dystonia as a major symptom.",10737119_1,-1,1097,-1,0.20496395
1103,dystonia parkinsonism syndrome,4,7,18,48,"1 in the X-linked dystonia parkinsonism syndrome and to Xq22 in X-linked sensorineural deafness, dystonia, and mental retardation.",10737119_9,-1,1103,-1,0.19375126
1104,deafness,13,14,87,95,"1 in the X-linked dystonia parkinsonism syndrome and to Xq22 in X-linked sensorineural deafness, dystonia, and mental retardation.",10737119_9,-1,1104,-1,0.19472118
1106,mental retardation,18,20,111,129,"1 in the X-linked dystonia parkinsonism syndrome and to Xq22 in X-linked sensorineural deafness, dystonia, and mental retardation.",10737119_9,-1,1106,-1,0.19657022
1107,disease,1,2,4,11,The disease genes have been identified in two autosomal dominant forms and in one X-linked recessive form.,10737119_10,-1,1107,-1,0.22444215
1110,deafness,2,3,17,25,"In sensorineural deafness, dystonia, and mental retardation , mutations were found in the gene DDP coding for a polypeptide of unknown function.",10737119_12,-1,1110,-1,0.1760822
1112,mental retardation,7,9,41,59,"In sensorineural deafness, dystonia, and mental retardation , mutations were found in the gene DDP coding for a polypeptide of unknown function.",10737119_12,-1,1112,-1,0.1946162
1113,dystonias,10,11,68,77,"This article reviews the clinical and molecular genetics of primary dystonias, critically discusses present findings, and proposes referring to the known forms, most of which can be distinguished by genetic criteria, as dystonias 1-12.",10737119_13,-1,1113,-1,0.20314099
1114,dystonias,36,37,220,229,"This article reviews the clinical and molecular genetics of primary dystonias, critically discusses present findings, and proposes referring to the known forms, most of which can be distinguished by genetic criteria, as dystonias 1-12.",10737119_13,-1,1114,-1,0.22431496
1115,adrenoleukodystrophy,4,5,29,49,"Determination of 30 X-linked adrenoleukodystrophy mutations, including 15 not previously described.",10737980_0,-1,1115,-1,0.20269133
1116,Adrenoleukodystrophy,1,2,10,30,"
X-linked Adrenoleukodystrophy (X-ALD) is the most frequent peroxisomal disease.",10737980_1,-1,1116,-1,0.1945042
1117,disease,10,11,72,79,"
X-linked Adrenoleukodystrophy (X-ALD) is the most frequent peroxisomal disease.",10737980_1,-1,1117,-1,0.19146499
1118,fatty acids,10,12,87,98,"The principal biochemical abnormality is the accumulation of saturated very-long-chain fatty acids (VLCFAs  > C22  0, mainly C26  0), which is due to impaired capacity for beta-oxidation in peroxisomes.",10737980_4,-1,1118,-1,0.2603586
1119,disease,13,14,65,72,"Six of the eight patients with the infantile, severe form of the disease presented cardiac involvement, a feature rarely associated with GM1-gangliosidosis.",10737981_3,-1,1119,-1,0.21719505
1120,amino acid,21,23,129,139,"Molecular analysis of the patients RNA and DNA identified two new RNA splicing defects, three new and three previously described amino acid substitutions.",10737981_4,-1,1120,-1,0.27106142
1121,contrast,28,29,137,145,"Interestingly, all patients with cardiac involvement were homozygous for one of these mutations  R59H, Y591C, Y591N, or IVS14-2A > G. In contrast, all other patients were compound heterozygous for one of the following mutations  R201H, R482H, G579D, IVS8 + 2T > C. Although we could not directly correlate the presence of cardiac abnormalities with specific genetic lesions, the mutations identified in patients with cardiomyopathy fell in the GLB1 cDNA region common to the lysosomal enzyme and the Hbeta-Gal-related protein, also known as the elastin binding protein (EBP).",10737981_5,-1,1121,-1,0.25119844
1122,C.,54,55,262,264,"Interestingly, all patients with cardiac involvement were homozygous for one of these mutations  R59H, Y591C, Y591N, or IVS14-2A > G. In contrast, all other patients were compound heterozygous for one of the following mutations  R201H, R482H, G579D, IVS8 + 2T > C. Although we could not directly correlate the presence of cardiac abnormalities with specific genetic lesions, the mutations identified in patients with cardiomyopathy fell in the GLB1 cDNA region common to the lysosomal enzyme and the Hbeta-Gal-related protein, also known as the elastin binding protein (EBP).",10737981_5,-1,1122,-1,0.32356408
1123,cardiac abnormalities,64,66,322,343,"Interestingly, all patients with cardiac involvement were homozygous for one of these mutations  R59H, Y591C, Y591N, or IVS14-2A > G. In contrast, all other patients were compound heterozygous for one of the following mutations  R201H, R482H, G579D, IVS8 + 2T > C. Although we could not directly correlate the presence of cardiac abnormalities with specific genetic lesions, the mutations identified in patients with cardiomyopathy fell in the GLB1 cDNA region common to the lysosomal enzyme and the Hbeta-Gal-related protein, also known as the elastin binding protein (EBP).",10737981_5,-1,1123,-1,0.22439758
1125,obesity,6,7,36,43,In vivo modulation of Hmgic reduces obesity.,10742101_0,-1,1125,-1,0.2811466
1126,tumour,10,11,60,66,"It is disrupted and misexpressed in a number of mesenchymal tumour cell types, including fat-cell tumours (lipomas).",10742101_3,-1,1126,-1,0.17722543
1127,tumours,16,17,98,105,"It is disrupted and misexpressed in a number of mesenchymal tumour cell types, including fat-cell tumours (lipomas).",10742101_3,-1,1127,-1,0.17388333
1128,fat,8,9,47,50,In addition Hmgic-/- mice have a deficiency in fat tissue.,10742101_4,-1,1128,-1,0.23596522
1129,obesity,7,8,38,45,"To study its role in adipogenesis and obesity, we examined Hmgic expression in the adipose tissue of adult, obese mice.",10742101_5,-1,1129,-1,0.17544504
1130,obesity,11,12,74,81,Mice with a partial or complete deficiency of Hmgic resisted diet-induced obesity.,10742101_6,-1,1130,-1,0.22223923
1131,obesity,8,9,46,53,Disruption of Hmgic caused a reduction in the obesity induced by leptin deficiency (Lepob/Lepob) in a gene-dose-dependent manner.,10742101_7,-1,1131,-1,0.24818942
1132,leptin,11,12,65,71,Disruption of Hmgic caused a reduction in the obesity induced by leptin deficiency (Lepob/Lepob) in a gene-dose-dependent manner.,10742101_7,-1,1132,-1,0.261848
1133,obesity,23,24,140,147,"Our studies implicate a role for HMGIC in fat-cell proliferation, indicating that it may be an adipose-specific target for the treatment of obesity..",10742101_8,-1,1133,-1,0.19334626
1134,factor X deficiency,7,10,61,80,Molecular analysis of the genotype-phenotype relationship in factor X deficiency.,10746568_0,-1,1134,-1,0.24012986
1135,Factor X deficiency,0,3,1,20,"
Factor X deficiency is a rare haemorrhagic condition, normally inherited as an autosomal recessive trait, in which a variable clinical presentation correlates poorly with laboratory phenotype.",10746568_1,-1,1135,-1,0.26961133
1136,factor X deficiency,12,15,58,77,The factor X (F10) genes of 14 unrelated individuals with factor X deficiency (12 familial and two sporadic cases) were sequenced yielding a total of 13 novel mutations.,10746568_2,-1,1136,-1,0.24503453
1137,lead,25,26,183,187,One family manifesting an autosomal dominant pattern of inheritance possessed three clinically affected members who were heterozygous for a splice-site mutation that was predicted to lead to the production of a truncated protein product.,10746568_6,-1,1137,-1,0.27922526
1138,contrast,1,2,3,11,"By contrast, no such relationship could be discerned between laboratory phenotype and polymorphism genotype..",10746568_9,-1,1138,-1,0.25093323
1139,fat,19,20,121,124,"Despite the ubiquitous expression of the truncated HMG I-C protein, the transgenic mice develop a selective abundance of fat tissue early in life, show marked adipose tissue inflammation, and have an abnormally high incidence of lipomas.",10747931_3,-1,1139,-1,0.198677
1142,diseases,2,3,10,18,"
The rare diseases ataxia-telangiectasia (AT), caused by mutations in the ATM gene, and Nijmegen breakage syndrome (NBS), with mutations in the p95/nbs1 gene, share a variety of phenotypic abnormalities such as chromosomal instability, radiation sensitivity and defects in cell-cycle checkpoints in response to ionizing radiation.",10766245_1,-1,1142,-1,0.18570447
1143,Nijmegen breakage syndrome,17,20,88,114,"
The rare diseases ataxia-telangiectasia (AT), caused by mutations in the ATM gene, and Nijmegen breakage syndrome (NBS), with mutations in the p95/nbs1 gene, share a variety of phenotypic abnormalities such as chromosomal instability, radiation sensitivity and defects in cell-cycle checkpoints in response to ionizing radiation.",10766245_1,-1,1143,-1,0.19663309
1144,chromosomal instability,39,41,211,234,"
The rare diseases ataxia-telangiectasia (AT), caused by mutations in the ATM gene, and Nijmegen breakage syndrome (NBS), with mutations in the p95/nbs1 gene, share a variety of phenotypic abnormalities such as chromosomal instability, radiation sensitivity and defects in cell-cycle checkpoints in response to ionizing radiation.",10766245_1,-1,1144,-1,0.17963186
1145,diseases,21,22,140,148,These observations link ATM and p95/nbs1 in a common signalling pathway and provide an explanation for phenotypic similarities in these two diseases..,10766245_7,-1,1145,-1,0.16611181
1146,fragile X syndrome,5,8,37,55,Understanding the molecular basis of fragile X syndrome.,10767313_0,-1,1146,-1,0.21671034
1147,Fragile X syndrome,0,3,1,19,"
Fragile X syndrome, a common form of inherited mental retardation, is mainly caused by massive expansion of CGG triplet repeats located in the 5-untranslated region of the fragile X mental retardation-1 (FMR1) gene.",10767313_1,-1,1147,-1,0.20381042
1148,mental retardation,9,11,48,66,"
Fragile X syndrome, a common form of inherited mental retardation, is mainly caused by massive expansion of CGG triplet repeats located in the 5-untranslated region of the fragile X mental retardation-1 (FMR1) gene.",10767313_1,-1,1148,-1,0.17133883
1149,fragile X syndrome,3,6,17,35,"In patients with fragile X syndrome, the expanded CGG triplet repeats are hypermethylated and the expression of the FMR1 gene is repressed, which leads to the absence of FMR1 protein (FMRP) and subsequent mental retardation.",10767313_2,-1,1149,-1,0.19411194
1150,mental retardation,37,39,205,223,"In patients with fragile X syndrome, the expanded CGG triplet repeats are hypermethylated and the expression of the FMR1 gene is repressed, which leads to the absence of FMR1 protein (FMRP) and subsequent mental retardation.",10767313_2,-1,1150,-1,0.18234037
1151,diseases,17,18,97,105,These studies will not only help to illuminate the molecular basis of the general class of human diseases with trinucleotide repeat expansion but also provide an avenue to understand aspects of human cognition and intelligence..,10767313_6,-1,1151,-1,0.1824816
1156,Fragile X syndrome,0,3,1,19,"
Fragile X syndrome is a common cause of mental retardation involving loss of expression of the FMR1 gene.",10767339_1,-1,1156,-1,0.19848962
1157,mental retardation,8,10,41,59,"
Fragile X syndrome is a common cause of mental retardation involving loss of expression of the FMR1 gene.",10767339_1,-1,1157,-1,0.17080402
1158,macroorchidism,14,15,81,95,"Fmr1 knockout mice exhibit a phenotype with some similarities to humans, such as macroorchidism and behavioral abnormalities.",10767339_3,-1,1158,-1,0.25909108
1159,behavioral abnormalities,16,18,100,124,"Fmr1 knockout mice exhibit a phenotype with some similarities to humans, such as macroorchidism and behavioral abnormalities.",10767339_3,-1,1159,-1,0.20824271
1160,fragile X syndrome,19,22,121,139,"As a step toward understanding the function of FMR1 and the determination of the potential for therapeutic approaches to fragile X syndrome, yeast artificial chromosome (YAC) transgenic mice were generated in order to determine whether the Fmr1 knockout mouse phenotype could be rescued.",10767339_4,-1,1160,-1,0.19229963
1161,fragile X syndrome,9,12,66,84,These findings have significant implications for gene therapy for fragile X syndrome since overexpression of the gene may harbor its own phenotype..,10767339_11,-1,1161,-1,0.18519846
1162,DM,14,15,98,100,Transgenic mice carrying large human genomic sequences with expanded CTG repeat mimic closely the DM CTG repeat intergenerational and somatic instability.,10767343_0,-1,1162,-1,0.2818433
1163,Myotonic dystrophy,0,2,1,19,"
Myotonic dystrophy (DM) is caused by a CTG repeat expansion in the 3UTR of the DM protein kinase (DMPK) gene.",10767343_1,-1,1163,-1,0.19568291
1164,DM,3,4,21,23,"
Myotonic dystrophy (DM) is caused by a CTG repeat expansion in the 3UTR of the DM protein kinase (DMPK) gene.",10767343_1,-1,1164,-1,0.2149734
1165,DM,17,18,80,82,"
Myotonic dystrophy (DM) is caused by a CTG repeat expansion in the 3UTR of the DM protein kinase (DMPK) gene.",10767343_1,-1,1165,-1,0.24395771
1166,disease,25,26,152,159,A very high level of instability is observed through successive generations and the size of the repeat is generally correlated with the severity of the disease and with age at onset.,10767343_2,-1,1166,-1,0.21901426
1167,DM,4,5,26,28,"Furthermore, tissues from DM patients exhibit somatic mosaicism that increases with age.",10767343_3,-1,1167,-1,0.21380569
1168,DM,25,26,138,140,"We generated transgenic mice carrying large human genomic sequences with 20, 55 or > 300 CTG, cloned from patients from the same affected DM family.",10767343_4,-1,1168,-1,0.20707358
1169,DM,22,23,122,124,"Although we did not observe dramatic expansions (or big jumps over several hundred CTG repeats) as in congenital forms of DM, our model carrying > 300 CTG is the first to show instability so close to the human DM situation.",10767343_7,-1,1169,-1,0.21332218
1170,DM,41,42,210,212,"Although we did not observe dramatic expansions (or big jumps over several hundred CTG repeats) as in congenital forms of DM, our model carrying > 300 CTG is the first to show instability so close to the human DM situation.",10767343_7,-1,1170,-1,0.20052007
1171,Friedreich ataxia,3,5,20,37,Inactivation of the Friedreich ataxia mouse gene leads to early embryonic lethality without iron accumulation.,10767347_0,-1,1171,-1,0.22481142
1172,iron,13,14,92,96,Inactivation of the Friedreich ataxia mouse gene leads to early embryonic lethality without iron accumulation.,10767347_0,-1,1172,-1,0.21930337
1173,Friedreich ataxia,0,2,1,18,"
Friedreich ataxia (FRDA), the most common autosomal recessive ataxia, is caused in almost all cases by homozygous intronic expansions resulting in the loss of frataxin, a mitochondrial protein conserved through evolution, and involved in mitochondrial iron homeostasis.",10767347_1,-1,1173,-1,0.24228498
1175,iron,41,42,253,257,"
Friedreich ataxia (FRDA), the most common autosomal recessive ataxia, is caused in almost all cases by homozygous intronic expansions resulting in the loss of frataxin, a mitochondrial protein conserved through evolution, and involved in mitochondrial iron homeostasis.",10767347_1,-1,1175,-1,0.22176592
1176,iron,28,29,203,207,"Yeast knockout models, and histological and biochemical data from patient heart biopsies or autopsies indicate that the frataxin defect causes a specific iron-sulfur protein deficiency and mitochondrial iron accumulation leading to the pathological changes.",10767347_2,-1,1176,-1,0.20489985
1177,disease,6,7,30,37,"To study the mechanism of the disease, we generated a mouse model by deletion of exon 4 leading to inactivation of the Frda gene product.",10767347_4,-1,1177,-1,0.20226404
1178,iron,9,10,49,53,"Surprisingly, in the frataxin knockout mouse, no iron accumulation was observed during embryonic resorption, suggesting that cell death could be due to a mechanism independent of iron accumulation..",10767347_7,-1,1178,-1,0.20488548
1180,iron,29,30,179,183,"Surprisingly, in the frataxin knockout mouse, no iron accumulation was observed during embryonic resorption, suggesting that cell death could be due to a mechanism independent of iron accumulation..",10767347_7,-1,1180,-1,0.21481992
1181,Gaucher disease,0,2,0,15,Gaucher disease: the origins of the Ashkenazi Jewish N370S and 84GG acid beta-glucosidase mutations.,10777718_0,-1,1181,-1,0.21911542
1182,Gaucher disease,2,4,8,23,"
Type 1 Gaucher disease (GD), a non-neuronopathic lysosomal storage disorder, results from the deficient activity of acid beta-glucosidase (GBA).",10777718_1,-1,1182,-1,0.22265759
1183,disease,2,3,7,14,Type 1 disease is panethnic but is more prevalent in individuals of Ashkenazi Jewish (AJ) descent.,10777718_2,-1,1183,-1,0.21635103
1184,STR,17,18,97,100,"To investigate the genetic history of these mutations in the AJ population, short tandem repeat (STR) markers were used to map a 9.",10777718_4,-1,1184,-1,0.24701524
1185,map,23,24,123,126,"To investigate the genetic history of these mutations in the AJ population, short tandem repeat (STR) markers were used to map a 9.",10777718_4,-1,1185,-1,0.26485515
1186,contrast,1,2,3,11,"In contrast, a different conserved haplotype at these markers was identified on the 84GG chromosomes, which was unique to the AJ population.",10777718_8,-1,1186,-1,0.27392203
1187,spondylitis,7,8,39,50,HLA B27 and the genetics of ankylosing spondylitis.,107868_0,-1,1187,-1,0.20752685
1188,spondylitis,9,10,62,73,"
One hundred and twenty-eight of 145 patients with ankylosing spondylitis (AS) were found to be HLA B27 positive.",107868_1,-1,1188,-1,0.20613343
1190,psoriatic arthritis,11,13,89,108,Five patients had evidence of a sero-negative peripheral arthritis resembling peripheral psoriatic arthritis and 3 of these were B27 negative.,107868_2,-1,1190,-1,0.20006664
1191,spondylitis,10,11,63,74,One further B27 negative patients had a sister with ankylosing spondylitis and ulcerative colitis and a mother with ulcerative colitis.,107868_3,-1,1191,-1,0.21265787
1192,ulcerative colitis,12,14,79,97,One further B27 negative patients had a sister with ankylosing spondylitis and ulcerative colitis and a mother with ulcerative colitis.,107868_3,-1,1192,-1,0.17809962
1193,ulcerative colitis,18,20,116,134,One further B27 negative patients had a sister with ankylosing spondylitis and ulcerative colitis and a mother with ulcerative colitis.,107868_3,-1,1193,-1,0.18800333
1194,spondylitis,15,16,109,120,"These findings are interpreted as suggesting some degree of clinical and genetic heterogeneity in ankylosing spondylitis with genes for psoriasis and inflammatory bowel disease being important in some individuals, particularly those who are B27 negative.",107868_5,-1,1194,-1,0.2135003
1196,inflammatory bowel disease,21,24,150,176,"These findings are interpreted as suggesting some degree of clinical and genetic heterogeneity in ankylosing spondylitis with genes for psoriasis and inflammatory bowel disease being important in some individuals, particularly those who are B27 negative.",107868_5,-1,1196,-1,0.17347382
1197,spondylitis,5,6,51,62,Twenty-five first-degree relatives with ankylosing spondylitis were all B27 positive.,107868_6,-1,1197,-1,0.20966282
1198,spondylitis,8,9,47,58,The only instance of disassociation of B27 and spondylitis in a family was where the proband had ulcerative colitis as well as spondylitis.,107868_7,-1,1198,-1,0.22910915
1199,ulcerative colitis,17,19,97,115,The only instance of disassociation of B27 and spondylitis in a family was where the proband had ulcerative colitis as well as spondylitis.,107868_7,-1,1199,-1,0.19964641
1200,spondylitis,22,23,127,138,The only instance of disassociation of B27 and spondylitis in a family was where the proband had ulcerative colitis as well as spondylitis.,107868_7,-1,1200,-1,0.23380814
1201,spondylitis,13,14,78,89,Of 13 B27 positive fathers 3 could be diagnosed as having definite ankylosing spondylitis (23%).,107868_8,-1,1201,-1,0.215332
1202,spondylitis,15,16,96,107,These findings are thought to provide evidence against the concept that the gene for ankylosing spondylitis is not B27 but a closely linked gene and favour the occurrence of an environmental event affecting approximately one-fifth of B27 positive males to result in disease..,107868_9,-1,1202,-1,0.20578383
1203,disease,42,43,266,273,These findings are thought to provide evidence against the concept that the gene for ankylosing spondylitis is not B27 but a closely linked gene and favour the occurrence of an environmental event affecting approximately one-fifth of B27 positive males to result in disease..,107868_9,-1,1203,-1,0.21000786
1214,cancer syndrome,10,12,63,78,The single family with a BRCA2 mutation had the breast-ovarian cancer syndrome.,10788334_9,-1,1214,-1,0.15605792
1215,fatty acid,15,17,107,117,"
Very long chain acyl-CoA dehydrogenase (VLCAD) deficiency is a life-threatening disorder of mitochondrial fatty acid beta-oxidation.",10790204_1,-1,1215,-1,0.2641199
1216,VLCAD deficiency,8,10,46,62,All patients had the severe childhood form of VLCAD deficiency with early onset and high mortality.,10790204_3,-1,1216,-1,0.25764477
1217,65C,39,40,184,187,"As expected, null mutations were found in patients 2 and 3  patient 2 is homozygous for a frameshift mutation, del 4 bp at 798-801, and patient 3 is homozygous for a nonsense mutation 65C > A (S22X).",10790204_5,-1,1217,-1,0.28204468
1218,C,25,26,131,132,"Patient 1 was homozygous for a complex mutant allele containing two alterations, including a 194C > T transition (P65L) and 739A > C transversion (K247Q); in the case of P65L, the amino acid change does not reduce enzyme activity.",10790204_6,-1,1218,-1,0.3644308
1219,amino acid,38,40,180,190,"Patient 1 was homozygous for a complex mutant allele containing two alterations, including a 194C > T transition (P65L) and 739A > C transversion (K247Q); in the case of P65L, the amino acid change does not reduce enzyme activity.",10790204_6,-1,1219,-1,0.3008467
1220,nucleotide,3,4,13,23,"However, the nucleotide change resulted in exon 3 skipping, whereas the latter K247Q mutation had a drastic effect on enzyme activity.",10790204_7,-1,1220,-1,0.26884833
1221,Prader-Willi syndrome,5,7,40,61,Submicroscopic deletion in cousins with Prader-Willi syndrome causes a grandmatrilineal inheritance pattern: effects of imprinting.,10797418_0,-1,1221,-1,0.21735226
1222,Prader-Willi syndrome,1,3,5,26,"
The Prader-Willi syndrome (PWS) critical region on 15q11-q13 is subject to imprinting.",10797418_1,-1,1222,-1,0.23788488
1223,glycine,1,2,6,13,"Human glycine decarboxylase gene (GLDC) and its highly conserved processed pseudogene (psiGLDC): their structure and expression, and the identification of a large deletion in a family with nonketotic hyperglycinemia.",10798358_0,-1,1223,-1,0.24080838
1224,nonketotic hyperglycinemia,32,34,189,215,"Human glycine decarboxylase gene (GLDC) and its highly conserved processed pseudogene (psiGLDC): their structure and expression, and the identification of a large deletion in a family with nonketotic hyperglycinemia.",10798358_0,-1,1224,-1,0.18934427
1225,glycine,3,4,18,25,"
Mutations in the glycine decarboxylase gene (GLDC) cause nonketotic hyperglycinemia (NKH), an in-born error of metabolism characterized by severe neurological disturbance.",10798358_1,-1,1225,-1,0.24301478
1226,nonketotic hyperglycinemia,10,12,58,84,"
Mutations in the glycine decarboxylase gene (GLDC) cause nonketotic hyperglycinemia (NKH), an in-born error of metabolism characterized by severe neurological disturbance.",10798358_1,-1,1226,-1,0.1916824
1227,neurological disturbance,24,26,147,171,"
Mutations in the glycine decarboxylase gene (GLDC) cause nonketotic hyperglycinemia (NKH), an in-born error of metabolism characterized by severe neurological disturbance.",10798358_1,-1,1227,-1,0.197655
1228,GT-AG,9,10,53,58,"All donor and acceptor sites adhere to the canonical GT-AG rule, except for the donor site of intron 21, where a variant form GC is used instead of GT.",10798358_4,-1,1228,-1,0.33489043
1229,Prader-Willi syndrome,0,2,1,22,"
Prader-Willi syndrome (PWS) is a neurogenetic disease characterized by infantile hypotonia, gonadal hypoplasia, obsessive behaviour and neonatal feeding difficulties followed by hyperphagia, leading to profound obesity.",10802660_1,-1,1229,-1,0.22345693
1230,disease,8,9,47,54,"
Prader-Willi syndrome (PWS) is a neurogenetic disease characterized by infantile hypotonia, gonadal hypoplasia, obsessive behaviour and neonatal feeding difficulties followed by hyperphagia, leading to profound obesity.",10802660_1,-1,1230,-1,0.19514155
1231,hypotonia,12,13,82,91,"
Prader-Willi syndrome (PWS) is a neurogenetic disease characterized by infantile hypotonia, gonadal hypoplasia, obsessive behaviour and neonatal feeding difficulties followed by hyperphagia, leading to profound obesity.",10802660_1,-1,1231,-1,0.19715877
1232,hyperphagia,25,26,179,190,"
Prader-Willi syndrome (PWS) is a neurogenetic disease characterized by infantile hypotonia, gonadal hypoplasia, obsessive behaviour and neonatal feeding difficulties followed by hyperphagia, leading to profound obesity.",10802660_1,-1,1232,-1,0.21871935
1233,obesity,30,31,212,219,"
Prader-Willi syndrome (PWS) is a neurogenetic disease characterized by infantile hypotonia, gonadal hypoplasia, obsessive behaviour and neonatal feeding difficulties followed by hyperphagia, leading to profound obesity.",10802660_1,-1,1233,-1,0.20845708
1234,map,6,7,43,46,"Five imprinted, paternally expressed genes map to the PWS region, MKRN3 (ref. 3), NDN (ref. 4), NDNL1 (ref. 5), SNRPN (refs 6-8) and IPW (ref. 9), as well as two poorly characterized framents designated PAR-1 and PAR-5 (ref. 10).",10802660_3,-1,1234,-1,0.26976264
1236,myotonic dystrophy,9,11,59,77,Mice deficient in Six5 develop cataracts: implications for myotonic dystrophy.,10802667_0,-1,1236,-1,0.18565303
1237,myotonic dystrophy,22,24,112,130,"
Expansion of a CTG trinucleotide repeat in the 3 UTR of the gene DMPK at the DM1 locus on chromosome 19 causes myotonic dystrophy, a dominantly inherited disease characterized by skeletal muscle dystrophy and myotonia, cataracts and cardiac conduction defects.",10802667_1,-1,1237,-1,0.17777178
1238,disease,28,29,155,162,"
Expansion of a CTG trinucleotide repeat in the 3 UTR of the gene DMPK at the DM1 locus on chromosome 19 causes myotonic dystrophy, a dominantly inherited disease characterized by skeletal muscle dystrophy and myotonia, cataracts and cardiac conduction defects.",10802667_1,-1,1238,-1,0.20115782
1239,myotonia,35,36,210,218,"
Expansion of a CTG trinucleotide repeat in the 3 UTR of the gene DMPK at the DM1 locus on chromosome 19 causes myotonic dystrophy, a dominantly inherited disease characterized by skeletal muscle dystrophy and myotonia, cataracts and cardiac conduction defects.",10802667_1,-1,1239,-1,0.18848158
1242,myotonic dystrophy,28,30,166,184,"Targeted deletion of Dm15, the mouse orthologue of human DMPK, produced mice with a mild myopathy and cardiac conduction abnormalities, but without other features of myotonic dystrophy, such as myotonia and cataracts.",10802667_2,-1,1242,-1,0.18168975
1243,myotonia,33,34,194,202,"Targeted deletion of Dm15, the mouse orthologue of human DMPK, produced mice with a mild myopathy and cardiac conduction abnormalities, but without other features of myotonic dystrophy, such as myotonia and cataracts.",10802667_2,-1,1243,-1,0.20682476
1245,myotonic dystrophy,8,10,56,74,"To determine whether SIX5 deficiency contributes to the myotonic dystrophy phenotype, we disrupted mouse Six5 by replacing the first exon with a beta-galactosidase reporter.",10802667_4,-1,1245,-1,0.1641603
1247,myotonic dystrophy,12,14,82,100,"Our results suggest that SIX5 deficiency contributes to the cataract phenotype in myotonic dystrophy, and that myotonic dystrophy represents a multigenic disorder..",10802667_7,-1,1247,-1,0.17114998
1248,myotonic dystrophy,17,19,111,129,"Our results suggest that SIX5 deficiency contributes to the cataract phenotype in myotonic dystrophy, and that myotonic dystrophy represents a multigenic disorder..",10802667_7,-1,1248,-1,0.1834816
1250,Myotonic dystrophy,0,2,1,19,"
Myotonic dystrophy (DM) is an autosomal dominant disorder characterized by skeletal muscle wasting, myotonia, cardiac arrhythmia, hyperinsulinaemia, mental retardation and ocular cataracts.",10802668_1,-1,1250,-1,0.19763146
1251,DM,3,4,21,23,"
Myotonic dystrophy (DM) is an autosomal dominant disorder characterized by skeletal muscle wasting, myotonia, cardiac arrhythmia, hyperinsulinaemia, mental retardation and ocular cataracts.",10802668_1,-1,1251,-1,0.22850856
1252,myotonia,16,17,101,109,"
Myotonic dystrophy (DM) is an autosomal dominant disorder characterized by skeletal muscle wasting, myotonia, cardiac arrhythmia, hyperinsulinaemia, mental retardation and ocular cataracts.",10802668_1,-1,1252,-1,0.1903715
1253,cardiac arrhythmia,18,20,111,129,"
Myotonic dystrophy (DM) is an autosomal dominant disorder characterized by skeletal muscle wasting, myotonia, cardiac arrhythmia, hyperinsulinaemia, mental retardation and ocular cataracts.",10802668_1,-1,1253,-1,0.18743148
1254,mental retardation,23,25,150,168,"
Myotonic dystrophy (DM) is an autosomal dominant disorder characterized by skeletal muscle wasting, myotonia, cardiac arrhythmia, hyperinsulinaemia, mental retardation and ocular cataracts.",10802668_1,-1,1254,-1,0.17651019
1256,DM,4,5,22,24,"The genetic defect in DM is a CTG repeat expansion located in the 3 untranslated region of DMPK and 5 of a homeodomain-encoding gene, SIX5 (formerly DMAHP; refs 2-5).",10802668_2,-1,1256,-1,0.23894648
1257,DM,11,12,64,66,There are three mechanisms by which CTG expansion can result in DM.,10802668_3,-1,1257,-1,0.25193274
1258,DM,21,22,124,126,Previous studies have demonstrated that a dose-dependent loss of Dm15 (the mouse DMPK homologue) in mice produces a partial DM phenotype characterized by decreased development of skeletal muscle force and cardiac conduction disorders.,10802668_7,-1,1258,-1,0.21042065
1259,DM,8,9,33,35,"To test the role of Six5 loss in DM, we have analysed a strain of mice in which Six5 was deleted.",10802668_8,-1,1259,-1,0.22059323
1261,Na,12,13,68,70,Six5 +/- and Six5-/- mice show increased steady-state levels of the Na +/K + -ATPase alpha-1 subunit and decreased Dm15 mRNA levels.,10802668_10,-1,1261,-1,0.24702351
1264,DM,8,9,52,54,"As ocular cataracts are a characteristic feature of DM, these results demonstrate that decreased SIX5 transcription is important in the aetiology of DM.",10802668_12,-1,1264,-1,0.20564325
1265,DM,23,24,149,151,"As ocular cataracts are a characteristic feature of DM, these results demonstrate that decreased SIX5 transcription is important in the aetiology of DM.",10802668_12,-1,1265,-1,0.20276408
1266,DM,6,7,37,39,Our data support the hypothesis that DM is a contiguous gene syndrome associated with the partial loss of both DMPK and SIX5..,10802668_13,-1,1266,-1,0.22023855
1267,syndrome,11,12,61,69,Our data support the hypothesis that DM is a contiguous gene syndrome associated with the partial loss of both DMPK and SIX5..,10802668_13,-1,1267,-1,0.23744476
1268,cerebellar dysfunction,20,22,123,145,"
Mutations in the gene ATM are responsible for the genetic disorder ataxia-telangiectasia (A-T), which is characterized by cerebellar dysfunction, radiosensitivity, chromosomal instability and cancer predisposition.",10802669_1,-1,1268,-1,0.20236959
1269,chromosomal instability,25,27,165,188,"
Mutations in the gene ATM are responsible for the genetic disorder ataxia-telangiectasia (A-T), which is characterized by cerebellar dysfunction, radiosensitivity, chromosomal instability and cancer predisposition.",10802669_1,-1,1269,-1,0.17774773
1271,chromosomal instability,10,12,68,91,"There are strong parallels between the pattern of radiosensitivity, chromosomal instability and cancer predisposition in A-T patients and that in patients with Nijmegen breakage syndrome (NBS).",10802669_3,-1,1271,-1,0.18634652
1273,Nijmegen breakage syndrome,23,26,160,186,"There are strong parallels between the pattern of radiosensitivity, chromosomal instability and cancer predisposition in A-T patients and that in patients with Nijmegen breakage syndrome (NBS).",10802669_3,-1,1273,-1,0.18327577
1284,P,38,39,214,215,"RESULTS  Hereditary cancers were rarely diagnosed before age 40 years and were common after age 60 years, with mean age at diagnosis being significantly younger for BRCA1- vs BRCA2-linked patients (54 vs 62 years; P =.",10807385_9,-1,1284,-1,0.3219116
1285,recurrence,23,24,153,163,"The hereditary group had a longer disease-free interval following primary chemotherapy in comparison with the nonhereditary group, with a median time to recurrence of 14 months and 7 months, respectively (P <. 001).",10807385_12,-1,1285,-1,0.20123473
1286,P,33,34,205,206,"The hereditary group had a longer disease-free interval following primary chemotherapy in comparison with the nonhereditary group, with a median time to recurrence of 14 months and 7 months, respectively (P <. 001).",10807385_12,-1,1286,-1,0.32070342
1288,P,13,14,91,92,Those with hereditary cancers had improved survival compared with the nonhereditary group (P =. 004).,10807385_13,-1,1288,-1,0.27563182
1290,P,14,15,84,85,"For stage III cancers, BRCA mutation status was an independent prognostic variable (P =. 03).",10807385_14,-1,1290,-1,0.24528329
1296,familial Mediterranean fever,3,6,13,41,"The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators.",10807793_0,-1,1296,-1,0.19609366
1297,Familial Mediterranean fever,0,3,1,29,"
Familial Mediterranean fever (FMF) is a recessive disorder characterized by episodes of fever and neutrophil-mediated serosal inflammation.",10807793_1,-1,1297,-1,0.20550792
1300,interferon,9,10,66,76,"In vitro stimulation of monocytes with the proinflammatory agents interferon (IFN) gamma, tumor necrosis factor, and lipopolysaccharide induced MEFV expression, whereas the antiinflammatory cytokines interleukin (IL) 4, IL-10, and transforming growth factor beta inhibited such expression.",10807793_10,-1,1300,-1,0.21649389
1301,IFN,11,12,78,81,"In vitro stimulation of monocytes with the proinflammatory agents interferon (IFN) gamma, tumor necrosis factor, and lipopolysaccharide induced MEFV expression, whereas the antiinflammatory cytokines interleukin (IL) 4, IL-10, and transforming growth factor beta inhibited such expression.",10807793_10,-1,1301,-1,0.22296517
1302,tumor necrosis,15,17,90,104,"In vitro stimulation of monocytes with the proinflammatory agents interferon (IFN) gamma, tumor necrosis factor, and lipopolysaccharide induced MEFV expression, whereas the antiinflammatory cytokines interleukin (IL) 4, IL-10, and transforming growth factor beta inhibited such expression.",10807793_10,-1,1302,-1,0.2216771
1303,lipopolysaccharide,20,21,117,135,"In vitro stimulation of monocytes with the proinflammatory agents interferon (IFN) gamma, tumor necrosis factor, and lipopolysaccharide induced MEFV expression, whereas the antiinflammatory cytokines interleukin (IL) 4, IL-10, and transforming growth factor beta inhibited such expression.",10807793_10,-1,1303,-1,0.22956565
1304,cycloheximide,9,10,61,74,Induction by IFN-gamma occurred rapidly and was resistant to cycloheximide.,10807793_11,-1,1304,-1,0.24754705
1305,N-acetylgalactosamine-6-sulfate,8,9,61,92,Biochemical and structural analysis of missense mutations in N-acetylgalactosamine-6-sulfate sulfatase causing mucopolysaccharidosis IVA phenotypes.,10814710_0,-1,1305,-1,0.2888169
1306,IVA,12,13,133,136,Biochemical and structural analysis of missense mutations in N-acetylgalactosamine-6-sulfate sulfatase causing mucopolysaccharidosis IVA phenotypes.,10814710_0,-1,1306,-1,0.21657719
1307,IVA,1,2,23,26,"
Mucopolysaccharidosis IVA (MPS IVA; OMIM # 253000), a lysosomal storage disorder caused by a deficiency of N -acetylgalactosamine-6-sulfate sulfatase (GALNS), has variable clinical phenotypes.",10814710_1,-1,1307,-1,0.21517748
1308,IVA,4,5,32,35,"
Mucopolysaccharidosis IVA (MPS IVA; OMIM # 253000), a lysosomal storage disorder caused by a deficiency of N -acetylgalactosamine-6-sulfate sulfatase (GALNS), has variable clinical phenotypes.",10814710_1,-1,1308,-1,0.23884606
1309,N,20,21,108,109,"
Mucopolysaccharidosis IVA (MPS IVA; OMIM # 253000), a lysosomal storage disorder caused by a deficiency of N -acetylgalactosamine-6-sulfate sulfatase (GALNS), has variable clinical phenotypes.",10814710_1,-1,1309,-1,0.30698723
1310,IVA,14,15,76,79,"To date we have identified 65 missense mutations in the GALNS gene from MPS IVA patients, but the correlation between genotype and phenotype has remained unclear.",10814710_2,-1,1310,-1,0.23852545
1311,N -acetylgalacto-samine-4-sulfatase,17,19,101,136,"Thus, a tertiary structural model of human GALNS was constructed from the X-ray crystal structure of N -acetylgalacto-samine-4-sulfatase and arylsulfatase A, using homology modeling, and 32 missense mutations were investigated.",10814710_9,-1,1311,-1,0.27367994
1312,salt,37,38,189,193,"Consequently, we propose that there are at least three different reasons for the severe phenotype  (i) destruction of the hydrophobic core or modification of the packing; (ii) removal of a salt bridge to destabilize the entire conformation; (iii) modification of the active site.",10814710_10,-1,1312,-1,0.33402687
1313,contrast,1,2,3,11,"In contrast, mild mutations were mostly located on the surface of the GALNS protein.",10814710_11,-1,1313,-1,0.27124488
1314,IVA,11,12,78,81,These studies shed further light on the genotype-phenotype correlation of MPS IVA and structure-function relationship in the sulfatase family.,10814710_12,-1,1314,-1,0.26194108
1315,syndrome,17,18,117,125,"
Mutations at the ataxia-telangiectasia (A-T) locus on chromosome band 11q22 cause a distinctive autosomal recessive syndrome in homozygotes and predispose heterozygotes to cancer, ischemic heart disease, and early mortality.",10817650_1,-1,1315,-1,0.19982865
1317,ischemic heart disease,26,29,181,203,"
Mutations at the ataxia-telangiectasia (A-T) locus on chromosome band 11q22 cause a distinctive autosomal recessive syndrome in homozygotes and predispose heterozygotes to cancer, ischemic heart disease, and early mortality.",10817650_1,-1,1317,-1,0.19417824
1318,amino acid,5,7,29,39,Alterations of the length or amino acid composition of the A-T gene product affect the A-T clinical phenotype in different ways.,10817650_8,-1,1318,-1,0.27616182
1319,familial mediterranean fever,20,23,109,137,"Isolation, genomic organization, and expression analysis of the mouse and rat homologs of MEFV, the gene for familial mediterranean fever.",10818206_0,-1,1319,-1,0.18661676
1320,Familial Mediterranean fever,0,3,1,29,"
Familial Mediterranean fever (FMF) is a recessive disorder characterized by episodes of fever with serositis or synovitis.",10818206_1,-1,1320,-1,0.20242523
1322,serositis,16,17,100,109,"
Familial Mediterranean fever (FMF) is a recessive disorder characterized by episodes of fever with serositis or synovitis.",10818206_1,-1,1322,-1,0.1861635
1323,synovitis,18,19,113,122,"
Familial Mediterranean fever (FMF) is a recessive disorder characterized by episodes of fever with serositis or synovitis.",10818206_1,-1,1323,-1,0.19758134
1325,amino acid,2,4,15,25,A considerable amino acid sequence homology was observed between the mouse and human (47. 6% identity and 65.,10818206_5,-1,1325,-1,0.30124068
1326,zinc,18,19,113,117,"The predicted rodent proteins have several important domains and signals found in human pyrin, including a B-box zinc finger domain, Robbins-Dingwall nuclear localization signal, and coiled-coil domain.",10818206_7,-1,1326,-1,0.25901288
1327,Pelizaeus-Merzbacher disease,8,10,58,86,Additional copies of the proteolipid protein gene causing Pelizaeus-Merzbacher disease arise by separate integration into the X chromosome.,10827108_0,-1,1327,-1,0.24537317
1328,Pelizaeus-Merzbacher disease,9,11,60,88,Mutations and duplications of this gene are associated with Pelizaeus-Merzbacher disease (PMD).,10827108_2,-1,1328,-1,0.24530105
1329,disease,31,32,174,181,"To do this, a collaborative screening study was set up that involved 39 institutions from 19 countries and included 3, 580 unrelated individuals with a family history of the disease and 934 early-onset breast and/or ovarian cancer cases.",10827109_4,-1,1329,-1,0.20238215
1331,disease,5,6,25,32,"
Von Hippel-Lindau (VHL) disease is a hereditary tumor syndrome characterized by predisposition for bilateral and multi-centric hemangioblastoma in the retina and central nervous system, pheochromocytoma, renal cell carcinoma, and cysts in the kidney, pancreas, and epididymis.",10830910_1,-1,1331,-1,0.18856235
1332,tumor syndrome,9,11,49,63,"
Von Hippel-Lindau (VHL) disease is a hereditary tumor syndrome characterized by predisposition for bilateral and multi-centric hemangioblastoma in the retina and central nervous system, pheochromocytoma, renal cell carcinoma, and cysts in the kidney, pancreas, and epididymis.",10830910_1,-1,1332,-1,0.17741092
1333,hemangioblastoma,18,19,128,144,"
Von Hippel-Lindau (VHL) disease is a hereditary tumor syndrome characterized by predisposition for bilateral and multi-centric hemangioblastoma in the retina and central nervous system, pheochromocytoma, renal cell carcinoma, and cysts in the kidney, pancreas, and epididymis.",10830910_1,-1,1333,-1,0.17411806
1334,pheochromocytoma,27,28,187,203,"
Von Hippel-Lindau (VHL) disease is a hereditary tumor syndrome characterized by predisposition for bilateral and multi-centric hemangioblastoma in the retina and central nervous system, pheochromocytoma, renal cell carcinoma, and cysts in the kidney, pancreas, and epididymis.",10830910_1,-1,1334,-1,0.18194292
1335,renal cell carcinoma,29,32,205,225,"
Von Hippel-Lindau (VHL) disease is a hereditary tumor syndrome characterized by predisposition for bilateral and multi-centric hemangioblastoma in the retina and central nervous system, pheochromocytoma, renal cell carcinoma, and cysts in the kidney, pancreas, and epididymis.",10830910_1,-1,1335,-1,0.17222653
1336,cysts,34,35,231,236,"
Von Hippel-Lindau (VHL) disease is a hereditary tumor syndrome characterized by predisposition for bilateral and multi-centric hemangioblastoma in the retina and central nervous system, pheochromocytoma, renal cell carcinoma, and cysts in the kidney, pancreas, and epididymis.",10830910_1,-1,1336,-1,0.22342834
1337,disease,32,33,190,197,Our results show that (quantitative) Southern blot analysis is a sensitive method for detecting germline deletions of the VHL gene and should be implemented in routine DNA diagnosis for VHL disease.,10830910_6,-1,1337,-1,0.18606801
1338,pheochromocytoma,18,19,115,131,Our data support the previously established observation that families with a germline deletion have a low risk for pheochromocytoma.,10830910_7,-1,1338,-1,0.18390155
1339,disease,7,8,61,68,Further unraveling of genotype-phenotype correlations in VHL disease has revealed that families with a full or partial deletion of the VHL gene exhibit a phenotype with a preponderance of central nervous system hemangioblastoma..,10830910_8,-1,1339,-1,0.19925651
1340,hemangioblastoma,32,33,211,227,Further unraveling of genotype-phenotype correlations in VHL disease has revealed that families with a full or partial deletion of the VHL gene exhibit a phenotype with a preponderance of central nervous system hemangioblastoma..,10830910_8,-1,1340,-1,0.17416224
1341,Friedreich ataxia,10,12,61,78,Age of the intronic GAA triplet repeat expansion mutation in Friedreich ataxia.,10830915_0,-1,1341,-1,0.23310189
1342,Friedreich ataxia,0,2,1,18,"
Friedreich ataxia (FRDA), the most frequently inherited ataxia, is due in the vast majority of cases to a large expansion of an intronic GAA repeat.",10830915_1,-1,1342,-1,0.24811266
1344,Nijmegen breakage syndrome,5,8,50,76,Functional link between ataxia-telangiectasia and Nijmegen breakage syndrome gene products.,10839544_0,-1,1344,-1,0.20118117
1345,Nijmegen breakage syndrome,5,8,33,59,"
Ataxia-telangiectasia (A-T) and Nijmegen breakage syndrome (NBS) are recessive genetic disorders with susceptibility to cancer and similar cellular phenotypes.",10839544_1,-1,1345,-1,0.18751414
1347,Nijmegen breakage syndrome,9,12,58,84,The NBS1 protein is specifically mutated in patients with Nijmegen breakage syndrome and forms a complex with the DNA repair proteins Rad50 and Mrel1.,10839544_3,-1,1347,-1,0.18684475
1349,diseases,21,22,140,148,"Together, these results demonstrate a biochemical link between cell-cycle checkpoints activated by DNA damage and DNA repair in two genetic diseases with overlapping phenotypes..",10839544_8,-1,1349,-1,0.17607474
1350,microcephaly,6,7,38,50,"Homozygosity mapping in a family with microcephaly, mental retardation, and short stature to a Cohen syndrome region on 8q21.3-8q22.1: redefining a clinical entity.",10842298_0,-1,1350,-1,0.24816316
1351,mental retardation,8,10,52,70,"Homozygosity mapping in a family with microcephaly, mental retardation, and short stature to a Cohen syndrome region on 8q21.3-8q22.1: redefining a clinical entity.",10842298_0,-1,1351,-1,0.22055925
1352,Cohen syndrome,16,18,95,109,"Homozygosity mapping in a family with microcephaly, mental retardation, and short stature to a Cohen syndrome region on 8q21.3-8q22.1: redefining a clinical entity.",10842298_0,-1,1352,-1,0.28677034
1353,syndrome,1,2,3,11,"
A syndrome of microcephaly, progressive postnatal growth deficiency, and mental retardation was observed in two brothers and their cousin from a multiply consanguineous kindred of Lebanese descent.",10842298_1,-1,1353,-1,0.23676959
1354,microcephaly,3,4,15,27,"
A syndrome of microcephaly, progressive postnatal growth deficiency, and mental retardation was observed in two brothers and their cousin from a multiply consanguineous kindred of Lebanese descent.",10842298_1,-1,1354,-1,0.21295696
1355,mental retardation,11,13,74,92,"
A syndrome of microcephaly, progressive postnatal growth deficiency, and mental retardation was observed in two brothers and their cousin from a multiply consanguineous kindred of Lebanese descent.",10842298_1,-1,1355,-1,0.18854544
1356,Hypotonia,0,1,0,9,"Hypotonia, chorioretinal dystrophy, and myopia were also identified.",10842298_2,-1,1356,-1,0.2292286
1357,myopia,6,7,40,46,"Hypotonia, chorioretinal dystrophy, and myopia were also identified.",10842298_2,-1,1357,-1,0.22714514
1358,mental retardation,12,14,69,87,"Because of absence of a distinctive facial appearance, the degree of mental retardation, and short stature, the initially considered clinical diagnosis of Cohen syndrome was withdrawn and a novel genetic entity was assumed.",10842298_4,-1,1358,-1,0.22558647
1359,Cohen syndrome,25,27,155,169,"Because of absence of a distinctive facial appearance, the degree of mental retardation, and short stature, the initially considered clinical diagnosis of Cohen syndrome was withdrawn and a novel genetic entity was assumed.",10842298_4,-1,1359,-1,0.23385406
1360,Cohen syndrome,13,15,85,99,"Intriguingly enough, the identified gene region overlaps the refined gene region for Cohen syndrome (COH1) [Kolehmainen et al., 1997  Euro J Hum Genet 5  206-213].",10842298_10,-1,1360,-1,0.21422791
1361,Cohen syndrome,14,16,91,105,This fact encourages the hypothesis that the described kindred segregates for a variant of Cohen syndrome and suggests a redefinition of its phenotype,10842298_11,-1,1361,-1,0.21190387
1362,spondylitis,9,10,71,82,Polymorphisms of the CYP2D6 gene increase susceptibility to ankylosing spondylitis.,10861282_0,-1,1362,-1,0.20840645
1363,spondylitis,1,2,12,23,"
Ankylosing spondylitis (AS) is a common and highly familial rheumatic disorder.",10861282_1,-1,1363,-1,0.202005
1364,recurrence,2,3,12,22,The sibling recurrence risk ratio for the disease is 63 and heritability assessed in twins > 90%.,10861282_2,-1,1364,-1,0.23697168
1365,disease,7,8,42,49,The sibling recurrence risk ratio for the disease is 63 and heritability assessed in twins > 90%.,10861282_2,-1,1365,-1,0.21859619
1366,disease,19,20,90,97,"Although MHC genes, including HLA-B27, contribute only 20-50% of the genetic risk for the disease, no non-MHC gene has yet been convincingly demonstrated to influence either susceptibility to the disease or its phenotypic expression.",10861282_3,-1,1366,-1,0.20254105
1367,disease,35,36,196,203,"Although MHC genes, including HLA-B27, contribute only 20-50% of the genetic risk for the disease, no non-MHC gene has yet been convincingly demonstrated to influence either susceptibility to the disease or its phenotypic expression.",10861282_3,-1,1367,-1,0.20509566
1368,debrisoquine,29,30,160,172,"Previous linkage and association studies have suggested the presence of a susceptibility gene for AS close to, or within, the cytochrome P450 2D6 gene (CYP2D6, debrisoquine hydroxylase) located at chromosome 22q13.1.",10861282_4,-1,1368,-1,0.2787585
1369,Pendred syndrome,15,17,105,121,Functional differences of the PDS gene product are associated with phenotypic variation in patients with Pendred syndrome and non-syndromic hearing loss (DFNB4).,10861298_0,-1,1369,-1,0.20790991
1370,hearing loss,19,21,140,152,Functional differences of the PDS gene product are associated with phenotypic variation in patients with Pendred syndrome and non-syndromic hearing loss (DFNB4).,10861298_0,-1,1370,-1,0.17190869
1371,chloride,20,21,112,120,"
The PDS gene encodes a transmembrane protein, known as pendrin, which functions as a transporter of iodide and chloride.",10861298_1,-1,1371,-1,0.2388938
1372,Pendred syndrome,7,9,43,59,Mutations in this gene are responsible for Pendred syndrome and autosomal recessive non-syndromic hearing loss at the DFNB4 locus on chromosome 7q31.,10861298_2,-1,1372,-1,0.20887858
1373,hearing loss,13,15,98,110,Mutations in this gene are responsible for Pendred syndrome and autosomal recessive non-syndromic hearing loss at the DFNB4 locus on chromosome 7q31.,10861298_2,-1,1373,-1,0.1894728
1374,hearing loss,11,13,70,82,A screen of 20 individuals from the midwestern USA with non-syndromic hearing loss and dilated vestibular aqueducts identified three people (15%) with PDS mutations.,10861298_3,-1,1374,-1,0.20734587
1375,Pendred syndrome,8,10,55,71,"To determine whether PDS mutations in individuals with Pendred syndrome differ functionally from PDS mutations in individuals with non-syndromic hearing loss, we compared three common Pendred syndrome allele variants (L236P, T416P and E384G), with three PDS mutations reported only in individuals with non-syndromic hearing loss (V480D, V653A and I490L/G497S).",10861298_4,-1,1375,-1,0.20309842
1376,hearing loss,19,21,145,157,"To determine whether PDS mutations in individuals with Pendred syndrome differ functionally from PDS mutations in individuals with non-syndromic hearing loss, we compared three common Pendred syndrome allele variants (L236P, T416P and E384G), with three PDS mutations reported only in individuals with non-syndromic hearing loss (V480D, V653A and I490L/G497S).",10861298_4,-1,1376,-1,0.20646137
1377,Pendred syndrome,26,28,184,200,"To determine whether PDS mutations in individuals with Pendred syndrome differ functionally from PDS mutations in individuals with non-syndromic hearing loss, we compared three common Pendred syndrome allele variants (L236P, T416P and E384G), with three PDS mutations reported only in individuals with non-syndromic hearing loss (V480D, V653A and I490L/G497S).",10861298_4,-1,1377,-1,0.21141155
1378,hearing loss,49,51,316,328,"To determine whether PDS mutations in individuals with Pendred syndrome differ functionally from PDS mutations in individuals with non-syndromic hearing loss, we compared three common Pendred syndrome allele variants (L236P, T416P and E384G), with three PDS mutations reported only in individuals with non-syndromic hearing loss (V480D, V653A and I490L/G497S).",10861298_4,-1,1378,-1,0.20784332
1379,Pendred syndrome,4,6,30,46,"The mutations associated with Pendred syndrome have complete loss of pendrin-induced chloride and iodide transport, while alleles unique to people with DFNB4 are able to transport both iodide and chloride, albeit at a much lower level than wild-type pendrin.",10861298_5,-1,1379,-1,0.22876419
1380,chloride,11,12,85,93,"The mutations associated with Pendred syndrome have complete loss of pendrin-induced chloride and iodide transport, while alleles unique to people with DFNB4 are able to transport both iodide and chloride, albeit at a much lower level than wild-type pendrin.",10861298_5,-1,1380,-1,0.23717724
1381,chloride,30,31,196,204,"The mutations associated with Pendred syndrome have complete loss of pendrin-induced chloride and iodide transport, while alleles unique to people with DFNB4 are able to transport both iodide and chloride, albeit at a much lower level than wild-type pendrin.",10861298_5,-1,1381,-1,0.25084376
1382,goiter,18,19,111,117,We hypothesize that this residual level of anion transport is sufficient to eliminate or postpone the onset of goiter in individuals with DFNB4.,10861298_6,-1,1382,-1,0.23194833
1383,disease,23,24,133,140,"
Germline mutations are the major source of genetic variation that allows a species to evolve over time but at the cost of Mendelian disease and genetic predisposition to multifactorial diseases.",10874302_1,-1,1383,-1,0.21284534
1384,diseases,29,30,186,194,"
Germline mutations are the major source of genetic variation that allows a species to evolve over time but at the cost of Mendelian disease and genetic predisposition to multifactorial diseases.",10874302_1,-1,1384,-1,0.18573284
1385,hemophilia B,13,15,69,81,"Here, we compare the pattern of germline mutation in a population of hemophilia B patients from Mainland China (n = 66) to that in U. S. Caucasians, Blacks, and Mexican Hispanics and stratify by disease severity and ethnicity.",10874302_3,-1,1385,-1,0.19281974
1386,n,20,21,112,113,"Here, we compare the pattern of germline mutation in a population of hemophilia B patients from Mainland China (n = 66) to that in U. S. Caucasians, Blacks, and Mexican Hispanics and stratify by disease severity and ethnicity.",10874302_3,-1,1386,-1,0.2930593
1387,disease,39,40,195,202,"Here, we compare the pattern of germline mutation in a population of hemophilia B patients from Mainland China (n = 66) to that in U. S. Caucasians, Blacks, and Mexican Hispanics and stratify by disease severity and ethnicity.",10874302_3,-1,1387,-1,0.20275104
1389,autoimmune lymphoproliferative syndrome,18,21,142,181,"
Heterozygous mutations encoding abnormal forms of the death receptor Fas dominantly interfere with Fas-induced lymphocyte apoptosis in human autoimmune lymphoproliferative syndrome.",10875918_1,-1,1389,-1,0.14871266
1390,disease,19,20,136,143,These results show that formation of preassociated receptor complexes is necessary for Fas signaling and dominant interference in human disease..,10875918_4,-1,1390,-1,0.18923868
1391,Wiskott-Aldrich syndrome,6,8,40,64,Determination of carrier status for the Wiskott-Aldrich syndrome by flow cytometric analysis of Wiskott-Aldrich syndrome protein expression in peripheral blood mononuclear cells.,10878391_0,-1,1391,-1,0.19787101
1392,Wiskott-Aldrich syndrome,13,15,96,120,Determination of carrier status for the Wiskott-Aldrich syndrome by flow cytometric analysis of Wiskott-Aldrich syndrome protein expression in peripheral blood mononuclear cells.,10878391_0,-1,1392,-1,0.19979773
1393,Wiskott-Aldrich syndrome,1,3,5,29,"
The Wiskott-Aldrich syndrome (WAS) is caused by defects in the WAS protein (WASP) gene on the X chromosome.",10878391_1,-1,1393,-1,0.2008039
1394,contrast,1,2,3,11,"In contrast, lymphocytes from all the carriers except two lacked the WASPdim population.",10878391_7,-1,1394,-1,0.2607124
1395,retinal degeneration,7,9,60,80,Restoration of photoreceptor ultrastructure and function in retinal degeneration slow mice by gene therapy.,10888879_0,-1,1395,-1,0.21269718
1396,retinitis pigmentosa,18,20,117,137,"Mutations in Prph2 have been shown to result in a variety of photoreceptor dystrophies, including autosomal dominant retinitis pigmentosa and macular dystrophy.",10888879_3,-1,1396,-1,0.18390295
1397,diseases,5,6,26,34,"A common feature of these diseases is the loss of photoreceptor function, also seen in the retinal degeneration slow (rds or Prph2 Rd2/Rd2) mouse, which is homozygous for a null mutation in Prph2.",10888879_4,-1,1397,-1,0.18051124
1398,retinal degeneration,17,19,91,111,"A common feature of these diseases is the loss of photoreceptor function, also seen in the retinal degeneration slow (rds or Prph2 Rd2/Rd2) mouse, which is homozygous for a null mutation in Prph2.",10888879_4,-1,1398,-1,0.21301712
1399,afibrinogenemia,14,15,88,103,Mutations in the fibrinogen aalpha gene account for the majority of cases of congenital afibrinogenemia.,10891444_0,-1,1399,-1,0.22960767
1400,afibrinogenemia,1,2,12,27,"
Congenital afibrinogenemia is a rare, autosomal, recessive disorder characterized by the complete absence of detectable fibrinogen.",10891444_1,-1,1400,-1,0.23421054
1401,afibrinogenemia,5,6,21,36,"Consequently, 86% of afibrinogenemia alleles analyzed to date have truncating mutations of FGA, though mutations in all 3 fibrinogen genes, FGG, FGA, and FGB, might be predicted to cause congenital afibrinogenemia..",10891444_9,-1,1401,-1,0.22177626
1402,afibrinogenemia,37,38,198,213,"Consequently, 86% of afibrinogenemia alleles analyzed to date have truncating mutations of FGA, though mutations in all 3 fibrinogen genes, FGG, FGA, and FGB, might be predicted to cause congenital afibrinogenemia..",10891444_9,-1,1402,-1,0.21696945
1403,Myotonic dystrophy,0,2,0,18,Myotonic dystrophy: the role of the CUG triplet repeats in splicing of a novel DMPK exon and altered cytoplasmic DMPK mRNA isoform ratios.,10911990_0,-1,1403,-1,0.18655534
1404,n,7,8,30,31,"
The mechanism by which (CTG) n expansion in the 3 UTR of the DMPK gene causes myotonic dystrophy (DM) is unknown.",10911990_1,-1,1404,-1,0.39759186
1405,myotonic dystrophy,18,20,79,97,"
The mechanism by which (CTG) n expansion in the 3 UTR of the DMPK gene causes myotonic dystrophy (DM) is unknown.",10911990_1,-1,1405,-1,0.18009347
1406,DM,21,22,99,101,"
The mechanism by which (CTG) n expansion in the 3 UTR of the DMPK gene causes myotonic dystrophy (DM) is unknown.",10911990_1,-1,1406,-1,0.1987239
1407,C,8,9,47,48,"We identified four RNA splicing factors--hnRNP C, U2AF (U2 auxiliary factor), PTB (polypyrimidine tract binding protein), and PSF (PTB associated splicing factor) --that bind to two short regions 3 of the (CUG) n, and found a novel 3 DMPK exon resulting in an mRNA lacking the repeats.",10911990_2,-1,1407,-1,0.2538742
1408,n,45,46,211,212,"We identified four RNA splicing factors--hnRNP C, U2AF (U2 auxiliary factor), PTB (polypyrimidine tract binding protein), and PSF (PTB associated splicing factor) --that bind to two short regions 3 of the (CUG) n, and found a novel 3 DMPK exon resulting in an mRNA lacking the repeats.",10911990_2,-1,1408,-1,0.34792185
1409,n,7,8,26,27,We propose that the (CUG) n is an essential cis acting element for this splicing event.,10911990_3,-1,1409,-1,0.32353422
1410,contrast,1,2,3,11,"In contrast to (CUG) n containing mRNAs, the novel isoform is not retained in the nucleus in DM cells, resulting in imbalances in relative levels of cytoplasmic DMPK mRNA isoforms and a new dominant effect of the mutation on DMPK..",10911990_4,-1,1410,-1,0.23722
1411,n,6,7,21,22,"In contrast to (CUG) n containing mRNAs, the novel isoform is not retained in the nucleus in DM cells, resulting in imbalances in relative levels of cytoplasmic DMPK mRNA isoforms and a new dominant effect of the mutation on DMPK..",10911990_4,-1,1411,-1,0.34817684
1412,DM,20,21,93,95,"In contrast to (CUG) n containing mRNAs, the novel isoform is not retained in the nucleus in DM cells, resulting in imbalances in relative levels of cytoplasmic DMPK mRNA isoforms and a new dominant effect of the mutation on DMPK..",10911990_4,-1,1412,-1,0.21611284
1413,Prader-willi syndrome,9,11,54,75,Expression and imprinting of MAGEL2 suggest a role in Prader-willi syndrome and the homologous murine imprinting phenotype.,10915770_0,-1,1413,-1,0.2178497
1414,Prader-Willi syndrome,0,2,1,22,"
Prader-Willi syndrome (PWS) is caused by the loss of expression of imprinted genes in chromosome 15q11-q13.",10915770_1,-1,1414,-1,0.22780824
1415,hypotonia,4,5,38,47,"Affected individuals exhibit neonatal hypotonia, developmental delay and childhood-onset obesity.",10915770_2,-1,1415,-1,0.21460576
1416,obesity,10,11,89,96,"Affected individuals exhibit neonatal hypotonia, developmental delay and childhood-onset obesity.",10915770_2,-1,1416,-1,0.22705272
1417,amino acid,20,22,83,93,"In this study, we have characterized MAGEL2 (also known as NDNL1), a gene with 51% amino acid sequence similarity to necdin and located 41 kb distal to NDN in the PWS deletion region.",10915770_4,-1,1417,-1,0.31182432
1418,retinoschisis,4,5,28,41,"Retinoschisin, the X-linked retinoschisis protein, is a secreted photoreceptor protein, and is expressed and released by Weri-Rb1 cells.",10915776_0,-1,1418,-1,0.27321962
1419,retinoschisis,1,2,10,23,"
X-linked retinoschisis is characterized by microcystic-like changes of the macular region and schisis within the inner retinal layers, leading to visual deterioration in males.",10915776_1,-1,1419,-1,0.2670603
1420,amino acid,4,6,18,28,"RS1 encodes a 224 amino acid protein, retinoschisin, which contains a discoidin domain but is of unknown function.",10915776_3,-1,1420,-1,0.2740712
1421,dithiothreitol,29,30,181,195,"We have generated a polyclonal antibody against a peptide from a unique region within retinoschisin, which detects a protein of approximately 28 kDa in retinal samples reduced with dithiothreitol, but multimers sized > 40 kDa under non-reducing conditions.",10915776_4,-1,1421,-1,0.2587735
1422,retinoblastoma,3,4,28,42,"Furthermore, differentiated retinoblastoma cells (Weri-Rb1 cells) were found to express RS1 mRNA and to release retinoschisin.",10915776_8,-1,1422,-1,0.16722853
1423,retinoschisis,3,4,15,28,"Thus, X-linked retinoschisis is caused by abnormalities in a putative secreted photoreceptor protein and is the first example of a secreted photo-receptor protein associated with a retinal dystrophy..",10915776_10,-1,1423,-1,0.23239763
1424,sodium,4,5,27,33,Study of the voltage-gated sodium channel beta 1 subunit gene (SCN1B) in the benign familial infantile convulsions syndrome (BFIC).,10923035_0,-1,1424,-1,0.25209585
1425,convulsions syndrome,18,20,103,123,Study of the voltage-gated sodium channel beta 1 subunit gene (SCN1B) in the benign familial infantile convulsions syndrome (BFIC).,10923035_0,-1,1425,-1,0.18720856
1427,epilepsy syndrome,12,14,75,92,"
Benign familial infantile convulsions (BFIC) is a rare autosomal dominant epilepsy syndrome.",10923035_1,-1,1427,-1,0.1651129
1428,syndrome,1,2,5,13,This syndrome has been recently described in Italian and French pedigrees.,10923035_2,-1,1428,-1,0.21684769
1429,generalized seizures,6,8,36,56,"Patients present with partial, then generalized seizures, with onset at age three months.",10923035_3,-1,1429,-1,0.195634
1431,sodium,1,2,4,10,"The sodium channel beta1 subunit gene (SCN1B) maps to this candidate region and has been shown to be involved in one Australian pedigree with generalized epilepsy and febrile seizures "" plus "" (GEFS +).",10923035_6,-1,1431,-1,0.27356014
1434,attenuated familial adenomatous polyposis,16,20,111,152,Inactivation of germline mutant APC alleles by attenuated somatic mutations: a molecular genetic mechanism for attenuated familial adenomatous polyposis.,10924409_0,-1,1434,-1,0.17736603
1435,adenomatous polyposis coli,4,7,27,53,"
Germline mutations of the adenomatous polyposis coli (APC) tumor-suppressor gene result in familial adenomatous polyposis (FAP).",10924409_1,-1,1435,-1,0.20316172
1437,colorectal cancer,14,16,102,119,Patients with FAP typically develop hundreds to thousands of benign colorectal tumors and early-onset colorectal cancer.,10924409_2,-1,1437,-1,0.16683845
1443,Friedreich ataxia,9,11,77,94,Iron-dependent self-assembly of recombinant yeast frataxin: implications for Friedreich ataxia.,10930361_0,-1,1443,-1,0.22318205
1444,Friedreich ataxia,7,9,45,62,"
Frataxin deficiency is the primary cause of Friedreich ataxia (FRDA), an autosomal recessive cardiodegenerative and neurodegenerative disease.",10930361_1,-1,1444,-1,0.22130758
1445,neurodegenerative disease,18,20,117,142,"
Frataxin deficiency is the primary cause of Friedreich ataxia (FRDA), an autosomal recessive cardiodegenerative and neurodegenerative disease.",10930361_1,-1,1445,-1,0.16487916
1446,iron,13,14,86,90,Genetic inactivation of the yeast frataxin homologue (Yfh1p) results in mitochondrial iron accumulation and hypersensitivity to oxidative stress.,10930361_3,-1,1446,-1,0.2131694
1448,iron,1,2,10,14,Increased iron deposition and evidence of oxidative damage have also been observed in cardiac tissue and cultured fibroblasts from patients with FRDA.,10930361_4,-1,1448,-1,0.22780307
1449,iron,9,10,69,73,These findings indicate that frataxin is essential for mitochondrial iron homeostasis and protection from iron-induced formation of free radicals.,10930361_5,-1,1449,-1,0.20837803
1450,free radicals,17,19,132,145,These findings indicate that frataxin is essential for mitochondrial iron homeostasis and protection from iron-induced formation of free radicals.,10930361_5,-1,1450,-1,0.22909339
1451,Da,10,11,46,48,"Isolated mYfh1p is a soluble monomer (13, 783 Da) that contains no iron and shows no significant tendency to self-associate.",10930361_8,-1,1451,-1,0.28350046
1452,iron,15,16,67,71,"Isolated mYfh1p is a soluble monomer (13, 783 Da) that contains no iron and shows no significant tendency to self-associate.",10930361_8,-1,1452,-1,0.2641939
1453,iron,4,5,28,32,Aerobic addition of ferrous iron to mYfh1p results in assembly of regular spherical multimers with a molecular mass of approximately 1. 1 MDa (megadaltons) and a diameter of 13 +/-2 nm.,10930361_9,-1,1453,-1,0.23770921
1454,MDa,23,24,138,141,Aerobic addition of ferrous iron to mYfh1p results in assembly of regular spherical multimers with a molecular mass of approximately 1. 1 MDa (megadaltons) and a diameter of 13 +/-2 nm.,10930361_9,-1,1454,-1,0.32559797
1455,iron,16,17,88,92,"Each multimer consists of approximately 60 subunits and can sequester > 3, 000 atoms of iron.",10930361_10,-1,1455,-1,0.26775545
1456,iron,5,6,36,40,Titration of mYfh1p with increasing iron concentrations supports a stepwise mechanism of multimer assembly.,10930361_11,-1,1456,-1,0.24357143
1457,iron,4,5,26,30,"Sequential addition of an iron chelator and a reducing agent results in quantitative iron release with concomitant disassembly of the multimer, indicating that mYfh1p sequesters iron in an available form.",10930361_12,-1,1457,-1,0.21432193
1458,iron,13,14,85,89,"Sequential addition of an iron chelator and a reducing agent results in quantitative iron release with concomitant disassembly of the multimer, indicating that mYfh1p sequesters iron in an available form.",10930361_12,-1,1458,-1,0.23148952
1459,iron,26,27,178,182,"Sequential addition of an iron chelator and a reducing agent results in quantitative iron release with concomitant disassembly of the multimer, indicating that mYfh1p sequesters iron in an available form.",10930361_12,-1,1459,-1,0.23894037
1460,Fe,6,7,23,25,"After addition of (55) Fe to the medium, immunoprecipitates of this species contain > 16 atoms of (55) Fe per molecule of mYfh1p.",10930361_14,-1,1460,-1,0.24336755
1461,Fe,23,24,103,105,"After addition of (55) Fe to the medium, immunoprecipitates of this species contain > 16 atoms of (55) Fe per molecule of mYfh1p.",10930361_14,-1,1461,-1,0.261206
1462,iron,16,17,127,131,We propose that iron-dependent self-assembly of recombinant mYfh1p reflects a physiological role for frataxin in mitochondrial iron sequestration and bioavailability..,10930361_15,-1,1462,-1,0.19268285
1463,faciogenital dysplasia,19,21,93,115,A mutation in the pleckstrin homology (PH) domain of the FGD1 gene in an Italian family with faciogenital dysplasia (Aarskog-Scott syndrome).,10930571_0,-1,1463,-1,0.19184507
1464,syndrome,23,24,131,139,A mutation in the pleckstrin homology (PH) domain of the FGD1 gene in an Italian family with faciogenital dysplasia (Aarskog-Scott syndrome).,10930571_0,-1,1464,-1,0.18958774
1465,Syndrome,1,2,15,23,"
Aarskog-Scott Syndrome (AAS) is an X-linked disorder characterised by short stature and multiple facial, limb and genital abnormalities.",10930571_1,-1,1465,-1,0.19200793
1466,nucleotide,27,28,138,148,"A gene, FGD1, altered in a patient with AAS phenotype, has been identified and found to encode a protein with homology to Rho/Rac guanine nucleotide exchange factors (Rho/Rac GEF).",10930571_2,-1,1466,-1,0.23552763
1467,nucleotide,9,10,51,61,One patient presented a mutation that results in a nucleotide change in exon 10 of the FGD1 gene (G2559 > A) substituting a Gln for Arg in position 610.,10930571_5,-1,1467,-1,0.29960153
1468,tyrosine,9,10,49,57,The same residue is often mutated in the Brutons tyrosine kinase (Btk) gene in patients with an X-linked agammaglobulinemia.,10930571_8,-1,1468,-1,0.20393947
1469,agammaglobulinemia,20,21,105,123,The same residue is often mutated in the Brutons tyrosine kinase (Btk) gene in patients with an X-linked agammaglobulinemia.,10930571_8,-1,1469,-1,0.19422992
1470,diseases,31,32,177,185,The Arg610Gln mutation represents the first case of a mutation in the PH domain of the FGD1 gene and additional evidence that mutations in PH domains can be associated to human diseases..,10930571_9,-1,1470,-1,0.18403554
1472,Huntington disease,0,2,1,19,"
Huntington disease (HD) is caused by expansion of a glutamine repeat in the amino-terminal region of huntingtin.",10932179_1,-1,1472,-1,0.20551212
1473,glutamine,11,12,53,62,"
Huntington disease (HD) is caused by expansion of a glutamine repeat in the amino-terminal region of huntingtin.",10932179_1,-1,1473,-1,0.26656884
1474,neuronal loss,9,11,71,84,"Despite its widespread expression, mutant huntingtin induces selective neuronal loss in striatal neurons.",10932179_2,-1,1474,-1,0.20060903
1475,glutamate,11,12,80,89,N-terminal mutant huntingtin also binds to synaptic vesicles and inhibits their glutamate uptake in vitro.,10932179_5,-1,1475,-1,0.2532417
1480,adenomatous polyposis coli,1,4,5,31,"
The adenomatous polyposis coli gene (APC) is mutated in familial adenomatous polyposis and in sporadic colorectal tumors.",10947987_1,-1,1480,-1,0.20169489
1482,nucleotide,18,19,105,115,"Here the APC gene product is shown to bind through its armadillo repeat domain to a Rac-specific guanine nucleotide exchange factor (GEF), termed Asef.",10947987_2,-1,1482,-1,0.22094886
1483,Colorectal Cancer,16,18,112,129,"
The axonal chemoattractant netrin-1 guides spinal commissural axons by activating its receptor DCC (Deleted in Colorectal Cancer ).",10958786_1,-1,1483,-1,0.14782631
1484,Myotonic dystrophy,0,2,0,18,Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat.,10976074_0,-1,1484,-1,0.20322596
1485,Myotonic dystrophy,0,2,1,19,"
Myotonic dystrophy (DM), the most common form of muscular dystrophy in adult humans, results from expansion of a CTG repeat in the 3 untranslated region of the DMPK gene.",10976074_1,-1,1485,-1,0.19518551
1486,DM,3,4,21,23,"
Myotonic dystrophy (DM), the most common form of muscular dystrophy in adult humans, results from expansion of a CTG repeat in the 3 untranslated region of the DMPK gene.",10976074_1,-1,1486,-1,0.21196087
1487,muscular dystrophy,11,13,50,68,"
Myotonic dystrophy (DM), the most common form of muscular dystrophy in adult humans, results from expansion of a CTG repeat in the 3 untranslated region of the DMPK gene.",10976074_1,-1,1487,-1,0.16738977
1488,myotonia,7,8,51,59,"Mice that expressed expanded CUG repeats developed myotonia and myopathy, whereas mice expressing a nonexpanded repeat did not.",10976074_4,-1,1488,-1,0.19653301
1490,DM,12,13,73,75,"Thus, transcripts with expanded CUG repeats are sufficient to generate a DM phenotype.",10976074_5,-1,1490,-1,0.23056978
1491,disease,11,12,56,63,This result supports a role for RNA gain of function in disease pathogenesis..,10976074_6,-1,1491,-1,0.18891466
1492,adenomatous polyposis coli,4,7,27,53,"
Germline mutations of the adenomatous polyposis coli (APC) tumor-suppressor gene result in the hereditary colorectal cancer syndrome familial adenomatous polyposis (FAP).",10982189_1,-1,1492,-1,0.20267779
1493,colorectal cancer syndrome,16,19,107,133,"
Germline mutations of the adenomatous polyposis coli (APC) tumor-suppressor gene result in the hereditary colorectal cancer syndrome familial adenomatous polyposis (FAP).",10982189_1,-1,1493,-1,0.1476707
1494,episodic ataxia,0,2,0,15,"episodic ataxia type 2 (EA-2), familial hemiplegic migraine (FHM) and spinocerebellar ataxia 6 (SCA6).",10987655_2,-1,1494,-1,0.22227661
1495,familial hemiplegic migraine,8,11,31,59,"episodic ataxia type 2 (EA-2), familial hemiplegic migraine (FHM) and spinocerebellar ataxia 6 (SCA6).",10987655_2,-1,1495,-1,0.20467879
1497,amino acid,7,9,39,49,The consequence of this mutation is an amino acid substitution at a highly conserved position within the CACNA1A gene.,10987655_8,-1,1497,-1,0.29640758
1501,serum albumin,8,10,59,72,"Apparent compensatory mechanisms which come into play when serum albumin is low include prolonged half-life of albumin and transferrin, an increase in serum globulins, beta lipoprotein, and glycoproteins, arterial hypotension with reduced capillary hydrostatic pressure, and the ability to respond with rapid sodium and chloride diuresis in response to small volume changes.",1127526_3,-1,1501,-1,0.26610574
1502,arterial hypotension,32,34,205,225,"Apparent compensatory mechanisms which come into play when serum albumin is low include prolonged half-life of albumin and transferrin, an increase in serum globulins, beta lipoprotein, and glycoproteins, arterial hypotension with reduced capillary hydrostatic pressure, and the ability to respond with rapid sodium and chloride diuresis in response to small volume changes.",1127526_3,-1,1502,-1,0.26901275
1503,sodium,47,48,309,315,"Apparent compensatory mechanisms which come into play when serum albumin is low include prolonged half-life of albumin and transferrin, an increase in serum globulins, beta lipoprotein, and glycoproteins, arterial hypotension with reduced capillary hydrostatic pressure, and the ability to respond with rapid sodium and chloride diuresis in response to small volume changes.",1127526_3,-1,1503,-1,0.29963195
1504,chloride,49,50,320,328,"Apparent compensatory mechanisms which come into play when serum albumin is low include prolonged half-life of albumin and transferrin, an increase in serum globulins, beta lipoprotein, and glycoproteins, arterial hypotension with reduced capillary hydrostatic pressure, and the ability to respond with rapid sodium and chloride diuresis in response to small volume changes.",1127526_3,-1,1504,-1,0.28400233
1505,amino acids,3,5,22,33,"Examination of plasma amino acids, an investigation not previously reported, revealed an extremely low plasma tryptophan level, a finding which may be important in view of the role of tryptophan in albumin synthesis..",1127526_4,-1,1505,-1,0.24184744
1506,tryptophan,17,18,110,120,"Examination of plasma amino acids, an investigation not previously reported, revealed an extremely low plasma tryptophan level, a finding which may be important in view of the role of tryptophan in albumin synthesis..",1127526_4,-1,1506,-1,0.23541977
1507,tryptophan,32,33,184,194,"Examination of plasma amino acids, an investigation not previously reported, revealed an extremely low plasma tryptophan level, a finding which may be important in view of the role of tryptophan in albumin synthesis..",1127526_4,-1,1507,-1,0.23931354
1508,Histidinemia,0,1,0,12,Histidinemia.,1146783_0,-1,1508,-1,0.30319634
1509,histidinemia,10,11,39,51,"
Two brothers, 6 and 13 years old, had histidinemia.",1146783_2,-1,1509,-1,0.25725314
1510,disease,21,22,118,125,"On the basis of clinical and biochemical observations, the younger boy was considered to have a classical type of the disease, while the older boy had an atypical form characterized by partial impairment of the skin histidase activity and a moderately prolonged half-life of blood histidine.",1146783_3,-1,1510,-1,0.22074936
1511,pyruvate,3,4,21,29,Carrier detection of pyruvate carboxylase deficiency in fibroblasts and lymphocytes.,116187_0,-1,1511,-1,0.2321524
1512,Pyruvate,0,1,1,9,"
Pyruvate carboxylase (E. C. 6. 4. 1. 1) activity was determined in the circulating peripheral lymphocytes and cultured skin fibroblasts from the family of a patient with hepatic, cerebral, renal cortical, leukocyte, and fibroblast pyruvate carboxylase deficiency (PC Portland deficiency).",116187_1,-1,1512,-1,0.24792245
1513,pyruvate,43,44,232,240,"
Pyruvate carboxylase (E. C. 6. 4. 1. 1) activity was determined in the circulating peripheral lymphocytes and cultured skin fibroblasts from the family of a patient with hepatic, cerebral, renal cortical, leukocyte, and fibroblast pyruvate carboxylase deficiency (PC Portland deficiency).",116187_1,-1,1513,-1,0.21595874
1514,disease,5,6,32,39,These data demonstrate that the disease is inherited in an autosomal recessive manner and that lymphocytes and fibroblasts can be used to detect carriers.,116187_4,-1,1514,-1,0.23583114
1515,pyruvate,1,2,8,16,Neither pyruvate carboxylase nor mitochondrial PEPCK activity in lymphocytes was increased by a 21-hr fast.,116187_5,-1,1515,-1,0.24548168
1518,chromosome breakage,11,13,81,100,Skin fibroblasts of affected individuals showed several orders of magnitude more chromosome breakage than lymphocytes.,1222588_4,-1,1518,-1,0.24561572
1519,Wolman disease,3,5,22,36,Prenatal diagnosis of Wolman disease.,122435_0,-1,1519,-1,0.2320134
1520,Wolman disease,5,7,29,43,"
Two pregnancies at risk for Wolman disease were monitored by assay and electrophoresis of acid lipase in cultured amniotic-fluid cells.",122435_1,-1,1520,-1,0.20564778
1521,Wolman disease,20,22,117,131,"Electrophoresis of cell extracts revealed the absence of the A form of acid lipase, consistent with the diagnosis of Wolman disease.",122435_3,-1,1521,-1,0.21809396
1522,Wolman disease,8,10,51,65,The results suggest that the prenatal diagnosis of Wolman disease be made using the radioassay of acid lipase and/or electrophoresis..,122435_8,-1,1522,-1,0.21486418
1523,neoplasms,1,2,10,19,Malignant neoplasms in the families of patients with ataxia-telangiectasia.,1248000_0,-1,1523,-1,0.18610038
1524,syndrome,8,9,55,63,"
Ataxia-telangiectasia (A-T) is an autosomal recessive syndrome associated with a greatly increased incidence of malignant neoplasms in homozygous affected individuals.",1248000_1,-1,1524,-1,0.17468837
1525,neoplasms,17,18,123,132,"
Ataxia-telangiectasia (A-T) is an autosomal recessive syndrome associated with a greatly increased incidence of malignant neoplasms in homozygous affected individuals.",1248000_1,-1,1525,-1,0.1472392
1528,neoplasms,12,13,67,76,"For this reason, we compared the incidence of death from malignant neoplasms in 2 families of patients with A-T to that expected in a random sample of the general population.",1248000_4,-1,1528,-1,0.15928021
1530,neoplasms,6,7,36,45,"There were 59 deaths from malignant neoplasms in relatives dying before age 75, compared to 42.",1248000_5,-1,1530,-1,0.1667944
1531,p,3,4,12,13,6 expected (p less than 0. 02).,1248000_6,-1,1531,-1,0.3083506
1532,neoplasm,15,16,78,86,"For A-T heterozygotes younger than age 45, the risk of dying from a malignant neoplasm was estimated to be greater than 5 times the risk for the general population.",1248000_7,-1,1532,-1,0.1586842
1534,leukemia,13,14,72,80,"The incidence of ovarian, gastric, and biliary system carcinomas and of leukemia and lymphoma was increased in these A-T families.",1248000_9,-1,1534,-1,0.16751549
1535,lymphoma,15,16,85,93,"The incidence of ovarian, gastric, and biliary system carcinomas and of leukemia and lymphoma was increased in these A-T families.",1248000_9,-1,1535,-1,0.16697003
1536,neoplasms,1,2,6,15,"Other neoplasms that may be associated with this gene in heterozygotes include pancreatic, basal cell, colonic, breast, and cervical carcinomas.",1248000_10,-1,1536,-1,0.15451932
1537,spondylitis,4,5,34,45,"Striking prevalence of ankylosing spondylitis in ""healthy"" w27 positive males and females.",126380_0,-1,1537,-1,0.20820294
1538,spondylitis,1,2,12,23,"
Ankylosing spondylitis is diagnosed once or twice in each 1000 males and one tenth as frequently in females, but the true prevalence is unknown.",126380_1,-1,1538,-1,0.22932512
1539,spondylitis,31,32,213,224,"Evaluation by postal questionnaires, and pelvic radiography of 78 HL-A 27W-positive blood donors selected from a group of apparently healthy subjects revealed 14 who satisfied the criteria for definite ankylosing spondylitis.",126380_3,-1,1539,-1,0.20174356
1540,spondylitis,22,23,105,116,"For a person of either sex with HL-A W27, there appears to be about a 20 per cent chance that ankylosing spondylitis will develop, suggesting a prevalence of 10 to 15 per thousand.",126380_6,-1,1540,-1,0.21393865
1541,atopic dermatitis,12,14,97,114,"
Analbuminemia was fortuitously detected in a nonedematous 12-year-old American Indian girl with atopic dermatitis, mild bronchial asthma, a mild seizure disorder, and hyperlipoproteinemia with a corneal arcus.",1269174_1,-1,1541,-1,0.19739568
1542,bronchial asthma,16,18,121,137,"
Analbuminemia was fortuitously detected in a nonedematous 12-year-old American Indian girl with atopic dermatitis, mild bronchial asthma, a mild seizure disorder, and hyperlipoproteinemia with a corneal arcus.",1269174_1,-1,1542,-1,0.1681017
1543,seizure disorder,21,23,146,162,"
Analbuminemia was fortuitously detected in a nonedematous 12-year-old American Indian girl with atopic dermatitis, mild bronchial asthma, a mild seizure disorder, and hyperlipoproteinemia with a corneal arcus.",1269174_1,-1,1543,-1,0.18855223
1544,serum albumin,13,15,79,92,Immunologic methods revealed trace amounts (17 mg/100 ml) of apparently normal serum albumin.,1269174_2,-1,1544,-1,0.23793873
1545,serum albumin,5,7,38,51,Heterozygotes had subnormal levels of serum albumin.,1269174_5,-1,1545,-1,0.24545284
1546,thalassemia,5,6,27,38,"These findings suggest a "" thalassemia "" -like mutation for this disorder..",1269174_9,-1,1546,-1,0.21862039
1547,piebaldism,11,12,55,65,Deletion of the KIT and PDGFRA genes in a patient with piebaldism.,1279971_0,-1,1547,-1,0.2608999
1548,piebaldism,6,7,37,47,"
We have previously shown that human piebaldism results from mutations of the KIT gene, which encodes the receptor for the mast/stem cell growth factor and is located in chromosome segment 4q12.",1279971_1,-1,1548,-1,0.26190233
1549,piebaldism,6,7,28,38,"Using DNA of a patient with piebaldism, mental retardation, and multiple congenital anomalies associated with a 46, XY, del (4) (q12q21.",1279971_2,-1,1549,-1,0.24488597
1550,mental retardation,8,10,40,58,"Using DNA of a patient with piebaldism, mental retardation, and multiple congenital anomalies associated with a 46, XY, del (4) (q12q21.",1279971_2,-1,1550,-1,0.20926148
1551,congenital anomalies,13,15,73,93,"Using DNA of a patient with piebaldism, mental retardation, and multiple congenital anomalies associated with a 46, XY, del (4) (q12q21.",1279971_2,-1,1551,-1,0.21960719
1552,disease,34,35,267,274,A germ line mutation within the coding sequence for the putative 5-phosphoribosyl-1-pyrophosphate binding site of hypoxanthine-guanine phosphoribosyltransferase (HPRT) in a Lesch-Nyhan patient: missense mutations within a functionally important region probably cause disease.,1282899_0,-1,1552,-1,0.20764802
1553,Lesch-Nyhan syndrome,0,2,1,21,"
Lesch-Nyhan syndrome caused by a complete deficiency of hypoxanthine guanine phosphoribosyltransferase (HPRT) is the result of a heterogeneous group of germ line mutations.",1282899_1,-1,1553,-1,0.20903529
1554,Lesch-Nyhan syndrome,13,15,75,95,We report here a newly identified HPRT mutation in a Japanese patient with Lesch-Nyhan syndrome.,1282899_3,-1,1554,-1,0.20242663
1555,nucleotide,10,11,47,57,"This gene, designated HPRT Tokyo, had a single nucleotide change from G to A, as identified by sequencing cDNA amplified by the polymerase chain reaction.",1282899_4,-1,1555,-1,0.25903782
1556,lead,3,4,20,24,This mutation would lead to an amino acid substitution of Asp for Gly at the amino acid position 140 located within the putative 5-phosphoribosyl-1-pyrophosphate (PRPP) binding region.,1282899_6,-1,1556,-1,0.2947759
1557,amino acid,6,8,31,41,This mutation would lead to an amino acid substitution of Asp for Gly at the amino acid position 140 located within the putative 5-phosphoribosyl-1-pyrophosphate (PRPP) binding region.,1282899_6,-1,1557,-1,0.31193784
1558,amino acid,15,17,77,87,This mutation would lead to an amino acid substitution of Asp for Gly at the amino acid position 140 located within the putative 5-phosphoribosyl-1-pyrophosphate (PRPP) binding region.,1282899_6,-1,1558,-1,0.35495856
1559,disease,39,40,221,228,"However, a comparison of the data suggested that both missense and synonymous mutations can occur at any coding sequence of the human germ line HPRT gene, but that a limited percentage of all the missense mutations cause disease.",1282899_8,-1,1559,-1,0.20772766
1560,disease,7,8,43,50,The probability that a mutation will cause disease tends to be higher when the missense mutation is within a functionally important sequence..,1282899_9,-1,1560,-1,0.22038107
1561,folate,6,7,27,33,It appears to be a typical folate sensitive fragile site.,1301146_1,-1,1561,-1,0.24661371
1562,mental retardation,7,9,40,58,"The fragile site is not associated with mental retardation, it does not give abnormal results when subjected to Southern analysis with probe pfxa3 which detects the unstable DNA sequence characteristic of fragile X syndrome.",1301146_2,-1,1562,-1,0.21433169
1563,fragile X syndrome,32,35,205,223,"The fragile site is not associated with mental retardation, it does not give abnormal results when subjected to Southern analysis with probe pfxa3 which detects the unstable DNA sequence characteristic of fragile X syndrome.",1301146_2,-1,1563,-1,0.21151172
1564,fragile X syndrome,25,28,168,186,"The distinction between the two fragile sites is important clinically since cytogenetic detection of FRAXE, without molecular analysis, could result in misdiagnosis of fragile X syndrome..",1301146_4,-1,1564,-1,0.2090108
1565,Norrie disease,1,3,4,18,The Norrie disease gene maps to a 150 kb region on chromosome Xp11.3.,1301161_0,-1,1565,-1,0.22333859
1566,Norrie disease,0,2,1,15,"
Norrie disease is a human X-linked recessive disorder of unknown etiology characterized by congenital blindness, sensory neural deafness and mental retardation.",1301161_1,-1,1566,-1,0.22235204
1567,blindness,14,15,103,112,"
Norrie disease is a human X-linked recessive disorder of unknown etiology characterized by congenital blindness, sensory neural deafness and mental retardation.",1301161_1,-1,1567,-1,0.19302002
1568,deafness,18,19,129,137,"
Norrie disease is a human X-linked recessive disorder of unknown etiology characterized by congenital blindness, sensory neural deafness and mental retardation.",1301161_1,-1,1568,-1,0.198447
1569,mental retardation,20,22,142,160,"
Norrie disease is a human X-linked recessive disorder of unknown etiology characterized by congenital blindness, sensory neural deafness and mental retardation.",1301161_1,-1,1569,-1,0.18644802
1570,disease,1,2,5,12,This disease gene was previously linked to the DXS7 (L1. 28) locus and the MAO genes in band Xp11.,1301161_2,-1,1570,-1,0.21278997
1571,MAO,17,18,75,78,This disease gene was previously linked to the DXS7 (L1. 28) locus and the MAO genes in band Xp11.,1301161_2,-1,1571,-1,0.27239454
1572,Norrie disease,12,14,75,89,We report here fine physical mapping of the obligate region containing the Norrie disease gene (NDP) defined by a recombination and by the smallest submicroscopic chromosomal deletion associated with Norrie disease identified to date.,1301161_4,-1,1572,-1,0.19567148
1573,Norrie disease,31,33,200,214,We report here fine physical mapping of the obligate region containing the Norrie disease gene (NDP) defined by a recombination and by the smallest submicroscopic chromosomal deletion associated with Norrie disease identified to date.,1301161_4,-1,1573,-1,0.21460502
1574,n,8,9,37,38,"A recombination event between a (GT) n polymorphism in intron 2 of the MAOB gene and the NDP locus, in a family previously reported to have a recombination between DXS7 and NDP, delineates a flanking marker telomeric to this disease gene.",1301161_6,-1,1574,-1,0.35371506
1575,disease,43,44,225,232,"A recombination event between a (GT) n polymorphism in intron 2 of the MAOB gene and the NDP locus, in a family previously reported to have a recombination between DXS7 and NDP, delineates a flanking marker telomeric to this disease gene.",1301161_6,-1,1575,-1,0.19499211
1576,disease,10,11,51,58,"28, serves as a flanking marker centromeric to the disease gene.",1301161_8,-1,1576,-1,0.22636962
1577,MAO,9,10,46,49,An Alu-PCR fragment from the right arm of the MAO YAC (YMAO.,1301161_9,-1,1577,-1,0.30855432
1578,disease,17,18,96,103,AluR) is not deleted in this patient and also delineates the centromeric extent of the obligate disease region.,1301161_10,-1,1578,-1,0.21722895
1579,phenylalanine,14,15,112,125,Molecular basis of phenylketonuria and related hyperphenylalaninemias: mutations and polymorphisms in the human phenylalanine hydroxylase gene.,1301187_0,-1,1579,-1,0.24502525
1580,phenylalanine,4,5,24,37,"
Mutations in the human phenylalanine hydroxylase gene producing phenylketonuria or hyperphenylalaninemia have now been identified in many patients from various ethnic groups.",1301187_1,-1,1580,-1,0.23547134
1581,PAH,17,18,130,133,These mutations all exhibit a high degree of association with specific restriction fragment-length polymorphism haplotypes at the PAH locus.,1301187_2,-1,1581,-1,0.23922426
1582,amino acid,7,9,37,47,One splicing mutation results in a 3 amino acid in-frame insertion.,1301187_4,-1,1582,-1,0.31617504
1583,PAH,24,25,154,157,"About half of all missense mutations have been examined by in vitro expression analysis, and a significant correlation has been observed between residual PAH activity and disease phenotype.",1301187_8,-1,1583,-1,0.22193862
1584,disease,27,28,171,178,"About half of all missense mutations have been examined by in vitro expression analysis, and a significant correlation has been observed between residual PAH activity and disease phenotype.",1301187_8,-1,1584,-1,0.18160442
1585,aspartate,5,6,16,25,A glycine250--> aspartate substitution in the alpha-subunit of hexosaminidase A causes juvenile-onset Tay-Sachs disease in a Lebanese-Canadian family.,1301189_0,-1,1585,-1,0.2475183
1586,Tay-Sachs disease,15,17,102,119,A glycine250--> aspartate substitution in the alpha-subunit of hexosaminidase A causes juvenile-onset Tay-Sachs disease in a Lebanese-Canadian family.,1301189_0,-1,1586,-1,0.26755434
1587,Tay-Sachs disease,4,6,31,48,"
The mutation causing juvenile Tay-Sachs disease (TSD) in two sibs of Lebanese-Maronite origin is described.",1301189_1,-1,1587,-1,0.26469907
1588,Lebanese-Maronite,13,14,70,87,"
The mutation causing juvenile Tay-Sachs disease (TSD) in two sibs of Lebanese-Maronite origin is described.",1301189_1,-1,1588,-1,0.25206897
1589,Tay-Sachs disease,16,18,102,119,The predicted protein environment in which the mutation occurs is compared to that of the adult-onset Tay-Sachs disease mutation caused by a Gly269-- > Ser substitution in exon 7.,1301189_9,-1,1589,-1,0.27146733
1590,Tay-Sachs disease,1,3,6,23,Novel Tay-Sachs disease mutations from China.,1301190_0,-1,1590,-1,0.2659474
1591,Tay-Sachs disease,8,10,60,77,"
We describe three HEXA mutations associated with infantile Tay-Sachs disease (TSD) in three unrelated nonconsanguineous Chinese families.",1301190_1,-1,1591,-1,0.26627827
1592,C,16,17,111,112,Single strand conformational polymorphism analysis and direct sequencing of amplified exon 13 revealed a T-- > C transition at nt 1453 with the corresponding amino acid substitution W485R in the second family.,1301190_7,-1,1592,-1,0.31337538
1593,amino acid,24,26,158,168,Single strand conformational polymorphism analysis and direct sequencing of amplified exon 13 revealed a T-- > C transition at nt 1453 with the corresponding amino acid substitution W485R in the second family.,1301190_7,-1,1593,-1,0.3098814
1594,C,10,11,65,66,When the site-specific mutagenized alpha cDNA carrying the T-- > C transition at nt 1453 was expressed in COS 1 cells hexosaminidase S activity was not detectable above background.,1301190_10,-1,1594,-1,0.34168106
1595,K,16,17,67,68,A G-- > A transition at nt 1444 (exon 13) corresponding to the E482K substitution was found in the third family.,1301190_11,-1,1595,-1,0.3396171
1596,phenylalanine,20,21,121,134,"
The genetic defects responsible for most phenylketonuria (PKU) and hyperphenylalaninemia (HPA) cases are located in the phenylalanine hydroxylase (PAH) gene.",1301200_1,-1,1596,-1,0.25256845
1597,PAH,23,24,148,151,"
The genetic defects responsible for most phenylketonuria (PKU) and hyperphenylalaninemia (HPA) cases are located in the phenylalanine hydroxylase (PAH) gene.",1301200_1,-1,1597,-1,0.23570031
1598,PAH,17,18,107,110,"Most mutations are linked to specific haplotypes, as defined by eight polymorphic restriction sites in the PAH gene.",1301200_3,-1,1598,-1,0.237177
1599,glycine,19,20,113,120,"Sequence analysis revealed a C-to-G transversion at the second base of codon 322, resulting in a substitution of glycine for alanine, in four mutant haplotype 12 genes, and a G-to-A transition at the second base of codon 408, resulting in a substitution of glutamine for arginine, in another three mutant haplotype 12 genes.",1301200_5,-1,1599,-1,0.26062766
1600,alanine,21,22,125,132,"Sequence analysis revealed a C-to-G transversion at the second base of codon 322, resulting in a substitution of glycine for alanine, in four mutant haplotype 12 genes, and a G-to-A transition at the second base of codon 408, resulting in a substitution of glutamine for arginine, in another three mutant haplotype 12 genes.",1301200_5,-1,1600,-1,0.2795396
1601,glutamine,47,48,257,266,"Sequence analysis revealed a C-to-G transversion at the second base of codon 322, resulting in a substitution of glycine for alanine, in four mutant haplotype 12 genes, and a G-to-A transition at the second base of codon 408, resulting in a substitution of glutamine for arginine, in another three mutant haplotype 12 genes.",1301200_5,-1,1601,-1,0.29763487
1602,PAH,16,17,108,111,"Both mutations were tested in a eukaryotic expression system in which enzyme activities of different mutant PAH enzymes reflect the relative severities of the mutations, although these in vitro activities cannot be translated directly into in vivo hepatic activities.",1301200_7,-1,1602,-1,0.27226266
1603,PAH,4,5,17,20,The A322G mutant PAH had about 75% and the R408Q mutant PAH about 55% of the wild-type PAH enzyme activity.,1301200_8,-1,1603,-1,0.22594228
1604,PAH,13,14,56,59,The A322G mutant PAH had about 75% and the R408Q mutant PAH about 55% of the wild-type PAH enzyme activity.,1301200_8,-1,1604,-1,0.26864403
1605,PAH,20,21,87,90,The A322G mutant PAH had about 75% and the R408Q mutant PAH about 55% of the wild-type PAH enzyme activity.,1301200_8,-1,1605,-1,0.23755315
1606,PAH,10,11,62,65,These in vitro activities are the highest reported for mutant PAH enzymes produced in the same expression system.,1301200_9,-1,1606,-1,0.28390497
1607,phenylalanine,14,15,68,81,In vitro and in vivo correlations for I65T and M1V mutations at the phenylalanine hydroxylase locus.,1301201_0,-1,1607,-1,0.22937854
1608,phenylalanine,3,4,18,31,"
Mutations at the phenylalanine hydroxylase (PAH) locus are the major cause of hyperphenylalaninemia.",1301201_1,-1,1608,-1,0.2455471
1609,PAH,6,7,45,48,"
Mutations at the phenylalanine hydroxylase (PAH) locus are the major cause of hyperphenylalaninemia.",1301201_1,-1,1609,-1,0.218985
1610,PAH,18,19,85,88,"We have previously described four mutations (M1V, IVS12nt1, R408W, and S349P) at the PAH locus in French Canadians with ancestry in eastern Quebec.",1301201_2,-1,1610,-1,0.25442335
1611,PAH,80,81,401,404,"Here we report (1) identification of another mutation, on a haplotype 9 chromosome, which converts codon 65 from isoleucine (ATT) to threonine (ACT), (2) expression analysis of the I65T mutation in COS cells demonstrating 75% loss of both immunoreactive protein and enzyme activity, and (3) expression analysis of the most prevalent PKU allele (M1V) in eastern Quebec, showing nondetectable levels of PAH protein and activity, a finding compatible with a mutation in the translation initiation codon.",1301201_3,-1,1611,-1,0.27003282
1612,Tay-Sachs disease,7,9,41,58,"
Following the birth of two infants with Tay-Sachs disease (TSD), a non-Jewish, Pennsylvania Dutch kindred was screened for TSD carriers using the biochemical assay.",1301937_1,-1,1612,-1,0.26573864
1613,nucleotide,9,10,36,46,"The second, a C-- > T transition at nucleotide 739 (Arg247Trp), has been shown by Triggs-Raine et al. (1992) to be a clinically benign "" pseudodeficient "" allele associated with reduced enzyme activity against artificial substrate.",1301937_6,-1,1613,-1,0.3394782
1614,Tay-Sachs disease,5,7,32,49,A mutation common in non-Jewish Tay-Sachs disease: frequency and RNA studies.,1301938_0,-1,1614,-1,0.26956317
1615,Tay-Sachs disease,0,2,1,18,"
Tay-Sachs disease (TSD) is an autosomal recessive genetic disorder resulting from mutation of the HEXA gene encoding the alpha-subunit of the lysosomal enzyme, beta-N-acetylhexosaminidase A (Hex A).",1301938_1,-1,1615,-1,0.2713356
1616,disease,35,36,137,144,"We have discovered that a Tay-Sachs mutation, IVS-9 + 1 G-- > A, first detected by Akli et al. (Genomics 11  124-134, 1991), is a common disease allele in non-Jewish Caucasians (10/58 alleles examined).",1301938_2,-1,1616,-1,0.20367528
1617,choroideremia,11,12,60,73,Aberrant splicing of the CHM gene is a significant cause of choroideremia.,1302003_0,-1,1617,-1,0.21516784
1618,Choroideremia,0,1,1,14,"
Choroideremia (CHM) is an X-linked progressive degeneration of the choroid and retina.",1302003_1,-1,1618,-1,0.22267233
1619,nucleotide,6,7,29,39,In one large family a single nucleotide (T) insertion into the donor splice site of exon C leads to two aberrantly spliced mRNAs both producing a premature stop codon.,1302003_6,-1,1619,-1,0.2875118
1620,C,18,19,89,90,In one large family a single nucleotide (T) insertion into the donor splice site of exon C leads to two aberrantly spliced mRNAs both producing a premature stop codon.,1302003_6,-1,1620,-1,0.2548846
1621,tumour,9,10,53,59,Germline intronic and exonic mutations in the Wilms' tumour gene (WT1) affecting urogenital development.,1302008_0,-1,1621,-1,0.19700284
1622,Denys-Drash syndrome,0,2,1,21,"
Denys-Drash syndrome is a rare human developmental disorder affecting the urogenital system and leading to renal failure, intersex disorders and Wilms tumour.",1302008_1,-1,1622,-1,0.22805966
1623,renal failure,15,17,108,121,"
Denys-Drash syndrome is a rare human developmental disorder affecting the urogenital system and leading to renal failure, intersex disorders and Wilms tumour.",1302008_1,-1,1623,-1,0.20349345
1624,tumour,22,23,152,158,"
Denys-Drash syndrome is a rare human developmental disorder affecting the urogenital system and leading to renal failure, intersex disorders and Wilms tumour.",1302008_1,-1,1624,-1,0.21844172
1625,syndrome,8,9,43,51,"In this report, four individuals with this syndrome are described carrying germline point mutations in the Wilms tumour suppressor gene, WT1.",1302008_2,-1,1625,-1,0.18564704
1626,tumour,18,19,113,119,"In this report, four individuals with this syndrome are described carrying germline point mutations in the Wilms tumour suppressor gene, WT1.",1302008_2,-1,1626,-1,0.17712595
1627,zinc,7,8,37,41,Three of these mutations were in the zinc finger domains of WT1.,1302008_3,-1,1627,-1,0.28641358
1628,myotonic dystrophy,3,5,24,42,Characterization of the myotonic dystrophy region predicts multiple protein isoform-encoding mRNAs.,1302022_0,-1,1628,-1,0.18142174
1629,myotonic dystrophy,3,5,25,43,"
The mutation underlying myotonic dystrophy (DM) has been identified as an expansion of a polymorphic CTG-repeat in a gene encoding protein kinase activity.",1302022_1,-1,1629,-1,0.1798243
1630,DM,6,7,45,47,"
The mutation underlying myotonic dystrophy (DM) has been identified as an expansion of a polymorphic CTG-repeat in a gene encoding protein kinase activity.",1302022_1,-1,1630,-1,0.20604947
1631,DM,3,4,24,26,Characterization of the DM region of both species reveals another active gene (DMR-N9) in close proximity to the kinase gene.,1302022_4,-1,1631,-1,0.27127394
1632,DM,3,4,26,28,Clinical manifestation of DM may be caused by the expanded CTG-repeat compromising the (alternative) expression of DM-kinase or DMR-N9 proteins..,1302022_6,-1,1632,-1,0.2326796
1633,Fragile X syndrome,0,3,0,18,Fragile X syndrome without CCG amplification has an FMR1 deletion.,1302032_0,-1,1633,-1,0.2159317
1634,fragile X syndrome,10,13,61,79,"
We describe a patient with typical clinical features of the fragile X syndrome, but without cytogenetic expression of the fragile X or an amplified CCG trinucleotide repeat fragment.",1302032_1,-1,1634,-1,0.20094042
1635,fragile X syndrome,27,30,155,173,"This finding confirms that the fragile X phenotype can exist, without amplification of the CCG repeat or cytogenetic expression of the fragile X, and that fragile X syndrome is a genetically homogeneous disorder involving FMR1.",1302032_3,-1,1635,-1,0.20408808
1636,Huntington disease,3,5,15,33,Cloning of the Huntington disease region in yeast artificial chromosomes.,1303170_0,-1,1636,-1,0.2119512
1637,Huntington disease,4,6,26,44,"
The gene responsible for Huntington disease has been localized to a 2. 5 million base pair (Mb) region between the loci D4S10 and D4S168 on the short arm of chromosome 4.",1303170_1,-1,1637,-1,0.19392632
1638,Mb,18,19,93,95,"
The gene responsible for Huntington disease has been localized to a 2. 5 million base pair (Mb) region between the loci D4S10 and D4S168 on the short arm of chromosome 4.",1303170_1,-1,1638,-1,0.22271806
1639,Mb,1,2,2,4,"2 Mb of the HD region in YACs, including one continuous segment of 2.",1303170_7,-1,1639,-1,0.2959056
1640,Mb,1,2,2,4,0 Mb covering the region that most likely contains the HD gene.,1303170_8,-1,1640,-1,0.2756895
1641,Mb,16,17,76,78,Ten of the twenty eight YAC clones comprise a minimal set spanning the 2. 2 Mb.,1303170_9,-1,1641,-1,0.26036087
1642,Norrie disease,10,12,56,70,Characterization of a YAC containing part or all of the Norrie disease locus.,1303171_0,-1,1642,-1,0.23381436
1643,monoamine oxidase,13,15,73,90,"
It has been shown from pulsed-field gel electrophoresis (PFGE) that the monoamine oxidase genes A and B (MAOA & MAOB) and DXS7 loci are physically very close.",1303171_1,-1,1643,-1,0.24546795
1644,map,1,2,4,7,The map derived from the YL1.,1303171_5,-1,1644,-1,0.33346364
1645,map,6,7,35,38,28-YAC is compatible both with the map from an independently derived YAC carrying MAOA and B genes and with the long range genomic map for the region.,1303171_6,-1,1645,-1,0.26617232
1646,map,23,24,131,134,28-YAC is compatible both with the map from an independently derived YAC carrying MAOA and B genes and with the long range genomic map for the region.,1303171_6,-1,1646,-1,0.24947189
1647,Norrie disease,34,36,175,189,A series of subclones prepared from a phage library (lambda DASH II) of the YAC have been characterised and have been employed to determine the end point of the deletion of a Norrie disease (NDP) patient who has been shown to lack both DXS7 and MAO coding sequences.,1303171_7,-1,1647,-1,0.21714585
1648,MAO,49,50,245,248,A series of subclones prepared from a phage library (lambda DASH II) of the YAC have been characterised and have been employed to determine the end point of the deletion of a Norrie disease (NDP) patient who has been shown to lack both DXS7 and MAO coding sequences.,1303171_7,-1,1648,-1,0.31356433
1649,glucose,4,5,24,31,"
The high prevalence of glucose 6-phosphate dehydrogenase (G6PD) deficiency in African populations is due almost entirely to the enzyme variant A-, which differs from the wild-type G6PD B by two amino acid replacements, 68 Val-- > Met and 126 Asn-- > Asp.",1303173_1,-1,1649,-1,0.24135095
1650,amino acid,33,35,195,205,"
The high prevalence of glucose 6-phosphate dehydrogenase (G6PD) deficiency in African populations is due almost entirely to the enzyme variant A-, which differs from the wild-type G6PD B by two amino acid replacements, 68 Val-- > Met and 126 Asn-- > Asp.",1303173_1,-1,1650,-1,0.31591165
1651,Glu,10,11,66,69,Comparable results were produced when the replacement 119 Gln-- > Glu was studied instead of 126 Asn-- > Asp.,1303173_8,-1,1651,-1,0.26223144
1652,N,4,5,44,45,"Small nuclear ribonucleoprotein polypeptide N (SNRPN), an expressed gene in the Prader-Willi syndrome critical region.",1303277_0,-1,1652,-1,0.22473365
1653,Prader-Willi syndrome,14,16,80,101,"Small nuclear ribonucleoprotein polypeptide N (SNRPN), an expressed gene in the Prader-Willi syndrome critical region.",1303277_0,-1,1653,-1,0.21933942
1654,Prader-Willi syndrome,0,2,1,22,"
Prader-Willi syndrome (PWS) is associated with paternally derived chromosomal deletions in region 15q11-13 or with maternal disomy for chromosome 15.",1303277_1,-1,1654,-1,0.23063266
1655,Tay-Sachs disease,6,8,40,57,The presence of two different infantile Tay-Sachs disease mutations in a Cajun population.,1307230_0,-1,1655,-1,0.25333259
1656,Tay-Sachs disease,13,15,73,90,"
A study was undertaken to characterize the mutation (s) responsible for Tay-Sachs disease (TSD) in a Cajun population in southwest Louisiana and to identify the origins of these mutations.",1307230_1,-1,1656,-1,0.28428894
1657,contrast,1,2,3,11,"In contrast, the intron 9 mutation apparently was introduced within the last century and probably is limited to a few Louisiana families..",1307230_7,-1,1657,-1,0.23115985
1658,Norrie disease,6,8,36,50,Mutations in the candidate gene for Norrie disease.,1307245_0,-1,1658,-1,0.2536642
1659,X,11,12,60,61,"
Recently, we and others have isolated a candidate gene for X linked Norrie disease (ND) which was found to be deleted or disrupted in several patients.",1307245_1,-1,1659,-1,0.24522707
1660,Norrie disease,13,15,69,83,"
Recently, we and others have isolated a candidate gene for X linked Norrie disease (ND) which was found to be deleted or disrupted in several patients.",1307245_1,-1,1660,-1,0.20289092
1661,Norrie disease,24,26,143,157,"These findings, and the absence of functionally relevant base changes in healthy controls, emphasize the causal role of this candidate gene in Norrie disease and pave the way for reliable diagnosis and carrier detection..",1307245_6,-1,1661,-1,0.20947395
1662,muscular dystrophy,11,13,69,87,Co-amplification of 11 exons from genomic DNA of Duchenne and Becker muscular dystrophy (DMD/BMD) patients with no deletion or duplication was performed and the samples subjected to multiple SSCP analysis.,1307253_2,-1,1662,-1,0.17866601
1663,nucleoside,4,5,45,55,Proliferation-related expression of p19/nm23 nucleoside diphosphate kinase.,1311721_0,-1,1663,-1,0.22063184
1664,nucleoside,12,13,64,74,"
High level expression of the nm23-H1 gene, which encodes for a nucleoside diphosphate kinase, has been found to correlate with diminished metastasis in some tumors but not in others.",1311721_1,-1,1664,-1,0.21128128
1665,metastasis,23,24,139,149,"
High level expression of the nm23-H1 gene, which encodes for a nucleoside diphosphate kinase, has been found to correlate with diminished metastasis in some tumors but not in others.",1311721_1,-1,1665,-1,0.20093727
1667,neuroblastoma,1,2,3,16,"In neuroblastoma, higher levels of p19/nm23, which are associated with amplification of the N-myc oncogene, large tumor mass, and metastasis, were observed in advanced stage tumors compared with limited stage disease.",1311721_3,-1,1667,-1,0.19204381
1669,metastasis,23,24,130,140,"In neuroblastoma, higher levels of p19/nm23, which are associated with amplification of the N-myc oncogene, large tumor mass, and metastasis, were observed in advanced stage tumors compared with limited stage disease.",1311721_3,-1,1669,-1,0.1932421
1671,disease,35,36,209,216,"In neuroblastoma, higher levels of p19/nm23, which are associated with amplification of the N-myc oncogene, large tumor mass, and metastasis, were observed in advanced stage tumors compared with limited stage disease.",1311721_3,-1,1671,-1,0.18650001
1673,leukemia,16,17,105,113,The levels of p19/nm23 were compared between resting and mitotically stimulated normal human PBLs and in leukemia cells.,1311721_5,-1,1673,-1,0.17798187
1674,leukemia,1,2,3,11,"In leukemia cells obtained from patients with different subtypes of acute leukemia, p19/nm23 levels were also increased relative to resting normal lymphocytes.",1311721_7,-1,1674,-1,0.16904938
1675,leukemia,11,12,74,82,"In leukemia cells obtained from patients with different subtypes of acute leukemia, p19/nm23 levels were also increased relative to resting normal lymphocytes.",1311721_7,-1,1675,-1,0.15463199
1676,cyclosporin,6,7,53,64,"Treatment of mitotically stimulated lymphocytes with cyclosporin, which inhibits proliferation, blocked the increase in p19/nm23; treatment of the leukemia cell line HL-60 with dimethylsulfoxide, which induces terminal differentiation, resulted in diminished levels of p19/nm23.",1311721_8,-1,1676,-1,0.27454227
1677,leukemia,21,22,147,155,"Treatment of mitotically stimulated lymphocytes with cyclosporin, which inhibits proliferation, blocked the increase in p19/nm23; treatment of the leukemia cell line HL-60 with dimethylsulfoxide, which induces terminal differentiation, resulted in diminished levels of p19/nm23.",1311721_8,-1,1677,-1,0.17594567
1678,adenomatous polyposis coli,8,11,65,91,An intrachromosomal insertion causing 5q22 deletion and familial adenomatous polyposis coli in two generations.,1313112_0,-1,1678,-1,0.19918106
1679,adenomatous polyposis coli,3,6,20,46,"
We report familial adenomatous polyposis coli (FAPC) with epidermoid cysts, osteomata, and areas of congenital hypertrophy of the retinal pigment epithelium (CHRPEs) in a male patient and his maternal aunt, both of whom suffered a mild to moderate degree of mental handicap.",1313112_1,-1,1679,-1,0.21135877
1680,cysts,11,12,70,75,"
We report familial adenomatous polyposis coli (FAPC) with epidermoid cysts, osteomata, and areas of congenital hypertrophy of the retinal pigment epithelium (CHRPEs) in a male patient and his maternal aunt, both of whom suffered a mild to moderate degree of mental handicap.",1313112_1,-1,1680,-1,0.1996813
1682,cGMP,6,7,44,48,Chromosome mapping of the rod photoreceptor cGMP phosphodiesterase beta-subunit gene in mouse and human: tight linkage to the Huntington disease region (4p16.3).,1315306_0,-1,1682,-1,0.2392866
1683,Huntington disease,19,21,126,144,Chromosome mapping of the rod photoreceptor cGMP phosphodiesterase beta-subunit gene in mouse and human: tight linkage to the Huntington disease region (4p16.3).,1315306_0,-1,1683,-1,0.19917864
1684,retinal degeneration,1,3,5,25,"
The retinal degeneration mouse (gene symbol, rd) is an animal model for certain forms of human hereditary retinopathies.",1315306_1,-1,1684,-1,0.18782762
1685,rd,8,9,46,48,"
The retinal degeneration mouse (gene symbol, rd) is an animal model for certain forms of human hereditary retinopathies.",1315306_1,-1,1685,-1,0.23787649
1686,rd,8,9,46,48,Recent findings of a nonsense mutation in the rd mouse PDE beta-subunit gene (Pdeb) prompted us to investigate the chromosome locations of the mouse and human genes.,1315306_2,-1,1686,-1,0.2565737
1687,cM,6,7,11,13,1 +/- 2. 3 cM distal of Mgsa on mouse chromosome 5.,1315306_4,-1,1687,-1,0.30546272
1688,Huntington disease,6,8,21,39,"3, very close to the Huntington disease (HD) region.",1315306_6,-1,1688,-1,0.20129122
1689,map,4,5,28,31,Analysis of the comparative map for mice and humans shows that the mouse homologue of the HD gene will reside on chromosome 5.,1315306_7,-1,1689,-1,0.23960409
1690,sarcoma,2,3,18,25,Coincident Kaposi sarcoma and T-cell lymphoma in a patient with the Wiskott-Aldrich syndrome.,1316718_0,-1,1690,-1,0.14827688
1691,lymphoma,5,6,37,45,Coincident Kaposi sarcoma and T-cell lymphoma in a patient with the Wiskott-Aldrich syndrome.,1316718_0,-1,1691,-1,0.15722974
1692,Wiskott-Aldrich syndrome,11,13,68,92,Coincident Kaposi sarcoma and T-cell lymphoma in a patient with the Wiskott-Aldrich syndrome.,1316718_0,-1,1692,-1,0.20291136
1693,eczema,9,10,38,44,"
A 24 year old male with a history of eczema, recurrent mild infections, and thrombocytopenia consistent with the Wiskott-Aldrich syndrome (WAS) presented with a mediastinal mass, generalized lymphadenopathy, splenomegaly, and severe thrombocytopenia.",1316718_1,-1,1693,-1,0.21191895
1696,Wiskott-Aldrich syndrome,20,22,114,138,"
A 24 year old male with a history of eczema, recurrent mild infections, and thrombocytopenia consistent with the Wiskott-Aldrich syndrome (WAS) presented with a mediastinal mass, generalized lymphadenopathy, splenomegaly, and severe thrombocytopenia.",1316718_1,-1,1696,-1,0.21705578
1698,splenomegaly,34,35,209,221,"
A 24 year old male with a history of eczema, recurrent mild infections, and thrombocytopenia consistent with the Wiskott-Aldrich syndrome (WAS) presented with a mediastinal mass, generalized lymphadenopathy, splenomegaly, and severe thrombocytopenia.",1316718_1,-1,1698,-1,0.19653322
1700,sarcoma,9,10,67,74,An initial inguinal lymph node biopsy surprisingly revealed Kaposi sarcoma.,1316718_5,-1,1700,-1,0.16806842
1701,lymphoma,19,20,121,129,"However, following splenectomy to increase the platelet count, biopsy of the mediastinal mass revealed T-cell large cell lymphoma.",1316718_6,-1,1701,-1,0.18184718
1702,human immunodeficiency virus,32,35,192,220,"Studies of biopsied tissue for the presence of Epstein-Barr virus and cytomegalovirus were negative, as were studies of blood, including the polymerase chain reaction, for the presence of the human immunodeficiency virus (HIV).",1316718_7,-1,1702,-1,0.19946094
1703,sarcoma,7,8,35,42,This is the first report of Kaposi sarcoma arising in a patient with a congenital immunodeficiency syndrome.,1316718_8,-1,1703,-1,0.16345926
1704,immunodeficiency syndrome,15,17,82,107,This is the first report of Kaposi sarcoma arising in a patient with a congenital immunodeficiency syndrome.,1316718_8,-1,1704,-1,0.1577636
1705,sarcoma,2,3,16,23,"Although Kaposi sarcoma can arise in the face of the severe immunosuppression that follows allograft transplantation and in patients infected with HIV, we postulate that longevity in the face of mild immunosuppression was the major factor in the development of Kaposi sarcoma in this patient..",1316718_9,-1,1705,-1,0.16239668
1706,sarcoma,42,43,268,275,"Although Kaposi sarcoma can arise in the face of the severe immunosuppression that follows allograft transplantation and in patients infected with HIV, we postulate that longevity in the face of mild immunosuppression was the major factor in the development of Kaposi sarcoma in this patient..",1316718_9,-1,1706,-1,0.17402515
1707,gastric cancer,14,16,82,96,"The APC gene, responsible for familial adenomatous polyposis, is mutated in human gastric cancer.",1317264_0,-1,1707,-1,0.13528614
1708,gastric cancer,1,3,10,24,"
Although gastric cancer is the most common cancer in the world, genetic changes during its carcinogenesis are not well understood.",1317264_1,-1,1708,-1,0.14927706
1712,metaplasia,11,12,75,85,"Since some gastric cancers are considered to originate from the intestinal metaplasia, it is likely that the adenomatous polyposis coli (APC) gene, the mutation of which causes adenomatous polyps in the colon, is associated with carcinogenesis of gastric cancer.",1317264_2,-1,1712,-1,0.21503596
1713,adenomatous polyposis coli,18,21,109,135,"Since some gastric cancers are considered to originate from the intestinal metaplasia, it is likely that the adenomatous polyposis coli (APC) gene, the mutation of which causes adenomatous polyps in the colon, is associated with carcinogenesis of gastric cancer.",1317264_2,-1,1713,-1,0.21055436
1714,adenomatous polyps,31,33,177,195,"Since some gastric cancers are considered to originate from the intestinal metaplasia, it is likely that the adenomatous polyposis coli (APC) gene, the mutation of which causes adenomatous polyps in the colon, is associated with carcinogenesis of gastric cancer.",1317264_2,-1,1714,-1,0.20870696
1716,gastric cancer,42,44,247,261,"Since some gastric cancers are considered to originate from the intestinal metaplasia, it is likely that the adenomatous polyposis coli (APC) gene, the mutation of which causes adenomatous polyps in the colon, is associated with carcinogenesis of gastric cancer.",1317264_2,-1,1716,-1,0.14199783
1722,muscular dystrophy,10,12,59,77,A 71-kilodalton protein is a major product of the Duchenne muscular dystrophy gene in brain and other nonmuscle tissues.,1319059_0,-1,1722,-1,0.16003227
1723,muscular dystrophy,3,5,20,38,"
The known Duchenne muscular dystrophy (DMD) gene products, the muscle- and brain-type dystrophin isoforms, are 427-kDa proteins translated from 14-kilobase (kb) mRNAs.",1319059_1,-1,1723,-1,0.16625081
1724,amino acids,13,15,89,100,"It contains the C-terminal and the cysteine-rich domains of dystrophin, seven additional amino acids at the N terminus, and some modifications formed by alternative splicing in the C-terminal domain.",1319059_5,-1,1724,-1,0.2559821
1725,N,17,18,108,109,"It contains the C-terminal and the cysteine-rich domains of dystrophin, seven additional amino acids at the N terminus, and some modifications formed by alternative splicing in the C-terminal domain.",1319059_5,-1,1725,-1,0.25979125
1726,polyps,16,17,101,107,Correlation between the location of germ-line mutations in the APC gene and the number of colorectal polyps in familial adenomatous polyposis patients.,1319838_0,-1,1726,-1,0.15545733
1727,adenomatous polyposis coli,5,8,31,57,"
Recently we have isolated the adenomatous polyposis coli (APC) gene which causes familial adenomatous polyposis (FAP), and its germ-line mutations in a substantial number of FAP patients have been identified.",1319838_1,-1,1727,-1,0.20669611
1728,polyps,36,37,196,202,"On the basis of this information, we compared the location of germ-line mutations in the APC gene in 22 unrelated patients (12 of whom have been reported previously) with the number of colorectal polyps developed in FAP patients; 17 were sparse types and five were profuse types.",1319838_2,-1,1728,-1,0.18405883
1729,polyps,23,24,142,148,"The location of the germ-line mutations seems to correlate with the two clinical types; germ-line mutations in five FAP patients with profuse polyps were observed between codon 1250 and codon 1464, whereas mutations in 17 FAP patients with fewer polyps were observed in the other regions of the APC gene.",1319838_4,-1,1729,-1,0.19443752
1730,polyps,41,42,246,252,"The location of the germ-line mutations seems to correlate with the two clinical types; germ-line mutations in five FAP patients with profuse polyps were observed between codon 1250 and codon 1464, whereas mutations in 17 FAP patients with fewer polyps were observed in the other regions of the APC gene.",1319838_4,-1,1730,-1,0.19612694
1731,polyps,8,9,50,56,The result suggests that the number of colorectal polyps in FAP patients may be associated with a difference in the stability or biological function of the truncated APC protein..,1319838_5,-1,1731,-1,0.16954288
1732,Tay-Sachs disease,1,3,11,28,"
Infantile Tay-Sachs disease (TSD) is caused by mutations in the HEXA gene that result in the complete absence of beta-hexosaminidase A activity.",1322637_1,-1,1732,-1,0.26873782
1733,phenylalanine,12,13,70,83,Elsewhere we reported an in-frame deletion of one of the two adjacent phenylalanine codons at position 304 or 305 (delta F304/305) in one HEXA allele of a Moroccan Jewish TSD patient and in three obligate carriers from six unrelated Moroccan Jewish families.,1322637_4,-1,1733,-1,0.29226926
1734,Tay-Sachs disease,12,14,57,74,This mutation is at a CpG site in a Japanese infant with Tay-Sachs disease and was described elsewhere.,1322637_8,-1,1734,-1,0.25399065
1735,nucleotide,17,18,61,71,"The results show that 50% (47 of 94) were G to T mutation at nucleotide (nt) 1376, 21. 3% (20 of 94) were G to A mutation at nt 1388, 7.",1323345_4,-1,1735,-1,0.32997045
1736,C,26,27,65,66,"4% (7 of 94) were A to G mutation at nt 95, 4. 2% (4 of 94) were C to T mutation at nt 1024, 1. 1% (1 of 94) was G to T mutation at nt 392, and 1.",1323345_6,-1,1736,-1,0.3824636
1737,colorectal cancer,13,15,90,107,"
Familial adenomatous polyposis (FAP) is a dominantly inherited condition predisposing to colorectal cancer.",1324223_1,-1,1737,-1,0.14799222
1738,adenomatous polyposis coli,8,11,46,72,The recent isolation of the responsible gene (adenomatous polyposis coli or APC) has facilitated the search for germ line mutations in affected individuals.,1324223_2,-1,1738,-1,0.18792684
1739,colorectal carcinoma,12,14,55,75,1 megabase pairs of DNA around the MCC (for mutated in colorectal carcinoma) and APC (for adenomatous polyposis coli) genes at 5q21 have been isolated and characterized.,1325652_2,-1,1739,-1,0.16348462
1740,adenomatous polyposis coli,19,22,90,116,1 megabase pairs of DNA around the MCC (for mutated in colorectal carcinoma) and APC (for adenomatous polyposis coli) genes at 5q21 have been isolated and characterized.,1325652_2,-1,1740,-1,0.19716059
1741,Denys-Drash syndrome,4,6,26,46,Inherited WT1 mutation in Denys-Drash syndrome.,1327525_0,-1,1741,-1,0.25627097
1742,Denys-Drash syndrome,3,5,19,39,"
Patients with the Denys-Drash syndrome (Wilms tumor, genital anomalies, and nephropathy) have been demonstrated to carry de novo constitutional mutations in WT1, the Wilms tumor gene at chromosome 11p13.",1327525_1,-1,1742,-1,0.22348462
1743,Wilms tumor,6,8,41,52,"
Patients with the Denys-Drash syndrome (Wilms tumor, genital anomalies, and nephropathy) have been demonstrated to carry de novo constitutional mutations in WT1, the Wilms tumor gene at chromosome 11p13.",1327525_1,-1,1743,-1,0.18351762
1745,Wilms tumor,28,30,167,178,"
Patients with the Denys-Drash syndrome (Wilms tumor, genital anomalies, and nephropathy) have been demonstrated to carry de novo constitutional mutations in WT1, the Wilms tumor gene at chromosome 11p13.",1327525_1,-1,1745,-1,0.17210984
1746,Denys-Drash syndrome,20,22,128,148,This observation indicates that the WT1 exon 9 mutation affecting 394Arg demonstrated in over one-half of the patients with the Denys-Drash syndrome may exhibit incomplete penetrance.,1327525_4,-1,1746,-1,0.24606565
1747,syndrome,9,10,60,68,"Consequently, familial studies in patients affected by this syndrome are recommended..",1327525_5,-1,1747,-1,0.21758567
1748,Wilms tumor,26,28,154,165,"
Fluorescence in situ hybridization (FISH) with biotin-labeled probes mapping to 11p13 has been used for the molecular analysis of deletions of the WAGR (Wilms tumor, aniridia, genitourinary abnormalities, and mental retardation) locus.",1334370_1,-1,1748,-1,0.21062201
1749,aniridia,29,30,167,175,"
Fluorescence in situ hybridization (FISH) with biotin-labeled probes mapping to 11p13 has been used for the molecular analysis of deletions of the WAGR (Wilms tumor, aniridia, genitourinary abnormalities, and mental retardation) locus.",1334370_1,-1,1749,-1,0.2761928
1750,mental retardation,35,37,210,228,"
Fluorescence in situ hybridization (FISH) with biotin-labeled probes mapping to 11p13 has been used for the molecular analysis of deletions of the WAGR (Wilms tumor, aniridia, genitourinary abnormalities, and mental retardation) locus.",1334370_1,-1,1750,-1,0.22030337
1751,aniridia,12,13,75,83,"We have detected a submicroscopic 11p13 deletion in a child with inherited aniridia who subsequently presented with Wilms tumor in a horseshoe kidney, only revealed at surgery.",1334370_2,-1,1751,-1,0.25962564
1752,Wilms tumor,17,19,116,127,"We have detected a submicroscopic 11p13 deletion in a child with inherited aniridia who subsequently presented with Wilms tumor in a horseshoe kidney, only revealed at surgery.",1334370_2,-1,1752,-1,0.19685905
1753,aniridia,5,6,20,28,"The mother, who has aniridia, was also found to carry a deletion including both the aniridia candidate gene (AN2) and the Wilms tumor predisposition gene (WT1).",1334370_3,-1,1753,-1,0.2510781
1754,aniridia,17,18,84,92,"The mother, who has aniridia, was also found to carry a deletion including both the aniridia candidate gene (AN2) and the Wilms tumor predisposition gene (WT1).",1334370_3,-1,1754,-1,0.237611
1755,Wilms tumor,25,27,122,133,"The mother, who has aniridia, was also found to carry a deletion including both the aniridia candidate gene (AN2) and the Wilms tumor predisposition gene (WT1).",1334370_3,-1,1755,-1,0.17403361
1756,Wilms tumor,0,2,0,11,Wilms tumor has so far only been associated with sporadic de novo aniridia cases.,1334370_5,-1,1756,-1,0.19364175
1757,aniridia,12,13,66,74,Wilms tumor has so far only been associated with sporadic de novo aniridia cases.,1334370_5,-1,1757,-1,0.25709376
1758,aniridia,10,11,50,58,"We have shown that a cosmid probe for a candidate aniridia gene, homologous to the mouse Pax-6 gene, is deleted in cell lines from aniridia patients with previously characterized deletions at 11p13, while another cosmid marker mapping between two aniridia-associated translocation breakpoints (and hence a second candidate marker) is present on both chromosomes.",1334370_6,-1,1758,-1,0.24977912
1759,aniridia,26,27,131,139,"We have shown that a cosmid probe for a candidate aniridia gene, homologous to the mouse Pax-6 gene, is deleted in cell lines from aniridia patients with previously characterized deletions at 11p13, while another cosmid marker mapping between two aniridia-associated translocation breakpoints (and hence a second candidate marker) is present on both chromosomes.",1334370_6,-1,1759,-1,0.25411376
1760,disease,15,16,109,116,We present here a pedigree of a 31-year-old C2-deficient individual with clinical manifestations of Hodgkins disease.,133535_3,-1,1760,-1,0.182231
1761,adenomatous polyposis coli,13,16,73,99,"
We report here the result of a screening for germ-line mutations in the adenomatous polyposis coli (APC) gene in 61 new familial adenomatous polyposis (FAP) patients as well as a summary of the results of 150 patients.",1338764_1,-1,1761,-1,0.20309645
1762,cytosine,81,82,444,452,"Our findings revealed the following characteristics of the germ-line mutations of APC  1) the great majority of the mutations were found to truncate the APC product; 2) almost all of the mutations were located within the first half of the coding region; 3) no correlation was observed between the locations of germ-line mutations and extracolonic manifestations in FAP patients; 4) more than 80% of base substitutions in the APC gene were from cytosine to other nucleotides, nearly one-third of which occurred at the GpG site.",1338764_3,-1,1762,-1,0.26012075
1764,adenomatous polyposis coli,6,9,38,64,"
We examined somatic mutations of the adenomatous polyposis coli (APC) gene in 63 colorectal tumors (16 adenomas and 47 carcinomas) developed in familial adenomatous polyposis (FAP) and non-FAP patients.",1338904_1,-1,1764,-1,0.21504977
1766,adenomas,19,20,104,112,"
We examined somatic mutations of the adenomatous polyposis coli (APC) gene in 63 colorectal tumors (16 adenomas and 47 carcinomas) developed in familial adenomatous polyposis (FAP) and non-FAP patients.",1338904_1,-1,1766,-1,0.18603918
1771,adenomas,17,18,73,81,"Combining these data and the results of LOH, more than 80% of tumors (14 adenomas and 39 carcinomas) had at least one mutation in the APC gene, of which more than 60% (9 adenomas and 23 carcinomas) had two mutations.",1338904_8,-1,1771,-1,0.19176917
1772,adenomas,40,41,170,178,"Combining these data and the results of LOH, more than 80% of tumors (14 adenomas and 39 carcinomas) had at least one mutation in the APC gene, of which more than 60% (9 adenomas and 23 carcinomas) had two mutations.",1338904_8,-1,1772,-1,0.18885785
1774,Denys-Drash syndrome,9,11,58,78,Constitutional mutations in the WT1 gene in patients with Denys-Drash syndrome.,1338906_0,-1,1774,-1,0.23850402
1775,Denys-Drash syndrome,1,3,5,25,"
The Denys-Drash syndrome is characterised by a typical nephropathy, genital abnormalities and also predisposes to the development of Wilms tumor.",1338906_1,-1,1775,-1,0.24009107
1777,Wilms tumor,19,21,134,145,"
The Denys-Drash syndrome is characterised by a typical nephropathy, genital abnormalities and also predisposes to the development of Wilms tumor.",1338906_1,-1,1777,-1,0.18816473
1778,Wilms tumor,2,4,12,23,"A candidate Wilms tumor gene, WT1, from the 11p13 chromosome region has recently been cloned.",1338906_3,-1,1778,-1,0.1697
1779,nucleotide,3,4,14,24,Three were at nucleotide position 1180 resulting in an arg > trp amino acid change.,1338906_6,-1,1779,-1,0.33911598
1780,trp amino acid,11,14,61,75,Three were at nucleotide position 1180 resulting in an arg > trp amino acid change.,1338906_6,-1,1780,-1,0.3032191
1781,nucleotide,6,7,32,42,A single base pair insertion at nucleotide position 821 in exon 6 resulted in the generation of a premature stop codon in the last patient.,1338906_9,-1,1781,-1,0.31528562
1782,diastrophic dysplasia,8,10,64,85,Linkage disequilibrium mapping in isolated founder populations: diastrophic dysplasia in Finland.,1345170_0,-1,1782,-1,0.22806796
1783,disease,15,16,116,123,"
Linkage disequilibrium mapping in isolated populations provides a powerful tool for fine structure localization of disease genes.",1345170_1,-1,1783,-1,0.20315279
1784,disease,33,34,202,209,"Here, Luria and Delbrucks classical methods for analysing bacterial cultures are adapted to the study of human isolated founder populations in order to estimate (i) the recombination fraction between a disease locus and a marker; (ii) the expected degree of allelic homogeneity in a population; and (iii) the mutation rate of marker loci.",1345170_2,-1,1784,-1,0.2557218
1785,diastrophic dysplasia,10,12,67,88,"Using these methods, we report striking linkage disequilibrium for diastrophic dysplasia (DTD) in Finland indicating that the DTD gene should lie within 0.",1345170_3,-1,1785,-1,0.20424516
1786,Wiskott-Aldrich syndrome,1,3,4,28,"The Wiskott-Aldrich syndrome: refinement of the localization on Xp and identification of another closely linked marker locus, OATL1.",1346773_0,-1,1786,-1,0.20622984
1787,Wiskott-Aldrich syndrome,1,3,5,29,"
The Wiskott-Aldrich syndrome (WAS) has previously been mapped to the proximal short arm of the X chromosome between the DXS14 and DXS7 loci.",1346773_1,-1,1787,-1,0.21148933
1788,myotonic dystrophy,11,13,70,88,Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy.,1346924_0,-1,1788,-1,0.17899042
1789,Myotonic dystrophy,0,2,1,19,"
Myotonic dystrophy (DM) is the most common form of adult muscular dystrophy, with a prevalence of 2-14 per 100, 000 individuals.",1346924_1,-1,1789,-1,0.19067028
1790,DM,3,4,21,23,"
Myotonic dystrophy (DM) is the most common form of adult muscular dystrophy, with a prevalence of 2-14 per 100, 000 individuals.",1346924_1,-1,1790,-1,0.21181148
1791,muscular dystrophy,12,14,58,76,"
Myotonic dystrophy (DM) is the most common form of adult muscular dystrophy, with a prevalence of 2-14 per 100, 000 individuals.",1346924_1,-1,1791,-1,0.16794476
1792,disease,1,2,4,11,"The disease is characterized by progressive muscle weakness and sustained muscle contraction, often with a wide range of accompanying symptoms.",1346924_2,-1,1792,-1,0.22488539
1793,muscle weakness,6,8,44,59,"The disease is characterized by progressive muscle weakness and sustained muscle contraction, often with a wide range of accompanying symptoms.",1346924_2,-1,1793,-1,0.20975657
1794,disease,8,9,37,44,"The age at onset and severity of the disease show extreme variation, both within and between families.",1346924_3,-1,1794,-1,0.22266613
1795,DM,18,19,107,109,It is flanked by the tightly linked genetic markers ERCC1 proximally and D19S51 distally; these define the DM critical region.,1346924_6,-1,1795,-1,0.26262087
1796,disease,23,24,146,153,"The size of this fragment varies between affected siblings, and increases in size through generations in parallel with increasing severity of the disease.",1346924_8,-1,1796,-1,0.2209815
1797,DM,13,14,85,87,We postulate that this unstable DNA sequence is the molecular feature that underlies DM.,1346924_9,-1,1797,-1,0.25650027
1798,muscular dystrophy,43,45,211,229,"To learn about causative mechanisms, we have cloned and sequenced the breakpoints of a cytologically balanced constitutional reciprocal translocation, t (X; 4) (p21. 2; q31. 22), present in a girl with Duchenne muscular dystrophy (DMD).",1347968_2,-1,1798,-1,0.18816227
1799,DiGeorge syndrome,4,6,23,40,A genetic etiology for DiGeorge syndrome: consistent deletions and microdeletions of 22q11.,1349199_0,-1,1799,-1,0.21257648
1800,DiGeorge syndrome,0,2,1,18,"
DiGeorge syndrome (DGS), a developmental field defect of the third and fourth pharyngeal pouches, is characterized by aplasia or hypoplasia of the thymus and parathyroid glands and by conotruncal cardiac malformations.",1349199_1,-1,1800,-1,0.224941
1801,cardiac malformations,33,35,197,218,"
DiGeorge syndrome (DGS), a developmental field defect of the third and fourth pharyngeal pouches, is characterized by aplasia or hypoplasia of the thymus and parathyroid glands and by conotruncal cardiac malformations.",1349199_1,-1,1801,-1,0.20745379
1802,contrast,1,2,3,11,"In contrast, molecular analysis detected DNA deletions in all 14 probands.",1349199_6,-1,1802,-1,0.26336154
1803,adrenocortical carcinoma,10,12,44,68,Loss of normal allele of the APC gene in an adrenocortical carcinoma from a patient with familial adenomatous polyposis.,1351034_0,-1,1803,-1,0.15042402
1804,neoplasms,1,2,11,20,"
Endocrine neoplasms have been reported occasionally in patients with familial adenomatous polyposis (FAP).",1351034_1,-1,1804,-1,0.15018785
1806,adenomatous polyposis coli,12,15,56,82,"Loss of heterozygosity (LOH) in the region close to the adenomatous polyposis coli (APC) gene was detected in this carcinoma, and evidence was obtained that there was a loss of the normal allele of the APC gene.",1351034_3,-1,1806,-1,0.19388372
1812,RB1,8,9,44,47,Oncogenic point mutations in exon 20 of the RB1 gene in families showing incomplete penetrance and mild expression of the retinoblastoma phenotype.,1352883_0,-1,1812,-1,0.20911498
1813,retinoblastoma,20,21,122,136,Oncogenic point mutations in exon 20 of the RB1 gene in families showing incomplete penetrance and mild expression of the retinoblastoma phenotype.,1352883_0,-1,1813,-1,0.15238743
1814,RB1,4,5,41,44,"
The retinoblastoma-predisposition gene, RB1, segregates as an autosomal dominant trait with high (90%) penetrance.",1352883_1,-1,1814,-1,0.2136307
1816,RB1,7,8,35,38,Mutations were found in exon 20 of RB1 in both cases.,1352883_4,-1,1816,-1,0.25427544
1817,tryptophan,17,18,79,89,In one family a C----T transition in codon 661 converts an arginine (CGG) to a tryptophan (TGG) codon.,1352883_5,-1,1817,-1,0.32607326
1818,amino acid,21,23,142,152,"In this family, incomplete penetrance and mild phenotypic expression were observed in virtually all patients, possibly indicating that single amino acid changes may modify protein structure/function such that tumorigenesis is not inevitable.",1352883_6,-1,1818,-1,0.28845224
1819,glutamine,16,17,88,97,In the second family the mutation in codon 675 is a G----T transversion that converts a glutamine (GAA) to a stop (TAA) codon.,1352883_7,-1,1819,-1,0.36140206
1820,TAA,24,25,115,118,In the second family the mutation in codon 675 is a G----T transversion that converts a glutamine (GAA) to a stop (TAA) codon.,1352883_7,-1,1820,-1,0.3769803
1821,glutamine,20,21,111,120,"In that allele arginine84, a residue that is highly conserved in the arylsulfatase gene family, is replaced by glutamine.",1353340_2,-1,1821,-1,0.2943878
1822,contrast,1,2,3,11,"In contrast to alleles that cause early-onset MLD, the arginine84 to glutamine substitution is associated with some residual ARSA activity.",1353340_3,-1,1822,-1,0.27900863
1823,glutamine,12,13,69,78,"In contrast to alleles that cause early-onset MLD, the arginine84 to glutamine substitution is associated with some residual ARSA activity.",1353340_3,-1,1823,-1,0.28926948
1824,Trisomy,0,1,0,7,Trisomy 15 with loss of the paternal 15 as a cause of Prader-Willi syndrome due to maternal disomy.,1357962_0,-1,1824,-1,0.2721235
1825,Prader-Willi syndrome,12,14,54,75,Trisomy 15 with loss of the paternal 15 as a cause of Prader-Willi syndrome due to maternal disomy.,1357962_0,-1,1825,-1,0.23109731
1826,Uniparental disomy,0,2,1,19,"
Uniparental disomy has recently been recognized to cause human disorders, including Prader-Willi syndrome (PWS).",1357962_1,-1,1826,-1,0.25157365
1827,Prader-Willi syndrome,12,14,85,106,"
Uniparental disomy has recently been recognized to cause human disorders, including Prader-Willi syndrome (PWS).",1357962_1,-1,1827,-1,0.21571758
1828,uniparental disomy,14,16,110,128,We describe a particularly instructive case which raises important issues concerning the mechanisms producing uniparental disomy and whose evaluation provides evidence that trisomy may precede uniparental disomy in a fetus.,1357962_2,-1,1828,-1,0.23931688
1829,trisomy,22,23,173,180,We describe a particularly instructive case which raises important issues concerning the mechanisms producing uniparental disomy and whose evaluation provides evidence that trisomy may precede uniparental disomy in a fetus.,1357962_2,-1,1829,-1,0.2509764
1830,uniparental disomy,25,27,193,211,We describe a particularly instructive case which raises important issues concerning the mechanisms producing uniparental disomy and whose evaluation provides evidence that trisomy may precede uniparental disomy in a fetus.,1357962_2,-1,1830,-1,0.253233
1831,trisomy,9,10,71,78,"Chorionic villus sampling performed for advanced maternal age revealed trisomy 15 in all direct and cultured cells, though the fetus appeared normal.",1357962_3,-1,1831,-1,0.28864026
1832,uniparental disomy,30,32,170,188,"Maternal nondisjunction with fertilization of a disomic egg by a normal sperm, followed by loss of the paternal 15, is a likely cause of confined placental mosaicism and uniparental disomy in this case of PWS, and advanced maternal age may be a predisposing factor..",1357962_8,-1,1832,-1,0.2326876
1833,amelogenesis imperfecta,4,6,34,57,Genetic heterogeneity in X-linked amelogenesis imperfecta.,1358807_0,-1,1833,-1,0.22084759
1834,amelogenesis imperfecta,21,23,138,161,3 encodes for the enamel protein amelogenin and has been implicated as the gene responsible for the inherited dental abnormality X-linked amelogenesis imperfecta (XAI).,1358807_3,-1,1834,-1,0.24949807
1835,disease,15,16,75,82,"This supports the involvement of AMELX, located close to DXS16, in the XAI disease process (AIH1) in those families.",1358807_7,-1,1835,-1,0.21600944
1836,cM,8,9,31,33,30 for a location of AIH1 at 2 cM distal to DXS16.,1358807_9,-1,1836,-1,0.27879226
1837,cM,9,10,59,61,"The support interval around this location extended about 8 cM proximal to DXS92, and the AIH1 location could not be precisely defined by multipoint mapping.",1358807_10,-1,1837,-1,0.28969508
1838,cM,5,6,32,34,The support interval extended 9 cM proximal to DXS144E and 14 cM distal to F9.,1358807_17,-1,1838,-1,0.27912414
1839,cM,11,12,62,64,The support interval extended 9 cM proximal to DXS144E and 14 cM distal to F9.,1358807_17,-1,1839,-1,0.27381825
1840,amino acid,8,10,38,48,"
Phenylketonuria (PKU), a disorder of amino acid metabolism prevalent among Caucasians and other ethnic groups, is caused primarily by a deficiency of the hepatic enzyme phenylalanine hydroxylase (PAH).",1361100_1,-1,1840,-1,0.20826885
1841,phenylalanine,29,30,170,183,"
Phenylketonuria (PKU), a disorder of amino acid metabolism prevalent among Caucasians and other ethnic groups, is caused primarily by a deficiency of the hepatic enzyme phenylalanine hydroxylase (PAH).",1361100_1,-1,1841,-1,0.24203563
1842,PAH,32,33,197,200,"
Phenylketonuria (PKU), a disorder of amino acid metabolism prevalent among Caucasians and other ethnic groups, is caused primarily by a deficiency of the hepatic enzyme phenylalanine hydroxylase (PAH).",1361100_1,-1,1842,-1,0.22821376
1843,PAH,16,17,94,97,"PKU is a highly heterogeneous disorder, with more than 60 molecular lesions identified in the PAH gene.",1361100_2,-1,1843,-1,0.21826717
1844,PAH,12,13,86,89,"The haplotype associations, relative frequencies, and distributions of five prevalent PAH mutations (R158Q, R261Q, IVS10nt546, R408W, and IVS12n1) were established in a comprehensive European sample population and subsequently were examined to determine the potential roles of several genetic mechanisms in explaining the present distribution of the major PKU alleles.",1361100_3,-1,1844,-1,0.2536953
1845,PAH,26,27,148,151,Each of these five mutations was strongly associated with only one of the more than 70 chromosomal haplotypes defined by eight RFLPs in or near the PAH gene.,1361100_4,-1,1845,-1,0.22913624
1846,diseases,11,12,86,94,"
Inherited complement deficiencies are associated with a variety of connective tissue diseases.",1361318_1,-1,1846,-1,0.16080746
1848,sicca syndrome,27,29,169,183,A family with inherited deficiency of complement factor 2 (C2) is described in which two family members with homozygous C2 deficiency developed cutaneous vasculitis and sicca syndrome.,1361318_2,-1,1848,-1,0.19462028
1850,Pelizaeus-Merzbacher disease,17,19,77,105,New variant in exon 3 of the proteolipid protein (PLP) gene in a family with Pelizaeus-Merzbacher disease.,1376553_0,-1,1850,-1,0.2344597
1851,C,1,2,3,4,"
A C--greater than G transversion has been found in exon 3 of the PLP gene of affected males and their mother in a single sibship with Pelizaeus-merzbacher disease (PMD).",1376553_1,-1,1851,-1,0.33418465
1852,Pelizaeus-merzbacher disease,28,30,135,163,"
A C--greater than G transversion has been found in exon 3 of the PLP gene of affected males and their mother in a single sibship with Pelizaeus-merzbacher disease (PMD).",1376553_1,-1,1852,-1,0.23438355
1853,amino acid,7,9,41,51,The transversion should not result in an amino acid change in the protein but it does result in the loss of a HaeIII restriction endonuclease cleavage site.,1376553_2,-1,1853,-1,0.30596295
1854,disease,5,6,26,33,It is concordant with the disease in this family.,1376553_3,-1,1854,-1,0.24810016
1855,disease,3,4,13,20,"The cause of disease in this family remains unknown, but the association between this rare mutation and PMD is intriguing.",1376553_6,-1,1855,-1,0.21580593
1857,Pelizaeus-Merzbacher disease,20,22,128,156,"Mutations of the X-chromosome-linked PLP gene are lethal, identified first in the jimpy mouse and subsequently in patients with Pelizaeus-Merzbacher disease.",1380672_3,-1,1857,-1,0.2513661
1859,Pelizaeus-Merzbacher disease,34,36,188,216,"We suggest that PLP has a vital function in glial cell development, distinct from its later role in myelin assembly, and that this dichotomy of action may explain the clinical spectrum of Pelizaeus-Merzbacher disease..",1380672_8,-1,1859,-1,0.23944706
1860,Tay-Sachs disease,12,14,75,92,"
Deficiency of beta-hexosaminidase A (Hex A) activity typically results in Tay-Sachs disease.",1384323_1,-1,1860,-1,0.26111203
1861,Tay-Sachs disease,27,29,171,188,We analyzed the HEXA gene of one pseudodeficient subject and identified both a C739-to-T substitution that changes Arg247----Trp on one allele and a previously identified Tay-Sachs disease mutation on the second allele.,1384323_3,-1,1861,-1,0.30718866
1862,Tay-Sachs disease,12,14,67,84,This allele accounted for 32% (20/62) of non-Jewish enzyme-defined Tay-Sachs disease carriers but for none of 36 Jewish enzyme-defined carriers who did not have one of three known mutations common to this group.,1384323_5,-1,1862,-1,0.27260822
1863,Tay-Sachs disease,10,12,47,64,"The C739-to-T allele, together with a "" true "" Tay-Sachs disease allele, causes Hex A pseudodeficiency.",1384323_6,-1,1863,-1,0.28201124
1864,Tay-Sachs disease,26,28,187,204,"Given both the large proportion of non-Jewish carriers with this allele and that standard biochemical screening cannot differentiate between heterozygotes for the C739-to-T mutations and Tay-Sachs disease carriers, DNA testing for this mutation in at-risk couples is essential.",1384323_7,-1,1864,-1,0.2725871
1865,Pelizaeus-Merzbacher disease,0,2,0,28,"Pelizaeus-Merzbacher disease: detection of mutations Thr181----Pro and Leu223----Pro in the proteolipid protein gene, and prenatal diagnosis.",1384324_0,-1,1865,-1,0.24847507
1866,Pelizaeus-Merzbacher disease,8,10,47,75,"
A family with an apparent history of X-linked Pelizaeus-Merzbacher disease presented for genetic counseling, requesting carrier detection and prenatal diagnosis.",1384324_1,-1,1866,-1,0.23944513
1867,nucleotide,21,22,133,143,"Sequencing of the exon from the CVS, the predicted-carrier mother, and the obligate-carrier grandmother revealed an A-to-C change at nucleotide 541 in the two women but not in the fetus.",1384324_5,-1,1867,-1,0.32266006
1868,amino acid,9,11,49,59,"As this change results in a Thr-to-Pro change at amino acid 181 in a region of the gene predicted to be part of a transmembrane segment, it was concluded that this was the mutation causing the disease in this family.",1384324_6,-1,1868,-1,0.3656684
1869,disease,37,38,193,200,"As this change results in a Thr-to-Pro change at amino acid 181 in a region of the gene predicted to be part of a transmembrane segment, it was concluded that this was the mutation causing the disease in this family.",1384324_6,-1,1869,-1,0.22134736
1870,nucleotide,29,30,137,147,"In addition, in a second family, an exon 5 variant band pattern on SSCP analysis was shown by sequencing to be due to a T-to-C change at nucleotide 668.",1384324_7,-1,1870,-1,0.3343914
1871,Pelizaeus-Merzbacher disease,11,13,70,98,These results provide further examples of mutations in PLP that cause Pelizaeus-Merzbacher disease and illustrate the value of SSCP in genetic analysis..,1384324_9,-1,1871,-1,0.23024803
1872,disease,2,3,15,22,von Willebrand disease type B: a missense mutation selectively abolishes ristocetin-induced von Willebrand factor binding to platelet glycoprotein Ib.,1409710_0,-1,1872,-1,0.20747846
1873,disease,27,28,146,153,"A missense mutation, Gly-561-- > Ser, was identified within the proposed glycoprotein Ib binding domain of vWF in the proband with von Willebrand disease type B, a unique variant characterized by no ristocetin-induced, but normal botrocetin-induced, binding to glycoprotein Ib.",1409710_3,-1,1873,-1,0.20892438
1874,disease,33,34,205,212,"The corresponding mutant recombinant protein, rvWF (G561S), formed normal multimers and exhibited the same functional defect as the patients plasma vWF, confirming that this mutation causes von Willebrand disease type B. These data show that botrocetin and ristocetin cofactor activities of vWF can be dissociated by a point mutation and confirm that these mediators promote vWF binding to platelets by different mechanisms.",1409710_4,-1,1874,-1,0.23021166
1875,disease,22,23,149,156,The normal botrocetin-induced binding and the defective ristocetin-induced binding of rvWF (G561S) suggest that the primary defect in von Willebrand disease type B may be a failure of normal allosteric regulation of the glycoprotein Ib binding function of vWF..,1409710_5,-1,1875,-1,0.22486341
1876,syndrome,5,6,28,36,Typical and partial cat eye syndrome: identification of the marker chromosome by FISH.,1424237_0,-1,1876,-1,0.21162167
1877,syndrome,8,9,50,58,"
Three children are reported with typical cat eye syndrome (CES) and three more children with partial CES because of absence of coloboma, in which the supernumerary marker chromosome was studied by FISH.",1424237_1,-1,1877,-1,0.19041741
1878,tetrasomy,18,19,98,107,"Using a genomic library, and also a centromeric and particularly a cosmid probe of 22q11, partial tetrasomy was shown in all cases..",1424237_2,-1,1878,-1,0.27871573
1879,malaria,17,18,113,120,"Carriers of G6PD deficiency are residents of 11 villages located in Alasani-Aphtalan valley, highly endemic with malaria in the past; nearly all marriages are endogamic.",144081_2,-1,1879,-1,0.22395462
1880,Craniofrontonasal dysplasia,0,2,0,27,Craniofrontonasal dysplasia.,1468459_0,-1,1880,-1,0.24122591
1881,craniofrontonasal dysplasia,6,8,33,60,"
We report on nine patients with craniofrontonasal dysplasia (CFND).",1468459_1,-1,1881,-1,0.20402467
1882,frontonasal dysplasia,8,10,56,77,Seven classical cases had facial features suggestive of frontonasal dysplasia and coronal craniosynostosis.,1468459_2,-1,1882,-1,0.20528917
1883,syndactyly,11,12,88,98,Extracranial abnormalities such as brittle nails with prominent longitudinal grooves or syndactyly of fingers and toes were observed in individual patients.,1468459_3,-1,1883,-1,0.2497716
1884,Hypotonia,0,1,0,9,Hypotonia and laxity of joints are common and may necessitate supportive measures.,1468459_6,-1,1884,-1,0.23965012
1885,contrast,1,2,3,11,"In contrast to previous reports of this condition, one of our severely affected cases is a male..",1468459_9,-1,1885,-1,0.26054507
1886,Tay-Sachs disease,10,12,52,69,The intron 7 donor splice site transition: a second Tay-Sachs disease mutation in French Canada.,1483696_0,-1,1886,-1,0.2830369
1887,Tay-Sachs disease,11,13,59,76,"
Mutations at the hexosaminidase A (HEXA) gene which cause Tay-Sachs disease (TSD) have elevated frequency in the Ashkenazi Jewish and French-Canadian populations.",1483696_1,-1,1887,-1,0.26667765
1888,disease,17,18,105,112,We report a novel TSD allele in the French-Canadian population associated with the infantile form of the disease.,1483696_2,-1,1888,-1,0.20551082
1889,Aspartylglucosaminuria,0,1,1,23,"
Aspartylglucosaminuria (AGU) is a recessive autosomally inherited lysosomal storage disorder due to deficiency of the enzyme aspartylglucosaminidase (AGA).",1505217_1,-1,1889,-1,0.2530197
1890,aniridia,8,9,50,58,"Resolution of the two loci for autosomal dominant aniridia, AN1 and AN2, to a single locus on chromosome 11p13.",1505982_0,-1,1890,-1,0.2458394
1891,aniridia,7,8,42,50,"
Two distinct loci have been proposed for aniridia; AN1 for autosomal dominant aniridia on chromosome 2p and AN2 for the aniridia in the WAGR contiguous gene syndrome on chromosome 11p13.",1505982_1,-1,1891,-1,0.25487652
1892,aniridia,13,14,79,87,"
Two distinct loci have been proposed for aniridia; AN1 for autosomal dominant aniridia on chromosome 2p and AN2 for the aniridia in the WAGR contiguous gene syndrome on chromosome 11p13.",1505982_1,-1,1892,-1,0.24817562
1893,aniridia,21,22,121,129,"
Two distinct loci have been proposed for aniridia; AN1 for autosomal dominant aniridia on chromosome 2p and AN2 for the aniridia in the WAGR contiguous gene syndrome on chromosome 11p13.",1505982_1,-1,1893,-1,0.26592022
1894,syndrome,27,28,158,166,"
Two distinct loci have been proposed for aniridia; AN1 for autosomal dominant aniridia on chromosome 2p and AN2 for the aniridia in the WAGR contiguous gene syndrome on chromosome 11p13.",1505982_1,-1,1894,-1,0.24792671
1895,aniridia,10,11,63,71,"In this report, the kindred segregating for autosomal dominant aniridia, which suggested linkage to acid phosphatase-1 (ACP1) and led to the assignment of the AN1 locus on chromosome 2p, has been updated and expanded.",1505982_2,-1,1895,-1,0.25312904
1896,aniridia,4,5,29,37,"Linkage analysis between the aniridia phenotype and ACP1 does not support the original linkage results, excluding linkage up to theta = 0.",1505982_3,-1,1896,-1,0.26346052
1897,aniridia,13,14,54,62,"APOB, D2S71, D2S5, and D2S1, also excluded linkage to aniridia.",1505982_6,-1,1897,-1,0.27576366
1898,aniridia,15,16,92,100,Markers that have been isolated from the chromosome 11p13 region were then analyzed in this aniridia family.,1505982_7,-1,1898,-1,0.26121056
1899,aniridia,7,8,36,44,These data suggest that a locus for aniridia (AN1) on chromosome 2p has been misassigned and that this autosomal dominant aniridia family is segregating for an aniridia mutation linked to markers in the 11p13 region.,1505982_17,-1,1899,-1,0.24781002
1900,aniridia,22,23,122,130,These data suggest that a locus for aniridia (AN1) on chromosome 2p has been misassigned and that this autosomal dominant aniridia family is segregating for an aniridia mutation linked to markers in the 11p13 region.,1505982_17,-1,1900,-1,0.24147952
1901,an aniridia,27,29,157,168,These data suggest that a locus for aniridia (AN1) on chromosome 2p has been misassigned and that this autosomal dominant aniridia family is segregating for an aniridia mutation linked to markers in the 11p13 region.,1505982_17,-1,1901,-1,0.2555779
1902,pyoderma gangrenosum,1,3,6,26,Fatal pyoderma gangrenosum in association with C7 deficiency.,1517503_0,-1,1902,-1,0.19680528
1903,pyoderma gangrenosum,1,3,10,30,"
Although pyoderma gangrenosum (PG) is often associated with systemic diseases, it has not been reported in association with congenital complement deficiencies.",1517503_1,-1,1903,-1,0.21422677
1904,PG,4,5,32,34,"
Although pyoderma gangrenosum (PG) is often associated with systemic diseases, it has not been reported in association with congenital complement deficiencies.",1517503_1,-1,1904,-1,0.2320151
1905,diseases,11,12,70,78,"
Although pyoderma gangrenosum (PG) is often associated with systemic diseases, it has not been reported in association with congenital complement deficiencies.",1517503_1,-1,1905,-1,0.17407763
1906,PG,9,10,55,57,We describe an aggressive and ultimately fatal case of PG in a patient with a congenital C7 deficiency.,1517503_2,-1,1906,-1,0.24283695
1907,PG,25,26,175,177,"Deficiencies of C7 can be associated with decreased neutrophil chemotaxis, phagocytosis, and opsonization, similar to the immunologic abnormalities described in patients with PG.",1517503_3,-1,1907,-1,0.25049996
1908,PG,14,15,87,89,"Our patients decreased complement level, if not directly related to the development of PG, may have contributed to the aggressive nature of her disease..",1517503_4,-1,1908,-1,0.2389748
1909,disease,25,26,144,151,"Our patients decreased complement level, if not directly related to the development of PG, may have contributed to the aggressive nature of her disease..",1517503_4,-1,1909,-1,0.19222042
1910,nucleotide,22,23,97,107,"The first type of mutation (487 G----A) was found in an affected Chinese with a G to A change at nucleotide 487, which results in a (163) Gly to Ser substitution.",1562739_7,-1,1910,-1,0.3418932
1911,nucleotide,9,10,41,51,"This mutation causes an A to G change at nucleotide position 493, producing an (165) Asn to Asp substitution.",1562739_9,-1,1911,-1,0.33238018
1912,nucleotide,9,10,40,50,This mutation causes a G to T change at nucleotide position 1376 that results in an (459) Arg to Leu substitution.,1562739_12,-1,1912,-1,0.33570105
1913,nucleotide,9,10,40,50,This mutation causes a G to A change at nucleotide 1388 that produces an (463) Arg to His substitution.,1562739_15,-1,1913,-1,0.33933806
1914,muscular dystrophy,9,11,59,77,"An error in dystrophin mRNA processing in golden retriever muscular dystrophy, an animal homologue of Duchenne muscular dystrophy.",1577476_0,-1,1914,-1,0.16935192
1915,muscular dystrophy,17,19,111,129,"An error in dystrophin mRNA processing in golden retriever muscular dystrophy, an animal homologue of Duchenne muscular dystrophy.",1577476_0,-1,1915,-1,0.15608692
1916,muscular dystrophy,2,4,18,36,"
Golden retriever muscular dystrophy (GRMD) is a spontaneous, X-linked, progressively fatal disease of dogs and is also a homologue of Duchenne muscular dystrophy (DMD).",1577476_1,-1,1916,-1,0.17083015
1917,disease,15,16,92,99,"
Golden retriever muscular dystrophy (GRMD) is a spontaneous, X-linked, progressively fatal disease of dogs and is also a homologue of Duchenne muscular dystrophy (DMD).",1577476_1,-1,1917,-1,0.18586816
1918,muscular dystrophy,25,27,144,162,"
Golden retriever muscular dystrophy (GRMD) is a spontaneous, X-linked, progressively fatal disease of dogs and is also a homologue of Duchenne muscular dystrophy (DMD).",1577476_1,-1,1918,-1,0.1733695
1919,contrast,4,5,21,29,"The polymorphism, in contrast, has near normal activity.",1610789_3,-1,1919,-1,0.29306397
1921,Denys-Drash syndrome,16,18,110,130,Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome.,1655284_0,-1,1921,-1,0.21957426
1922,Denys-Drash syndrome,0,2,1,21,"
Denys-Drash syndrome is a rare human condition in which severe urogenital aberrations result in renal failure, pseudohermaphroditism, and Wilms tumor (nephroblastoma).",1655284_1,-1,1922,-1,0.23890358
1923,renal failure,14,16,97,110,"
Denys-Drash syndrome is a rare human condition in which severe urogenital aberrations result in renal failure, pseudohermaphroditism, and Wilms tumor (nephroblastoma).",1655284_1,-1,1923,-1,0.2089915
1924,Wilms tumor,20,22,139,150,"
Denys-Drash syndrome is a rare human condition in which severe urogenital aberrations result in renal failure, pseudohermaphroditism, and Wilms tumor (nephroblastoma).",1655284_1,-1,1924,-1,0.1900575
1925,Wilms tumor,14,16,75,86,"To investigate its possible role, we have analyzed the coding exons of the Wilms tumor suppressor gene (WT1) for germline mutations.",1655284_2,-1,1925,-1,0.16318467
1926,Denys-Drash syndrome,5,7,28,48,"In ten independent cases of Denys-Drash syndrome, point mutations in the zinc finger domains of one WT1 gene copy were found.",1655284_3,-1,1926,-1,0.22662902
1927,zinc,12,13,73,77,"In ten independent cases of Denys-Drash syndrome, point mutations in the zinc finger domains of one WT1 gene copy were found.",1655284_3,-1,1927,-1,0.25017095
1928,zinc,10,11,49,53,Nine of these mutations are found within exon 9 (zinc finger III); the remaining mutation is in exon 8 (zinc finger II).,1655284_4,-1,1928,-1,0.30826345
1929,zinc,23,24,104,108,Nine of these mutations are found within exon 9 (zinc finger III); the remaining mutation is in exon 8 (zinc finger II).,1655284_4,-1,1929,-1,0.30093375
1931,granulosa,8,9,53,62,Wilms tumors from three individuals and one juvenile granulosa cell tumor demonstrate reduction to homozygosity for the mutated WT1 allele.,1655284_7,-1,1931,-1,0.18458351
1933,Denys-Drash syndrome,11,13,57,77,Our results provide evidence of a direct role for WT1 in Denys-Drash syndrome and thus urogenital system development..,1655284_8,-1,1933,-1,0.21556228
1934,adrenoleukodystrophy,4,5,29,49,Linkage analysis in X-linked adrenoleukodystrophy and application in post- and prenatal diagnosis.,1671851_0,-1,1934,-1,0.1961191
1935,factor VIII,13,15,80,91,"
We have performed linkage analysis with the DNA markers DXS52 and the clotting factor VIII gene (F8C), in several large families with X-linked adrenoleukodystrophy (ALD).",1671851_1,-1,1935,-1,0.2622452
1936,adrenoleukodystrophy,26,27,144,164,"
We have performed linkage analysis with the DNA markers DXS52 and the clotting factor VIII gene (F8C), in several large families with X-linked adrenoleukodystrophy (ALD).",1671851_1,-1,1936,-1,0.19363368
1937,vision blindness,26,28,145,161,"In four patients with ALD, no major structural rearrangement in the Xqter region was observed; in particular, there were no abnormalities in the vision blindness genes.",1671851_6,-1,1937,-1,0.26071578
1938,disease,6,7,53,60,"
Classical phenylketonuria is an autosomal recessive disease caused by a deficiency of hepatic phenylalanine hydroxylase (PAH).",1671881_1,-1,1938,-1,0.19147564
1939,phenylalanine,13,14,95,108,"
Classical phenylketonuria is an autosomal recessive disease caused by a deficiency of hepatic phenylalanine hydroxylase (PAH).",1671881_1,-1,1939,-1,0.23127232
1940,PAH,16,17,122,125,"
Classical phenylketonuria is an autosomal recessive disease caused by a deficiency of hepatic phenylalanine hydroxylase (PAH).",1671881_1,-1,1940,-1,0.22633761
1941,PAH,14,15,79,82,"The abolition of an invariant BamHI site located in the coding sequence of the PAH gene (exon 7) led to the recognition of two new point mutations at codon 272 and 273 (272gly----stop and 273ser----phe, respectively).",1671881_2,-1,1941,-1,0.26413012
1942,PAH,24,25,149,152,The present study supports the view that the clinical heterogeneity in PKU is accounted for by the large variety of mutant genotypes associated with PAH deficiencies..,1671881_4,-1,1942,-1,0.2340962
1943,map,3,4,22,25,A detailed multipoint map of human chromosome 4 provides evidence for linkage heterogeneity and position-specific recombination rates.,1673289_0,-1,1943,-1,0.2235416
1944,map,19,20,121,124,"
Utilizing the CEPH reference panel and genotypic data for 53 markers, we have constructed a 20-locus multipoint genetic map of human chromosome 4.",1673289_1,-1,1944,-1,0.20252311
1945,map,1,2,4,7,The map integrates a high-resolution genetic map of 4p16 into a continuous map extending to 4q31 and an unlinked cluster of three loci at 4q35.,1673289_3,-1,1945,-1,0.24749789
1946,map,6,7,45,48,The map integrates a high-resolution genetic map of 4p16 into a continuous map extending to 4q31 and an unlinked cluster of three loci at 4q35.,1673289_3,-1,1946,-1,0.23187236
1947,map,12,13,75,78,The map integrates a high-resolution genetic map of 4p16 into a continuous map extending to 4q31 and an unlinked cluster of three loci at 4q35.,1673289_3,-1,1947,-1,0.2105601
1948,cM,11,12,61,63,The 20 linked markers form a continuous linkage group of 152 cM in males and 202 cM in females.,1673289_4,-1,1948,-1,0.31185266
1949,cM,16,17,81,83,The 20 linked markers form a continuous linkage group of 152 cM in males and 202 cM in females.,1673289_4,-1,1949,-1,0.2962946
1950,map,1,2,4,7,The map was constructed employing the LINKAGE and CRIMAP computational methodologies to build the multipoint map via a stepwise algorithm.,1673289_6,-1,1950,-1,0.27136198
1951,map,15,16,109,112,The map was constructed employing the LINKAGE and CRIMAP computational methodologies to build the multipoint map via a stepwise algorithm.,1673289_6,-1,1951,-1,0.2530477
1952,map,3,4,20,23,A detailed 10-point map of the 4p16 region constructed from the CEPH panel provides evidence for heterogeneity in the linkage maps constructed from families segregating for Huntington disease (HD).,1673289_7,-1,1952,-1,0.23204218
1953,Huntington disease,26,28,173,191,A detailed 10-point map of the 4p16 region constructed from the CEPH panel provides evidence for heterogeneity in the linkage maps constructed from families segregating for Huntington disease (HD).,1673289_7,-1,1953,-1,0.18101677
1954,Pelizaeus-Merzbacher disease,6,8,44,72,Carrier detection and prenatal diagnosis of Pelizaeus-Merzbacher disease using a combination of anonymous DNA polymorphisms and the proteolipid protein (PLP) gene cDNA.,1676565_0,-1,1954,-1,0.24150056
1955,Pelizaeus-Merzbacher disease,16,18,111,139,"
We report carrier identification and a prenatal diagnosis using DNA polymorphisms in 2 families with X-linked Pelizaeus-Merzbacher disease (PMD).",1676565_1,-1,1955,-1,0.2283273
1956,adenomatous polyposis coli,20,23,106,132,"
Small (100-260 kb), nested deletions were characterized in DNA from two unrelated patients with familial adenomatous polyposis coli (APC).",1678319_1,-1,1956,-1,0.17136653
1957,familial Mediterranean fever,4,7,29,57,Exclusion of linkage between familial Mediterranean fever and the human serum amyloid A (SAA) gene cluster.,1679035_0,-1,1957,-1,0.2255772
1958,familial Mediterranean fever,9,12,67,95,"
We studied the relationship between the autosomal recessive trait familial Mediterranean fever (FMF) and the serum amyloid A (SAA) genes by comparing alleles of a highly polymorphic dinucleotide repeat and a conventional restriction fragment length polymorphism (RFLP) in the SAA gene cluster in Israeli FMF kindreds.",1679035_1,-1,1958,-1,0.19972552
1959,cM,1,2,2,4,4 cM including and surrounding the SAA gene cluster as the site of the FMF mutation although SAA proteins are prominent physiologic markers of the acute attacks.,1679035_4,-1,1959,-1,0.3108157
1960,lymphoma,12,13,72,80,"PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma.",1682919_0,-1,1960,-1,0.15497419
1961,lymphoma,6,7,35,43,"
Rearrangement of the BCL1 (B-cell lymphoma 1) region on chromosome 11q13 appears to be highly characteristic of centrocytic lymphoma and also is found infrequently in other B-cell neoplasms.",1682919_1,-1,1961,-1,0.15924394
1962,lymphoma,20,21,125,133,"
Rearrangement of the BCL1 (B-cell lymphoma 1) region on chromosome 11q13 appears to be highly characteristic of centrocytic lymphoma and also is found infrequently in other B-cell neoplasms.",1682919_1,-1,1962,-1,0.15823792
1963,neoplasms,29,30,181,190,"
Rearrangement of the BCL1 (B-cell lymphoma 1) region on chromosome 11q13 appears to be highly characteristic of centrocytic lymphoma and also is found infrequently in other B-cell neoplasms.",1682919_1,-1,1963,-1,0.1462747
1964,parathyroid hormone,18,20,118,137,"PRAD1, previously designated D11S287E, was identified on 11q13 as a chromosomal breakpoint region rearranged with the parathyroid hormone gene in a subset of parathyroid adenomas; this highly conserved putative oncogene, which encodes a novel cyclin, has been linked to BCL1 and implicated also in subsets of breast and squamous cell neoplasms with 11q13 amplification.",1682919_3,-1,1964,-1,0.21653537
1965,adenomas,26,27,170,178,"PRAD1, previously designated D11S287E, was identified on 11q13 as a chromosomal breakpoint region rearranged with the parathyroid hormone gene in a subset of parathyroid adenomas; this highly conserved putative oncogene, which encodes a novel cyclin, has been linked to BCL1 and implicated also in subsets of breast and squamous cell neoplasms with 11q13 amplification.",1682919_3,-1,1965,-1,0.15558346
1966,neoplasms,55,56,334,343,"PRAD1, previously designated D11S287E, was identified on 11q13 as a chromosomal breakpoint region rearranged with the parathyroid hormone gene in a subset of parathyroid adenomas; this highly conserved putative oncogene, which encodes a novel cyclin, has been linked to BCL1 and implicated also in subsets of breast and squamous cell neoplasms with 11q13 amplification.",1682919_3,-1,1966,-1,0.14399073
1967,lymphomas,10,11,65,74,"PRAD1 mRNA is abundantly expressed in seven of seven centrocytic lymphomas (Kiel classification), in contrast to 13 closely related but noncentrocytic lymphomas.",1682919_5,-1,1967,-1,0.1557906
1968,contrast,17,18,101,109,"PRAD1 mRNA is abundantly expressed in seven of seven centrocytic lymphomas (Kiel classification), in contrast to 13 closely related but noncentrocytic lymphomas.",1682919_5,-1,1968,-1,0.2789187
1969,lymphomas,24,25,151,160,"PRAD1 mRNA is abundantly expressed in seven of seven centrocytic lymphomas (Kiel classification), in contrast to 13 closely related but noncentrocytic lymphomas.",1682919_5,-1,1969,-1,0.1502412
1970,lymphomas,5,6,31,40,Three of the seven centrocytic lymphomas had detectable BCL1 DNA rearrangement.,1682919_6,-1,1970,-1,0.16188659
1971,contrast,14,15,79,87,"Also, two unusual cases of CLL with BCL1 rearrangement overexpressed PRAD1, in contrast to five CLL controls.",1682919_7,-1,1971,-1,0.28872812
1972,neoplasms,27,28,149,158,"Thus, PRAD1 is an excellent candidate "" BCL1 oncogene. "" Its overexpression may be a key consequence of rearrangement of the BCL1 vicinity in B-cell neoplasms and a unifying pathogenetic feature in centrocytic lymphoma.",1682919_8,-1,1972,-1,0.14609584
1973,lymphoma,35,36,210,218,"Thus, PRAD1 is an excellent candidate "" BCL1 oncogene. "" Its overexpression may be a key consequence of rearrangement of the BCL1 vicinity in B-cell neoplasms and a unifying pathogenetic feature in centrocytic lymphoma.",1682919_8,-1,1973,-1,0.151084
1974,disease,30,31,181,188,"However, combinations with other MLD mutations suggest that the point mutation in exon 3 does result in some residual enzyme activity and is associated with late-onset forms of the disease.",1684088_14,-1,1974,-1,0.19068617
1975,Wiskott-Aldrich syndrome,9,11,72,96,Analysis of X-chromosome inactivation and presumptive expression of the Wiskott-Aldrich syndrome (WAS) gene in hematopoietic cell lineages of a thrombocytopenic carrier female of WAS.,1684569_0,-1,1975,-1,0.18800619
1976,Wiskott-Aldrich syndrome,12,14,73,97,"
We report on a thrombocytopenic female belonging to a pedigree with the Wiskott-Aldrich syndrome (WAS).",1684569_1,-1,1976,-1,0.20682403
1978,Pelizaeus-Merzbacher disease,16,18,77,105,A new mutation in the proteolipid protein (PLP) gene in a German family with Pelizaeus-Merzbacher disease.,1707231_0,-1,1978,-1,0.23320335
1979,Pelizaeus-Merzbacher disease,25,27,127,155,"
A C-to-T transition in exon 4 of the PLP gene was found in 2 affected males and two obligate carriers in a German family with Pelizaeus-Merzbacher disease.",1707231_1,-1,1979,-1,0.2359213
1980,amino acid,12,14,60,70,"The mutation, which causes loss of an HphI site and changes amino acid 155 from threonine to isoleucine, was absent from 108 normal chromosomes.",1707231_2,-1,1980,-1,0.37011987
1981,phenylalanine,7,8,39,52,A 3-base pair in-frame deletion of the phenylalanine hydroxylase gene results in a kinetic variant of phenylketonuria.,1709636_0,-1,1981,-1,0.25604725
1982,disease,8,9,49,56,"
Phenylketonuria (PKU) is an autosomal recessive disease due to deficiency of a hepatic enzyme, phenylalanine hydroxylase (PAH).",1709636_1,-1,1982,-1,0.1954392
1983,phenylalanine,17,18,96,109,"
Phenylketonuria (PKU) is an autosomal recessive disease due to deficiency of a hepatic enzyme, phenylalanine hydroxylase (PAH).",1709636_1,-1,1983,-1,0.24792154
1984,PAH,20,21,123,126,"
Phenylketonuria (PKU) is an autosomal recessive disease due to deficiency of a hepatic enzyme, phenylalanine hydroxylase (PAH).",1709636_1,-1,1984,-1,0.23219009
1985,PAH,3,4,15,18,The absence of PAH activity results in typical PKU while persistence of a residual enzyme activity gives rise to variant forms of the disease.,1709636_2,-1,1985,-1,0.25898045
1986,disease,23,24,134,141,The absence of PAH activity results in typical PKU while persistence of a residual enzyme activity gives rise to variant forms of the disease.,1709636_2,-1,1986,-1,0.21913205
1987,PAH,10,11,54,57,"We report here a 3-base pair in-frame deletion of the PAH gene (delta 194) in a mild variant, with markedly reduced affinity of the enzyme for phenylalanine (Km = 160 nM), and we provide functional evidence for responsibility of the deletion in the mutant phenotype.",1709636_3,-1,1987,-1,0.25286156
1988,phenylalanine,29,30,143,156,"We report here a 3-base pair in-frame deletion of the PAH gene (delta 194) in a mild variant, with markedly reduced affinity of the enzyme for phenylalanine (Km = 160 nM), and we provide functional evidence for responsibility of the deletion in the mutant phenotype.",1709636_3,-1,1988,-1,0.25061104
1989,phenylalanine,35,36,186,199,"Since the deletion was located in the third exon of the gene, which presents no homology with other hydroxylases, we suggest that exon 3 is involved in the specificity of the enzyme for phenylalanine.",1709636_4,-1,1989,-1,0.2593958
1990,piebaldism,14,15,83,93,Mutation of the KIT (mast/stem cell growth factor receptor) protooncogene in human piebaldism.,1717985_0,-1,1990,-1,0.27324095
1991,Piebaldism,0,1,1,11,"
Piebaldism is an autosomal dominant genetic disorder characterized by cogenital patches of skin and hair from which melanocytes are completely absent.",1717985_1,-1,1991,-1,0.2697764
1992,piebaldism,13,14,79,89,We identified a KIT gene mutation in a proband with classic autosomal dominant piebaldism.,1717985_3,-1,1992,-1,0.26063877
1993,tyrosine,13,14,76,84,"This mutation results in a Gly----Arg substitution at codon 664, within the tyrosine kinase domain.",1717985_4,-1,1993,-1,0.2355321
1994,Piebaldism,0,1,0,10,Piebaldism in this family thus appears to be the human homologue to dominant white spotting (W) of the mouse..,1717985_6,-1,1994,-1,0.2891311
1995,abetalipoproteinemia,8,9,64,84,Genetic analysis of a Japanese family with normotriglyceridemic abetalipoproteinemia indicates a lack of linkage to the apolipoprotein B gene.,1731805_0,-1,1995,-1,0.22380193
1996,abetalipoproteinemia,1,2,22,42,"
Normotriglyceridemic abetalipoproteinemia is a rare familial disorder characterized by an isolated deficiency of apoB-100.",1731805_1,-1,1996,-1,0.23044704
1997,disease,8,9,48,55,"We have previously reported a patient with this disease, who had normal apoB-48 but no apoB-100.",1731805_2,-1,1997,-1,0.22154804
1998,contrast,1,2,3,11,"By contrast, an American case had a point substitution in the apoB gene generating an in-frame stop codon.",1731805_5,-1,1998,-1,0.28636974
1999,Norrie disease,5,7,29,43,Localisation of the gene for Norrie disease to between DXS7 and DXS426 on Xp.,1733838_0,-1,1999,-1,0.24041791
2000,Norrie disease,17,19,84,98,"4-Xp11 4-Xp11. 23, has been used to refine further the localisation of the gene for Norrie disease (NDP).",1733838_2,-1,2000,-1,0.2041616
2001,phenylalanine,3,4,21,34,Aberrant splicing of phenylalanine hydroxylase mRNA: the major cause for phenylketonuria in parts of southern Europe.,1769645_0,-1,2001,-1,0.24728628
2002,phenylalanine,6,7,33,46,"
We report a mutation within the phenylalanine hydroxylase (PAH) gene that causes aberrant splicing of the mRNA and that is in tight association with chromosomal haplotypes 6, 10, and 36.",1769645_1,-1,2002,-1,0.25547627
2003,PAH,9,10,60,63,"
We report a mutation within the phenylalanine hydroxylase (PAH) gene that causes aberrant splicing of the mRNA and that is in tight association with chromosomal haplotypes 6, 10, and 36.",1769645_1,-1,2003,-1,0.23557243
2004,PAH,29,30,150,153,"Because of the high frequency of these particular haplotypes in Bulgaria, Italy, and Turkey, it appears to be one of the more frequent defects in the PAH gene causing classical phenylketonuria in this part of Europe.",1769645_2,-1,2004,-1,0.24105854
2005,PAH,16,17,72,75,"The mutation is a G to A transition at position 546 in intron 10 of the PAH gene, 11 bp upstream from the intron 10/exon 11 boundary.",1769645_3,-1,2005,-1,0.24427003
2006,PAH,4,5,24,27,"Normal amounts of liver PAH protein are present in homozygous patients, but no catalytic activity can be detected.",1769645_5,-1,2006,-1,0.25507087
2007,amino acids,18,20,123,134,This loss of enzyme activity is probably caused by conformational changes resulting from the insertion of three additional amino acids (Gly-Leu-Gln) between the normal sequences encoded by exon 10 and exon 11..,1769645_6,-1,2007,-1,0.26736134
2008,Gardner syndrome,0,2,0,16,Gardner syndrome in a boy with interstitial deletion of the long arm of chromosome 5.,1776638_0,-1,2008,-1,0.24389215
2009,Gardner syndrome,6,8,37,53,"
We described a 15-year-old boy with Gardner syndrome (GS), mental retardation, and craniofacial abnormalities.",1776638_1,-1,2009,-1,0.21419738
2010,mental retardation,12,14,60,78,"
We described a 15-year-old boy with Gardner syndrome (GS), mental retardation, and craniofacial abnormalities.",1776638_1,-1,2010,-1,0.20086943
2011,craniofacial abnormalities,16,18,84,110,"
We described a 15-year-old boy with Gardner syndrome (GS), mental retardation, and craniofacial abnormalities.",1776638_1,-1,2011,-1,0.22447641
2012,adenomatous polyposis coli,14,17,83,109,"The breakpoints in the present case and in 3 previously reported 5q- patients with adenomatous polyposis coli suggest that the gene responsible for GS/or familial polyposis coli (FPC) is in the 5q22 region, a result consistent with the findings of linkage studies",1776638_4,-1,2012,-1,0.18009979
2013,Huntington disease,0,2,0,18,Huntington disease and childhood-onset Tourette syndrome.,1831007_0,-1,2013,-1,0.21278523
2014,Tourette syndrome,4,6,39,56,Huntington disease and childhood-onset Tourette syndrome.,1831007_0,-1,2014,-1,0.20592256
2015,Tourette syndrome,5,7,40,57,"
A 40-year-old man with childhood-onset Tourette syndrome (TS) developed Huntington disease (HD).",1831007_1,-1,2015,-1,0.20515032
2016,TS,8,9,59,61,"
A 40-year-old man with childhood-onset Tourette syndrome (TS) developed Huntington disease (HD).",1831007_1,-1,2016,-1,0.23358521
2017,Huntington disease,11,13,73,91,"
A 40-year-old man with childhood-onset Tourette syndrome (TS) developed Huntington disease (HD).",1831007_1,-1,2017,-1,0.20799978
2018,TS,11,12,65,67,We believe this to be the first reported case of childhood-onset TS with adult onset HD.,1831007_2,-1,2018,-1,0.24597958
2019,Tay-Sachs disease,16,18,88,105,"Sequence of DNA flanking the exons of the HEXA gene, and identification of mutations in Tay-Sachs disease.",1833974_0,-1,2019,-1,0.26719233
2020,Tay-Sachs disease,6,8,47,64,"
The rapid identification of mutations causing Tay-Sachs disease requires the capacity to readily screen the regions of the HEXA gene most likely to be affected by mutation.",1833974_1,-1,2020,-1,0.27279916
2021,Tay-Sachs disease,4,6,26,43,"Five novel mutations from Tay-Sachs disease patients were detected  a 5-bp deletion of TCTCC in IVS-9; a 2-bp deletion of TG in exon 5; G78 to A, giving a stop codon in exon 1; G533 to T in exon 5, producing the third amino acid substitution detected at this site; and G to C at position 1 of IVS-2, expected to produce abnormal splicing.",1833974_4,-1,2021,-1,0.2816838
2022,TG,22,23,122,124,"Five novel mutations from Tay-Sachs disease patients were detected  a 5-bp deletion of TCTCC in IVS-9; a 2-bp deletion of TG in exon 5; G78 to A, giving a stop codon in exon 1; G533 to T in exon 5, producing the third amino acid substitution detected at this site; and G to C at position 1 of IVS-2, expected to produce abnormal splicing.",1833974_4,-1,2022,-1,0.30286077
2023,amino acid,49,51,218,228,"Five novel mutations from Tay-Sachs disease patients were detected  a 5-bp deletion of TCTCC in IVS-9; a 2-bp deletion of TG in exon 5; G78 to A, giving a stop codon in exon 1; G533 to T in exon 5, producing the third amino acid substitution detected at this site; and G to C at position 1 of IVS-2, expected to produce abnormal splicing.",1833974_4,-1,2023,-1,0.30863082
2024,C,60,61,274,275,"Five novel mutations from Tay-Sachs disease patients were detected  a 5-bp deletion of TCTCC in IVS-9; a 2-bp deletion of TG in exon 5; G78 to A, giving a stop codon in exon 1; G533 to T in exon 5, producing the third amino acid substitution detected at this site; and G to C at position 1 of IVS-2, expected to produce abnormal splicing.",1833974_4,-1,2024,-1,0.3701339
2025,galactose,8,9,58,67,"
Galactosemia is an autosomal recessive disorder of human galactose metabolism caused by deficiency of the enzyme galactose-1-phosphate uridyl transferase (GALT).",1897530_1,-1,2025,-1,0.20454781
2026,nucleotide,5,6,24,34,"First, we identified at nucleotide 591 a transition which substitutes glutamine 188 by arginine.",1897530_4,-1,2026,-1,0.3359292
2027,glutamine,11,12,70,79,"First, we identified at nucleotide 591 a transition which substitutes glutamine 188 by arginine.",1897530_4,-1,2027,-1,0.3460702
2028,glutamine,2,3,12,21,"The mutated glutamine is not only highly conserved in evolution (conserved also in Escherichia coli and Saccharomyces cerevisiae), but is also two amino acid residues downstream from the active site histidine-proline-histidine triad and results in about 10% of normal enzymatic activity.",1897530_5,-1,2028,-1,0.31770292
2029,amino acid,25,27,147,157,"The mutated glutamine is not only highly conserved in evolution (conserved also in Escherichia coli and Saccharomyces cerevisiae), but is also two amino acid residues downstream from the active site histidine-proline-histidine triad and results in about 10% of normal enzymatic activity.",1897530_5,-1,2029,-1,0.30078837
2030,tryptophan,10,11,54,64,"Second, we report the substitution of arginine 333 by tryptophan, caused by a transition at nucleotide 1025.",1897530_8,-1,2030,-1,0.31689444
2031,nucleotide,17,18,92,102,"Second, we report the substitution of arginine 333 by tryptophan, caused by a transition at nucleotide 1025.",1897530_8,-1,2031,-1,0.33309978
2032,Lesch-Nyhan syndrome,1,3,5,25,"
The Lesch-Nyhan syndrome is a severe X chromosome-linked human disease caused by a virtual absence of hypoxanthine-guanine phosphoribosyltransferase (HPRT) activity.",1937471_1,-1,2032,-1,0.20851515
2033,disease,9,10,64,71,"
The Lesch-Nyhan syndrome is a severe X chromosome-linked human disease caused by a virtual absence of hypoxanthine-guanine phosphoribosyltransferase (HPRT) activity.",1937471_1,-1,2033,-1,0.18832701
2034,gouty arthritis,12,14,66,81,A partial deficiency in the activity of this enzyme can result in gouty arthritis.,1937471_2,-1,2034,-1,0.2082375
2035,Lesch-Nyhan syndrome,30,32,165,185,"To determine the genetic basis for reduction or loss of enzyme activity, we have amplified and sequenced the coding region of HPRT cDNA from four patients  one with Lesch-Nyhan syndrome (HPRTPerth) and three with partial deficiencies of HPRT activity, which have been designated HPRTUrangan, HPRTSwan and HPRTToowong.",1937471_3,-1,2035,-1,0.22341476
2036,amino acid,31,33,157,167,"In all four patients, the only mutation identified was a single base substitution in exons 2 or 3 of the coding region, which in each case predicts a single amino acid substitution in the translated protein.",1937471_4,-1,2036,-1,0.29100075
2037,abetalipoproteinemia,9,10,78,98,Molecular and metabolic basis for the metabolic disorder normotriglyceridemic abetalipoproteinemia.,1939657_0,-1,2037,-1,0.223855
2038,abetalipoproteinemia,8,9,63,83,"
We have previously described a disorder, normotriglyceridemic abetalipoproteinemia, that is characterized by the virtual absence of plasma low density lipoproteins and complete absence of apoB-100, but with apparently normal secretion of triglyceride-rich lipoproteins containing apoB-48.",1939657_1,-1,2038,-1,0.23344466
2039,nucleotide,12,13,67,77,"We have found this individual to be homozygous for a single C-to-T nucleotide substitution at apoB codon 2252, which produces a premature in-frame stop codon.",1939657_3,-1,2039,-1,0.2767829
2040,disease,7,8,38,45,"
Phenylketonuria (PKU) is a metabolic disease caused by recessive mutations of the gene encoding the hepatic enzyme phenylalanine hydroxylase (PAH).",1968617_1,-1,2040,-1,0.19392923
2041,phenylalanine,19,20,116,129,"
Phenylketonuria (PKU) is a metabolic disease caused by recessive mutations of the gene encoding the hepatic enzyme phenylalanine hydroxylase (PAH).",1968617_1,-1,2041,-1,0.24261013
2042,PAH,22,23,143,146,"
Phenylketonuria (PKU) is a metabolic disease caused by recessive mutations of the gene encoding the hepatic enzyme phenylalanine hydroxylase (PAH).",1968617_1,-1,2042,-1,0.23031572
2043,PAH,17,18,89,92,Here we report that a single molecular defect--a deletion spanning the third exon of the PAH gene--is responsible for all the PKU cases among the Yemenite Jews.,1968617_4,-1,2043,-1,0.24333408
2044,PAH,3,4,21,24,"Although the deleted PAH gene was traced to 25 different locations throughout Yemen, family histories and official documents of the Yemenite Jewish community showed that the common ancestor of all the carriers of this genetic defect lived in Sana, the capital of Yemen, before the eighteenth century..",1968617_6,-1,2044,-1,0.25456038
2045,aspartylglucosaminuria,2,3,11,33,"Linkage of aspartylglucosaminuria (AGU) to marker loci on the long arm of chromosome 4.
Aspartylglucosaminuria (AGU) is caused by deficient activity of the enzyme aspartylglucosaminidase (AGA).",1973404_0,-1,2045,-1,0.2471925
2046,AGU,4,5,35,38,"Linkage of aspartylglucosaminuria (AGU) to marker loci on the long arm of chromosome 4.
Aspartylglucosaminuria (AGU) is caused by deficient activity of the enzyme aspartylglucosaminidase (AGA).",1973404_0,-1,2046,-1,0.24905361
2047,Aspartylglucosaminuria,17,18,88,110,"Linkage of aspartylglucosaminuria (AGU) to marker loci on the long arm of chromosome 4.
Aspartylglucosaminuria (AGU) is caused by deficient activity of the enzyme aspartylglucosaminidase (AGA).",1973404_0,-1,2047,-1,0.25223505
2048,aspartylglucosaminidase,29,30,163,186,"Linkage of aspartylglucosaminuria (AGU) to marker loci on the long arm of chromosome 4.
Aspartylglucosaminuria (AGU) is caused by deficient activity of the enzyme aspartylglucosaminidase (AGA).",1973404_0,-1,2048,-1,0.27844405
2049,map,4,5,20,23,We have studied the map position of the AGU locus in relation to other marker loci on the long arm of chromosome 4 using linkage analyses.,1973404_2,-1,2049,-1,0.2500768
2050,AGU,8,9,40,43,We have studied the map position of the AGU locus in relation to other marker loci on the long arm of chromosome 4 using linkage analyses.,1973404_2,-1,2050,-1,0.30568704
2051,AGU,35,36,184,187,"Restriction fragment length polymorphism alleles for the ADH2, ADH3, EGF, FG alpha and FG beta loci and blood group antigens for the MNS locus were determined in a panel of 12 Finnish AGU families.",1973404_3,-1,2051,-1,0.30846086
2052,AGU,4,5,21,24,"Loose linkage of the AGU locus to the FG and MNS loci was observed (z = 1. 16, z = 1. 39, respectively).",1973404_6,-1,2052,-1,0.32807124
2053,map,5,6,33,36,Multipoint analysis to the fixed map [ADH- (0. 03) -EGF- (0. 35) -FG- (0. 11) -MNS] suggests that the location of the AGU locus is 0. 05-0. 30 recombination units distal to MNS (z = 3. 03).,1973404_7,-1,2053,-1,0.2854259
2054,AGU,33,34,118,121,Multipoint analysis to the fixed map [ADH- (0. 03) -EGF- (0. 35) -FG- (0. 11) -MNS] suggests that the location of the AGU locus is 0. 05-0. 30 recombination units distal to MNS (z = 3. 03).,1973404_7,-1,2054,-1,0.3287319
2055,myotonic dystrophy,16,18,90,108,Linkage relationships of the apolipoprotein C1 gene and a cytochrome P450 gene (CYP2A) to myotonic dystrophy.,1975560_0,-1,2055,-1,0.19873764
2056,myotonic dystrophy,32,34,152,170,"
We have studied the genetic linkage of two markers, the apolipoprotein C1 (APOC1) gene and a cytochrome P450 (CYP2A) gene, in relation to the gene for myotonic dystrophy (DM).",1975560_1,-1,2056,-1,0.1863302
2057,DM,35,36,172,174,"
We have studied the genetic linkage of two markers, the apolipoprotein C1 (APOC1) gene and a cytochrome P450 (CYP2A) gene, in relation to the gene for myotonic dystrophy (DM).",1975560_1,-1,2057,-1,0.20499705
2058,cM,3,4,8,10,"29 at 2 cM was observed for APOC1-DM, with a lod score of 8.",1975560_3,-1,2058,-1,0.3334289
2059,cM,3,4,8,10,55 at 4 cM for CYP2A-DM.,1975560_4,-1,2059,-1,0.330167
2060,map,13,14,83,86,"From examination of the genotypes of the recombinant individuals, CYP2A appears to map proximal to DM because in one recombinant individual CYP2A, APOC2 and CKMM had all recombined with DM.",1975560_6,-1,2060,-1,0.30722633
2061,DM,16,17,99,101,"From examination of the genotypes of the recombinant individuals, CYP2A appears to map proximal to DM because in one recombinant individual CYP2A, APOC2 and CKMM had all recombined with DM.",1975560_6,-1,2061,-1,0.2499546
2062,DM,31,32,186,188,"From examination of the genotypes of the recombinant individuals, CYP2A appears to map proximal to DM because in one recombinant individual CYP2A, APOC2 and CKMM had all recombined with DM.",1975560_6,-1,2062,-1,0.26516104
2063,DM,17,18,94,96,Localisation of CYP2A on a panel of somatic cell hybrids also suggests that it is proximal to DM and APOC2/C1/E gene cluster.,1975560_8,-1,2063,-1,0.28677347
2064,map,2,3,16,19,Genetic linkage map of six polymorphic DNA markers around the gene for familial adenomatous polyposis on chromosome 5.,1978564_0,-1,2064,-1,0.22994438
2065,map,3,4,19,22,"
A genetic linkage map of six polymorphic DNA markers close to the gene (APC) for familial adenomatous polyposis (FAP) on chromosome 5q is reported.",1978564_1,-1,2065,-1,0.22551455
2066,map,25,26,151,154,"A number of crucial recombination events have been identified which are informative at three or more loci, allowing confident ordering of parts of the map.",1978564_3,-1,2066,-1,0.26828915
2067,e,1,2,11,12,"48-telomer e, although EF5. 44 could lie in the interval L5.",1978564_7,-1,2067,-1,0.2886294
2068,cM,23,24,116,118,"48, but published deletion mapping in colorectal carcinomas and linkage analysis in FAP suggest that YN5. 48 is 1-3 cM from APC.",1978564_12,-1,2068,-1,0.2918561
2069,map,19,20,118,121,These data not only allow use of flanking markers for presymptomatic diagnosis of FAP but also provide a high-density map of the region for isolation of the APC gene itself and for further assessment of the role of chromosome 5 deletions in the biology of sporadic colorectal cancer.,1978564_16,-1,2069,-1,0.20153397
2070,colorectal cancer,46,48,265,282,These data not only allow use of flanking markers for presymptomatic diagnosis of FAP but also provide a high-density map of the region for isolation of the APC gene itself and for further assessment of the role of chromosome 5 deletions in the biology of sporadic colorectal cancer.,1978564_16,-1,2070,-1,0.13809323
2071,P,4,5,20,21,Serum amyloid A and P protein genes in familial Mediterranean fever.,1981994_0,-1,2071,-1,0.2836172
2072,familial Mediterranean fever,8,11,39,67,Serum amyloid A and P protein genes in familial Mediterranean fever.,1981994_0,-1,2072,-1,0.21175238
2073,P,15,16,80,81,"
Two recent studies have suggested the involvement of serum amyloid A (SAA) and P (APCS) genes in familial Mediterranean fever (MEF).",1981994_1,-1,2073,-1,0.28472382
2074,familial Mediterranean fever,21,24,98,126,"
Two recent studies have suggested the involvement of serum amyloid A (SAA) and P (APCS) genes in familial Mediterranean fever (MEF).",1981994_1,-1,2074,-1,0.20322013
2075,amyloidosis,31,32,157,168,"To test the role of SAA and APCS in MEF and MEF-amyloidosis, we studied 17 informative families (15 Armenians, 2 non-Ashkenazi Jews) and 8 MEF patients with amyloidosis using a candidate gene approach.",1981994_2,-1,2075,-1,0.19977629
2076,nucleotide,25,26,149,159,"All three of these variants, believed on the basis of biochemical characterization and population origin to be unique, have the G----A transition at nucleotide 202 and the A----G transition at nucleotide 376, mutations that we now recognize to be characteristic of G6PD A-.",1999339_3,-1,2076,-1,0.31893653
2077,nucleotide,32,33,193,203,"All three of these variants, believed on the basis of biochemical characterization and population origin to be unique, have the G----A transition at nucleotide 202 and the A----G transition at nucleotide 376, mutations that we now recognize to be characteristic of G6PD A-.",1999339_3,-1,2077,-1,0.3167752
2078,lupus erythematosus,8,10,56,75,Hereditary deficiency of C5 in association with discoid lupus erythematosus.,1999552_0,-1,2078,-1,0.20881733
2079,lupus erythematosus,5,7,34,53,"
A 29-year-old woman with discoid lupus erythematosus had undetectable classic pathway complement activity.",1999552_1,-1,2079,-1,0.21035814
2080,lupus erythematosus,14,16,85,104,To our knowledge this is the first documented case of an association between discoid lupus erythematosus and C5 deficiency..,1999552_4,-1,2080,-1,0.21954468
2081,phenylalanine,9,10,54,67,"
A missense mutation has been identified in the human phenylalanine hydroxylase [PAH; phenylalanine 4-monooxygenase; L-phenylalanine, tetrahydrobiopterin  oxygen oxidoreductase (4-hydroxylating), EC 1. 14. 16. 1] gene in a Chinese patient with classic phenylketonuria (PKU).",2006152_1,-1,2081,-1,0.25112712
2082,PAH,12,13,81,84,"
A missense mutation has been identified in the human phenylalanine hydroxylase [PAH; phenylalanine 4-monooxygenase; L-phenylalanine, tetrahydrobiopterin  oxygen oxidoreductase (4-hydroxylating), EC 1. 14. 16. 1] gene in a Chinese patient with classic phenylketonuria (PKU).",2006152_1,-1,2082,-1,0.25431636
2083,phenylalanine,14,15,86,99,"
A missense mutation has been identified in the human phenylalanine hydroxylase [PAH; phenylalanine 4-monooxygenase; L-phenylalanine, tetrahydrobiopterin  oxygen oxidoreductase (4-hydroxylating), EC 1. 14. 16. 1] gene in a Chinese patient with classic phenylketonuria (PKU).",2006152_1,-1,2083,-1,0.27390572
2084,oxygen,21,22,155,161,"
A missense mutation has been identified in the human phenylalanine hydroxylase [PAH; phenylalanine 4-monooxygenase; L-phenylalanine, tetrahydrobiopterin  oxygen oxidoreductase (4-hydroxylating), EC 1. 14. 16. 1] gene in a Chinese patient with classic phenylketonuria (PKU).",2006152_1,-1,2084,-1,0.25857648
2085,PAH,25,26,170,173,"Population genetic studies reveal that this mutation is tightly linked to restriction fragment length polymorphism haplotype 4, which is the predominant haplotype of the PAH locus in the Oriental population.",2006152_4,-1,2085,-1,0.2639812
2086,Na+/glucose,8,9,58,69,Glucose/galactose malabsorption caused by a defect in the Na+/glucose cotransporter.,2008213_0,-1,2086,-1,0.2768138
2087,disease,9,10,65,72,"
Glucose/galactose malabsorption (GGM) is an autosomal recessive disease manifesting within the first weeks of life and characterized by a selective failure to absorb dietary glucose and galactose from the intestine.",2008213_1,-1,2087,-1,0.21067995
2088,glucose,26,27,175,182,"
Glucose/galactose malabsorption (GGM) is an autosomal recessive disease manifesting within the first weeks of life and characterized by a selective failure to absorb dietary glucose and galactose from the intestine.",2008213_1,-1,2088,-1,0.22946939
2089,galactose,28,29,187,196,"
Glucose/galactose malabsorption (GGM) is an autosomal recessive disease manifesting within the first weeks of life and characterized by a selective failure to absorb dietary glucose and galactose from the intestine.",2008213_1,-1,2089,-1,0.21847887
2090,diarrhoea,3,4,22,31,The consequent severe diarrhoea and dehydration are usually fatal unless these sugars are eliminated from the diet.,2008213_2,-1,2090,-1,0.2368168
2092,Na,11,12,71,73,Intestinal biopsies of GGM patients have revealed a specific defect in Na (+) -dependent absorption of glucose in the brush border.,2008213_3,-1,2092,-1,0.28437188
2093,glucose,18,19,103,110,Intestinal biopsies of GGM patients have revealed a specific defect in Na (+) -dependent absorption of glucose in the brush border.,2008213_3,-1,2093,-1,0.24607338
2094,glucose,1,2,7,14,Normal glucose absorption is mediated by the Na +/glucose cotransporter in the brush border membrane of the intestinal epithelium.,2008213_4,-1,2094,-1,0.21711914
2095,Na,7,8,45,47,Normal glucose absorption is mediated by the Na +/glucose cotransporter in the brush border membrane of the intestinal epithelium.,2008213_4,-1,2095,-1,0.26781532
2096,Na,7,8,47,49,Cellular influx is driven by the transmembrane Na + electrochemical potential gradient; thereafter the sugar moves to the blood across the basolateral membrane via the facilitated glucose carrier.,2008213_5,-1,2096,-1,0.2950799
2097,glucose,27,28,180,187,Cellular influx is driven by the transmembrane Na + electrochemical potential gradient; thereafter the sugar moves to the blood across the basolateral membrane via the facilitated glucose carrier.,2008213_5,-1,2097,-1,0.24541524
2098,Na,7,8,42,44,"We have previously cloned and sequenced a Na +/glucose cotransporter from normal human ileum and shown that this gene, SGLT1, resides on the distal q arm of chromosome 22.",2008213_6,-1,2098,-1,0.25979823
2099,Na,27,28,169,171,Sequence analysis of the amplified products has revealed a single missense mutation in SGLT1 which cosegregates with the GGM phenotype and results in a complete loss of Na (+) -dependent glucose transport in Xenopus oocytes injected with this complementary RNA..,2008213_8,-1,2099,-1,0.303112
2100,glucose,32,33,187,194,Sequence analysis of the amplified products has revealed a single missense mutation in SGLT1 which cosegregates with the GGM phenotype and results in a complete loss of Na (+) -dependent glucose transport in Xenopus oocytes injected with this complementary RNA..,2008213_8,-1,2100,-1,0.25346872
2101,Prader-Willi syndrome,13,15,86,107,A de novo unbalanced reciprocal translocation identified as paternal in origin in the Prader-Willi syndrome.,2016095_0,-1,2101,-1,0.22140811
2102,Prader-Willi syndrome,18,20,130,151,"
Interstitial cytogenetic deletions involving the paternally derived chromosome 15q11-13 have been described in patients with the Prader-Willi syndrome (PWS).",2016095_1,-1,2102,-1,0.21374048
2103,myotonic dystrophy,3,5,20,38,Localisation of the myotonic dystrophy locus to 19q13.2-19q13.3 and its relationship to twelve polymorphic loci on 19q.,2037285_0,-1,2103,-1,0.1983966
2104,myotonic dystrophy,8,10,47,65,We report here the linkage relationship of the myotonic dystrophy (DM) locus to twelve of these markers as studied in 45 families with DM.,2037285_2,-1,2104,-1,0.18999025
2105,DM,11,12,67,69,We report here the linkage relationship of the myotonic dystrophy (DM) locus to twelve of these markers as studied in 45 families with DM.,2037285_2,-1,2105,-1,0.21963856
2106,DM,25,26,135,137,We report here the linkage relationship of the myotonic dystrophy (DM) locus to twelve of these markers as studied in 45 families with DM.,2037285_2,-1,2106,-1,0.2162708
2107,map,3,4,22,25,The resulting genetic map is supported by the localisation of the DNA markers in a panel of somatic cell hybrids.,2037285_3,-1,2107,-1,0.21021572
2108,DM,13,14,64,66,"Ten of the twelve markers have been shown to be proximal to the DM gene and two, PRKCG and D19S22, distal but at distances of approximately 25 cM and 15 cM, respectively.",2037285_4,-1,2108,-1,0.2612469
2109,cM,29,30,143,145,"Ten of the twelve markers have been shown to be proximal to the DM gene and two, PRKCG and D19S22, distal but at distances of approximately 25 cM and 15 cM, respectively.",2037285_4,-1,2109,-1,0.3123649
2110,cM,32,33,153,155,"Ten of the twelve markers have been shown to be proximal to the DM gene and two, PRKCG and D19S22, distal but at distances of approximately 25 cM and 15 cM, respectively.",2037285_4,-1,2110,-1,0.30900246
2111,creatine kinase,13,15,70,85,"The closest proximal markers are APOC2 (apolipoprotein C-II) and CKM (creatine kinase, muscle) approximately 3 cM and 2 cM from the DM gene respectively, in the order APOC2-CKM-DM.",2037285_5,-1,2111,-1,0.28067777
2112,cM,20,21,111,113,"The closest proximal markers are APOC2 (apolipoprotein C-II) and CKM (creatine kinase, muscle) approximately 3 cM and 2 cM from the DM gene respectively, in the order APOC2-CKM-DM.",2037285_5,-1,2112,-1,0.3153633
2113,cM,23,24,120,122,"The closest proximal markers are APOC2 (apolipoprotein C-II) and CKM (creatine kinase, muscle) approximately 3 cM and 2 cM from the DM gene respectively, in the order APOC2-CKM-DM.",2037285_5,-1,2113,-1,0.313295
2114,DM,26,27,132,134,"The closest proximal markers are APOC2 (apolipoprotein C-II) and CKM (creatine kinase, muscle) approximately 3 cM and 2 cM from the DM gene respectively, in the order APOC2-CKM-DM.",2037285_5,-1,2114,-1,0.25844565
2115,APOC2-CKM-DM,33,34,167,179,"The closest proximal markers are APOC2 (apolipoprotein C-II) and CKM (creatine kinase, muscle) approximately 3 cM and 2 cM from the DM gene respectively, in the order APOC2-CKM-DM.",2037285_5,-1,2115,-1,0.26121727
2116,DM,7,8,36,38,"The distance between APOC2, CKM and DM (of the order of 2 million base pairs) and their known orientation should permit directional chromosome walking and jumping.",2037285_6,-1,2116,-1,0.30156752
2117,DM,23,24,136,138,The data presented here should enable us to determine whether or not new markers are distal to APOC2/CKM and thus potentially flank the DM gene..,2037285_7,-1,2117,-1,0.266539
2118,HAL,9,10,56,59,"
The human gene for histidase (histidine ammonia-lyase; HAL), the enzyme deficient in histidinemia, was assigned to human chromosome 12 by Southern blot analysis of human X mouse somatic cell hybrid DNA.",2055114_1,-1,2118,-1,0.27412066
2119,histidinemia,16,17,86,98,"
The human gene for histidase (histidine ammonia-lyase; HAL), the enzyme deficient in histidinemia, was assigned to human chromosome 12 by Southern blot analysis of human X mouse somatic cell hybrid DNA.",2055114_1,-1,2119,-1,0.2246812
2120,Hal,7,8,35,38,"The homologous locus in the mouse (Hal) was mapped to region 10C2----D1 by in situ hybridization, using a cell line from a mouse homozygous for a 1. 10 Robertsonian translocation.",2055114_4,-1,2120,-1,0.2725152
2121,phenylalanine,20,21,135,148,"These assignments extend the conserved syntenic region between human chromosome 12 and mouse chromosome 10 that includes the genes for phenylalanine hydroxylase, gamma interferon, peptidase, and citrate synthase.",2055114_5,-1,2121,-1,0.2528279
2122,interferon,24,25,168,178,"These assignments extend the conserved syntenic region between human chromosome 12 and mouse chromosome 10 that includes the genes for phenylalanine hydroxylase, gamma interferon, peptidase, and citrate synthase.",2055114_5,-1,2122,-1,0.2672863
2123,citrate,29,30,195,202,"These assignments extend the conserved syntenic region between human chromosome 12 and mouse chromosome 10 that includes the genes for phenylalanine hydroxylase, gamma interferon, peptidase, and citrate synthase.",2055114_5,-1,2123,-1,0.2542025
2124,histidinemia,19,20,112,124,"The localization of histidase to mouse chromosome 10 suggests that the histidase regulatory locus (Hsd) and the histidinemia mutation (his), which are both known to be on chromosome 10, may be alleles of the histidase structural gene locus.",2055114_6,-1,2124,-1,0.26276898
2125,Lesch-Nyhan syndrome,7,9,51,71,Determination of the mutations responsible for the Lesch-Nyhan syndrome in 17 subjects.,2071157_0,-1,2125,-1,0.21271771
2126,purine,9,10,61,67,"
Hypoxanthine--guanine phosphoribosyltransferase (HPRT) is a purine salvage enzyme that catalyzes the conversion of hypoxanthine to inosine monophosphate and guanine to guanosine monophosphate.",2071157_1,-1,2126,-1,0.21516798
2127,guanosine,24,25,169,178,"
Hypoxanthine--guanine phosphoribosyltransferase (HPRT) is a purine salvage enzyme that catalyzes the conversion of hypoxanthine to inosine monophosphate and guanine to guanosine monophosphate.",2071157_1,-1,2127,-1,0.25426772
2128,Lesch-Nyhan syndrome,32,34,237,257,The direct sequencing of the polymerase chain reaction-amplified product of reverse-transcribed HPRT mRNA enabled the rapid identification of the mutations found in 17 previously uncharacterized cell lines derived from patients with the Lesch-Nyhan syndrome..,2071157_4,-1,2128,-1,0.18632351
2129,adrenoleukodystrophy,10,11,64,84,"
We present a large kindred that contained patients with either adrenoleukodystrophy (ALD) or adrenomyeloneuropathy (AMN).",2161209_1,-1,2129,-1,0.2032039
2130,MZ,6,7,34,36,Skewed X inactivation in a female MZ twin results in Duchenne muscular dystrophy.,2180286_0,-1,2130,-1,0.25784868
2131,muscular dystrophy,11,13,62,80,Skewed X inactivation in a female MZ twin results in Duchenne muscular dystrophy.,2180286_0,-1,2131,-1,0.16972834
2132,MZ,3,4,15,17,"
One of female MZ twins presented with muscular dystrophy.",2180286_1,-1,2132,-1,0.27659005
2133,muscular dystrophy,7,9,39,57,"
One of female MZ twins presented with muscular dystrophy.",2180286_1,-1,2133,-1,0.18385719
2134,creatine,3,4,22,30,"Physical examination, creatine phosphokinase levels, and muscle biopsy were consistent with Duchenne muscular dystrophy (DMD).",2180286_2,-1,2134,-1,0.27806637
2135,muscular dystrophy,14,16,101,119,"Physical examination, creatine phosphokinase levels, and muscle biopsy were consistent with Duchenne muscular dystrophy (DMD).",2180286_2,-1,2135,-1,0.17257516
2136,muscular dystrophy,12,14,68,86,"However, because of her sex she was diagnosed as having limb-girdle muscular dystrophy.",2180286_3,-1,2136,-1,0.1705343
2138,uniparental disomy,21,23,139,157,"Both linkage analysis and DNA fingerprint analysis revealed that each twin has two different X chromosomes, eliminating the possibility of uniparental disomy as a mechanism for DMD expression.",2180286_11,-1,2138,-1,0.23429416
2139,MZ,15,16,92,94,"On the basis of methylation differences of the paternal and maternal X chromosomes in these MZ twins, we propose uneven lyonization (X chromosome inactivation) as the underlying mechanism for disease expression in the affected female..",2180286_12,-1,2139,-1,0.22209288
2140,disease,32,33,192,199,"On the basis of methylation differences of the paternal and maternal X chromosomes in these MZ twins, we propose uneven lyonization (X chromosome inactivation) as the underlying mechanism for disease expression in the affected female..",2180286_12,-1,2140,-1,0.20972721
2141,adrenal insufficiency,6,8,71,92,Adrenoleukodystrophy and adrenomyeloneuropathy associated with partial adrenal insufficiency in three generations of a kindred.,218453_0,-1,2141,-1,0.19662385
2142,adrenoleukodystrophy,3,4,15,35,"
Four cases of adrenoleukodystrophy (ALD) and one case of adrenomyeloneuropathy (AMN) have developed in a kindred over three generations demonstrating that AMN is a clinical variant of ALD.",218453_1,-1,2142,-1,0.20647593
2143,adrenoleukodystrophy,3,4,15,35,"
Four cases of adrenoleukodystrophy (ALD) and one case of adrenomyeloneuropathy (AMN) have developed in a kindred over three generations demonstrating that AMN is a clinical variant of ALD.",218453_1,-1,2143,-1,0.20647593
2144,ACTH,8,9,59,63,"However, basal morning plasma adrenocorticotropic hormone (ACTH) levels were markedly elevated in the two males with ALD and AMN, despite the fact that they had no clinical signs of adrenal insufficiency and that morning plasma cortisol levels and their response to maximal exogenous ACTH stimulation appeared to be normal.",218453_4,-1,2144,-1,0.22859228
2145,adrenal insufficiency,33,35,182,203,"However, basal morning plasma adrenocorticotropic hormone (ACTH) levels were markedly elevated in the two males with ALD and AMN, despite the fact that they had no clinical signs of adrenal insufficiency and that morning plasma cortisol levels and their response to maximal exogenous ACTH stimulation appeared to be normal.",218453_4,-1,2145,-1,0.2147151
2146,cortisol,39,40,228,236,"However, basal morning plasma adrenocorticotropic hormone (ACTH) levels were markedly elevated in the two males with ALD and AMN, despite the fact that they had no clinical signs of adrenal insufficiency and that morning plasma cortisol levels and their response to maximal exogenous ACTH stimulation appeared to be normal.",218453_4,-1,2146,-1,0.21479757
2147,ACTH,47,48,284,288,"However, basal morning plasma adrenocorticotropic hormone (ACTH) levels were markedly elevated in the two males with ALD and AMN, despite the fact that they had no clinical signs of adrenal insufficiency and that morning plasma cortisol levels and their response to maximal exogenous ACTH stimulation appeared to be normal.",218453_4,-1,2147,-1,0.20420693
2148,Friedreich ataxia,4,6,29,46,Regional localisation of the Friedreich ataxia locus to human chromosome 9q13----q21.1.,2209091_0,-1,2148,-1,0.24124278
2149,Friedreich ataxia,5,7,33,50,"
We have previously assigned the Friedreich ataxia locus (FRDA) to chromosome 9; the current maximal lod score between FRDA and MCT112 (D9S15) is greater than 50 at a recombination fraction of theta = 0.",2209091_1,-1,2149,-1,0.21521391
2150,disease,37,38,190,197,"We have used in situ hybridisation with MCT112, a corresponding cosmid MJ1, and DR47 (D9S5), coupled with mapping studies on hybrid cell panels, to define more precisely the location of the disease locus.",2209091_3,-1,2150,-1,0.24753714
2151,cholesteryl esters,12,14,79,97,The plasma cholesteryl-ester transfer protein (CETP) catalyzes the transfer of cholesteryl esters from high-density lipoprotein (HDL) to other lipoproteins.,2215607_2,-1,2151,-1,0.27190202
2152,n,7,8,47,48,"Family members homozygous for CETP deficiency (n = 10) had moderate hypercholesterolemia (mean total cholesterol level [+/- SD], 7. 01 +/- 0. 83 mmol per liter), markedly increased levels of HDL cholesterol (4. 24 +/- 1.",2215607_8,-1,2152,-1,0.28313437
2154,cholesterol,17,18,101,112,"Family members homozygous for CETP deficiency (n = 10) had moderate hypercholesterolemia (mean total cholesterol level [+/- SD], 7. 01 +/- 0. 83 mmol per liter), markedly increased levels of HDL cholesterol (4. 24 +/- 1.",2215607_8,-1,2154,-1,0.2316017
2155,SD,22,23,124,126,"Family members homozygous for CETP deficiency (n = 10) had moderate hypercholesterolemia (mean total cholesterol level [+/- SD], 7. 01 +/- 0. 83 mmol per liter), markedly increased levels of HDL cholesterol (4. 24 +/- 1.",2215607_8,-1,2155,-1,0.34314555
2156,cholesterol,43,44,195,206,"Family members homozygous for CETP deficiency (n = 10) had moderate hypercholesterolemia (mean total cholesterol level [+/- SD], 7. 01 +/- 0. 83 mmol per liter), markedly increased levels of HDL cholesterol (4. 24 +/- 1.",2215607_8,-1,2156,-1,0.24134763
2157,cholesterol,15,16,91,102,"01 mmol per liter) and apolipoprotein A-I, and decreased levels of low-density lipoprotein cholesterol (1. 99 +/- 0. 80 mmol per liter) and apolipoprotein B. Members heterozygous for the deficiency (n = 20), whose CETP levels were in the lower part of the normal range, had moderately increased levels of HDL cholesterol and apolipoprotein A-I and an increased ratio of HDL subclass 2 to HDL subclass 3, as compared with unaffected family members (1. 5 +/- 0. 8 vs. 0. 7 +/- 0. 4).",2215607_9,-1,2157,-1,0.24925585
2158,n,38,39,199,200,"01 mmol per liter) and apolipoprotein A-I, and decreased levels of low-density lipoprotein cholesterol (1. 99 +/- 0. 80 mmol per liter) and apolipoprotein B. Members heterozygous for the deficiency (n = 20), whose CETP levels were in the lower part of the normal range, had moderately increased levels of HDL cholesterol and apolipoprotein A-I and an increased ratio of HDL subclass 2 to HDL subclass 3, as compared with unaffected family members (1. 5 +/- 0. 8 vs. 0. 7 +/- 0. 4).",2215607_9,-1,2158,-1,0.31349877
2159,cholesterol,62,63,309,320,"01 mmol per liter) and apolipoprotein A-I, and decreased levels of low-density lipoprotein cholesterol (1. 99 +/- 0. 80 mmol per liter) and apolipoprotein B. Members heterozygous for the deficiency (n = 20), whose CETP levels were in the lower part of the normal range, had moderately increased levels of HDL cholesterol and apolipoprotein A-I and an increased ratio of HDL subclass 2 to HDL subclass 3, as compared with unaffected family members (1. 5 +/- 0. 8 vs. 0. 7 +/- 0. 4).",2215607_9,-1,2159,-1,0.2742083
2160,cholesterol,12,13,74,85,CETP deficiency was not found in six unrelated subjects with elevated HDL cholesterol levels who were from different parts of the United States.,2215607_10,-1,2160,-1,0.25265437
2161,premature atherosclerosis,5,7,25,50,There was no evidence of premature atherosclerosis in the families with CETP deficiency.,2215607_14,-1,2161,-1,0.27667427
2162,cM,22,23,121,123,The present paper describes further mapping of the AT locus by means of a panel of 10 markers that span approximately 60 cM in the 11q22-23 region centered around S144 and THY1.,2220826_4,-1,2162,-1,0.30706295
2164,C9 deficiency,3,5,14,27,First case of C9 deficiency in Europe.,2241452_1,-1,2164,-1,0.2917926
2165,C9 deficiency,11,13,51,64,"
We describe the first cases, to our knowledge, of C9 deficiency in Europe that were detected in a Swiss family, of which two members--one with a complete deficiency and the other with approximately half-normal C9 levels--experienced bacterial meningitis.",2241452_2,-1,2165,-1,0.2847802
2169,hemolytic,21,22,132,141,"Complement assays showed a complete deficiency of the C9 component, while the other individual component levels were normal and the hemolytic activity (measured using the CH50 assay) was only slightly reduced.",2241452_5,-1,2169,-1,0.24156407
2170,C9 deficiency,5,7,33,46,"A family study revealed complete C9 deficiency in the patients healthy brother and half-normal C9 concentrations in his sister, his son (who also had experienced an episode of bacterial meningitis), and his niece, consistent with an inherited C9 deficiency.",2241452_6,-1,2170,-1,0.2837786
2172,C9 deficiency,42,44,243,256,"A family study revealed complete C9 deficiency in the patients healthy brother and half-normal C9 concentrations in his sister, his son (who also had experienced an episode of bacterial meningitis), and his niece, consistent with an inherited C9 deficiency.",2241452_6,-1,2172,-1,0.27342647
2174,C9 deficiency,12,14,73,86,"This first case of recurrent meningitis in a white patient with complete C9 deficiency suggests that this complement defect may also be a risk factor for bacterial, especially neisserial, infections..",2241452_7,-1,2174,-1,0.24801402
2176,muscular dystrophy,26,28,150,168,"When used in conjunction with an existing primer set, these two multiplex reactions detect about 98% of deletions in patients with Duchenne or Becker muscular dystrophy (DMD, BMD).",2253937_2,-1,2176,-1,0.17126408
2177,protein deficiency,50,52,256,274,These data demonstrate that  1) there is an identical 2-base pair deletion in an exon of the C5 gene in several different C5-deficient mouse strains; 2) the mRNA transcribed from the C5D gene retains this deletion; and 3) this mutation should result in C5 protein deficiency.,2303408_15,-1,2177,-1,0.20549062
2178,phenylalanine,17,18,100,113,Molecular genetics of PKU in eastern Europe: a nonsense mutation associated with haplotype 4 of the phenylalanine hydroxylase gene.,2309142_0,-1,2178,-1,0.23874769
2179,phenylalanine,14,15,82,95,"
Phenylketonuria (PKU) is a genetic disorder secondary to a deficiency of hepatic phenylalanine hydroxylase (PAH).",2309142_1,-1,2179,-1,0.23476179
2180,PAH,17,18,109,112,"
Phenylketonuria (PKU) is a genetic disorder secondary to a deficiency of hepatic phenylalanine hydroxylase (PAH).",2309142_1,-1,2180,-1,0.23471718
2181,PAH,4,5,25,28,"Several mutations in the PAH gene have recently been reported, and linkage disequilibrium was observed between RFLP haplotypes and specific mutations.",2309142_2,-1,2181,-1,0.21584003
2182,PAH,12,13,60,63,A new molecular lesion has been identified in exon 7 of the PAH gene in a Hungarian PKU patient by direct sequencing of PCR-amplified DNA.,2309142_3,-1,2182,-1,0.23591332
2183,PAH,24,25,140,143,"The C-to-T transition causes the substitution of Arg243 to a termination codon, and the mutant allele is associated with haplotype 4 of the PAH gene.",2309142_4,-1,2183,-1,0.26189542
2184,adrenoleukodystrophy,7,8,44,64,The red-green visual pigment gene region in adrenoleukodystrophy.,2309698_0,-1,2184,-1,0.20607436
2185,adrenoleukodystrophy,15,16,117,137,"
Although recent data established that a specific very-long-chain fatty acyl-CoA synthetase is defective in X-linked adrenoleukodystrophy (ALD), the ALD gene is still unidentified.",2309698_1,-1,2185,-1,0.18722357
2186,color vision defects,42,45,243,263,"The previous report of such rearrangements was based on small numbers and lack of knowledge that the frequency of "" abnormal "" color vision arrays on molecular analysis was twice as high as expected on the basis of the frequency of phenotypic color vision defects.",2309698_7,-1,2186,-1,0.23800962
2187,disease,24,25,140,147,"It is possible, however, that phenotypic color vision anomalies in AMN may be phenocopies secondary to retinal or neural involvement by the disease.",2309698_13,-1,2187,-1,0.23087476
2188,diseases,15,16,91,99,The single case of blue cone monochromacy may therefore be a fortuitous coincidence of two diseases..,2309698_14,-1,2188,-1,0.20248958
2189,haemolysis,7,8,41,51,"Surprisingly, she has suffered only mild haemolysis and has never experienced massive spontaneous haemolysis.",2310692_4,-1,2189,-1,0.21077913
2190,haemolysis,14,15,98,108,"Surprisingly, she has suffered only mild haemolysis and has never experienced massive spontaneous haemolysis.",2310692_4,-1,2190,-1,0.23067063
2192,haemolysis,17,18,93,103,Both the Ham test and the sugar water test using normal human serum or plasma yielded marked haemolysis of the patients erythrocytes.,2310692_7,-1,2192,-1,0.20993416
2193,haemolysis,10,11,59,69,Addition of purified human C9 to her plasma fully restored haemolysis.,2310692_9,-1,2193,-1,0.24661107
2194,haemolysis,20,21,129,139,These observations indicated that C9 may play a critical role in haemolytic attacks in patients with PNH and that characteristic haemolysis in PNH may be tempered by coexisting C9 deficiency..,2310692_10,-1,2194,-1,0.19682558
2195,C9 deficiency,28,30,177,190,These observations indicated that C9 may play a critical role in haemolytic attacks in patients with PNH and that characteristic haemolysis in PNH may be tempered by coexisting C9 deficiency..,2310692_10,-1,2195,-1,0.24242257
2196,muscular dystrophy,5,7,39,57,"Duplicational mutation at the Duchenne muscular dystrophy locus: its frequency, distribution, origin, and phenotypegenotype correlation.",2316519_0,-1,2196,-1,0.17178132
2197,muscular dystrophy,12,14,74,92,"
Partial gene deletion is the major cause of mutation leading to Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD).",2316519_1,-1,2197,-1,0.16761449
2198,muscular dystrophy,19,21,110,128,"
Partial gene deletion is the major cause of mutation leading to Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD).",2316519_1,-1,2198,-1,0.17044847
2199,map,15,16,116,119,"The extent of these duplications has been characterized according to the published exon-containing HindIII fragment map, and in six of the 10 duplications a novel restriction fragment that spanned the duplication junction was detected.",2316519_5,-1,2199,-1,0.2867752
2200,Glucose,0,1,0,7,Glucose 6-phosphate dehydrogenase variants: Gd (+) Alexandra associated with neonatal jaundice and Gd (-) Camperdown in a young man with lamellar cataracts.,23402_0,-1,2200,-1,0.2600472
2207,von Hippel-Lindau disease,9,12,56,81,"Statistical analysis of the two stage mutation model in von Hippel-Lindau disease, and in sporadic cerebellar haemangioblastoma and renal cell carcinoma.",2352258_0,-1,2207,-1,0.19590847
2208,renal cell carcinoma,19,22,132,152,"Statistical analysis of the two stage mutation model in von Hippel-Lindau disease, and in sporadic cerebellar haemangioblastoma and renal cell carcinoma.",2352258_0,-1,2208,-1,0.16581051
2209,retinoblastoma,10,11,67,81,"
Analysis of the age incidence curves for unilateral and bilateral retinoblastoma led Knudson to propose that hereditary tumours may arise by a single event and sporadic tumours by a two stage mutation process.",2352258_1,-1,2209,-1,0.17553525
2210,tumours,17,18,121,128,"
Analysis of the age incidence curves for unilateral and bilateral retinoblastoma led Knudson to propose that hereditary tumours may arise by a single event and sporadic tumours by a two stage mutation process.",2352258_1,-1,2210,-1,0.15800306
2211,tumours,26,27,170,177,"
Analysis of the age incidence curves for unilateral and bilateral retinoblastoma led Knudson to propose that hereditary tumours may arise by a single event and sporadic tumours by a two stage mutation process.",2352258_1,-1,2211,-1,0.17588706
2212,renal cell carcinoma,7,10,45,65,It has been suggested recently that sporadic renal cell carcinoma may arise from a two stage mutation process.,2352258_2,-1,2212,-1,0.15235482
2213,renal cell carcinoma,8,11,53,73,"We analysed the age incidence curves for symptomatic renal cell carcinoma (n = 26) and cerebellar haemangioblastoma (n = 68) in 109 patients with von Hippel-Lindau (VHL) disease, and compared them to 104 patients with sporadic renal cell carcinoma and 43 patients with sporadic cerebellar haemangioblastoma.",2352258_3,-1,2213,-1,0.18218224
2214,n,12,13,75,76,"We analysed the age incidence curves for symptomatic renal cell carcinoma (n = 26) and cerebellar haemangioblastoma (n = 68) in 109 patients with von Hippel-Lindau (VHL) disease, and compared them to 104 patients with sporadic renal cell carcinoma and 43 patients with sporadic cerebellar haemangioblastoma.",2352258_3,-1,2214,-1,0.25341633
2215,n,20,21,117,118,"We analysed the age incidence curves for symptomatic renal cell carcinoma (n = 26) and cerebellar haemangioblastoma (n = 68) in 109 patients with von Hippel-Lindau (VHL) disease, and compared them to 104 patients with sporadic renal cell carcinoma and 43 patients with sporadic cerebellar haemangioblastoma.",2352258_3,-1,2215,-1,0.2579576
2216,disease,33,34,170,177,"We analysed the age incidence curves for symptomatic renal cell carcinoma (n = 26) and cerebellar haemangioblastoma (n = 68) in 109 patients with von Hippel-Lindau (VHL) disease, and compared them to 104 patients with sporadic renal cell carcinoma and 43 patients with sporadic cerebellar haemangioblastoma.",2352258_3,-1,2216,-1,0.20716892
2217,renal cell carcinoma,43,46,227,247,"We analysed the age incidence curves for symptomatic renal cell carcinoma (n = 26) and cerebellar haemangioblastoma (n = 68) in 109 patients with von Hippel-Lindau (VHL) disease, and compared them to 104 patients with sporadic renal cell carcinoma and 43 patients with sporadic cerebellar haemangioblastoma.",2352258_3,-1,2217,-1,0.18924972
2218,renal cell carcinoma,5,8,29,49,"The age incidence curves for renal cell carcinoma and cerebellar haemangioblastoma in VHL disease were compatible with a single mutation model, whereas the age incidence curves for sporadic renal cell carcinoma and cerebellar haemangioblastoma suggested a two stage mutation process.",2352258_4,-1,2218,-1,0.175132
2219,disease,13,14,90,97,"The age incidence curves for renal cell carcinoma and cerebellar haemangioblastoma in VHL disease were compatible with a single mutation model, whereas the age incidence curves for sporadic renal cell carcinoma and cerebellar haemangioblastoma suggested a two stage mutation process.",2352258_4,-1,2219,-1,0.21413477
2220,renal cell carcinoma,29,32,190,210,"The age incidence curves for renal cell carcinoma and cerebellar haemangioblastoma in VHL disease were compatible with a single mutation model, whereas the age incidence curves for sporadic renal cell carcinoma and cerebellar haemangioblastoma suggested a two stage mutation process.",2352258_4,-1,2220,-1,0.17039719
2221,tumour,12,13,71,77,These data are compatible with the VHL gene functioning as a recessive tumour suppressor gene.,2352258_5,-1,2221,-1,0.15526403
2222,renal cell carcinoma,5,8,47,67,Sporadic cerebellar haemangioblastoma and some renal cell carcinoma may arise from somatic mutations inactivating both alleles at the VHL locus..,2352258_6,-1,2222,-1,0.16430548
2223,Tay-Sachs disease,4,6,26,43,Screening for carriers of Tay-Sachs disease among Ashkenazi Jews.,2355960_0,-1,2223,-1,0.24829686
2224,Tay-Sachs disease,3,5,18,35,"The prevention of Tay-Sachs disease (GM2 gangliosidosis, type 1) depends on the identification of carriers of the gene for this autosomal recessive disorder.",2355960_3,-1,2224,-1,0.24442576
2225,Tay-Sachs disease,10,12,63,80,We compared the enzyme-based test widely used in screening for Tay-Sachs disease with a test based on analysis of DNA.,2355960_4,-1,2225,-1,0.270299
2226,Tay-Sachs disease,25,27,151,168,"We developed methods to detect the three mutations in the HEXA gene that occur with high frequency among Ashkenazi Jews  two mutations cause infantile Tay-Sachs disease, and the third causes the adult-onset form of the disease.",2355960_5,-1,2226,-1,0.26077378
2227,disease,37,38,219,226,"We developed methods to detect the three mutations in the HEXA gene that occur with high frequency among Ashkenazi Jews  two mutations cause infantile Tay-Sachs disease, and the third causes the adult-onset form of the disease.",2355960_5,-1,2227,-1,0.20553386
2228,Tay-Sachs disease,6,8,40,57,"Among 62 Ashkenazi obligate carriers of Tay-Sachs disease, the three specific mutations accounted for all but one of the mutant alleles (98 percent).",2355960_8,-1,2228,-1,0.25885695
2229,disease,35,36,192,199,"Of the 177, 79 percent had the exon 11 insertion mutation, 18 percent had the intron 12 splice-junction mutation, and 3 percent had the less severe exon 7 mutation associated with adult-onset disease.",2355960_10,-1,2229,-1,0.20728835
2230,e,25,26,127,128,"In addition, of 152 persons defined as noncarriers by the enzyme-based test, 1 was identified as a carrier by DNA analysis (i. e e., a false negative enzyme-test result).",2355960_12,-1,2230,-1,0.35507557
2231,Tay-Sachs disease,26,28,159,176,The increased specificity and predictive value of the DNA-based test make it a useful adjunct to the diagnostic tests currently used to screen for carriers of Tay-Sachs disease.,2355960_14,-1,2231,-1,0.26535934
2232,cholesteryl ester,4,6,27,44,Total deficiency of plasma cholesteryl ester transfer protein in subjects homozygous and heterozygous for the intron 14 splicing defect.,2390095_0,-1,2232,-1,0.25836527
2233,cholesteryl ester,4,6,24,41,"
The molecular basis of cholesteryl ester transfer protein (CETP) deficiency was investigated in 4 unrelated CETP-deficient families.",2390095_1,-1,2233,-1,0.26392987
2234,C----T,1,2,2,8,"A C----T mutation at nucleotide 563 of G6PD Mediterranean has been identified by Vulliamy et al., and the same mutation has been found by De Vita et al. in G6PD Mediterranean, G6PD Sassari, and G6PD Cagliari.",2393028_4,-1,2234,-1,0.33354476
2235,nucleotide,4,5,21,31,"A C----T mutation at nucleotide 563 of G6PD Mediterranean has been identified by Vulliamy et al., and the same mutation has been found by De Vita et al. in G6PD Mediterranean, G6PD Sassari, and G6PD Cagliari.",2393028_4,-1,2235,-1,0.32344365
2236,nucleotide,9,10,51,61,"The latter subjects had an additional mutation, at nucleotide 1311, that did not produce a coding change.",2393028_5,-1,2236,-1,0.32389012
2237,nucleotide,6,7,29,39,All had both the mutation at nucleotide 563 and that at nucleotide 1311.,2393028_7,-1,2237,-1,0.33464843
2238,nucleotide,11,12,56,66,All had both the mutation at nucleotide 563 and that at nucleotide 1311.,2393028_7,-1,2238,-1,0.32376224
2239,nucleotide,33,34,205,215,"A sixth sample, resembling G6PD Mediterranean kinetically but with a slightly rapid electrophoretic mobility, was designated G6PD Andalus and was found to have a different mutation, a G----A transition at nucleotide 1361, producing an arginine-to-histidine substitution.",2393028_8,-1,2239,-1,0.32155558
2240,muscular dystrophy,24,26,138,156,"
We describe two brothers with identical inherited deletions of one single exon within the middle of the DMD gene; one brother has Becker muscular dystrophy diagnosed at 11 years of age, whereas the older brother is normal at 18.",2404853_1,-1,2240,-1,0.16472009
2241,muscular dystrophy,14,16,103,121,These results have implications for genetic counselling and prenatal diagnosis in families with Becker muscular dystrophy..,2404853_2,-1,2241,-1,0.15504473
2242,muscular dystrophy,1,3,9,27,Duchenne muscular dystrophy gene expression in normal and diseased human muscle.,2450401_0,-1,2242,-1,0.18064368
2243,muscular dystrophy,9,11,39,57,"
A probe for the 5 end of the Duchenne muscular dystrophy (DMD) gene was used to study expression of the gene in normal human muscle, myogenic cell cultures, and muscle from patients with DMD.",2450401_1,-1,2243,-1,0.16476999
2244,muscular dystrophy,15,17,109,127,Molecular and phenotypic analysis of patients with deletions within the deletion-rich region of the Duchenne muscular dystrophy (DMD) gene.,2491010_0,-1,2244,-1,0.16637939
2245,muscular dystrophy,5,7,44,62,"
Eighty unrelated individuals with Duchenne muscular dystrophy (DMD)or Becker muscular dystrophy (BMD) were found to have deletions in the major deletion-rich region of the DMD locus.",2491010_1,-1,2245,-1,0.16368215
2246,muscular dystrophy,9,11,78,96,"
Eighty unrelated individuals with Duchenne muscular dystrophy (DMD)or Becker muscular dystrophy (BMD) were found to have deletions in the major deletion-rich region of the DMD locus.",2491010_1,-1,2246,-1,0.16839142
2247,contrast,18,19,89,97,"This is in agreement with recent findings by Baumbach et al. and Koenig et al. but is in contrast to findings, by Malhotra et al. at the 5 ' end of the gene.",2491010_9,-1,2247,-1,0.31642947
2248,aniridia,9,10,78,86,"
Chromosome translocations involving 11p13 have been associated with familial aniridia in two kindreds highlighting the chromosomal localization of the AN2 locus.",2544995_1,-1,2248,-1,0.22437799
2249,Wilms tumor,10,12,45,56,"This locus is also part of the WAGR complex (Wilms tumor, aniridia, genitourinary abnormalities, and mental retardation).",2544995_2,-1,2249,-1,0.19574115
2250,aniridia,13,14,58,66,"This locus is also part of the WAGR complex (Wilms tumor, aniridia, genitourinary abnormalities, and mental retardation).",2544995_2,-1,2250,-1,0.26197517
2251,mental retardation,19,21,101,119,"This locus is also part of the WAGR complex (Wilms tumor, aniridia, genitourinary abnormalities, and mental retardation).",2544995_2,-1,2251,-1,0.20529439
2252,myotonic dystrophy,8,10,51,69,Linkage analysis of the apolipoprotein C2 gene and myotonic dystrophy on human chromosome 19 reveals linkage disequilibrium in a French-Canadian population.,2562820_0,-1,2252,-1,0.19952846
2253,muscular dystrophy,33,35,163,181,"
The gene for human apolipoprotein C2 (APOC2), situated on the proximal long arm of chromosome 19, is closely linked to the gene for the most common form of adult muscular dystrophy, myotonic dystrophy (DM).",2562820_1,-1,2253,-1,0.15722871
2254,myotonic dystrophy,36,38,183,201,"
The gene for human apolipoprotein C2 (APOC2), situated on the proximal long arm of chromosome 19, is closely linked to the gene for the most common form of adult muscular dystrophy, myotonic dystrophy (DM).",2562820_1,-1,2254,-1,0.18657228
2255,DM,39,40,203,205,"
The gene for human apolipoprotein C2 (APOC2), situated on the proximal long arm of chromosome 19, is closely linked to the gene for the most common form of adult muscular dystrophy, myotonic dystrophy (DM).",2562820_1,-1,2255,-1,0.20793866
2256,DM,5,6,34,36,We have conducted a comprehensive DM linkage study utilizing all six RFLPs and involving 50 families and 372 individuals.,2562820_3,-1,2256,-1,0.2899864
2257,DM,6,7,51,53,We also demonstrate linkage disequilibrium between DM and APOC2 in our French-Canadian population (standardized disequilibrium constant phi =.,2562820_9,-1,2257,-1,0.27995563
2258,P,13,14,27,28,"22, chi 2 = 5. 12, df = 1, P less than 0. 04).",2562820_10,-1,2258,-1,0.3098206
2259,DM,12,13,83,85,This represents the first evidence of linkage disequilibrium between APOC2 and the DM locus.,2562820_11,-1,2259,-1,0.29407176
2260,Phenylalanine,0,1,0,13,Phenylalanine hydroxylase gene haplotypes in Polynesians: evolutionary origins and absence of alleles associated with severe phenylketonuria.,2563633_0,-1,2260,-1,0.24142313
2261,phenylalanine,7,8,35,48,"
A total of 630 haplotypes for the phenylalanine hydroxylase (PAH) gene locus were established in five groups of Polynesians comprising Samoans, Tongans, Cook Islanders, Maori, and Niueans.",2563633_1,-1,2261,-1,0.25411388
2262,PAH,10,11,62,65,"
A total of 630 haplotypes for the phenylalanine hydroxylase (PAH) gene locus were established in five groups of Polynesians comprising Samoans, Tongans, Cook Islanders, Maori, and Niueans.",2563633_1,-1,2262,-1,0.24084981
2263,PAH,20,21,116,119,"The absence of severe phenylketonuria (PKU) in both Polynesians and Southeast Asians is consistent with the lack of PAH haplotypes 2 and 3, on which the severe PKU mutants have arisen among Caucasians..",2563633_5,-1,2263,-1,0.2994327
2264,retinoblastoma,8,9,57,71,Preferential germline mutation of the paternal allele in retinoblastoma.,2568588_0,-1,2264,-1,0.18644899
2265,retinoblastoma tumours,9,11,56,78,"
The event triggering malignant proliferation in 70% of retinoblastoma tumours is loss of heterozygosity for chromosome 13q14, whereby the normal retinoblastoma gene (RB1) allele is lost and an already mutated RB1 allele remains in the tumour.",2568588_1,-1,2265,-1,0.16676603
2266,retinoblastoma,22,23,146,160,"
The event triggering malignant proliferation in 70% of retinoblastoma tumours is loss of heterozygosity for chromosome 13q14, whereby the normal retinoblastoma gene (RB1) allele is lost and an already mutated RB1 allele remains in the tumour.",2568588_1,-1,2266,-1,0.16595626
2267,RB1,25,26,167,170,"
The event triggering malignant proliferation in 70% of retinoblastoma tumours is loss of heterozygosity for chromosome 13q14, whereby the normal retinoblastoma gene (RB1) allele is lost and an already mutated RB1 allele remains in the tumour.",2568588_1,-1,2267,-1,0.20459326
2268,RB1,34,35,210,213,"
The event triggering malignant proliferation in 70% of retinoblastoma tumours is loss of heterozygosity for chromosome 13q14, whereby the normal retinoblastoma gene (RB1) allele is lost and an already mutated RB1 allele remains in the tumour.",2568588_1,-1,2268,-1,0.2118515
2269,tumour,39,40,236,242,"
The event triggering malignant proliferation in 70% of retinoblastoma tumours is loss of heterozygosity for chromosome 13q14, whereby the normal retinoblastoma gene (RB1) allele is lost and an already mutated RB1 allele remains in the tumour.",2568588_1,-1,2269,-1,0.17620364
2270,retinoblastoma,8,9,50,64,"Most bilateral patients have no family history of retinoblastoma and are presumed to have new germline mutations which arose in the egg, sperm or early embryo.",2568588_3,-1,2270,-1,0.17654485
2271,retinoblastoma tumours,12,14,70,92,We have determined the parental origin of the retained allele in nine retinoblastoma tumours from eight unrelated non-familial cases by using RB1-linked genetic markers.,2568588_4,-1,2271,-1,0.1540683
2272,tumours,1,2,4,11,Six tumours retained the paternal allele and three retained the maternal allele.,2568588_5,-1,2272,-1,0.26168305
2273,tumours,4,5,24,31,"Of the three unilateral tumours, only one retained the paternal RB1 allele.",2568588_6,-1,2273,-1,0.18141398
2274,RB1,11,12,64,67,"Of the three unilateral tumours, only one retained the paternal RB1 allele.",2568588_6,-1,2274,-1,0.22160783
2275,RB1,9,10,45,48,"Thus, there is no evidence that the paternal RB1 allele is preferentially retained in retinoblastoma, as has been suggested to be the case in osteosarcoma.",2568588_7,-1,2275,-1,0.20208637
2276,retinoblastoma,15,16,86,100,"Thus, there is no evidence that the paternal RB1 allele is preferentially retained in retinoblastoma, as has been suggested to be the case in osteosarcoma.",2568588_7,-1,2276,-1,0.15891899
2277,osteosarcoma,26,27,142,154,"Thus, there is no evidence that the paternal RB1 allele is preferentially retained in retinoblastoma, as has been suggested to be the case in osteosarcoma.",2568588_7,-1,2277,-1,0.17040214
2278,contrast,1,2,3,11,"By contrast, tumours from four of the five bilateral patients retained the paternal RB1 allele.",2568588_8,-1,2278,-1,0.26846904
2279,tumours,3,4,13,20,"By contrast, tumours from four of the five bilateral patients retained the paternal RB1 allele.",2568588_8,-1,2279,-1,0.20911041
2280,RB1,14,15,84,87,"By contrast, tumours from four of the five bilateral patients retained the paternal RB1 allele.",2568588_8,-1,2280,-1,0.22086135
2281,RB1,6,7,39,42,"This suggests either that new germline RB1 mutations arise more frequently during spermatogenesis than during oogenesis, or that imprinting in the early embryo affects chromosomal susceptibility to mutation..",2568588_9,-1,2281,-1,0.21198167
2282,phenylalanine,4,5,26,39,Haplotype analysis of the phenylalanine hydroxylase gene in Turkish phenylketonuria families.,2569949_0,-1,2282,-1,0.24027996
2283,phenylalanine,10,11,67,80,"
We have estimated the haplotype distribution of mutant and normal phenylalanine hydroxylase (PAH) alleles for 17 Turkish phenylketonuria (PKU) families  20 normal and 27 mutated PAH alleles could be identified.",2569949_1,-1,2283,-1,0.24611168
2284,PAH,13,14,94,97,"
We have estimated the haplotype distribution of mutant and normal phenylalanine hydroxylase (PAH) alleles for 17 Turkish phenylketonuria (PKU) families  20 normal and 27 mutated PAH alleles could be identified.",2569949_1,-1,2284,-1,0.2163452
2285,PAH,30,31,179,182,"
We have estimated the haplotype distribution of mutant and normal phenylalanine hydroxylase (PAH) alleles for 17 Turkish phenylketonuria (PKU) families  20 normal and 27 mutated PAH alleles could be identified.",2569949_1,-1,2285,-1,0.20212542
2286,Huntington disease,0,2,0,18,Huntington disease: no evidence for locus heterogeneity.,2571579_0,-1,2286,-1,0.21372171
2287,Huntington disease,6,8,29,47,"
A total of 63 families with Huntington disease (HD) were examined for linkage between HD and G8 (D4S10).",2571579_1,-1,2287,-1,0.19047634
2288,choroideremia,7,8,53,66,Haplotype and multipoint linkage analysis in Finnish choroideremia families.,2575071_0,-1,2288,-1,0.2176675
2289,choroideremia,4,5,32,45,"
Multipoint linkage analysis of choroideremia (TCD) and seven X chromosomal restriction fragment length polymorphisms (RFLPs) was carried out in 18 Finnish TCD families.",2575071_1,-1,2289,-1,0.20462327
2290,choroideremia,11,12,82,95,"This supports the previously described hypothesis that the large Northern Finnish choroideremia pedigrees, comprising a total of over 80 living patients representing more than a fifth of all TCD patients described worldwide, carry the same mutation.",2575071_8,-1,2290,-1,0.22546065
2291,aniridia,2,3,19,27,Autosomal dominant aniridia linked to the chromosome 11p13 markers catalase and D11S151 in a large Dutch family.,2575483_0,-1,2291,-1,0.27284214
2292,aniridia,7,8,45,53,"
In a large pedigree with autosomal dominant aniridia, we found close linkage between the aniridia locus AN2 and the markers catalase (CAT) (zeta = 7.",2575483_1,-1,2292,-1,0.23776384
2293,aniridia,15,16,90,98,"
In a large pedigree with autosomal dominant aniridia, we found close linkage between the aniridia locus AN2 and the markers catalase (CAT) (zeta = 7.",2575483_1,-1,2293,-1,0.24144503
2294,aniridia,6,7,40,48,We conclude that the autosomal dominant aniridia in this family is due to a mutation at the AN2 locus on 11p13.,2575483_5,-1,2294,-1,0.25652662
2295,aniridia,19,20,82,90,We have excluded linkage (zeta less than -2 at theta less than 0. 18) between the aniridia and the chromosome 2p25 marker D2S1 (linked to ACP1).,2575483_6,-1,2295,-1,0.30254775
2296,myotonic dystrophy,4,6,33,51,Recombination events that locate myotonic dystrophy distal to APOC2 on 19q.,2591962_0,-1,2296,-1,0.21563894
2297,myotonic dystrophy,9,11,62,80,"
We previously reported a recombination in an individual with myotonic dystrophy (DM) which placed the markers D19S19 and APOC2 on the same side of the DM locus.",2591962_1,-1,2297,-1,0.19608757
2298,DM,12,13,82,84,"
We previously reported a recombination in an individual with myotonic dystrophy (DM) which placed the markers D19S19 and APOC2 on the same side of the DM locus.",2591962_1,-1,2298,-1,0.22660388
2299,DM,27,28,152,154,"
We previously reported a recombination in an individual with myotonic dystrophy (DM) which placed the markers D19S19 and APOC2 on the same side of the DM locus.",2591962_1,-1,2299,-1,0.23846659
2300,DM,15,16,102,104,Haplotyping of this family with more recently characterized probes which are either tightly linked to DM or distal to the linkage group at q13.,2591962_2,-1,2300,-1,0.26803967
2301,DM,4,5,17,19,2 shows that the DM locus is distal to APOC2.,2591962_3,-1,2301,-1,0.3121672
2302,DM,7,8,46,48,This is confirmed by other recombinants where DM segregates with distal probes.,2591962_4,-1,2302,-1,0.3194832
2303,DM,18,19,127,129,"Additional marker to marker recombinations in unaffected individuals are reported and support the order and orientation of the DM linkage group as pter- (INSR, LDLR, S9) - (S19, BCL3, APOC2) - (CKMM, DM) - (S22, + + + PRKCG) -qter.",2591962_5,-1,2303,-1,0.2469464
2304,DM,42,43,200,202,"Additional marker to marker recombinations in unaffected individuals are reported and support the order and orientation of the DM linkage group as pter- (INSR, LDLR, S9) - (S19, BCL3, APOC2) - (CKMM, DM) - (S22, + + + PRKCG) -qter.",2591962_5,-1,2304,-1,0.29110807
2305,DM,8,9,49,51,The data presented here cannot determine whether DM is proximal or distal to CKMM.,2591962_6,-1,2305,-1,0.2898602
2306,DM,21,22,129,131,The consequences of this probe order for antenatal diagnosis and future research aiming to isolate the gene which is affected in DM are discussed.,2591962_7,-1,2306,-1,0.2303
2307,RB1,3,4,17,20,Mutations in the RB1 gene and their effects on transcription.,2601691_0,-1,2307,-1,0.22291668
2308,RB1,6,7,37,40,"
Inactivation of both alleles of the RB1 gene during normal retinal development initiates the formation of a retinoblastoma (RB) tumor.",2601691_1,-1,2308,-1,0.20384392
2309,retinoblastoma,17,18,109,123,"
Inactivation of both alleles of the RB1 gene during normal retinal development initiates the formation of a retinoblastoma (RB) tumor.",2601691_1,-1,2309,-1,0.16449495
2311,RB1,6,7,43,46,"To identify the mutations which inactivate RB1, 21 RB tumors isolated from 19 patients were analyzed with the polymerase chain reaction or an RNase protection assay or both.",2601691_2,-1,2311,-1,0.2115416
2315,nucleotide,18,19,84,94,"Mutations were identified in 13 of 21 RB tumors; in 8 tumors, the precise errors in nucleotide sequence were characterized.",2601691_3,-1,2315,-1,0.24238339
2316,RB1,32,33,192,195,"Each of four germ line mutations involved a small deletion or duplication, while three somatic mutations were point mutations leading to splice alterations and loss of an exon from the mature RB1 mRNA.",2601691_4,-1,2316,-1,0.2149537
2318,RB1,44,45,264,267,"We were unable to detect expression of the mutant allele in lymphoblasts of three bilaterally affected patients, although the mutation was present in the genomic DNA and transcripts containing the mutations were obvious in the RB tumors in the absence of a normal RB1 allele.",2601691_5,-1,2318,-1,0.20292366
2319,RB1,13,14,88,91,The variations in the level of expression of mutant transcripts suggest deregulation of RB1 transcription in the absence of a functional RB1 gene product..,2601691_6,-1,2319,-1,0.20286937
2320,RB1,21,22,137,140,The variations in the level of expression of mutant transcripts suggest deregulation of RB1 transcription in the absence of a functional RB1 gene product..,2601691_6,-1,2320,-1,0.20303628
2321,Langer-Giedion syndrome,4,6,28,51,Partial deletion 8q without Langer-Giedion syndrome: a recognisable syndrome.,2651669_0,-1,2321,-1,0.24245818
2322,syndrome,9,10,68,76,Partial deletion 8q without Langer-Giedion syndrome: a recognisable syndrome.,2651669_0,-1,2322,-1,0.2217972
2323,Langer-Giedion syndrome,12,14,73,96,The clinical features were similar and there were no obvious stigmata of Langer-Giedion syndrome (LGS).,2651669_3,-1,2323,-1,0.24272396
2324,Myotonic dystrophy,0,2,0,18,Myotonic dystrophy is closely linked to the gene for muscle-type creatine kinase (CKMM).,2703233_0,-1,2324,-1,0.1965771
2325,creatine kinase,10,12,65,80,Myotonic dystrophy is closely linked to the gene for muscle-type creatine kinase (CKMM).,2703233_0,-1,2325,-1,0.21736048
2326,creatine,9,10,54,62,"
We have studied genetic linkage between the gene for creatine kinase muscle type (CKMM) and the gene for myotonic dystrophy (DM).",2703233_1,-1,2326,-1,0.24461272
2327,myotonic dystrophy,20,22,106,124,"
We have studied genetic linkage between the gene for creatine kinase muscle type (CKMM) and the gene for myotonic dystrophy (DM).",2703233_1,-1,2327,-1,0.18216588
2328,DM,23,24,126,128,"
We have studied genetic linkage between the gene for creatine kinase muscle type (CKMM) and the gene for myotonic dystrophy (DM).",2703233_1,-1,2328,-1,0.2169377
2329,myotonic dystrophy,5,7,17,35,"In a panel of 65 myotonic dystrophy families from Canada and the Netherlands, a maximum lod score (Zmax) of 22.",2703233_2,-1,2329,-1,0.21571513
2330,Color vision defects,0,3,0,20,Color vision defects in adrenomyeloneuropathy.,2729274_0,-1,2330,-1,0.24401844
2331,adrenoleukodystrophy,34,35,191,211,"These observations confirm our earlier impression that the frequency of abnormal color vision is increased in these kindreds, and it supports our contentions that (1) AMN (and its companion, adrenoleukodystrophy) are very closely linked to the visual pigment loci at Xq28 and (2) this proximity might provide the opportunity to observe contiguous gene defects..",2729274_4,-1,2331,-1,0.22519141
2332,Lesch-Nyhan,12,13,78,89,"
We report the identification of a female patient with the X-linked recessive Lesch-Nyhan syndrome (hypoxanthine phosphoribosyltransferase [HPRT] deficiency).",2760209_1,-1,2332,-1,0.2416644
2333,syndrome,13,14,90,98,"
We report the identification of a female patient with the X-linked recessive Lesch-Nyhan syndrome (hypoxanthine phosphoribosyltransferase [HPRT] deficiency).",2760209_1,-1,2333,-1,0.19362994
2334,disease,34,35,200,207,"Comparison of this patients DNA with the DNA of her parents revealed that a microdeletion, which occurred within a maternal gamete and involved the entire HPRT gene, was partially responsible for the disease in this patient.",2760209_3,-1,2334,-1,0.22691156
2335,Pelizaeus-Merzbacher disease,0,2,0,28,Pelizaeus-Merzbacher disease: an X-linked neurologic disorder of myelin metabolism with a novel mutation in the gene encoding proteolipid protein.,2773936_0,-1,2335,-1,0.23965183
2336,Pelizaeus-Merzbacher disease,2,4,14,42,"Historically, Pelizaeus-Merzbacher disease has encompassed a host of neurologic disorders that present with a deficit of myelin, the membrane elaborated by glial cells that encircles and successively enwraps axons.",2773936_2,-1,2336,-1,0.24192351
2337,Pelizaeus-Merzbacher disease,4,6,28,56,"To discriminate variants of Pelizaeus-Merzbacher disease, a set of oligonucleotide primers was constructed to polymerase-chain-reaction (PCR) amplify and sequence the gene encoding proteolipid protein (PLP), a structural protein that comprises half of the protein of the myelin sheath.",2773936_4,-1,2337,-1,0.24545261
2338,Pelizaeus-Merzbacher disease,7,9,47,75,"Our results delineate the clinical features of Pelizaeus-Merzbacher disease, define the possible molecular pathology of this dysmyelinating disorder, and address the molecular classification of inborn errors of myelin metabolism.",2773936_6,-1,2338,-1,0.23887691
2339,Pelizaeus-Merzbacher disease,18,20,94,122,"Patients with the classical form (type I) and the more severely affected, connatal variant of Pelizaeus-Merzbacher disease (type II) would be predicted to display mutation at the PLP locus.",2773936_7,-1,2339,-1,0.2514814
2340,Pelizaeus-Merzbacher disease,14,16,76,104,"The other variants (types III-VI), which have sometimes been categorized as Pelizaeus-Merzbacher disease, may represent mutations in genes encoding other structural myelin proteins or proteins critical to myelination..",2773936_8,-1,2340,-1,0.24106817
2341,disease,6,7,40,47,Molecular basis of human von Willebrand disease: analysis of platelet von Willebrand factor mRNA.,2786201_0,-1,2341,-1,0.20547454
2342,disease,2,3,16,23,"
von Willebrand disease (vWD), the most common inherited bleeding disorder in humans, can result from either a quantitative or a qualitative defect in the adhesive glycoprotein, von Willebrand factor (vWF).",2786201_1,-1,2342,-1,0.20771873
2346,aniridia,7,8,67,75,Translocation t(5;11)(q13.1;p13) associated with familial isolated aniridia.,2817003_0,-1,2346,-1,0.24950424
2347,aniridia,6,7,37,45,"
A father and daughter with isolated aniridia were observed to have an apparently balanced, reciprocal translocation involving chromosomes 5 and 11 [t (5; 11) (q13. 1; p13)].",2817003_1,-1,2347,-1,0.24006443
2348,aniridia,15,16,82,90,"This finding, in association with 3 other instances of single breaks at 11p13 and aniridia, supports the assignment of AN2 to 11p13.",2817003_3,-1,2348,-1,0.28646475
2349,disease,4,5,38,45,Homozygous hypobetalipoproteinemia: a disease distinct from abetalipoproproteinemia at the molecular level.,2828430_0,-1,2349,-1,0.22698443
2350,abetalipoproproteinemia,7,8,60,83,Homozygous hypobetalipoproteinemia: a disease distinct from abetalipoproproteinemia at the molecular level.,2828430_0,-1,2350,-1,0.23744653
2351,abetalipoproteinemia,9,10,58,78,"These results are distinct from those previously noted in abetalipoproteinemia, which was characterized by an elevated level of hepatic apoB mRNA and accumulation of intracellular hepatic apoB protein..",2828430_7,-1,2351,-1,0.22410388
2352,Lesch-Nyhan syndrome,8,10,51,71,"
Molecular analysis of an unusual patient with the Lesch-Nyhan syndrome has suggested that the mutation is due to a partial HPRT gene duplication.",2835825_1,-1,2352,-1,0.20840396
2353,Lesch-Nyhan syndrome,9,11,53,73,This may explain the relatively mild symptoms of the Lesch-Nyhan syndrome exhibited by this patient..,2835825_8,-1,2353,-1,0.19336334
2354,glycerol kinase deficiency,1,4,8,34,"Complex glycerol kinase deficiency: molecular-genetic, cytogenetic, and clinical studies of five Japanese patients.",2852474_0,-1,2354,-1,0.22798243
2355,glycerol kinase deficiency,6,9,42,68,"
Five male Japanese patients with complex glycerol kinase deficiency (CGKD) and their relatives were studied clinically, cytogenetically, and molecular-genetically.",2852474_1,-1,2355,-1,0.21654892
2356,muscular dystrophy,3,5,17,35,"All patients had muscular dystrophy or muscle weakness, mental retardation, congenital adrenal hypoplasia, and glycerol kinase deficiency.",2852474_2,-1,2356,-1,0.18683374
2357,muscle weakness,6,8,39,54,"All patients had muscular dystrophy or muscle weakness, mental retardation, congenital adrenal hypoplasia, and glycerol kinase deficiency.",2852474_2,-1,2357,-1,0.18903735
2358,mental retardation,9,11,56,74,"All patients had muscular dystrophy or muscle weakness, mental retardation, congenital adrenal hypoplasia, and glycerol kinase deficiency.",2852474_2,-1,2358,-1,0.19624394
2359,glycerol kinase deficiency,17,20,111,137,"All patients had muscular dystrophy or muscle weakness, mental retardation, congenital adrenal hypoplasia, and glycerol kinase deficiency.",2852474_2,-1,2359,-1,0.23060015
2360,muscular dystrophy,16,18,103,121,A comparison of the clinical manifestations of the present five patients and reported CGKD or Duchenne muscular dystrophy (DMD) patients with DNA deletion suggests the existence of a certain gene responsible for gonadotropin deficiency (GTD).,2852474_7,-1,2360,-1,0.18738736
2361,ornithine,15,16,87,96,"The result of the present study and results of previous studies suggest that genes for ornithine transcarbamylase (OTC), DMD, and GK and putative genes responsible for congenital adrenal hypoplasia (AHC) and GTD are arranged from telomere to centromere as pter--GTD--AHC--GK--DMD--OTC--cen",2852474_8,-1,2361,-1,0.2500935
2362,chronic active hepatitis,10,13,67,91,Genetically determined low C4: a predisposing factor to autoimmune chronic active hepatitis.,2862466_0,-1,2362,-1,0.19285314
2363,chronic active hepatitis,5,8,32,56,"
Of 26 patients with autoimmune chronic active hepatitis (CAH) starting in childhood 18 (69%) had low C4 and 5 (19%) had low C3 serum levels.",2862466_1,-1,2363,-1,0.19481446
2364,phenylalanine,17,18,106,119,"
Phenylketonuria (PKU) is an autosomal recessive human genetic disorder caused by a deficiency of hepatic phenylalanine hydroxylase (PAH, phenylalanine 4-monooxygenase, EC 1. 14. 16. 1).",2884570_1,-1,2364,-1,0.23085283
2365,PAH,20,21,133,136,"
Phenylketonuria (PKU) is an autosomal recessive human genetic disorder caused by a deficiency of hepatic phenylalanine hydroxylase (PAH, phenylalanine 4-monooxygenase, EC 1. 14. 16. 1).",2884570_1,-1,2365,-1,0.27426314
2366,phenylalanine,22,23,138,151,"
Phenylketonuria (PKU) is an autosomal recessive human genetic disorder caused by a deficiency of hepatic phenylalanine hydroxylase (PAH, phenylalanine 4-monooxygenase, EC 1. 14. 16. 1).",2884570_1,-1,2366,-1,0.2707613
2367,PAH,20,21,128,131,"To define the molecular basis of PKU, we characterized twelve restriction fragment-length polymorphism (RFLP) haplotypes of the PAH locus in the northern European population and observed that 90% of the PKU alleles in this population are confined to four common RFLP haplotypes.",2884570_3,-1,2367,-1,0.25114822
2368,PAH,9,10,53,56,We have recently reported a splicing mutation in the PAH gene that is associated with RFLP haplotype 3 which is present at about 40% of mutant alleles.,2884570_4,-1,2368,-1,0.2446545
2369,Trp,19,20,104,107,This defect is caused by a C-to-T transition in exon 12 resulting in an amino-acid substitution (Arg to Trp) at residue 408 of PAH.,2884570_6,-1,2369,-1,0.28007063
2370,PAH,25,26,127,130,This defect is caused by a C-to-T transition in exon 12 resulting in an amino-acid substitution (Arg to Trp) at residue 408 of PAH.,2884570_6,-1,2370,-1,0.28460175
2371,PAH,34,35,220,223,Direct hybridization analysis of the point mutation using a specific oligonucleotide probe demonstrated that this mutation is also in linkage disequilibrium with RFLP haplotype 2 alleles that make up about 20% of mutant PAH genes,2884570_7,-1,2371,-1,0.22946864
2372,Choroideremia,0,1,0,13,Choroideremia: close linkage to DXYS1 and DXYS12 demonstrated by segregation analysis and historical-genealogical evidence.,2886237_0,-1,2372,-1,0.22473216
2373,choroideremia,14,15,106,119,"
Linkage studies using restriction fragment length polymorphisms were conducted in the X-linked disorder, choroideremia, designated TCD for Progressive Tapeto-Choroidal Dystrophy.",2886237_1,-1,2373,-1,0.22594905
2374,disease,1,2,4,11,The disease mainly occurs in three large kindreds in remote Northern Finland.,2886237_6,-1,2374,-1,0.22685714
2375,Von Hippel-Lindau disease,0,3,0,25,Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma.,2894613_0,-1,2375,-1,0.22071111
2376,renal cell carcinoma,12,15,77,97,Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma.,2894613_0,-1,2376,-1,0.1598258
2377,Von Hippel-Lindau disease,0,3,1,26,"
Von Hippel-Lindau disease (VHL) is an autosomal dominant disorder with inherited susceptibility to various forms of cancer, including hemangioblastomas of the central nervous system, phaeochromocytomas, pancreatic malignancies, and renal cell carcinomas.",2894613_1,-1,2377,-1,0.2239097
2381,tumours,19,20,128,135,"Renal cell carcinomas constitute a particularly frequent cause of death in this disorder, occurring as bilateral and multifocal tumours, and presenting at an earlier age than in sporadic, non-familial cases of this tumour type.",2894613_2,-1,2381,-1,0.1516339
2382,tumour,35,36,215,221,"Renal cell carcinomas constitute a particularly frequent cause of death in this disorder, occurring as bilateral and multifocal tumours, and presenting at an earlier age than in sporadic, non-familial cases of this tumour type.",2894613_2,-1,2382,-1,0.17379381
2383,tumour,9,10,56,62,An alternative or prior event to oncogene activation in tumour formation may be the inactivation of a putative tumour suppressor which can be associated with both the inherited and sporadic forms of the cancer.,2894613_6,-1,2383,-1,0.17149663
2384,tumour,18,19,111,117,An alternative or prior event to oncogene activation in tumour formation may be the inactivation of a putative tumour suppressor which can be associated with both the inherited and sporadic forms of the cancer.,2894613_6,-1,2384,-1,0.17144856
2386,renal cell carcinoma,7,10,51,71,"Consequently, sporadic and VHL-associated forms of renal cell carcinoma might both result from alterations causing loss of function of the same tumour suppressor gene on this chromosome..",2894613_8,-1,2386,-1,0.14616871
2387,tumour,22,23,144,150,"Consequently, sporadic and VHL-associated forms of renal cell carcinoma might both result from alterations causing loss of function of the same tumour suppressor gene on this chromosome..",2894613_8,-1,2387,-1,0.1490231
2388,oculocerebrorenal syndrome,7,9,45,71,"Tightly linked flanking markers for the Lowe oculocerebrorenal syndrome, with application to carrier assessment.",2895982_0,-1,2388,-1,0.22175317
2389,oculocerebrorenal syndrome,2,4,10,36,"
The Lowe oculocerebrorenal syndrome (OCRL) is characterized by congenital cataract, mental retardation, and defective renal tubular function.",2895982_1,-1,2389,-1,0.21151929
2391,mental retardation,13,15,85,103,"
The Lowe oculocerebrorenal syndrome (OCRL) is characterized by congenital cataract, mental retardation, and defective renal tubular function.",2895982_1,-1,2391,-1,0.20016319
2392,map,1,2,2,5,"A map assignment of OCRL to Xq24-q26 has been made previously by linkage analysis with DXS42 at Xq24-q26 (theta = 0, z = 5. 09) and with DXS10 at Xq26 (theta = 0, z = 6. 45).",2895982_2,-1,2392,-1,0.3238204
2393,syndrome,13,14,69,77,Evidence for placing OCRL at Xq25 also comes from a female with Lowe syndrome and an X; 3 translocation.,2895982_6,-1,2393,-1,0.22509214
2394,nucleotide,4,5,27,37,Identification of a single nucleotide change in the hypoxanthine-guanine phosphoribosyltransferase gene (HPRTYale) responsible for Lesch-Nyhan syndrome.,2910902_0,-1,2394,-1,0.22958308
2395,Lesch-Nyhan syndrome,16,18,131,151,Identification of a single nucleotide change in the hypoxanthine-guanine phosphoribosyltransferase gene (HPRTYale) responsible for Lesch-Nyhan syndrome.,2910902_0,-1,2395,-1,0.20506366
2396,Lesch-Nyhan syndrome,10,12,89,109,"
Complete deficiency of hypoxanthine-guanine phosphoribosyltransferase (HPRT) causes the Lesch-Nyhan syndrome.",2910902_1,-1,2396,-1,0.1976523
2397,Lesch-Nyhan syndrome,16,18,86,106,"Previous characterization of a mutant form of HPRT, HPRTYale, from a subject with the Lesch-Nyhan syndrome revealed normal mRNA and protein concentrations, no residual catalytic activity, and cathodal migration upon PAGE.",2910902_2,-1,2397,-1,0.20511928
2398,nucleotide,1,2,4,14,The nucleotide sequence of full-length HPRTYale cDNA revealed a single nucleotide substitution compared with normal HPRT cDNA  G----C at nucleotide position 211.,2910902_4,-1,2398,-1,0.26413333
2399,nucleotide,10,11,71,81,The nucleotide sequence of full-length HPRTYale cDNA revealed a single nucleotide substitution compared with normal HPRT cDNA  G----C at nucleotide position 211.,2910902_4,-1,2399,-1,0.28427953
2400,nucleotide,20,21,137,147,The nucleotide sequence of full-length HPRTYale cDNA revealed a single nucleotide substitution compared with normal HPRT cDNA  G----C at nucleotide position 211.,2910902_4,-1,2400,-1,0.32835308
2401,glycine,7,8,56,63,"This transversion predicts substitution of arginine for glycine at amino acid position 71, explaining the cathodal migration of HPRTYale.",2910902_5,-1,2401,-1,0.26693475
2402,amino acid,9,11,67,77,"This transversion predicts substitution of arginine for glycine at amino acid position 71, explaining the cathodal migration of HPRTYale.",2910902_5,-1,2402,-1,0.37306544
2403,glycine,10,11,55,62,Inclusion of the bulky arginine side chain in place of glycine probably disrupts protein folding as well.,2910902_7,-1,2403,-1,0.26997152
2404,glucose,5,6,34,41,"
The human X-linked gene encoding glucose 6-phosphate dehydrogenase (G6PD) is highly polymorphic; more than 300 G6PD variants have been identified.",2912069_1,-1,2404,-1,0.25316557
2406,glucose,8,9,52,59,Chronic nonspherocytic hemolytic anemia (CNSHA) and glucose 6 phosphate dehydrogenase (G6PD) deficiency in a patient with familial amyloidotic polyneuropathy (FAP).,2912886_0,-1,2406,-1,0.259297
2412,C,22,23,116,117,"Heat stability was found to be markedly decreased (8% of residual activity after 20 min of incubation at 46 degrees C) and a particular characteristic of this enzyme was a biphasic pH curve with a greatly increased activity at low pH. Although molecular characteristics of this variant closely resemble those of G6PD Bangkok and G6PD Duarte, it can be distinguished from these and all other previously reported variants by virtue of its unusual pH curve.",2912886_7,-1,2412,-1,0.3064662
2413,retinoblastoma,9,10,76,90,Molecular detection of chromosomal translocations that disrupt the putative retinoblastoma susceptibility locus.,2927388_0,-1,2413,-1,0.16114129
2414,retinoblastoma,12,13,72,86,"
A candidate DNA sequence with many of the properties predicted for the retinoblastoma susceptibility (RB1) locus has been cloned (S. H. Friend, R. Bernards, S. Rogelj, R. A. Weinberg, J. M. Rapaport, D. M. Albert, and T. P. Dryja, Nature [London] 323  643-645, 1986).",2927388_1,-1,2414,-1,0.17868896
2415,RB1,15,16,103,106,"
A candidate DNA sequence with many of the properties predicted for the retinoblastoma susceptibility (RB1) locus has been cloned (S. H. Friend, R. Bernards, S. Rogelj, R. A. Weinberg, J. M. Rapaport, D. M. Albert, and T. P. Dryja, Nature [London] 323  643-645, 1986).",2927388_1,-1,2415,-1,0.22033972
2416,ca,7,8,29,31,The large size of this gene (ca.,2927388_2,-1,2416,-1,0.29783627
2417,map,14,15,83,86,"Here we used field inversion gel electrophoresis (FIGE) to construct a restriction map of approximately 1, 000 kb of DNA surrounding the RB1 locus and to detect the translocation breakpoints in three retinoblastoma patients.",2927388_4,-1,2417,-1,0.21469532
2418,RB1,25,26,137,140,"Here we used field inversion gel electrophoresis (FIGE) to construct a restriction map of approximately 1, 000 kb of DNA surrounding the RB1 locus and to detect the translocation breakpoints in three retinoblastoma patients.",2927388_4,-1,2418,-1,0.22339216
2419,retinoblastoma,35,36,200,214,"Here we used field inversion gel electrophoresis (FIGE) to construct a restriction map of approximately 1, 000 kb of DNA surrounding the RB1 locus and to detect the translocation breakpoints in three retinoblastoma patients.",2927388_4,-1,2419,-1,0.16884832
2420,RB1,26,27,159,162,"Both probes identified an additional hybridizing fragment in the DNA from each patient, permitting the breakpoints in all three to be mapped within the cloned RB1 gene.",2927388_6,-1,2420,-1,0.20979749
2421,RB1,11,12,70,73,Analysis of the breakpoint in one translocation cell line allowed the RB1 gene to be oriented with its 5 end toward the centromere.,2927388_7,-1,2421,-1,0.22739089
2422,retinoblastoma,11,12,72,86,The detection and mapping of the translocation breakpoints of all three retinoblastoma patients to within the putative RB1 gene substantiated the authenticity of this candidate sequence and demonstrated the utility of FIGE in detecting chromosomal rearrangements affecting this locus.,2927388_9,-1,2422,-1,0.15767518
2423,RB1,17,18,119,122,The detection and mapping of the translocation breakpoints of all three retinoblastoma patients to within the putative RB1 gene substantiated the authenticity of this candidate sequence and demonstrated the utility of FIGE in detecting chromosomal rearrangements affecting this locus.,2927388_9,-1,2423,-1,0.2064899
2426,bacterial infections,15,17,104,124,"
A 10-year-old Laotian boy had homozygous deficiency of the third component of complement and recurrent bacterial infections beginning at age 5 months.",2963536_1,-1,2426,-1,0.20189247
2427,hemolytic,2,3,26,35,"Serum complement-mediated hemolytic, chemotactic, and opsonic activities were deficient.",2963536_3,-1,2427,-1,0.2139913
2428,hemolytic,10,11,59,68,"In vitro addition of purified C3 to patient serum restored hemolytic complement to normal levels, and plasma infusion during each of four episodes of pneumonia significantly enhanced serum opsonic activity for as long as 36 hours.",2963536_4,-1,2428,-1,0.23336439
2429,pneumonia,25,26,150,159,"In vitro addition of purified C3 to patient serum restored hemolytic complement to normal levels, and plasma infusion during each of four episodes of pneumonia significantly enhanced serum opsonic activity for as long as 36 hours.",2963536_4,-1,2429,-1,0.20262422
2431,disease,11,12,84,91,These findings further support the association of C3 deficiency with immune-complex disease and suggest that plasma infusion may be an adjunct to antibiotic therapy in the management of severe pyogenic infections in patients with C3 deficiency..,2963536_6,-1,2431,-1,0.18897212
2433,emphysema,36,37,174,183,"A deficiency of AAT in individuals homozygous for the PI Z allele occurs in about 1 in 2, 000-8, 000 caucasians and is associated with an increased risk of early adult onset emphysema and liver disease in childhood.",2989709_2,-1,2433,-1,0.19025663
2434,disease,39,40,194,201,"A deficiency of AAT in individuals homozygous for the PI Z allele occurs in about 1 in 2, 000-8, 000 caucasians and is associated with an increased risk of early adult onset emphysema and liver disease in childhood.",2989709_2,-1,2434,-1,0.18891275
2435,muscular dystrophy,11,13,80,98,Segregation analysis of a marker localised Xp21.2-Xp21.3 in Duchenne and Becker muscular dystrophy families.,2995231_0,-1,2435,-1,0.1775713
2436,muscular dystrophy,10,12,57,75,"3, has been studied in kindreds segregating for Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD).",2995231_3,-1,2436,-1,0.16444778
2437,muscular dystrophy,17,19,93,111,"3, has been studied in kindreds segregating for Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD).",2995231_3,-1,2437,-1,0.16523899
2438,Prader-Willi syndrome,12,14,83,104,Isolation of molecular probes associated with the chromosome 15 instability in the Prader-Willi syndrome.,3012567_0,-1,2438,-1,0.2188882
2439,Prader-Willi syndrome,18,20,113,134,"
Flow cytometry and recombinant DNA techniques have been used to obtain reagents for a molecular analysis of the Prader-Willi syndrome (PWS).",3012567_1,-1,2439,-1,0.22528
2440,diseases,20,21,117,125,2 may elucidate the molecular basis for the instability of this chromosomal region in patients with the PWS or other diseases associated with chromosomal abnormalities in the proximal long arm of human chromosome 15,3012567_10,-1,2440,-1,0.15161963
2441,muscular dystrophy,11,13,68,86,Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy.,3014348_0,-1,2441,-1,0.17248821
2442,muscular dystrophy,1,3,10,28,"
Duchenne muscular dystrophy (DMD) is an X-linked recessive genetic disorder for which the biochemical defect is as yet unknown.",3014348_1,-1,2442,-1,0.17946497
2443,muscular dystrophy,33,35,198,216,Here we describe the combined results of more than 20 research laboratories with respect to the occurrence of deletions at the DXS164 locus in DNA samples isolated from patients with DMD and Becker muscular dystrophy (BMD).,3014348_5,-1,2443,-1,0.16926633
2444,Lesch-Nyhan syndrome,5,7,29,49,A potential animal model for Lesch-Nyhan syndrome through introduction of HPRT mutations into mice.,3029599_0,-1,2444,-1,0.21289551
2445,Lesch-Nyhan syndrome,2,4,11,31,"
The human Lesch-Nyhan syndrome is a rare neurological and behavioural disorder, affecting only males, which is caused by an inherited deficiency in the level of activity of the purine salvage enzyme hypoxanthine-guanosine phosphoribosyl transferase (HPRT).",3029599_1,-1,2445,-1,0.21701868
2446,purine,30,31,178,184,"
The human Lesch-Nyhan syndrome is a rare neurological and behavioural disorder, affecting only males, which is caused by an inherited deficiency in the level of activity of the purine salvage enzyme hypoxanthine-guanosine phosphoribosyl transferase (HPRT).",3029599_1,-1,2446,-1,0.2165251
2447,purine,5,6,33,39,How the resulting alterations in purine metabolism lead to the severe symptoms characteristic of Lesch-Nyhan patients is still not understood.,3029599_2,-1,2447,-1,0.22172357
2448,lead,7,8,51,55,How the resulting alterations in purine metabolism lead to the severe symptoms characteristic of Lesch-Nyhan patients is still not understood.,3029599_2,-1,2448,-1,0.27379367
2449,Lesch-Nyhan syndrome,7,9,34,54,"To derive an animal model for the Lesch-Nyhan syndrome, we have used cultured mouse embryonic stem cells, mutagenized by retroviral insertion and selected for loss of HPRT activity, to construct chimaeric mice.",3029599_4,-1,2449,-1,0.20993921
2450,retinoblastoma,12,13,75,89,Re-evaluation of the sublocalization of esterase D and its relation to the retinoblastoma locus by in situ hybridization.,3032521_0,-1,2450,-1,0.18232253
2451,retinoblastoma,6,7,33,47,"A deletion in an individual with retinoblastoma was reported to separate the closely linked ESD and retinoblastoma (RB1) loci, placing ESD proximal to RB1.",3032521_6,-1,2451,-1,0.16916914
2452,retinoblastoma,16,17,100,114,"A deletion in an individual with retinoblastoma was reported to separate the closely linked ESD and retinoblastoma (RB1) loci, placing ESD proximal to RB1.",3032521_6,-1,2452,-1,0.17951587
2453,RB1,18,19,116,119,"A deletion in an individual with retinoblastoma was reported to separate the closely linked ESD and retinoblastoma (RB1) loci, placing ESD proximal to RB1.",3032521_6,-1,2453,-1,0.22297142
2454,RB1,26,27,151,154,"A deletion in an individual with retinoblastoma was reported to separate the closely linked ESD and retinoblastoma (RB1) loci, placing ESD proximal to RB1.",3032521_6,-1,2454,-1,0.22045925
2455,RB1,26,27,149,152,"From these findings, we conclude that the deletion in this individual cannot be used to determine the orientation nor the sublocalization of ESD and RB1 within the 13q14 region.",3032521_9,-1,2455,-1,0.23855014
2456,common variable immunodeficiency,5,8,41,73,Hereditary C2 deficiency associated with common variable immunodeficiency.,313733_0,-1,2456,-1,0.18867095
2457,immunodeficiency,11,12,76,92,"
Homozygous C2 deficiency in a 19-year-old boy was associated with variable immunodeficiency manifested by marked hypoimmunoglobulinemia and impaired antibody responses, normal circulating B lymphocytes, and subnormal T-cell functions.",313733_1,-1,2457,-1,0.15978625
2458,muscular dystrophy,3,5,16,34,Mild and severe muscular dystrophy associated with deletions in Xp21 of the human X chromosome.,3162536_0,-1,2458,-1,0.17625928
2459,muscular dystrophy,11,13,70,88,"
We have analysed over 300 patients suffering from Duchenne or Becker muscular dystrophy (DMD or BMD).",3162536_1,-1,2459,-1,0.17556961
2460,muscular dystrophy,8,10,50,68,Patterns of exon deletions in Duchenne and Becker muscular dystrophy.,3169738_0,-1,2460,-1,0.17786635
2461,muscular dystrophy,8,10,46,64,"
A panel of patients with Duchenne and Becker muscular dystrophy (DMD and BMD) has been screened with the cDNA probes Cf56a and Cf23a, which detect exons in the central part of the DMD gene.",3169738_1,-1,2461,-1,0.16867752
2463,skin rash,14,16,82,91,"Hereditary deficiency of the third component of complement in a child with fever, skin rash, and arthralgias: response to transfusion of whole blood.",318684_0,-1,2463,-1,0.19832475
2464,arthralgias,18,19,97,108,"Hereditary deficiency of the third component of complement in a child with fever, skin rash, and arthralgias: response to transfusion of whole blood.",318684_0,-1,2464,-1,0.21135132
2466,skin rash,9,11,60,69,"
A previously well 34-month-old male presenting with fever, skin rash, and arthralgias was found to lack C3 by immunochemical (undetectable) and hemolytic (1% normal) assays.",318684_1,-1,2466,-1,0.21629038
2467,arthralgias,13,14,75,86,"
A previously well 34-month-old male presenting with fever, skin rash, and arthralgias was found to lack C3 by immunochemical (undetectable) and hemolytic (1% normal) assays.",318684_1,-1,2467,-1,0.22460647
2468,hemolytic,25,26,145,154,"
A previously well 34-month-old male presenting with fever, skin rash, and arthralgias was found to lack C3 by immunochemical (undetectable) and hemolytic (1% normal) assays.",318684_1,-1,2468,-1,0.24410655
2469,hemolytic,9,10,35,44,"C4, C5, properdin, and C3b-INA and hemolytic activities of complement components C1 to C9 except C3 were normal or elevated; total hemolytic complement activity was 13% of normal and was reconstituted by purified C3.",318684_4,-1,2469,-1,0.2585135
2470,hemolytic,25,26,131,140,"C4, C5, properdin, and C3b-INA and hemolytic activities of complement components C1 to C9 except C3 were normal or elevated; total hemolytic complement activity was 13% of normal and was reconstituted by purified C3.",318684_4,-1,2470,-1,0.25366673
2471,skin rash,49,51,263,272,A transfusion of 320 ml 1-hour-old normal whole blood on the fifty-second day resulted in transitory elevation of the C3 level to 25 mg/dl with a fall-off (approximately 2 1/2% per hour) to undetectable levels by 69 hours; it was followed by disappearance of the skin rash and arthralgias and return to normal of the previously elevated temperature and CRP levels.,318684_7,-1,2471,-1,0.29501814
2472,arthralgias,52,53,277,288,A transfusion of 320 ml 1-hour-old normal whole blood on the fifty-second day resulted in transitory elevation of the C3 level to 25 mg/dl with a fall-off (approximately 2 1/2% per hour) to undetectable levels by 69 hours; it was followed by disappearance of the skin rash and arthralgias and return to normal of the previously elevated temperature and CRP levels.,318684_7,-1,2472,-1,0.2531856
2475,skin rash,24,26,142,151,"Thus, this child is a unique individual with inherited C3 deficiency presenting with absence of repeated infections, whose symptoms of fever, skin rash, and arthralgia were abated by whole blood transfusion..",318684_9,-1,2475,-1,0.19559197
2476,arthralgia,28,29,157,167,"Thus, this child is a unique individual with inherited C3 deficiency presenting with absence of repeated infections, whose symptoms of fever, skin rash, and arthralgia were abated by whole blood transfusion..",318684_9,-1,2476,-1,0.21275268
2477,disease,18,19,122,129,Homozygous and heterozygous deletions of the von Willebrand factor gene in patients and carriers of severe von Willebrand disease.,3258663_0,-1,2477,-1,0.1787112
2478,disease,3,4,23,30,"
Severe von Willebrand disease is characterized by undetectable or trace quantities of von Willebrand factor in plasma and tissue stores.",3258663_1,-1,2478,-1,0.19773047
2479,P,22,23,148,149,Gene dosage analysis was consistent with heterozygous deletions in both of the asymptomatic parents and four asymptomatic siblings of this kindred (P less than 0. 01).,3258663_5,-1,2479,-1,0.2827448
2480,disease,12,13,86,93,These techniques should prove useful in identifying carriers of severe von Willebrand disease and also in defining patients predictably at risk of developing alloantibodies to vWF.,3258663_10,-1,2480,-1,0.21549648
2481,Sjogren-Larsson syndrome,0,2,0,24,Sjogren-Larsson syndrome.,3343337_0,-1,2481,-1,0.26726502
2482,alcohol,2,3,15,22,Impaired fatty alcohol oxidation in cultured fibroblasts due to deficient fatty alcohol:nicotinamide adenine dinucleotide oxidoreductase activity.,3343337_1,-1,2482,-1,0.22729445
2483,alcohol,11,12,80,87,Impaired fatty alcohol oxidation in cultured fibroblasts due to deficient fatty alcohol:nicotinamide adenine dinucleotide oxidoreductase activity.,3343337_1,-1,2483,-1,0.24653877
2484,Sjogren-Larsson syndrome,15,17,102,126,"
Lipid metabolism was studied in cultured skin fibroblasts from patients with the inherited disorder, Sjogren-Larsson syndrome (SLS).",3343337_2,-1,2484,-1,0.20897968
2485,alcohol,8,9,56,63,Hexadecanol accumulation was not due to increased fatty alcohol synthesis nor its deficient utilization for glycerol ether synthesis.,3343337_5,-1,2485,-1,0.28252485
2486,ether,16,17,117,122,Hexadecanol accumulation was not due to increased fatty alcohol synthesis nor its deficient utilization for glycerol ether synthesis.,3343337_5,-1,2486,-1,0.30005383
2487,fatty acid,36,38,203,213,"The half-life of intracellular hexadecanol loaded into SLS fibroblasts was increased (70 min) compared with normal (15 min), and intact SLS fibroblasts showed impaired oxidation of [14C] -hexadecanol to fatty acid.",3343337_6,-1,2487,-1,0.30581853
2488,alcohol  NAD,1,4,6,18,"Fatty alcohol  NAD + oxidoreductase, the enzyme catalyzing this reaction, was deficient in SLS fibroblasts.",3343337_7,-1,2488,-1,0.28644034
2489,n,7,8,40,41,Mean total activity in SLS fibroblasts (n = 5),3343337_8,-1,2489,-1,0.30060604
2490,alcohol  NAD,13,16,76,88,These results suggest that the primary defect in SLS is deficiency of fatty alcohol  NAD + oxidoreductase.,3343337_11,-1,2490,-1,0.269654
2491,alcohol,15,16,100,107,SLS represents the first inherited disorder in man associated with an isolated abnormality in fatty alcohol metabolism..,3343337_12,-1,2491,-1,0.21287677
2492,muscular dystrophy,4,6,31,49,Germinal mosaicism in Duchenne muscular dystrophy.,3346017_0,-1,2492,-1,0.17473885
2493,muscular dystrophy,5,7,31,49,"
We have identified a Duchenne muscular dystrophy (DMD) pedigree where the disease is associated with a molecular deletion within the DMD locus.",3346017_1,-1,2493,-1,0.17282936
2494,disease,13,14,75,82,"
We have identified a Duchenne muscular dystrophy (DMD) pedigree where the disease is associated with a molecular deletion within the DMD locus.",3346017_1,-1,2494,-1,0.19446582
2495,muscular dystrophy,13,15,75,93,"
The presence of nebulin in a muscle specimen from a patient with Duchenne muscular dystrophy (DMD) due to a large deletion precludes the possibility that this protein is the DMD gene product..",3346018_1,-1,2495,-1,0.16740738
2496,muscular dystrophy,5,7,34,52,Expression of the murine Duchenne muscular dystrophy gene in muscle and brain.,3347839_0,-1,2496,-1,0.17572409
2497,muscular dystrophy,6,8,35,53,5 kilobases of the murine Duchenne muscular dystrophy (Dmd) messenger RNA (mRNA).,3347839_2,-1,2497,-1,0.18087596
2498,muscular dystrophy,16,18,100,118,The identification of Dmd mRNA in brain raises the possibility of a relation between human Duchenne muscular dystrophy (DMD) gene expression and the mental retardation found in some DMD males.,3347839_5,-1,2498,-1,0.16524145
2499,mental retardation,25,27,149,167,The identification of Dmd mRNA in brain raises the possibility of a relation between human Duchenne muscular dystrophy (DMD) gene expression and the mental retardation found in some DMD males.,3347839_5,-1,2499,-1,0.19019727
2500,Glucose,0,1,0,7,Glucose 6-phosphate dehydrogenase deficiency and incidence of hematologic malignancy.,3348216_0,-1,2500,-1,0.26348063
2502,glucose,10,11,68,75,"
We have evaluated the hypothesis of a negative association between glucose 6-phosphate dehydrogenase (G6PD) deficiency and cancer in a cohort of 481 Sardinian males with hematological malignancies.",3348216_1,-1,2502,-1,0.2397815
2504,hematological malignancies,27,29,171,197,"
We have evaluated the hypothesis of a negative association between glucose 6-phosphate dehydrogenase (G6PD) deficiency and cancer in a cohort of 481 Sardinian males with hematological malignancies.",3348216_1,-1,2504,-1,0.15093553
2505,disease,24,25,149,156,The same conclusion resulted from the comparison of the frequency of expression of the GdB gene in 23 heterozygous women having a clonal hematologic disease and a control group of 37 healthy heterozygotes.,3348216_3,-1,2505,-1,0.1951464
2506,hematologic neoplasms,17,19,110,131,Therefore at present there is no evidence that G6PD deficiency has a protective effect against development of hematologic neoplasms..,3348216_4,-1,2506,-1,0.15258136
2507,Hepatoblastoma,0,1,0,14,"Hepatoblastoma, pigmented ocular fundus lesions and jaw lesions in Gardner syndrome.",3354603_0,-1,2507,-1,0.17581332
2508,Gardner syndrome,10,12,67,83,"Hepatoblastoma, pigmented ocular fundus lesions and jaw lesions in Gardner syndrome.",3354603_0,-1,2508,-1,0.22678275
2509,Hepatoblastoma,0,1,1,15,"
Hepatoblastoma is a rare neoplasm of infants and children only recently documented in association with hereditary adenomatous polyposis of the colon [Kingston et al., 1983].",3354603_1,-1,2509,-1,0.18343768
2510,neoplasm,4,5,26,34,"
Hepatoblastoma is a rare neoplasm of infants and children only recently documented in association with hereditary adenomatous polyposis of the colon [Kingston et al., 1983].",3354603_1,-1,2510,-1,0.18060008
2511,hepatoblastoma,5,6,29,43,We report four children with hepatoblastoma from four unrelated families with Gardner syndrome (GS).,3354603_2,-1,2511,-1,0.17138356
2512,Gardner syndrome,11,13,78,94,We report four children with hepatoblastoma from four unrelated families with Gardner syndrome (GS).,3354603_2,-1,2512,-1,0.19623119
2513,hepatoblastoma,14,15,61,75,"One child, now 19 years old, survived after a resection of a hepatoblastoma in infancy and recently was found to have GS.",3354603_3,-1,2513,-1,0.17889254
2514,odontoma,4,5,21,29,"He has an associated odontoma and pigmented ocular fundus lesions, both of which have been shown to be clinical markers of GS.",3354603_4,-1,2514,-1,0.20193557
2515,colonic polyps,3,5,13,27,A search for colonic polyps should be made in families of infants and children with hepatoblastoma.,3354603_6,-1,2515,-1,0.19221604
2516,hepatoblastoma,15,16,84,98,A search for colonic polyps should be made in families of infants and children with hepatoblastoma.,3354603_6,-1,2516,-1,0.16463031
2517,colonic polyps,16,18,81,95,"If the child survives, he or she should be monitored for the later appearance of colonic polyps.",3354603_7,-1,2517,-1,0.20720069
2518,Tay-Sachs disease,8,10,54,71,Identification of an altered splice site in Ashkenazi Tay-Sachs disease.,3362213_0,-1,2518,-1,0.24395366
2519,Tay-Sachs disease,0,2,1,18,"
Tay-Sachs disease is an autosomal recessive genetic disorder resulting from mutation of the HEXA gene encoding the alpha-subunit of the lysosomal enzyme, beta-N-acetylhexosaminidase A (ref. 1).",3362213_1,-1,2519,-1,0.26641867
2520,disease,17,18,82,89,"A relatively high frequency of carriers (1/27) of a lethal, infantile form of the disease is found in the Ashkenazi Jewish population, but it is not yet evident whether this has resulted from a founder effect and random genetic drift or from a selective advantage of heterozygotes.",3362213_2,-1,2520,-1,0.22759077
2521,C,7,8,35,36,"This change, the substitution of a C for G in the first nucleotide of intron 12 is expected to result in defective splicing of the messenger RNA.",3362213_4,-1,2521,-1,0.3137928
2522,nucleotide,13,14,56,66,"This change, the substitution of a C for G in the first nucleotide of intron 12 is expected to result in defective splicing of the messenger RNA.",3362213_4,-1,2522,-1,0.29354602
2523,Tay-Sachs disease,42,44,237,254,"A test for the mutant allele based on amplification of DNA by the polymerase chain rection and cleavage of a DdeI restriction site generated by the mutation revealed that this case and two other cases of the Ashkenazi, infantile form of Tay-Sachs disease are heterozygous for two different mutations.",3362213_5,-1,2523,-1,0.2579113
2524,X-linked,0,1,0,8,X-linked glucose-6-phosphate dehydrogenase deficiency in Mus musculus.,3377761_0,-1,2524,-1,0.26916423
2526,favism,13,14,70,76,"In one of the commonest, G6PD Mediterranean, which is associated with favism among other clinical manifestations, a single amino acid replacement was found (serine----phenylalanine)  it must be responsible for the decreased stability and the reduced catalytic efficiency of this enzyme.",3393536_7,-1,2526,-1,0.2792484
2527,amino acid,21,23,123,133,"In one of the commonest, G6PD Mediterranean, which is associated with favism among other clinical manifestations, a single amino acid replacement was found (serine----phenylalanine)  it must be responsible for the decreased stability and the reduced catalytic efficiency of this enzyme.",3393536_7,-1,2527,-1,0.30370387
2530,myotonic dystrophy,3,5,22,40,Tight linkage between myotonic dystrophy and apolipoprotein E genes revealed with allele-specific oligonucleotides.,3417303_0,-1,2530,-1,0.18607864
2531,E,7,8,60,61,Tight linkage between myotonic dystrophy and apolipoprotein E genes revealed with allele-specific oligonucleotides.,3417303_0,-1,2531,-1,0.21897331
2532,myotonic dystrophy,4,6,21,39,"
In 16 families with myotonic dystrophy (DM) a novel approach based on use of allele-specific oligonucleotides has been employed to study the linkage relationship between the apolipoprotein E (APOE) gene and DM.",3417303_1,-1,2532,-1,0.18726708
2533,DM,7,8,41,43,"
In 16 families with myotonic dystrophy (DM) a novel approach based on use of allele-specific oligonucleotides has been employed to study the linkage relationship between the apolipoprotein E (APOE) gene and DM.",3417303_1,-1,2533,-1,0.18874356
2534,E,29,30,190,191,"
In 16 families with myotonic dystrophy (DM) a novel approach based on use of allele-specific oligonucleotides has been employed to study the linkage relationship between the apolipoprotein E (APOE) gene and DM.",3417303_1,-1,2534,-1,0.22687216
2535,DM,35,36,208,210,"
In 16 families with myotonic dystrophy (DM) a novel approach based on use of allele-specific oligonucleotides has been employed to study the linkage relationship between the apolipoprotein E (APOE) gene and DM.",3417303_1,-1,2535,-1,0.1985356
2536,DM,1,2,4,6,"For DM and APOE, a maximum lod score (zmax of 7. 47 was obtained at a recombination frequency (theta) of 0.",3417303_4,-1,2536,-1,0.28192905
2537,DM,17,18,93,95,"These results suggest that, in addition to APOC2, APOE is a useful marker for presymptomatic DM diagnosis.",3417303_9,-1,2537,-1,0.20255129
2538,choroideremia,19,20,123,136,Regional localization of polymorphic DNA loci on the proximal long arm of the X chromosome using deletions associated with choroideremia.,3422216_0,-1,2538,-1,0.20246658
2539,choroideremia,12,13,71,84,"
In two unrelated families, males have been identified who suffer from choroideremia and at the same time have an interstitial deletion on the proximal long arm of the X chromosome.",3422216_1,-1,2539,-1,0.21236081
2540,choroideremia,21,22,125,138,By Southern blot analysis we have mapped ten different polymorphic DNA loci relative to the position of the deletion and the choroideremia locus TCD.,3422216_7,-1,2540,-1,0.22612286
2541,phenylalanine,5,6,43,56,Retroviral-mediated gene transfer of human phenylalanine hydroxylase into NIH 3T3 and hepatoma cells.,3455778_0,-1,2541,-1,0.26276267
2542,hepatoma,11,12,86,94,Retroviral-mediated gene transfer of human phenylalanine hydroxylase into NIH 3T3 and hepatoma cells.,3455778_0,-1,2542,-1,0.18136436
2543,phenylalanine,12,13,69,82,"
Phenylketonuria (PKU) is caused by deficiency of the hepatic enzyme phenylalanine hydroxylase (PAH).",3455778_1,-1,2543,-1,0.24571337
2544,PAH,15,16,96,99,"
Phenylketonuria (PKU) is caused by deficiency of the hepatic enzyme phenylalanine hydroxylase (PAH).",3455778_1,-1,2544,-1,0.23338903
2545,PAH,3,4,20,23,"A full-length human PAH cDNA sequence has been inserted into pzip-neoSV (X), which is a retroviral vector containing the bacterial neo gene.",3455778_2,-1,2545,-1,0.2797949
2546,PAH,22,23,128,131,"Recombinant virus was detected in the culture medium of the transfected psi 2 cells, which is capable of transmitting the human PAH gene into mouse NIH 3T3 cells by infection leading to stable incorporation of the recombinant provirus.",3455778_4,-1,2546,-1,0.286894
2548,PAH,3,4,23,26,"Infected cells express PAH mRNA, immunoreactive PAH protein, and exhibit pterin-dependent phenylalanine hydroxylase activity.",3455778_5,-1,2548,-1,0.22494145
2549,PAH,7,8,48,51,"Infected cells express PAH mRNA, immunoreactive PAH protein, and exhibit pterin-dependent phenylalanine hydroxylase activity.",3455778_5,-1,2549,-1,0.20580766
2550,phenylalanine,13,14,90,103,"Infected cells express PAH mRNA, immunoreactive PAH protein, and exhibit pterin-dependent phenylalanine hydroxylase activity.",3455778_5,-1,2550,-1,0.22738856
2551,hepatoma,10,11,59,67,The recombinant virus is also capable of infecting a mouse hepatoma cell line that does not normally synthesize PAH.,3455778_6,-1,2551,-1,0.17572382
2552,PAH,18,19,112,115,The recombinant virus is also capable of infecting a mouse hepatoma cell line that does not normally synthesize PAH.,3455778_6,-1,2552,-1,0.28469205
2553,PAH,0,1,0,3,PAH activity is present in the cellular extracts and the entire hydroxylation system is reconstituted in the hepatoma cells infected with the recombinant viruses.,3455778_7,-1,2553,-1,0.27126175
2554,hepatoma,17,18,109,117,PAH activity is present in the cellular extracts and the entire hydroxylation system is reconstituted in the hepatoma cells infected with the recombinant viruses.,3455778_7,-1,2554,-1,0.2046613
2555,PAH,6,7,43,46,"Thus, recombinant viruses containing human PAH cDNA provide a means for introducing functional PAH into mammalian cells of hepatic origin and can potentially be introduced into whole animals as a model for somatic gene therapy for PKU..",3455778_8,-1,2555,-1,0.21989973
2556,PAH,14,15,95,98,"Thus, recombinant viruses containing human PAH cDNA provide a means for introducing functional PAH into mammalian cells of hepatic origin and can potentially be introduced into whole animals as a model for somatic gene therapy for PKU..",3455778_8,-1,2556,-1,0.21522598
2557,muscular dystrophy,19,21,122,140,Estimation of the male to female ratio of mutation rates from the segregation of X-chromosomal DNA haplotypes in Duchenne muscular dystrophy families.,3464560_0,-1,2557,-1,0.16363887
2558,muscular dystrophy,17,19,100,118,"
A novel procedure is presented to estimate the ratio of male to female mutation rates for Duchenne muscular dystrophy (DMD).",3464560_1,-1,2558,-1,0.1669947
2559,contrast,1,2,3,11,"In contrast to classical methods, the proposed procedure is not restricted to sporadic or familiar cases nor is any information on the carrier status of female relatives required..",3464560_4,-1,2559,-1,0.27459687
2561,Retinoblastoma,0,1,1,15,"
Retinoblastoma is a childhood tumor that can arise because of mutant alleles acquired as somatic or germinal mutations.",3480530_1,-1,2561,-1,0.19133863
2563,RB1,23,24,144,147,The mutations creating these alleles act by inactivating copies of a recessive oncogene located within band q14 of chromosome 13 and termed the RB1 locus.,3480530_3,-1,2563,-1,0.20998944
2564,retinoblastoma,19,20,125,139,We have reported isolation of a cDNA fragment that recognizes chromosomal sequences possessing many of the attributes of the retinoblastoma gene associated with the RB1 locus.,3480530_4,-1,2564,-1,0.1653955
2565,RB1,24,25,165,168,We have reported isolation of a cDNA fragment that recognizes chromosomal sequences possessing many of the attributes of the retinoblastoma gene associated with the RB1 locus.,3480530_4,-1,2565,-1,0.20030859
2567,retinoblastoma,23,24,154,168,We now report that this segment is additionally the target of somatic mutations in mesenchymal tumors among patients having no apparent predisposition to retinoblastoma and no previous evidence of retinoblastoma.,3480530_5,-1,2567,-1,0.16607754
2568,retinoblastoma,29,30,197,211,We now report that this segment is additionally the target of somatic mutations in mesenchymal tumors among patients having no apparent predisposition to retinoblastoma and no previous evidence of retinoblastoma.,3480530_5,-1,2568,-1,0.17654447
2570,muscular dystrophy,3,5,22,40,Treatment of Duchenne muscular dystrophy with growth hormone inhibitors.,3524231_0,-1,2570,-1,0.1804864
2571,growth hormone,6,8,46,60,Treatment of Duchenne muscular dystrophy with growth hormone inhibitors.,3524231_0,-1,2571,-1,0.21529432
2572,mazindol,9,10,60,68,"
A controlled, double-blind therapeutic trial with the drug mazindol, a growth hormone inhibitor, was performed in a pair of 7 1/2 year-old monozygotic twins, with Duchenne muscular dystrophy (DMD).",3524231_1,-1,2572,-1,0.29207775
2573,muscular dystrophy,30,32,173,191,"
A controlled, double-blind therapeutic trial with the drug mazindol, a growth hormone inhibitor, was performed in a pair of 7 1/2 year-old monozygotic twins, with Duchenne muscular dystrophy (DMD).",3524231_1,-1,2573,-1,0.17371652
2574,growth hormone,19,21,111,125,"The rationale for this trial was based on a patient (reported previously) affected simultaneously with DMD and growth hormone (GH) deficiency, who is showing a benign course of the dystrophic process and is still walking at 18 years.",3524231_2,-1,2574,-1,0.22731453
2575,mg,6,7,28,30,"One of the twins received 2 mg of mazindol daily, while the other received a placebo.",3524231_3,-1,2575,-1,0.32035902
2576,mazindol,8,9,34,42,"One of the twins received 2 mg of mazindol daily, while the other received a placebo.",3524231_3,-1,2576,-1,0.33979183
2577,disease,5,6,33,40,"
Many mutations leading to human disease are the result of single DNA base pair changes that cannot be identified by Southern analysis.",3563511_1,-1,2577,-1,0.20186368
2578,Lesch-Nyhan syndrome,36,38,253,273,"The recently described ribonuclease A cleavage procedure, with a polyuridylic acid-paper affinity chromatography step, has been used to identify the mutational lesions in the hypoxanthine phosphoribosyltransferase (HPRT) messenger RNAs of patients with Lesch-Nyhan syndrome.",3563511_3,-1,2578,-1,0.19829983
2579,Lesch-Nyhan syndrome,14,16,79,99,This approach now allows HPRT mutation detection in 50 percent of the cases of Lesch-Nyhan syndrome.,3563511_5,-1,2579,-1,0.20656382
2582,syndrome,26,27,166,174,"Since sporadic variants of G6PD causing HNSHA show no special racial predilection, the diagnosis of G6PD deficiency should always be considered in patients with this syndrome..",3565372_5,-1,2582,-1,0.20043646
2583,Wiskott-Aldrich syndrome,8,10,58,82,"Sialophorin, a surface sialoglycoprotein defective in the Wiskott-Aldrich syndrome, is involved in human T lymphocyte proliferation.",3572301_0,-1,2583,-1,0.20477046
2584,immunodeficiency Wiskott-Aldrich syndrome,30,33,200,241,"
The mAb L10 was used to determine the distribution and the function of sialophorin, the heavily glycosylated surface molecule that is deficient/defective in lymphocytes of patients with the X-linked immunodeficiency Wiskott-Aldrich syndrome.",3572301_1,-1,2584,-1,0.18568528
2585,thymidine,22,23,143,152,Functional studies demonstrated that L10 mAb stimulates the proliferation of peripheral blood T lymphocytes as measured by stimulation of [3H] thymidine incorporation.,3572301_3,-1,2585,-1,0.24138746
2586,thymidine,10,11,48,57,The time course and magnitude of increased [3H] thymidine incorporation by T lymphocytes in response to L10 mAb paralleled that induced by anti-CD3 mAb.,3572301_4,-1,2586,-1,0.26532957
2587,Hypopigmentation,0,1,0,16,Hypopigmentation in the Prader-Willi syndrome.,3578281_0,-1,2587,-1,0.26758593
2588,Prader-Willi syndrome,3,5,24,45,Hypopigmentation in the Prader-Willi syndrome.,3578281_0,-1,2588,-1,0.23653576
2589,Prader-Willi syndrome,11,13,77,98,"
Cutaneous and ocular pigmentation were evaluated in 29 individuals with the Prader-Willi syndrome (PWS).",3578281_1,-1,2589,-1,0.22601867
2590,hypopigmentation,2,3,13,29,"Criteria for hypopigmentation included the presence of type I or II skin, the lightest skin type in the family by history, and iris translucency on globe transillumination.",3578281_2,-1,2590,-1,0.28210056
2591,hypopigmentation,3,4,16,32,"The presence of hypopigmentation correlated with a small interstitial deletion on the proximal long arm of chromosome 15; however, this deletion was also found in individuals who did not meet the full criteria for hypopigmentation.",3578281_4,-1,2591,-1,0.2472712
2592,hypopigmentation,36,37,214,230,"The presence of hypopigmentation correlated with a small interstitial deletion on the proximal long arm of chromosome 15; however, this deletion was also found in individuals who did not meet the full criteria for hypopigmentation.",3578281_4,-1,2592,-1,0.23796508
2593,glutathione,4,5,33,44,"Hairbulb tyrosinase activity and glutathione content, as well as urine cysteinyldopa excretion, were low in PWS individuals with and without hypopigmentation and did not separate these two groups.",3578281_5,-1,2593,-1,0.25428107
2594,hypopigmentation,22,23,141,157,"Hairbulb tyrosinase activity and glutathione content, as well as urine cysteinyldopa excretion, were low in PWS individuals with and without hypopigmentation and did not separate these two groups.",3578281_5,-1,2594,-1,0.2769875
2595,hypopigmentation,3,4,17,33,We conclude that hypopigmentation is found in a significant proportion of individuals with PWS and that the hypopigmentation may be associated with a deletion of the long arm of chromosome 15.,3578281_6,-1,2595,-1,0.26198855
2596,hypopigmentation,17,18,108,124,We conclude that hypopigmentation is found in a significant proportion of individuals with PWS and that the hypopigmentation may be associated with a deletion of the long arm of chromosome 15.,3578281_6,-1,2596,-1,0.244943
2597,hypopigmentation,4,5,22,38,The mechanism for the hypopigmentation is unknown..,3578281_7,-1,2597,-1,0.2660589
2598,adrenoleukodystrophy,10,11,81,101,Phenotype heterogeneity among hemizygotes in a family biochemically screened for adrenoleukodystrophy.,3591825_0,-1,2598,-1,0.20214538
2599,adrenoleukodystrophy,14,15,83,103,"
We report on two clinically, neurologically normal relatives of a boy affected by adrenoleukodystrophy (ALD); they were found repeatedly to have the biochemical defect of an ALD hemizygote.",3591825_1,-1,2599,-1,0.20175041
2600,fatty acids,8,10,60,71,The assay consisted in the determination of very-long-chain fatty acids in lyophilized and reconstituted plasma.,3591825_2,-1,2600,-1,0.27034083
2601,disease,5,6,32,39,"While no evidence of neurologic disease (leukodystrophy or myeloneuropathy) was present in these hemizygotes, adrenocortical insufficiency provoking compensatory high ACTH release was found in both.",3591825_3,-1,2601,-1,0.22091009
2602,ACTH,22,23,167,171,"While no evidence of neurologic disease (leukodystrophy or myeloneuropathy) was present in these hemizygotes, adrenocortical insufficiency provoking compensatory high ACTH release was found in both.",3591825_3,-1,2602,-1,0.2231047
2603,muscular dystrophy,10,12,55,73,The mapping of a cDNA from the human X-linked Duchenne muscular dystrophy gene to the mouse X chromosome.,3600793_0,-1,2603,-1,0.18016997
2604,muscular dystrophy,11,13,63,81,"
The recent discovery of sequences at the site of the Duchenne muscular dystrophy (DMD) gene in humans has opened up the possibility of a detailed molecular analysis of the genes in humans and in related mammalian species.",3600793_1,-1,2604,-1,0.1706498
2605,disease,13,14,76,83,"Until relatively recently, there was no obvious mouse model of this genetic disease for the development of therapeutic strategies.",3600793_2,-1,2605,-1,0.20219819
2606,muscular dystrophy,8,10,54,72,"The identification of a mouse X-linked mutant showing muscular dystrophy, mdx, has provided a candidate mouse genetic homologue to the DMD locus; the relatively mild pathological features of mdx suggest it may have more in common with mutations of the Becker muscular dystrophy type at the same human locus, however. But the close genetic linkage of mdx to G6PD and Hprt on the mouse X chromosome, coupled with its comparatively mild pathology, have suggested that the mdx mutation may instead correspond to Emery Dreifuss muscular dystrophy which itself is closely linked to DNA markers at Xq28-qter in the region of G6PD on the human X chromosome.",3600793_3,-1,2606,-1,0.16988723
2607,muscular dystrophy,44,46,259,277,"The identification of a mouse X-linked mutant showing muscular dystrophy, mdx, has provided a candidate mouse genetic homologue to the DMD locus; the relatively mild pathological features of mdx suggest it may have more in common with mutations of the Becker muscular dystrophy type at the same human locus, however. But the close genetic linkage of mdx to G6PD and Hprt on the mouse X chromosome, coupled with its comparatively mild pathology, have suggested that the mdx mutation may instead correspond to Emery Dreifuss muscular dystrophy which itself is closely linked to DNA markers at Xq28-qter in the region of G6PD on the human X chromosome.",3600793_3,-1,2607,-1,0.1654628
2608,muscular dystrophy,91,93,523,541,"The identification of a mouse X-linked mutant showing muscular dystrophy, mdx, has provided a candidate mouse genetic homologue to the DMD locus; the relatively mild pathological features of mdx suggest it may have more in common with mutations of the Becker muscular dystrophy type at the same human locus, however. But the close genetic linkage of mdx to G6PD and Hprt on the mouse X chromosome, coupled with its comparatively mild pathology, have suggested that the mdx mutation may instead correspond to Emery Dreifuss muscular dystrophy which itself is closely linked to DNA markers at Xq28-qter in the region of G6PD on the human X chromosome.",3600793_3,-1,2608,-1,0.17629531
2609,map,2,3,16,19,"These sequences map provocatively close to the mdx mutation and unexpectedly distant from sparse fur, spf, the mouse homologue of OTC (ornithine transcarbamylase) which is closely linked to DMD on the human X chromosome..",3600793_5,-1,2609,-1,0.3181728
2610,ornithine,24,25,135,144,"These sequences map provocatively close to the mdx mutation and unexpectedly distant from sparse fur, spf, the mouse homologue of OTC (ornithine transcarbamylase) which is closely linked to DMD on the human X chromosome..",3600793_5,-1,2610,-1,0.2221619
2611,muscular dystrophy,8,10,54,72,Localization of the region homologous to the Duchenne muscular dystrophy locus on the mouse X chromosome.,3600794_0,-1,2611,-1,0.17639302
2612,muscular dystrophies,16,18,92,112,"
Recent progress has resulted in part of the gene mutated in Duchenne and the milder Becker muscular dystrophies being cloned and has suggested that the gene itself extends over 1, 000 to 2, 000 kilobases (kb).",3600794_1,-1,2612,-1,0.1956576
2613,disease,27,28,146,153,"To study how mutations in this gene affect muscle development and integrity, it would be of interest to have available a mouse model of the human disease.",3600794_2,-1,2613,-1,0.20039019
2614,syndrome,11,12,68,76,"The mouse mdx mutation affects muscle and confers a mild dystrophic syndrome, but it is not clear whether this mutation is equivalent to Duchenne/Becker muscular dystrophy in man.",3600794_3,-1,2614,-1,0.18573418
2615,muscular dystrophy,25,27,153,171,"The mouse mdx mutation affects muscle and confers a mild dystrophic syndrome, but it is not clear whether this mutation is equivalent to Duchenne/Becker muscular dystrophy in man.",3600794_3,-1,2615,-1,0.16995272
2616,muscular dystrophy,12,14,66,84,Here we describe the use of two sequences from the human Duchenne muscular dystrophy (DMD) gene that cross-hybridize to mouse X-linked sequences to localize the gene homologous to DMD in the mouse.,3600794_4,-1,2616,-1,0.17088985
2617,map,2,3,15,18,"Both sequences map to the region of 10 centimorgan lying between the Tabby (Ta) and St14-1 (DxPas8) loci, close to the phosphorylase b kinase locus (Phk).",3600794_5,-1,2617,-1,0.29201984
2618,muscular dystrophy,35,37,194,212,"By analogy with the human X-chromosome, we conclude that the region in the mouse around the G6pd and St14-1 loci may contain two genes corresponding to distinct human myopathies  Emery Dreifuss muscular dystrophy which is known to be closely linked to St14-1 in man and the DMD homologue described here..",3600794_6,-1,2618,-1,0.16621453
2619,phenylalanine,18,19,116,129,"
Classical Phenylketonuria (PKU) is an autosomal recessive human genetic disorder caused by a deficiency of hepatic phenylalanine hydroxylase (PAH).",3615198_1,-1,2619,-1,0.22819254
2620,PAH,21,22,143,146,"
Classical Phenylketonuria (PKU) is an autosomal recessive human genetic disorder caused by a deficiency of hepatic phenylalanine hydroxylase (PAH).",3615198_1,-1,2620,-1,0.23179023
2621,PAH,4,5,27,30,"We isolated several mutant PAH cDNA clones from a PKU carrier individual and showed that they contained an internal 116 base pair deletion, corresponding precisely to exon 12 of the human chromosomal PAH gene.",3615198_2,-1,2621,-1,0.20972145
2622,PAH,33,34,200,203,"We isolated several mutant PAH cDNA clones from a PKU carrier individual and showed that they contained an internal 116 base pair deletion, corresponding precisely to exon 12 of the human chromosomal PAH gene.",3615198_2,-1,2622,-1,0.21094216
2623,amino acids,13,15,83,94,The deletion causes the synthesis of a truncated protein lacking the C-terminal 52 amino acids.,3615198_3,-1,2623,-1,0.3057647
2624,PAH,8,9,54,57,Gene transfer and expression studies using the mutant PAH cDNA indicated that the deletion abolishes PAH activity in the cell as a result of protein instability.,3615198_4,-1,2624,-1,0.25015292
2625,PAH,15,16,101,104,Gene transfer and expression studies using the mutant PAH cDNA indicated that the deletion abolishes PAH activity in the cell as a result of protein instability.,3615198_4,-1,2625,-1,0.22611384
2626,PAH,12,13,73,76,"To determine the molecular basis of the deletion, the mutant chromosomal PAH gene was isolated from this individual and shown to contain a GT-- greater than AT substitution at the 5 splice donor site of intron 12.",3615198_5,-1,2626,-1,0.23420535
2627,muscular dystrophy,4,6,29,47,Conservation of the Duchenne muscular dystrophy gene in mice and humans.,3659917_0,-1,2627,-1,0.18123017
2628,muscular dystrophy,5,7,27,45,"
A portion of the Duchenne muscular dystrophy (DMD) gene transcript from human fetal skeletal muscle and mouse adult heart was sequenced, representing approximately 25 percent of the total, 14-kb DMD transcript.",3659917_1,-1,2628,-1,0.1656332
2629,amino acid,5,7,31,41,The nucleic acid and predicted amino acid sequences from the two species are nearly 90 percent homologous.,3659917_2,-1,2629,-1,0.28234017
2630,amino acid,1,3,4,14,"The amino acid sequence that is predicted from this portion of the DMD gene indicates that the protein product might serve a structural role in muscle, but the abundance and tissue distribution of the messenger RNA suggests that the DMD protein is not nebulin..",3659917_3,-1,2630,-1,0.24879402
2631,Prader-Willi syndrome,1,3,9,30,Familial Prader-Willi syndrome with apparently normal chromosomes.,3674116_0,-1,2631,-1,0.21510041
2632,Prader-Willi syndrome,12,14,35,56,"
We report on 4 sibs (2F, 2M) with Prader-Willi syndrome (PWS).",3674116_1,-1,2632,-1,0.2439124
2633,muscular dystrophy,6,8,41,59,Nebulin and titin expression in Duchenne muscular dystrophy appears normal.,3678494_0,-1,2633,-1,0.16787626
2634,muscular dystrophy,24,26,171,189,"
Monoclonal antibodies which recognize different epitopes on either titin or nebulin show normal staining patterns on frozen sections of three muscle biopsies of Duchenne muscular dystrophy (DMD).",3678494_1,-1,2634,-1,0.16265054
2636,myasthenia gravis,7,9,55,72,"Heterozygous C2 deficiency associated with angioedema, myasthenia gravis, and systemic lupus erythematosus.",3718019_0,-1,2636,-1,0.22095016
2637,systemic lupus erythematosus,11,14,78,106,"Heterozygous C2 deficiency associated with angioedema, myasthenia gravis, and systemic lupus erythematosus.",3718019_0,-1,2637,-1,0.18338415
2638,myasthenia gravis,5,7,28,45,"
We describe a patient with myasthenia gravis, systemic lupus erythematosus, and angioedema associated with heterozygous complement factor 2 (C2) deficiency.",3718019_1,-1,2638,-1,0.23324195
2639,systemic lupus erythematosus,8,11,47,75,"
We describe a patient with myasthenia gravis, systemic lupus erythematosus, and angioedema associated with heterozygous complement factor 2 (C2) deficiency.",3718019_1,-1,2639,-1,0.18434088
2641,phenylalanine,6,7,38,51,Gene transfer and expression of human phenylalanine hydroxylase.,3856322_0,-1,2641,-1,0.25525832
2642,phenylalanine,13,14,71,84,"
Phenylketonuria (PKU) is caused by a genetic deficiency of the enzyme phenylalanine hydroxylase (PAH).",3856322_1,-1,2642,-1,0.24214388
2643,PAH,16,17,98,101,"
Phenylketonuria (PKU) is caused by a genetic deficiency of the enzyme phenylalanine hydroxylase (PAH).",3856322_1,-1,2643,-1,0.23138015
2644,PAH,7,8,47,50,A full-length complementary DNA clone of human PAH was inserted into a eukaryotic expression vector and transferred into mouse NIH3T3 cells which do not normally express PAH.,3856322_2,-1,2644,-1,0.23401536
2645,PAH,26,27,170,173,A full-length complementary DNA clone of human PAH was inserted into a eukaryotic expression vector and transferred into mouse NIH3T3 cells which do not normally express PAH.,3856322_2,-1,2645,-1,0.21277931
2646,PAH,5,6,38,41,"The transformed mouse cells expressed PAH messenger RNA, immunoreactive protein, and enzymatic activity that are characteristic of the normal human liver products, demonstrating that a single gene contains all of the necessary genetic information to code for functional PAH.",3856322_3,-1,2646,-1,0.23470388
2647,PAH,41,42,270,273,"The transformed mouse cells expressed PAH messenger RNA, immunoreactive protein, and enzymatic activity that are characteristic of the normal human liver products, demonstrating that a single gene contains all of the necessary genetic information to code for functional PAH.",3856322_3,-1,2647,-1,0.21192649
2648,PAH,8,9,43,46,"These results support the use of the human PAH probe in prenatal diagnosis and detection of carriers, to provide new opportunities for the biochemical characterization of normal and mutant enzymes, and in the investigation of alternative genetic therapies for PKU..",3856322_4,-1,2648,-1,0.24718674
2649,phenylalanine,4,5,24,37,Regional mapping of the phenylalanine hydroxylase gene and the phenylketonuria locus in the human genome.,3862128_0,-1,2649,-1,0.25463733
2650,amino acid metabolism,10,13,61,82,"
Phenylketonuria (PKU) is an autosomal recessive disorder of amino acid metabolism caused by a deficiency of the hepatic enzyme phenylalanine hydroxylase (PAH; phenylalanine 4-monooxygenase, EC 1. 14. 16. 1).",3862128_1,-1,2650,-1,0.19726548
2651,phenylalanine,21,22,128,141,"
Phenylketonuria (PKU) is an autosomal recessive disorder of amino acid metabolism caused by a deficiency of the hepatic enzyme phenylalanine hydroxylase (PAH; phenylalanine 4-monooxygenase, EC 1. 14. 16. 1).",3862128_1,-1,2651,-1,0.24403484
2652,PAH,24,25,155,158,"
Phenylketonuria (PKU) is an autosomal recessive disorder of amino acid metabolism caused by a deficiency of the hepatic enzyme phenylalanine hydroxylase (PAH; phenylalanine 4-monooxygenase, EC 1. 14. 16. 1).",3862128_1,-1,2652,-1,0.26165506
2653,phenylalanine,26,27,160,173,"
Phenylketonuria (PKU) is an autosomal recessive disorder of amino acid metabolism caused by a deficiency of the hepatic enzyme phenylalanine hydroxylase (PAH; phenylalanine 4-monooxygenase, EC 1. 14. 16. 1).",3862128_1,-1,2653,-1,0.263194
2654,PAH,5,6,23,26,A cDNA clone for human PAH has previously been used to assign the corresponding gene to human chromosome 12.,3862128_2,-1,2654,-1,0.25539398
2655,map,4,5,23,26,"To define the regional map position of the disease locus and the PAH gene on human chromosome 12, DNA was isolated from human-hamster somatic cell hybrids with various deletions of human chromosome 12 and was analyzed by Southern blot analysis using the human cDNA PAH clone as a hybridization probe.",3862128_3,-1,2655,-1,0.22919068
2656,disease,8,9,43,50,"To define the regional map position of the disease locus and the PAH gene on human chromosome 12, DNA was isolated from human-hamster somatic cell hybrids with various deletions of human chromosome 12 and was analyzed by Southern blot analysis using the human cDNA PAH clone as a hybridization probe.",3862128_3,-1,2656,-1,0.2092723
2657,PAH,12,13,65,68,"To define the regional map position of the disease locus and the PAH gene on human chromosome 12, DNA was isolated from human-hamster somatic cell hybrids with various deletions of human chromosome 12 and was analyzed by Southern blot analysis using the human cDNA PAH clone as a hybridization probe.",3862128_3,-1,2657,-1,0.21571144
2658,PAH,45,46,265,268,"To define the regional map position of the disease locus and the PAH gene on human chromosome 12, DNA was isolated from human-hamster somatic cell hybrids with various deletions of human chromosome 12 and was analyzed by Southern blot analysis using the human cDNA PAH clone as a hybridization probe.",3862128_3,-1,2658,-1,0.20975459
2659,PAH,24,25,158,161,"From these results, together with detailed biochemical and cytogenetic characterization of the hybrid cells, the region on chromosome 12 containing the human PAH gene has been defined as 12q14.",3862128_4,-1,2659,-1,0.25444645
2660,PAH map,1,3,4,11,The PAH map position on chromosome 12 was further localized by in situ hybridization of 125I-labeled human PAH cDNA to chromosomes prepared from a human lymphoblastoid cell line.,3862128_6,-1,2660,-1,0.24345572
2661,PAH,17,18,107,110,The PAH map position on chromosome 12 was further localized by in situ hybridization of 125I-labeled human PAH cDNA to chromosomes prepared from a human lymphoblastoid cell line.,3862128_6,-1,2661,-1,0.2206317
2662,PAH,13,14,90,93,Results of these experiments demonstrated that the region on chromosome 12 containing the PAH gene and the PKU locus in man is 12q22----12q24. 1.,3862128_7,-1,2662,-1,0.2588839
2663,map,7,8,46,49,These results not only provide a regionalized map position for a major human disease locus but also can serve as a reference point for linkage analysis with other DNA markers on human chromosome 12,3862128_8,-1,2663,-1,0.19999363
2664,disease,13,14,77,84,These results not only provide a regionalized map position for a major human disease locus but also can serve as a reference point for linkage analysis with other DNA markers on human chromosome 12,3862128_8,-1,2664,-1,0.19012071
2665,disease,6,7,39,46,Heterogeneity of type I von Willebrand disease: evidence for a subgroup with an abnormal von Willebrand factor.,3876122_0,-1,2665,-1,0.19973025
2666,disease,4,5,23,30,"
Type I von Willebrand disease (vWD) is characterized by equally low plasma concentrations of von Willebrand factor antigen (vWF  Ag) and ristocetin cofactor (RiCof) and by the presence of all vWF multimers in sodium dodecyl sulfate (SDS) -agarose gel electrophoresis.",3876122_1,-1,2666,-1,0.19825037
2667,Ag,23,24,130,132,"
Type I von Willebrand disease (vWD) is characterized by equally low plasma concentrations of von Willebrand factor antigen (vWF  Ag) and ristocetin cofactor (RiCof) and by the presence of all vWF multimers in sodium dodecyl sulfate (SDS) -agarose gel electrophoresis.",3876122_1,-1,2667,-1,0.3003005
2668,sodium,40,41,210,216,"
Type I von Willebrand disease (vWD) is characterized by equally low plasma concentrations of von Willebrand factor antigen (vWF  Ag) and ristocetin cofactor (RiCof) and by the presence of all vWF multimers in sodium dodecyl sulfate (SDS) -agarose gel electrophoresis.",3876122_1,-1,2668,-1,0.3237426
2669,Ag,21,22,107,109,"For 17 patients (13 kindreds) diagnosed with these criteria, we have studied the platelet contents of vWF  Ag and RiCof and the changes of these in plasma after DDAVP infusion.",3876122_2,-1,2669,-1,0.3176408
2670,DDAVP,32,33,161,166,"For 17 patients (13 kindreds) diagnosed with these criteria, we have studied the platelet contents of vWF  Ag and RiCof and the changes of these in plasma after DDAVP infusion.",3876122_2,-1,2670,-1,0.2584537
2671,Ag,3,4,14,16,"Platelet vWF  Ag and RiCof were normal in four kindreds (called "" platelet normal "" subgroup); following 1-deamino-8-D-arginine vasopressin; plasma vWF  Ag, RiCof and the bleeding time (BT) became normal.",3876122_3,-1,2671,-1,0.3012413
2672,vasopressin,22,23,128,139,"Platelet vWF  Ag and RiCof were normal in four kindreds (called "" platelet normal "" subgroup); following 1-deamino-8-D-arginine vasopressin; plasma vWF  Ag, RiCof and the bleeding time (BT) became normal.",3876122_3,-1,2672,-1,0.29468283
2673,Ag,27,28,153,155,"Platelet vWF  Ag and RiCof were normal in four kindreds (called "" platelet normal "" subgroup); following 1-deamino-8-D-arginine vasopressin; plasma vWF  Ag, RiCof and the bleeding time (BT) became normal.",3876122_3,-1,2673,-1,0.31215864
2675,Ag,7,8,31,33,"In six kindreds, platelet vWF  Ag and RiCof were equally low (platelet low); after DDAVP, plasma vWF  Ag and RiCof remained low, and the BT was prolonged.",3876122_4,-1,2675,-1,0.2840796
2676,DDAVP,19,20,83,88,"In six kindreds, platelet vWF  Ag and RiCof were equally low (platelet low); after DDAVP, plasma vWF  Ag and RiCof remained low, and the BT was prolonged.",3876122_4,-1,2676,-1,0.28451598
2677,Ag,24,25,102,104,"In six kindreds, platelet vWF  Ag and RiCof were equally low (platelet low); after DDAVP, plasma vWF  Ag and RiCof remained low, and the BT was prolonged.",3876122_4,-1,2677,-1,0.28792152
2678,Ag,12,13,80,82,"In three additional kindreds, platelets contained normal concentrations of vWF  Ag, but RiCof was very low (platelet discordant); even though a complete set of multimers was found in plasma and platelets, there was a relatively small amount of large multimers.",3876122_5,-1,2678,-1,0.3179571
2679,DDAVP,1,2,6,11,"After DDAVP, plasma vWF  Ag became normal, but RiCof remained low and the BT was very prolonged.",3876122_6,-1,2679,-1,0.30218846
2680,Ag,6,7,25,27,"After DDAVP, plasma vWF  Ag became normal, but RiCof remained low and the BT was very prolonged.",3876122_6,-1,2680,-1,0.31989712
2681,Ag,16,17,84,86,"These findings demonstrated that there can be an abnormal vWF (RiCof less than vWF  Ag) even in type I vWD, coexisting with a complete set of vWF multimers (platelet discordant); that the abnormal vWF can be shown more clearly in platelets than in plasma or else in plasma after DDAVP infusion; and that DDAVP normalizes the BT only in those patients with normal platelet levels of both vWF  Ag and RiCof (platelet normal)..",3876122_7,-1,2681,-1,0.2790081
2682,DDAVP,56,57,279,284,"These findings demonstrated that there can be an abnormal vWF (RiCof less than vWF  Ag) even in type I vWD, coexisting with a complete set of vWF multimers (platelet discordant); that the abnormal vWF can be shown more clearly in platelets than in plasma or else in plasma after DDAVP infusion; and that DDAVP normalizes the BT only in those patients with normal platelet levels of both vWF  Ag and RiCof (platelet normal)..",3876122_7,-1,2682,-1,0.31114677
2683,DDAVP,61,62,304,309,"These findings demonstrated that there can be an abnormal vWF (RiCof less than vWF  Ag) even in type I vWD, coexisting with a complete set of vWF multimers (platelet discordant); that the abnormal vWF can be shown more clearly in platelets than in plasma or else in plasma after DDAVP infusion; and that DDAVP normalizes the BT only in those patients with normal platelet levels of both vWF  Ag and RiCof (platelet normal)..",3876122_7,-1,2683,-1,0.33369514
2684,Ag,77,78,392,394,"These findings demonstrated that there can be an abnormal vWF (RiCof less than vWF  Ag) even in type I vWD, coexisting with a complete set of vWF multimers (platelet discordant); that the abnormal vWF can be shown more clearly in platelets than in plasma or else in plasma after DDAVP infusion; and that DDAVP normalizes the BT only in those patients with normal platelet levels of both vWF  Ag and RiCof (platelet normal)..",3876122_7,-1,2684,-1,0.28108293
2685,van der Woude syndrome,5,9,34,56,Genetic analysis in families with van der Woude syndrome.,4019732_0,-1,2685,-1,0.23478839
2686,van der Woude syndrome,37,41,224,246,"
We have brought together information on 864 affected individuals in 164 families (including three new pedigrees) reported in the 137 year period since 1845 when Demarquay first described a family with what was later called van der Woude syndrome (VWS).",4019732_1,-1,2686,-1,0.22048853
2687,cleft palate,6,8,26,38,"Both types of oral cleft, cleft palate (CP) and cleft lip with or without CP (CLP), segregate in these families together with lower lip pits or fistulae in an autosomal dominant mode with high penetrance estimated to be K =.",4019732_2,-1,2687,-1,0.20802763
2688,CP,9,10,40,42,"Both types of oral cleft, cleft palate (CP) and cleft lip with or without CP (CLP), segregate in these families together with lower lip pits or fistulae in an autosomal dominant mode with high penetrance estimated to be K =.",4019732_2,-1,2688,-1,0.23531766
2689,cleft lip,12,14,48,57,"Both types of oral cleft, cleft palate (CP) and cleft lip with or without CP (CLP), segregate in these families together with lower lip pits or fistulae in an autosomal dominant mode with high penetrance estimated to be K =.",4019732_2,-1,2689,-1,0.23031129
2690,CP,17,18,74,76,"Both types of oral cleft, cleft palate (CP) and cleft lip with or without CP (CLP), segregate in these families together with lower lip pits or fistulae in an autosomal dominant mode with high penetrance estimated to be K =.",4019732_2,-1,2690,-1,0.22278577
2691,K,44,45,220,221,"Both types of oral cleft, cleft palate (CP) and cleft lip with or without CP (CLP), segregate in these families together with lower lip pits or fistulae in an autosomal dominant mode with high penetrance estimated to be K =.",4019732_2,-1,2691,-1,0.30697477
2692,CP,5,6,21,23,"Cleft types (CLP and CP) occur in VWS in the same proportions as in the general non-VWS population, ie, about twice as many cleft-bearing individuals have CLP as have CP.",4019732_5,-1,2692,-1,0.27271423
2693,ie,21,22,100,102,"Cleft types (CLP and CP) occur in VWS in the same proportions as in the general non-VWS population, ie, about twice as many cleft-bearing individuals have CLP as have CP.",4019732_5,-1,2693,-1,0.34154785
2694,CP,33,34,167,169,"Cleft types (CLP and CP) occur in VWS in the same proportions as in the general non-VWS population, ie, about twice as many cleft-bearing individuals have CLP as have CP.",4019732_5,-1,2694,-1,0.24643995
2695,CP,16,17,78,80,"On the other hand, we do not find the usually observed excess of females with CP and excess of males with CLP; in VWS the sex ratios are more nearly equal.",4019732_6,-1,2695,-1,0.27234572
2696,spondylitis,14,15,93,104,"
The serum of a 44-yr-old woman of French-Canadian descent having a B-27 positive ankylosing spondylitis was deficient in the seventh component of complement (C7) as determined by hemolytic and immunochemical methods.",409732_2,-1,2696,-1,0.20870419
2697,hemolytic,29,30,180,189,"
The serum of a 44-yr-old woman of French-Canadian descent having a B-27 positive ankylosing spondylitis was deficient in the seventh component of complement (C7) as determined by hemolytic and immunochemical methods.",409732_2,-1,2697,-1,0.22738595
2698,CM,20,21,111,113,Studies of the HLA antigens in all the 22 subjects and in three spouses indicated no close linkage between the CM deficienty and the HLA system.,409732_8,-1,2698,-1,0.35243002
2704,hemolytic,15,16,83,92,"The proband, who has had nine episodes of disseminated gonococcal infection, has a hemolytic C5 level of approximately 0.",495634_3,-1,2704,-1,0.2571474
2705,hemolytic,14,15,77,86,"The probands twin as well as another sister also had extremely low levels of hemolytic C5 (approximately 0. 5 per cent normal), but both these subjects have been healthy.",495634_6,-1,2705,-1,0.26594743
2706,Hemolytic,0,1,0,9,Hemolytic complement and bacteriolytic activity could be restored by the addition of purified C5.,495634_7,-1,2706,-1,0.25179324
2708,hemolytic,12,13,81,90,Twenty-two of 32 other family members from three generations had depressed whole hemolytic complement levels.,495634_10,-1,2708,-1,0.26365614
2709,hemolytic,9,10,38,47,"In 19 of 30 family members, levels of hemolytic C5 ranged from 13 to 64 per cent of normal.",495634_11,-1,2709,-1,0.28148735
2710,NADPH,15,16,66,71,"These three variants had normal levels of Km G6P, Km NADP, and Ki NADPH, normal utilizations of both 2-deoxy-G6P and deamino-NAPD, normal heat stability, and a normal pH curve.",511159_8,-1,2710,-1,0.28372443
2711,Lesch-Nyhan syndrome,17,19,104,124,"Utilization of purines by an HPRT variant in an intelligent, nonmutilative patient with features of the Lesch-Nyhan syndrome.",523196_0,-1,2711,-1,0.20511244
2712,hyperuricemia,8,9,38,51,"B., was among the first reported with hyperuricemia and central nervous system symptoms.",523196_2,-1,2712,-1,0.2634502
2713,Lesch-Nyhan syndrome,10,12,57,77,8) distinct from the enzyme present in patients with the Lesch-Nyhan syndrome.,523196_5,-1,2713,-1,0.22085999
2714,spasticity,5,6,33,43,"The patient had chroeoathetosis, spasticity, dysarthric speech, and hyperuricemia.",523196_6,-1,2714,-1,0.20323215
2715,hyperuricemia,11,12,68,81,"The patient had chroeoathetosis, spasticity, dysarthric speech, and hyperuricemia.",523196_6,-1,2715,-1,0.26748374
2716,purine,9,10,48,54,"Using a newly developed method for the study of purine metabolism in intact cultured cells, this patient was found to metabolize some 9% of 8-14C-hypoxanthine, and 90% of the isotope utilized was converted to adenine and guanine nucleotides.",523196_9,-1,2716,-1,0.21649984
2717,contrast,1,2,3,11,"In contrast, cells from patients with the Lesch-Nyhan syndrome were virtually completely unable to convert hypoxanthine to nucleotides.",523196_10,-1,2717,-1,0.25437522
2718,Lesch-Nyhan syndrome,8,10,42,62,"In contrast, cells from patients with the Lesch-Nyhan syndrome were virtually completely unable to convert hypoxanthine to nucleotides.",523196_10,-1,2718,-1,0.20879574
2719,thymidine,16,17,117,126,"The growth of the cultured fibroblasts of this patient was intermediate in media containing hypoxanthine aminopterin thymidine (HAT), whereas the growth of Lesch-Nyhan cells was inhibited and normal cells grew normally.",523196_12,-1,2719,-1,0.23153824
2720,8-azaguanine,2,3,13,25,"Similarly in 8-azaguanine, 6-thioguanine, and 8-azahypoxanthine, the growth of the patients cells was intermediate between normal and Lesch-Nyhan cells.",523196_13,-1,2720,-1,0.2900236
2721,8-azaguanine,2,3,13,25,"Similarly in 8-azaguanine, 6-thioguanine, and 8-azahypoxanthine, the growth of the patients cells was intermediate between normal and Lesch-Nyhan cells.",523196_13,-1,2721,-1,0.2900236
2722,6-thioguanine,4,5,27,40,"Similarly in 8-azaguanine, 6-thioguanine, and 8-azahypoxanthine, the growth of the patients cells was intermediate between normal and Lesch-Nyhan cells.",523196_13,-1,2722,-1,0.282482
2723,purine,13,14,103,109,These observations provide further evidence for genetic heterogeneity among patients with disorders in purine metabolism involving the HPRT gene.,523196_14,-1,2723,-1,0.20765772
2724,muscular dystrophy,4,6,27,45,Localisation of the Becker muscular dystrophy gene on the short arm of the X chromosome by linkage to cloned DNA sequences.,6086495_0,-1,2724,-1,0.17161807
2725,muscular dystrophy,6,8,30,48,"
A linkage study in 30 Becker muscular dystrophy (BMD) kindreds using three cloned DNA sequences from the X chromosome which demonstrate restriction fragment length polymorphisms (RFLPs), suggests that the BMD gene is located on the short arm of the X chromosome, in the p21 region.",6086495_1,-1,2725,-1,0.16197
2726,gouty arthritis,6,8,46,61,"Partial HPRT deficiencies are associated with gouty arthritis, while absence of activity results in Lesch-Nyhan syndrome (L-N).",6087154_3,-1,2726,-1,0.20949565
2727,Lesch-Nyhan syndrome,15,17,100,120,"Partial HPRT deficiencies are associated with gouty arthritis, while absence of activity results in Lesch-Nyhan syndrome (L-N).",6087154_3,-1,2727,-1,0.19563197
2728,syndrome,19,20,110,118,"Thus, Haldanes principle predicts that new mutations at the hprt locus must occur frequently in order for L-N syndrome to be maintained in the population.",6087154_5,-1,2728,-1,0.24500121
2729,Wiskott-Aldrich syndrome,12,14,93,117,Allelic exclusion of glucose-6-phosphate dehydrogenase in platelets and T lymphocytes from a Wiskott-Aldrich syndrome carrier.,6101415_0,-1,2729,-1,0.20710438
2730,Wiskott-Aldrich syndrome,5,7,28,52,"
An obligate carrier of the Wiskott-Aldrich syndrome (WAS) who was also heterozygous for the A and B types of X-linked glucose-6-phosphate dehydrogenase was found.",6101415_1,-1,2730,-1,0.2162941
2731,Wiskott-Aldrich syndrome,35,37,223,247,These findings suggest that selection against the WAS gene occurs in platelets and thymus-derived T lymphocytes and that the defects associated with WAS expressed in these cell-types may be implicated in the genesis of the Wiskott-Aldrich syndrome..,6101415_5,-1,2731,-1,0.19271287
2732,nephritis,3,4,26,35,Complement deficiency and nephritis.,6103091_0,-1,2732,-1,0.24893758
2735,haematuria,16,17,135,145,One child with heterozygous C3 deficiency was found to have membranoproliferative glomerulonephritis; proteinuria and/or microscopical haematuria was present in all three homozygous C3-deficient children.,6103091_3,-1,2735,-1,0.22759911
2738,renal disease,17,19,94,107,The only child of the family with normal complement had no increased risk of infection and no renal disease.,6103091_5,-1,2738,-1,0.23194864
2739,nephritis,14,15,94,103,This family study provides further support for the proposal that C3 deficiency predisposes to nephritis..,6103091_6,-1,2739,-1,0.20604537
2740,thalassemia,20,21,131,142,"In Sardinians with the beta 0-thalassemia trait, parasite growth was normal except when G6PD deficiency occurred together with the thalassemia trait.",6337374_3,-1,2740,-1,0.23124605
2741,malaria,30,31,186,193,"The data support the hypothesis that G6PD deficiency may confer a selective advantage in a malarious area; the female heterozygote may be at a particular advantage because resistance to malaria equals that of male hemizygotes, but the risk of fatal hemolysis may be less.",6337374_4,-1,2741,-1,0.23798561
2743,adrenoleukodystrophy,4,5,26,46,Bone marrow transplant in adrenoleukodystrophy.,6387532_0,-1,2743,-1,0.2183428
2744,adrenoleukodystrophy,24,25,146,166,"
An allogeneic bone marrow transplant (BMT) from a normal HLA identical sibling donor was performed in a 13-year-old boy with rapidly progressive adrenoleukodystrophy (ALD).",6387532_1,-1,2744,-1,0.19553144
2745,neurologic deterioration,11,13,75,99,"Engraftment and complete hematologic recovery occurred within 4 weeks, but neurologic deterioration continued.",6387532_2,-1,2745,-1,0.20668398
2746,adenovirus infection,5,7,23,43,The patient died of an adenovirus infection 141 days after BMT.,6387532_3,-1,2746,-1,0.20630032
2747,fatty acids,12,14,73,84,ALD is characterized by abnormally high plasma levels of very long chain fatty acids (VLCFA) as a result of impaired capacity to degrade them.,6387532_4,-1,2747,-1,0.27068302
2748,IV,14,15,79,81,Among 7 samples of G6PD with normal and increased activity two new variants of IV class -- Nukha and Bash-Kungut -- were found..,6453040_6,-1,2748,-1,0.30595937
2749,Adrenoleukodystrophy,0,1,0,20,"Adrenoleukodystrophy: survey of 303 cases: biochemistry, diagnosis, and therapy.",6524872_0,-1,2749,-1,0.24133301
2750,Adrenoleukodystrophy,0,1,1,21,"
Adrenoleukodystrophy (ALD) is a genetically determined disorder associated with progressive central demyelination and adrenal cortical insufficiency.",6524872_1,-1,2750,-1,0.21213125
2751,fatty acids,10,12,83,94,"All affected persons show increased levels of saturated unbranched very-long-chain fatty acids, particularly hexacosanoate (C26  0), because of impaired capacity to degrade these acids.",6524872_2,-1,2751,-1,0.27068245
2752,syndrome,20,21,141,149,"This degradation normally takes place in a subcellular organelle called the peroxisome, and ALD, together with Zellwegers cerebrohepatorenal syndrome, is now considered to belong to the newly formed category of peroxisomal disorders.",6524872_3,-1,2752,-1,0.21859933
2753,peroxisomal disorders,33,35,211,232,"This degradation normally takes place in a subcellular organelle called the peroxisome, and ALD, together with Zellwegers cerebrohepatorenal syndrome, is now considered to belong to the newly formed category of peroxisomal disorders.",6524872_3,-1,2753,-1,0.2067541
2754,syndrome,16,17,109,117,"Neonatal ALD, a distinct entity with autosomal recessive inheritance and points of resemblance to Zellwegers syndrome, accounted for 7% of the cases.",6524872_8,-1,2754,-1,0.20302649
2755,muscular dystrophy,11,13,60,78,Clinical use of DNA markers linked to the gene for Duchenne muscular dystrophy.,6585184_0,-1,2755,-1,0.16593504
2756,muscular dystrophy,4,6,32,50,"
Seventy families with Duchenne muscular dystrophy (DMD) known to the Institute of Child Health fall into three categories with respect to potential linkage analysis with the X chromosome DNA markers RC8 and L1.",6585184_1,-1,2756,-1,0.1704891
2757,n,12,13,72,73,Families in which there is at least one obligatory female heterozygote (n = 13).,6585184_3,-1,2757,-1,0.30415264
2758,n,19,20,93,94,"Families in which there is a single affected boy, who also has one or more healthy brothers (n = 26).",6585184_5,-1,2758,-1,0.31880224
2759,n,10,11,53,54,Families with a single affected boy with no brother (n = 30).,6585184_7,-1,2759,-1,0.31713444
2760,syndrome,5,6,30,38,"Family studies in Bechterew's syndrome (ankylosing spondylitis) III. Genetics.
The results of segregation analyses in 75 families where the proband had ankylosing spondylitis, are presented.",6604602_0,-1,2760,-1,0.2070725
2761,spondylitis,8,9,51,62,"Family studies in Bechterew's syndrome (ankylosing spondylitis) III. Genetics.
The results of segregation analyses in 75 families where the proband had ankylosing spondylitis, are presented.",6604602_0,-1,2761,-1,0.22879633
2762,spondylitis,27,28,163,174,"Family studies in Bechterew's syndrome (ankylosing spondylitis) III. Genetics.
The results of segregation analyses in 75 families where the proband had ankylosing spondylitis, are presented.",6604602_0,-1,2762,-1,0.22391956
2763,spondylitis,10,11,66,77,The results were in agreement with our hypothesis that ankylosing spondylitis is part of a syndrome where different genetic factors interact.,6604602_3,-1,2763,-1,0.20769618
2764,syndrome,15,16,91,99,The results were in agreement with our hypothesis that ankylosing spondylitis is part of a syndrome where different genetic factors interact.,6604602_3,-1,2764,-1,0.20017113
2765,disease,7,8,42,49,"Such known factors are HLA B27 associated disease susceptibility, susceptibility to psoriatic arthropathy and susceptibility to entero-arthropathy.",6604602_4,-1,2765,-1,0.20433673
2766,psoriatic,12,13,84,93,"Such known factors are HLA B27 associated disease susceptibility, susceptibility to psoriatic arthropathy and susceptibility to entero-arthropathy.",6604602_4,-1,2766,-1,0.22919363
2769,disease,11,12,69,76,"Environmental factors (intestinal bacteria) are known to trigger the disease at least in some persons, and we have postulated that all or most of them have the predisposition to develop disease.",6604602_6,-1,2769,-1,0.2439787
2770,disease,33,34,186,193,"Environmental factors (intestinal bacteria) are known to trigger the disease at least in some persons, and we have postulated that all or most of them have the predisposition to develop disease.",6604602_6,-1,2770,-1,0.23198369
2771,syndrome,3,4,10,18,"Thus, the syndrome has a multifactorial etiology.",6604602_7,-1,2771,-1,0.25249892
2773,uveitis,17,18,127,134,"The phenotypic expressions of the different genetic predispositions involved, include sacro-iliitis, psoriasis, acute anterior uveitis, peripheral arthropathy and inflammatory bowel disease.",6604602_8,-1,2773,-1,0.20932896
2774,inflammatory bowel disease,22,25,163,189,"The phenotypic expressions of the different genetic predispositions involved, include sacro-iliitis, psoriasis, acute anterior uveitis, peripheral arthropathy and inflammatory bowel disease.",6604602_8,-1,2774,-1,0.18563367
2776,syndrome,14,15,94,102,We suggest the descriptive name HEREDITARY MULTIFOCAL RELAPSING INFLAMMATION (HEMRI) for this syndrome.,6604602_9,-1,2776,-1,0.22051951
2777,spondylitis,1,2,11,22,"Ankylosing spondylitis, psoriatic arthropathy and entero-arthropathy may be regarded as clinical sub-types of the syndrome..",6604602_10,-1,2777,-1,0.20771618
2778,psoriatic,3,4,24,33,"Ankylosing spondylitis, psoriatic arthropathy and entero-arthropathy may be regarded as clinical sub-types of the syndrome..",6604602_10,-1,2778,-1,0.2313823
2779,syndrome,15,16,114,122,"Ankylosing spondylitis, psoriatic arthropathy and entero-arthropathy may be regarded as clinical sub-types of the syndrome..",6604602_10,-1,2779,-1,0.2594297
2780,Prader-Willi syndrome,0,2,0,21,Prader-Willi syndrome and chromosome 15.,6618488_0,-1,2780,-1,0.24996114
2781,Prader-Willi syndrome,20,22,107,128,"
A chromosome 15 anomaly was observed in 12 of 20 patients, 17 of whom were clinically suspected of having Prader-Willi syndrome (PWS).",6618488_2,-1,2781,-1,0.2236825
2782,Tay-Sachs disease,1,3,4,21,The Tay-Sachs disease gene in North American Jewish populations: geographic variations and origin.,6650504_0,-1,2782,-1,0.25759843
2783,Tay-Sachs disease,7,9,41,58,"
From data collected in a North American Tay-Sachs disease (TSD) heterozygote screening program, the TSD carrier frequency among 46, 304 Jewish individuals was found to be.",6650504_1,-1,2783,-1,0.26473385
2784,P,32,33,176,177,"Relative to Jews of Polish and Russian origins, there was at least a twofold increase in the TSD carrier frequency in Jews of Austrian, Hungarian, and Czechoslovakian origins (P less than. 005).",6650504_7,-1,2784,-1,0.28323177
2787,hemolytic,2,3,17,26,Serum complement hemolytic and bactericidal activities were lacking and could be restored to normal by addition of appropriate amounts of purified C6.,6783144_3,-1,2787,-1,0.2259015
2794,lupus erythematosus,2,4,17,36,Familial discoid lupus erythematosus associated with heterozygote C2 deficiency.,6902670_0,-1,2794,-1,0.19855143
2795,lupus erythematosus,5,7,35,54,"
Two siblings with chronic discoid lupus erythematosus and several family members were found with heterozygous C2 deficiency.",6902670_1,-1,2795,-1,0.20184027
2800,C,11,12,65,66,"0 with otherwise normal properties (heat stability at 46 degrees C, apparent affinity for substrates, optimum pH, and utilization of substrate analogues).",7055648_4,-1,2800,-1,0.306868
2801,favism,22,23,151,157,"Heterogeneity of ""Mediterranean type"" glucose-6-phosphate dehydrogenase (G6PD) deficiency in Spain and description of two new variants associated with favism.",7106752_0,-1,2801,-1,0.268775
2803,Favism,3,4,4,10,"(3) Favism has been observed associated with all kinds of variants described here. (4) G6PD Betica, which is the most frequent variant found in subjects of Southern Spanish origin, has been observed associated with favism in all cases except one.",7106752_11,-1,2803,-1,0.23879752
2804,favism,41,42,215,221,"(3) Favism has been observed associated with all kinds of variants described here. (4) G6PD Betica, which is the most frequent variant found in subjects of Southern Spanish origin, has been observed associated with favism in all cases except one.",7106752_11,-1,2804,-1,0.24274537
2808,hemolytic,4,5,19,28,He had episodes of hemolytic crisis several times after upper respiratory infection.,7166314_3,-1,2808,-1,0.1913461
2810,NADPH,30,31,167,172,"The enzymatic characteristics were examined when he was 5 years old, and his G6PD showed faster-than-normal electrophoretic mobility, low Km G6P, high Km NADP, low Ki NADPH, normal utilization of substrate analogues, heat instability, and a normal pH optimum curve.",7166314_6,-1,2810,-1,0.27246803
2813,myasthenia gravis,3,5,31,48,Heterozygous C2-deficiency and myasthenia gravis.,7191069_0,-1,2813,-1,0.21597722
2814,myasthenia gravis,4,6,33,50,"
Complement deficiency states in myasthenia gravis (MG) have not been reported previously.",7191069_1,-1,2814,-1,0.21631649
2815,MG,7,8,52,54,"
Complement deficiency states in myasthenia gravis (MG) have not been reported previously.",7191069_1,-1,2815,-1,0.22691411
2816,MG,7,8,45,47,"We describe a 19-year-old woman with typical MG and heterozygous C2 deficiency, along with HLA typing of the patient and her immediate family..",7191069_2,-1,2816,-1,0.24521382
2817,Adrenoleukodystrophy,0,1,0,20,Adrenoleukodystrophy: increased plasma content of saturated very long chain fatty acids.,7202134_0,-1,2817,-1,0.23279713
2818,fatty acids,10,12,76,87,Adrenoleukodystrophy: increased plasma content of saturated very long chain fatty acids.,7202134_0,-1,2818,-1,0.2503233
2819,fatty acids,11,13,61,72,"
With a new method we measured the saturated very long chain fatty acids in the plasma of adrenoleukodystrophy (ALD) hemizygotes, ALD heterozygotes, and controls.",7202134_1,-1,2819,-1,0.26382297
2820,adrenoleukodystrophy,17,18,90,110,"
With a new method we measured the saturated very long chain fatty acids in the plasma of adrenoleukodystrophy (ALD) hemizygotes, ALD heterozygotes, and controls.",7202134_1,-1,2820,-1,0.21288243
2821,fatty acid,9,11,62,72,ALD hemizygotes showed increased levels of hexacosanoate (C26 fatty acid) which represented 0.,7202134_2,-1,2821,-1,0.30902222
2822,fatty acids,12,14,32,43,"081 +/- 0. 0066% (SEM) of total fatty acids, compared to 0. 015 +/- 0. 0032% in the controls.",7202134_3,-1,2822,-1,0.3287374
2823,fatty acids,6,8,18,29,"C25, C24, and C23 fatty acids were also increased, but the C22 and C20 fatty acids were normal.",7202134_4,-1,2823,-1,0.3141184
2824,fatty acids,17,19,71,82,"C25, C24, and C23 fatty acids were also increased, but the C22 and C20 fatty acids were normal.",7202134_4,-1,2824,-1,0.30659288
2825,fatty acids,9,11,26,37,057 +/- 0. 0063% of total fatty acids.,7202134_6,-1,2825,-1,0.33475426
2826,xanthomatosis,6,7,55,68,Abnormal high density lipoproteins in cerebrotendinous xanthomatosis.,7298854_0,-1,2826,-1,0.18334223
2827,disease,18,19,117,124,"
The plasma lipoprotein profiles and high density lipoproteins (HDL) were characterized in patients with the genetic disease cerebrotendinous xanthomatosis (CTX).",7298854_1,-1,2827,-1,0.23582387
2828,xanthomatosis,20,21,142,155,"
The plasma lipoprotein profiles and high density lipoproteins (HDL) were characterized in patients with the genetic disease cerebrotendinous xanthomatosis (CTX).",7298854_1,-1,2828,-1,0.19183418
2829,CTX,22,23,157,160,"
The plasma lipoprotein profiles and high density lipoproteins (HDL) were characterized in patients with the genetic disease cerebrotendinous xanthomatosis (CTX).",7298854_1,-1,2829,-1,0.21462893
2830,cholesterol,26,27,176,187,Abnormalities in the HDL may contribute to their increased atherogenesis and excessive deposits of tissue sterols in the presence of low or low-normal concentrations of plasma cholesterol (165 +/- 25 mg/dl) and low density lipoproteins (LDL).,7298854_2,-1,2830,-1,0.22126725
2831,CTX,6,7,46,49,"The mean HDL-cholesterol concentration in the CTX plasmas was 14. 5 +/- 3. 2 mg/dl, about one-third the normal value.",7298854_3,-1,2831,-1,0.33176437
2832,cholesteryl esters,6,8,28,46,"Relative to normal HDL, the cholesteryl esters are low, free cholesterol and phospholipids essentially normal, and triglycerides increased.",7298854_5,-1,2832,-1,0.2865823
2833,cholesterol,12,13,61,72,"Relative to normal HDL, the cholesteryl esters are low, free cholesterol and phospholipids essentially normal, and triglycerides increased.",7298854_5,-1,2833,-1,0.22229499
2834,triglycerides,19,20,115,128,"Relative to normal HDL, the cholesteryl esters are low, free cholesterol and phospholipids essentially normal, and triglycerides increased.",7298854_5,-1,2834,-1,0.26725608
2835,cholesterol,9,10,39,50,The ratio of apoprotein (apo) to total cholesterol in the HDL of CTX was two to three times greater than normal.,7298854_6,-1,2835,-1,0.25189626
2836,CTX,14,15,65,68,The ratio of apoprotein (apo) to total cholesterol in the HDL of CTX was two to three times greater than normal.,7298854_6,-1,2836,-1,0.31741023
2837,CTX,2,3,7,10,"In the CTX HDL, the ratio of apoAI to apoAII was high, the proportion of apoC low, and a normally minor form of apoAI increased relative to other forms.",7298854_7,-1,2837,-1,0.30271542
2838,bile acid,29,31,185,194,The abnormalities in lipoprotein distribution profile and composition of the plasma HDL result from metabolic defects that are not understood but may be linked to the genetic defect in bile acid synthesis in CTX.,7298854_9,-1,2838,-1,0.27100867
2839,CTX,33,34,208,211,The abnormalities in lipoprotein distribution profile and composition of the plasma HDL result from metabolic defects that are not understood but may be linked to the genetic defect in bile acid synthesis in CTX.,7298854_9,-1,2839,-1,0.27381346
2840,cholesterol,26,27,153,164,"As a consequence, it is probable that the normal functions of the HDL, possibly including modulation of LDL-cholesterol uptake and the removal of excess cholesterol from peripheral tissues, are perturbed significantly in this disease.",7298854_10,-1,2840,-1,0.22218262
2841,disease,36,37,226,233,"As a consequence, it is probable that the normal functions of the HDL, possibly including modulation of LDL-cholesterol uptake and the removal of excess cholesterol from peripheral tissues, are perturbed significantly in this disease.",7298854_10,-1,2841,-1,0.21632014
2842,xanthomatosis,3,4,29,42,Genetics of cerebrotendinous xanthomatosis (CTX): an autosomal recessive trait with high gene frequency in Sephardim of Moroccan origin.,7315872_0,-1,2842,-1,0.18487033
2843,CTX,5,6,44,47,Genetics of cerebrotendinous xanthomatosis (CTX): an autosomal recessive trait with high gene frequency in Sephardim of Moroccan origin.,7315872_0,-1,2843,-1,0.22906086
2844,xanthomatosis,12,13,74,87,"
We described 6 patients (from 3 families) affected with cerebrotendinous xanthomatosis (CTX).",7315872_1,-1,2844,-1,0.19116035
2845,CTX,14,15,89,92,"
We described 6 patients (from 3 families) affected with cerebrotendinous xanthomatosis (CTX).",7315872_1,-1,2845,-1,0.2185239
2846,CTX,7,8,31,34,"In view of the small number of CTX patients diagnosed in the world (a total of 50 including our 6 patients), we are probably dealing with an ethnic subgroup with a high CTX gene frequency, which we have estimated to be 1/108.",7315872_3,-1,2846,-1,0.25288856
2847,CTX,35,36,169,172,"In view of the small number of CTX patients diagnosed in the world (a total of 50 including our 6 patients), we are probably dealing with an ethnic subgroup with a high CTX gene frequency, which we have estimated to be 1/108.",7315872_3,-1,2847,-1,0.257607
2848,disease,8,9,50,57,"Since there are differences in expression in this disease, we recommend cholestanol study in cases of undiagnosed cataract or tendinous xanthomas in childhood or early adolescence.",7315872_4,-1,2848,-1,0.19852927
2850,CTX,3,4,17,20,"The diagnosis in CTX is important not only for genetic counseling, but also in veiw of possible treatment..",7315872_5,-1,2850,-1,0.25873744
2851,glucose,4,5,24,31,New genetic variants of glucose 6-phosphate dehydrogenase (G6PD) in Italy.,7316485_0,-1,2851,-1,0.25183198
2852,haemolysis,22,23,115,125,"All of them were found in Italian males and all were associated with enzyme deficiency, but only two with signs of haemolysis.",7316485_2,-1,2852,-1,0.22055495
2853,map,21,22,111,114,"These and other variants reported in the literature, which must thus far be regarded as sporadic, are found to map in parts of Italy where common types of G6PD deficiency are also prevalent..",7316485_3,-1,2853,-1,0.37261948
2855,Wiskott-Aldrich syndrome,3,5,19,43,Nephropathy in the Wiskott-Aldrich syndrome.,7422429_0,-1,2855,-1,0.22353448
2857,Wiskott-Aldrich syndrome,10,12,58,82,"
Nephropathy was detected in five of 32 patients with the Wiskott-Aldrich syndrome who were participating in a study of transfer factor (TF) therapy.",7422429_1,-1,2857,-1,0.2158903
2859,renal,8,9,51,56,An additional patient was identified who died with renal failure without having received TF.,7422429_6,-1,2859,-1,0.25640365
2860,renal failure,4,6,25,38,The results suggest that renal failure occurs in the Wiskott-Aldrich syndrome more frequently than generally recognized and that administration of TF may precipitate or accelerate the renal disease in patients with this syndrome..,7422429_7,-1,2860,-1,0.22316962
2861,Wiskott-Aldrich syndrome,9,11,53,77,The results suggest that renal failure occurs in the Wiskott-Aldrich syndrome more frequently than generally recognized and that administration of TF may precipitate or accelerate the renal disease in patients with this syndrome..,7422429_7,-1,2861,-1,0.20845082
2862,disease,27,28,190,197,The results suggest that renal failure occurs in the Wiskott-Aldrich syndrome more frequently than generally recognized and that administration of TF may precipitate or accelerate the renal disease in patients with this syndrome..,7422429_7,-1,2862,-1,0.21820349
2863,syndrome,32,33,220,228,The results suggest that renal failure occurs in the Wiskott-Aldrich syndrome more frequently than generally recognized and that administration of TF may precipitate or accelerate the renal disease in patients with this syndrome..,7422429_7,-1,2863,-1,0.2012406
2864,Wiskott-Aldrich syndrome,0,2,0,24,Wiskott-Aldrich syndrome: cellular impairments and their implication for carrier detection.,7437512_0,-1,2864,-1,0.21779607
2865,Wiskott-Aldrich syndrome,10,12,56,80,"
A family in which two male siblings were affected with Wiskott-Aldrich syndrome (WAS) was studied using G-6-PD isoenzymes as an X-linked marker in order to investigate the nature of cellular abnormalities.",7437512_1,-1,2865,-1,0.20674501
2866,adrenoleukodystrophy,5,6,20,40,A new CT pattern in adrenoleukodystrophy.,7444053_0,-1,2866,-1,0.2172752
2867,adrenoleukodystrophy,10,11,50,70,"
A new CT pattern was observed in 2 patients with adrenoleukodystrophy (ALD).",7444053_1,-1,2867,-1,0.20005135
2868,contrast,30,31,186,194,"This pattern, which the authors call Type II, is characterized by the absence of posterior periventricular areas of decreased attenuation around the trigone on non-contrast scans  after contrast infusion, however, there is striking enhancement of various white-matter structures (tracts or fiber systems) such as the internal capsules, corpus callosum, corona radiata, forceps major, and cerebral peduncles.",7444053_2,-1,2868,-1,0.30068126
2873,riboflavin,17,18,99,109,"Moreover, G6PD deficiency should be added to other conditions, such as the galactosemic states and riboflavin deficiency, where cataracts represent a sensitive indicator of metabolic abnormalities of the RBC..",7458742_5,-1,2873,-1,0.2511874
2875,metabolic abnormalities,27,29,173,196,"Moreover, G6PD deficiency should be added to other conditions, such as the galactosemic states and riboflavin deficiency, where cataracts represent a sensitive indicator of metabolic abnormalities of the RBC..",7458742_5,-1,2875,-1,0.23298302
2877,sudden death,12,14,116,128,Molecular basis of human mitochondrial very-long-chain acyl-CoA dehydrogenase deficiency causing cardiomyopathy and sudden death in childhood.,7479827_0,-1,2877,-1,0.17227261
2878,fatty acids,3,5,30,41,"
beta-Oxidation of long-chain fatty acids provides the major source of energy in the heart.",7479827_1,-1,2878,-1,0.27408496
2881,liver failure,19,21,127,140,"Defects in enzymes of the beta-oxidation pathway cause sudden, unexplained death in childhood, acute hepatic encephalopathy or liver failure, skeletal myopathy, and cardiomyopathy.",7479827_2,-1,2881,-1,0.1911594
2884,nucleotide,13,14,75,85,We have isolated the human VLCAD cDNA and gene and determined the complete nucleotide sequences.,7479827_4,-1,2884,-1,0.2665257
2885,VLCAD deficiency,18,20,123,139,Polymerase chain reaction amplification of VLCAD mRNA and genomic exons defined the molecular defects in two patients with VLCAD deficiency who presented with unexplained cardiac arrest and cardiomyopathy.,7479827_5,-1,2885,-1,0.2555871
2888,tryptophan,26,27,127,137,"The second patient was a compound heterozygote, with a missense mutation, C1837-- > T, changing the arginine at residue 613 to tryptophan on one allele and a single base deletion at the intron-exon 6 boundary as the second mutation.",7479827_7,-1,2888,-1,0.28956679
2889,VLCAD deficiency,10,12,67,83,This initial delineation of human mutations in VLCAD suggests that VLCAD deficiency reduces myocardial fatty acid beta-oxidation and energy production and is associated with cardiomyopathy and sudden death in childhood.,7479827_8,-1,2889,-1,0.24105996
2890,fatty acid,14,16,103,113,This initial delineation of human mutations in VLCAD suggests that VLCAD deficiency reduces myocardial fatty acid beta-oxidation and energy production and is associated with cardiomyopathy and sudden death in childhood.,7479827_8,-1,2890,-1,0.26757059
2892,sudden death,26,28,193,205,This initial delineation of human mutations in VLCAD suggests that VLCAD deficiency reduces myocardial fatty acid beta-oxidation and energy production and is associated with cardiomyopathy and sudden death in childhood.,7479827_8,-1,2892,-1,0.17917165
2898,Wilson disease,7,9,38,52,Mapping of the mouse homologue of the Wilson disease gene to mouse chromosome 8.,7490097_0,-1,2898,-1,0.23205055
2899,Wilson disease,6,8,28,42,"
ATP7B, the gene altered in Wilson disease (WD) patients, lies in a block of homology shared between human chromosome 13q14 and the central region of mouse chromosome 14.",7490097_1,-1,2899,-1,0.20441644
2900,map,15,16,87,90,ATP4B lies in 13q34 and is separated from ATP7B by several loci whose mouse homologues map to mouse chromosome 14.,7490097_4,-1,2900,-1,0.261771
2912,lead,16,17,91,95,"An in-frame stop codon is found 17 codons downstream from the intron boundary, which would lead to a truncated polypeptide 13.",7535801_7,-1,2912,-1,0.28040072
2913,Myotonic dystrophy,0,2,0,18,Myotonic dystrophy: evidence for a possible dominant-negative RNA mutation.,7543316_0,-1,2913,-1,0.20060489
2914,myotonic dystrophy,5,7,46,64,"
The trinucleotide expansion mutation causing myotonic dystrophy is in the 3 untranslated region of a protein kinase gene.",7543316_1,-1,2914,-1,0.17825699
2915,disease,14,15,103,110,"The molecular mechanisms by which the expanded repeat causes the clinically variable and multisystemic disease, myotonic dystrophy, are not understood.",7543316_2,-1,2915,-1,0.18882181
2916,myotonic dystrophy,16,18,112,130,"The molecular mechanisms by which the expanded repeat causes the clinically variable and multisystemic disease, myotonic dystrophy, are not understood.",7543316_2,-1,2916,-1,0.19252156
2917,myotonic dystrophy,8,10,55,73,"Here we use muscle biopsies from classical adult-onset myotonic dystrophy patients to study the accumulation of transcripts from both the normal and expanded DM kinase genes in patient muscle, and compare the results to normal and myopathic controls.",7543316_4,-1,2917,-1,0.17290992
2918,DM,23,24,158,160,"Here we use muscle biopsies from classical adult-onset myotonic dystrophy patients to study the accumulation of transcripts from both the normal and expanded DM kinase genes in patient muscle, and compare the results to normal and myopathic controls.",7543316_4,-1,2918,-1,0.26085123
2919,myopathic,37,38,231,240,"Here we use muscle biopsies from classical adult-onset myotonic dystrophy patients to study the accumulation of transcripts from both the normal and expanded DM kinase genes in patient muscle, and compare the results to normal and myopathic controls.",7543316_4,-1,2919,-1,0.18372984
2920,DM,6,7,39,41,"We found relatively small decreases of DM kinase RNA in the total RNA pool from muscle; however, these reductions were not disease specific.",7543316_5,-1,2920,-1,0.2990711
2921,disease,23,24,123,130,"We found relatively small decreases of DM kinase RNA in the total RNA pool from muscle; however, these reductions were not disease specific.",7543316_5,-1,2921,-1,0.23492494
2922,DM,17,18,83,85,"Analysis of poly (A) + RNA showed dramatic decreases of both the mutant and normal DM kinase RNAs, and these changes were disease-specific.",7543316_6,-1,2922,-1,0.26658925
2923,myotonic dystrophy,11,13,78,96,"Our findings are consistent with a novel molecular pathogenetic mechanism for myotonic dystrophy  both the normal and expanded DM kinase genes are transcribed in patient muscle, but the abnormal expansion-containing RNA has a dominant effect on RNA metabolism by preventing the accumulation of poly (A) + RNA.",7543316_7,-1,2923,-1,0.18993917
2924,DM,19,20,127,129,"Our findings are consistent with a novel molecular pathogenetic mechanism for myotonic dystrophy  both the normal and expanded DM kinase genes are transcribed in patient muscle, but the abnormal expansion-containing RNA has a dominant effect on RNA metabolism by preventing the accumulation of poly (A) + RNA.",7543316_7,-1,2924,-1,0.2656227
2925,myotonic dystrophy,20,22,101,119,The ability of the expansion mutation to alter accumulation of poly (A) + RNA in trans suggests that myotonic dystrophy may be the first example of a dominant-negative mutation manifested at the RNA level..,7543316_8,-1,2925,-1,0.18248203
2928,amino acids,21,23,117,128,"The BRCA1 gene is expressed in numerous tissues, including breast and ovary, and encodes a predicted protein of 1863 amino acids.",7545954_4,-1,2928,-1,0.24475816
2929,zinc,4,5,24,28,"This protein contains a zinc finger domain in its amino-terminal region, but is otherwise unrelated to previously described proteins.",7545954_5,-1,2929,-1,0.25377688
2932,nucleotide,13,14,68,78,"The other was a splicing mutation, an A-to-G transition at the 38th nucleotide in exon 3 (318A-- > G), resulting in a 38-bp deletion in the GALT cDNA by activating a cryptic splice acceptor site.",7550229_4,-1,2932,-1,0.31180796
2933,aniridia,2,3,12,20,Three novel aniridia mutations in the human PAX6 gene.,7550230_0,-1,2933,-1,0.2584085
2934,Aniridia,0,1,1,9,"
Aniridia (iris hypoplasia) is an autosomal dominant congenital disorder of the eye.",7550230_1,-1,2934,-1,0.25992268
2935,aniridia,4,5,23,31,Mutations in the human aniridia (PAX6) gene have now been identified in many patients from various ethnic groups.,7550230_2,-1,2935,-1,0.2407578
2936,aniridia,17,18,99,107,In the study reported here we describe PAX6 mutations in one sporadic and five familial cases with aniridia.,7550230_3,-1,2936,-1,0.23255396
2937,C--,16,17,97,100,"Of the four different mutations identified, one was identical to a previously reported mutation (C-- > T transition at codon 240), and three were novel  two in the glycine-rich region and one in the proline/serine/threonine-rich (PST) region.",7550230_4,-1,2937,-1,0.35839877
2939,an aniridia,13,15,75,86,One PAX6 mutation found in the PST region was associated with cataracts in an aniridia family.,7550230_5,-1,2939,-1,0.22874428
2940,aniridia,10,11,57,65,Another splice mutation in the PST domain occurred in an aniridia patient with anosmia (inability to smell).,7550230_6,-1,2940,-1,0.25887975
2941,anosmia,13,14,79,86,Another splice mutation in the PST domain occurred in an aniridia patient with anosmia (inability to smell).,7550230_6,-1,2941,-1,0.2588914
2942,aniridia,3,4,12,20,The six new aniridia cases reported here have mutations predicted to generate incomplete PAX6 proteins.,7550230_7,-1,2942,-1,0.24090874
2943,aniridia,7,8,44,52,These results support the theory that human aniridia is caused by haploinsufficiency of PAX6..,7550230_8,-1,2943,-1,0.22700469
2952,Huntington disease,1,3,5,23,"
The Huntington disease (HD) phenotype is associated with expansion of a trinucleotide repeat in the IT15 gene, which is predicted to encode a 348-kDa protein named huntington.",7568002_1,-1,2952,-1,0.19641371
2955,cerebellar ataxia,13,15,73,90,"
The spinocerebellar ataxia 3 locus (SCA3) for type I autosomal dominant cerebellar ataxia (ADCA type I), a clinically and genetically heterogeneous group of neurodegenerative disorders, has been mapped to chromosome 14q32.",7573040_1,-1,2955,-1,0.17960137
2956,neurodegenerative disorders,28,30,158,185,"
The spinocerebellar ataxia 3 locus (SCA3) for type I autosomal dominant cerebellar ataxia (ADCA type I), a clinically and genetically heterogeneous group of neurodegenerative disorders, has been mapped to chromosome 14q32.",7573040_1,-1,2956,-1,0.16847023
2957,Machado-Joseph disease,19,21,107,129,"1 1. ADCA type I patients from families segregating SCA3 share clinical features in common with those with Machado-Joseph disease (MJD), the gene of which maps to the same region.",7573040_2,-1,2957,-1,0.24910924
2958,disease,5,6,22,29,We show here that the disease gene segregating in each of three French ADCA type I kindreds and in a French family with neuropathological findings suggesting the ataxochoreic form of dentatorubropallidoluysian atrophy carries an expanded CAG repeat sequence located at the same locus as that for MJD.,7573040_3,-1,2958,-1,0.22252078
2960,disease,25,26,148,155,Analysis of the mutation in these families shows a strong negative correlation between size of the expanded CAG repeat and age at onset of clinical disease.,7573040_4,-1,2960,-1,0.21823291
2961,Pelizaeus-Merzbacher disease,9,11,58,86,Overexpression of DM20 messenger RNA in two brothers with Pelizaeus-Merzbacher disease.,7574457_0,-1,2961,-1,0.2552549
2962,Pelizaeus-Merzbacher disease,0,2,1,29,"
Pelizaeus-Merzbacher disease is a rare, sex-linked recessive, dysmyelinating disease of the central nervous system that has been associated with mutations in the myelin proteolipid protein (PLP) gene.",7574457_1,-1,2962,-1,0.23142691
2963,disease,10,11,78,85,"
Pelizaeus-Merzbacher disease is a rare, sex-linked recessive, dysmyelinating disease of the central nervous system that has been associated with mutations in the myelin proteolipid protein (PLP) gene.",7574457_1,-1,2963,-1,0.18232748
2964,Pelizaeus-Merzbacher disease,7,9,34,62,"Only 25% of patients studied with Pelizaeus-Merzbacher disease have exonic mutations in this gene, the underlying cause of the disease in the remaining patients is unknown.",7574457_2,-1,2964,-1,0.24315855
2965,disease,21,22,127,134,"Only 25% of patients studied with Pelizaeus-Merzbacher disease have exonic mutations in this gene, the underlying cause of the disease in the remaining patients is unknown.",7574457_2,-1,2965,-1,0.21652393
2966,Pelizaeus-Merzbacher disease,9,11,58,86,We studied cultured skin fibroblasts from 2 brothers with Pelizaeus-Merzbacher disease who exhibited no detectable exonic mutation of the PLP gene.,7574457_5,-1,2966,-1,0.2371654
2967,Pelizaeus-Merzbacher disease,8,10,44,72,"Our findings suggest that in some patients, Pelizaeus-Merzbacher disease is caused by overexpression of PLP gene transcripts, and that in these families a 50% increase of DM20 messenger RNA in females, relative to the increase in affected males, can identify a female carrier..",7574457_8,-1,2967,-1,0.23767059
2968,Wiskott-Aldrich syndrome,1,3,4,28,The Wiskott-Aldrich syndrome and X-linked congenital thrombocytopenia are caused by mutations of the same gene.,7579347_0,-1,2968,-1,0.21069716
2970,Wiskott-Aldrich syndrome,1,3,5,29,"
The Wiskott-Aldrich syndrome (WAS) is an X-linked recessive disorder characterized by thrombocytopenia, small platelets, eczema, recurrent infections, and immunodeficiency.",7579347_1,-1,2970,-1,0.19710377
2972,eczema,18,19,122,128,"
The Wiskott-Aldrich syndrome (WAS) is an X-linked recessive disorder characterized by thrombocytopenia, small platelets, eczema, recurrent infections, and immunodeficiency.",7579347_1,-1,2972,-1,0.18795142
2974,immunodeficiency,24,25,156,172,"
The Wiskott-Aldrich syndrome (WAS) is an X-linked recessive disorder characterized by thrombocytopenia, small platelets, eczema, recurrent infections, and immunodeficiency.",7579347_1,-1,2974,-1,0.16567165
2976,eczema,26,27,156,162,"Besides the classic WAS phenotype, there is a group of patients with congenital X-linked thrombocytopenia (XLT) who have small platelets but only transient eczema, if any, and minimal immune deficiency.",7579347_2,-1,2976,-1,0.24125849
2977,amino acid,33,35,220,230,"Direct sequence analysis of cDNA and genomic DNA obtained from patient-derived cell lines showed 12 unique mutations distributed throughout the WAS gene, including insertions, deletions, and point mutations resulting in amino acid substitutions, termination, exon skipping, or splicing defects.",7579347_5,-1,2977,-1,0.2848494
2978,Myotonia,0,1,0,8,Myotonia levior is a chloride channel disorder.,7581380_0,-1,2978,-1,0.2368142
2979,chloride,4,5,21,29,Myotonia levior is a chloride channel disorder.,7581380_0,-1,2979,-1,0.24701065
2980,myotonia congenita,1,3,9,27,"Dominant myotonia congenita (Thomsens disease) is linked to CLCN1, the gene encoding the major muscle chloride channel, localized on chromosome 7q35.",7581380_2,-1,2980,-1,0.19860075
2981,disease,5,6,38,45,"Dominant myotonia congenita (Thomsens disease) is linked to CLCN1, the gene encoding the major muscle chloride channel, localized on chromosome 7q35.",7581380_2,-1,2981,-1,0.2061907
2982,chloride,18,19,102,110,"Dominant myotonia congenita (Thomsens disease) is linked to CLCN1, the gene encoding the major muscle chloride channel, localized on chromosome 7q35.",7581380_2,-1,2982,-1,0.21678752
2983,contrast,1,2,3,11,"In contrast, dominant myotonias sensitive to potassium are caused by point mutations in SCN4A on chromosome 17q, the gene for the alpha subunit of the adult skeletal muscle sodium channel.",7581380_3,-1,2983,-1,0.26636702
2984,myotonias,4,5,22,31,"In contrast, dominant myotonias sensitive to potassium are caused by point mutations in SCN4A on chromosome 17q, the gene for the alpha subunit of the adult skeletal muscle sodium channel.",7581380_3,-1,2984,-1,0.19938767
2985,potassium,7,8,45,54,"In contrast, dominant myotonias sensitive to potassium are caused by point mutations in SCN4A on chromosome 17q, the gene for the alpha subunit of the adult skeletal muscle sodium channel.",7581380_3,-1,2985,-1,0.27139097
2986,sodium,30,31,173,179,"In contrast, dominant myotonias sensitive to potassium are caused by point mutations in SCN4A on chromosome 17q, the gene for the alpha subunit of the adult skeletal muscle sodium channel.",7581380_3,-1,2986,-1,0.25916198
2987,myotonia,11,12,61,69,"No linkage or molecular genetic data are as yet available on myotonia levior characterized by milder symptoms and later onset of myotonia than in Thomsens disease, and absence of muscle hypertrophy.",7581380_4,-1,2987,-1,0.24423066
2988,myotonia,21,22,129,137,"No linkage or molecular genetic data are as yet available on myotonia levior characterized by milder symptoms and later onset of myotonia than in Thomsens disease, and absence of muscle hypertrophy.",7581380_4,-1,2988,-1,0.2197944
2989,disease,25,26,155,162,"No linkage or molecular genetic data are as yet available on myotonia levior characterized by milder symptoms and later onset of myotonia than in Thomsens disease, and absence of muscle hypertrophy.",7581380_4,-1,2989,-1,0.22861403
2990,muscle hypertrophy,30,32,179,197,"No linkage or molecular genetic data are as yet available on myotonia levior characterized by milder symptoms and later onset of myotonia than in Thomsens disease, and absence of muscle hypertrophy.",7581380_4,-1,2990,-1,0.22578096
2991,myotonia,16,17,111,119,We report a CLCN1 Gln-552-Arg substitution for a family with dominant inheritance previously diagnosed to have myotonia levior.,7581380_5,-1,2991,-1,0.23266779
2992,disease,10,11,53,60,"Thus, this disorder appears as a variant of Thomsens disease due to mutations leading to low clinical expressivity.",7581380_6,-1,2992,-1,0.19220927
2993,disease,8,9,58,65,"In another family previously diagnosed as having Thomsens disease, we unexpectedly found a CLCN1 14 bp deletion known to cause recessive myotonia, and a rare Trp-118-Gly polymorphism..",7581380_8,-1,2993,-1,0.19007744
2994,myotonia,22,23,137,145,"In another family previously diagnosed as having Thomsens disease, we unexpectedly found a CLCN1 14 bp deletion known to cause recessive myotonia, and a rare Trp-118-Gly polymorphism..",7581380_8,-1,2994,-1,0.18462476
2995,Lesch-Nyhan syndrome,15,17,113,133,Southern analysis reveals a large deletion at the hypoxanthine phosphoribosyltransferase locus in a patient with Lesch-Nyhan syndrome.,7586656_0,-1,2995,-1,0.20841034
2996,Lesch-Nyhan syndrome,30,32,173,193,"
Whole genomic hprt clones were used in Southern analysis to screen the integrity of the hprt gene in a family that includes a patient with HPRT enzyme deficiency causal to Lesch-Nyhan syndrome.",7586656_1,-1,2996,-1,0.21255192
2997,amelogenesis imperfecta,6,8,50,73,Characterisation of molecular defects in X-linked amelogenesis imperfecta (AIH1).,7599636_0,-1,2997,-1,0.2420074
2998,amelogenesis imperfecta,6,8,42,65,"Disturbances of enamel formation occur in amelogenesis imperfecta, a clinically heterogenous group of inherited disorders characterised by defective enamel biomineralisation.",7599636_2,-1,2998,-1,0.2272884
2999,amelogenesis imperfecta,12,14,66,89,3) and has been implicated in the molecular pathology of X-linked amelogenesis imperfecta (AIH1).,7599636_4,-1,2999,-1,0.2216173
3000,cytosine,19,20,103,111,"Three novel mutations were identified  a C-T substitution in exon 5, and a G-T substitution and single cytosine deletion in exon 6, confirming the existence of extensive allelic heterogeneity in this condition.",7599636_6,-1,3000,-1,0.26128334
3001,disease,25,26,196,203,The identification of family-specific mutations will enable early identification of affected individuals and correlation of clinical phenotype with genotype will facilitate an objective system of disease classification.,7599636_7,-1,3001,-1,0.19937819
3002,cholesteryl ester,12,14,51,68,Frequency of exon 15 missense mutation (442D:G) in cholesteryl ester transfer protein gene in hyperalphalipoproteinemic Japanese subjects.,7605382_0,-1,3002,-1,0.26363498
3003,Cholesteryl ester,0,2,1,18,"
Cholesteryl ester transfer protein (CETP) transfers cholesteryl ester from high density lipoprotein (HDL) to apo B-containing lipoproteins.",7605382_1,-1,3003,-1,0.30312052
3004,cholesteryl ester,8,10,53,70,"
Cholesteryl ester transfer protein (CETP) transfers cholesteryl ester from high density lipoprotein (HDL) to apo B-containing lipoproteins.",7605382_1,-1,3004,-1,0.29074407
3005,corneal opacity,21,23,132,147,One of the homozygotes for the 442D  G mutation was the patient previously described by us as having hyperalphalipoproteinemia with corneal opacity and coronary heart disease.,7605382_9,-1,3005,-1,0.22623761
3006,coronary heart disease,24,27,152,174,One of the homozygotes for the 442D  G mutation was the patient previously described by us as having hyperalphalipoproteinemia with corneal opacity and coronary heart disease.,7605382_9,-1,3006,-1,0.22506939
3008,IVA,2,3,27,30,Mucopolysaccharidosis type IVA: common double deletion in the N-acetylgalactosamine-6-sulfatase gene (GALNS).,7607677_0,-1,3008,-1,0.21189636
3009,N-acetylgalactosamine-6-sulfatase,9,10,62,95,Mucopolysaccharidosis type IVA: common double deletion in the N-acetylgalactosamine-6-sulfatase gene (GALNS).,7607677_0,-1,3009,-1,0.26491553
3010,IVA,1,2,23,26,"
Mucopolysaccharidosis IVA (MPS IVA) is an autosomal recessive disorder caused by a deficiency in N-acetylgalactosamine-6-sulfatase (GALNS).",7607677_1,-1,3010,-1,0.2108279
3011,IVA,4,5,32,35,"
Mucopolysaccharidosis IVA (MPS IVA) is an autosomal recessive disorder caused by a deficiency in N-acetylgalactosamine-6-sulfatase (GALNS).",7607677_1,-1,3011,-1,0.22613646
3012,N-acetylgalactosamine-6-sulfatase,16,17,98,131,"
Mucopolysaccharidosis IVA (MPS IVA) is an autosomal recessive disorder caused by a deficiency in N-acetylgalactosamine-6-sulfatase (GALNS).",7607677_1,-1,3012,-1,0.27977985
3020,carcinomatosis,11,12,73,87,A 40-bp deletion was detected in a patient who developed intra-abdominal carcinomatosis 1 year after prophylactic oophorectomy.,7611277_8,-1,3020,-1,0.16327077
3023,severe malaria,14,16,92,106,Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria.,7617034_0,-1,3023,-1,0.19990447
3024,malaria,11,12,83,90,The geographical correlation of its distribution with the historical endemicity of malaria suggests that this disorder has risen in frequency through natural selection by malaria.,7617034_2,-1,3024,-1,0.2089279
3025,malaria,24,25,171,178,The geographical correlation of its distribution with the historical endemicity of malaria suggests that this disorder has risen in frequency through natural selection by malaria.,7617034_2,-1,3025,-1,0.20817599
3026,malaria,14,15,91,98,"However, attempts to confirm that G6PD deficiency is protective in case-control studies of malaria have yielded conflicting results.",7617034_3,-1,3026,-1,0.19634433
3027,severe malaria,41,43,190,204,"Here we report that, in two large case-control studies of over 2, 000 African children, the common African form of G6PD deficiency (G6PD A-) is associated with a 46-58% reduction in risk of severe malaria for both female heterozygotes and male hemizygotes.",7617034_6,-1,3027,-1,0.20861225
3028,malaria,9,10,76,83,"A mathematical model incorporating the measured selective advantage against malaria suggests that a counterbalancing selective disadvantage, associated with this enzyme deficiency, has retarded its rise in frequency in malaria-endemic regions.",7617034_7,-1,3028,-1,0.21227163
3029,rhabdomyosarcoma,2,3,13,29,The alveolar rhabdomyosarcoma PAX3/FKHR fusion protein is a transcriptional activator.,7630639_0,-1,3029,-1,0.16957012
3031,rhabdomyosarcoma,21,22,72,88,"The PAX3/FKHR fusion gene, formed by a t (2; 13) (q35; q14) in alveolar rhabdomyosarcoma, encodes a hybrid protein that contains both PAX3 DNA binding domains, the paired box and homeodomain, linked to the bisected DNA binding domain of FKHR, a member of the forkhead family of transcription factors.",7630639_2,-1,3031,-1,0.16054446
3033,melanoma,12,13,82,90,A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma.,7652577_0,-1,3033,-1,0.17328039
3034,melanoma,11,12,66,74,1-restricted autologous cytolytic T lymphocytes (CTLs) in a human melanoma.,7652577_2,-1,3034,-1,0.19640037
3035,melanoma,9,10,59,67,"The mutated CDK4 allele was present in autologous cultured melanoma cells and metastasis tissue, but not in the patients lymphocytes.",7652577_3,-1,3035,-1,0.1531243
3036,metastasis,12,13,78,88,"The mutated CDK4 allele was present in autologous cultured melanoma cells and metastasis tissue, but not in the patients lymphocytes.",7652577_3,-1,3036,-1,0.18246374
3037,melanoma,8,9,46,54,The same mutation was found in one additional melanoma among 28 melanomas analyzed.,7652577_5,-1,3037,-1,0.18346074
3041,nucleotide,17,18,99,109,"In 45 patients from breast and/or ovarian cancer families we found six novel mutations  two single nucleotide insertions, three small deletions (1-5 bp) and a nonsense mutation identified two unrelated families.",7663517_3,-1,3041,-1,0.27187356
3042,amino acids,22,24,113,124,"The cDNA inserts of these clones together encompass a region of 2, 177 bases, encoding the entire protein of 655 amino acids, including a 40-amino acid leader peptide and a 615-amino acid mature polypeptide.",7668252_2,-1,3042,-1,0.24975681
3043,VLCAD deficiency,9,11,54,70,This is the first demonstration of a mutation causing VLCAD deficiency.,7668252_6,-1,3043,-1,0.25585908
3044,vaccinia,15,16,100,108,"Quantitative cDNA expression of normal human VLCAD was performed in the patients fibroblasts, using vaccinia viral system, which demonstrated that the deficiency of the normal VLCAD protein causes impaired long-chain fatty acid beta-oxidation activity in the patients fibroblasts.",7668252_7,-1,3044,-1,0.27719307
3045,fatty acid,32,34,217,227,"Quantitative cDNA expression of normal human VLCAD was performed in the patients fibroblasts, using vaccinia viral system, which demonstrated that the deficiency of the normal VLCAD protein causes impaired long-chain fatty acid beta-oxidation activity in the patients fibroblasts.",7668252_7,-1,3045,-1,0.24668871
3046,VLCAD deficiency,44,46,287,303,"In patient fibroblasts, raising VLCAD activity to approximately 20% of normal control fibroblast activity raised palmitic acid beta-oxidation flux to the level found in control fibroblasts, which may offer important information for the rational design of future somatic gene therapy for VLCAD deficiency..",7668252_8,-1,3046,-1,0.24602056
3047,disease,1,2,6,13,Brain disease and molecular analysis in myotonic dystrophy.,7696601_0,-1,3047,-1,0.22522631
3048,myotonic dystrophy,6,8,40,58,Brain disease and molecular analysis in myotonic dystrophy.,7696601_0,-1,3048,-1,0.19936411
3049,myotonic dystrophy,14,16,83,101,"
Abnormal amplification of a CTG repeat on chromosome 19 is the molecular basis of myotonic dystrophy (DM).",7696601_1,-1,3049,-1,0.18083413
3050,DM,17,18,103,105,"
Abnormal amplification of a CTG repeat on chromosome 19 is the molecular basis of myotonic dystrophy (DM).",7696601_1,-1,3050,-1,0.20755479
3051,disease,15,16,94,101,Expansion of the repeat has been correlated with severity of several clinical features of the disease.,7696601_2,-1,3051,-1,0.23043914
3052,DM,21,22,124,126,"We performed extensive cognitive testing, cerebral magnetic resonance imaging (MRI) and a molecular analysis in 28 cases of DM to determine the relationship between the molecular defect and brain disease.",7696601_3,-1,3052,-1,0.23277472
3053,disease,32,33,196,203,"We performed extensive cognitive testing, cerebral magnetic resonance imaging (MRI) and a molecular analysis in 28 cases of DM to determine the relationship between the molecular defect and brain disease.",7696601_3,-1,3053,-1,0.19961698
3055,Disease,0,1,0,7,Disease duration influenced the appearance and amount of white matter lesions on MRI.,7696601_8,-1,3055,-1,0.22420183
3056,DM,17,18,105,107,Quantification of CTG repeat size may allow an early estimate on the probability of brain involvement in DM; cognitive dysfunction is associated with white matter lesions and cerebral atrophy later on in the course..,7696601_9,-1,3056,-1,0.22580746
3057,cognitive dysfunction,19,21,109,130,Quantification of CTG repeat size may allow an early estimate on the probability of brain involvement in DM; cognitive dysfunction is associated with white matter lesions and cerebral atrophy later on in the course..,7696601_9,-1,3057,-1,0.19825134
3058,adrenoleukodystrophy,6,7,35,55,Mutations in the gene for X-linked adrenoleukodystrophy in patients with different clinical phenotypes.,7717396_0,-1,3058,-1,0.18180466
3059,adrenoleukodystrophy,12,13,71,91,"
Recently, the gene for the most common peroxisomal disorder, X-linked adrenoleukodystrophy (X-ALD), has been described encoding a peroxisomal membrane transporter protein.",7717396_1,-1,3059,-1,0.19201514
3060,Addison disease,48,50,298,313,"We analyzed the entire protein-coding sequence of this gene by reverse-transcription PCR, SSCP, and DNA sequencing in five patients with different clinical expression of X-ALD and in their female relatives; these clinical expressions were cerebral childhood ALD, adrenomyeloneuropathy (AMN), and "" Addison disease only "" (ADO) phenotype.",7717396_2,-1,3060,-1,0.23290473
3061,amino acid,40,42,224,234,"In the three patients exhibiting the classical picture of severe childhood ALD we identified in the 5 portion of the X-ALD gene a 38-bp deletion that causes a frameshift mutation, a 3-bp deletion leading to a deletion of an amino acid in the ATP-binding domain of the ALD protein, and a missense mutation.",7717396_3,-1,3061,-1,0.27397016
3062,muscular dystrophy,1,3,9,27,Duchenne muscular dystrophy and myotonic dystrophy in the same patient.,7726234_0,-1,3062,-1,0.18948954
3063,myotonic dystrophy,4,6,32,50,Duchenne muscular dystrophy and myotonic dystrophy in the same patient.,7726234_0,-1,3063,-1,0.20878753
3064,myotonic dystrophy,8,10,48,66,"
We report on the first patient identified with myotonic dystrophy and Duchenne muscular dystrophy (DMD).",7726234_1,-1,3064,-1,0.193278
3065,muscular dystrophy,12,14,80,98,"
We report on the first patient identified with myotonic dystrophy and Duchenne muscular dystrophy (DMD).",7726234_1,-1,3065,-1,0.17794377
3066,myotonic dystrophy,10,12,53,71,"The family of the propositus had a strong history of myotonic dystrophy, and there was an intrafamilial pathological expansion of the responsible CTG repeat between the mildly affected mother (160 repeats; normal 27 repeats) and her more severely affected son (650 repeats), and his sister (650 repeats).",7726234_2,-1,3066,-1,0.18234219
3067,muscular dystrophy,8,10,48,66,The propositus was an isolated case of Duchenne muscular dystrophy with marked dystrophin deficiency in muscle biopsy.,7726234_3,-1,3067,-1,0.16913104
3068,Myotonic dystrophy,0,2,0,18,Myotonic dystrophy could interfere to some extent with the progression of Duchenne dystrophy.,7726234_5,-1,3068,-1,0.21176046
3081,contrast,1,2,3,11,"In contrast, there was no overall evidence of linkage in the group of 10 families with breast cancer without ovarian cancer.",7759076_3,-1,3081,-1,0.25283563
3089,melanoma,23,24,149,157,"Other cancers of interest that appeared in the BRCA1-linked families included primary peritoneal cancer, cancer of the fallopian tube, and malignant melanoma..",7759076_5,-1,3089,-1,0.15625215
3090,Huntington disease,11,13,56,74,Structural analysis of the 5' region of mouse and human Huntington disease genes reveals conservation of putative promoter region and di- and trinucleotide polymorphisms.,7759106_0,-1,3090,-1,0.1854531
3091,Huntington disease,11,13,73,91,"
We have previously cloned and characterized the murine homologue of the Huntington disease (HD) gene and shown that it maps to mouse chromosome 5 within a region of conserved synteny with human chromosome 4p16.",7759106_1,-1,3091,-1,0.19059023
3092,CA,15,16,89,91,Two dinucleotide (CT) and one trinucleotide intronic polymorphism in Hdh and an intronic CA polymorphism in the HD gene were identified.,7759106_5,-1,3092,-1,0.3281037
3093,nucleotide,21,22,113,123,Comparison of 940-bp sequence 5 to the putative translation start site reveals a highly conserved region (78. 8% nucleotide identity) between Hdh and the HD gene from nucleotide -56 to -206 (of Hdh).,7759106_6,-1,3093,-1,0.29658535
3094,Huntington disease,34,36,200,218,The high sequence identity between Hdh and the HD gene for approximately 200 bp 5 to the putative translation start site indicates that these sequences may play a role in regulating expression of the Huntington disease gene,7759106_8,-1,3094,-1,0.18581255
3095,syndrome,5,6,30,38,"The protein deficient in Lowe syndrome is a phosphatidylinositol-4,5-bisphosphate 5-phosphatase.",7761412_0,-1,3095,-1,0.23959234
3096,syndrome,1,2,6,14,"
Lowe syndrome, also known as oculocerebrorenal syndrome, is caused by mutations in the X chromosome-encoded OCRL gene.",7761412_1,-1,3096,-1,0.21147642
3097,oculocerebrorenal syndrome,6,8,30,56,"
Lowe syndrome, also known as oculocerebrorenal syndrome, is caused by mutations in the X chromosome-encoded OCRL gene.",7761412_1,-1,3097,-1,0.2186261
3098,inositol,8,9,37,45,"The OCRL protein is 51% identical to inositol polyphosphate 5-phosphatase II (5-phosphatase II) from human platelets over a span of 744 aa, suggesting that OCRL may be a similar enzyme.",7761412_2,-1,3098,-1,0.25093442
3099,amino acids,10,12,56,67,We engineered a construct of the OCRL cDNA that encodes amino acids homologous to the platelet 5-phosphatase for expression in baculovirus-infected Sf9 insect cells.,7761412_3,-1,3099,-1,0.27050802
3100,inositol,3,4,19,27,"Thus OCRL converts inositol 1, 4, 5-trisphosphate to inositol 1, 4-bisphosphate, and it converts inositol 1, 3, 4, 5-tetrakisphosphate to inositol 1, 3, 4-trisphosphate.",7761412_6,-1,3100,-1,0.2746366
3101,inositol,10,11,53,61,"Thus OCRL converts inositol 1, 4, 5-trisphosphate to inositol 1, 4-bisphosphate, and it converts inositol 1, 3, 4, 5-tetrakisphosphate to inositol 1, 3, 4-trisphosphate.",7761412_6,-1,3101,-1,0.27966684
3102,inositol,18,19,97,105,"Thus OCRL converts inositol 1, 4, 5-trisphosphate to inositol 1, 4-bisphosphate, and it converts inositol 1, 3, 4, 5-tetrakisphosphate to inositol 1, 3, 4-trisphosphate.",7761412_6,-1,3102,-1,0.2730023
3103,inositol,27,28,138,146,"Thus OCRL converts inositol 1, 4, 5-trisphosphate to inositol 1, 4-bisphosphate, and it converts inositol 1, 3, 4, 5-tetrakisphosphate to inositol 1, 3, 4-trisphosphate.",7761412_6,-1,3103,-1,0.2788902
3104,syndrome,11,12,79,87,Deficiency of this enzyme apparently causes the protean manifestations of Lowe syndrome..,7761412_11,-1,3104,-1,0.23358434
3105,myotonic dystrophy,5,7,30,48,New founder haplotypes at the myotonic dystrophy locus in southern Africa.,7762560_0,-1,3105,-1,0.19395955
3106,myotonic dystrophy,26,28,172,190,"
The association between normal alleles at the CTG repeat and two nearby polymorphisms in the myotonin protein kinase gene, the Alu insertion/deletion polymorphism and the myotonic dystrophy kinase (DMK) (G/T) intron 9/HinfI polymorphism, has been analyzed in South African Negroids, a population in which myotonic dystrophy (DM) has not been described.",7762560_1,-1,3106,-1,0.19494924
3107,myotonic dystrophy,51,53,306,324,"
The association between normal alleles at the CTG repeat and two nearby polymorphisms in the myotonin protein kinase gene, the Alu insertion/deletion polymorphism and the myotonic dystrophy kinase (DMK) (G/T) intron 9/HinfI polymorphism, has been analyzed in South African Negroids, a population in which myotonic dystrophy (DM) has not been described.",7762560_1,-1,3107,-1,0.19551566
3108,DM,54,55,326,328,"
The association between normal alleles at the CTG repeat and two nearby polymorphisms in the myotonin protein kinase gene, the Alu insertion/deletion polymorphism and the myotonic dystrophy kinase (DMK) (G/T) intron 9/HinfI polymorphism, has been analyzed in South African Negroids, a population in which myotonic dystrophy (DM) has not been described.",7762560_1,-1,3108,-1,0.20470434
3109,DM,24,25,127,129,"These data provide support for the "" out of Africa "" model for the origin of modern humans and suggest that the rare ancestral DM mutation event may have occurred after the migration from Africa, hence the absence of DM in sub-Saharan Negroid peoples..",7762560_6,-1,3109,-1,0.23565482
3110,DM,40,41,217,219,"These data provide support for the "" out of Africa "" model for the origin of modern humans and suggest that the rare ancestral DM mutation event may have occurred after the migration from Africa, hence the absence of DM in sub-Saharan Negroid peoples..",7762560_6,-1,3110,-1,0.24673694
3111,myotonic dystrophy,4,6,31,49,Discordant clinical outcome in myotonic dystrophy relatives showing (CTG)n > 700 repeats.,7767095_0,-1,3111,-1,0.18890876
3112,(CTG)n,8,9,68,74,Discordant clinical outcome in myotonic dystrophy relatives showing (CTG)n > 700 repeats.,7767095_0,-1,3112,-1,0.31814852
3113,myotonic dystrophy,1,3,3,21,"
A myotonic dystrophy (DM) family is described in which discordant DM phenotypes were found in the children of two affected sisters with similar CTG expansion and clinical manifestations.",7767095_1,-1,3113,-1,0.19183984
3114,DM,4,5,23,25,"
A myotonic dystrophy (DM) family is described in which discordant DM phenotypes were found in the children of two affected sisters with similar CTG expansion and clinical manifestations.",7767095_1,-1,3114,-1,0.2074993
3115,DM,12,13,67,69,"
A myotonic dystrophy (DM) family is described in which discordant DM phenotypes were found in the children of two affected sisters with similar CTG expansion and clinical manifestations.",7767095_1,-1,3115,-1,0.19575581
3116,DM,15,16,87,89,"In this family, congenital as well as early severe childhood and later childhood onset DM coexist.",7767095_2,-1,3116,-1,0.24813327
3117,DM,17,18,140,142,This observation strengthens the limited ability of lymphocytes CTG repeat number analysis in predicting genotype-phenotype correlations in DM patients..,7767095_3,-1,3117,-1,0.2038325
3118,VLCAD deficiency,31,33,229,245,"The seven deficient fibroblast lines were characterized by measuring acyl-coenzyme A dehydrogenation activities, overall palmitic acid oxidation, and VLCAD protein synthesis using pulse-chase, further confirming the diagnosis of VLCAD deficiency.",7769092_5,-1,3118,-1,0.24910273
3119,VLCAD deficiency,5,7,30,46,"Clinically, all patients with VLCAD deficiency exhibited cardiac disease.",7769092_7,-1,3119,-1,0.26560047
3120,cardiac disease,8,10,57,72,"Clinically, all patients with VLCAD deficiency exhibited cardiac disease.",7769092_7,-1,3120,-1,0.21325222
3121,hypertrophic cardiomyopathy,7,9,37,64,At least four of them presented with hypertrophic cardiomyopathy.,7769092_8,-1,3121,-1,0.20922378
3122,fatty acid,21,23,119,129,This frequency (> 57%) was much higher than that observed in patients with other disorders of mitochondrial long-chain fatty acid oxidation that may be accompanied by cardiac disease in infants..,7769092_9,-1,3122,-1,0.24867596
3123,cardiac disease,29,31,167,182,This frequency (> 57%) was much higher than that observed in patients with other disorders of mitochondrial long-chain fatty acid oxidation that may be accompanied by cardiac disease in infants..,7769092_9,-1,3123,-1,0.19297566
3124,systemic lupus erythematosus,6,9,30,58,"The proband, who has inactive systemic lupus erythematosus is completely lacking C5, while her healthy half-sister has 1-2% of normal levels.",777027_4,-1,3124,-1,0.20796926
3125,hemoglobinuria,16,17,109,123,"The probands serum was incapable of mediating lysis of erythrocytes from a patient with paroxysmal nocturnal hemoglobinuria in both the sucrose hemolysia and acid hemolysis tests, and also lacked bactericidal activity against sensitized or unsensitized Salmonella typhi.",777027_10,-1,3125,-1,0.21858941
3126,sucrose,20,21,136,143,"The probands serum was incapable of mediating lysis of erythrocytes from a patient with paroxysmal nocturnal hemoglobinuria in both the sucrose hemolysia and acid hemolysis tests, and also lacked bactericidal activity against sensitized or unsensitized Salmonella typhi.",777027_10,-1,3126,-1,0.30515382
3128,peroxisomal disorders,15,17,116,137,Human peroxisomal targeting signal-1 receptor restores peroxisomal protein import in cells from patients with fatal peroxisomal disorders.,7790377_0,-1,3128,-1,0.17248963
3129,adrenoleukodystrophy,25,26,167,187,The PTS1R cDNA also complements the PTS1 protein-import defect in skin fibroblasts from patients--belonging to complementation group two--diagnosed as having neonatal adrenoleukodystrophy or Zellweger syndrome.,7790377_13,-1,3129,-1,0.18576507
3130,Zellweger syndrome,27,29,191,209,The PTS1R cDNA also complements the PTS1 protein-import defect in skin fibroblasts from patients--belonging to complementation group two--diagnosed as having neonatal adrenoleukodystrophy or Zellweger syndrome.,7790377_13,-1,3130,-1,0.19682747
3131,map,19,20,115,118,The PTS1R gene has been localized to a chromosomal location where no other peroxisomal disorder genes are known to map.,7790377_14,-1,3131,-1,0.26523924
3132,peroxisomal disorders,17,19,108,129,Our findings represent the only case in which the molecular basis of the protein-import deficiency in human peroxisomal disorders is understood.,7790377_15,-1,3132,-1,0.17745881
3133,RB1,6,7,38,41,Spectrum of germline mutations in the RB1 gene: a study of 232 patients with hereditary and non hereditary retinoblastoma.,7795591_0,-1,3133,-1,0.19695693
3134,retinoblastoma,19,20,107,121,Spectrum of germline mutations in the RB1 gene: a study of 232 patients with hereditary and non hereditary retinoblastoma.,7795591_0,-1,3134,-1,0.14916885
3135,RB1,4,5,27,30,"
Germline mutations in the RB1 gene confer hereditary predisposition to retinoblastoma.",7795591_1,-1,3135,-1,0.20053835
3136,retinoblastoma,10,11,72,86,"
Germline mutations in the RB1 gene confer hereditary predisposition to retinoblastoma.",7795591_1,-1,3136,-1,0.15691501
3137,RB1,8,9,43,46,We have performed a mutation survey of the RB1 gene in 232 patients with hereditary or non hereditary retinoblastoma.,7795591_2,-1,3137,-1,0.2095072
3138,retinoblastoma,18,19,102,116,We have performed a mutation survey of the RB1 gene in 232 patients with hereditary or non hereditary retinoblastoma.,7795591_2,-1,3138,-1,0.15461592
3139,RB1,14,15,91,94,All types of point mutations are represented and are found unequally distributed along the RB1 gene sequence.,7795591_4,-1,3139,-1,0.2414856
3140,RB1,21,22,124,127,"The range of frequency of detection of germline mutations is about 20%, indicating that other mechanisms of inactivation of RB1 should be involved.",7795591_6,-1,3140,-1,0.21760434
3141,retinoblastoma,14,15,91,105,The spectrum of mutations presented here should help to improve the clinical management of retinoblastoma and to understand the molecular mechanisms leading to tumorigenesis..,7795591_7,-1,3141,-1,0.15975074
3142,aniridia,4,5,32,40,"
Current evidence suggests that aniridia (absence of iris) is caused by loss of function of one copy of the PAX6 gene, which maps to 11p13.",7795596_1,-1,3142,-1,0.23631868
3143,aniridia,7,8,47,55,We present the further characterisation of two aniridia pedigrees in which the disease segregates with chromosomal rearrangements which involve 11p13 but do not disrupt the PAX6 gene.,7795596_2,-1,3143,-1,0.2466438
3144,disease,12,13,79,86,We present the further characterisation of two aniridia pedigrees in which the disease segregates with chromosomal rearrangements which involve 11p13 but do not disrupt the PAX6 gene.,7795596_2,-1,3144,-1,0.21729411
3145,disease,31,32,197,204,We propose that the PAX6 gene on the rearranged chromosome 11 is in an inappropriate chromatin environment for normal expression and therefore that a position effect is the underlying mechanism of disease in these families..,7795596_5,-1,3145,-1,0.20646489
3146,tumours,9,10,56,63,Somatic mutations in the BRCA1 gene in sporadic ovarian tumours.,7795652_0,-1,3146,-1,0.15083133
3147,syndrome,12,13,77,85,"
The BRCA1 gene on chromosome 17q21 is responsible for an autosomal dominant syndrome of increased susceptibility to breast and ovarian cancer but no somatic mutations in tumours have yet been described.",7795652_1,-1,3147,-1,0.1917353
3149,tumours,26,27,171,178,"
The BRCA1 gene on chromosome 17q21 is responsible for an autosomal dominant syndrome of increased susceptibility to breast and ovarian cancer but no somatic mutations in tumours have yet been described.",7795652_1,-1,3149,-1,0.15588722
3151,tumour,17,18,96,102,"To study the potential role of BRCA1 in sporadic carcinogenesis, we analysed the genomic DNA of tumour and normal fractions of 47 ovarian cancers for mutations in BRCA1 using the single-strand conformation polymorphism technique.",7795652_2,-1,3151,-1,0.20460655
3153,tumours,10,11,53,60,We now describe somatic mutations in the DNA of four tumours which also had loss of heterozygosity (LOH) at a BRCA1 intragenic marker.,7795652_3,-1,3153,-1,0.16888292
3154,tumour,4,5,19,25,Our data support a tumour suppressor mechanism for BRCA1; somatic mutations and LOH may result in inactivation of BRCA1 in at least a small number of ovarian cancers..,7795652_4,-1,3154,-1,0.16812676
3159,carcinoma in situ,10,13,68,85,BRCA1 mRNA levels are markedly decreased during the transition from carcinoma in situ to invasive cancer.,7795653_2,-1,3159,-1,0.16922759
3162,muscular dystrophy,13,15,99,117,Additional case of female monozygotic twins discordant for the clinical manifestations of Duchenne muscular dystrophy due to opposite X-chromosome inactivation.,7802009_0,-1,3162,-1,0.17154343
3163,MZ,6,7,31,33,"
A pair of female monozygotic (MZ) twins, heterozygous carriers for a deletion in the DMD gene and discordant for the clinical manifestations of Duchenne muscular dystrophy, were analyzed by molecular studies, in situ hybridization, and methylation pattern of X chromosomes to search for opposite X inactivation as an explanation of their clinical discordance.",7802009_1,-1,3163,-1,0.22726563
3164,muscular dystrophy,27,29,154,172,"
A pair of female monozygotic (MZ) twins, heterozygous carriers for a deletion in the DMD gene and discordant for the clinical manifestations of Duchenne muscular dystrophy, were analyzed by molecular studies, in situ hybridization, and methylation pattern of X chromosomes to search for opposite X inactivation as an explanation of their clinical discordance.",7802009_1,-1,3164,-1,0.18035065
3165,MZ,4,5,20,22,A review shows that MZ female twins discordant for X-linked diseases are not uncommon.,7802009_3,-1,3165,-1,0.25602317
3166,diseases,10,11,60,68,A review shows that MZ female twins discordant for X-linked diseases are not uncommon.,7802009_3,-1,3166,-1,0.19278166
3167,adrenoleukodystrophy,1,2,9,29,X-linked adrenoleukodystrophy (ALD): a novel mutation of the ALD gene in 6 members of a family presenting with 5 different phenotypes.,7811247_0,-1,3167,-1,0.19992921
3168,adrenoleukodystrophy,3,4,18,38,"
Fragments of the adrenoleukodystrophy (ALD) cDNA from a patient with adolescent ALD were amplified by polymerase chain reaction and subcloned.",7811247_1,-1,3168,-1,0.20857804
3169,cytosine,10,11,67,75,"Bidirectional sequencing of the entire coding ALD gene disclosed a cytosine to guanine transversion at nucleotide 1451 in exon five, resulting in substitution of proline 484 by arginine.",7811247_2,-1,3169,-1,0.29204053
3170,nucleotide,15,16,103,113,"Bidirectional sequencing of the entire coding ALD gene disclosed a cytosine to guanine transversion at nucleotide 1451 in exon five, resulting in substitution of proline 484 by arginine.",7811247_2,-1,3170,-1,0.33608806
3171,fatty acids,31,33,179,190,"Five of nine siblings of the patient, comprising two cerebral ALD, one adrenomyeloneuropathy, one Addison only as well as the symptomatic mother (all accumulating very long chain fatty acids) carried this mutation, which was not found in the unaffected persons, in five unrelated ALD patients, and in twenty controls.",7811247_3,-1,3171,-1,0.29802212
3172,disease,8,9,53,60,"We propose that this missense mutation generated the disease per se as well as the metabolic defect; the different phenotypes, however, must have originated by means of additional pathogenetic factors..",7811247_4,-1,3172,-1,0.23609094
3173,se,10,11,65,67,"We propose that this missense mutation generated the disease per se as well as the metabolic defect; the different phenotypes, however, must have originated by means of additional pathogenetic factors..",7811247_4,-1,3173,-1,0.25050023
3174,Norrie disease,8,10,46,60,Novel mutation at the initiation codon in the Norrie disease gene in two Japanese families.,7814011_0,-1,3174,-1,0.21943326
3175,Norrie disease,7,9,38,52,"
We have identified a new mutation of Norrie disease (ND) gene in two Japanese males from unrelated families; they showed typical ocular features of ND but no mental retardation or hearing impairment.",7814011_1,-1,3175,-1,0.20323905
3176,mental retardation,30,32,159,177,"
We have identified a new mutation of Norrie disease (ND) gene in two Japanese males from unrelated families; they showed typical ocular features of ND but no mental retardation or hearing impairment.",7814011_1,-1,3176,-1,0.19988951
3177,hearing impairment,33,35,181,199,"
We have identified a new mutation of Norrie disease (ND) gene in two Japanese males from unrelated families; they showed typical ocular features of ND but no mental retardation or hearing impairment.",7814011_1,-1,3177,-1,0.1963779
3178,nucleotide,27,28,123,133,"A mutation was found in both patients at the initiation codon of exon 2 of the ND gene (ATG to GTG), with otherwise normal nucleotide sequences.",7814011_2,-1,3178,-1,0.26846603
3179,disease,19,20,103,110,"Their mothers had the normal and mutant types of the gene, which was expected for heterozygotes of the disease.",7814011_3,-1,3179,-1,0.20779265
3180,amino,22,23,133,138,The mutation of the initiation codon would cause the failure of ND gene expression or a defect in translation thereby truncating the amino terminus of ND protein.,7814011_4,-1,3180,-1,0.27147007
3181,myotonic dystrophy,6,8,45,63,Anticipation resulting in elimination of the myotonic dystrophy gene: a follow up study of one extended family.,7815415_0,-1,3181,-1,0.19886595
3182,myotonic dystrophy,5,7,33,51,"
We have re-examined an extended myotonic dystrophy (DM) family, previously described in 1955, in order to study the long term effects of anticipation in DM and in particular the implications for families affected by this disease.",7815415_1,-1,3182,-1,0.19056079
3183,DM,8,9,53,55,"
We have re-examined an extended myotonic dystrophy (DM) family, previously described in 1955, in order to study the long term effects of anticipation in DM and in particular the implications for families affected by this disease.",7815415_1,-1,3183,-1,0.20060803
3184,DM,28,29,154,156,"
We have re-examined an extended myotonic dystrophy (DM) family, previously described in 1955, in order to study the long term effects of anticipation in DM and in particular the implications for families affected by this disease.",7815415_1,-1,3184,-1,0.20243223
3185,disease,39,40,222,229,"
We have re-examined an extended myotonic dystrophy (DM) family, previously described in 1955, in order to study the long term effects of anticipation in DM and in particular the implications for families affected by this disease.",7815415_1,-1,3185,-1,0.18497427
3186,disease,16,17,87,94,"Clinical anticipation, defined as the cascade of mild, adult, childhood, or congenital disease in subsequent generations, appeared to be a relentless process, occurring in all affected branches of the family.",7815415_3,-1,3186,-1,0.20397994
3187,disease,22,23,136,143,"The cascade was found to proceed asynchronously in the different branches, mainly because of an unequal number of generations with mild disease.",7815415_4,-1,3187,-1,0.23185186
3188,infertility,11,12,54,65,"Gene loss in the patient group was complete, owing to infertility of the male patients with adult onset disease and the fact that mentally retarded patients did not procreate.",7815415_8,-1,3188,-1,0.23922041
3189,disease,19,20,104,111,"Gene loss in the patient group was complete, owing to infertility of the male patients with adult onset disease and the fact that mentally retarded patients did not procreate.",7815415_8,-1,3189,-1,0.2039624
3190,DM,7,8,41,43,Therefore it is highly probable that the DM gene will be eliminated from this pedigree within one generation.,7815415_12,-1,3190,-1,0.2870571
3191,DM,5,6,33,35,"The high population frequency of DM can at present not be explained by the contribution of asymptomatic cases in the younger generations of known families, but is probably caused by the events in the ancestral generations..",7815415_13,-1,3191,-1,0.22616397
3192,cerebellar ataxia,4,6,20,37,The gene for spinal cerebellar ataxia 3 (SCA3) is located in a region of approximately 3 cM on chromosome 14q24.3-q32.2.,7825578_0,-1,3192,-1,0.2002838
3193,cM,18,19,89,91,The gene for spinal cerebellar ataxia 3 (SCA3) is located in a region of approximately 3 cM on chromosome 14q24.3-q32.2.,7825578_0,-1,3193,-1,0.3084198
3194,cerebellar ataxia,6,8,27,44,"
SCA3, the gene for spinal cerebellar ataxia 3, was recently mapped to a 15-cM interval between D14S67 and D14S81 on chromosome 14q, by linkage analysis in two families of French ancestry.",7825578_1,-1,3194,-1,0.18941909
3195,disease,8,9,48,55,The same allele for D14S280 segregates with the disease locus in the three kindreds.,7825578_6,-1,3195,-1,0.22387952
3196,Machado-Joseph disease,6,8,30,52,"2 containing the gene for the Machado-Joseph disease, which is clinically related to the phenotype determined by SCA3, but it cannot yet be concluded that both diseases result from alterations of the same gene",7825578_10,-1,3196,-1,0.23696579
3197,diseases,29,30,160,168,"2 containing the gene for the Machado-Joseph disease, which is clinically related to the phenotype determined by SCA3, but it cannot yet be concluded that both diseases result from alterations of the same gene",7825578_10,-1,3197,-1,0.20389347
3200,syndrome,3,4,32,40,"
The breast-ovary cancer-family syndrome is a dominant predisposition to cancer of the breast and ovaries which has been mapped to chromosome region 17q12-q21.",7825586_2,-1,3200,-1,0.19153212
3210,syndrome,7,8,57,65,These data suggest that the breast-ovarian cancer-family syndrome is genetically heterogeneous.,7825586_9,-1,3210,-1,0.19947472
3213,fructosuria,4,5,29,40,Molecular basis of essential fructosuria: molecular cloning and mutational analysis of human ketohexokinase (fructokinase).,7833921_0,-1,3213,-1,0.2622975
3214,fructosuria,1,2,11,22,"
Essential fructosuria is one of the oldest known inborn errors of metabolism.",7833921_1,-1,3214,-1,0.2919426
3215,fructosuria,20,21,120,131,"Despite the early recognition of this disorder, the primary structure of human KHK and the molecular basis of essential fructosuria have not been previously defined.",7833921_5,-1,3215,-1,0.2890507
3216,fructosuria,14,15,83,94,Direct evidence that mutation of the KHK structural gene is the cause of essential fructosuria was also obtained.,7833921_9,-1,3216,-1,0.268577
3217,fructosuria,12,13,70,81,"In a well-characterized family, in which three of eight siblings have fructosuria, all affected individuals are compound heterozygotes for two mutations Gly40Arg and Ala43Thr.",7833921_10,-1,3217,-1,0.3251974
3218,amino acid,3,5,27,37,An additional conservative amino acid change (Val49IIe) was present on the KHK allele bearing Ala43Thr,7833921_13,-1,3218,-1,0.31520718
3219,Gaucher disease,15,17,84,99,"Homozygous presence of the crossover (fusion gene) mutation identified in a type II Gaucher disease fetus: is this analogous to the Gaucher knock-out mouse model?
Gaucher disease (GD) is an inherited deficiency of beta-glucocerebrosidase (EC 3. 1. 2. 45, gene symbol GBA).",7857677_0,-1,3219,-1,0.20786749
3220,Gaucher disease,29,31,163,178,"Homozygous presence of the crossover (fusion gene) mutation identified in a type II Gaucher disease fetus: is this analogous to the Gaucher knock-out mouse model?
Gaucher disease (GD) is an inherited deficiency of beta-glucocerebrosidase (EC 3. 1. 2. 45, gene symbol GBA).",7857677_0,-1,3220,-1,0.22773007
3221,nucleotide,22,23,123,133,"It may occur alone as a single base-pair mutation but often is found as part of a complex allele containing additional GBA nucleotide substitutions, G6468C (A456P) and G6482C (V460V), without (recNciI) or with (recTL) G5957C (D409H).",7857677_3,-1,3221,-1,0.2697697
3222,disease,13,14,85,92,"Neonates showing a severe clinical phenotype, analogous to the early neonatal lethal disease occurring in mice homozygous for a null allele produced by targeted disruption of GBA, have been described elsewhere, but the specific mutations in these cases have not yet been characterized.",7857677_11,-1,3222,-1,0.19772387
3223,neurodegenerative disease,7,9,41,66,"
Metachromatic Leukodystrophy (MLD) is a neurodegenerative disease in which the lysosomal enzyme, Aryl sulfatase A (ARSA) is deficient.",7858169_1,-1,3223,-1,0.18203577
3224,disease,1,2,4,11,"The disease is inherited as an autosomal recessive trait and its frequency is estimated to be 1/40, 000 live births.",7858169_2,-1,3224,-1,0.2213417
3225,PD,3,4,18,20,"Another mutation, PD, leads to the deficiency of the enzyme in vitro (pseudodeficiency) without any known clinical effect.",7858169_4,-1,3225,-1,0.31454262
3226,PD,1,2,4,6,The PD mutation is frequent in all populations.,7858169_5,-1,3226,-1,0.30029804
3227,PD,18,19,114,116,"The molecular analysis demonstrated that in the Habbanite population, the mutation occurred on an allele with the PD mutation.",7858169_7,-1,3227,-1,0.28936848
3228,C,11,12,53,54,The loss of ARSA activity is due to a point mutation C > T leading to a change of proline to leucine.,7858169_8,-1,3228,-1,0.31650978
3229,leucine,21,22,93,100,The loss of ARSA activity is due to a point mutation C > T leading to a change of proline to leucine.,7858169_8,-1,3229,-1,0.2758163
3230,disease,12,13,64,71,"The Christian Arabs in Israel also have a high incidence of the disease (1/10, 000 live births); the mutation in this population is still unknown.",7858169_12,-1,3230,-1,0.24690284
3231,amino acid,2,4,9,19,A single amino acid substitution (G103D) in the type II collagen triple helix produces Kniest dysplasia.,7874117_0,-1,3231,-1,0.28554404
3232,Kniest dysplasia,16,18,87,103,A single amino acid substitution (G103D) in the type II collagen triple helix produces Kniest dysplasia.,7874117_0,-1,3232,-1,0.2571656
3233,Kniest dysplasia,0,2,1,17,"
Kniest dysplasia is a moderately severe chondrodysplasia phenotype that results from mutations in the gene for type II collagen, COL2A1.",7874117_1,-1,3233,-1,0.23213136
3234,cleft palate,14,16,92,104,"Characteristics of the disorder include a short trunk and extremities, mid-face hypoplasia, cleft palate, myopia, retinal detachment, and hearing loss.",7874117_2,-1,3234,-1,0.23872077
3235,myopia,17,18,106,112,"Characteristics of the disorder include a short trunk and extremities, mid-face hypoplasia, cleft palate, myopia, retinal detachment, and hearing loss.",7874117_2,-1,3235,-1,0.21882205
3236,retinal detachment,19,21,114,132,"Characteristics of the disorder include a short trunk and extremities, mid-face hypoplasia, cleft palate, myopia, retinal detachment, and hearing loss.",7874117_2,-1,3236,-1,0.20645893
3237,hearing loss,23,25,138,150,"Characteristics of the disorder include a short trunk and extremities, mid-face hypoplasia, cleft palate, myopia, retinal detachment, and hearing loss.",7874117_2,-1,3237,-1,0.20638503
3238,Kniest dysplasia,16,18,87,103,"Recently, deletions of all or part of exon 12 have been identified in individuals with Kniest dysplasia, suggesting that mutations within this region of the protein may primarily result in the Kniest dysplasia phenotype.",7874117_3,-1,3238,-1,0.2036029
3239,Kniest dysplasia,33,35,193,209,"Recently, deletions of all or part of exon 12 have been identified in individuals with Kniest dysplasia, suggesting that mutations within this region of the protein may primarily result in the Kniest dysplasia phenotype.",7874117_3,-1,3239,-1,0.19354652
3240,Kniest dysplasia,17,19,105,121,We used SSCP to analyze an amplified genomic DNA fragment containing exon 12 from seven individuals with Kniest dysplasia.,7874117_4,-1,3240,-1,0.2218577
3241,aspartate,26,27,165,174,DNA sequence analysis demonstrated that the patient was heterozygous for a G to A transition that implied substitution of glycine103 of the triple helical domain by aspartate.,7874117_6,-1,3241,-1,0.27199018
3242,amino acid,10,12,67,77,"These data demonstrate that point mutations which result in single amino acid substitutions can produce Kniest dysplasia and further support the hypothesis that alteration of a domain, which includes the region encoded by exon 12, in the type II collagen protein leads to this disorder..",7874117_9,-1,3242,-1,0.26443613
3243,Kniest dysplasia,15,17,104,120,"These data demonstrate that point mutations which result in single amino acid substitutions can produce Kniest dysplasia and further support the hypothesis that alteration of a domain, which includes the region encoded by exon 12, in the type II collagen protein leads to this disorder..",7874117_9,-1,3243,-1,0.22033608
3244,Machado-Joseph disease,7,9,35,57,CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1.,7874163_0,-1,3244,-1,0.23758733
3245,Machado-Joseph disease,6,8,25,47,"1, the genetic locus for Machado-Joseph disease (MJD).",7874163_2,-1,3245,-1,0.22336006
3246,diseases,15,16,97,105,These results raise the possibility that similar abnormalities in related genes may give rise to diseases similar to MJD.,7874163_5,-1,3246,-1,0.17481306
3249,cysteine,15,16,77,85,"In addition, we found two missense mutations, one of which changes the final cysteine of the BRCA1 zinc finger motif to glycine.",7894491_3,-1,3249,-1,0.27195993
3250,zinc,19,20,99,103,"In addition, we found two missense mutations, one of which changes the final cysteine of the BRCA1 zinc finger motif to glycine.",7894491_3,-1,3250,-1,0.25171942
3251,glycine,23,24,120,127,"In addition, we found two missense mutations, one of which changes the final cysteine of the BRCA1 zinc finger motif to glycine.",7894491_3,-1,3251,-1,0.28273514
3252,tumour,6,7,33,39,"These data are consistent with a tumour suppressor model, and support the notion that this candidate gene is in fact BRCA1.",7894491_4,-1,3252,-1,0.16093332
3257,lead,2,3,16,20,Seven mutations lead to protein truncations at sites throughout the gene.,7894493_3,-1,3257,-1,0.2850568
3258,cysteine,16,17,88,96,One missense mutation (which occurred independently in two families) leads to loss of a cysteine in the zinc binding domain.,7894493_4,-1,3258,-1,0.27566072
3259,zinc,19,20,104,108,One missense mutation (which occurred independently in two families) leads to loss of a cysteine in the zinc binding domain.,7894493_4,-1,3259,-1,0.2565352
3261,myotonic dystrophy,14,16,101,119,High resolution genetic analysis suggests one ancestral predisposing haplotype for the origin of the myotonic dystrophy mutation.,7909252_0,-1,3261,-1,0.191114
3262,myotonic dystrophy,3,5,22,40,"
The mutation causing myotonic dystrophy (DM) has been identified as an amplification of an unstable trinucleotide (CTG) n repeat in over 99% of the global DM population.",7909252_1,-1,3262,-1,0.1775008
3263,DM,6,7,42,44,"
The mutation causing myotonic dystrophy (DM) has been identified as an amplification of an unstable trinucleotide (CTG) n repeat in over 99% of the global DM population.",7909252_1,-1,3263,-1,0.2020393
3264,n,21,22,121,122,"
The mutation causing myotonic dystrophy (DM) has been identified as an amplification of an unstable trinucleotide (CTG) n repeat in over 99% of the global DM population.",7909252_1,-1,3264,-1,0.32178682
3265,DM,30,31,156,158,"
The mutation causing myotonic dystrophy (DM) has been identified as an amplification of an unstable trinucleotide (CTG) n repeat in over 99% of the global DM population.",7909252_1,-1,3265,-1,0.19813208
3266,DM,13,14,85,87,"It is in complete linkage disequilibrium with an Alu element polymorphism within the DM kinase gene, suggesting that DM is a consequence of one or few ancestral mutations.",7909252_2,-1,3266,-1,0.2724606
3267,DM,19,20,117,119,"It is in complete linkage disequilibrium with an Alu element polymorphism within the DM kinase gene, suggesting that DM is a consequence of one or few ancestral mutations.",7909252_2,-1,3267,-1,0.25103307
3268,Fragile X syndrome,18,21,115,133,"A recent analysis utilizing this polymorphism as well as a flanking dinucleotide marker, suggested that similar to Fragile X syndrome, DM exhibited a founder effect (Imbert et al., 1993 Nature Genet. 4, 72-76).",7909252_3,-1,3268,-1,0.21423016
3269,DM,22,23,135,137,"A recent analysis utilizing this polymorphism as well as a flanking dinucleotide marker, suggested that similar to Fragile X syndrome, DM exhibited a founder effect (Imbert et al., 1993 Nature Genet. 4, 72-76).",7909252_3,-1,3269,-1,0.2665781
3270,contrast,1,2,3,11,"In contrast, the low reproductive fitness of individuals with congenital DM (the endpoint of genetic anticipation in myotonic dystrophy) suggests a higher rate of new mutations.",7909252_4,-1,3270,-1,0.26504758
3271,DM,11,12,73,75,"In contrast, the low reproductive fitness of individuals with congenital DM (the endpoint of genetic anticipation in myotonic dystrophy) suggests a higher rate of new mutations.",7909252_4,-1,3271,-1,0.2135999
3272,myotonic dystrophy,19,21,117,135,"In contrast, the low reproductive fitness of individuals with congenital DM (the endpoint of genetic anticipation in myotonic dystrophy) suggests a higher rate of new mutations.",7909252_4,-1,3272,-1,0.17579459
3273,DM,9,10,53,55,"We present a high resolution genetic analysis of the DM locus using PCR based assays of nine polymorphisms, spanning a physical distance of 30 kb, within and immediately flanking the DM kinase gene.",7909252_5,-1,3273,-1,0.24395928
3274,DM,32,33,183,185,"We present a high resolution genetic analysis of the DM locus using PCR based assays of nine polymorphisms, spanning a physical distance of 30 kb, within and immediately flanking the DM kinase gene.",7909252_5,-1,3274,-1,0.26787314
3275,DM,7,8,51,53,The persistent complete allelic association of the DM mutation with all these polymorphisms provides further support to previous observations and suggests more strongly that the DM mutation occurred on the background of a particular haplotype in which the (CTG) n repeat became inherently unstable and therefore predisposed to amplification.,7909252_6,-1,3275,-1,0.2306477
3276,DM,25,26,178,180,The persistent complete allelic association of the DM mutation with all these polymorphisms provides further support to previous observations and suggests more strongly that the DM mutation occurred on the background of a particular haplotype in which the (CTG) n repeat became inherently unstable and therefore predisposed to amplification.,7909252_6,-1,3276,-1,0.22575243
3280,cystadenocarcinoma,16,17,84,102,"In clones and subclones derived serially from one of these cell lines (2774; serous cystadenocarcinoma), a very high proportion of microsatellites distributed in many different regions of the genome change their size in a mercurial fashion.",7937795_2,-1,3280,-1,0.16456702
3281,genomic instability,3,5,17,36,We conclude that genomic instability in ovarian tumors is a dynamic and ongoing process whose high frequency may have been previously underestimated by PCR-based allelotyping of bulk tumor tissue.,7937795_3,-1,3281,-1,0.19617192
3285,colorectal cancer,43,45,246,263,"We have identified the source of the genetic instability in one ovarian tumor as a point mutation (R524P) in the human mismatch-repair gene MSH2 (Salmonella MutS homologue), which has recently been shown to be involved in hereditary nonpolyposis colorectal cancer.",7937795_4,-1,3285,-1,0.13826708
3298,aniridia,11,12,63,71,"PAX6 gene dosage effect in a family with congenital cataracts, aniridia, anophthalmia and central nervous system defects.",7951315_0,-1,3298,-1,0.22530404
3299,anophthalmia,13,14,73,85,"PAX6 gene dosage effect in a family with congenital cataracts, aniridia, anophthalmia and central nervous system defects.",7951315_0,-1,3299,-1,0.20941044
3300,aniridia,4,5,28,36,"
The human eye malformation aniridia results from haploinsufficiency of PAX6, a paired box DNA-binding protein.",7951315_1,-1,3300,-1,0.22703424
3301,aniridia,15,16,89,97,"To study this dosage effect, we characterized two PAX6 mutations in a family segregating aniridia and a milder syndrome consisting of congenital cataracts and late onset corneal dystrophy.",7951315_2,-1,3301,-1,0.23395693
3302,syndrome,19,20,111,119,"To study this dosage effect, we characterized two PAX6 mutations in a family segregating aniridia and a milder syndrome consisting of congenital cataracts and late onset corneal dystrophy.",7951315_2,-1,3302,-1,0.17543496
3304,malformations,3,4,15,28,The pattern of malformations is similar to that in homozygous Sey mice and suggests a critical role for PAX6 in controlling the migration and differentiation of specific neuronal progenitor cells in the brain..,7951315_6,-1,3304,-1,0.26038083
3305,map,2,3,11,14,A physical map and candidate genes in the BRCA1 region on chromosome 17q12-21.,7951316_0,-1,3305,-1,0.22993636
3306,map,5,6,32,35,"
We have constructed a physical map of a 4 cM region on chromosome 17q12-21 that contains the hereditary breast and ovarian cancer gene BRCA1.",7951316_1,-1,3306,-1,0.21578579
3307,cM,9,10,43,45,"
We have constructed a physical map of a 4 cM region on chromosome 17q12-21 that contains the hereditary breast and ovarian cancer gene BRCA1.",7951316_1,-1,3307,-1,0.28182748
3309,map,1,2,4,7,"The map comprises a contig of 137 overlapping yeast artificial chromosomes and P1 clones, onto which we have placed 112 PCR markers.",7951316_2,-1,3309,-1,0.25766358
3310,map,9,10,45,48,"We have localized more than 20 genes on this map, ten of which had not been mapped to the region previously, and have isolated 30 cDNA clones representing partial sequences of as yet unidentified genes.",7951316_3,-1,3310,-1,0.24058616
3312,copper,8,9,34,40,The LEC rat has a deletion in the copper transporting ATPase gene homologous to the Wilson disease gene.,7951327_0,-1,3312,-1,0.24340944
3313,Wilson disease,15,17,84,98,The LEC rat has a deletion in the copper transporting ATPase gene homologous to the Wilson disease gene.,7951327_0,-1,3313,-1,0.23298775
3314,Wilson disease,10,12,55,69,"
The Long-Evans Cinnamon (LEC) rat shows similarity to Wilson disease in many clinical and biochemical features.",7951327_1,-1,3314,-1,0.22803473
3315,Wilson disease,15,17,70,84,We have cloned cDNAs for the rat gene (Atp7b) homologous to the human Wilson disease gene (ATP7B) and have used them to identify a partial deletion in the Atp7b gene in the LEC rat.,7951327_2,-1,3315,-1,0.21594954
3316,ATP,19,20,93,96,"The deletion removes at least 900 bp of the coding region at the 3 end, includes the crucial ATP binding domain and extends downstream of the gene.",7951327_3,-1,3316,-1,0.23977435
3317,Wilson disease,15,17,88,102,Our results provide convincing evidence for defining the LEC rat as an animal model for Wilson disease.,7951327_4,-1,3317,-1,0.21491072
3318,Wilson disease,14,16,92,106,"This model will be important for studying liver pathophysiology, for developing therapy for Wilson disease and for studying the pathway of copper transport and its possible interaction with other heavy metals..",7951327_5,-1,3318,-1,0.18214718
3319,copper,22,23,139,145,"This model will be important for studying liver pathophysiology, for developing therapy for Wilson disease and for studying the pathway of copper transport and its possible interaction with other heavy metals..",7951327_5,-1,3319,-1,0.21507509
3320,adrenoleukodystrophy,4,5,28,48,Genomic organization of the adrenoleukodystrophy gene.,7959759_0,-1,3320,-1,0.20952868
3321,Adrenoleukodystrophy,0,1,1,21,"
Adrenoleukodystrophy (ALD), the most frequent peroxisomal disorder, is a severe neurodegenerative disease associated with an impairment of very long chain fatty acids beta-oxidation.",7959759_1,-1,3321,-1,0.20193005
3322,neurodegenerative disease,14,16,81,106,"
Adrenoleukodystrophy (ALD), the most frequent peroxisomal disorder, is a severe neurodegenerative disease associated with an impairment of very long chain fatty acids beta-oxidation.",7959759_1,-1,3322,-1,0.17677999
3323,fatty acids,24,26,156,167,"
Adrenoleukodystrophy (ALD), the most frequent peroxisomal disorder, is a severe neurodegenerative disease associated with an impairment of very long chain fatty acids beta-oxidation.",7959759_1,-1,3323,-1,0.25678277
3324,map,9,10,51,54,"The ALD gene has been positioned on a pulsed-field map between DXS15 and the L1CAM gene, about 650 kb upstream from the color pigment genes.",7959759_8,-1,3324,-1,0.23212352
3325,syndrome,27,28,170,178,The frequent occurrence of color vision anomalies observed in patients with adrenomyeloneuropathy (the adult onset form of ALD) thus does not represent a contiguous gene syndrome but a secondary manifestation of ALD..,7959759_9,-1,3325,-1,0.2448157
3326,Huntington disease,5,7,29,47,The murine homologues of the Huntington disease gene (Hdh) and the alpha-adducin gene (Add1) map to mouse chromosome 5 within a region of conserved synteny with human chromosome 4p16.3.,7959767_0,-1,3326,-1,0.18863033
3327,map,18,19,93,96,The murine homologues of the Huntington disease gene (Hdh) and the alpha-adducin gene (Add1) map to mouse chromosome 5 within a region of conserved synteny with human chromosome 4p16.3.,7959767_0,-1,3327,-1,0.26902634
3328,Huntington disease,0,2,1,19,"
Huntington disease (HD) is a severe autosomal dominant neurodegenerative disorder associated with a novel gene (IT15).",7959767_1,-1,3328,-1,0.20692624
3329,neurodegenerative,10,11,56,73,"
Huntington disease (HD) is a severe autosomal dominant neurodegenerative disorder associated with a novel gene (IT15).",7959767_1,-1,3329,-1,0.17497043
3330,map,4,5,20,23,"Both of these genes map in the same position on mouse chromosome 5 in a region associated with ancestral chromosomal rearrangements and show no recombination with D5H4S43, D5H4S115, and D5H4S62, the murine homologues of D4S43, D4S115, and D4S62, respectively.",7959767_4,-1,3330,-1,0.3156071
3331,cholesteryl ester transfer protein deficiency,1,6,8,53,Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol.,7962532_0,-1,3331,-1,0.21165831
3332,cholesterol,22,23,159,170,Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol.,7962532_0,-1,3332,-1,0.20868388
3333,cholesterol,4,5,29,40,"
Genetic determinants of HDL cholesterol (HDL-C) levels in the general population are poorly understood.",7962532_1,-1,3333,-1,0.25489908
3334,cholesteryl ester,4,6,31,48,We previously described plasma cholesteryl ester transfer protein (CETP) deficiency due to an intron 14 G (+ 1) -to-A mutation (Int14 A) in several families with very high HDL-C levels in Japan.,7962532_2,-1,3334,-1,0.27582738
3335,n,9,10,38,39,Subjects with HDL-C > or = 100 mg/dl (n = 130) were screened by PCR single strand conformational polymorphism analysis of the CETP gene.,7962532_3,-1,3335,-1,0.2982696
3336,map,11,12,85,88,Two other mutations were identified by DNA sequencing or primer-mediated restriction map modification of PCR products  a novel intron 14 splice donor site mutation caused by a T insertion at position + 3 from the exon14/intron14 boundary (Int14 T) and a missense mutation (Asp442 to Gly) within exon 15 (D442G).,7962532_4,-1,3336,-1,0.29146641
3337,n,22,23,117,118,"Furthermore, prevalences of the D442G and Int14 A mutations were extremely high in a general sample of Japanese men (n = 236), with heterozygote frequencies of 7% and 2%, respectively.",7962532_7,-1,3337,-1,0.30238494
3338,xanthomatosis,3,4,30,43,"Treatment of cerebrotendinous xanthomatosis: effects of chenodeoxycholic acid, pravastatin, and combined use.",7964884_0,-1,3338,-1,0.18920995
3339,pravastatin,10,11,79,90,"Treatment of cerebrotendinous xanthomatosis: effects of chenodeoxycholic acid, pravastatin, and combined use.",7964884_0,-1,3339,-1,0.27115184
3340,pravastatin,20,21,132,143,"
Treatments by oral administration of chenodeoxycholic acid (CDCA) alone, 3-hydroxy-3-methylglutaryl (HMG) CoA reductase inhibitor (pravastatin) alone, and combination of the two drugs were attempted for 7 patients with cerebrotendinous xanthomatosis (CTX).",7964884_1,-1,3340,-1,0.30390558
3341,xanthomatosis,37,38,237,250,"
Treatments by oral administration of chenodeoxycholic acid (CDCA) alone, 3-hydroxy-3-methylglutaryl (HMG) CoA reductase inhibitor (pravastatin) alone, and combination of the two drugs were attempted for 7 patients with cerebrotendinous xanthomatosis (CTX).",7964884_1,-1,3341,-1,0.18890904
3342,CTX,39,40,252,255,"
Treatments by oral administration of chenodeoxycholic acid (CDCA) alone, 3-hydroxy-3-methylglutaryl (HMG) CoA reductase inhibitor (pravastatin) alone, and combination of the two drugs were attempted for 7 patients with cerebrotendinous xanthomatosis (CTX).",7964884_1,-1,3342,-1,0.22971924
3343,cholesterol,15,16,71,82,"However, the sera of the patients changed to be "" atherogenic ""; total cholesterol, triglyceride and low-density lipoprotein (LDL) -cholesterol were increased, while high-density lipoprotein (HDL) -cholesterol was decreased.",7964884_3,-1,3343,-1,0.2282872
3344,triglyceride,17,18,84,96,"However, the sera of the patients changed to be "" atherogenic ""; total cholesterol, triglyceride and low-density lipoprotein (LDL) -cholesterol were increased, while high-density lipoprotein (HDL) -cholesterol was decreased.",7964884_3,-1,3344,-1,0.24833414
3345,pravastatin,2,3,12,23,"Contrarily, pravastatin at a dose of 10 mg/day improved the sera of the patients to be markedly "" anti-atherogenic "", but the reductions of cholestanol (30. 4%), lathosterol (44. 0%), campesterol (22. 9%) and sitosterol (9. 6%) were inadequate.",7964884_4,-1,3345,-1,0.3150475
3346,pravastatin,5,6,33,44,Combined treatment with CDCA and pravastatin showed good overlapping of the effects of each drug alone.,7964884_5,-1,3346,-1,0.2949552
3347,cholesterol,31,32,182,193,"Serum cholestanol concentration was still 2. 7 times higher than in controls, but the serum lathosterol level was within the normal range, indicating that the enhancement of overall cholesterol synthesis in the patients was sufficiently suppressed.",7964884_7,-1,3347,-1,0.23822215
3348,sterol,1,2,6,12,Plant sterol levels were also within the normal range.,7964884_8,-1,3348,-1,0.29567218
3349,pravastatin,5,6,28,39,"The combination of CDCA and pravastatin was a good treatment for CTX, based on the improvement of serum lipoprotein metabolism, the suppression of cholesterol synthesis, and reductions of cholestanol and plant sterol levels.",7964884_9,-1,3349,-1,0.28027838
3350,CTX,11,12,65,68,"The combination of CDCA and pravastatin was a good treatment for CTX, based on the improvement of serum lipoprotein metabolism, the suppression of cholesterol synthesis, and reductions of cholestanol and plant sterol levels.",7964884_9,-1,3350,-1,0.26761317
3351,cholesterol,25,26,147,158,"The combination of CDCA and pravastatin was a good treatment for CTX, based on the improvement of serum lipoprotein metabolism, the suppression of cholesterol synthesis, and reductions of cholestanol and plant sterol levels.",7964884_9,-1,3351,-1,0.22432697
3352,sterol,34,35,210,216,"The combination of CDCA and pravastatin was a good treatment for CTX, based on the improvement of serum lipoprotein metabolism, the suppression of cholesterol synthesis, and reductions of cholestanol and plant sterol levels.",7964884_9,-1,3352,-1,0.24788374
3353,disease,9,10,41,48,"In all of 7 patients, the progression of disease was arrested, but dramatic effects on clinical manifestations, xanthoma, and electrophysiological findings could not be found after the treatment of these drugs",7964884_10,-1,3353,-1,0.20429021
3354,choroideremia,10,11,56,69,Mutation spectrum in the CHM gene of Danish and Swedish choroideremia patients.,7981671_0,-1,3354,-1,0.216664
3355,choroideremia,11,12,64,77,"
The recent isolation of the complete open reading frame of the choroideremia (CHM) gene and the characterization of the exon-intron boundaries has paved the way to mutation detection in patients with classical choroideremia.",7981671_1,-1,3355,-1,0.21296833
3356,choroideremia,34,35,211,224,"
The recent isolation of the complete open reading frame of the choroideremia (CHM) gene and the characterization of the exon-intron boundaries has paved the way to mutation detection in patients with classical choroideremia.",7981671_1,-1,3356,-1,0.21332036
3357,map,25,26,153,156,Mapping of the deletion endpoints in these four patients and in another 11 male patients with sizeable deletions enabled us to construct a very detailed map of intervals 2 and 3 of Xq21.,7981671_6,-1,3357,-1,0.23005062
3358,choroideremia,10,11,59,72,"Interestingly, all CHM gene mutations detected thus far in choroideremia patients give rise to the introduction of a premature stop codon..",7981671_8,-1,3358,-1,0.21466209
3359,adrenoleukodystrophy,7,8,64,84,Predominance of the adrenomyeloneuropathy phenotype of X-linked adrenoleukodystrophy in The Netherlands: a survey of 30 kindreds.,7991123_0,-1,3359,-1,0.19445379
3360,adrenoleukodystrophy,1,2,10,30,"
X-linked adrenoleukodystrophy (X-ALD) is an inherited disorder of peroxisomal beta-oxidation associated with accumulation of saturated very long-chain fatty acids, which results in central and peripheral demyelination and in impaired function of adrenal cortex and testes.",7991123_1,-1,3360,-1,0.19816886
3361,fatty acids,19,21,152,163,"
X-linked adrenoleukodystrophy (X-ALD) is an inherited disorder of peroxisomal beta-oxidation associated with accumulation of saturated very long-chain fatty acids, which results in central and peripheral demyelination and in impaired function of adrenal cortex and testes.",7991123_1,-1,3361,-1,0.2243524
3362,Adrenoleukodystrophy,0,1,0,20,Adrenoleukodystrophy gene encodes an 80 kDa membrane protein.,8002973_0,-1,3362,-1,0.21425477
3363,adrenoleukodystrophy,17,18,114,134,"
An antibody against the synthetic C-terminal peptides deduced from the cDNA of the gene responsible for X-linked adrenoleukodystrophy (ALD) was produced to characterize the product of the ALD gene.",8002973_1,-1,3363,-1,0.19812527
3364,syndrome,6,7,33,41,Isolation of the gene for McLeod syndrome that encodes a novel membrane transport protein.,8004674_0,-1,3364,-1,0.2198544
3365,syndrome,1,2,8,16,"
McLeod syndrome is an X-linked multisystem disorder characterized by abnormalities in the neuromuscular and hematopoietic systems.",8004674_1,-1,3365,-1,0.2027323
3366,Nucleotide,0,1,0,10,Nucleotide sequence analysis of XK from two unrelated McLeod patients has identified point mutations at conserved splice donor and acceptor sites.,8004674_6,-1,3366,-1,0.26523554
3367,syndrome,11,12,73,81,These findings provide direct evidence that XK is responsible for McLeod syndrome..,8004674_7,-1,3367,-1,0.22590967
3368,paraplegia,2,3,17,27,X-linked spastic paraplegia and Pelizaeus-Merzbacher disease are allelic disorders at the proteolipid protein locus.,8012387_0,-1,3368,-1,0.20152584
3369,Pelizaeus-Merzbacher disease,4,6,32,60,X-linked spastic paraplegia and Pelizaeus-Merzbacher disease are allelic disorders at the proteolipid protein locus.,8012387_0,-1,3369,-1,0.25254083
3370,paraplegia,5,6,33,43,"
Three forms of X-linked spastic paraplegia (SPG) have been defined.",8012387_1,-1,3370,-1,0.21817455
3371,maps,6,7,18,22,One locus (SPG 1) maps to Xq28 while two clinically distinct forms map to Xq22 (SPG2).,8012387_2,-1,3371,-1,0.2904076
3372,map,14,15,67,70,One locus (SPG 1) maps to Xq28 while two clinically distinct forms map to Xq22 (SPG2).,8012387_2,-1,3372,-1,0.3181341
3373,Pelizaeus-Merzbacher disease,11,13,71,99,"A rare X-linked dysmyelinating disorder of the central nervous system, Pelizaeus-Merzbacher disease (PMD), has also been mapped to Xq21-q22, and is caused by mutations in the proteolipid protein gene (PLP) which encodes two myelin proteins, PLP and DM20.",8012387_3,-1,3373,-1,0.24776444
3374,disease,22,23,122,129,"While narrowing the genetic interval containing SPG2 in a large pedigree, we found that PLP was the closest marker to the disease locus, implicating PLP as a possible candidate gene.",8012387_4,-1,3374,-1,0.21284012
3375,disease,30,31,144,151,"We have found that a point mutation (His139Tyr) in exon 3B of an affected male produces a mutant PLP but a normal DM20, and segregates with the disease (Zmax = 6.",8012387_5,-1,3375,-1,0.22175942
3376,Canavan disease,0,2,0,15,Canavan disease: mutations among Jewish and non-Jewish patients.,8023850_0,-1,3376,-1,0.2350398
3377,Canavan disease,0,2,1,16,"
Canavan disease is an autosomal recessive leukodystrophy caused by the deficiency of aspartoacylase (ASPA).",8023850_1,-1,3377,-1,0.22730654
3378,C,8,9,44,45,"Three point mutations--693C-- > A, 854A-- > C, and 914C-- > A--were identified in the coding sequence.",8023850_3,-1,3378,-1,0.3429343
3379,glu,25,26,105,108,"The 693C-- > A and 914C-- > A base changes, resulting in nonsense tyr231-- > ter and missense ala305-- > glu mutations, respectively, lead to complete loss of ASPA activity in in vitro expression studies.",8023850_4,-1,3379,-1,0.27915415
3380,lead,30,31,134,138,"The 693C-- > A and 914C-- > A base changes, resulting in nonsense tyr231-- > ter and missense ala305-- > glu mutations, respectively, lead to complete loss of ASPA activity in in vitro expression studies.",8023850_4,-1,3380,-1,0.27266
3381,C,3,4,13,14,The 854A-- > C transversion converted glu to ala in codon 285.,8023850_5,-1,3381,-1,0.3436338
3382,glu,6,7,38,41,The 854A-- > C transversion converted glu to ala in codon 285.,8023850_5,-1,3382,-1,0.273996
3383,lead,4,5,31,35,"The splice-site mutation would lead to skipping of exon 3, accompanied by a frameshift, and thus would produce aberrant ASPA.",8023850_8,-1,3383,-1,0.28086227
3384,glu,5,6,15,18,The ala305-- > glu mutation was found exclusively in non-Jewish probands of European descent and constituted 60% of the 40 mutant chromosomes.,8023850_13,-1,3384,-1,0.2752496
3385,Canavan disease,12,14,96,111,Predominant occurrence of certain mutations among Ashkenazi Jewish and non-Jewish patients with Canavan disease would suggest a founding-father effect in propagation of these mutant chromosomes,8023850_14,-1,3385,-1,0.20703894
3386,myotonic dystrophy,4,6,33,51,"Intelligence quotient profile in myotonic dystrophy, intergenerational deficit, and correlation with CTG amplification.",8071955_0,-1,3386,-1,0.17659928
3387,myotonic dystrophy,23,25,152,170,"
An abbreviated Wechsler Adult Intelligence Scale Revised (WAIS-R) was used to assess verbal and arithmetical cognitive performance in 55 subjects with myotonic dystrophy (DM), covering all grades of disease severity, and 31 controls at 50% risk of inheriting DM.",8071955_1,-1,3387,-1,0.19001794
3388,DM,26,27,172,174,"
An abbreviated Wechsler Adult Intelligence Scale Revised (WAIS-R) was used to assess verbal and arithmetical cognitive performance in 55 subjects with myotonic dystrophy (DM), covering all grades of disease severity, and 31 controls at 50% risk of inheriting DM.",8071955_1,-1,3388,-1,0.201397
3389,disease,33,34,200,207,"
An abbreviated Wechsler Adult Intelligence Scale Revised (WAIS-R) was used to assess verbal and arithmetical cognitive performance in 55 subjects with myotonic dystrophy (DM), covering all grades of disease severity, and 31 controls at 50% risk of inheriting DM.",8071955_1,-1,3389,-1,0.19599558
3390,DM,45,46,260,262,"
An abbreviated Wechsler Adult Intelligence Scale Revised (WAIS-R) was used to assess verbal and arithmetical cognitive performance in 55 subjects with myotonic dystrophy (DM), covering all grades of disease severity, and 31 controls at 50% risk of inheriting DM.",8071955_1,-1,3390,-1,0.20803577
3391,DM,12,13,58,60,"Significant IQ differences were found between  (1) all 55 DM subjects (mean 90. 2, SD 16.",8071955_3,-1,3391,-1,0.2779642
3392,SD,20,21,83,85,"Significant IQ differences were found between  (1) all 55 DM subjects (mean 90. 2, SD 16.",8071955_3,-1,3392,-1,0.3617718
3393,SD,10,11,28,30,"1) and 31 controls (102. 6, SD 9. 4), with no sex differences in either group; (2) 15 affected parents (99. 3, SD 12. 2) and their affected children (88. 1, SD 17. 2), where significance was dependent on parental sex being female; and (3) 15 pairs of affected sibs (89. 6, SD 13. 2) and their normal sibs (100. 2, SD 7. 6).",8071955_4,-1,3393,-1,0.333791
3394,SD,35,36,111,113,"1) and 31 controls (102. 6, SD 9. 4), with no sex differences in either group; (2) 15 affected parents (99. 3, SD 12. 2) and their affected children (88. 1, SD 17. 2), where significance was dependent on parental sex being female; and (3) 15 pairs of affected sibs (89. 6, SD 13. 2) and their normal sibs (100. 2, SD 7. 6).",8071955_4,-1,3394,-1,0.3408694
3395,SD,49,50,157,159,"1) and 31 controls (102. 6, SD 9. 4), with no sex differences in either group; (2) 15 affected parents (99. 3, SD 12. 2) and their affected children (88. 1, SD 17. 2), where significance was dependent on parental sex being female; and (3) 15 pairs of affected sibs (89. 6, SD 13. 2) and their normal sibs (100. 2, SD 7. 6).",8071955_4,-1,3395,-1,0.33730593
3396,SD,79,80,273,275,"1) and 31 controls (102. 6, SD 9. 4), with no sex differences in either group; (2) 15 affected parents (99. 3, SD 12. 2) and their affected children (88. 1, SD 17. 2), where significance was dependent on parental sex being female; and (3) 15 pairs of affected sibs (89. 6, SD 13. 2) and their normal sibs (100. 2, SD 7. 6).",8071955_4,-1,3396,-1,0.32798937
3397,SD,93,94,314,316,"1) and 31 controls (102. 6, SD 9. 4), with no sex differences in either group; (2) 15 affected parents (99. 3, SD 12. 2) and their affected children (88. 1, SD 17. 2), where significance was dependent on parental sex being female; and (3) 15 pairs of affected sibs (89. 6, SD 13. 2) and their normal sibs (100. 2, SD 7. 6).",8071955_4,-1,3397,-1,0.34407827
3398,signs and symptoms,12,15,48,66,"IQ steadily declined as (1) the age of onset of signs and symptoms decreased, and (2) the CTG expansion size increased.",8071955_5,-1,3398,-1,0.28212297
3399,DM,12,13,74,76,"The correlation of IQ difference and CTG expansion difference in both the DM parent-child pairs and normal sib-affected sib pairs was poor, indicating that CTG expansion is not a reliable predictor of IQ either in individual persons or families.",8071955_7,-1,3399,-1,0.24731001
3400,DM,6,7,42,44,Further analysis of cognitive function in DM is required to clarify specific deficits characteristic of this patient group,8071955_8,-1,3400,-1,0.22222477
3401,Adenomatous polyposis coli,0,3,0,26,Adenomatous polyposis coli and a cytogenetic deletion of chromosome 5 resulting from a maternal intrachromosomal insertion.,8071957_0,-1,3401,-1,0.20144732
3402,autism,15,16,111,117,"
We present the clinical and laboratory findings in an institutionalised adult patient originally referred for autism.",8071957_1,-1,3402,-1,0.21794516
3403,colorectal cancer,4,6,15,32,"A high risk of colorectal cancer was predicted when an interstitial deletion of the long arm of chromosome 5, del (5) (q15q22. 3), was detected in her lymphocytes and deletion of the MCC and APC genes confirmed by molecular analysis.",8071957_2,-1,3403,-1,0.14355373
3404,Adenomatous polyposis coli,0,3,0,26,Adenomatous polyposis coli and carcinoma of the rectum were subsequently diagnosed in the patient.,8071957_3,-1,3404,-1,0.21612027
3414,melanoma,12,13,60,68,"The EWS gene, involved in Ewing family of tumors, malignant melanoma of soft parts and desmoplastic small round cell tumors, codes for an RNA binding protein with novel regulatory domains.",8084618_0,-1,3414,-1,0.17391233
3417,sarcoma,26,27,130,137,"
The EWS gene, which maps to band q12 of human chromosome 22, is involved in a wide variety of human solid tumors including Ewing sarcoma, related primitive neuroectodermal tumors, malignant melanoma of soft parts and desmoplastic small round cell tumors.",8084618_1,-1,3417,-1,0.15103179
3418,neuroectodermal tumors,30,32,157,179,"
The EWS gene, which maps to band q12 of human chromosome 22, is involved in a wide variety of human solid tumors including Ewing sarcoma, related primitive neuroectodermal tumors, malignant melanoma of soft parts and desmoplastic small round cell tumors.",8084618_1,-1,3418,-1,0.19351222
3419,melanoma,34,35,191,199,"
The EWS gene, which maps to band q12 of human chromosome 22, is involved in a wide variety of human solid tumors including Ewing sarcoma, related primitive neuroectodermal tumors, malignant melanoma of soft parts and desmoplastic small round cell tumors.",8084618_1,-1,3419,-1,0.1779938
3422,amino acids,13,15,94,105,Sequence analysis of this cDNA revealed differential splicing involving two exons encoding 72 amino acids.,8084618_4,-1,3422,-1,0.25573426
3423,amino acids,29,31,147,158,"The EWS-b protein binds to RNA in vitro and, specifically, to poly G and poly U. The RNA binding activity was localized to the carboxy terminal 86 amino acids, which constitute RGG box.",8084618_7,-1,3423,-1,0.28349793
3424,amino,2,3,9,14,"Thus the amino terminal domain of EWS (NTD-EWS), which is involved in chromosome translocation may regulate the specificity of RNA binding activity of EWS.",8084618_8,-1,3424,-1,0.2457442
3425,sarcoma,10,11,54,61,"An EWS-erg chimeric protein, which is found in Ewings sarcoma cells, functions as a transcriptional activator.",8084618_9,-1,3425,-1,0.16030708
3426,Canavan disease,0,2,0,15,Canavan disease: genomic organization and localization of human ASPA to 17p13-ter and conservation of the ASPA gene during evolution.,8088831_0,-1,3426,-1,0.22344355
3427,Canavan disease,0,2,1,16,"
Canavan disease, or spongy degeneration of the brain, is a severe leukodystrophy caused by the deficiency of aspartoacylase (ASPA).",8088831_1,-1,3427,-1,0.22625484
3428,Canavan disease,15,17,94,109,"Recently, a missense mutation was identified in human ASPA coding sequence from patients with Canavan disease.",8088831_2,-1,3428,-1,0.21134889
3429,gt/ag,7,8,49,54,The exon/intron splice junction sites follow the gt/ag consensus sequence rule.,8088831_6,-1,3429,-1,0.31374046
3430,lead,14,15,88,92,It should now be possible to identify mutations in the noncoding genomic sequences that lead to Canavan disease and to study the regulation of ASPA..,8088831_13,-1,3430,-1,0.22272994
3431,Canavan disease,16,18,96,111,It should now be possible to identify mutations in the noncoding genomic sequences that lead to Canavan disease and to study the regulation of ASPA..,8088831_13,-1,3431,-1,0.18913448
3432,Myotonic dystrophy,0,2,0,18,"Myotonic dystrophy: size- and sex-dependent dynamics of CTG meiotic instability, and somatic mosaicism.",8098180_0,-1,3432,-1,0.1929758
3433,Myotonic dystrophy,0,2,1,19,"
Myotonic dystrophy (DM) is a progressive neuromuscular disorder which results from elongations of an unstable (CTG) n repeat, located in the 3 untranslated region of the DM gene.",8098180_1,-1,3433,-1,0.193539
3434,DM,3,4,21,23,"
Myotonic dystrophy (DM) is a progressive neuromuscular disorder which results from elongations of an unstable (CTG) n repeat, located in the 3 untranslated region of the DM gene.",8098180_1,-1,3434,-1,0.20712268
3435,DM,31,32,171,173,"
Myotonic dystrophy (DM) is a progressive neuromuscular disorder which results from elongations of an unstable (CTG) n repeat, located in the 3 untranslated region of the DM gene.",8098180_1,-1,3435,-1,0.23070076
3436,disease,20,21,119,126,A correlation has been demonstrated between the increase in the repeat number of this sequence and the severity of the disease.,8098180_2,-1,3436,-1,0.23974934
3437,DM,8,9,56,58,Our observation of differently sized repeats in various DM tissues from the same individual may explain why the size of the mutation observed in lymphocytes does not necessarily correlate with the severity and nature of symptoms.,8098180_5,-1,3437,-1,0.22338988
3438,DM,11,12,68,70,"Through a molecular and genetic study of 142 families including 418 DM patients, we have investigated the dynamics of the CTG repeat meiotic instability.",8098180_6,-1,3438,-1,0.21993552
3439,phenylalanine,4,5,34,47,Illegitimate transcription of the phenylalanine hydroxylase gene in lymphocytes for identification of mutations in phenylketonuria.,8098245_0,-1,3439,-1,0.24839346
3440,phenylalanine,8,9,59,72,"
Taking advantage of the illegitimate transcription of the phenylalanine hydroxylase (PAH) gene, we have been able to analyse the PAH cDNA sequence of hyperphenylalaninemic children in circulating lymphocytes.",8098245_1,-1,3440,-1,0.241245
3441,PAH,11,12,86,89,"
Taking advantage of the illegitimate transcription of the phenylalanine hydroxylase (PAH) gene, we have been able to analyse the PAH cDNA sequence of hyperphenylalaninemic children in circulating lymphocytes.",8098245_1,-1,3441,-1,0.22715399
3442,PAH,22,23,130,133,"
Taking advantage of the illegitimate transcription of the phenylalanine hydroxylase (PAH) gene, we have been able to analyse the PAH cDNA sequence of hyperphenylalaninemic children in circulating lymphocytes.",8098245_1,-1,3442,-1,0.22996297
3443,C,17,18,91,92,"One mutation, detected by the abnormal pattern of migration of an amplified fragment, is a C to T transition in the splice acceptor site of intron 10, which resulted in the skipping of exon 11 with the premature termination of RNA translation downstream from exon 12 (-3 IVS10).",8098245_3,-1,3443,-1,0.34322742
3444,PAH,13,14,85,88,The present study supports the view that circulating lymphocytes give easy access to PAH gene transcripts whose nucleotide sequence is identical to that reported in liver and therefore represent a useful tool for molecular genetic studies in phenylketonuria..,8098245_5,-1,3444,-1,0.23102702
3445,nucleotide,17,18,112,122,The present study supports the view that circulating lymphocytes give easy access to PAH gene transcripts whose nucleotide sequence is identical to that reported in liver and therefore represent a useful tool for molecular genetic studies in phenylketonuria..,8098245_5,-1,3445,-1,0.24111204
3446,C,22,23,121,122,"Analysis of the ARSA gene in this patient revealed heterozygosity for two new mutant alleles  in one allele, deletion of C 447 in exon 2 leads to a frameshift and to a premature stop codon at amino acid position 105; in the second allele, a G-- > A transition in exon 5 causes a Gly309-- > Ser substitution.",8101038_3,-1,3446,-1,0.3539661
3447,amino acid,38,40,192,202,"Analysis of the ARSA gene in this patient revealed heterozygosity for two new mutant alleles  in one allele, deletion of C 447 in exon 2 leads to a frameshift and to a premature stop codon at amino acid position 105; in the second allele, a G-- > A transition in exon 5 causes a Gly309-- > Ser substitution.",8101038_3,-1,3447,-1,0.3906152
3448,contrast,4,5,22,30,These findings are in contrast to previous results showing that the late-infantile type of MLD is always associated with the complete absence of ARSA activity.,8101038_6,-1,3448,-1,0.28231704
3449,C--,9,10,45,48,The patient was found to be homozygous for a C-- > T transition in exon IV that results in the substitution of a highly conserved threonine residue at amino acid 274 with a methionine (T274M).,8104633_5,-1,3449,-1,0.34306443
3450,amino acid,28,30,151,161,The patient was found to be homozygous for a C-- > T transition in exon IV that results in the substitution of a highly conserved threonine residue at amino acid 274 with a methionine (T274M).,8104633_5,-1,3450,-1,0.37347478
3451,methionine,33,34,173,183,The patient was found to be homozygous for a C-- > T transition in exon IV that results in the substitution of a highly conserved threonine residue at amino acid 274 with a methionine (T274M).,8104633_5,-1,3451,-1,0.32965472
3452,amino acid,2,4,12,22,"The altered amino acid is rigidly conserved among 10 sulfatases from Escherichia coli to humans; therefore, it is most likely that the resultant mutant protein will have little or no enzyme activity.",8104633_8,-1,3452,-1,0.29252866
3453,aniridia,9,10,55,63,Mutations in the PAX6 gene in patients with hereditary aniridia.,8111379_0,-1,3453,-1,0.22627395
3454,aniridia,15,16,79,87,"
The 14 exons of the PAX6 gene have been analysed exon-by-exon using SSCP in 6 aniridia families.",8111379_1,-1,3454,-1,0.2564543
3455,C--,3,4,23,26,Two mutations involved C-- > T transitions in CGAarg codons in exons 9 and 11.,8111379_3,-1,3455,-1,0.34929043
3456,C--,1,2,8,11,Another C-- > T transition converted a CAG-glutamine to a TAG-stop in exon 7.,8111379_4,-1,3456,-1,0.3420544
3457,aniridia,14,15,91,99,This data strongly supports the candidature of PAX6 as the gene responsible for hereditary aniridia..,8111379_9,-1,3457,-1,0.23115084
3458,protein S deficiency,9,12,65,85,"Three novel mutations in five unrelated subjects with hereditary protein S deficiency type I.
A panel of eight unrelated subjects with inherited type I protein S deficiency was screened for mutations in the PROS1 gene.",8113388_0,-1,3458,-1,0.22338538
3459,protein S deficiency,24,27,152,172,"Three novel mutations in five unrelated subjects with hereditary protein S deficiency type I.
A panel of eight unrelated subjects with inherited type I protein S deficiency was screened for mutations in the PROS1 gene.",8113388_0,-1,3459,-1,0.20776016
3460,amino acids,31,33,165,176,Also in two subjects an A-- > T transversion was detected in the stopcodon of the PROS1 gene; this transversion predicts a protein S molecule that is extended by 14 amino acids.,8113388_3,-1,3460,-1,0.26514944
3461,protein S deficiency,16,19,92,112,The latter indicates that a mRNA based approach is not feasible for the genetic analysis of protein S deficiency type I..,8113388_9,-1,3461,-1,0.24839014
3462,myotonic dystrophy,9,11,71,89,Characteristics of intergenerational contractions of the CTG repeat in myotonic dystrophy.,8116611_0,-1,3462,-1,0.18838537
3463,myotonic dystrophy,1,3,4,22,"
In myotonic dystrophy (DM), the size of a CTG repeat in the DM kinase gene generally increases in successive generations with clinical evidence of anticipation.",8116611_1,-1,3463,-1,0.18091507
3464,DM,4,5,24,26,"
In myotonic dystrophy (DM), the size of a CTG repeat in the DM kinase gene generally increases in successive generations with clinical evidence of anticipation.",8116611_1,-1,3464,-1,0.19763277
3465,DM,15,16,61,63,"
In myotonic dystrophy (DM), the size of a CTG repeat in the DM kinase gene generally increases in successive generations with clinical evidence of anticipation.",8116611_1,-1,3465,-1,0.2585547
3466,DM,5,6,19,21,"We examined 1, 489 DM parent-offspring pairs, of which 95 (6. 4%) showed such contractions in peripheral blood leukocytes (PBL).",8116611_3,-1,3466,-1,0.29647097
3467,DM,25,26,118,120,"It is surprising that anticipation occurred in 27 (48%) of these 56 pairs, while none clearly showed a later onset of DM in the symptomatic offspring.",8116611_5,-1,3467,-1,0.27488664
3468,P,20,21,98,99,Anticipation was observed more frequently in maternal (85%) than in paternal (37%) transmissions (P <. 001).,8116611_7,-1,3468,-1,0.29952058
3469,P,17,18,94,95,"The parental repeat size correlated with the size of intergenerational contraction (r2 =. 50, P < <. 001), and the slope of linear regression was steeper in paternal (-. 62) than in maternal (-. 30) transmissions (P < <. 001).",8116611_8,-1,3469,-1,0.29809302
3470,P,49,50,214,215,"The parental repeat size correlated with the size of intergenerational contraction (r2 =. 50, P < <. 001), and the slope of linear regression was steeper in paternal (-. 62) than in maternal (-. 30) transmissions (P < <. 001).",8116611_8,-1,3470,-1,0.31811717
3471,DM,1,2,8,10,Sixteen DM parents had multiple DM offspring with the CTG repeat contractions.,8116611_9,-1,3471,-1,0.24103516
3472,DM,5,6,32,34,Sixteen DM parents had multiple DM offspring with the CTG repeat contractions.,8116611_9,-1,3472,-1,0.23426497
3473,DM,25,26,126,128,"This frequency was higher than the frequency expected from the probability of the repeat contractions (6. 4%) and the size of DM sib population (1. 54 DM offspring per DM parent, in 968 DM parents).",8116611_10,-1,3473,-1,0.26979673
3474,DM,32,33,151,153,"This frequency was higher than the frequency expected from the probability of the repeat contractions (6. 4%) and the size of DM sib population (1. 54 DM offspring per DM parent, in 968 DM parents).",8116611_10,-1,3474,-1,0.28071532
3475,DM,35,36,168,170,"This frequency was higher than the frequency expected from the probability of the repeat contractions (6. 4%) and the size of DM sib population (1. 54 DM offspring per DM parent, in 968 DM parents).",8116611_10,-1,3475,-1,0.26054326
3476,DM,40,41,186,188,"This frequency was higher than the frequency expected from the probability of the repeat contractions (6. 4%) and the size of DM sib population (1. 54 DM offspring per DM parent, in 968 DM parents).",8116611_10,-1,3476,-1,0.2469327
3477,DM,22,23,149,151,"We conclude that (1) intergenerational contractions of the CTG repeat in leukocyte DNA frequently accompanies apparent anticipation, especially when DM is maternally transmitted, and (2) the paternal origin of the repeat and the presence of the repeat contraction in a sibling increase the probability of the CTG repeat contraction",8116611_11,-1,3477,-1,0.2578647
3478,myotonic dystrophy,3,5,23,41,Gonosomal mosaicism in myotonic dystrophy patients: involvement of mitotic events in (CTG)n repeat variation and selection against extreme expansion in sperm.,8128954_0,-1,3478,-1,0.17837355
3479,Myotonic dystrophy,0,2,1,19,"
Myotonic dystrophy (DM) is caused by abnormal expansion of a polymorphic (CTG) n repeat, located in the DM protein kinase gene.",8128954_1,-1,3479,-1,0.19663985
3480,DM,3,4,21,23,"
Myotonic dystrophy (DM) is caused by abnormal expansion of a polymorphic (CTG) n repeat, located in the DM protein kinase gene.",8128954_1,-1,3480,-1,0.21379387
3481,DM,22,23,105,107,"
Myotonic dystrophy (DM) is caused by abnormal expansion of a polymorphic (CTG) n repeat, located in the DM protein kinase gene.",8128954_1,-1,3481,-1,0.23775317
3482,n,6,7,24,25,"We determined the (CTG) n repeat lengths in a broad range of tissue DNAs from patients with mild, classical, or congenital manifestation of DM.",8128954_2,-1,3482,-1,0.32834458
3483,DM,27,28,140,142,"We determined the (CTG) n repeat lengths in a broad range of tissue DNAs from patients with mild, classical, or congenital manifestation of DM.",8128954_2,-1,3483,-1,0.2216842
3484,DM,12,13,74,76,Differences in the repeat length were seen in somatic tissues from single DM individuals and twins.,8128954_3,-1,3484,-1,0.23589432
3485,contrast,1,2,3,11,"In contrast, male patients with large allele expansions in blood (> 700 CTGs) had similar or smaller repeats in sperm, when detectable.",8128954_6,-1,3485,-1,0.27018005
3486,DM,3,4,17,19,"We conclude that DM patients can be considered gonosomal mosaics, i. e e., combined somatic and germ-line tissue mosaics.",8128954_8,-1,3486,-1,0.21237813
3487,e e.,12,14,69,73,"We conclude that DM patients can be considered gonosomal mosaics, i. e e., combined somatic and germ-line tissue mosaics.",8128954_8,-1,3487,-1,0.2712209
3488,DM,10,11,82,84,A model explaining mitotic instability and sex-dependent segregation phenomena in DM manifestation is discussed,8128954_12,-1,3488,-1,0.23127645
3489,adenomatous polyposis coli,21,24,129,155,Regionally clustered APC mutations are associated with a severe phenotype and occur at a high frequency in new mutation cases of adenomatous polyposis coli.,8162051_0,-1,3489,-1,0.1786821
3490,syndrome adenomatous polyposis coli,13,17,73,108,"
Germline mutation in APC at 5q21-22 results in the dominantly inherited syndrome adenomatous polyposis coli (APC).",8162051_1,-1,3490,-1,0.20882839
3491,disease,8,9,47,54,"Eighteen patients had no family history of the disease; of these 11 were classified as having a severe phenotype, based on an early age at presentation or cancer development.",8162051_5,-1,3491,-1,0.20963646
3493,contrast,1,2,3,11,In contrast all of the APC mutations detected in affected individuals with an average phenotype were located prior to codon 1309.,8162051_9,-1,3493,-1,0.28024206
3494,malformations,11,12,72,85,Mutations at the PAX6 locus are found in heterogeneous anterior segment malformations including Peters' anomaly.,8162071_0,-1,3494,-1,0.17304313
3495,aniridia,11,12,63,71,"
Mutation or deletion of the PAX6 gene underlies many cases of aniridia.",8162071_1,-1,3495,-1,0.21881415
3496,malformations,14,15,87,100,Three lines of evidence now converge to implicate PAX6 more widely in anterior segment malformations including Peters anomaly.,8162071_2,-1,3496,-1,0.18677855
3497,Peters anomaly,16,18,111,125,Three lines of evidence now converge to implicate PAX6 more widely in anterior segment malformations including Peters anomaly.,8162071_2,-1,3497,-1,0.2235338
3498,Peters anomaly,5,7,20,34,"First, a child with Peters anomaly is deleted for one copy of PAX6.",8162071_3,-1,3498,-1,0.2171744
3499,malformations,12,13,80,93,"Second, affected members of a family with dominantly inherited anterior segment malformations, including Peters anomaly are heterozygous for an R26G mutation in the PAX6 paired box.",8162071_4,-1,3499,-1,0.18549325
3500,Peters anomaly,15,17,105,119,"Second, affected members of a family with dominantly inherited anterior segment malformations, including Peters anomaly are heterozygous for an R26G mutation in the PAX6 paired box.",8162071_4,-1,3500,-1,0.24455681
3501,Peters anomaly,23,25,134,148,"Third, a proportion of Sey/+ Smalleye mice, heterozygous for a nonsense mutation in murine Pax-6, have an ocular phenotype resembling Peters anomaly.",8162071_5,-1,3501,-1,0.24444759
3502,Huntington disease,0,2,0,18,"Huntington disease without CAG expansion: phenocopies or errors in assignment?
Huntington disease (HD) has been shown to be associated with an expanded CAG repeat within a novel gene on 4p16.",8178825_0,-1,3502,-1,0.19565527
3503,Huntington disease,12,14,79,97,"Huntington disease without CAG expansion: phenocopies or errors in assignment?
Huntington disease (HD) has been shown to be associated with an expanded CAG repeat within a novel gene on 4p16.",8178825_0,-1,3503,-1,0.2068456
3504,disease,27,28,99,106,"A total of 30 of 1, 022 affected persons (2. 9% of our cohort) did not have an expanded CAG in the disease range.",8178825_2,-1,3504,-1,0.23015054
3505,androgen,8,9,48,56,Frequent detection of codon 877 mutation in the androgen receptor gene in advanced prostate cancers.,8187068_0,-1,3505,-1,0.19080926
3508,androgen,24,25,185,193,"
Prostatic tissue specimens derived from transurethral resections of patients with metastatic prostate cancer were analyzed for genetic alterations in the hormone-binding domain of the androgen receptor (AR) gene.",8187068_1,-1,3508,-1,0.18725675
3510,estrogens,33,34,202,211,"This same AR mutation has been reported previously in a metastatic prostate cancer cell line, LNCaP, where this mutation confers upon the AR an altered ligand-binding specificity which is stimulated by estrogens, progestagens, and antiandrogens.",8187068_3,-1,3510,-1,0.20816027
3511,progestagens,35,36,213,225,"This same AR mutation has been reported previously in a metastatic prostate cancer cell line, LNCaP, where this mutation confers upon the AR an altered ligand-binding specificity which is stimulated by estrogens, progestagens, and antiandrogens.",8187068_3,-1,3511,-1,0.22427864
3513,estrogens,1,2,9,18,"Although estrogens are used infrequently, antiandrogens are used increasingly in hormonal therapy for patients with advanced prostate cancer.",8187068_5,-1,3513,-1,0.23678134
3515,disease,27,28,180,187,The stimulatory effect of these therapeutic agents on the codon 877 mutant AR further suggests that this frequently observed AR mutation may contribute to the treatment refractory disease..,8187068_6,-1,3515,-1,0.19080992
3516,alkaptonuria,4,5,19,31,The human gene for alkaptonuria (AKU) maps to chromosome 3q.,8188241_0,-1,3516,-1,0.26676357
3517,Alkaptonuria,0,1,1,13,"
Alkaptonuria (AKU; McKusick no. 203500) is a rare autosomal recessive disorder caused by the lack of homogentisic acid oxidase activity.",8188241_1,-1,3517,-1,0.29616216
3518,Ochronosis,0,1,0,10,"Ochronosis is the predominant clinical complication of the disease leading to ochronotic arthropathy, dark urine, pigment changes of the skin, and other clinical features.",8188241_3,-1,3518,-1,0.2485629
3519,disease,8,9,59,66,"Ochronosis is the predominant clinical complication of the disease leading to ochronotic arthropathy, dark urine, pigment changes of the skin, and other clinical features.",8188241_3,-1,3519,-1,0.23267145
3520,alkaptonuria,3,4,19,31,A mutation causing alkaptonuria in the mouse has mapped to chromosome 16.,8188241_4,-1,3520,-1,0.26580435
3521,map,8,9,47,50,"Considering conserved synteny, we were able to map the human gene to chromosome 3q in six alkaptonuria pedigrees of Slovak origin..",8188241_5,-1,3521,-1,0.21524128
3522,alkaptonuria,17,18,90,102,"Considering conserved synteny, we were able to map the human gene to chromosome 3q in six alkaptonuria pedigrees of Slovak origin..",8188241_5,-1,3522,-1,0.29102385
3523,glucose,4,5,30,37,"
Intestinal uptake of dietary glucose and galactose is mediated by the SGLT1 Na +/glucose cotransporter of the brush border.",8195156_1,-1,3523,-1,0.24311908
3524,galactose,6,7,42,51,"
Intestinal uptake of dietary glucose and galactose is mediated by the SGLT1 Na +/glucose cotransporter of the brush border.",8195156_1,-1,3524,-1,0.24453646
3525,Na,12,13,77,79,"
Intestinal uptake of dietary glucose and galactose is mediated by the SGLT1 Na +/glucose cotransporter of the brush border.",8195156_1,-1,3525,-1,0.3033201
3528,Na,7,8,38,40,We have mapped the entire human SGLT1 Na +/glucose cotransporter gene from cosmid and lambda phage clones representing a genomic region of 112 kilobases.,8195156_3,-1,3528,-1,0.28698942
3529,Na,4,5,18,20,This is the first Na (+) -dependent cotransporter gene structure reported.,8195156_8,-1,3529,-1,0.27149084
3530,Na,24,25,181,183,These data facilitate the search for new glucose/galactose malabsorption-related mutations in this important gene and provide a basis for future evolutionary comparisons with other Na (+) -dependent cotransporters..,8195156_9,-1,3530,-1,0.30742434
3531,prolidase deficiency,5,7,32,52,Four novel PEPD alleles causing prolidase deficiency.,8198124_0,-1,3531,-1,0.23273738
3532,prolidase deficiency,6,8,35,55,"
Mutations at the PEPD locus cause prolidase deficiency (McKusick 170100), a rare autosomal recessive disorder characterized by iminodipeptiduria, skin ulcers, mental retardation, and recurrent infections.",8198124_1,-1,3532,-1,0.22253202
3533,ulcers,23,24,152,158,"
Mutations at the PEPD locus cause prolidase deficiency (McKusick 170100), a rare autosomal recessive disorder characterized by iminodipeptiduria, skin ulcers, mental retardation, and recurrent infections.",8198124_1,-1,3533,-1,0.18511625
3534,mental retardation,25,27,160,178,"
Mutations at the PEPD locus cause prolidase deficiency (McKusick 170100), a rare autosomal recessive disorder characterized by iminodipeptiduria, skin ulcers, mental retardation, and recurrent infections.",8198124_1,-1,3534,-1,0.20541492
3536,C,24,25,155,156,Conventional PCR and direct sequencing then established the intron-exon borders of the mutant genomic DNA revealing two splice acceptor mutations  a G-- > C substitution at position -1 of intron 4 and an A-- > G substitution at position -2 of intron 6.,8198124_8,-1,3536,-1,0.34198985
3537,prolidase deficiency,8,10,45,65,Our results indicate that the severe form of prolidase deficiency is caused by multiple PEPD alleles.,8198124_9,-1,3537,-1,0.23112176
3538,Friedreich ataxia,8,10,65,82,Recombinations in individuals homozygous by descent localize the Friedreich ataxia locus in a cloned 450-kb interval.,8198128_0,-1,3538,-1,0.22172606
3539,Friedreich ataxia,3,5,15,32,"
The locus for Friedreich ataxia (FRDA), a severe neurodegenerative disease, is tightly linked to markers D9S5 and D9S15, and analysis of rare recombination events has suggested the order cen-FRDA-D9S5-D9S15-qter.",8198128_1,-1,3539,-1,0.2129085
3540,neurodegenerative disease,11,13,50,75,"
The locus for Friedreich ataxia (FRDA), a severe neurodegenerative disease, is tightly linked to markers D9S5 and D9S15, and analysis of rare recombination events has suggested the order cen-FRDA-D9S5-D9S15-qter.",8198128_1,-1,3540,-1,0.17266834
3541,map,3,4,12,15,"In order to map these markers with respect to the FRDA locus, all within a 1-cM confidence interval, we sought to increase the genetic information of available FRDA families by considering homozygosity by descent and association with founder haplotypes in isolated populations.",8198128_3,-1,3541,-1,0.2501327
3542,map,5,6,35,38,A detailed rare cutter restriction map and a cosmid contig covering this interval were constructed and should facilitate the search of genes in this region..,8198128_8,-1,3542,-1,0.2209221
3543,Prader-Willi syndrome,7,9,67,88,Investigation of thermoregulatory characteristics in patients with Prader-Willi syndrome.,8209890_0,-1,3543,-1,0.2320748
3544,Prader-Willi syndrome,13,15,95,116,"
A survey instrument is used to assess temperature regulation characteristics in children with Prader-Willi syndrome (PWS) compared to 3 control groups  sibs of PWS patients (SIB), neurodevelopmentally handicapped children (ND), and age and gender matched well children (WC).",8209890_1,-1,3544,-1,0.24272412
3546,retinitis pigmentosa,3,5,31,51,"Phenotypic variation including retinitis pigmentosa, pattern dystrophy, and fundus flavimaculatus in a single family with a deletion of codon 153 or 154 of the peripherin/RDS gene.",8240110_0,-1,3546,-1,0.20210546
3547,retinitis pigmentosa,15,17,106,126,"
BACKGROUND AND OBJECTIVES  Mutations of the peripherin/RDS gene have been reported in autosomal dominant retinitis pigmentosa, pattern macular dystrophy, and retinitis punctata albescens.",8240110_1,-1,3547,-1,0.20985106
3548,retinitis,23,24,159,168,"
BACKGROUND AND OBJECTIVES  Mutations of the peripherin/RDS gene have been reported in autosomal dominant retinitis pigmentosa, pattern macular dystrophy, and retinitis punctata albescens.",8240110_1,-1,3548,-1,0.22059093
3549,retinitis pigmentosa,19,21,113,133,"RESULTS  The mother presented at age 63 years with a profoundly abnormal electroretinogram (ERG) and adult-onset retinitis pigmentosa that progressed dramatically over 12 years, with marked loss of peripheral visual field.",8240110_6,-1,3549,-1,0.21535611
3550,disease,13,14,66,73,"At age 44 years, her ERG was moderately abnormal but her clinical disease was limited to the macula.",8240110_8,-1,3550,-1,0.22600012
3551,macular degeneration,8,10,48,68,Another daughter presented at age 42 years with macular degeneration and over 10 years developed the clinical picture of fundus flavimaculatus.,8240110_9,-1,3551,-1,0.20823444
3552,Na,1,2,5,7,"
The Na +/glucose cotransporter gene SGLT1 encodes the primary carrier protein responsible for the uptake of the dietary sugars glucose and galactose from the intestinal lumen.",8244393_1,-1,3552,-1,0.27619886
3553,glucose,20,21,128,135,"
The Na +/glucose cotransporter gene SGLT1 encodes the primary carrier protein responsible for the uptake of the dietary sugars glucose and galactose from the intestinal lumen.",8244393_1,-1,3553,-1,0.24323931
3554,galactose,22,23,140,149,"
The Na +/glucose cotransporter gene SGLT1 encodes the primary carrier protein responsible for the uptake of the dietary sugars glucose and galactose from the intestinal lumen.",8244393_1,-1,3554,-1,0.23592347
3555,disease,7,8,45,52,"In two patients with the autosomal recessive disease glucose/galactose malabsorption, the underlying cause was found to be a missense mutation in SGLT1, and the Asp28-- > Asn change was demonstrated in vitro to eliminate SGLT1 transport activity.",8244393_4,-1,3555,-1,0.21263118
3556,diseases,18,19,88,96,"1, and provide an example of the utility of the SGLT1 probe as a diagnostic for genetic diseases associated with translocations of chromosome 22.",8244393_7,-1,3556,-1,0.17069547
3557,adenomatous polyposis coli,13,16,80,106,Restriction of ocular fundus lesions to a specific subgroup of APC mutations in adenomatous polyposis coli patients.,8252631_0,-1,3557,-1,0.1847474
3559,adenomatous polyposis coli,13,16,65,91,"
In humans, alteration of the tumor suppressor gene, APC, causes adenomatous polyposis coli, a condition causing predisposition to colorectal cancer.",8252631_1,-1,3559,-1,0.18675448
3560,colorectal cancer,22,24,131,148,"
In humans, alteration of the tumor suppressor gene, APC, causes adenomatous polyposis coli, a condition causing predisposition to colorectal cancer.",8252631_1,-1,3560,-1,0.14718206
3561,syndrome,1,2,4,12,The syndrome inconsistently associates characteristic patches of congenital hypertrophy of the retinal pigment epithelium (CHRPE).,8252631_2,-1,3561,-1,0.2434723
3563,lead,8,9,47,51,In all cases these mutations were predicted to lead to the synthesis of a truncated protein.,8252631_5,-1,3563,-1,0.27027094
3564,muscular dystrophy,16,18,90,108,The authors earlier findings of a negative electroretinogram (ERG) in a boy with Duchenne muscular dystrophy (DMD) led them to investigate dystrophin gene deletions and ERGs in five boys with DMD.,8258524_2,-1,3564,-1,0.17435402
3566,colorectal cancer,12,14,75,92,"
Mutations of APC appear to initiate sporadic and inherited forms of human colorectal cancer.",8259519_1,-1,3566,-1,0.1410196
3567,nucleotide,10,11,65,75,Two cellular proteins that associate with APC were identified by nucleotide sequence analysis and peptide mapping as the E-cadherin-associated proteins alpha- and beta-catenin.,8259519_3,-1,3567,-1,0.23832838
3569,Angelman syndrome,17,19,104,121,Difference in methylation patterns within the D15S9 region of chromosome 15q11-13 in first cousins with Angelman syndrome and Prader-Willi syndrome.,8266996_0,-1,3569,-1,0.19417518
3570,Prader-Willi syndrome,20,22,126,147,Difference in methylation patterns within the D15S9 region of chromosome 15q11-13 in first cousins with Angelman syndrome and Prader-Willi syndrome.,8266996_0,-1,3570,-1,0.21371117
3571,Angelman syndrome,10,12,65,82,"
Abnormalities of chromosome region 15q11-13 are associated with Angelman syndrome (AS) and Prader-Willi syndrome (PWS).",8266996_1,-1,3571,-1,0.21595527
3572,Prader-Willi syndrome,16,18,92,113,"
Abnormalities of chromosome region 15q11-13 are associated with Angelman syndrome (AS) and Prader-Willi syndrome (PWS).",8266996_1,-1,3572,-1,0.22610803
3573,Wilson disease,3,5,21,35,Haplotype studies in Wilson disease.,8279472_0,-1,3573,-1,0.23136202
3574,Wilson disease,4,6,21,35,"
In 51 families with Wilson disease, we have studied DNA haplotypes of dinucleotide repeat polymorphisms (CA repeats) in the 13q14.",8279472_1,-1,3574,-1,0.1968029
3575,CA,17,18,106,108,"
In 51 families with Wilson disease, we have studied DNA haplotypes of dinucleotide repeat polymorphisms (CA repeats) in the 13q14.",8279472_1,-1,3575,-1,0.32400647
3576,Wilson disease,11,13,60,74,"3 region, to examine these markers for association with the Wilson disease gene (WND).",8279472_2,-1,3576,-1,0.20381017
3577,Wilson disease,14,16,107,121,These findings have important implications for mutation detection and molecular diagnosis in families with Wilson disease.,8279472_6,-1,3577,-1,0.20300859
3579,disease,24,25,156,163,"
We have analyzed a single multi-affected breast/ovarian cancer pedigree (BOV3) and have shown consistent inheritance of markers on chromosome 17q with the disease confirming that this family is due to the BRCA1 gene.",8281142_1,-1,3579,-1,0.20915101
3581,Mb,1,2,2,4,5 Mb in length.,8281142_4,-1,3581,-1,0.2847437
3582,tumours,15,16,97,104,All seven breast tumour/blood pairs examined from this family show loss of heterozygosity in the tumours.,8281142_5,-1,3582,-1,0.17444097
3583,tumour,5,6,27,33,The allel retained in each tumour was from the disease-bearing chromosome implicating BRCA1 as a tumour suppressor gene.,8281142_6,-1,3583,-1,0.18990782
3584,tumour,15,16,97,103,The allel retained in each tumour was from the disease-bearing chromosome implicating BRCA1 as a tumour suppressor gene.,8281142_6,-1,3584,-1,0.15391712
3585,Myotonic dystrophy,0,2,0,18,Myotonic dystrophy kinase is a component of neuromuscular junctions.,8281152_0,-1,3585,-1,0.22011489
3586,myotonic dystrophy,4,6,31,49,"
The clinical manifestation of myotonic dystrophy (DM) is correlated to the extent of expansion of an unstable [CTG] n DNA motif.",8281152_1,-1,3586,-1,0.1817745
3587,DM,7,8,51,53,"
The clinical manifestation of myotonic dystrophy (DM) is correlated to the extent of expansion of an unstable [CTG] n DNA motif.",8281152_1,-1,3587,-1,0.20232472
3588,n,22,23,117,118,"
The clinical manifestation of myotonic dystrophy (DM) is correlated to the extent of expansion of an unstable [CTG] n DNA motif.",8281152_1,-1,3588,-1,0.3498987
3589,myotonic dystrophy,32,34,207,225,"Recent studies have demonstrated that this trinucleotide motif forms part of the last, 3 untranslated exon of a gene which potentially encodes multiple protein isoforms of a serine/threonine protein kinase (myotonic dystrophy protein kinase, DM-PK).",8281152_2,-1,3589,-1,0.18569855
3590,DM,18,19,110,112,Immunoreactive DM-kinase protein of 53 kD is present at low levels in skeletal and cardiac muscle extracts of DM patients and normal controls.,8281152_4,-1,3590,-1,0.24745134
3591,DM,21,22,123,125,"Strikingly, presence of the protein can also be demonstrated for NMJs of muscular tissues of adult and congenital cases of DM, with no gross changes in structural organisation.",8281152_7,-1,3591,-1,0.22073987
3592,DM,34,35,223,225,Our findings provide a basis for further characterisation of the role of the kinase in protein assembly processes or signal mediation at synaptic sites and ultimately for the understanding of the complex pathophysiology of DM..,8281152_8,-1,3592,-1,0.2680701
3593,cholesterol,19,20,135,146,Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye disease.,8282802_0,-1,3593,-1,0.25282735
3594,disease,24,25,187,194,Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye disease.,8282802_0,-1,3594,-1,0.20881468
3595,cholesterol,6,7,30,41,"
Classic (complete) lecithin  cholesterol acyltransferase (LCAT) deficiency and Fish-eye disease (partial LCAT deficiency) are genetic syndromes associated with markedly decreased plasma levels of high density lipoprotein (HDL) cholesterol but not with an increased risk of atherosclerotic cardiovascular disease.",8282802_1,-1,3595,-1,0.2697917
3596,disease,14,15,89,96,"
Classic (complete) lecithin  cholesterol acyltransferase (LCAT) deficiency and Fish-eye disease (partial LCAT deficiency) are genetic syndromes associated with markedly decreased plasma levels of high density lipoprotein (HDL) cholesterol but not with an increased risk of atherosclerotic cardiovascular disease.",8282802_1,-1,3596,-1,0.22053103
3597,cholesterol,36,37,228,239,"
Classic (complete) lecithin  cholesterol acyltransferase (LCAT) deficiency and Fish-eye disease (partial LCAT deficiency) are genetic syndromes associated with markedly decreased plasma levels of high density lipoprotein (HDL) cholesterol but not with an increased risk of atherosclerotic cardiovascular disease.",8282802_1,-1,3597,-1,0.21904318
3598,atherosclerotic cardiovascular disease,44,47,274,312,"
Classic (complete) lecithin  cholesterol acyltransferase (LCAT) deficiency and Fish-eye disease (partial LCAT deficiency) are genetic syndromes associated with markedly decreased plasma levels of high density lipoprotein (HDL) cholesterol but not with an increased risk of atherosclerotic cardiovascular disease.",8282802_1,-1,3598,-1,0.225105
3599,disease,33,34,189,196,"We investigated the metabolism of the HDL apolipoproteins (apo) apoA-I and apoA-II in a total of five patients with LCAT deficiency, one with classic LCAT deficiency and four with Fish-eye disease.",8282802_2,-1,3599,-1,0.21141355
3601,disease,39,40,242,249,"Because LpA-I has been proposed to be more protective than LpA-I  A-II against atherosclerosis, this selective effect on the metabolism of LpA-I  A-II may provide a potential explanation why patients with classic LCAT deficiency and Fish-eye disease are not at increased risk for premature atherosclerosis despite markedly decreased levels of HDL cholesterol and apoA-I",8282802_10,-1,3601,-1,0.20622972
3602,premature atherosclerosis,46,48,280,305,"Because LpA-I has been proposed to be more protective than LpA-I  A-II against atherosclerosis, this selective effect on the metabolism of LpA-I  A-II may provide a potential explanation why patients with classic LCAT deficiency and Fish-eye disease are not at increased risk for premature atherosclerosis despite markedly decreased levels of HDL cholesterol and apoA-I",8282802_10,-1,3602,-1,0.23862614
3603,cholesterol,54,55,347,358,"Because LpA-I has been proposed to be more protective than LpA-I  A-II against atherosclerosis, this selective effect on the metabolism of LpA-I  A-II may provide a potential explanation why patients with classic LCAT deficiency and Fish-eye disease are not at increased risk for premature atherosclerosis despite markedly decreased levels of HDL cholesterol and apoA-I",8282802_10,-1,3603,-1,0.26618943
3606,Wiskott-Aldrich syndrome,38,40,195,219,Results of DNA analysis with the probe M27 beta are consistent with X linkage and indicate also that the locus of the relevant gene lies close to or is identical to the locus of the gene for the Wiskott-Aldrich syndrome (WAS).,8301658_4,-1,3606,-1,0.21070005
3608,retinal degeneration,11,13,70,90,Macular dystrophy associated with mutations at codon 172 in the human retinal degeneration slow gene.,8302543_0,-1,3608,-1,0.21210061
3609,retinal degeneration,7,9,40,60,"
BACKGROUND  Recently, mutations in the retinal degeneration slow (rds) gene which codes for peripherin-rds have been implicated as a cause of autosomal dominant retinitis pigmentosa.",8302543_1,-1,3609,-1,0.20290245
3610,retinitis pigmentosa,27,29,162,182,"
BACKGROUND  Recently, mutations in the retinal degeneration slow (rds) gene which codes for peripherin-rds have been implicated as a cause of autosomal dominant retinitis pigmentosa.",8302543_1,-1,3610,-1,0.19194546
3612,scotoma,27,28,156,163,"RESULTS  In all but one affected member, symptoms of progressive central visual loss developed in the third or fourth decade of life accompanied by central scotoma and well-demarcated atrophy of the retinal pigment epithelium and choriocapillaris of the macula.",8302543_5,-1,3612,-1,0.20672403
3614,hemochromatosis,15,16,100,115,"Anonymous marker loci within 400 kb of HLA-A generate haplotypes in linkage disequilibrium with the hemochromatosis gene (HFE)
The hemochromatosis gene (HFE) maps to 6p21.",8304342_0,-1,3614,-1,0.18802166
3615,hemochromatosis,21,22,131,146,"Anonymous marker loci within 400 kb of HLA-A generate haplotypes in linkage disequilibrium with the hemochromatosis gene (HFE)
The hemochromatosis gene (HFE) maps to 6p21.",8304342_0,-1,3615,-1,0.19812258
3616,cM,6,7,21,23,"3 and is less than 1 cM from the HLA class I genes; however, the precise physical location of the gene has remained elusive and controversial.",8304342_1,-1,3616,-1,0.3001894
3617,hemochromatosis,8,9,59,74,The unambiguous identification of a crossover event within hemochromatosis families is very difficult; it is particularly hampered by the variability of the phenotypic expression as well as by the sex- and age-related penetrance of the disease.,8304342_2,-1,3617,-1,0.20569457
3618,disease,36,37,236,243,The unambiguous identification of a crossover event within hemochromatosis families is very difficult; it is particularly hampered by the variability of the phenotypic expression as well as by the sex- and age-related penetrance of the disease.,8304342_2,-1,3618,-1,0.20466281
3619,hemochromatosis,6,7,26,41,"In the present report, 66 hemochromatosis families yielding 151 hemochromatosis chromosomes and 182 normal chromosomes were RFLP-typed with a battery of probes, including two newly derived polymorphic markers from the 6.",8304342_5,-1,3619,-1,0.2034569
3620,hemochromatosis,10,11,64,79,"In the present report, 66 hemochromatosis families yielding 151 hemochromatosis chromosomes and 182 normal chromosomes were RFLP-typed with a battery of probes, including two newly derived polymorphic markers from the 6.",8304342_5,-1,3620,-1,0.20643455
3621,disease,24,25,132,139,"7 locus, both of which are comprised by the major ancestral or founder HFE haplotype in Brittany, supports the possibility that the disease gene may reside immediately telomeric to the 6.",8304342_11,-1,3621,-1,0.2353315
3622,hemochromatosis,2,3,14,29,"Additionally, hemochromatosis haplotypes possessing HLA-A11 and the low-frequency HLA-F polymorphism (allele 2) are supportive of a separate founder chromosome containing a second, independently arising mutant allele.",8304342_13,-1,3622,-1,0.1972476
3623,hemochromatosis,8,9,41,56,"Overall, the establishment of a likely "" hemochromatosis critical region "" centromeric boundary and the identification of a linkage-disequilibrium zone both significantly contribute to a reduction in the amount of DNA required to be searched for novel coding sequences constituting the HFE defect",8304342_14,-1,3623,-1,0.18992999
3624,sarcoma,32,33,156,163,"
The EWS gene has been identified based on its location at the chromosome 22 breakpoint of the t (11; 22) (q24; q12) translocation that characterizes Ewing sarcoma and related neuroectodermal tumors.",8307570_1,-1,3624,-1,0.1626153
3625,neuroectodermal tumors,35,37,176,198,"
The EWS gene has been identified based on its location at the chromosome 22 breakpoint of the t (11; 22) (q24; q12) translocation that characterizes Ewing sarcoma and related neuroectodermal tumors.",8307570_1,-1,3625,-1,0.1711291
3626,nucleotide,1,2,4,14,The nucleotide sequence of the exons is identical to that of the previously described cDNA.,8307570_3,-1,3626,-1,0.26153392
3627,tyrosine,25,26,136,144,"The first 7 exons encode the N-terminal domain of EWS, which consists of a repeated degenerated polypeptide of 7 to 12 residues rich in tyrosine, serine, threonine, glycine, and glutamine.",8307570_4,-1,3627,-1,0.22038992
3628,glycine,31,32,165,172,"The first 7 exons encode the N-terminal domain of EWS, which consists of a repeated degenerated polypeptide of 7 to 12 residues rich in tyrosine, serine, threonine, glycine, and glutamine.",8307570_4,-1,3628,-1,0.25453204
3629,glutamine,34,35,178,187,"The first 7 exons encode the N-terminal domain of EWS, which consists of a repeated degenerated polypeptide of 7 to 12 residues rich in tyrosine, serine, threonine, glycine, and glutamine.",8307570_4,-1,3629,-1,0.25538525
3631,Norrie disease,0,2,0,14,Norrie disease gene: characterization of deletions and possible function.,8314592_0,-1,3631,-1,0.24589248
3632,Norrie disease,14,16,96,110,"
Positional cloning experiments have resulted recently in the isolation of a candidate gene for Norrie disease (pseudoglioma; NDP), a severe X-linked neurodevelopmental disorder.",8314592_1,-1,3632,-1,0.19605072
3633,neurodevelopmental disorder,25,27,150,177,"
Positional cloning experiments have resulted recently in the isolation of a candidate gene for Norrie disease (pseudoglioma; NDP), a severe X-linked neurodevelopmental disorder.",8314592_1,-1,3633,-1,0.17477202
3634,Huntington disease,2,4,11,29,"The normal Huntington disease (HD) allele, or a closely linked gene, influences age at onset of HD.",8317477_0,-1,3634,-1,0.19518426
3635,Huntington disease,5,7,34,52,"
We evaluated the hypothesis that Huntington disease (HD) is influenced by the normal HD allele by comparing transmission patterns of genetically linked markers at the D4S10 locus in the normal parent against age at onset in the affected offspring.",8317477_1,-1,3635,-1,0.19847032
3636,Tay-Sachs disease,16,18,106,123,Further investigation of the HEXA gene intron 9 donor splice site mutation frequently found in non-Jewish Tay-Sachs disease patients from the British Isles.,8326491_0,-1,3636,-1,0.27513996
3637,Tay-Sachs disease,8,10,37,54,"
In a previous study we found that a Tay-Sachs disease (TSD) causing mutation in the intron 9 donor splice site of the HEXA gene occurs at high frequency in non-Jewish patients and carriers from the British Isles.",8326491_1,-1,3637,-1,0.26846185
3638,p,22,23,106,107,"All six had Irish ancestry, compared with nine of the 20 other (intron 9 mutation negative) TSD carriers (p < 0. 05).",8326491_5,-1,3638,-1,0.3443527
3640,retinoblastoma,13,14,98,112,Molecular mechanisms of oncogenic mutations in tumors from patients with bilateral and unilateral retinoblastoma.,8346255_0,-1,3640,-1,0.16026853
3641,RB1,1,2,5,8,"
The RB1 gene from 12 human retinoblastoma tumors has been analyzed exon-by-exon with the single-strand conformation polymorphism technique.",8346255_1,-1,3641,-1,0.21499614
3642,retinoblastoma tumors,6,8,28,49,"
The RB1 gene from 12 human retinoblastoma tumors has been analyzed exon-by-exon with the single-strand conformation polymorphism technique.",8346255_1,-1,3642,-1,0.15029398
3646,aniridia,3,4,18,26,PAX6 mutations in aniridia.,8364574_0,-1,3646,-1,0.24687085
3647,Aniridia,0,1,1,9,"
Aniridia is a congenital malformation of the eye, chiefly characterised by iris hypoplasia, which can cause blindness.",8364574_1,-1,3647,-1,0.26845473
3648,blindness,18,19,109,118,"
Aniridia is a congenital malformation of the eye, chiefly characterised by iris hypoplasia, which can cause blindness.",8364574_1,-1,3648,-1,0.21244445
3649,aniridia,8,9,42,50,The PAX6 gene was isolated as a candidate aniridia gene by positional cloning from the smallest region of overlap of aniridia-associated deletions.,8364574_2,-1,3649,-1,0.23052385
3650,aniridia,18,19,114,122,"Subsequently PAX6 intragenic mutations were demonstrated in Smalleye, a mouse mutant which is an animal model for aniridia, and six human aniridia patients.",8364574_3,-1,3650,-1,0.23632936
3651,aniridia,23,24,138,146,"Subsequently PAX6 intragenic mutations were demonstrated in Smalleye, a mouse mutant which is an animal model for aniridia, and six human aniridia patients.",8364574_3,-1,3651,-1,0.24412732
3652,aniridia,11,12,66,74,"In this paper we describe four additional PAX6 point mutations in aniridia patients, both sporadic and familial.",8364574_4,-1,3652,-1,0.24764377
3653,aniridia,23,24,126,134,"In addition, the frequency at which we have found PAX6 mutations suggests that lesions in PAX6 will account for most cases of aniridia..",8364574_6,-1,3653,-1,0.21722922
3654,arginine vasopressin,4,6,21,41,Detection of a novel arginine vasopressin defect by dideoxy fingerprinting.,8370681_0,-1,3654,-1,0.22797391
3655,diabetes insipidus,3,5,37,55,"
Autosomal dominant neurohypophyseal diabetes insipidus is a familial form of diabetes insipidus.",8370681_1,-1,3655,-1,0.21990407
3656,diabetes insipidus,10,12,78,96,"
Autosomal dominant neurohypophyseal diabetes insipidus is a familial form of diabetes insipidus.",8370681_1,-1,3656,-1,0.22058724
3657,arginine vasopressin,8,10,52,72,"This disorder is associated with variable levels of arginine vasopressin (AVP) and diabetes insipidus of varying severity, which responds to exogenous AVP.",8370681_2,-1,3657,-1,0.22274129
3658,AVP,11,12,74,77,"This disorder is associated with variable levels of arginine vasopressin (AVP) and diabetes insipidus of varying severity, which responds to exogenous AVP.",8370681_2,-1,3658,-1,0.26663265
3659,diabetes insipidus,14,16,83,101,"This disorder is associated with variable levels of arginine vasopressin (AVP) and diabetes insipidus of varying severity, which responds to exogenous AVP.",8370681_2,-1,3659,-1,0.23260564
3660,AVP,24,25,151,154,"This disorder is associated with variable levels of arginine vasopressin (AVP) and diabetes insipidus of varying severity, which responds to exogenous AVP.",8370681_2,-1,3660,-1,0.2812888
3661,diabetes insipidus,9,11,72,90,"To determine the molecular basis of autosomal dominant neurohypophyseal diabetes insipidus, the AVP genes of members of a large kindred were analyzed.",8370681_3,-1,3661,-1,0.21727215
3662,AVP,13,14,96,99,"To determine the molecular basis of autosomal dominant neurohypophyseal diabetes insipidus, the AVP genes of members of a large kindred were analyzed.",8370681_3,-1,3662,-1,0.269353
3663,AVP,13,14,67,70,"A new method, called dideoxy fingerprinting, was used to detect an AVP mutation that was characterized by DNA sequencing.",8370681_4,-1,3663,-1,0.27704325
3664,AVP,10,11,53,56,"The novel defect found changes the last codon of the AVP signal peptide from alanine to threonine, which should perturb cleavage of mature AVP from its precursor protein and inhibit its secretion or action..",8370681_5,-1,3664,-1,0.2604348
3665,alanine,14,15,77,84,"The novel defect found changes the last codon of the AVP signal peptide from alanine to threonine, which should perturb cleavage of mature AVP from its precursor protein and inhibit its secretion or action..",8370681_5,-1,3665,-1,0.31237686
3666,AVP,24,25,139,142,"The novel defect found changes the last codon of the AVP signal peptide from alanine to threonine, which should perturb cleavage of mature AVP from its precursor protein and inhibit its secretion or action..",8370681_5,-1,3666,-1,0.26407966
3667,muscular dystrophy,5,7,33,51,Germinal mosaicism in a Duchenne muscular dystrophy family: implications for genetic counselling.,8375105_0,-1,3667,-1,0.17251858
3668,muscular dystrophy,16,18,101,119,"
In this study we describe a three-generation family in which two siblings were affected by Duchenne muscular dystrophy (DMD).",8375105_1,-1,3668,-1,0.17549288
3669,cancer syndrome,5,7,38,53,Genetic mapping of the breast-ovarian cancer syndrome to a small interval on chromosome 17q12-21: exclusion of candidate genes EDH17B2 and RARA.,8401501_0,-1,3669,-1,0.16578443
3671,estradiol,10,11,62,71,"Candidate genes in this region include EDH17B2, which encodes estradiol 17 beta-hydroxysteroid dehydrogenase II (17 beta-HSD II), and RARA, the gene for retinoic acid receptor alpha.",8401501_2,-1,3671,-1,0.2896866
3674,map,4,5,23,26,Both BRCA1 and EDH17B2 map to a 6 cM interval (between THRA1 and D17S579) and no recombination was observed between the two genes.,8401501_5,-1,3674,-1,0.29958966
3675,cM,8,9,34,36,Both BRCA1 and EDH17B2 map to a 6 cM interval (between THRA1 and D17S579) and no recombination was observed between the two genes.,8401501_5,-1,3675,-1,0.29496235
3676,cancer syndrome,17,19,107,122,"Mutations in the EDH17B2 gene, therefore do not appear to be responsible for the hereditary breast-ovarian cancer syndrome.",8401501_7,-1,3676,-1,0.15478061
3677,cholesteryl ester,5,7,27,44,A missense mutation in the cholesteryl ester transfer protein gene with possible dominant effects on plasma high density lipoproteins.,8408659_0,-1,3677,-1,0.2662817
3679,Cholesteryl ester,0,2,0,17,Cholesteryl ester transfer protein (CETP; 476 amino acids) transfers cholesteryl ester from HDL to other lipoproteins.,8408659_2,-1,3679,-1,0.30430016
3680,amino acids,8,10,46,57,Cholesteryl ester transfer protein (CETP; 476 amino acids) transfers cholesteryl ester from HDL to other lipoproteins.,8408659_2,-1,3680,-1,0.3115164
3681,cholesteryl ester,12,14,69,86,Cholesteryl ester transfer protein (CETP; 476 amino acids) transfers cholesteryl ester from HDL to other lipoproteins.,8408659_2,-1,3681,-1,0.2911951
3682,Familial Mediterranean fever,0,3,0,28,Familial Mediterranean fever in the colchicine era: the fate of one family.,8434621_0,-1,3682,-1,0.22209297
3683,familial Mediterranean fever,15,18,99,127,"
In order to demonstrate the effect of prophylactic colchicine treatment on the natural history of familial Mediterranean fever (FMF), a family is presented with 6 out of 9 siblings affected by FMF.",8434621_1,-1,3683,-1,0.20825747
3684,kidney disease,9,11,61,75,Each patient represents a different stage of the amyloidotic kidney disease of FMF and the effect of continuous colchicine treatment on its course.,8434621_2,-1,3684,-1,0.20043786
3685,disease,21,22,124,131,"Considered together, the members of this family present an almost complete clinical, genetic, and behavioral picture of the disease..",8434621_3,-1,3685,-1,0.23140408
3686,Norrie disease,5,7,34,48,Detection of a new submicroscopic Norrie disease deletion interval with a novel DNA probe isolated by differential Alu PCR fingerprint cloning.,8440142_0,-1,3686,-1,0.24089949
3687,p11,4,5,6,9,4-- > p11.,8440142_2,-1,3687,-1,0.33568376
3688,Norrie disease,17,19,93,107,"This novel sequence, cpXr318 (DXS742), detects a new submicroscopic deletion interval at the Norrie disease locus (NDP).",8440142_4,-1,3688,-1,0.20363247
3689,map,7,8,46,49,"Combining our data with the consensus genetic map of the proximal short arm of the X chromosome, we propose the physical order Xcen-DXS14-DXS255- (DXS426, TIMP) - (DXS742- ([MAOB-MAOA-DXS7], NDP) -DXS77-DXS228) -DXS209-DXS148-DXS196- + + + Xpter.",8440142_5,-1,3689,-1,0.2329669
3690,map,15,16,71,74,"Finally, DXS742, DSX7, DXS77, and MAOA were integrated into a physical map spanning the Norrie disease locus",8440142_7,-1,3690,-1,0.22798042
3691,Norrie disease,18,20,88,102,"Finally, DXS742, DSX7, DXS77, and MAOA were integrated into a physical map spanning the Norrie disease locus",8440142_7,-1,3691,-1,0.23022132
3692,adrenoleukodystrophy,2,3,18,38,Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters.,8441467_0,-1,3692,-1,0.19755353
3693,Adrenoleukodystrophy,0,1,1,21,"
Adrenoleukodystrophy (ALD) is an X-linked disease affecting 1/20, 000 males either as cerebral ALD in childhood or as adrenomyeloneuropathy (AMN) in adults.",8441467_1,-1,3693,-1,0.21692613
3694,disease,7,8,43,50,"
Adrenoleukodystrophy (ALD) is an X-linked disease affecting 1/20, 000 males either as cerebral ALD in childhood or as adrenomyeloneuropathy (AMN) in adults.",8441467_1,-1,3694,-1,0.20151097
3695,neurological,11,12,53,65,"Childhood ALD is the more severe form, with onset of neurological symptoms between 5-12 years of age.",8441467_2,-1,3695,-1,0.20147862
3697,disease,7,8,28,35,AMN is a milder form of the disease with onset at 15-30 years of age and a more progressive course.,8441467_4,-1,3697,-1,0.23402037
3698,Adrenal insufficiency,0,2,0,21,Adrenal insufficiency (Addisons disease) may remain the only clinical manifestation of ALD.,8441467_5,-1,3698,-1,0.206382
3699,disease,4,5,32,39,Adrenal insufficiency (Addisons disease) may remain the only clinical manifestation of ALD.,8441467_5,-1,3699,-1,0.24269092
3700,fatty acids,11,13,84,95,The principal biochemical abnormality of ALD is the accumulation of very-long-chain fatty acids (VLCFA) because of impaired beta-oxidation in peroxisomes.,8441467_6,-1,3700,-1,0.24692215
3701,disease,9,10,53,60,"In familial cases, the deletions segregated with the disease.",8441467_9,-1,3701,-1,0.2193169
3702,K,19,20,110,111,The deduced protein sequence shows significant sequence identity to a peroxisomal membrane protein of M (r) 70K that is involved in peroxisome biogenesis and belongs to the ATP-binding cassette superfamily of transporters..,8441467_12,-1,3702,-1,0.25900295
3703,cholesterol,22,23,156,167,"
Familial hypobetalipoproteinemia is an autosomal codominant disorder resulting in a dramatic reduction in plasma concentrations of apolipoprotein (apo) B, cholesterol, and beta-migrating lipoproteins.",8460149_1,-1,3703,-1,0.23323338
3704,disease,15,16,113,120,A benefit of hypobetalipoproteinemia is that mildly affected individuals may be protected from coronary vascular disease.,8460149_2,-1,3704,-1,0.21441483
3705,cholesterol,35,36,226,237,"Mice containing this allele display all of the hallmarks of human hypobetalipoproteinemia  they produce a truncated apoB protein, apoB70, and have markedly decreased plasma concentrations of apoB, beta-lipoproteins, and total cholesterol.",8460149_4,-1,3705,-1,0.21268108
3706,triglyceride,19,20,145,157,"In addition, the mice manifest several characteristics that are occasionally observed in human hypobetalipoproteinemia, including reduced plasma triglyceride concentrations, fasting chylomicronemia, and reduced high density lipoprotein cholesterol.",8460149_5,-1,3706,-1,0.22484069
3707,cholesterol,30,31,236,247,"In addition, the mice manifest several characteristics that are occasionally observed in human hypobetalipoproteinemia, including reduced plasma triglyceride concentrations, fasting chylomicronemia, and reduced high density lipoprotein cholesterol.",8460149_5,-1,3707,-1,0.21501356
3708,hydrocephalus,15,16,100,113,An unexpected finding is that the modified Apob allele is strongly associated with exencephalus and hydrocephalus.,8460149_6,-1,3708,-1,0.21026298
3709,hydrocephalus,18,19,130,143,"These mice should help increase our understanding of hypobetalipoproteinemia, atherogenesis, and the etiology of exencephalus and hydrocephalus..",8460149_7,-1,3709,-1,0.19173698
3710,disease,2,3,8,15,A novel disease with deficiency of mitochondrial very-long-chain acyl-CoA dehydrogenase.,8466512_0,-1,3710,-1,0.2155929
3711,fatty acid,13,15,107,117,"
Palmitoyl-CoA dehydrogenase activity in skin fibroblasts from seven patients with unidentified defects of fatty acid oxidation was measured in the presence and absence of antibodies against medium-chain, long-chain, and very-long-chain acyl-CoA dehydrogenases (VLCAD).",8466512_1,-1,3711,-1,0.26673928
3712,disease,18,19,68,75,"Two of the patients, 4-5 month old boys, were found to have a novel disease, VLCAD deficiency, as judged from the results of very low palmitoyl-CoA dehydrogenase activity and the lack of immunoreactivity toward antibody raised to purified VLCAD..",8466512_2,-1,3712,-1,0.22993499
3713,VLCAD deficiency,20,22,77,93,"Two of the patients, 4-5 month old boys, were found to have a novel disease, VLCAD deficiency, as judged from the results of very low palmitoyl-CoA dehydrogenase activity and the lack of immunoreactivity toward antibody raised to purified VLCAD..",8466512_2,-1,3713,-1,0.2734262
3714,nucleotide,12,13,66,76,"From these 43 samples, we have identified five different types of nucleotide substitutions in the G6PD gene  at cDNA 1388 from G to A (Arg to His); at cDNA 1376 from G to T (Arg to Leu); at cDNA 1024 from C to T (Leu to Phe); at cDNA 392 from G to T (Gly to Val); at cDNA 95 from A to G (His to Arg).",8471773_4,-1,3714,-1,0.27176732
3715,C,49,50,205,206,"From these 43 samples, we have identified five different types of nucleotide substitutions in the G6PD gene  at cDNA 1388 from G to A (Arg to His); at cDNA 1376 from G to T (Arg to Leu); at cDNA 1024 from C to T (Leu to Phe); at cDNA 392 from G to T (Gly to Val); at cDNA 95 from A to G (His to Arg).",8471773_4,-1,3715,-1,0.366767
3716,Phe,55,56,220,223,"From these 43 samples, we have identified five different types of nucleotide substitutions in the G6PD gene  at cDNA 1388 from G to A (Arg to His); at cDNA 1376 from G to T (Arg to Leu); at cDNA 1024 from C to T (Leu to Phe); at cDNA 392 from G to T (Gly to Val); at cDNA 95 from A to G (His to Arg).",8471773_4,-1,3716,-1,0.28142795
3717,Val,68,69,258,261,"From these 43 samples, we have identified five different types of nucleotide substitutions in the G6PD gene  at cDNA 1388 from G to A (Arg to His); at cDNA 1376 from G to T (Arg to Leu); at cDNA 1024 from C to T (Leu to Phe); at cDNA 392 from G to T (Gly to Val); at cDNA 95 from A to G (His to Arg).",8471773_4,-1,3717,-1,0.2630668
3718,nucleotide,2,3,11,21,These five nucleotide substitutions account for over 83% of our 43 G6PD-deficient samples and these substitutions have not been reported in non-Asians.,8471773_5,-1,3718,-1,0.23528256
3719,choroideremia,5,6,38,51,Identification of mutations in Danish choroideremia families.,8477262_0,-1,3719,-1,0.22351363
3720,choroideremia,7,8,39,52,"
We have searched for mutations in the choroideremia gene (CHM) in patients from 12 Danish families in which CHM is segregating.",8477262_1,-1,3720,-1,0.20651723
3721,myotonic dystrophy,6,8,38,56,Structure and genomic sequence of the myotonic dystrophy (DM kinase) gene.,8499920_0,-1,3721,-1,0.18898334
3722,DM,9,10,58,60,Structure and genomic sequence of the myotonic dystrophy (DM kinase) gene.,8499920_0,-1,3722,-1,0.2611286
3723,myotonic dystrophy,3,5,22,40,"
The mutation causing myotonic dystrophy (DM) has recently been identified as an unstable CTG trinucleotide repeat located in the 3 untranslated region of a gene encoding for a protein with putative serine-threonine protein kinase activity.",8499920_1,-1,3723,-1,0.1722093
3724,DM,6,7,42,44,"
The mutation causing myotonic dystrophy (DM) has recently been identified as an unstable CTG trinucleotide repeat located in the 3 untranslated region of a gene encoding for a protein with putative serine-threonine protein kinase activity.",8499920_1,-1,3724,-1,0.20116493
3725,DM,13,14,72,74,In this report we present the genomic sequences of the human and murine DM kinase gene.,8499920_2,-1,3725,-1,0.2755774
3726,DM,34,35,192,194,"A comparison of these sequences with each other and with known cDNA sequences from both species, led us to predict a translation initiation codon, as well as determine the organization of the DM kinase gene.",8499920_3,-1,3726,-1,0.29494363
3727,DM,5,6,39,41,"Several polymorphisms within the human DM kinase gene have been identified, and PCR assays to detect two of these are described.",8499920_4,-1,3727,-1,0.29295358
3728,DM,10,11,67,69,"The complete sequence and characterization of the structure of the DM kinase gene, as well as the identification of novel polymorphisms within the gene, represent an important step in a further understanding of the genetics of myotonic dystrophy and the molecular biology of the gene..",8499920_5,-1,3728,-1,0.27440098
3729,myotonic dystrophy,38,40,227,245,"The complete sequence and characterization of the structure of the DM kinase gene, as well as the identification of novel polymorphisms within the gene, represent an important step in a further understanding of the genetics of myotonic dystrophy and the molecular biology of the gene..",8499920_5,-1,3729,-1,0.17925625
3730,hemophilia A,4,6,36,48,Autosomal recessive transmission of hemophilia A due to a von Willebrand factor mutation.,8500791_0,-1,3730,-1,0.21347131
3732,hemophilia A,9,11,63,75,"
The differential diagnosis of the genetic bleeding disorders, hemophilia A and von Willebrand disease, is occasionally confounded by the close molecular relationship of coagulation factor VIII and von Willebrand factor (vWF).",8500791_1,-1,3732,-1,0.21295968
3733,disease,14,15,95,102,"
The differential diagnosis of the genetic bleeding disorders, hemophilia A and von Willebrand disease, is occasionally confounded by the close molecular relationship of coagulation factor VIII and von Willebrand factor (vWF).",8500791_1,-1,3733,-1,0.20451322
3734,coagulation factor VIII,25,28,170,193,"
The differential diagnosis of the genetic bleeding disorders, hemophilia A and von Willebrand disease, is occasionally confounded by the close molecular relationship of coagulation factor VIII and von Willebrand factor (vWF).",8500791_1,-1,3734,-1,0.2711476
3735,hemophilia A,8,10,53,65,This report describes the autosomal inheritance of a hemophilia A phenotype due to a mutation of vWF that results in defective factor VIII binding.,8500791_2,-1,3735,-1,0.20414215
3736,factor VIII,21,23,127,138,This report describes the autosomal inheritance of a hemophilia A phenotype due to a mutation of vWF that results in defective factor VIII binding.,8500791_2,-1,3736,-1,0.2731009
3737,factor VIII,10,12,52,63,The proband was a female patient with low levels of factor VIII activity.,8500791_3,-1,3737,-1,0.3127784
3738,factor VIII,18,20,118,129,Polymerase chain reaction (PCR) amplification and DNA sequencing were employed to examine exons encoding the putative factor VIII binding domain of vWF.,8500791_4,-1,3738,-1,0.2757137
3739,amino acid,19,21,105,115,The patient was found to be homozygous for a single point mutation causing a Thr-- > Met substitution at amino acid position 28 in the mature vWF subunit.,8500791_5,-1,3739,-1,0.35746542
3740,amino acid,5,7,40,50,Recombinant vWF containing the observed amino acid substitution was expressed in COS-1 cells.,8500791_7,-1,3740,-1,0.3037304
3741,factor VIII,7,9,35,46,"However, the mutant failed to bind factor VIII, demonstrating that the mutation was functionally related to the observed hemophilia phenotype.",8500791_9,-1,3741,-1,0.2922473
3743,cystadenoma,8,9,59,70,Somatic von Hippel-Lindau mutation in clear cell papillary cystadenoma of the epididymis.,8522307_0,-1,3743,-1,0.17485249
3744,cystadenoma,1,2,11,22,"
Papillary cystadenoma of the epididymis is an uncommon benign lesion that may occur sporadically or as a manifestation of von Hippel-Lindau (VHL) disease.",8522307_1,-1,3744,-1,0.18473086
3745,disease,24,25,147,154,"
Papillary cystadenoma of the epididymis is an uncommon benign lesion that may occur sporadically or as a manifestation of von Hippel-Lindau (VHL) disease.",8522307_1,-1,3745,-1,0.19519731
3746,cystadenoma,9,10,55,66,"The authors describe two cases of clear cell papillary cystadenoma of the epididymis, both of which were initially confused with metastatic renal cell carcinoma.",8522307_3,-1,3746,-1,0.17823376
3747,renal cell carcinoma,22,25,140,160,"The authors describe two cases of clear cell papillary cystadenoma of the epididymis, both of which were initially confused with metastatic renal cell carcinoma.",8522307_3,-1,3747,-1,0.17475489
3748,cystadenoma,4,5,29,40,"Because clear cell papillary cystadenoma is similar to renal cell carcinoma histologically, and because both occur as components of the von Hippel-Lindau disease complex, the authors analyzed both cases for the presence of mutations in the VHL gene.",8522307_6,-1,3748,-1,0.17230996
3749,renal cell carcinoma,8,11,55,75,"Because clear cell papillary cystadenoma is similar to renal cell carcinoma histologically, and because both occur as components of the von Hippel-Lindau disease complex, the authors analyzed both cases for the presence of mutations in the VHL gene.",8522307_6,-1,3749,-1,0.17231472
3750,von Hippel-Lindau disease,21,24,136,161,"Because clear cell papillary cystadenoma is similar to renal cell carcinoma histologically, and because both occur as components of the von Hippel-Lindau disease complex, the authors analyzed both cases for the presence of mutations in the VHL gene.",8522307_6,-1,3750,-1,0.21267237
3752,cytosine,4,5,29,37,"Direct sequencing revealed a cytosine to thymine transition at nucleotide 694, resulting in the replacement of an arginine with a stop codon after the sixth amino acid of exon 3.",8522307_8,-1,3752,-1,0.2754735
3753,thymine,6,7,41,48,"Direct sequencing revealed a cytosine to thymine transition at nucleotide 694, resulting in the replacement of an arginine with a stop codon after the sixth amino acid of exon 3.",8522307_8,-1,3753,-1,0.27351466
3754,nucleotide,9,10,63,73,"Direct sequencing revealed a cytosine to thymine transition at nucleotide 694, resulting in the replacement of an arginine with a stop codon after the sixth amino acid of exon 3.",8522307_8,-1,3754,-1,0.32922933
3755,amino acid,26,28,157,167,"Direct sequencing revealed a cytosine to thymine transition at nucleotide 694, resulting in the replacement of an arginine with a stop codon after the sixth amino acid of exon 3.",8522307_8,-1,3755,-1,0.29324412
3757,Wiskott-Aldrich syndrome,7,9,50,74,Identification of WASP mutations in patients with Wiskott-Aldrich syndrome and isolated thrombocytopenia reveals allelic heterogeneity at the WAS locus.,8528198_0,-1,3757,-1,0.20237814
3759,Wiskott-Aldrich syndrome,22,24,141,165,"
Mutation in the gene encoding the recently isolated WASP protein has now been identified as the genetic defect responsible for the X-linked Wiskott-Aldrich syndrome (WAS), a primary immunodeficiency disease associated with extensive phenotypic variability.",8528198_1,-1,3759,-1,0.19505185
3760,immunodeficiency disease,30,32,183,207,"
Mutation in the gene encoding the recently isolated WASP protein has now been identified as the genetic defect responsible for the X-linked Wiskott-Aldrich syndrome (WAS), a primary immunodeficiency disease associated with extensive phenotypic variability.",8528198_1,-1,3760,-1,0.16542992
3767,Wiskott-Aldrich syndrome,4,6,23,47,WASP gene mutations in Wiskott-Aldrich syndrome and X-linked thrombocytopenia.,8528199_0,-1,3767,-1,0.19679134
3769,Wiskott-Aldrich syndrome,11,13,54,78,23 and shown to be mutated in three patients with the Wiskott-Aldrich syndrome (WAS).,8528199_2,-1,3769,-1,0.22063549
3770,amino acid,1,3,5,15,"Four amino acid substitutions, Leu27Phe, Thr48Ile, Val75Met and Arg477Lys, were found in patients with congenital thrombocytopenia and no clinically evident immune defect indicating that the WASP gene is the site for mutations in X-linked thrombocytopenia as well as in WAS.",8528199_6,-1,3770,-1,0.2964846
3773,amino acids,10,12,78,89,"The distribution of eight missense mutations provides valuable information on amino acids which are essential for normal protein function, and suggests that sites in the first two exons are hot-spots for mutation.",8528199_8,-1,3773,-1,0.2730067
3774,Machado-Joseph disease,25,27,173,195,Evidence for inter-generational instability in the CAG repeat in the MJD1 gene and for conserved haplotypes at flanking markers amongst Japanese and Caucasian subjects with Machado-Joseph disease.,8528200_0,-1,3774,-1,0.22466506
3775,(CAG)n,4,5,17,23,"
The size of the (CAG)n repeat array in the 3' end of the MJD1 gene and the haplotype at a series of microsatellite markers surrounding the MJD1 gene were examined in a large cohort of Japanese and Caucasian subjects affected with Machado-Joseph disease (MJD).",8528200_1,-1,3775,-1,0.37376234
3776,Machado-Joseph disease,42,44,231,253,"
The size of the (CAG)n repeat array in the 3' end of the MJD1 gene and the haplotype at a series of microsatellite markers surrounding the MJD1 gene were examined in a large cohort of Japanese and Caucasian subjects affected with Machado-Joseph disease (MJD).",8528200_1,-1,3776,-1,0.24369778
3777,p,23,24,114,115,"Third, the size of the expanded allele is not only inversely correlated with the age-of-onset of MJD (r = -0.738, p < 0.001), but is also correlated with the frequency of other clinical features [e.g. pseudoexophthalmos and pyramidal signs were more frequent in subjects with large repeats (p < 0.001 and p < 0.05 respectively)].",8528200_5,-1,3777,-1,0.31214163
3778,p,54,55,291,292,"Third, the size of the expanded allele is not only inversely correlated with the age-of-onset of MJD (r = -0.738, p < 0.001), but is also correlated with the frequency of other clinical features [e.g. pseudoexophthalmos and pyramidal signs were more frequent in subjects with large repeats (p < 0.001 and p < 0.05 respectively)].",8528200_5,-1,3778,-1,0.33704206
3779,p,58,59,305,306,"Third, the size of the expanded allele is not only inversely correlated with the age-of-onset of MJD (r = -0.738, p < 0.001), but is also correlated with the frequency of other clinical features [e.g. pseudoexophthalmos and pyramidal signs were more frequent in subjects with large repeats (p < 0.001 and p < 0.05 respectively)].",8528200_5,-1,3779,-1,0.3179487
3780,disease,3,4,12,19,"Fourth, the disease phenotype is significantly more severe and had an early age of onset (16 years) in a subject homozygous for the expanded allele, which contrasts with Huntington disease and suggests that the expanded allele in the MJD1 gene could exert its effect either by a dominant negative effect (putatively excluded in HD) or by a gain of function effect as proposed for HD.",8528200_6,-1,3780,-1,0.18627116
3781,Huntington disease,32,34,170,188,"Fourth, the disease phenotype is significantly more severe and had an early age of onset (16 years) in a subject homozygous for the expanded allele, which contrasts with Huntington disease and suggests that the expanded allele in the MJD1 gene could exert its effect either by a dominant negative effect (putatively excluded in HD) or by a gain of function effect as proposed for HD.",8528200_6,-1,3781,-1,0.21673167
3782,Langer-Giedion syndrome,7,9,39,62,A 4-megabase YAC contig that spans the Langer-Giedion syndrome region on human chromosome 8q24.1: use in refining the location of the trichorhinophalangeal syndrome and multiple exostoses genes (TRPS1 and EXT1).,8530105_0,-1,3782,-1,0.23819466
3783,syndrome,23,24,156,164,A 4-megabase YAC contig that spans the Langer-Giedion syndrome region on human chromosome 8q24.1: use in refining the location of the trichorhinophalangeal syndrome and multiple exostoses genes (TRPS1 and EXT1).,8530105_0,-1,3783,-1,0.20467721
3784,exostoses,26,27,178,187,A 4-megabase YAC contig that spans the Langer-Giedion syndrome region on human chromosome 8q24.1: use in refining the location of the trichorhinophalangeal syndrome and multiple exostoses genes (TRPS1 and EXT1).,8530105_0,-1,3784,-1,0.2370551
3785,map,5,6,32,35,"
We have constructed a physical map covering over 4 Mb of human chromosome 8q24.",8530105_1,-1,3785,-1,0.21755591
3786,Mb,9,10,52,54,"
We have constructed a physical map covering over 4 Mb of human chromosome 8q24.",8530105_1,-1,3786,-1,0.23617253
3787,map,4,5,16,19,1 and used this map to refine the locations of the genes responsible for Langer-Giedion syndrome.,8530105_2,-1,3787,-1,0.2655327
3788,Langer-Giedion syndrome,14,16,73,96,1 and used this map to refine the locations of the genes responsible for Langer-Giedion syndrome.,8530105_2,-1,3788,-1,0.24029258
3789,map,1,2,4,7,The map is composed of overlapping YAC clones that were identified and ordered in relation to sequence tagged sites mapped to the Langer-Giedion chromosomal region on somatic cell hybrids.,8530105_3,-1,3789,-1,0.2547176
3790,Langer-Giedion syndrome,6,8,33,56,"The minimal region of overlap of Langer-Giedion syndrome deletions, previously identified by analysis of 15 patients, was placed on the map by analysis of 2 patients whose deletions define the endpoints.",8530105_4,-1,3790,-1,0.24691124
3791,map,22,23,136,139,"The minimal region of overlap of Langer-Giedion syndrome deletions, previously identified by analysis of 15 patients, was placed on the map by analysis of 2 patients whose deletions define the endpoints.",8530105_4,-1,3791,-1,0.24264252
3792,syndrome,8,9,59,67,3) translocation from a patient with trichorhinophalangeal syndrome (TRPS I) was found to be located just within the proximal end of the minimal deletion region.,8530105_6,-1,3792,-1,0.19588697
3793,exostoses,6,7,29,38,"3 in a patient with multiple exostoses was found to overlap the distal end of the LGS deletion region, indicating that the EXT1 gene is distal to the TRPS1 gene and supporting the hypothesis that Langer-Giedion syndrome is due to loss of functional copies of both the TRPS1 and the EXT1 genes",8530105_9,-1,3793,-1,0.22558972
3794,Langer-Giedion syndrome,36,38,196,219,"3 in a patient with multiple exostoses was found to overlap the distal end of the LGS deletion region, indicating that the EXT1 gene is distal to the TRPS1 gene and supporting the hypothesis that Langer-Giedion syndrome is due to loss of functional copies of both the TRPS1 and the EXT1 genes",8530105_9,-1,3794,-1,0.22740278
3810,prostatic cancer,22,24,140,156,"In one family, penetrance was complete, with females developing early-onset breast cancer or ovarian cancer and the male carrier developing prostatic cancer, whereas, in the other family, penetrance was incomplete and only breast cancer occurred, diagnosed at ages 38-81 years.",8533757_6,-1,3810,-1,0.1562179
3815,malaria,19,20,121,128,"
Deficiency of glucose-6-phosphate dehydrogenase (G6PD) is usually found at high frequencies in areas of the world where malaria has been endemic.",8533762_1,-1,3815,-1,0.23192735
3816,Phe,53,54,280,283,"Remarkably, a previously unreported deficient variant, G6PD Orissa (44 Ala-- > Gly), is responsible for most of the G6PD deficiency in tribal Indian populations but is not found in urban populations, where most of the G6PD deficiency is due to the G6PD Mediterranean (188 Ser-- > Phe) variant.",8533762_5,-1,3816,-1,0.3013346
3817,alanine,9,10,37,44,This may be due to the fact that the alanine residue that is replaced by glycine is part of a putative coenzyme-binding site..,8533762_7,-1,3817,-1,0.27296165
3818,glycine,15,16,73,80,This may be due to the fact that the alanine residue that is replaced by glycine is part of a putative coenzyme-binding site..,8533762_7,-1,3818,-1,0.25225738
3820,bipolar affective disorder,14,17,94,120,"
A susceptibility gene on chromosome 18 and a parent-of-origin effect have been suggested for bipolar affective disorder (BPAD).",8533768_1,-1,3820,-1,0.17358005
3822,P,20,21,91,92,The greatest sharing was at D18S37  64% in bipolar and recurrent unipolar (RUP) sib pairs (P =. 0006).,8533768_5,-1,3822,-1,0.30929214
3824,P,45,46,247,248,"In addition, excess sharing of the paternally, but not maternally, transmitted alleles was observed at three markers on 18q  at D18S41, 51 bipolar and RUP sib pairs were concordant for paternally transmitted alleles, and 21 pairs were discordant (P = 0004).",8533768_6,-1,3824,-1,0.32572487
3825,e,20,21,100,101,"The evidence for linkage to loci on both 18p and 18q was strongest in the 11 paternal pedigrees, i. e e., those in which the father or one of the fathers sibs is affected.",8533768_7,-1,3825,-1,0.3294035
3826,P,12,13,54,55,"In these pedigrees, the greatest allele sharing (81%; P =. 00002) and the highest LOD score (3. 51; phi = 0. 0) were observed at D18S41.",8533768_8,-1,3826,-1,0.30334255
3827,C--,9,10,46,49,METHODS  We discovered a mutation caused by a C-- > T transition at base-pair 1158 of the GALT gene that results in a serine-to-leucine substitution at codon 135 (S135L).,8551426_2,-1,3827,-1,0.34885466
3832,syndrome,12,13,73,81,It is expected that the majority of clear examples of the breast-ovarian syndrome will be associated with germ-line mutations in the coding region of BRCA1..,8554067_9,-1,3832,-1,0.17365873
3836,tumours,6,7,31,38,The loss of wild-type BRCA1 in tumours of individuals carrying one nonfunctional BRCA1 allele suggests that BRCA1 encodes a tumour suppressor that may inhibit the proliferation of mammary epithelial cells.,8563759_3,-1,3836,-1,0.17621034
3837,tumour,19,20,124,130,The loss of wild-type BRCA1 in tumours of individuals carrying one nonfunctional BRCA1 allele suggests that BRCA1 encodes a tumour suppressor that may inhibit the proliferation of mammary epithelial cells.,8563759_3,-1,3837,-1,0.14291371
3839,spina bifida,23,25,138,150,"Abnormalities in Brca1-deficient embryos were most evident in the neural tube, with 40% of the embryos presenting with varying degrees of spina bifida and anencephaly.",8563759_6,-1,3839,-1,0.1981812
3841,Adrenoleukodystrophy,0,1,1,21,"
Adrenoleukodystrophy (ALD), an X-linked inherited metabolic disorder, is the most frequent inborn peroxisomal disease.",8566952_1,-1,3841,-1,0.20599982
3842,disease,17,18,111,118,"
Adrenoleukodystrophy (ALD), an X-linked inherited metabolic disorder, is the most frequent inborn peroxisomal disease.",8566952_1,-1,3842,-1,0.18824928
3843,fatty acids,7,9,54,65,"Defective beta-oxidation of saturated very long chain fatty acids (VLCFAs; C22  0-C26  0) in peroxisomes has been shown to lead to an accumulation of VLCFAs in leukoid areas of the central nervous system, peripheral nerves, adrenal gland, and blood.",8566952_3,-1,3843,-1,0.24372685
3844,lead,24,25,123,127,"Defective beta-oxidation of saturated very long chain fatty acids (VLCFAs; C22  0-C26  0) in peroxisomes has been shown to lead to an accumulation of VLCFAs in leukoid areas of the central nervous system, peripheral nerves, adrenal gland, and blood.",8566952_3,-1,3844,-1,0.26059192
3847,amino acid,25,27,122,132,4 kb of the region of these clones corresponding to part of human exon 11 revealed 72% nucleic acid identity but only 50% amino acid identity with the human gene.,8566965_6,-1,3847,-1,0.3007684
3848,diastrophic dysplasia,9,11,55,76,Atelosteogenesis type II is caused by mutations in the diastrophic dysplasia sulfate-transporter gene (DTDST): evidence for a phenotypic series involving three chondrodysplasias.,8571951_0,-1,3848,-1,0.21963874
3849,diastrophic dysplasia,27,29,187,208,"
Atelosteogenesis type II (AO II) is a neonatally lethal chondrodysplasia whose clinical and histological characteristics resemble those of another chondrodysplasia, the much less severe diastrophic dysplasia (DTD).",8571951_1,-1,3849,-1,0.19366303
3850,diastrophic dysplasia,9,11,54,75,DTD is caused by mutations in the recently identified diastrophic dysplasia sulfate-transporter gene (DTDST).,8571951_3,-1,3850,-1,0.24869813
3851,lead,13,14,68,72,"Here, we report that AOII patients also have DTDST mutations, which lead to defective uptake of inorganic sulfate and insufficient sulfation of macromolecules by patient mesenchymal cells in vitro.",8571951_4,-1,3851,-1,0.2610629
3852,achondrogenesis,13,14,85,100,"Together with our recent observation that a third even more severe chondrodysplasia, achondrogenesis type IB, is also caused by mutations in DTDST, these results demonstrate a phenotypic series of three chondrodysplasias of increasing severity caused by lesions in a single sulfate-transporter gene.",8571951_5,-1,3852,-1,0.24974819
3856,P,23,24,129,130,"A comparison of the six mutations in the relative proportions of cases of breast and ovarian cancer was suggestive of an effect (P =. 069), with 57% of women presumed affected because of the 1294 del 40 BRCA1 mutation having ovarian cancer, compared with 14% of affected women with the splice-site mutation in intron 5 of BRCA1.",8571953_4,-1,3856,-1,0.29703176
3859,nucleotide,17,18,96,106,DNA sequence analysis revealed that the mouse and human coding regions are 75% identical at the nucleotide level while the predicted amino acid identity is only 58%.,8575748_4,-1,3859,-1,0.27744898
3860,amino,22,23,133,138,DNA sequence analysis revealed that the mouse and human coding regions are 75% identical at the nucleotide level while the predicted amino acid identity is only 58%.,8575748_4,-1,3860,-1,0.29522124
3861,map,13,14,69,72,A DNA sequence variant in the Brca1 locus was identified and used to map this gene on a (Mus m. musculus Czech II x C57BL/KsJ) F1 x C57BL/KsJ intersubspecific backcross to distal mouse chromosome 11.,8575748_5,-1,3861,-1,0.25584874
3862,muscular dystrophy,10,12,74,92,Emerin deficiency at the nuclear membrane in patients with Emery-Dreifuss muscular dystrophy.,8589715_0,-1,3862,-1,0.17260598
3863,X-linked Emery-Dreifuss muscular dystrophy,15,19,78,120,"
Mutations in the STA gene at the Xq28 locus have been found in patients with X-linked Emery-Dreifuss muscular dystrophy (EDMD).",8589715_1,-1,3863,-1,0.19500919
3864,neuromuscular diseases,25,27,149,171,"Using both antisera, we found positive nuclear membrane staining in skeletal, cardiac and smooth muscles in the normal controls and in patients with neuromuscular diseases other than EDMD.",8589715_4,-1,3864,-1,0.16738631
3865,contrast,1,2,3,11,"In contrast, a deficiency in immunofluorescent staining of skeletal and cardiac muscle from EDMD patients was observed.",8589715_5,-1,3865,-1,0.25550607
3866,Growth retardation,0,2,0,18,Growth retardation and tumour inhibition by BRCA1.,8589721_0,-1,3866,-1,0.20997213
3867,tumour,3,4,23,29,Growth retardation and tumour inhibition by BRCA1.,8589721_0,-1,3867,-1,0.21137644
3871,lung cancer,30,32,161,172,"Here, we show that retroviral transfer of the wild-type BRCA1 gene inhibits growth in vitro of all breast and ovarian cancer cell lines tested, but not colon or lung cancer cells or fibroblasts.",8589721_2,-1,3871,-1,0.14382136
3874,tumours,3,4,21,28,"Development of MCF-7 tumours in nude mice is inhibited when MCF-7 cells are transfected with wild-type, but not mutant, BRCA1.",8589721_4,-1,3874,-1,0.17268316
3875,tumours,8,9,52,59,"Most importantly, among mice with established MCF-7 tumours, peritoneal treatment with a retroviral vector expressing wild-type BRCA1 significantly inhibits tumour growth and increased survival..",8589721_5,-1,3875,-1,0.1586076
3876,tumour,21,22,157,163,"Most importantly, among mice with established MCF-7 tumours, peritoneal treatment with a retroviral vector expressing wild-type BRCA1 significantly inhibits tumour growth and increased survival..",8589721_5,-1,3876,-1,0.17783308
3878,C,14,15,82,83,"Interestingly, BRCA2 also includes a motif similar to the granin consensus at the C terminus of the protein.",8589722_4,-1,3878,-1,0.290299
3879,tumour,17,18,104,110,"As a regulated secretory protein, BRCA1 appears to function by a mechanism not previously described for tumour suppressor gene products..",8589722_6,-1,3879,-1,0.14974439
3888,P,30,31,160,161,"The risk for ovarian cancer was 2. 11 times greater for BRCA1 carriers harbouring one or two rare HRAS1 alleles, compared to carriers with only common alleles (P = 0. 015).",8589723_8,-1,3888,-1,0.29744798
3892,myotonic dystrophy,14,16,91,109,A novel homeodomain-encoding gene is associated with a large CpG island interrupted by the myotonic dystrophy unstable (CTG)n repeat.,8595416_0,-1,3892,-1,0.20540446
3893,Myotonic dystrophy,0,2,1,19,"
Myotonic dystrophy (DM) is associated with a (CTG) n trinucleotide repeat expansion in the 3-untranslated region of a protein kinase-encoding gene, DMPK, which maps to chromosome 19q13.",8595416_1,-1,3893,-1,0.19135788
3894,DM,3,4,21,23,"
Myotonic dystrophy (DM) is associated with a (CTG) n trinucleotide repeat expansion in the 3-untranslated region of a protein kinase-encoding gene, DMPK, which maps to chromosome 19q13.",8595416_1,-1,3894,-1,0.2116948
3895,n,12,13,52,53,"
Myotonic dystrophy (DM) is associated with a (CTG) n trinucleotide repeat expansion in the 3-untranslated region of a protein kinase-encoding gene, DMPK, which maps to chromosome 19q13.",8595416_1,-1,3895,-1,0.3700716
3896,DM,1,2,4,6,"The DM region of chromosome 19 is gene rich, and it is possible that the repeat expansion may lead to dysfunction of a number of transcription units in the vicinity, perhaps as a consequence of chromatin disruption.",8595416_4,-1,3896,-1,0.25242957
3897,lead,19,20,94,98,"The DM region of chromosome 19 is gene rich, and it is possible that the repeat expansion may lead to dysfunction of a number of transcription units in the vicinity, perhaps as a consequence of chromatin disruption.",8595416_4,-1,3897,-1,0.27657458
3898,RB1,4,5,26,29,Germline mutations in the RB1 gene in patients with hereditary retinoblastoma.,8605116_0,-1,3898,-1,0.20248291
3899,retinoblastoma,10,11,63,77,Germline mutations in the RB1 gene in patients with hereditary retinoblastoma.,8605116_0,-1,3899,-1,0.15588322
3900,RB1,12,13,62,65,"
We have analyzed the 27 exons and the promoter region of the RB1 gene in familial or sporadic bilateral retinoblastoma by using single-strand conformation polymorphism analysis.",8605116_1,-1,3900,-1,0.19990326
3901,retinoblastoma,19,20,105,119,"
We have analyzed the 27 exons and the promoter region of the RB1 gene in familial or sporadic bilateral retinoblastoma by using single-strand conformation polymorphism analysis.",8605116_1,-1,3901,-1,0.1501559
3902,amino acid,1,3,16,26,Allele-specific amino acid substitutions (Ser189 --> Phe; Gly444 --> Arg) cause impaired C2 secretion.,8621452_1,-1,3902,-1,0.30777422
3903,Phe,8,9,53,56,Allele-specific amino acid substitutions (Ser189 --> Phe; Gly444 --> Arg) cause impaired C2 secretion.,8621452_1,-1,3903,-1,0.2765738
3904,nucleotide,6,7,18,28,"One is in exon 5 (nucleotide C566 -- > T; Ser189 -- > Phe) of the C2Q0 gene linked to the MHC haplotype A11, B35, DRw1, BFS, C4A0B1.",8621452_6,-1,3904,-1,0.32312754
3905,Phe,15,16,54,57,"One is in exon 5 (nucleotide C566 -- > T; Ser189 -- > Phe) of the C2Q0 gene linked to the MHC haplotype A11, B35, DRw1, BFS, C4A0B1.",8621452_6,-1,3905,-1,0.29480582
3906,disease,19,20,112,119,Defective dimerization of von Willebrand factor subunits due to a Cys-> Arg mutation in type IID von Willebrand disease.,8622978_0,-1,3906,-1,0.18968768
3907,C,6,7,29,30,"
The same heterozygous T - > C transition at nt 8567 of the von Willebrand factor (vWF) transcript was found in two unrelated patients with type IID von Willebrand disease, with no other apparent abnormality.",8622978_1,-1,3907,-1,0.31446823
3908,disease,31,32,164,171,"
The same heterozygous T - > C transition at nt 8567 of the von Willebrand factor (vWF) transcript was found in two unrelated patients with type IID von Willebrand disease, with no other apparent abnormality.",8622978_1,-1,3908,-1,0.20798695
3909,contrast,1,2,3,11,"In contrast, cells expressing the mutant fragment secreted a monomeric molecule of apparent molecular mass of 80 kDa, which remained unchanged after reduction.",8622978_6,-1,3909,-1,0.24122874
3910,disease,38,39,268,275,We conclude that CyS2010 is essential for normal dimerization of vWF subunits through disulfide bonding of carboxyl-terminal domains and that a heterozygous mutation in the corresponding codon is responsible for defective multimer formation in type IID von Willebrand disease..,8622978_7,-1,3910,-1,0.19782852
3911,Wiskott-Aldrich syndrome,0,2,0,24,"Wiskott-Aldrich syndrome protein, a novel effector for the GTPase CDC42Hs, is implicated in actin polymerization.",8625410_0,-1,3911,-1,0.19653922
3912,Wiskott-Aldrich syndrome,11,13,58,82,"We have identified WASP, the protein that is defective in Wiskott-Aldrich syndrome (WAS), as a novel effector for CDC42Hs, but not for the other Rho family members, Rac and Rho.",8625410_2,-1,3912,-1,0.19982219
3913,adrenoleukodystrophy,1,2,9,29,X-linked adrenoleukodystrophy is a frequent cause of idiopathic Addison's disease in young adult male patients.,8636252_0,-1,3913,-1,0.18422273
3914,disease,10,11,74,81,X-linked adrenoleukodystrophy is a frequent cause of idiopathic Addison's disease in young adult male patients.,8636252_0,-1,3914,-1,0.18626802
3915,adrenoleukodystrophy,1,2,10,30,"
X-Linked adrenoleukodystrophy (ALD) is a genetic disease associated with demyelination of the central nervous system, adrenal insufficiency, and accumulation of very long chain fatty acids in tissue and body fluids.",8636252_1,-1,3915,-1,0.19488618
3916,disease,8,9,50,57,"
X-Linked adrenoleukodystrophy (ALD) is a genetic disease associated with demyelination of the central nervous system, adrenal insufficiency, and accumulation of very long chain fatty acids in tissue and body fluids.",8636252_1,-1,3916,-1,0.1960999
3917,adrenal insufficiency,18,20,119,140,"
X-Linked adrenoleukodystrophy (ALD) is a genetic disease associated with demyelination of the central nervous system, adrenal insufficiency, and accumulation of very long chain fatty acids in tissue and body fluids.",8636252_1,-1,3917,-1,0.18630688
3918,fatty acids,27,29,178,189,"
X-Linked adrenoleukodystrophy (ALD) is a genetic disease associated with demyelination of the central nervous system, adrenal insufficiency, and accumulation of very long chain fatty acids in tissue and body fluids.",8636252_1,-1,3918,-1,0.23169914
3919,Adrenal insufficiency,0,2,0,21,Adrenal insufficiency (Addisons disease) is frequently associated with AMN or cerebral ALD and may remain the only clinical expression of ALD (8% of cases).,8636252_5,-1,3919,-1,0.19737719
3920,disease,4,5,32,39,Adrenal insufficiency (Addisons disease) is frequently associated with AMN or cerebral ALD and may remain the only clinical expression of ALD (8% of cases).,8636252_5,-1,3920,-1,0.23028722
3921,disease,8,9,49,56,The prevalence of ALD among adults with Addisons disease remains unknown.,8636252_6,-1,3921,-1,0.25430185
3922,fatty acids,13,15,82,93,"To evaluate this prevalence, we performed biochemical analysis of very long chain fatty acids in 14 male patients (age ranging from 12-45 yr at diagnosis) previously diagnosed as having primary idiopathic adrenocortical insufficiency.",8636252_7,-1,3922,-1,0.25785732
3923,fatty acids,17,19,77,88,"In 5 of 14 patients (35%), elevated plasma concentrations of very long chain fatty acids were detected.",8636252_8,-1,3923,-1,0.27255493
3924,disease,14,15,84,91,Our data support the hypothesis that ALD is a frequent cause of idiopathic Addisons disease in children and adults..,8636252_11,-1,3924,-1,0.22242397
3928,cancer deaths,9,11,53,66,"
Prostate cancer is the second leading cause of male cancer deaths in the United States. Yet, despite a large international effort, little is known about the molecular mechanisms that underlie this devastating disease.",8637912_1,-1,3928,-1,0.17742315
3929,disease,35,36,210,217,"
Prostate cancer is the second leading cause of male cancer deaths in the United States. Yet, despite a large international effort, little is known about the molecular mechanisms that underlie this devastating disease.",8637912_1,-1,3929,-1,0.17947482
3930,androgen,13,14,112,120,"Prostate secretory epithelial cells and androgen-dependent prostate carcinomas undergo apoptosis in response to androgen deprivation and, furthermore, most prostate carcinomas become androgen independent and refractory to further therapeutic manipulations during disease progression.",8637912_2,-1,3930,-1,0.1906081
3931,androgen,23,24,183,191,"Prostate secretory epithelial cells and androgen-dependent prostate carcinomas undergo apoptosis in response to androgen deprivation and, furthermore, most prostate carcinomas become androgen independent and refractory to further therapeutic manipulations during disease progression.",8637912_2,-1,3931,-1,0.17715232
3932,disease,32,33,263,270,"Prostate secretory epithelial cells and androgen-dependent prostate carcinomas undergo apoptosis in response to androgen deprivation and, furthermore, most prostate carcinomas become androgen independent and refractory to further therapeutic manipulations during disease progression.",8637912_2,-1,3932,-1,0.1806501
3934,prostatic adenocarcinoma,26,28,167,191,We report the functional definition of a novel genetic locus within human chromosome 10pter-q11 that mediates both in vivo tumor suppression and in vitro apoptosis of prostatic adenocarcinoma cells.,8637912_4,-1,3934,-1,0.15154327
3935,adenocarcinoma,15,16,95,109,A defined fragment of human chromosome 10 was transferred via microcell fusion into a prostate adenocarcinoma cell line.,8637912_5,-1,3935,-1,0.17170793
3937,adenocarcinoma,14,15,84,98,"These data functionally define a novel genetic locus, designated PAC1, for prostate adenocarcinoma 1, involved in tumor suppression of human prostate carcinoma and furthermore strongly suggest that the cell death pathway can be functionally restored in prostatic adenocarcinoma..",8637912_8,-1,3937,-1,0.15348886
3941,prostatic adenocarcinoma,39,41,253,277,"These data functionally define a novel genetic locus, designated PAC1, for prostate adenocarcinoma 1, involved in tumor suppression of human prostate carcinoma and furthermore strongly suggest that the cell death pathway can be functionally restored in prostatic adenocarcinoma..",8637912_8,-1,3941,-1,0.13501503
3944,tumour,5,6,38,44,"
Inherited mutant alleles of familial tumour suppressor genes predispose individuals to particular types of cancer.",8640236_1,-1,3944,-1,0.1524336
3947,tumour,12,13,75,81,"In addition to an involvement in inherited susceptibility to cancer, these tumour suppressor genes are targets for somatic mutations in sporadic cancers of the same type found in the familial forms.",8640236_2,-1,3947,-1,0.16183776
3954,tumour,9,10,52,58,"Like BRCA1, BRCA2 behaves as a dominantly inherited tumour suppressor gene.",8640236_6,-1,3954,-1,0.1501545
3956,tumours,16,17,91,98,"Individuals who inherit one mutant allele are at increased risk for breast cancer, and the tumours they develop lose the wild-type allele by heterozygous deletion.",8640236_7,-1,3956,-1,0.1806647
3958,tumour,23,24,129,135,Here we investigate the rate of BRCA2 mutation in sporadic breast cancers and in a set of cell lines that represent twelve other tumour types.,8640236_9,-1,3958,-1,0.15658
3961,tumour,9,10,54,60,"However, a probable germline mutation in a pancreatic tumour cell line suggests a role for BRCA2 in susceptibility to pancreatic cancer..",8640236_11,-1,3961,-1,0.15788166
3965,nucleotide,9,10,59,69,"Four novel Swedish founding mutations were identified  the nucleotide 2595 deletion A was found in five families, the C 1806 T nonsense mutation in three families, the 3166 insertion TGAGA in three families, and the nucleotide 1201 deletion 11 in two families.",8644702_4,-1,3965,-1,0.3272006
3966,C,20,21,118,119,"Four novel Swedish founding mutations were identified  the nucleotide 2595 deletion A was found in five families, the C 1806 T nonsense mutation in three families, the 3166 insertion TGAGA in three families, and the nucleotide 1201 deletion 11 in two families.",8644702_4,-1,3966,-1,0.35599664
3967,nucleotide,39,40,216,226,"Four novel Swedish founding mutations were identified  the nucleotide 2595 deletion A was found in five families, the C 1806 T nonsense mutation in three families, the 3166 insertion TGAGA in three families, and the nucleotide 1201 deletion 11 in two families.",8644702_4,-1,3967,-1,0.34758607
3974,melanoma,21,22,126,134,"Other tumor types found in BRCA1 mutation/haplotype carriers included prostatic, pancreas, skin, and lung cancer, a malignant melanoma, an oligodendroglioma, and a carcinosarcoma.",8644702_8,-1,3974,-1,0.15342736
3975,oligodendroglioma,24,25,139,156,"Other tumor types found in BRCA1 mutation/haplotype carriers included prostatic, pancreas, skin, and lung cancer, a malignant melanoma, an oligodendroglioma, and a carcinosarcoma.",8644702_8,-1,3975,-1,0.1673391
3976,carcinosarcoma,28,29,164,178,"Other tumor types found in BRCA1 mutation/haplotype carriers included prostatic, pancreas, skin, and lung cancer, a malignant melanoma, an oligodendroglioma, and a carcinosarcoma.",8644702_8,-1,3976,-1,0.1694411
3978,P,27,28,144,145,"In all, 12 of 16 kindreds manifesting BRCA1 mutation or linkage contained ovarian cancer, as compared with only 6 of the remaining 31 families (P <.",8644702_9,-1,3978,-1,0.30969697
3979,disease,9,10,55,62,The present study confirms the involvement of BRCA1 in disease predisposition for a subset of hereditary breast cancer families often characterized by ovarian cancers.,8644702_11,-1,3979,-1,0.16165154
3986,Li-Fraumeni syndrome,14,16,93,113,A previously undescribed mutation within the tetramerisation domain of TP53 in a family with Li-Fraumeni syndrome.,8649785_0,-1,3986,-1,0.25849554
3987,Li-Fraumeni syndrome,8,10,44,64,"
We report details of a family with classic Li-Fraumeni syndrome in which there is a mutation in codon 344 of the tumour suppressor gene TP53.",8649785_1,-1,3987,-1,0.27585915
3988,tumour,21,22,114,120,"
We report details of a family with classic Li-Fraumeni syndrome in which there is a mutation in codon 344 of the tumour suppressor gene TP53.",8649785_1,-1,3988,-1,0.15719585
3989,amino acid,13,15,70,80,"Codon 344 is a key residue within the tetramerisation domain, and the amino acid substitution of a proline for a leucine is predicted to have profound implications for tetramerisation and potentially DNA binding.",8649785_2,-1,3989,-1,0.32460505
3990,leucine,21,22,113,120,"Codon 344 is a key residue within the tetramerisation domain, and the amino acid substitution of a proline for a leucine is predicted to have profound implications for tetramerisation and potentially DNA binding.",8649785_2,-1,3990,-1,0.26259145
3991,tumours,14,15,74,81,This is the first report of a mutation at this residue in either sporadic tumours or in the germline and the first report of a germline mutation within the tetramerisation domain.,8649785_3,-1,3991,-1,0.17962825
3992,tumours,12,13,63,70,"The family does not appear to be remarkable in the spectrum of tumours, and there is loss of the wild-type allele in a leiomyosarcoma from the proband.",8649785_4,-1,3992,-1,0.16551632
3993,leiomyosarcoma,24,25,119,133,"The family does not appear to be remarkable in the spectrum of tumours, and there is loss of the wild-type allele in a leiomyosarcoma from the proband.",8649785_4,-1,3993,-1,0.16710068
3994,tumour,8,9,42,48,"A cell line has been established from the tumour of the proband and cytogenetic and molecular studies carried out, providing an extensive analysis in this family..",8649785_5,-1,3994,-1,0.24552847
3995,RB1,3,4,16,19,The spectrum of RB1 germ-line mutations in hereditary retinoblastoma.,8651278_0,-1,3995,-1,0.20499282
3996,retinoblastoma,8,9,54,68,The spectrum of RB1 germ-line mutations in hereditary retinoblastoma.,8651278_0,-1,3996,-1,0.15636057
3997,RB1,5,6,32,35,"
We have searched for germ-line RB1 mutations in 119 patients with hereditary retinoblastoma.",8651278_1,-1,3997,-1,0.20334141
3998,retinoblastoma,12,13,78,92,"
We have searched for germ-line RB1 mutations in 119 patients with hereditary retinoblastoma.",8651278_1,-1,3998,-1,0.1522253
3999,RB1,4,5,17,20,No region of the RB1 gene was preferentially involved in single base substitutions.,8651278_6,-1,3999,-1,0.23461685
4000,RB1,12,13,72,75,Recurrent transitions were observed at most of the 14 codons within the RB1.,8651278_7,-1,4000,-1,0.28636006
4001,RB1,10,11,65,68,This suggests that mutations within the 3-terminal region of the RB1 gene may not be oncogenic.,8651278_9,-1,4001,-1,0.22206132
4004,Huntington disease,12,14,73,91,Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats.,8659522_0,-1,4004,-1,0.19599123
4005,Huntington disease,10,12,63,81,"
Abnormal CAG expansions in the IT-15 gene are associated with Huntington disease (HD).",8659522_1,-1,4005,-1,0.19403712
4006,disease,11,12,66,73,Many of these experiments found an overlap between the normal and disease size ranges.,8659522_4,-1,4006,-1,0.214966
4007,disease,19,20,117,124,Subsequent findings that the CCG repeats vary by 8 trinucleotide lengths suggested that the limits of the normal and disease size ranges should be reevaluated with assays that exclude the CCG polymorphism.,8659522_5,-1,4007,-1,0.22094639
4008,disease,15,16,85,92,"Seven HD patients had 36 repeats, which confirms that this allele is associated with disease.",8659522_9,-1,4008,-1,0.21044683
4009,Canavan disease,11,13,86,101,Identification and expression of eight novel mutations among non-Jewish patients with Canavan disease.,8659549_0,-1,4009,-1,0.22004884
4010,Canavan disease,0,2,1,16,"
Canavan disease is inherited as an autosomal recessive trait that is caused by the deficiency of aspartoacylase (ASPA).",8659549_1,-1,4010,-1,0.229548
4011,Canavan disease,5,7,30,45,The majority of patients with Canavan disease are from an Ashkenazi Jewish background.,8659549_2,-1,4011,-1,0.23075607
4012,lead,4,5,23,27,"Mutations in ASPA that lead to loss of enzymatic activity have been identified, and E285A and Y231X are the two predominant mutations that account for 97% of the mutant chromosomes in Ashkenazi Jewish patients.",8659549_3,-1,4012,-1,0.26699477
4013,Canavan disease,11,13,62,77,The current study was aimed at finding the molecular basis of Canavan disease in 25 independent patients of non-Jewish background.,8659549_4,-1,4013,-1,0.22867805
4014,Canavan disease,16,18,107,122,The homozygous 32 deltaT deletion was identified in the only known patient of African-American origin with Canavan disease.,8659549_8,-1,4014,-1,0.2232231
4015,Canavan disease,24,26,142,157,In vitro expression of mutant cDNA clones demonstrated that all of these mutations led to a deficiency of ASPA and should therefore result in Canavan disease..,8659549_12,-1,4015,-1,0.19741401
4016,amino acids,23,25,130,141,The entire coding sequence of the Atm transcript was cloned and found to contain an open reading frame encoding a protein of 3066 amino acids with 84% overall identity and 91% similarity to the human ATM protein.,8661102_2,-1,4016,-1,0.25307387
4017,Wiskott-Aldrich syndrome,5,7,25,49,The mouse homolog of the Wiskott-Aldrich syndrome protein (WASP) gene is highly conserved and maps near the scurfy (sf) mutation on the X chromosome.,8666397_0,-1,4017,-1,0.19258179
4018,Wiskott-Aldrich syndrome,12,14,57,81,"
The mouse WASP gene, the homolog of the gene mutated in Wiskott-Aldrich syndrome, has been isolated and sequenced.",8666397_1,-1,4018,-1,0.21607374
4019,amino acid,2,4,14,24,the predicted amino acid sequence is 86% identical to the human WASP sequence.,8666397_2,-1,4019,-1,0.30176818
4020,disease,16,17,108,115,"This localization makes Wasp a candidate for involvement in scurfy, a T cell-mediated fatal lymphoreticular disease of mice that has previously been proposed as a mouse homolog of Wiskott-Aldrich syndrome.",8666397_7,-1,4020,-1,0.17150398
4021,Wiskott-Aldrich syndrome,29,31,180,204,"This localization makes Wasp a candidate for involvement in scurfy, a T cell-mediated fatal lymphoreticular disease of mice that has previously been proposed as a mouse homolog of Wiskott-Aldrich syndrome.",8666397_7,-1,4021,-1,0.19192
4022,familial Mediterranean fever,7,10,43,71,Colchicine in breast milk of patients with familial Mediterranean fever.,8670333_0,-1,4022,-1,0.20592862
4023,familial Mediterranean fever,26,29,149,177,"To clarify whether colchicine is excreted in breast milk, and to compare its concentrations in the serum and breast milk of lactating women who have familial Mediterranean fever (FMF).",8670333_2,-1,4023,-1,0.20001522
4024,myotonic dystrophy,1,3,9,27,Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice.,8673131_0,-1,4024,-1,0.21538632
4026,Myotonic dystrophy,0,2,1,19,"
Myotonic dystrophy (DM) is commonly associated with CTG repeat expansions within the gene for DM-protein kinase (DMPK).",8673131_1,-1,4026,-1,0.19154198
4027,DM,3,4,21,23,"
Myotonic dystrophy (DM) is commonly associated with CTG repeat expansions within the gene for DM-protein kinase (DMPK).",8673131_1,-1,4027,-1,0.21027605
4028,hypertrophic cardiomyopathy,30,32,174,201,"Nullizygous (-/-) mice showed only inconsistent and minor size changes in head and neck muscle fibres at older age, animals with the highest DMPK transgene expression showed hypertrophic cardiomyopathy and enhanced neonatal mortality.",8673131_3,-1,4028,-1,0.17211236
4029,DM,7,8,41,43,"However, both models lack other frequent DM symptoms including the fibre-type dependent atrophy, myotonia, cataract and male-infertility.",8673131_4,-1,4029,-1,0.21794786
4030,myotonia,15,16,97,105,"However, both models lack other frequent DM symptoms including the fibre-type dependent atrophy, myotonia, cataract and male-infertility.",8673131_4,-1,4030,-1,0.20771128
4032,disease,22,23,147,154,These results strengthen the contention that simple loss- or gain-of-expression of DMPK is not the only crucial requirement for development of the disease..,8673131_5,-1,4032,-1,0.20890355
4033,myotonic dystrophy,3,5,17,35,Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy.,8673132_0,-1,4033,-1,0.1998578
4035,Myotonic dystrophy,0,2,1,19,"
Myotonic dystrophy (DM) is an autosomal dominant disorder resulting from the expansion of a CTG repeat in the 3 untranslated region of a putative protein kinase (DMPK).",8673132_1,-1,4035,-1,0.19354731
4036,DM,3,4,21,23,"
Myotonic dystrophy (DM) is an autosomal dominant disorder resulting from the expansion of a CTG repeat in the 3 untranslated region of a putative protein kinase (DMPK).",8673132_1,-1,4036,-1,0.20938757
4037,DM,7,8,33,35,To elucidate the role of DMPK in DM pathogenesis we have developed Dmpk deficient (Dmpk-/-) mice.,8673132_2,-1,4037,-1,0.20312797
4039,DM,14,15,108,110,"Dmpk-/-mice develop a late-onset, progressive skeletal myopathy that shares some pathological features with DM.",8673132_3,-1,4039,-1,0.228624
4041,DM,28,29,171,173,Our results indicate that DMPK may be necessary for the maintenance of skeletal muscle structure and function and suggest that a decrease in DMPK levels may contribute to DM pathology..,8673132_6,-1,4041,-1,0.20522709
4045,E,21,22,141,142,"In vivo, mutant embryos do not exhibit increased apoptosis but show reduced cell proliferation accompanied by decreased expression of cyclin E and mdm-2, a regulator of p53 activity.",8674108_7,-1,4045,-1,0.20449747
4047,coronary heart disease,1,4,10,32,Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels.,8675707_0,-1,4047,-1,0.22288069
4048,cholesteryl ester,11,13,79,96,Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels.,8675707_0,-1,4048,-1,0.2713065
4049,coronary heart disease,19,22,127,149,"
Plasma high density lipoprotein (HDL) levels are strongly genetically determined and show a general inverse relationship with coronary heart disease (CHD).",8675707_1,-1,4049,-1,0.2116571
4050,cholesteryl ester,1,3,4,21,The cholesteryl ester transfer protein (CETP) mediates the transfer of cholesteryl esters from HDL to other lipoproteins and is a key participant in the reverse transport of cholesterol from the periphery to the liver.,8675707_2,-1,4050,-1,0.28046137
4051,cholesteryl esters,12,14,71,89,The cholesteryl ester transfer protein (CETP) mediates the transfer of cholesteryl esters from HDL to other lipoproteins and is a key participant in the reverse transport of cholesterol from the periphery to the liver.,8675707_2,-1,4051,-1,0.27170688
4052,cholesterol,29,30,174,185,The cholesteryl ester transfer protein (CETP) mediates the transfer of cholesteryl esters from HDL to other lipoproteins and is a key participant in the reverse transport of cholesterol from the periphery to the liver.,8675707_2,-1,4052,-1,0.23002869
4053,P,6,7,26,27,"43 in men with mutations (P <. 05); after adjustment for CHD risk factors, the RR was 1.",8675707_6,-1,4053,-1,0.31756386
4054,P,2,3,4,5,"55 (P =. 02); after additional adjustment for HDL levels, the RR was 1.",8675707_7,-1,4054,-1,0.28093562
4055,P,2,3,4,5,68 (P =. 008).,8675707_8,-1,4055,-1,0.3129194
4056,cholesterol,11,12,69,80,"The findings suggest that both HDL concentration and the dynamics of cholesterol transport through HDL (i. e., reverse cholesterol transport) determine the anti-atherogenicity of the HDL fraction.",8675707_12,-1,4056,-1,0.25944048
4057,cholesterol,20,21,119,130,"The findings suggest that both HDL concentration and the dynamics of cholesterol transport through HDL (i. e., reverse cholesterol transport) determine the anti-atherogenicity of the HDL fraction.",8675707_12,-1,4057,-1,0.27060288
4058,Rb1,6,7,33,36,Mapping the homolog of the human Rb1 gene to chromosome 14 of higher primates.,8678979_0,-1,4058,-1,0.22468622
4059,Rb1,1,2,5,8,"
The Rb1 gene has been implicated with retinoblastoma and is located on human Chromosome (Chr) 13q14.",8678979_1,-1,4059,-1,0.22004144
4060,retinoblastoma,7,8,39,53,"
The Rb1 gene has been implicated with retinoblastoma and is located on human Chromosome (Chr) 13q14.",8678979_1,-1,4060,-1,0.1631569
4061,Rb1,7,8,29,32,2 2. A unique sequence human Rb1 cosmid DNA probe has been used to localize this region on apes Chr 14 by the FISH technique.,8678979_2,-1,4061,-1,0.2384612
4062,Rb1,4,5,24,27,The conservation of the Rb1 gene in higher primates at the corresponding equivalent chromosome locus (14q14) of the human may serve as a phylogenetic marker to further trace the evolutionary pathway of human descent.,8678979_3,-1,4062,-1,0.21755493
4063,Wiskott-Aldrich syndrome,0,2,0,24,Wiskott-Aldrich syndrome: no strict genotype-phenotype correlations but clustering of missense mutations in the amino-terminal part of the WASP gene product.,8682510_0,-1,4063,-1,0.20768479
4064,Wiskott-Aldrich syndrome,1,3,5,29,"
The Wiskott-Aldrich syndrome protein (WASP) gene was found to be mutated in patients presenting with WAS and in patients showing X-linked thrombocytopenia.",8682510_1,-1,4064,-1,0.1933272
4066,disease,13,14,79,86,A substitution at codon 86 resulted in an extremely variable expression of the disease in a large Swiss family.,8682510_6,-1,4066,-1,0.23126353
4067,Aniridia,0,1,1,9,"
Aniridia in man and Small eye in mice are semidominant developmental disorders caused by mutations within the paired box gene PAX6.",8689689_1,-1,4067,-1,0.22404307
4068,cysteine,8,9,50,58,"Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract.",8696339_0,-1,4068,-1,0.2350233
4070,Huntington disease,12,14,67,85,"
Apoptosis has recently been recognized as a mode of cell death in Huntington disease (HD).",8696339_1,-1,4070,-1,0.19112456
4071,cysteine,8,9,45,53,"Apopain, a human counterpart of the nematode cysteine protease death-gene product, CED-3, has a key role in proteolytic events leading to apoptosis.",8696339_2,-1,4071,-1,0.21980184
4072,cysteine proteases,8,10,47,65,Our results show that huntingtin is cleaved by cysteine proteases and suggest that HD might be a disorder of inappropriate apoptosis..,8696339_5,-1,4072,-1,0.21282117
4074,nucleotide,27,28,157,167,"Sequence analysis of the duplicated exons of BRCA1 and 1A1-3B and flanking genomic DNA reveals maintenance of the intron-exon structure and a high degree of nucleotide sequence identity, suggesting that these are non-processed pseudogenes and that the duplication is a recent event in evolutionary terms.",8700509_3,-1,4074,-1,0.27118665
4075,N,6,7,56,57,Deletion of small nuclear ribonucleoprotein polypeptide N (SNRPN) in Prader-Willi syndrome detected by fluorescence in situ hybridization: two sibs with the typical phenotype without a cytogenetic deletion in chromosome 15q.,8723064_0,-1,4075,-1,0.20949385
4076,Prader-Willi syndrome,11,13,69,90,Deletion of small nuclear ribonucleoprotein polypeptide N (SNRPN) in Prader-Willi syndrome detected by fluorescence in situ hybridization: two sibs with the typical phenotype without a cytogenetic deletion in chromosome 15q.,8723064_0,-1,4076,-1,0.22951229
4077,N,5,6,49,50,"
The small nuclear ribonucleoprotein polypeptide N (SNRPN) gene is regarded as one of the candidates for Prader-Willi syndrome (PWS).",8723064_1,-1,4077,-1,0.20906787
4078,Prader-Willi syndrome,18,20,105,126,"
The small nuclear ribonucleoprotein polypeptide N (SNRPN) gene is regarded as one of the candidates for Prader-Willi syndrome (PWS).",8723064_1,-1,4078,-1,0.21821934
4079,von Hippel-Lindau disease tumour,3,7,18,50,Expression of the von Hippel-Lindau disease tumour suppressor gene during human embryogenesis.,8733131_0,-1,4079,-1,0.1994574
4080,disease,6,7,29,36,"
The von Hippel-Lindau (VHL) disease product is thought to down-regulate transcription by antagonizing elongin-enhanced transcriptional elongation.",8733131_1,-1,4080,-1,0.20479946
4081,renal cell carcinoma,16,19,112,132,"Germline VHL gene mutations predispose to the development of retinal, cerebellar and spinal haemangioblastomas, renal cell carcinoma and phaeochromocytoma.",8733131_2,-1,4081,-1,0.16118504
4082,renal cell carcinoma,13,16,74,94,"In addition, somatic Inactivation of the VHL gene is frequent in sporadic renal cell carcinoma and haemangioblastoma.",8733131_3,-1,4082,-1,0.15171477
4094,disease,19,20,113,120,An intronic mutation in a lariat branchpoint sequence is a direct cause of an inherited human disorder (fish-eye disease).,8755645_0,-1,4094,-1,0.20507064
4095,nucleotide,3,4,20,30,"A distinct intronic nucleotide sequence, known as the branchpoint region, plays a central role in this process.",8755645_2,-1,4095,-1,0.26603246
4096,disease,8,9,49,56,"Three sisters were shown to suffer from fish-eye disease (FED), a disorder which is caused by mutations in the gene coding for lecithin  cholesterol acyltransferase (LCAT).",8755645_4,-1,4096,-1,0.20765118
4097,cholesterol,27,28,137,148,"Three sisters were shown to suffer from fish-eye disease (FED), a disorder which is caused by mutations in the gene coding for lecithin  cholesterol acyltransferase (LCAT).",8755645_4,-1,4097,-1,0.26303336
4098,cerebellar ataxia,21,23,116,133,The level of the 137-bp PCR product containing the insertion was lowest in two patients who showed a later onset of cerebellar ataxia.,8755918_5,-1,4098,-1,0.19602638
4099,tumours,21,22,124,131,"
To define the possible role of the VHL gene in the development of sporadic renal cell carcinomas, 91 different parenchymal tumours of the kidney have been investigated for mutation of the VHL gene by single strand conformation polymorphism (SSCP) and/or heteroduplex (HD) techniques.",8758207_1,-1,4099,-1,0.18285246
4100,tumours,7,8,37,44,"In addition, 15 papillary renal cell tumours and ten renal oncocytomas, which are characterized by genetic changes other than loss of chromosome 3p sequences, were analysed for mutation of the VHL gene.",8758207_5,-1,4100,-1,0.17022085
4101,tumours,3,4,14,21,None of these tumours showed abnormal migration patterns.,8758207_6,-1,4101,-1,0.2178026
4102,renal cell carcinoma,17,20,115,135,The results indicate that mutation of the VHL gene is associated exclusively with the development of non-papillary renal cell carcinoma..,8758207_7,-1,4102,-1,0.14362432
4103,muscular dystrophy,2,4,19,37,"The Emery-Dreifuss muscular dystrophy protein, emerin, is a nuclear membrane protein.",8776595_0,-1,4103,-1,0.17099752
4104,muscular dystrophy,6,8,39,57,"A muscle biopsy from an Emery-Dreifuss muscular dystrophy (EMDM) patient showed complete absence of emerin by both Western blotting and immunohistochemistry, suggesting a simple diagnostic antibody test for EDMD families.",8776595_5,-1,4104,-1,0.17538741
4105,sucrose,20,21,133,140,"Biochemical fractionation of brain and liver tissues showed that emerin was present in nuclei purified by centrifugation through 65% sucrose and was absent from soluble fractions (post-100, 000 g).",8776595_6,-1,4105,-1,0.20813802
4107,tumours,2,3,12,19,"
Many human tumours have length alterations in repetitive sequence elements.",8782829_1,-1,4107,-1,0.18946081
4108,microsatellite instability,2,4,14,40,"Although this microsatellite instability has been attributed to mutations in four DNA mismatch repair genes in hereditary nonpolyposis colorectal cancer (HNPCC) kindreds, many sporadic tumours exhibit instability but no detectable mutations in these genes.",8782829_2,-1,4108,-1,0.19094594
4109,colorectal cancer,18,20,135,152,"Although this microsatellite instability has been attributed to mutations in four DNA mismatch repair genes in hereditary nonpolyposis colorectal cancer (HNPCC) kindreds, many sporadic tumours exhibit instability but no detectable mutations in these genes.",8782829_2,-1,4109,-1,0.13389438
4110,tumours,27,28,185,192,"Although this microsatellite instability has been attributed to mutations in four DNA mismatch repair genes in hereditary nonpolyposis colorectal cancer (HNPCC) kindreds, many sporadic tumours exhibit instability but no detectable mutations in these genes.",8782829_2,-1,4110,-1,0.15910006
4111,microsatellite instability,14,16,68,94,"In yeast, mutations in several genes, including RTH and MSH3, cause microsatellite instability.",8782829_4,-1,4111,-1,0.18343928
4112,microsatellite instability,8,10,49,75,"Thus, we screened 16 endometrial carcinomas with microsatellite instability for alterations in FEN1 (the human homolog of RTH) and in MSH3 (refs 12-14).",8782829_5,-1,4112,-1,0.18726574
4113,endometrial carcinoma,16,18,86,107,"Although we found no FEN1 mutations, a frameshift mutation in MSH3 was observed in an endometrial carcinoma and in an endometrial carcinoma cell line.",8782829_6,-1,4113,-1,0.15062293
4114,endometrial carcinoma,21,23,118,139,"Although we found no FEN1 mutations, a frameshift mutation in MSH3 was observed in an endometrial carcinoma and in an endometrial carcinoma cell line.",8782829_6,-1,4114,-1,0.16089651
4115,tumours,26,27,154,161,"Together the data suggest that the MSH3 gene encodes a product that functions in repair of some but not all pre-mutational intermediates, its mutation in tumours can result in genomic instability and, as in yeast, MSH3 and MSH6 are partially redundant for mismatch repair..",8782829_11,-1,4115,-1,0.19830205
4116,genomic instability,30,32,176,195,"Together the data suggest that the MSH3 gene encodes a product that functions in repair of some but not all pre-mutational intermediates, its mutation in tumours can result in genomic instability and, as in yeast, MSH3 and MSH6 are partially redundant for mismatch repair..",8782829_11,-1,4116,-1,0.18520944
4117,cM,24,25,106,108,"No recombinations were found among the Atm, Npat, Acat1, and D9Mit6 loci, and these loci were mapped 2. 0 cM distal to D9Mit99 and 1.",8786135_7,-1,4117,-1,0.31328517
4118,cM,1,2,2,4,3 cM proximal to D9Mit102.,8786135_8,-1,4118,-1,0.2857979
4119,map,4,5,26,29,Comparison of the linkage map of mouse chromosome 9 (MMU9) and that of human chromosome 11 (HSA11) indicates that there is a chromosomal rearrangement due to an inversion between Ets1 and Atm-Npat-Acat1 and that the inversion of MMU9 originated from the chromosomal breakage at the boundary between Gria4 and Atm-Npat-Acat1 on HSA11.,8786135_9,-1,4119,-1,0.22374748
4120,Norrie disease,4,6,20,34,An animal model for Norrie disease (ND): gene targeting of the mouse ND gene.,8789439_0,-1,4120,-1,0.21974841
4121,Norrie disease,13,15,82,96,"
In order to elucidate the cellular and molecular processes which are involved in Norrie disease (ND), we have used gene targeting technology to generate ND mutant mice.",8789439_1,-1,4121,-1,0.21103153
4122,amino acid,21,23,104,114,The murine homologue of the ND gene was cloned and shown to encode a polypeptide that shares 94% of the amino acid sequence with its human counterpart.,8789439_2,-1,4122,-1,0.27704588
4123,retinal ganglion,27,29,172,188,Hemizygous mice carrying a replacement mutation in exon 2 of the ND gene developed retrolental structures in the vitreous body and showed an overall disorganization of the retinal ganglion cell layer.,8789439_4,-1,4123,-1,0.21000253
4124,rhabdomyosarcoma,7,8,48,64,The hybrid PAX3-FKHR fusion protein of alveolar rhabdomyosarcoma transforms fibroblasts in culture.,8790412_0,-1,4124,-1,0.15914634
4125,rhabdomyosarcoma,2,3,20,36,"
Pediatric alveolar rhabdomyosarcoma is characterized by a chromosomal translocation that fuses parts of the PAX3 and FKHR genes.",8790412_1,-1,4125,-1,0.16627453
4127,myotonic dystrophy,13,15,81,99,"Analysis of meiotic segregation, using single-sperm typing: meiotic drive at the myotonic dystrophy locus.",8808606_0,-1,4127,-1,0.19655253
4128,myotonic dystrophy,4,6,22,40,"
Meiotic drive at the myotonic dystrophy (DM) locus has recently been suggested as being responsible for maintaining the frequency, in the human population, of DM chromosomes capable of expansion to the disease state.",8808606_1,-1,4128,-1,0.17270292
4129,DM,7,8,42,44,"
Meiotic drive at the myotonic dystrophy (DM) locus has recently been suggested as being responsible for maintaining the frequency, in the human population, of DM chromosomes capable of expansion to the disease state.",8808606_1,-1,4129,-1,0.21047117
4130,DM,28,29,160,162,"
Meiotic drive at the myotonic dystrophy (DM) locus has recently been suggested as being responsible for maintaining the frequency, in the human population, of DM chromosomes capable of expansion to the disease state.",8808606_1,-1,4130,-1,0.20792139
4131,disease,35,36,203,210,"
Meiotic drive at the myotonic dystrophy (DM) locus has recently been suggested as being responsible for maintaining the frequency, in the human population, of DM chromosomes capable of expansion to the disease state.",8808606_1,-1,4131,-1,0.19325118
4132,DM,20,21,117,119,"In order to test this hypothesis, we have studied samples of single sperm from three individuals heterozygous at the DM locus, each with one allele larger and one allele smaller than 19 CTG repeats.",8808606_2,-1,4132,-1,0.27322146
4133,DM,40,41,232,234,"To guard against the possible problem of differential PCR amplification rates based on the lengths of the alleles, the sperm were also typed at another closely linked marker whose allele size was unrelated to the allele size at the DM locus.",8808606_3,-1,4133,-1,0.28814515
4134,myotonic dystrophy,11,13,71,89,This suggests that any greater amount of segregation distortion at the myotonic dystrophy locus must result from events following sperm ejaculation.,8808606_6,-1,4134,-1,0.19625086
4135,chromosome aberrations,10,12,71,93,"
A major cytogenetic subgroup of lipomas is characterized by recurrent chromosome aberrations, mainly translocations, that involve chromosome segment 12q13-q15.",8812423_1,-1,4135,-1,0.20927192
4136,lipoma,22,23,142,148,"Here, we report the identification and characterization of the chromosome 3-derived translocation partner gene, which we have designated LPP (lipoma preferred partner gene).",8812423_4,-1,4136,-1,0.20951281
4137,lipoma,8,9,53,59,"Using 3-RACE analysis of HMGIC fusion transcripts in lipoma cell line Li-501/SV40, ectopic genetic sequences were obtained, which by CASH (chromosome assignment using somatic cell hybrids) and FISH (fluorescence in situ hybridization) analysis were found to originate from chromosome segment 3q27-q28.",8812423_5,-1,4137,-1,0.18565947
4138,Nucleotide,0,1,0,10,Nucleotide sequence analysis of a composite cDNA of LPP revealed an open reading frame of 1836 nucleotides encoding a proline-rich protein containing a leucine-zipper motif in its amino-terminal region and three LIM domains in its carboxy-terminal region.,8812423_9,-1,4138,-1,0.27931893
4139,lipoma,15,16,100,106,"Using reverse transcriptase combined with polymerase chain reactions in the analysis of a number of lipoma cell lines and primary lipomas, it appeared that LPP is frequently rearranged also in cases without a cytogenetically detectable involvement of 3q27-q28.",8812423_11,-1,4139,-1,0.18001886
4140,disease,2,3,11,18,Absence of disease phenotype and intergenerational stability of the CAG repeat in transgenic mice expressing the human Huntington disease transcript.,8824873_0,-1,4140,-1,0.17963469
4141,Huntington disease,17,19,119,137,Absence of disease phenotype and intergenerational stability of the CAG repeat in transgenic mice expressing the human Huntington disease transcript.,8824873_0,-1,4141,-1,0.20022666
4142,Huntington disease,3,5,25,43,"
The mutation underlying Huntington disease (HD) is CAG expansion in the first exon of the HD gene.",8824873_1,-1,4142,-1,0.2067476
4143,behavioral abnormalities,8,10,30,54,"By 1 year, these mice have no behavioral abnormalities and morphometric analysis at 6 (one animal) and 9 (two animals) months age revealed no changes.",8824873_3,-1,4143,-1,0.26243463
4144,nucleotide,27,28,149,159,In vitro transfection studies indicated that the inclusion of 120 bp of the 5 UTR in the cDNA construct and the presence of a frameshift mutation at nucleotide 2349 prevented expression of the HD cDNA.,8824873_5,-1,4144,-1,0.32651293
4145,disease,31,32,196,203,These findings suggest that the pathogenesis of HD is not mediated through DNA-protein interaction and that presence of the RNA transcript with an expanded CAG repeat is insufficient to cause the disease.,8824873_6,-1,4145,-1,0.19101539
4146,contrast,1,2,3,11,"In contrast to that seen in humans, the CAG repeat in these mice was remarkably stable in 97 meioses.",8824873_8,-1,4146,-1,0.26969463
4147,aniridia,7,8,40,48,FISH studies in a patient with sporadic aniridia and t(7;11) (q31.2;p13).,8825052_0,-1,4147,-1,0.24788351
4148,aniridia,9,10,56,64,"
A 2 year old female presenting with bilateral sporadic aniridia was found to have an apparently balanced reciprocal translocation with a chromosome 11 breakpoint within band p13.",8825052_1,-1,4148,-1,0.23525746
4149,aniridia,22,23,142,150,Fluorescence in situ hybridisation (FISH) studies with distal 11p13 specific cosmids showed that the chromosome 11 breakpoint lay between the aniridia (PAX6) locus and a region approximately 100 kb distal to PAX6 defined by the cosmid FO2121.,8825052_2,-1,4149,-1,0.26935306
4150,aniridia,13,14,74,82,"Although this patient did not have a detectable deletion within PAX6, her aniridia may have resulted from a disruption of the distal chromatin domain containing either enhancers or regulators for PAX6.",8825052_3,-1,4150,-1,0.27339065
4151,aniridia,8,9,46,54,This case may therefore be another example of aniridia caused by a position effect as recently described in two familial aniridia patients in which the phenotype cosegregated with chromosome abnormalities with 11p13 breakpoints..,8825052_4,-1,4151,-1,0.21027087
4152,aniridia,20,21,121,129,This case may therefore be another example of aniridia caused by a position effect as recently described in two familial aniridia patients in which the phenotype cosegregated with chromosome abnormalities with 11p13 breakpoints..,8825052_4,-1,4152,-1,0.21970308
4153,p,26,27,141,142,A statistically significant relationship was found in the activity of G6PD between erythrocytes and muscle of the male subjects (r = 0. 968; p = 0. 00008).,8825599_5,-1,4153,-1,0.31313995
4154,phenylalanine,16,17,102,115,"
Classical phenylketonuria (PKU) is an autosomal recessive disorder caused by a deficiency of hepatic phenylalanine hydroxylase (PAH).",8828602_1,-1,4154,-1,0.22848836
4155,PAH,19,20,129,132,"
Classical phenylketonuria (PKU) is an autosomal recessive disorder caused by a deficiency of hepatic phenylalanine hydroxylase (PAH).",8828602_1,-1,4155,-1,0.23281924
4156,PAH,14,15,101,104,"Vectors derived from a recombinant retrovirus or a DNA/protein complex can efficiently transduce the PAH cDNA into PAH-deficient hepatocytes in vitro, but the application of these vector systems is presently limited by their low transduction efficiency in vivo.",8828602_4,-1,4156,-1,0.24130872
4157,contrast,1,2,3,11,"In contrast, a vector derived from a recombinant adenovirus can restore 10% -80% of normal hepatic PAH activity into PAH-deficient mice, which completely normalizes serum phenylalanine levels.",8828602_5,-1,4157,-1,0.26699048
4158,PAH,19,20,99,102,"In contrast, a vector derived from a recombinant adenovirus can restore 10% -80% of normal hepatic PAH activity into PAH-deficient mice, which completely normalizes serum phenylalanine levels.",8828602_5,-1,4158,-1,0.22815359
4159,phenylalanine,29,30,171,184,"In contrast, a vector derived from a recombinant adenovirus can restore 10% -80% of normal hepatic PAH activity into PAH-deficient mice, which completely normalizes serum phenylalanine levels.",8828602_5,-1,4159,-1,0.25220954
4160,acetylcholine,7,8,54,67,Exon-intron structure of the human neuronal nicotinic acetylcholine receptor alpha 4 subunit (CHRNA4).,8833159_0,-1,4160,-1,0.19603786
4161,acetylcholine,4,5,30,43,"
The human neuronal nicotinic acetylcholine receptor alpha 4 subunit gene (CHRNA4) is located in the candidate region for three different phenotypes  benign familial neonatal convulsions, autosomal dominant nocturnal frontal lobe epilepsy, and low-voltage EEG.",8833159_1,-1,4161,-1,0.21116689
4163,nocturnal frontal lobe epilepsy,31,35,207,238,"
The human neuronal nicotinic acetylcholine receptor alpha 4 subunit gene (CHRNA4) is located in the candidate region for three different phenotypes  benign familial neonatal convulsions, autosomal dominant nocturnal frontal lobe epilepsy, and low-voltage EEG.",8833159_1,-1,4163,-1,0.19689949
4164,frontal lobe epilepsy,20,23,127,148,"Recently, a missense mutation in transmembrane domain 2 of CHRNA4 was found to be associated with autosomal dominant nocturnal frontal lobe epilepsy in one extended pedigree.",8833159_2,-1,4164,-1,0.16788517
4165,nucleotide,1,2,4,14,The nucleotide sequence obtained from the genomic regions adjacent to the exon boundaries enabled us to develop a set of primer pairs for PCR amplification of the complete coding region.,8833159_4,-1,4165,-1,0.24866177
4166,epilepsies,24,25,166,176,The sequence analysis provides the basis for a comprehensive mutation screening of CHRNA4 in the above-mentioned phenotypes and possibly in other types of idiopathic epilepsies..,8833159_5,-1,4166,-1,0.17530605
4177,growth retardation,6,8,36,54,"Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma.",8843194_0,-1,4177,-1,0.18661878
4178,lymphoma,19,20,125,133,"Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma.",8843194_0,-1,4178,-1,0.17210169
4179,infertility,1,2,4,15,The infertility of ATM-/- mice results from meiotic failure.,8843194_5,-1,4179,-1,0.20897907
4180,behavioral abnormalities,21,23,113,137,The cerebella of ATM-/- mice appear normal by histologic examination at 3 to 4 months and the mice have no gross behavioral abnormalities.,8843194_8,-1,4180,-1,0.22760011
4181,lymphomas,8,9,51,60,The majority of mutant mice rapidly develop thymic lymphomas and die before 4 months of age.,8843194_9,-1,4181,-1,0.18048252
4183,fatty acid,30,32,205,215,"
Very-long-chain acyl-CoA dehydrogenase (VLCAD) is one of four straight-chain acyl-CoA dehydrogenase (ACD) enzymes, which are all nuclear encoded mitochondrial flavoproteins catalyzing the initial step in fatty acid beta-oxidation.",8845838_1,-1,4183,-1,0.2669661
4184,amino acid,4,6,27,37,Alignment of the predicted amino acid sequence of human VLCAD with those of the other human ACD enzymes revealed extensive sequence homology.,8845838_3,-1,4184,-1,0.29345784
4185,VLCAD deficiency,16,18,101,117,This agrees well with the fact that cardiac and muscle symptoms are characteristic for patients with VLCAD deficiency.,8845838_7,-1,4185,-1,0.272155
4186,VLCAD deficiency,16,18,107,123,Northern blot analysis and sequencing of cloned PCR amplified VLCAD cDNA from four unrelated patients with VLCAD deficiency showed that VLCAD mRNA was undetectable in one patient and that the other three have mutations in both VLCAD alleles.,8845838_8,-1,4186,-1,0.23893204
4187,lead,17,18,110,114,"The haplotype has been found in combination with a number of other haplotypes containing defective genes that lead either to C6 or C7 deficiency, but with different consequences.",8871666_6,-1,4187,-1,0.261026
4188,contrast,1,2,3,11,"In contrast, where the C7 genes are both defective (but still partially functional), there may be a profound deficit of circulating C7 because there is ample C6 to produce C56 and consume the already small amount of C7.",8871666_8,-1,4188,-1,0.251887
4189,bacterial infections,11,13,72,92,"
Complement C7 deficiency (C7D) is associated frequently with recurrent bacterial infections, especially meningitis caused by Neisseria meningitidis.",8892662_1,-1,4189,-1,0.16418055
4191,nucleotide,13,14,63,73,"The mutation of case 1 was a homozygous T to A transversion at nucleotide 2250, the third nucleotide of the codon TGT for Cys728, leading to a stop codon TGA (C728X).",8892662_5,-1,4191,-1,0.36062092
4192,nucleotide,18,19,90,100,"The mutation of case 1 was a homozygous T to A transversion at nucleotide 2250, the third nucleotide of the codon TGT for Cys728, leading to a stop codon TGA (C728X).",8892662_5,-1,4192,-1,0.31233862
4193,lesch-nyhan syndrome,7,9,45,65,HPRT-APRT-deficient mice are not a model for lesch-nyhan syndrome.,8894695_0,-1,4193,-1,0.20916714
4194,Lesch-Nyhan syndrome,12,14,101,121,"
Complete hypoxanthine-guanine phosphoribosyl-transferase (HPRT) deficiency in humans results in the Lesch-Nyhan syndrome which is characterized, among other features, by compulsive self-injurious behavior.",8894695_1,-1,4194,-1,0.19522898
4195,Lesch-Nyhan syndrome,17,19,123,143,HPRT-deficient mice generated using mouse embryonic stem cells exhibit none of the behavioral symptoms associated with the Lesch-Nyhan syndrome.,8894695_2,-1,4195,-1,0.20031828
4196,lead,28,29,201,205,Administration of drugs that inhibit adenine phosphoribosyltransferase (APRT) in HPRT-deficient mice has produced the suggestion that deficiency of APRT in combination with HPRT-deficiency in mice may lead to self-mutilation behavior [C. L. Wu and D. W. Melton (1993) Nature Genet.,8894695_3,-1,4196,-1,0.23642242
4197,purine,10,11,56,62,"Thus, APRT-HPRT-deficient mice, which are devoid of any purine salvage pathways, show no novel phenotype and are not a model for the behavioral abnormalities associated with the Lesch-Nyhan syndrome as previously suggested",8894695_7,-1,4197,-1,0.20629723
4198,behavioral abnormalities,25,27,133,157,"Thus, APRT-HPRT-deficient mice, which are devoid of any purine salvage pathways, show no novel phenotype and are not a model for the behavioral abnormalities associated with the Lesch-Nyhan syndrome as previously suggested",8894695_7,-1,4198,-1,0.2028257
4199,Lesch-Nyhan syndrome,30,32,178,198,"Thus, APRT-HPRT-deficient mice, which are devoid of any purine salvage pathways, show no novel phenotype and are not a model for the behavioral abnormalities associated with the Lesch-Nyhan syndrome as previously suggested",8894695_7,-1,4199,-1,0.18985127
4204,colorectal cancer,17,19,104,121,"METHODS  Mutation analyses of the DPC4 gene were performed on complementary DNA samples from 31 primary colorectal cancer specimens using a combination of polymerase chain reaction, single-strand conformation polymorphism, and DNA sequencing.",8898652_4,-1,4204,-1,0.14396495
4205,amino acid,6,8,43,53,RESULTS  Four missense mutations producing amino acid substitutions and a somatic 12-base pair deletion in the coding region of the DPC4 gene were detected in the 31 cancers (16%; 5 of 31).,8898652_5,-1,4205,-1,0.2836364
4209,lead,26,27,136,140,"Furthermore, we demonstrate that the Atm protein exists as two discrete molecular species, and that loss of one or of both of these can lead to the development of the disease..",8917548_6,-1,4209,-1,0.2453178
4210,disease,32,33,167,174,"Furthermore, we demonstrate that the Atm protein exists as two discrete molecular species, and that loss of one or of both of these can lead to the development of the disease..",8917548_6,-1,4210,-1,0.18553565
4211,colorectal cancer,6,8,33,50,The DCC protein and prognosis in colorectal cancer.,8929264_0,-1,4211,-1,0.16054544
4212,colorectal cancer,16,18,94,111,"
BACKGROUND  Allelic loss of chromosome 18q predicts a poor outcome in patients with stage II colorectal cancer.",8929264_1,-1,4212,-1,0.14161393
4213,colorectal cancer,19,21,105,122,"Although the specific gene inactivated by this allelic loss has not been elucidated, the DCC (deleted in colorectal cancer) gene is a candidate.",8929264_2,-1,4213,-1,0.14671601
4215,colorectal carcinoma,17,19,99,119,We investigated whether the expression of the DCC protein in tumor cells is a prognostic marker in colorectal carcinoma.,8929264_3,-1,4215,-1,0.1437658
4218,disease,5,6,26,33,"In patients with stage II disease whose tumors expressed DCC, the five-year survival rate was 94. 3 percent, whereas in patients with DCC-negative tumors, the survival rate was 61. 6 percent (P < 0. 001).",8929264_7,-1,4218,-1,0.20688173
4221,P,37,38,192,193,"In patients with stage II disease whose tumors expressed DCC, the five-year survival rate was 94. 3 percent, whereas in patients with DCC-negative tumors, the survival rate was 61. 6 percent (P < 0. 001).",8929264_7,-1,4221,-1,0.27201462
4222,disease,5,6,27,34,"In patients with stage III disease, the respective survival rates were 59. 3 percent and 33. 2 percent (P = 0. 03).",8929264_8,-1,4222,-1,0.21244481
4223,P,22,23,104,105,"In patients with stage III disease, the respective survival rates were 59. 3 percent and 33. 2 percent (P = 0. 03).",8929264_8,-1,4223,-1,0.2590348
4224,colorectal cancer,15,17,79,96,CONCLUSIONS  DCC is a prognostic marker in patients with stage II or stage III colorectal cancer.,8929264_9,-1,4224,-1,0.15608054
4226,serotonin,9,10,65,74,Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region.,8929413_0,-1,4226,-1,0.25172976
4227,serotonin,3,4,35,44,"
Transporter-facilitated uptake of serotonin (5-hydroxytryptamine or 5-HT) has been implicated in anxiety in humans and animal models and is the site of action of widely used uptake-inhibiting antidepressant and antianxiety drugs.",8929413_1,-1,4227,-1,0.24053356
4228,anxiety,13,14,98,105,"
Transporter-facilitated uptake of serotonin (5-hydroxytryptamine or 5-HT) has been implicated in anxiety in humans and animal models and is the site of action of widely used uptake-inhibiting antidepressant and antianxiety drugs.",8929413_1,-1,4228,-1,0.19568446
4229,antidepressant,29,30,193,207,"
Transporter-facilitated uptake of serotonin (5-hydroxytryptamine or 5-HT) has been implicated in anxiety in humans and animal models and is the site of action of widely used uptake-inhibiting antidepressant and antianxiety drugs.",8929413_1,-1,4229,-1,0.20159434
4230,5-HT,1,2,6,10,Human 5-HT transporter (5-HTT) gene transcription is modulated by a common polymorphism in its upstream regulatory region.,8929413_2,-1,4230,-1,0.3307571
4231,5-HT,22,23,149,153,"The short variant of the polymorphism reduces the transcriptional efficiency of the 5-HTT gene promoter, resulting in decreased 5-HTT expression and 5-HT uptake in lymphoblasts.",8929413_3,-1,4231,-1,0.27943256
4232,atelosteogenesis type 2,5,8,41,64,Phenotypic and genotypic overlap between atelosteogenesis type 2 and diastrophic dysplasia.,8931695_0,-1,4232,-1,0.25357157
4233,diastrophic dysplasia,9,11,69,90,Phenotypic and genotypic overlap between atelosteogenesis type 2 and diastrophic dysplasia.,8931695_0,-1,4233,-1,0.21757275
4234,diastrophic dysplasia,3,5,18,39,"
Mutations in the diastrophic dysplasia sulfate transporter gene DTDST have been associated with a family of chondrodysplasias that comprises, in order of increasing severity, diastrophic dysplasia (DTD), atelosteogenesis type 2 (AO2), and achondrogenesis type 1B (ACG1B).",8931695_1,-1,4234,-1,0.21340756
4235,diastrophic dysplasia,26,28,176,197,"
Mutations in the diastrophic dysplasia sulfate transporter gene DTDST have been associated with a family of chondrodysplasias that comprises, in order of increasing severity, diastrophic dysplasia (DTD), atelosteogenesis type 2 (AO2), and achondrogenesis type 1B (ACG1B).",8931695_1,-1,4235,-1,0.20877114
4236,atelosteogenesis type 2,32,35,205,228,"
Mutations in the diastrophic dysplasia sulfate transporter gene DTDST have been associated with a family of chondrodysplasias that comprises, in order of increasing severity, diastrophic dysplasia (DTD), atelosteogenesis type 2 (AO2), and achondrogenesis type 1B (ACG1B).",8931695_1,-1,4236,-1,0.25870216
4237,achondrogenesis type 1B,40,43,240,263,"
Mutations in the diastrophic dysplasia sulfate transporter gene DTDST have been associated with a family of chondrodysplasias that comprises, in order of increasing severity, diastrophic dysplasia (DTD), atelosteogenesis type 2 (AO2), and achondrogenesis type 1B (ACG1B).",8931695_1,-1,4237,-1,0.25662783
4238,cytosine,20,21,102,110,"The third patient (with AO2) had the R279W mutation compounded with a novel mutation, the deletion of cytosine 418 (delta c418), predicting a frameshift with premature termination.",8931695_6,-1,4238,-1,0.26751542
4239,Wiskott-Aldrich syndrome,15,17,111,135,"Identification of WASP mutations, mutation hotspots and genotype-phenotype disparities in 24 patients with the Wiskott-Aldrich syndrome.",8931701_0,-1,4239,-1,0.20255163
4240,Wiskott-Aldrich syndrome,1,3,5,29,"
The Wiskott-Aldrich syndrome (WAS), an X-linked immunodeficiency disease caused by mutation in the recently isolated gene encoding WAS protein (WASP), is known to be associated with extensive clinical heterogeneity.",8931701_1,-1,4240,-1,0.20362866
4241,immunodeficiency disease,9,11,49,73,"
The Wiskott-Aldrich syndrome (WAS), an X-linked immunodeficiency disease caused by mutation in the recently isolated gene encoding WAS protein (WASP), is known to be associated with extensive clinical heterogeneity.",8931701_1,-1,4241,-1,0.1578616
4242,disease,25,26,160,167,"Cumulative mutation data have revealed that WASP genotypes are also highly variable among WAS patients, but the relationship of phenotype with genotype in this disease remains unclear.",8931701_2,-1,4242,-1,0.18344918
4243,disease,29,30,168,175,"To address this issue we characterized WASP mutations in 24 unrelated WAS patients, including 18 boys with severe classical WAS and 6 boys expressing mild forms of the disease, and then examined the degree of correlation of these as well as all previously published WASP mutations with disease severity.",8931701_3,-1,4243,-1,0.21285239
4244,disease,49,50,286,293,"To address this issue we characterized WASP mutations in 24 unrelated WAS patients, including 18 boys with severe classical WAS and 6 boys expressing mild forms of the disease, and then examined the degree of correlation of these as well as all previously published WASP mutations with disease severity.",8931701_3,-1,4244,-1,0.18768843
4245,disease,15,16,83,90,"These characteristics were observed, however, in both severe and mild cases of the disease.",8931701_5,-1,4245,-1,0.24645434
4247,disease,55,56,341,348,"Similarly, while the cumulative data revealed a predominance of missense mutations among the WASP gene lesions observed in boys with isolated thrombocytopenia, missense mutations were not exclusively associated with milder WAS phenotypes, but also comprised a substantial portion (38%) of the WASP gene defects found in patients with severe disease.",8931701_6,-1,4247,-1,0.18235774
4248,disease,36,37,215,222,"These findings, as well as the detection of identical WASP mutations in patients with disparate phenotypes, reveal a lack of phenotype concordance with genotype in WAS and thus imply that phenotypic outcome in this disease cannot be reliably predicted solely on the basis of WASP genotypes..",8931701_7,-1,4248,-1,0.19027907
4249,adenomatous polyposis coli,22,25,120,146,Germline mutations in the 3' part of APC exon 15 do not result in truncated proteins and are associated with attenuated adenomatous polyposis coli.,8931709_0,-1,4249,-1,0.18231347
4250,colorectal cancer,11,13,72,89,"
Familial adenomatous polyposis (FAP) is an inherited predisposition to colorectal cancer characterized by the development of numerous adenomatous polyps predominantly in the colorectal region.",8931709_1,-1,4250,-1,0.14881751
4251,adenomatous polyps,19,21,135,153,"
Familial adenomatous polyposis (FAP) is an inherited predisposition to colorectal cancer characterized by the development of numerous adenomatous polyps predominantly in the colorectal region.",8931709_1,-1,4251,-1,0.1806334
4252,adenomatous polyposis coli,4,7,26,52,Germline mutations in the adenomatous polyposis coli (APC) gene are responsible for most cases of FAP.,8931709_2,-1,4252,-1,0.19454801
4253,disease,19,20,92,99,"Mutations at the 5 end of APC are known to be associated with a relatively mild form of the disease, called attenuated adenomatous polyposis coli (AAPC).",8931709_3,-1,4253,-1,0.18996784
4254,adenomatous polyposis coli,23,26,119,145,"Mutations at the 5 end of APC are known to be associated with a relatively mild form of the disease, called attenuated adenomatous polyposis coli (AAPC).",8931709_3,-1,4254,-1,0.19521676
4259,chromosomal instability,13,15,81,104,"To identify possible features of the BRCA1 genomic region that may contribute to chromosomal instability as well as potential transcriptional regulatory elements, a 117, 143-bp DNA sequence encompassing BRCA1 was obtained by random sequencing of four cosmids identified from a human chromosome 17 specific library.",8938427_4,-1,4259,-1,0.17145622
4260,interferon,15,16,72,82,"Partial sequences of the 1A1-3B B-box protein pseudogene and IFP 35, an interferon induced leucine zipper protein, reside within the contig.",8938427_8,-1,4260,-1,0.22119404
4261,leucine,17,18,91,98,"Partial sequences of the 1A1-3B B-box protein pseudogene and IFP 35, an interferon induced leucine zipper protein, reside within the contig.",8938427_8,-1,4261,-1,0.25377566
4263,C,36,37,232,233,"This BRCA1-associated RING domain (BARD1) protein contains an N-terminal RING motif, three tandem ankyrin repeats, and a C-terminal sequence with significant homology to the phylogenetically conserved BRCT domains that lie near the C terminus of BRCA1.",8944023_3,-1,4263,-1,0.27735093
4265,tumour,24,25,170,176,"The BARD1/BRCA1 interaction is disrupted by BRCA1 missense mutations that segregate with breast cancer susceptibility, indicating that BARD1 may be involved in mediating tumour suppression by BRCA1..",8944023_4,-1,4265,-1,0.16531098
4267,nucleotide,2,3,13,23,Eight single nucleotide polymorphisms were also readily detected.,8944024_6,-1,4267,-1,0.2635813
4268,primary hyperparathyroidism,2,4,19,46,Autosomal dominant primary hyperparathyroidism and jaw tumor syndrome associated with renal hamartomas and cystic kidney disease: linkage to 1q21-q32 and loss of the wild type allele in renal hamartomas.,8954016_0,-1,4268,-1,0.19348091
4269,tumor syndrome,6,8,55,69,Autosomal dominant primary hyperparathyroidism and jaw tumor syndrome associated with renal hamartomas and cystic kidney disease: linkage to 1q21-q32 and loss of the wild type allele in renal hamartomas.,8954016_0,-1,4269,-1,0.17532656
4270,kidney disease,14,16,114,128,Autosomal dominant primary hyperparathyroidism and jaw tumor syndrome associated with renal hamartomas and cystic kidney disease: linkage to 1q21-q32 and loss of the wild type allele in renal hamartomas.,8954016_0,-1,4270,-1,0.18568684
4271,tumor syndrome,2,4,36,50,"
Hereditary hyperparathyroidism-jaw tumor syndrome (HPT-JT) is an autosomal dominant disease (OMIM 145001) that has recently been mapped to chromosomal region 1q21-q32 (HRPT2).",8954016_1,-1,4271,-1,0.17508177
4272,disease,11,12,85,92,"
Hereditary hyperparathyroidism-jaw tumor syndrome (HPT-JT) is an autosomal dominant disease (OMIM 145001) that has recently been mapped to chromosomal region 1q21-q32 (HRPT2).",8954016_1,-1,4272,-1,0.21049793
4273,syndrome,7,8,40,48,"Here we report two families with HPT-JT syndrome in which adult renal hamartomas or cystic kidney disease were prominent associated features, possibly representing a new phenotypic variant of the HPT-JT syndrome.",8954016_2,-1,4273,-1,0.20799656
4274,kidney disease,15,17,91,105,"Here we report two families with HPT-JT syndrome in which adult renal hamartomas or cystic kidney disease were prominent associated features, possibly representing a new phenotypic variant of the HPT-JT syndrome.",8954016_2,-1,4274,-1,0.19575077
4275,syndrome,31,32,203,211,"Here we report two families with HPT-JT syndrome in which adult renal hamartomas or cystic kidney disease were prominent associated features, possibly representing a new phenotypic variant of the HPT-JT syndrome.",8954016_2,-1,4275,-1,0.19942364
4276,kidney disease,22,24,128,142,"In the second family, JT was found in three of the five affected individuals and two affected members also exhibited polycystic kidney disease.",8954016_4,-1,4276,-1,0.2034108
4277,multiple endocrine neoplasia,16,19,92,120,"Twenty microsatellite markers in the HRPT2 region were typed, in addition to markers in the multiple endocrine neoplasia (MEN) types 1 and 2 regions at 11q13 and 10q11.",8954016_7,-1,4277,-1,0.1708987
4278,disease,1,2,4,11,The disease in these two kindreds was linked to five markers in the 1q21-q32 region (logarithm-of-odds scores  3. 2-4 2-4.,8954016_8,-1,4278,-1,0.23184517
4282,glucose,10,11,63,70,Independent origin of single and double mutations in the human glucose 6-phosphate dehydrogenase gene.,8956035_0,-1,4282,-1,0.25707388
4283,favism,53,54,269,275,"In the four polymorphic variants that have two point mutations, one of the mutations is always 376 A-- > G (126 Asn-- > Asp), which on its own gives rise to the nondeficient polymorphic variant, G6PD A. In a study of G6PD deficient patients who presented with clinical favism in Spain, we have found a new polymorphic variant that we have called G6PD Malaga, whose only abnormality is a 542 A-- > T (181 Asp-- > Val) mutation.",8956035_2,-1,4283,-1,0.28658292
4284,T,79,80,397,398,"In the four polymorphic variants that have two point mutations, one of the mutations is always 376 A-- > G (126 Asn-- > Asp), which on its own gives rise to the nondeficient polymorphic variant, G6PD A. In a study of G6PD deficient patients who presented with clinical favism in Spain, we have found a new polymorphic variant that we have called G6PD Malaga, whose only abnormality is a 542 A-- > T (181 Asp-- > Val) mutation.",8956035_2,-1,4284,-1,0.37370414
4285,Val,84,85,412,415,"In the four polymorphic variants that have two point mutations, one of the mutations is always 376 A-- > G (126 Asn-- > Asp), which on its own gives rise to the nondeficient polymorphic variant, G6PD A. In a study of G6PD deficient patients who presented with clinical favism in Spain, we have found a new polymorphic variant that we have called G6PD Malaga, whose only abnormality is a 542 A-- > T (181 Asp-- > Val) mutation.",8956035_2,-1,4285,-1,0.2779119
4289,C--,10,11,49,52,"We report a novel missense change in BRCA1, 2640 C-- > T (R841W), found in 3 cases from a subject group of 305 breast and 79 ovarian cancer cases from Orange County, CA.",8968716_4,-1,4289,-1,0.37048587
4291,CA,37,38,166,168,"We report a novel missense change in BRCA1, 2640 C-- > T (R841W), found in 3 cases from a subject group of 305 breast and 79 ovarian cancer cases from Orange County, CA.",8968716_4,-1,4291,-1,0.27970052
4298,immunodeficiency,20,21,137,153,"
The ATM gene is responsible for the autosomal recessive disorder ataxia-telangiectasia (A-T), characterized by cerebellar degeneration, immunodeficiency and cancer predisposition.",8968760_1,-1,4298,-1,0.16055793
4311,Los,5,6,31,34,Molecular basis for Duarte and Los Angeles variant galactosemia.,9012409_0,-1,4311,-1,0.23416403
4312,Los,13,14,81,84,"The characteristic Duarte isoform is also associated with a variant called the "" Los Angeles (LA) phenotype, "" which has increased GALT enzyme activity.",9012409_3,-1,4312,-1,0.22567892
4313,LA,16,17,94,96,"The characteristic Duarte isoform is also associated with a variant called the "" Los Angeles (LA) phenotype, "" which has increased GALT enzyme activity.",9012409_3,-1,4313,-1,0.28195322
4314,LA,5,6,24,26,"We found seven with the LA biochemical phenotype, and all had a 1721C-- > T transition in exon 7 in cis with the N314D missense mutation.",9012409_5,-1,4314,-1,0.28764898
4315,leucine,10,11,57,64,The 1721C-- > T transition is a neutral polymorphism for leucine at amino acid 218 (L218L).,9012409_6,-1,4315,-1,0.3045694
4316,amino acid,12,14,68,78,The 1721C-- > T transition is a neutral polymorphism for leucine at amino acid 218 (L218L).,9012409_6,-1,4316,-1,0.37713325
4317,LA,12,13,70,72,"In pedigree analyses, this 1721C-- > T transition segregated with the LA phenotype of increased GALT activity in three different biochemical phenotypes (LA/N, LA/G, and LA/D).",9012409_7,-1,4317,-1,0.24375384
4318,LA,9,10,57,59,"To determine the mechanism for increased activity of the LA variant, we compared GALT mRNA, protein abundance, and enzyme thermal stability in lymphoblast cell lines of D and LA phenotypes with comparable genotypes.",9012409_8,-1,4318,-1,0.2664315
4319,LA,31,32,175,177,"To determine the mechanism for increased activity of the LA variant, we compared GALT mRNA, protein abundance, and enzyme thermal stability in lymphoblast cell lines of D and LA phenotypes with comparable genotypes.",9012409_8,-1,4319,-1,0.29730362
4320,LA,6,7,40,42,"GALT protein abundance was increased in LA compared to D alleles, but mRNA was similar among all genotypes.",9012409_9,-1,4320,-1,0.3432402
4321,C,46,47,234,235,"When LA/D and D/D GALT biochemical phenotypes were compared to N/N GALT phenotypes, both had 50%, as compared to 21%, reduction in GALT activity in the wild type (N/N) after exposure at identical initial enzyme activity to 50 degrees C for 15 min.",9012409_10,-1,4321,-1,0.2764741
4322,LA,18,19,102,104,We conclude that the codon change N314D in cis with the base-pair transition 1721C-- > T produces the LA variant of galactosemia and that this nucleotide change increases GALT activity by increasing GALT protein abundance without increasing transcription or decreasing thermal lability.,9012409_11,-1,4322,-1,0.29950264
4323,nucleotide,25,26,143,153,We conclude that the codon change N314D in cis with the base-pair transition 1721C-- > T produces the LA variant of galactosemia and that this nucleotide change increases GALT activity by increasing GALT protein abundance without increasing transcription or decreasing thermal lability.,9012409_11,-1,4323,-1,0.252907
4331,Myotonic dystrophy,0,2,1,19,"
Myotonic dystrophy (DM) is associated with the expansion of a (CTG) n trinucleotide repeat in the 3 untranslated region (UTR) of the DM protein kinase gene (DMPK).",9020847_1,-1,4331,-1,0.19544329
4332,DM,3,4,21,23,"
Myotonic dystrophy (DM) is associated with the expansion of a (CTG) n trinucleotide repeat in the 3 untranslated region (UTR) of the DM protein kinase gene (DMPK).",9020847_1,-1,4332,-1,0.21341205
4333,n,15,16,69,70,"
Myotonic dystrophy (DM) is associated with the expansion of a (CTG) n trinucleotide repeat in the 3 untranslated region (UTR) of the DM protein kinase gene (DMPK).",9020847_1,-1,4333,-1,0.3693963
4334,DM,28,29,134,136,"
Myotonic dystrophy (DM) is associated with the expansion of a (CTG) n trinucleotide repeat in the 3 untranslated region (UTR) of the DM protein kinase gene (DMPK).",9020847_1,-1,4334,-1,0.24825424
4335,n,7,8,22,23,"The size of the (CTG) n repeat, which increases through generations, generally correlates with clinical severity and age of onset.",9020847_3,-1,4335,-1,0.3490332
4336,DM,8,9,58,60,"Moreover, mitotic instability analysis of different human DM tissues shows length mosaicism between different cell lineages.",9020847_5,-1,4336,-1,0.2346624
4337,contrast,1,2,3,11,"In contrast to other mouse models containing CAG repeats within cDNAs, these mice showed both intergenerational and somatic repeat instability..",9020847_8,-1,4337,-1,0.25821486
4338,autoimmune lymphoproliferative syndrome,8,11,48,87,Missense mutations in the Fas gene resulting in autoimmune lymphoproliferative syndrome: a molecular and immunological analysis.,9028321_0,-1,4338,-1,0.15478095
4340,autoimmune lymphoproliferative syndrome,25,28,165,204,"The Fas/Apo-1 receptor plays a crucial role in the regulation of apoptosis, as demonstrated by lymphoproliferation in MRL-lpr/lpr mice and by the recently described autoimmune lymphoproliferative syndrome (ALPS) in humans, both of which are due to mutations in the Fas gene.",9028321_2,-1,4340,-1,0.175326
4341,splenomegaly,7,8,54,66,"The children share common clinical features including splenomegaly and lymphadenopathy, but only one developed severe autoimmune manifestations.",9028321_4,-1,4341,-1,0.20547123
4343,amino acid,23,25,142,152,"
The product of the ataxia-telangiectasia gene (ATM) was identified by using an antiserum developed to a peptide corresponding to the deduced amino acid sequence.",9050866_1,-1,4343,-1,0.29745057
4344,contrast,21,22,135,143,"Exposure of normal human cells to gamma-irradiation and the radiomimetic drug neocarzinostatin had no effect on ATM protein levels, in contrast to a noted rise in p53 levels over the same time interval.",9050866_5,-1,4344,-1,0.31104735
4345,Ehlers-Danlos syndrome,14,16,72,94,"Mutations in the COL3A1 gene have been implicated as a cause of type IV Ehlers-Danlos syndrome, a disease leading to aortic rupture in early adult life.",9050868_3,-1,4345,-1,0.22323266
4346,disease,18,19,98,105,"Mutations in the COL3A1 gene have been implicated as a cause of type IV Ehlers-Danlos syndrome, a disease leading to aortic rupture in early adult life.",9050868_3,-1,4346,-1,0.17589271
4347,aortic rupture,21,23,117,131,"Mutations in the COL3A1 gene have been implicated as a cause of type IV Ehlers-Danlos syndrome, a disease leading to aortic rupture in early adult life.",9050868_3,-1,4347,-1,0.19099125
4348,disease,10,11,56,63,"To directly study the role of Col3a1 in development and disease, we have inactivated the Col3a1 gene in embryonic stem cells by homologous recombination.",9050868_4,-1,4348,-1,0.16548158
4350,rupture,9,10,44,51,"The major cause of death of mutant mice was rupture of the major blood vessels, similar to patients with type IV Ehlers-Danlos syndrome.",9050868_7,-1,4350,-1,0.24349867
4351,Ehlers-Danlos syndrome,22,24,113,135,"The major cause of death of mutant mice was rupture of the major blood vessels, similar to patients with type IV Ehlers-Danlos syndrome.",9050868_7,-1,4351,-1,0.22073156
4352,Pelizaeus-Merzbacher disease,21,23,102,130,Nonsense mutation in exon 3 of the proteolipid protein gene (PLP) in a family with an unusual form of Pelizaeus-Merzbacher disease.,9056547_0,-1,4352,-1,0.23788953
4353,nucleotide,8,9,35,45,"
We report a G-- > A transition at nucleotide 431 of the proteolipid protein gene (PLP) results in a nonsense codon in a family with an unusual form of Pelizaeus-Merzbacher disease (PMD).",9056547_1,-1,4353,-1,0.31031698
4354,Pelizaeus-Merzbacher disease,31,33,152,180,"
We report a G-- > A transition at nucleotide 431 of the proteolipid protein gene (PLP) results in a nonsense codon in a family with an unusual form of Pelizaeus-Merzbacher disease (PMD).",9056547_1,-1,4354,-1,0.23433055
4355,paraplegia,9,10,65,75,The clinical picture resembles somewhat that of X-linked spastic paraplegia (SPG).,9056547_3,-1,4355,-1,0.21903045
4356,nystagmus,30,31,146,155,"It differs from this and both the classical and connatal forms of PMD in that it is relatively mild in form, onset is delayed beyond age 2 years, nystagmus is absent, tremors are prominent, mental retardation is not severe, some patients show dementia or personality disorders, the disease is progressive rather than static in some, and several females show signs of disease.",9056547_4,-1,4356,-1,0.26935658
4358,mental retardation,38,40,190,208,"It differs from this and both the classical and connatal forms of PMD in that it is relatively mild in form, onset is delayed beyond age 2 years, nystagmus is absent, tremors are prominent, mental retardation is not severe, some patients show dementia or personality disorders, the disease is progressive rather than static in some, and several females show signs of disease.",9056547_4,-1,4358,-1,0.24058439
4360,personality disorders,49,51,255,276,"It differs from this and both the classical and connatal forms of PMD in that it is relatively mild in form, onset is delayed beyond age 2 years, nystagmus is absent, tremors are prominent, mental retardation is not severe, some patients show dementia or personality disorders, the disease is progressive rather than static in some, and several females show signs of disease.",9056547_4,-1,4360,-1,0.20626687
4361,disease,53,54,282,289,"It differs from this and both the classical and connatal forms of PMD in that it is relatively mild in form, onset is delayed beyond age 2 years, nystagmus is absent, tremors are prominent, mental retardation is not severe, some patients show dementia or personality disorders, the disease is progressive rather than static in some, and several females show signs of disease.",9056547_4,-1,4361,-1,0.24661024
4362,disease,68,69,367,374,"It differs from this and both the classical and connatal forms of PMD in that it is relatively mild in form, onset is delayed beyond age 2 years, nystagmus is absent, tremors are prominent, mental retardation is not severe, some patients show dementia or personality disorders, the disease is progressive rather than static in some, and several females show signs of disease.",9056547_4,-1,4362,-1,0.22951424
4363,disease,33,34,185,192,"The nonsense mutation, which is in exon 3B, should block the synthesis of normal PLP but spare DM20, the isoform whose persistence has been associated with mild forms of PLP-associated disease in both humans and mice..",9056547_5,-1,4363,-1,0.17641826
4369,amino acid,11,13,72,82,There are several common polymorphisms in the BRCA1 gene which generate amino acid substitutions.,9063749_4,-1,4369,-1,0.2725176
4373,P,34,35,201,202,"However, our data suggest that the Arg356 allele may have a different genotype distribution in breast cancer patients from that in controls (Arg356 homozygotes are more frequent in the control groups, P = 0. 01), indicating that it may be protective against breast cancer.",9063749_10,-1,4373,-1,0.28672168
4375,Kniest,0,1,1,7,"
Kniest dysplasia is a severe chondrodysplasia caused by the defective formation of type II collagen.",9066888_1,-1,4375,-1,0.24977936
4376,dysplasia,1,2,8,17,"
Kniest dysplasia is a severe chondrodysplasia caused by the defective formation of type II collagen.",9066888_1,-1,4376,-1,0.22242203
4377,blindness,38,39,191,200,"We report about Dr. Kniest, who first described the condition in 1952, and his patient, who, at the age of 50 years is severely handicapped with short stature, restricted joint mobility, and blindness but is mentally alert and leads an active life.",9066888_2,-1,4377,-1,0.28695375
4378,Kniest dysplasia,11,13,69,85,"This is in accordance with molecular findings in other patients with Kniest dysplasia and confirms, in the original patient, that the disorder is caused by small inframe deletions often due to exon skipping as a result of COL2A1 splice site mutations..",9066888_4,-1,4378,-1,0.20544916
4379,alkaptonuria,11,12,69,81,"Cloning of the homogentisate 1,2-dioxygenase gene, the key enzyme of alkaptonuria in mouse.",9069115_0,-1,4379,-1,0.28403175
4380,amino acid,3,5,18,28,"
We determined 48 amino acid residues from five peptides from the homogeneous monomer of homogentisate 1, 2-dioxygenase (HGO; E. C. 1. 13. 11. 15) of mouse liver.",9069115_1,-1,4380,-1,0.27272537
4381,amino acid,13,15,91,101,"After digestion with trypsin, peptides were separated by reversed phase chromatography and amino acid sequenced.",9069115_2,-1,4381,-1,0.34033796
4382,amino acids,5,7,31,42,The positions of 122 conserved amino acids could be determined by multiple sequence alignment.,9069115_10,-1,4382,-1,0.2888462
4383,alkaptonuria,13,14,76,88,This corresponds well to the previous assignment of the locus for the human alkaptonuria gene (AKU) to the same chromosomal region by multipoint linkage analysis.,9069115_15,-1,4383,-1,0.29020834
4384,alkaptonuria,12,13,73,85,We therefore conclude that the HGO cDNA encodes the gene responsible for alkaptonuria.,9069115_16,-1,4384,-1,0.26681983
4385,tyrosine,5,6,25,33,"PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer.",9072974_0,-1,4385,-1,0.18669353
4392,glioblastomas,54,55,236,249,"In preliminary screens, mutations of PTEN were detected in 31% (13/42) of glioblastoma cell lines and xenografts, 100% (4/4) of prostate cancer cell lines, 6% (4/65) of breast cancer cell lines and xenografts, and 17% (3/18) of primary glioblastomas.",9072974_2,-1,4392,-1,0.20357847
4393,tyrosine,7,8,41,49,"The predicted PTEN product has a protein tyrosine phosphatase domain and extensive homology to tensin, a protein that interacts with actin filaments at focal adhesions.",9072974_3,-1,4393,-1,0.21636511
4395,tyrosine,13,14,90,98,These homologies suggest that PTEN may suppress tumor cell growth by antagonizing protein tyrosine kinases and may regulate tumor cell invasion and metastasis through interactions at focal adhesions..,9072974_4,-1,4395,-1,0.17374796
4397,metastasis,22,23,148,158,These homologies suggest that PTEN may suppress tumor cell growth by antagonizing protein tyrosine kinases and may regulate tumor cell invasion and metastasis through interactions at focal adhesions..,9072974_4,-1,4397,-1,0.14400272
4398,myotonia,4,5,51,59,Heterogeneity in Schwartz-Jampel chondrodystrophic myotonia.,9083764_0,-1,4398,-1,0.20921664
4399,syndrome,2,3,21,29,"
The Schwartz-Jampel syndrome (SJS; chondrodystrophic myotonia; McK 255, 800) is a recessively inherited condition defined by myotonia, short stature, and bone dysplasia.",9083764_1,-1,4399,-1,0.20149176
4400,myotonia,7,8,54,62,"
The Schwartz-Jampel syndrome (SJS; chondrodystrophic myotonia; McK 255, 800) is a recessively inherited condition defined by myotonia, short stature, and bone dysplasia.",9083764_1,-1,4400,-1,0.20837417
4401,myotonia,21,22,126,134,"
The Schwartz-Jampel syndrome (SJS; chondrodystrophic myotonia; McK 255, 800) is a recessively inherited condition defined by myotonia, short stature, and bone dysplasia.",9083764_1,-1,4401,-1,0.20360102
4402,myotonia,17,18,100,108,"We found that a group of patients have mild skeletal changes which may be secondary consequences of myotonia, while another group of patients appear to have primary bone dysplasia with myotonia.",9083764_5,-1,4402,-1,0.21733627
4403,myotonia,31,32,185,193,"We found that a group of patients have mild skeletal changes which may be secondary consequences of myotonia, while another group of patients appear to have primary bone dysplasia with myotonia.",9083764_5,-1,4403,-1,0.21762556
4404,Kniest dysplasia,52,54,304,320,"We tentatively isolate three different types of SJS  type 1A, usually recognized in childhood, with moderate bone dysplasia, corresponding to the original descriptions of Schwartz, Jampel and Aberfeld; type 1B, similar to type 1A but recognizable at birth, with more pronounced bone dysplasia resembling Kniest dysplasia; and type 2, manifest at birth, with increased mortality and bone dysplasia resembling Pyle disease.",9083764_7,-1,4404,-1,0.2221382
4405,Pyle disease,70,72,408,420,"We tentatively isolate three different types of SJS  type 1A, usually recognized in childhood, with moderate bone dysplasia, corresponding to the original descriptions of Schwartz, Jampel and Aberfeld; type 1B, similar to type 1A but recognizable at birth, with more pronounced bone dysplasia resembling Kniest dysplasia; and type 2, manifest at birth, with increased mortality and bone dysplasia resembling Pyle disease.",9083764_7,-1,4405,-1,0.26659694
4406,kidney cancer,15,17,90,103,"
Mutations in the WT1 gene were anticipated to explain the genetic basis of the childhood kidney cancer, Wilms tumour (WT).",9090524_1,-1,4406,-1,0.16613452
4407,tumour,19,20,111,117,"
Mutations in the WT1 gene were anticipated to explain the genetic basis of the childhood kidney cancer, Wilms tumour (WT).",9090524_1,-1,4407,-1,0.19983155
4408,tumours,7,8,32,39,"While only 5% of sporadic Wilms tumours have intragenic WT1 mutations, > 90% of patients with the Denys-Drash syndrome (renal nephropathy, gonadal anomaly, predisposition to WT) carry constitutional intragenic WT1 mutations.",9090524_3,-1,4408,-1,0.1899711
4409,Denys-Drash syndrome,20,22,98,118,"While only 5% of sporadic Wilms tumours have intragenic WT1 mutations, > 90% of patients with the Denys-Drash syndrome (renal nephropathy, gonadal anomaly, predisposition to WT) carry constitutional intragenic WT1 mutations.",9090524_3,-1,4409,-1,0.22432894
4411,tumour,10,11,65,71,"WT1 mutations have also been reported in juvenile granulosa cell tumour, non-asbestos related mesothelioma, desmoplastic small round cell tumour and, most recently, acute myeloid leukemia..",9090524_4,-1,4411,-1,0.18514262
4412,mesothelioma,14,15,94,106,"WT1 mutations have also been reported in juvenile granulosa cell tumour, non-asbestos related mesothelioma, desmoplastic small round cell tumour and, most recently, acute myeloid leukemia..",9090524_4,-1,4412,-1,0.1795322
4413,tumour,20,21,138,144,"WT1 mutations have also been reported in juvenile granulosa cell tumour, non-asbestos related mesothelioma, desmoplastic small round cell tumour and, most recently, acute myeloid leukemia..",9090524_4,-1,4413,-1,0.18738954
4414,acute myeloid leukemia,26,29,165,187,"WT1 mutations have also been reported in juvenile granulosa cell tumour, non-asbestos related mesothelioma, desmoplastic small round cell tumour and, most recently, acute myeloid leukemia..",9090524_4,-1,4414,-1,0.18471992
4415,myotonia congenita,5,7,33,51,A mutation in autosomal dominant myotonia congenita affects pore properties of the muscle chloride channel.,9122265_0,-1,4415,-1,0.20710374
4416,chloride,13,14,90,98,A mutation in autosomal dominant myotonia congenita affects pore properties of the muscle chloride channel.,9122265_0,-1,4416,-1,0.23861854
4417,myotonia congenita,2,4,20,38,"
Autosomal dominant myotonia congenita is an inherited disorder of skeletal muscle caused by mutations in a voltage-gated Cl- channel gene (CLCN1, 7q35).",9122265_1,-1,4417,-1,0.18840344
4418,glutamic acid,14,16,74,87,"Here, we report that a mutation predicting the substitution of Gly 230 by glutamic acid (G230E) between segments D3 and D4 dramatically alters the pore properties of a recombinant human muscle Cl- channel (hCIC-1) expressed in a mammalian cell line (tsA201).",9122265_2,-1,4418,-1,0.33046883
4419,Cl,11,12,86,88,"Whereas wild-type channels are characterized by pronounced inward rectification and a Cl > thiocyanate > Br > NO (3) > I > CH (3) SO (3) selectivity, G230E exhibits outward rectification at positive potentials and a thiocyanate > NO (3) > I > Br > Cl > CH (3) SO (3) selectivity.",9122265_4,-1,4419,-1,0.2699195
4420,Cl,54,55,248,250,"Whereas wild-type channels are characterized by pronounced inward rectification and a Cl > thiocyanate > Br > NO (3) > I > CH (3) SO (3) selectivity, G230E exhibits outward rectification at positive potentials and a thiocyanate > NO (3) > I > Br > Cl > CH (3) SO (3) selectivity.",9122265_4,-1,4420,-1,0.29640052
4421,aniridia,9,10,55,63,The incidence of PAX6 mutation in patients with simple aniridia: an evaluation of mutation detection in 12 cases.,9138149_0,-1,4421,-1,0.24689427
4422,aniridia,1,2,8,16,"
Twelve aniridia patients, five with a family history and seven presumed to be sporadic, were exhaustively screened in order to test what proportion of people with aniridia, uncomplicated by associated anomalies, carry mutations in the human PAX6 gene.",9138149_1,-1,4422,-1,0.22258157
4423,aniridia,28,29,164,172,"
Twelve aniridia patients, five with a family history and seven presumed to be sporadic, were exhaustively screened in order to test what proportion of people with aniridia, uncomplicated by associated anomalies, carry mutations in the human PAX6 gene.",9138149_1,-1,4423,-1,0.2488668
4424,diabetes mellitus,18,20,113,130,"Insulin gene region contributes to genetic susceptibility to, but may not to low incidence of, insulin-dependent diabetes mellitus in Japanese.",9144439_0,-1,4424,-1,0.18628621
4425,diabetes mellitus,20,22,121,138,"
In the Caucasian population, it has been demonstrated that the insulin gene (INS) region contains the insulin-dependent diabetes mellitus locus (IDDM2).",9144439_1,-1,4425,-1,0.20732224
4426,IDDM,21,22,125,129,"In the Japanese population, however, there has been no report demonstrating the contribution of IDDM2 to the pathogenesis of IDDM.",9144439_2,-1,4426,-1,0.25035384
4427,IDDM,6,7,37,41,We conducted an association study of IDDM in a large number of Japanese subjects with multiple polymorphisms in INS region.,9144439_3,-1,4427,-1,0.24352466
4428,IDDM,10,11,58,62,We found a significant association of the INS region with IDDM.,9144439_4,-1,4428,-1,0.2555665
4429,IDDM,4,5,35,39,"Alleles positively associated with IDDM in INS region were the same as those positively-associated with IDDM in Caucasian population, although positively-associated alleles are very common (allele frequencies > 0.",9144439_5,-1,4429,-1,0.25539312
4430,IDDM,15,16,104,108,"Alleles positively associated with IDDM in INS region were the same as those positively-associated with IDDM in Caucasian population, although positively-associated alleles are very common (allele frequencies > 0.",9144439_5,-1,4430,-1,0.25348714
4431,IDDM,12,13,75,79,These data suggest that IDDM2 is involved in the genetic susceptibility to IDDM in Japanese.,9144439_7,-1,4431,-1,0.24538592
4432,IDDM,22,23,146,150,The high frequencies of disease-associated alleles in the general population suggest that IDDM2 locus is not responsible for the low incidence of IDDM in Japanese.,9144439_8,-1,4432,-1,0.2417032
4434,C9 deficiency,9,11,62,75,We studied a previously described Swiss family with inherited C9 deficiency.,9144525_4,-1,4434,-1,0.2697317
4435,C9 deficiency,6,8,33,46,"To identify the genetic basis of C9 deficiency, we developed an approach using exon-specific PCR and direct DNA sequencing.",9144525_5,-1,4435,-1,0.2790842
4436,C9 deficiency,4,6,14,27,"As a cause of C9 deficiency , we found two different point mutations, both generating TGA stop codons in the coding sequence.",9144525_6,-1,4436,-1,0.26392698
4437,C,4,5,16,17,"One mutation, a C to A exchange, was detected in exon 2 at cDNA position 166, the other, a C to T exchange, was located in exon 4 (cDNA position 464).",9144525_7,-1,4437,-1,0.3246359
4438,C,23,24,91,92,"One mutation, a C to A exchange, was detected in exon 2 at cDNA position 166, the other, a C to T exchange, was located in exon 4 (cDNA position 464).",9144525_7,-1,4438,-1,0.35631865
4439,C9 deficiency,9,11,68,81,"In family studies of three first-degree relatives with heterozygous C9 deficiency, we demonstrated that the two mutations are segregating independently.",9144525_8,-1,4439,-1,0.2665713
4454,disease,13,14,72,79,"CONCLUSIONS  Among women with breast cancer and a family history of the disease, the percentage with BRCA1 coding-region mutations is less than the 45 percent predicted by genetic-linkage analysis.",9145677_9,-1,4454,-1,0.17733267
4465,C9 deficiency,5,7,37,50,Difficulties in the ascertainment of C9 deficiency: lessons to be drawn from a compound heterozygote C9-deficient subject.,9182899_0,-1,4465,-1,0.26345903
4466,C9 deficiency,32,34,177,190,"The patient was shown to be heterozygous for DNA markers in the C6, C7 and C9 region of chromosome 5 and therefore appears to be a compound heterozygote for two uncharacterized C9 deficiency genes.",9182899_4,-1,4466,-1,0.26417136
4467,C9 deficiency,4,6,21,34,We also suggest that C9 deficiency may be more common among Caucasians than has been reported..,9182899_8,-1,4467,-1,0.25295383
4470,tumour,19,20,116,122,"
In the present study, leukocyte DNA from 143 patients with familial clustering of breast and/or ovarian cancer and tumour DNA from 96 breast carcinomas were screened for base mutations in the estrogen receptor gene (ESR).",9195227_1,-1,4470,-1,0.24677373
4471,estrogen,32,33,193,201,"
In the present study, leukocyte DNA from 143 patients with familial clustering of breast and/or ovarian cancer and tumour DNA from 96 breast carcinomas were screened for base mutations in the estrogen receptor gene (ESR).",9195227_1,-1,4471,-1,0.21166019
4475,glycine,8,9,47,54,"Hence, a possible clinical significance of the glycine into cysteine cannot be completely ruled out and should be further investigated.",9195227_5,-1,4475,-1,0.33972618
4476,cysteine,10,11,60,68,"Hence, a possible clinical significance of the glycine into cysteine cannot be completely ruled out and should be further investigated.",9195227_5,-1,4476,-1,0.2958665
4477,tumours,9,10,50,57,"Somatic mutations were not detected in any of the tumours studied, and the present data do not provide support for somatic ESR base mutations as an important mechanism for hormonal therapy resistance in estrogen receptor-positive breast carcinomas..",9195227_6,-1,4477,-1,0.15961386
4478,estrogen,34,35,203,211,"Somatic mutations were not detected in any of the tumours studied, and the present data do not provide support for somatic ESR base mutations as an important mechanism for hormonal therapy resistance in estrogen receptor-positive breast carcinomas..",9195227_6,-1,4478,-1,0.1933607
4479,chromosome aberrations,21,23,140,162,"Overexpression of ATM cDNA in A-T cells enhanced the survival of these cells in response to radiation exposure, decreased radiation-induced chromosome aberrations, reduced radio-resistant DNA synthesis, and partially corrected defective cell cycle checkpoints and induction of stress-activated protein kinase.",9223307_4,-1,4479,-1,0.17883635
4480,rhabdomyosarcoma,14,15,125,141,Fusion genes resulting from alternative chromosomal translocations are overexpressed by gene-specific mechanisms in alveolar rhabdomyosarcoma.,9223312_0,-1,4480,-1,0.16205011
4483,rhabdomyosarcoma,6,7,38,54,"In the pediatric solid tumor alveolar rhabdomyosarcoma, a consistent t (2; 13) (q35; q14) or variant t (1; 13) (p36; q14) translocation generates PAX3-FKHR or PAX7-FKHR fusion proteins, respectively.",9223312_2,-1,4483,-1,0.17031556
4484,t,10,11,69,70,"In the pediatric solid tumor alveolar rhabdomyosarcoma, a consistent t (2; 13) (q35; q14) or variant t (1; 13) (p36; q14) translocation generates PAX3-FKHR or PAX7-FKHR fusion proteins, respectively.",9223312_2,-1,4484,-1,0.28395802
4485,contrast,1,2,3,11,"In contrast, PAX7-FKHR overexpression results from fusion gene amplification.",9223312_6,-1,4485,-1,0.2681818
4486,rhabdomyosarcoma,13,14,96,112,"Thus, gene-specific mechanisms were selected to overexpress PAX3-FKHR and PAX7-FKHR in alveolar rhabdomyosarcoma, presumably due to differences in regulation between the wild-type loci.",9223312_7,-1,4486,-1,0.16371231
4488,diseases,9,10,60,68,"
Mutations in atm and p53 cause the human cancer-associated diseases ataxia-telangiectasia and Li-Fraumeni syndrome, respectively.",9241281_1,-1,4488,-1,0.17383589
4489,Li-Fraumeni syndrome,12,14,95,115,"
Mutations in atm and p53 cause the human cancer-associated diseases ataxia-telangiectasia and Li-Fraumeni syndrome, respectively.",9241281_1,-1,4489,-1,0.26283556
4490,lymphomas,14,15,68,77,"Atm-null mice, as well as those null for p53, develop mainly T-cell lymphomas, supporting the view that these genes have similar roles in thymocyte development.",9241281_3,-1,4490,-1,0.15172018
4491,tumour,12,13,70,76,"Mice doubly null for atm and p53 exhibited a dramatic acceleration of tumour formation relative to singly null mice, indicating that both genes collaborate in a significant manner to prevent tumorigenesis.",9241281_5,-1,4491,-1,0.18695757
4492,contrast,2,3,15,23,"Finally-and in contrast to prior predictions-atm and p53 do not appear to interact in acute radiation toxicity, suggesting a separate atm effector pathway for this DNA damage response and having implications for the prognosis and treatment of human tumours..",9241281_8,-1,4492,-1,0.2891405
4494,tumours,39,40,249,256,"Finally-and in contrast to prior predictions-atm and p53 do not appear to interact in acute radiation toxicity, suggesting a separate atm effector pathway for this DNA damage response and having implications for the prognosis and treatment of human tumours..",9241281_8,-1,4494,-1,0.16478339
4495,myotonic dystrophy,5,7,38,56,Trinucleotide repeat expansion at the myotonic dystrophy locus reduces expression of DMAHP.,9241282_0,-1,4495,-1,0.17275108
4496,Myotonic dystrophy,0,2,1,19,"
Myotonic dystrophy, or dystrophia myotonica (DM), is an autosomal dominant multisystem disorder caused by the expansion of a CTG trinucleotide repeat in the 3 untranslated region of the DMPK protein kinase gene on chromosome 19q13.",9241282_1,-1,4496,-1,0.18245313
4497,DM,7,8,46,48,"
Myotonic dystrophy, or dystrophia myotonica (DM), is an autosomal dominant multisystem disorder caused by the expansion of a CTG trinucleotide repeat in the 3 untranslated region of the DMPK protein kinase gene on chromosome 19q13.",9241282_1,-1,4497,-1,0.21251234
4498,DM,2,3,13,15,"Although the DM mutation was identified more than five years ago, the pathogenic mechanisms underlying this most prevalent form of hereditary adult neuromuscular disease remain elusive.",9241282_3,-1,4498,-1,0.2474968
4499,neuromuscular disease,23,25,148,169,"Although the DM mutation was identified more than five years ago, the pathogenic mechanisms underlying this most prevalent form of hereditary adult neuromuscular disease remain elusive.",9241282_3,-1,4499,-1,0.17481856
4500,DM,8,9,45,47,Analysis of DMAHP expression in the cells of DM patients with loss of the hypersensitive site revealed a two- to fourfold reduction in steady-state DMAHP transcript levels relative to wild-type controls.,9241282_6,-1,4500,-1,0.2346004
4501,DM,17,18,121,123,"Together, these results demonstrate that CTG-repeat expansions can suppress local gene expression and implicate DMAHP in DM pathogenesis.",9241282_8,-1,4501,-1,0.20179014
4502,retinoblastoma,10,11,73,87,Constitutively methylated CpG dinucleotides as mutation hot spots in the retinoblastoma gene (RB1).,9245987_0,-1,4502,-1,0.16415986
4503,RB1,13,14,94,97,Constitutively methylated CpG dinucleotides as mutation hot spots in the retinoblastoma gene (RB1).,9245987_0,-1,4503,-1,0.20961697
4504,retinoblastoma,19,20,107,121,"
A wide spectrum of mutations, ranging from point mutations to large deletions, have been described in the retinoblastoma gene (RB1).",9245987_1,-1,4504,-1,0.16102153
4505,RB1,22,23,128,131,"
A wide spectrum of mutations, ranging from point mutations to large deletions, have been described in the retinoblastoma gene (RB1).",9245987_1,-1,4505,-1,0.21499884
4506,RB1,9,10,55,58,"Such recurrent CpG mutations, including those found in RB1, are likely the result of the deamination of 5-methylcytosine within these CpGs.",9245987_4,-1,4506,-1,0.22440593
4507,cytosine,13,14,78,86,"In the present study, we used the sodiumbisulfite conversion method to detect cytosine methylation in representative exons of RB1.",9245987_5,-1,4507,-1,0.2521871
4508,RB1,19,20,126,129,"In the present study, we used the sodiumbisulfite conversion method to detect cytosine methylation in representative exons of RB1.",9245987_5,-1,4508,-1,0.24696928
4509,RB1,14,15,82,85,"We analyzed DNA from a variety of tissues and specifically targeted CGA codons in RB1, where recurrent premature termination mutations have been reported.",9245987_6,-1,4509,-1,0.2303132
4510,RB1,6,7,37,40,"We found that DNA methylation within RB1 exons 8, 14, 25, and 27 appeared to be restricted to CpGs, including six CGA codons.",9245987_7,-1,4510,-1,0.24937047
4511,RB1,7,8,48,51,"Therefore, disease-causing mutations at CpGs in RB1 appear to be determined by several factors, including the constitutive presence of DNA methylation at cytosines within CpGs, the specific codon within which the methylated cytosine is located, and the particular region of the gene within which that codon resides..",9245987_9,-1,4511,-1,0.20403293
4512,cytosine,35,36,224,232,"Therefore, disease-causing mutations at CpGs in RB1 appear to be determined by several factors, including the constitutive presence of DNA methylation at cytosines within CpGs, the specific codon within which the methylated cytosine is located, and the particular region of the gene within which that codon resides..",9245987_9,-1,4512,-1,0.25262722
4515,renal cell carcinoma,18,21,105,125,"
The von Hippel-Lindau tumor suppressor gene (VHL) has a critical role in the pathogenesis of clear-cell renal cell carcinoma (RCC), as VHL mutations have been found in both von Hippel-Lindau disease-associated and sporadic RCCs.",9271438_1,-1,4515,-1,0.1606915
4517,von Hippel-Lindau,31,33,205,222,These observations support a new mechanism for VHL-mediated transcriptional repression via a direct inhibitory action on Sp1 and suggest that loss of Sp1 inhibition may be important in the pathogenesis of von Hippel-Lindau disease and RCC..,9271438_11,-1,4517,-1,0.19950356
4518,disease,33,34,223,230,These observations support a new mechanism for VHL-mediated transcriptional repression via a direct inhibitory action on Sp1 and suggest that loss of Sp1 inhibition may be important in the pathogenesis of von Hippel-Lindau disease and RCC..,9271438_11,-1,4518,-1,0.18537433
4519,disease,7,8,48,55,Adult onset globoid cell leukodystrophy (Krabbe disease): analysis of galactosylceramidase cDNA from four Japanese patients.,9272171_0,-1,4519,-1,0.19488443
4520,disease,19,20,125,132,"
We examined galactosylceramidase (GALC) cDNA in four Japanese patients with adult onset globoid cell leukodystrophy (Krabbe disease; AO-GLD) by polymerase chain reaction/single-strand conformation polymorphism (PCR-SSCP) analysis, subsequent sequence determination, and restriction enzyme digestion of PCR products, initial symptoms were the onset of slowly progressive spastic paraplegia from the middle of the second decade, and all patients had diminished GALC activity in their leukocytes.",9272171_1,-1,4520,-1,0.20128866
4521,paraplegia,55,56,379,389,"
We examined galactosylceramidase (GALC) cDNA in four Japanese patients with adult onset globoid cell leukodystrophy (Krabbe disease; AO-GLD) by polymerase chain reaction/single-strand conformation polymorphism (PCR-SSCP) analysis, subsequent sequence determination, and restriction enzyme digestion of PCR products, initial symptoms were the onset of slowly progressive spastic paraplegia from the middle of the second decade, and all patients had diminished GALC activity in their leukocytes.",9272171_1,-1,4521,-1,0.2187174
3411,breast cancer,30,32,159,172,Our results indicate that there is a gene (s) other than BRCA1 which predisposes to early-onset breast cancer in women and which confers a higher risk of male breast cancer.,8075631_4,0,3411,-1,0.15416214
3872,breast cancer,8,10,40,53,"Mutant BRCA1 has no effect on growth of breast cancer cells; ovarian cancer cell growth is not affected by BRCA1 mutations in the 5 portion of the gene, but is inhibited by 3 BRCA1 mutations.",8589721_3,0,3872,-1,0.1554207
3984,cancer,38,39,248,254,We have developed a multiplex heteroduplex analysis that is designed to analyze one-quarter of the coding sequence in a single-step screening procedure and that will detect approximately 50% of all BRCA1 mutations so far reported in breast/ovarian cancer families.,8644703_4,0,3984,-1,0.1327792
1847,vasculitis,25,26,154,164,A family with inherited deficiency of complement factor 2 (C2) is described in which two family members with homozygous C2 deficiency developed cutaneous vasculitis and sicca syndrome.,1361318_2,0,1847,-1,0.19747657
3293,tumors,26,27,155,161,"The BRCA1 region is also subject to allelic loss in sporadic breast and ovarian cancers, an indication that BRCA1 mutations may occur somatically in these tumors.",7939630_2,0,3293,-1,0.12832688
739,cardiomyopathy,13,14,80,94,"There was no significant correlation between the size of the smaller allele and cardiomyopathy, diabetes mellitus, loss of proprioception, or bladder symptoms.",10533031_6,0,739,-1,0.2654532
3613,atrophy,30,31,184,191,"RESULTS  In all but one affected member, symptoms of progressive central visual loss developed in the third or fourth decade of life accompanied by central scotoma and well-demarcated atrophy of the retinal pigment epithelium and choriocapillaris of the macula.",8302543_5,0,3613,-1,0.18539937
259,ovarian cancer,16,18,118,132,"
Germ-line mutations in the BRCA1 tumor-suppressor gene are associated with an increased susceptibility to breast and ovarian cancer.",10220405_1,0,259,-1,0.118189625
1808,tumors,13,14,74,80,This is the first demonstration of LOH at the APC locus in adrenocortical tumors.,1351034_4,0,1808,-1,0.13968508
2379,malignancies,31,32,215,227,"
Von Hippel-Lindau disease (VHL) is an autosomal dominant disorder with inherited susceptibility to various forms of cancer, including hemangioblastomas of the central nervous system, phaeochromocytomas, pancreatic malignancies, and renal cell carcinomas.",2894613_1,0,2379,-1,0.15869617
162,anemia,20,21,125,131,"These selection pressures could be due to infectious diseases, environmental conditions,  or other genetic disorders such as anemia.",10090890_11,0,162,-1,0.21687081
3283,tumor,27,28,183,188,We conclude that genomic instability in ovarian tumors is a dynamic and ongoing process whose high frequency may have been previously underestimated by PCR-based allelotyping of bulk tumor tissue.,7937795_3,0,3283,-1,0.15597345
4167,breast cancer,11,13,66,79,"
BRCA1 and BRCA2 are the two major identified causes of inherited breast cancer, with mutations in either gene conferring up to 80-90% lifetime risk of breast cancer in carrier females.",8841191_1,0,4167,-1,0.13661511
3808,breast cancer,12,14,76,89,"In one family, penetrance was complete, with females developing early-onset breast cancer or ovarian cancer and the male carrier developing prostatic cancer, whereas, in the other family, penetrance was incomplete and only breast cancer occurred, diagnosed at ages 38-81 years.",8533757_6,0,3808,-1,0.17233141
3287,tumor,6,7,40,45,"The genetic instability observed in the tumor and cell line DNA, together with the germ-line mutation in a mismatch-repair gene, suggest that the MSH2 gene is involved in the onset and/or progression in a subset of ovarian cancer..",7937795_7,0,3287,-1,0.1746662
4367,breast cancer,20,22,112,125,"However, these mutations are uncommon in the population and they probably account for only a few percent of all breast cancer incidence.",9063749_2,0,4367,-1,0.157628
2314,tumors,12,13,54,60,"Mutations were identified in 13 of 21 RB tumors; in 8 tumors, the precise errors in nucleotide sequence were characterized.",2601691_3,0,2314,-1,0.15515657
3945,cancer,14,15,108,114,"
Inherited mutant alleles of familial tumour suppressor genes predispose individuals to particular types of cancer.",8640236_1,0,3945,-1,0.14930536
3809,ovarian cancer,15,17,93,107,"In one family, penetrance was complete, with females developing early-onset breast cancer or ovarian cancer and the male carrier developing prostatic cancer, whereas, in the other family, penetrance was incomplete and only breast cancer occurred, diagnosed at ages 38-81 years.",8533757_6,0,3809,-1,0.15084405
3254,breast cancer,21,23,142,155,"
We provide genetic evidence supporting the identity of the candidate gene for BRCA1 through the characterization of germline mutations in 63 breast cancer patients and 10 ovarian cancer patients in ten families with cancer linked to chromosome 17q21.",7894493_1,0,3254,-1,0.14215508
1695,thrombocytopenia,16,17,77,93,"
A 24 year old male with a history of eczema, recurrent mild infections, and thrombocytopenia consistent with the Wiskott-Aldrich syndrome (WAS) presented with a mediastinal mass, generalized lymphadenopathy, splenomegaly, and severe thrombocytopenia.",1316718_1,0,1695,-1,0.21065167
3013,cancer,8,9,56,62,"Detection of eight BRCA1 mutations in 10 breast/ovarian cancer families, including 1 family with male breast cancer.",7611277_0,0,3013,-1,0.13817218
742,diabetes,13,14,78,86,"The duration of disease is correlated with wheelchair use and the presence of diabetes, scoliosis, bladder symptoms and impaired proprioception, and vibration sense but no other complications studied..",10533031_8,0,742,-1,0.22958882
3802,breast cancer,16,18,100,113,Alterations in BRCA1 were identified in approximately 10 percent of this cohort of young women with breast cancer.,8531967_15,0,3802,-1,0.14232284
3155,cancers,28,29,158,165,Our data support a tumour suppressor mechanism for BRCA1; somatic mutations and LOH may result in inactivation of BRCA1 in at least a small number of ovarian cancers..,7795652_4,0,3155,-1,0.14313623
3157,ovarian cancer,9,11,61,75,"
We have characterized expression of the familial breast and ovarian cancer gene, BRCA1, in cases of non-hereditary (sporadic) breast cancer and analyzed the effect of antisense inhibition of BRCA1 on the proliferative rate of mammary epithelial cells.",7795653_1,0,3157,-1,0.12075808
47,cancer,5,6,36,42,This cohort underwent follow-up for cancer incidence through the Finnish Cancer Registry to the end of 1995.,10064668_5,0,47,-1,0.17642887
4294,cancer,3,4,11,17,The age of cancer onset was not always distinct from typical sporadic cases.,8968716_7,0,4294,-1,0.16831608
306,inflammation,28,29,155,167,"To date, its diagnosis, which can be made only retrospectively, is one of exclusion, based entirely on nonspecific clinical signs that result from serosal inflammation and that may lead to unnecessary surgery.",10364520_2,0,306,-1,0.22561307
3507,prostate cancer,11,13,94,109,"
Prostatic tissue specimens derived from transurethral resections of patients with metastatic prostate cancer were analyzed for genetic alterations in the hormone-binding domain of the androgen receptor (AR) gene.",8187068_1,0,3507,-1,0.1424993
3845,ovarian cancer,8,10,43,57,The murine homolog of the human breast and ovarian cancer susceptibility gene Brca1 maps to mouse chromosome 11D.,8566965_0,0,3845,-1,0.12079951
1036,prostate cancer,17,19,115,130,"In addition, evidence for locus heterogeneity has been provided by the identification of other putative hereditary prostate cancer loci on Xq27-28, 1q42-43, and 1p36.",10712209_2,0,1036,-1,0.14185648
1699,thrombocytopenia,38,39,234,250,"
A 24 year old male with a history of eczema, recurrent mild infections, and thrombocytopenia consistent with the Wiskott-Aldrich syndrome (WAS) presented with a mediastinal mass, generalized lymphadenopathy, splenomegaly, and severe thrombocytopenia.",1316718_1,0,1699,-1,0.20546181
1330,ovarian cancer,37,39,216,230,"To do this, a collaborative screening study was set up that involved 39 institutions from 19 countries and included 3, 580 unrelated individuals with a family history of the disease and 934 early-onset breast and/or ovarian cancer cases.",10827109_4,0,1330,-1,0.1414349
3886,ovarian cancer,15,17,108,122,"To investigate whether the presence of rare HRAS1 alleles increases susceptibility to hereditary breast and ovarian cancer, we have typed a panel of 307 female BRCA1 carriers at this locus using a PCR-based technique.",8589723_7,0,3886,-1,0.112625904
3764,thrombocytopenia,21,22,137,153,These findings therefore confirm the association of WAS with WASP mutation and identify WASP mutation as a cause for isolated congenital thrombocytopenia in males.,8528198_6,0,3764,-1,0.1814034
4516,tumors,20,21,139,145,Recent studies suggest that vascular endothelial growth factor (VEGF) mRNA is upregulated in RCC- and von Hippel-Lindau disease-associated tumors.,9271438_2,0,4516,-1,0.13580666
3813,ovarian cancer,24,26,137,151,Two novel nonsense mutations led to the loss of mutant BRCA1 transcript in families with 10 and 6 cases of early-onset breast cancer and ovarian cancer.,8533757_7,0,3813,-1,0.115308516
1432,epilepsy,27,28,154,162,"The sodium channel beta1 subunit gene (SCN1B) maps to this candidate region and has been shown to be involved in one Australian pedigree with generalized epilepsy and febrile seizures "" plus "" (GEFS +).",10923035_6,0,1432,-1,0.17577933
1277,cancers,7,8,51,58,OBJECTIVE  To determine whether hereditary ovarian cancers have distinct clinical and pathological features compared with sporadic (nonhereditary) ovarian cancers.,10807385_3,0,1277,-1,0.13652799
3927,Prostate cancer,0,2,1,16,"
Prostate cancer is the second leading cause of male cancer deaths in the United States. Yet, despite a large international effort, little is known about the molecular mechanisms that underlie this devastating disease.",8637912_1,0,3927,-1,0.16265117
1045,prostate cancer,14,16,90,105,"Although HPC1 accounts for only a small proportion of all families affected by hereditary prostate cancer, it appears to play a more prominent role in the subset of families with several members affected at an early age and with male-to-male disease transmission.",10712209_26,0,1045,-1,0.13351811
774,tumor,18,19,112,117,"
The hSNF5/INI1 gene which encodes a member of the SWI/SNF chromatin ATP-dependent remodeling complex, is a new tumor suppressor gene localized on chromosome 22q11.",10556283_1,0,774,-1,0.14152636
1274,ovarian cancer,6,8,55,69,Clinicopathologic features of BRCA-linked and sporadic ovarian cancer.,10807385_0,0,1274,-1,0.12366816
384,prostate cancer,12,14,70,85,CONCLUSIONS  The incidence of each of the germline mutations in these prostate cancer patients closely matched their incidence (about 1%) in the general Ashkenazi Jewish population.,10398279_7,0,384,-1,0.14902815
1270,cancer,28,29,193,199,"
Mutations in the gene ATM are responsible for the genetic disorder ataxia-telangiectasia (A-T), which is characterized by cerebellar dysfunction, radiosensitivity, chromosomal instability and cancer predisposition.",10802669_1,0,1270,-1,0.1627283
4456,tumors,15,16,91,97,"At the cytogenetic level this region is frequently deleted in a variety of different solid tumors, although not in pancreatic cancer.",9174057_3,0,4456,-1,0.13117445
2206,cataract,22,23,154,162,"Although this association may be coincidental, it prompts further attention to the possibility that under certain circumstances G6PD deficiency may favor cataract formation.",23402_4,0,2206,-1,0.21717614
4169,breast cancer,10,12,61,74,"Mutations in BRCA1 account for approximately 45% of familial breast cancer and 90% of inherited breast/ovarian cancer, whereas mutations in BRCA2 account for a comparable percentage of inherited breast cancer cases.",8841191_2,0,4169,-1,0.15030193
1291,cancers,6,7,57,64,"CONCLUSIONS  Although BRCA-associated hereditary ovarian cancers in this population have surgical and pathological characteristics similar to those of sporadic cancers, advanced-stage hereditary cancer patients survive longer than nonhereditary cancer patients.",10807385_15,0,1291,-1,0.13812678
786,tumors,5,6,36,42,"These results suggest that rhabdoid tumors, choroid plexus carcinomas and a subset of medulloblastomas and cPNETs share common pathways of oncogenesis related to hSNF5/INI1 alteration and that hSNF5/INI1 mutations define a genetically homogeneous family of highly aggressive cancers mainly occurring in young children and frequently, but not always, exhibiting a rhabdoid phenotype",10556283_10,0,786,-1,0.13574275
3887,ovarian cancer,3,5,13,27,"The risk for ovarian cancer was 2. 11 times greater for BRCA1 carriers harbouring one or two rare HRAS1 alleles, compared to carriers with only common alleles (P = 0. 015).",8589723_8,0,3887,-1,0.13522637
35,arthritis,22,23,139,148,"
The serum of a 29-year old woman with a recent episode of disseminated gonococcal infection and a history of meningococcal meningitis and arthritis as a child was found to lack serum hemolytic complement activity.",100562_1,0,35,-1,0.2334925
1720,carcinogenesis,17,18,96,110,These results suggest that the mutation of the APC gene also plays an important role during the carcinogenesis of at least some gastric cancers..,1317264_5,0,1720,-1,0.16556428
3971,tumors,32,33,205,211,The set of 32 families in which no BRCA1 alterations were detected included 1 breast-ovarian cancer kindred manifesting clear linkage to the BRCA1 region and loss of the wild-type chromosome in associated tumors.,8644702_7,0,3971,-1,0.134072
4513,tumor,3,4,22,27,The von Hippel-Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity.,9271438_0,0,4513,-1,0.17043711
3278,cancers,14,15,92,99,"
We have analyzed the stability of microsatellites in cell lines derived from human ovarian cancers and found that 5 out of 10 of the ovarian tumor cell lines are genetically unstable at the majority of the loci analyzed.",7937795_1,0,3278,-1,0.13338514
4371,ovarian cancer,18,20,105,119,Thus the most common polymorphisms of the BRCA1 gene do not make a significant contribution to breast or ovarian cancer risk.,9063749_9,0,4371,-1,0.12229766
526,ovarian cancer,29,31,162,176,The overall findings were that disease started to occur at age 30 years and that by age 50 years 48% of the mutation-carrying women had experienced breast and/or ovarian cancer.,10441573_7,0,526,-1,0.13870004
4295,breast cancer,27,29,164,177,"Testing of a sample of 413 unrelated individuals to examine the hypothesis that R841W might be a rare polymorphism detected one additional instance in a woman with breast cancer diagnosed at age 77 years, and cancer in one parent.",8968716_8,0,4295,-1,0.16260278
4083,breast cancer,4,6,36,49,Genetic heterogeneity in hereditary breast cancer: role of BRCA1 and BRCA2.,8751855_0,0,4083,-1,0.14100195
4305,breast cancer,2,4,9,22,Two male breast cancer patients (4% of the total) were found to carry novel truncating mutations in the BRCA2 gene.,9012404_5,0,4305,-1,0.14524853
2501,malignancy,8,9,74,84,Glucose 6-phosphate dehydrogenase deficiency and incidence of hematologic malignancy.,3348216_0,0,2501,-1,0.16456665
2959,atrophy,31,32,210,217,We show here that the disease gene segregating in each of three French ADCA type I kindreds and in a French family with neuropathological findings suggesting the ataxochoreic form of dentatorubropallidoluysian atrophy carries an expanded CAG repeat sequence located at the same locus as that for MJD.,7573040_3,0,2959,-1,0.18467823
2503,cancer,18,19,124,130,"
We have evaluated the hypothesis of a negative association between glucose 6-phosphate dehydrogenase (G6PD) deficiency and cancer in a cohort of 481 Sardinian males with hematological malignancies.",3348216_1,0,2503,-1,0.15440841
3765,thrombocytopenia,8,9,53,69,"While the WASP gene defects responsible for isolated thrombocytopenia and other mild presentations of WAS do not appear distinct from those resulting in severe WAS, these data indicate that analysis of WASP gene mutation provides a valuable tool for distinguishing the spectrum of WAS patients and the subset of males with isolated thrombocytopenia who represent mild cases of WAS..",8528198_7,0,3765,-1,0.19628242
187,cancer,21,22,130,136,"One of the target genes for beta-catenin/TCF encodes c-MYC, explaining why constitutive activation of the WNT pathway can lead to cancer, particularly in the colon.",10192393_3,0,187,-1,0.15847094
1155,glaucoma,50,51,252,260,"Foxc1 (+/-) and Foxc2 (+/-) mice are useful models for studying anterior segment development and its anomalies, and may allow identification of genes that interact with Foxc1 and Foxc2 (or FKHL7 and FKHL14) to produce a phenotype with elevated IOP and glaucoma..",10767326_12,0,1155,-1,0.19074087
3853,ovarian cancer,14,16,91,105,"
Several BRCA1 mutations have now been found to occur in geographically diverse breast and ovarian cancer families.",8571953_1,0,3853,-1,0.120941125
767,tumor,18,19,115,120,"
von Hippel-Lindau (VHL) disease is an autosomal dominantly inherited cancer syndrome predisposing to a variety of tumor types that include retinal hemangioblastomas, hemangioblastomas of the central nervous system, renal cell carcinomas, pancreatic cysts and tumors, pheochromocytomas, endolymphatic sac tumors, and epididymal cystadenomas [W. M. Linehan et al., J. Am.",10554035_1,0,767,-1,0.1550349
126,dystonia,23,24,135,143,"
The authors report a mutation in exon 5 of GCH1 in a patient with adult-onset oromandibular dystonia and no obvious family history of dystonia.",10078749_1,0,126,-1,0.18786196
153,death,7,8,54,59,Mutations causing disruption of the intracellular Fas death domain also showed a higher penetrance of ALPS phenotype features in mutation-bearing relatives.,10090885_10,0,153,-1,0.23549111
3605,thrombocytopenia,9,10,52,68,"
A Saudi Arab boy presented in early childhood with thrombocytopenia, morphologically large and normal sized platelets, increased mean platelet volume, and a hypermegakaryocytic bone marrow.",8301658_1,0,3605,-1,0.20491707
2167,meningitis,13,14,70,80,"The index patient, a 56-year-old white man with a history of purulent meningitis at the age of 23 years, presented with an acute meningococcal meningitis.",2241452_3,0,2167,-1,0.18469232
4171,breast cancer,31,33,195,208,"Mutations in BRCA1 account for approximately 45% of familial breast cancer and 90% of inherited breast/ovarian cancer, whereas mutations in BRCA2 account for a comparable percentage of inherited breast cancer cases.",8841191_2,0,4171,-1,0.14622976
2772,psoriasis,13,14,101,110,"The phenotypic expressions of the different genetic predispositions involved, include sacro-iliitis, psoriasis, acute anterior uveitis, peripheral arthropathy and inflammatory bowel disease.",6604602_8,0,2772,-1,0.19525036
2166,meningitis,44,45,244,254,"
We describe the first cases, to our knowledge, of C9 deficiency in Europe that were detected in a Swiss family, of which two members--one with a complete deficiency and the other with approximately half-normal C9 levels--experienced bacterial meningitis.",2241452_2,0,2166,-1,0.18676886
3742,bleeding,15,16,104,112,"The family we describe demonstrates the recessive inheritance of a recently recognized class of genetic bleeding disorders, we call "" autosomal hemophilia. "" We conclude that vWF mutation may be an under recognized cause of hemophilia, especially in cases where the inheritance pattern is not consistent with X-linked transmission.",8500791_10,0,3742,-1,0.19527446
2474,fever,22,23,135,140,"Thus, this child is a unique individual with inherited C3 deficiency presenting with absence of repeated infections, whose symptoms of fever, skin rash, and arthralgia were abated by whole blood transfusion..",318684_9,0,2474,-1,0.21378124
2883,cardiomyopathy,26,27,165,179,"Defects in enzymes of the beta-oxidation pathway cause sudden, unexplained death in childhood, acute hepatic encephalopathy or liver failure, skeletal myopathy, and cardiomyopathy.",7479827_2,0,2883,-1,0.19200452
3972,tumor,1,2,6,11,"Other tumor types found in BRCA1 mutation/haplotype carriers included prostatic, pancreas, skin, and lung cancer, a malignant melanoma, an oligodendroglioma, and a carcinosarcoma.",8644702_8,0,3972,-1,0.15788206
519,cancer,11,12,89,95,"
For genetic counseling and predictive testing in families with inherited breast-ovarian cancer, penetrances and expressions of the underlying mutations should be known.",10441573_1,0,519,-1,0.14400588
4288,ovarian cancer,11,13,67,81,These common mutations have an etiological role in many breast and ovarian cancer cases and provide the opportunity to examine genotype-phenotype correlations and genotype-environment interactions in individuals with the identical BRCA1 lesion.,8968716_3,0,4288,-1,0.1181738
1033,prostate cancer,4,6,32,47,"Combined analysis of hereditary prostate cancer linkage to 1q24-25: results from 772 hereditary prostate cancer families from the International Consortium for Prostate Cancer Genetics.
A previous linkage study provided evidence for a prostate cancer-susceptibility locus at 1q24-25.",10712209_0,0,1033,-1,0.145957
4303,ovarian cancer,15,17,65,79,Nine (17%) of the patients had a family history of breast and/or ovarian cancer in at least one first-degree relative.,9012404_2,0,4303,-1,0.13638967
1440,tumors,17,18,90,96,"Functional analysis showed that 4666insA, a common somatic mutation in APC (AS9) in these tumors, did not inactivate the wild-type APC.",10924409_8,0,1440,-1,0.15596074
1719,tumors,22,23,121,127,"By screening nearly one-half of the coding region of the APC gene in 44 tumors, somatic mutations were detected in three tumors  a missense mutation, a nonsense mutation, and a 5-base pair deletion resulting in a frame shift which causes truncation of the gene product.",1317264_4,0,1719,-1,0.19058059
3083,cancer,21,22,117,123,"In contrast, there was no overall evidence of linkage in the group of 10 families with breast cancer without ovarian cancer.",7759076_3,0,3083,-1,0.14767613
